data_1s6l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1s6l _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.828 0.347 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.71 -21.99 50.4 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.519 2.146 . . . . 0.0 112.292 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 2.6 mt -52.0 -57.3 9.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.244 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.55 -27.09 62.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -61.0 -53.27 59.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.653 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.9 -25.07 62.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.298 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -67.0 -47.65 70.82 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.824 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.39 -25.85 17.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -67.74 -22.26 65.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.212 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.6 47.99 88.44 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.039 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.14 153.1 81.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.768 0.318 . . . . 0.0 110.928 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.01 109.08 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.596 2.197 . . . . 0.0 111.987 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 p -115.56 110.17 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.334 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 57.5 p -85.14 177.6 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.677 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.09 -37.17 72.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.192 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -26.46 67.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.814 0.34 . . . . 0.0 110.136 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -85.4 -42.65 14.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.11 -36.38 83.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.2 -43.0 62.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.492 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.01 -30.61 74.18 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.734 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 41' ' ' THR . 6.7 mt -79.16 -41.58 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.055 0.455 . . . . 0.0 110.297 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.5 mp -77.17 -9.66 58.91 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.336 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 t70 59.88 21.95 10.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -109.95 158.31 35.36 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.162 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.68 142.75 71.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.533 2.155 . . . . 0.0 112.02 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.64 -16.82 1.04 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -78.95 -34.34 44.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.062 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -41.58 84.39 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.36 -46.99 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.482 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.91 -51.35 61.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.383 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.96 -37.65 20.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.719 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 t -63.6 -53.01 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.793 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.52 -16.92 61.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.968 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -58.12 -19.58 33.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.049 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.85 12.57 12.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.825 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -123.06 76.5 1.38 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.771 0.796 . . . . 0.0 110.48 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 p -87.43 -26.95 23.02 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.762 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.25 -21.29 63.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.76 141.2 53.6 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.431 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.68 126.96 33.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 111.642 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -100.36 173.14 6.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.163 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -153.11 143.3 22.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 111.504 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 tptp 66.06 -104.06 0.09 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.82 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -92.73 -13.05 29.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.715 0.293 . . . . 0.0 111.782 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.64 31.98 0.63 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.14 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -87.14 170.56 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.82 0.343 . . . . 0.0 110.166 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.7 mp -79.7 109.43 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.159 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.505 HG21 HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.107 0.479 . . . . 0.0 111.002 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.864 0.364 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -129.43 159.62 35.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.6 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.8 mt -77.91 51.13 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.266 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 4.7 ttt-85 44.47 85.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.635 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.07 23.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.469 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.1 p -119.17 -171.07 2.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.114 0.483 . . . . 0.0 111.599 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 p -104.08 -29.14 11.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.301 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 95' ' ' TRP . 10.8 m-85 -79.27 111.83 15.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.628 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.57 140.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.059 0.457 . . . . 0.0 111.098 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.465 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 43.8 t80 -129.95 106.38 8.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.588 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -100.17 130.54 46.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.921 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.503 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -140.03 124.62 19.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.16 -70.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.283 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -166.94 34.39 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.251 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -137.71 111.94 8.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.906 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.42 121.56 24.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.837 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 85' ' ' PHE . 3.8 mm? -114.43 164.8 13.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.969 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.408 ' CZ ' ' HG3' ' A' ' 79' ' ' ARG . 24.8 m-85 -130.78 165.09 23.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.112 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.41 ' HB1' ' N ' ' A' ' 100' ' ' THR . . . -151.79 170.17 20.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.106 0.479 . . . . 0.0 111.848 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.405 ' O ' ' CE1' ' A' ' 83' ' ' TYR . 5.3 m95 -98.81 -18.67 17.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.684 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 28.1 m -147.61 162.55 38.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.924 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.463 ' CB ' ' CE1' ' A' ' 164' ' ' PHE . . . -52.03 -22.62 4.2 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 tp -85.79 -51.53 6.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.656 0.265 . . . . 0.0 111.305 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -45.16 -28.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.416 ' CG2' ' HB2' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -60.41 -39.1 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 110.549 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.3 pt? -121.87 174.9 6.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.059 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.2 mt -151.31 -46.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.044 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -156.92 79.02 3.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.742 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.407 ' HA ' HG12 ' A' ' 107' ' ' ILE . 20.3 Cg_endo -60.78 -40.13 56.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.703 2.269 . . . . 0.0 112.41 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.24 -25.94 67.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.547 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.3 tp -79.9 -26.47 40.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 104' ' ' PRO . 4.5 mm -64.5 -58.88 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.117 0.961 . . . . 0.0 111.013 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.54 22.14 13.22 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.637 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.07 -177.03 5.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.925 0.393 . . . . 0.0 110.344 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.54 154.11 20.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.227 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.465 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . . . -136.85 110.06 7.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.639 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -80.38 119.91 23.71 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.767 0.794 . . . . 0.0 111.277 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.434 HG22 ' CD1' ' A' ' 85' ' ' PHE . 47.2 t -112.05 129.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.947 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 m -122.87 137.56 54.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.114 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.411 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 0.6 OUTLIER -141.4 172.82 12.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.317 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -134.54 133.88 40.79 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . 0.407 ' O ' ' HA2' ' A' ' 121' ' ' GLY . 30.5 t -62.29 130.38 45.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.047 0.451 . . . . 0.0 112.037 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.95 -3.59 23.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.974 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.435 ' HB3' ' CG ' ' A' ' 174' ' ' TRP . . . -121.54 -49.85 2.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 111.545 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.476 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -91.77 -24.62 19.36 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.281 -179.522 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 117' ' ' CYS . . . 76.28 5.55 81.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.195 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -57.93 148.92 57.51 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-O 120.528 0.204 . . . . 0.0 110.636 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.31 104.1 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.686 2.258 . . . . 0.0 110.806 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.426 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 30.5 m -100.16 144.91 11.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.4 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.0 p -151.64 141.49 21.97 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.415 0.626 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -138.55 151.92 47.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.83 178.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 53.8 m -106.52 113.49 27.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.871 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.433 HG12 ' CE2' ' A' ' 193' ' ' PHE . 47.9 t -96.31 111.79 27.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.902 0.382 . . . . 0.0 111.474 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.25 168.53 8.05 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.08 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.75 -14.55 45.2 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.49 2.126 . . . . 0.0 113.015 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -118.84 -26.91 5.93 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 179.6 -163.29 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.16 0.505 . . . . 0.0 110.017 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -96.61 160.47 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.879 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -148.21 20.75 1.09 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.468 0.651 . . . . 0.0 112.194 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.94 86.69 0.08 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.408 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.2 t -103.54 115.4 45.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.193 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -146.27 122.28 5.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.74 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.87 157.0 99.14 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 123.523 -1.449 . . . . 0.0 112.283 0.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.42 79.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 0.0 110.553 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.58 16.61 0.15 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.407 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.428 ' HG3' ' CG1' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -60.13 156.49 15.01 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.065 0.459 . . . . 0.0 111.313 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -125.43 151.87 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.734 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.475 ' CG1' ' CE1' ' A' ' 164' ' ' PHE . 18.4 t -113.0 152.22 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.793 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.524 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 1.6 p -120.72 140.98 50.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.938 0.399 . . . . 0.0 110.945 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.7 tp -135.84 175.13 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.871 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.083 179.81 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.4 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.84 0.353 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -117.1 169.05 9.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.602 0.715 . . . . 0.0 109.801 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.475 ' CE1' ' CG1' ' A' ' 143' ' ' VAL . 2.5 m-85 -119.38 152.9 36.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.127 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.524 ' CE2' ' HB3' ' A' ' 144' ' ' SER . 49.1 m-85 -129.35 133.67 47.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.845 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -41.48 -27.51 0.09 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.491 ' O ' ' HB1' ' A' ' 171' ' ' ALA . 10.8 p -168.84 174.36 6.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.015 0.436 . . . . 0.0 111.511 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.6 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 85.6 t -68.6 -33.53 4.6 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.673 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.683 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.6 Cg_exo -72.51 -38.17 3.61 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.718 2.279 . . . . 0.0 110.371 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.553 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.54 -39.47 52.75 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.495 ' HA ' ' CG ' ' A' ' 165' ' ' PHE . . . -62.44 -46.02 90.42 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.584 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.7 mt-10 -78.78 -28.12 44.61 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.323 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 169' ' ' PRO . 12.3 t70 -71.33 -55.81 7.26 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.384 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.435 ' CG ' ' HB3' ' A' ' 119' ' ' ALA . 58.3 t-105 -64.04 -28.48 69.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.739 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -62.99 -42.22 99.79 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.166 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 71.1 m -51.37 -41.74 60.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.399 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 21.04 9.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.421 0.629 . . . . 0.0 111.298 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.42 ' CD2' HD21 ' A' ' 184' ' ' LEU . 2.8 t60 -128.4 28.74 5.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.864 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.709 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.42 HD21 ' CD2' ' A' ' 178' ' ' HIS . 6.0 tp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.817 0.341 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.29 150.08 42.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.037 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.454 HG21 ' CB ' ' A' ' 171' ' ' ALA . 10.6 mm -100.14 159.04 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.035 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.02 162.56 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.289 0.566 . . . . 0.0 112.076 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.415 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -88.53 129.52 35.45 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.669 178.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.428 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 2.2 m -46.44 -20.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.832 0.349 . . . . 0.0 110.717 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.415 ' N ' ' C ' ' A' ' 188' ' ' SER . 1.8 t-160 -73.82 -42.07 61.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.784 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -82.25 -21.2 36.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.25 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.4 -24.93 63.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.813 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.433 ' CE2' HG12 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -81.11 -24.91 37.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.72 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.81 -31.26 29.91 Favored Glycine 0 CA--C 1.509 -0.317 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.7 tp -82.13 -29.25 31.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -83.12 -27.43 40.59 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -82.28 -21.93 35.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.938 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -81.03 -26.21 36.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -52.68 -30.52 32.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.115 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.67 -54.46 27.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.016 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.7 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.857 0.361 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.2 -16.97 45.08 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.695 2.263 . . . . 0.0 112.456 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -54.25 -57.44 11.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.949 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 31' ' ' LEU . 9.2 tp -63.7 -27.05 68.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.982 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -68.43 -53.33 24.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.719 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.61 -29.72 63.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.318 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 28' ' ' LEU . 9.2 tt -67.25 -45.71 75.9 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.56 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.08 -23.06 18.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -22.75 62.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.005 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.3 39.72 98.09 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.26 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -133.38 166.09 31.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.595 0.236 . . . . 0.0 110.673 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.64 112.65 2.92 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.517 2.145 . . . . 0.0 112.201 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.4 t -112.22 109.92 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.331 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -90.46 -168.4 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.835 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 43' ' ' ALA . 27.9 ptt180 -78.07 -38.44 44.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.513 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -25.31 68.06 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.45 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -86.1 -43.56 12.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 tp -63.01 -35.46 80.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -74.24 -42.94 58.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.496 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.13 -30.96 74.11 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.579 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.3 mt -78.7 -44.44 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 120.995 0.426 . . . . 0.0 110.584 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.81 -9.8 58.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.421 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.6 t70 58.21 22.88 9.65 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -97.81 139.62 21.43 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.461 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.07 137.37 79.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.445 2.097 . . . . 0.0 111.797 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.85 -22.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -78.33 -36.12 46.73 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 110.951 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -67.07 -40.41 87.02 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -63.01 -47.98 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.487 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.04 -53.69 46.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.117 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.39 -48.28 77.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.836 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.31 -31.95 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.664 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.14 -31.4 71.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.581 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -58.17 -21.83 48.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -96.13 -19.57 19.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.002 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.75 32.07 3.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.466 0.651 . . . . 0.0 110.88 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.2 p -69.43 -13.04 62.14 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.173 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.7 p -90.91 -23.11 20.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 111.266 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.49 141.23 43.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.77 126.96 31.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.397 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.404 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 66.8 m-85 -102.14 173.25 6.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.505 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -152.77 147.09 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.948 0.404 . . . . 0.0 111.441 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.41 -104.01 0.09 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.745 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.65 -11.1 46.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.726 0.298 . . . . 0.0 111.726 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.04 27.69 1.82 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.076 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -86.64 168.47 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.64 120.41 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.379 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.3 tt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 179.803 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.854 0.359 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -100.32 152.6 20.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.88 -45.95 76.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -103.47 147.72 26.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.946 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 3.1 tt0 -59.43 132.21 53.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.2 p -110.09 -173.6 2.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.6 p -93.62 -35.74 12.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.928 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -79.15 109.72 13.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.385 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.55 137.51 34.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.139 0.495 . . . . 0.0 111.377 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 111' ' ' ALA . 21.7 t80 -132.58 105.77 7.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.103 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -102.52 135.26 44.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.387 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.463 ' CG2' ' CE1' ' A' ' 85' ' ' PHE . 2.8 pt -140.14 126.54 22.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t0 61.89 -72.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -158.05 37.7 0.25 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -140.34 148.74 41.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.611 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.88 86.19 2.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.094 0.473 . . . . 0.0 110.571 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.6 164.69 25.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.091 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.406 ' CZ ' ' HG3' ' A' ' 80' ' ' GLU . 9.7 m-85 -134.31 165.16 25.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.113 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.16 167.24 28.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.152 0.501 . . . . 0.0 111.849 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -101.09 -10.54 20.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.751 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.406 ' HB3' ' CG1' ' A' ' 162' ' ' VAL . 11.9 m -153.31 160.0 42.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.854 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.442 ' CB ' ' CE2' ' A' ' 164' ' ' PHE . . . -51.81 -22.46 3.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.93 -51.34 6.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.674 0.273 . . . . 0.0 111.172 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -44.38 -27.66 0.46 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.442 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -60.28 -39.2 86.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.892 0.377 . . . . 0.0 110.544 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 mt -93.45 -176.1 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.032 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 tp -174.67 -40.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -172.02 65.48 0.39 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.797 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.51 ' O ' HG23 ' A' ' 107' ' ' ILE . 33.6 Cg_exo -59.85 -42.04 48.94 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.73 2.287 . . . . 0.0 112.351 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 130' ' ' PRO . . . -79.07 -23.91 43.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.332 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -85.11 -38.33 19.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.481 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -57.19 -45.82 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 111.394 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.61 23.37 16.19 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.568 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.41 173.61 13.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.036 0.446 . . . . 0.0 110.954 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m -81.61 156.51 25.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.901 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.469 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . . . -136.76 109.96 7.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.847 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -81.28 120.07 24.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.717 0.77 . . . . 0.0 111.232 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.3 t -111.07 127.29 68.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.626 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.3 m -122.36 137.6 54.8 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.317 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.426 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 1.0 OUTLIER -141.5 172.85 12.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.265 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -134.32 133.23 40.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 22.6 t -62.77 131.84 50.23 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.248 0.547 . . . . 0.0 112.222 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.17 -3.59 20.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.988 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.473 ' CB ' ' HB2' ' A' ' 174' ' ' TRP . . . -123.27 -51.07 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.631 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.524 HG21 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -87.68 -24.57 23.85 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.208 -179.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.44 5.45 72.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.114 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 120' ' ' THR . . . -59.94 152.27 60.78 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-O 120.591 0.234 . . . . 0.0 110.515 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -84.71 105.03 0.97 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.683 2.255 . . . . 0.0 110.947 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.435 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 35.3 m -99.36 144.46 11.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.364 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 82.4 p -151.64 141.68 22.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.424 0.631 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -138.64 152.09 47.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.724 178.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 20.1 m -106.73 115.23 29.83 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.4 t -96.18 111.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.843 0.354 . . . . 0.0 111.211 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.97 175.79 1.9 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.32 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 105' ' ' ALA . 12.1 Cg_exo -70.77 -15.5 33.33 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.629 2.219 . . . . 0.0 112.978 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 18.0 t -118.96 -25.7 6.19 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 131' ' ' SER . 10.7 pt-20 178.56 -162.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.158 0.504 . . . . 0.0 110.036 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -93.44 156.49 3.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.94 178.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.72 18.59 2.0 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.469 0.652 . . . . 0.0 112.279 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.57 86.45 0.09 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.421 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.29 115.82 44.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.063 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -146.3 122.25 5.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.748 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.11 160.17 94.37 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.495 -1.461 . . . . 0.0 112.362 -0.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.64 78.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.673 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.0 16.92 0.16 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.33 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.472 ' HG3' ' CG1' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -58.67 155.03 13.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 111.619 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.88 151.9 44.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.977 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.465 ' CG2' ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -112.93 149.32 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.666 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.415 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 9.8 m -120.54 141.39 50.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.544 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.411 ' CD2' ' CG2' ' A' ' 187' ' ' VAL . 0.7 OUTLIER -146.79 176.64 9.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.031 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.811 179.64 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 96' ' ' CYS . 3.2 p . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.048 0.451 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.4 169.33 14.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.454 0.645 . . . . 0.0 110.379 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.465 ' CE1' ' CG2' ' A' ' 143' ' ' VAL . 14.0 m-85 -107.54 129.66 54.95 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.425 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.459 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 43.7 m-85 -108.78 139.73 43.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.347 0.594 . . . . 0.0 110.589 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -47.65 -26.64 1.58 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.797 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.541 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 49.0 m -164.43 168.99 17.87 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.836 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 82.1 t -68.47 -34.13 5.35 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.019 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.1 Cg_exo -72.5 -37.22 4.37 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.629 2.22 . . . . 0.0 110.27 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.44 -40.39 50.75 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.81 -46.43 89.54 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.68 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 3.0 mm-40 -78.98 -27.87 43.47 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.462 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.5 t70 -69.7 -55.85 8.84 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.165 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.473 ' HB2' ' CB ' ' A' ' 119' ' ' ALA . 71.5 t-105 -65.73 -28.3 68.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.795 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.68 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -63.96 -39.95 95.31 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.054 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.96 -43.66 63.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.249 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.51 22.43 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.289 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -145.79 29.89 1.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.911 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.167 179.799 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.895 0.379 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.57 149.09 40.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.815 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.447 HG23 ' HB3' ' A' ' 171' ' ' ALA . 16.3 mm -102.13 160.48 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.08 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.411 ' CG2' ' CD2' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -161.05 164.17 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.257 0.551 . . . . 0.0 112.067 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.413 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -89.61 127.99 35.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.744 178.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.472 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 2.0 m -46.63 -20.5 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.824 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.413 ' N ' ' C ' ' A' ' 188' ' ' SER . 2.4 m-70 -72.76 -42.88 63.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.211 0.529 . . . . 0.0 109.746 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.28 -21.92 35.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.153 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.11 61.88 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.832 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -81.06 -24.95 37.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.688 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.89 -29.91 33.42 Favored Glycine 0 CA--C 1.51 -0.277 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -28.49 32.32 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.81 -27.97 33.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.22 -22.02 36.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.99 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.06 -23.1 55.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.213 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -51.92 -37.17 51.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -81.08 -28.31 35.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.832 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.832 0.349 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.48 -24.77 22.03 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.518 2.145 . . . . 0.0 112.502 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.5 mt -54.89 -57.55 11.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.374 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.22 -27.36 38.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -53.23 15.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.966 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.92 -26.12 66.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.49 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 mt -73.68 -30.3 62.81 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.746 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.34 -28.77 30.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.199 0.524 . . . . 0.0 110.909 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -64.23 -19.46 65.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.208 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.0 48.49 83.05 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.038 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -129.78 164.92 36.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.658 0.266 . . . . 0.0 110.71 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.52 111.41 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.482 2.121 . . . . 0.0 112.2 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 t -120.32 109.98 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.358 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 p -91.51 -172.72 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.699 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -74.61 -37.85 62.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.192 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -28.25 68.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.973 0.416 . . . . 0.0 110.246 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.5 -42.36 15.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -62.53 -36.74 83.54 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB2' HG23 ' A' ' 53' ' ' VAL . . . -72.62 -42.95 63.91 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.589 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -31.98 77.09 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.613 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.0 mt -78.66 -43.36 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 120.936 0.398 . . . . 0.0 110.478 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 7.5 mp -78.52 -7.41 57.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.485 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 54.91 23.64 5.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.416 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 18.0 m0 -101.02 152.03 37.77 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.285 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -65.18 137.05 50.33 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.433 2.089 . . . . 0.0 111.92 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.22 -21.29 0.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.15 -36.69 47.4 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.959 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.416 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -66.71 -40.52 88.46 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.84 -47.97 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.423 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.7 -53.7 43.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.239 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.82 73.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.849 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.7 t -64.36 -34.63 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.744 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.88 -32.63 73.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.607 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -57.9 -22.49 48.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -94.26 -19.85 20.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.997 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.77 32.22 2.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.435 0.636 . . . . 0.0 111.041 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.8 p -62.16 -19.13 62.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.888 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 m -90.09 -21.99 22.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.37 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.61 141.23 55.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.384 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -78.86 131.06 36.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 111.634 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.433 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.7 m-85 -105.26 173.18 6.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.278 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.54 146.68 26.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 111.43 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.5 -103.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.77 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -89.88 -11.02 43.11 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.63 29.37 1.43 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.975 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -87.55 172.14 9.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.835 0.35 . . . . 0.0 110.143 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.9 mp -79.58 118.42 27.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.272 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.488 HD13 HG23 ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.004 0.431 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--O 1.23 0.03 0 CA-C-O 120.747 0.308 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.6 p -104.25 159.08 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.811 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.7 mt -91.73 49.21 1.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -178.29 137.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.08 121.32 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.7 p -109.24 -174.89 2.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.083 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -93.0 -34.35 13.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.974 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.415 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 7.7 m-85 -83.76 112.41 20.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.316 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.456 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.5 t -107.84 144.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.985 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.485 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 38.4 t80 -133.93 105.36 6.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.144 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -97.47 131.9 43.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.052 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.05 124.29 18.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 -71.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.537 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -161.22 35.44 0.14 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.601 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -137.62 142.28 41.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.295 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.94 86.28 2.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 110.74 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.62 164.7 25.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.781 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -134.91 164.18 28.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.161 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.413 ' HB3' ' N ' ' A' ' 100' ' ' THR . . . -151.02 167.03 28.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.014 0.435 . . . . 0.0 111.881 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -95.09 -18.92 20.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.62 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.443 ' HB3' ' CG1' ' A' ' 162' ' ' VAL . 1.7 m -150.11 166.61 29.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.154 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.469 ' CB ' ' CD1' ' A' ' 164' ' ' PHE . . . -53.76 -21.81 8.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.8 mp -84.67 -51.59 6.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.561 0.22 . . . . 0.0 111.536 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.403 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -47.96 -28.16 2.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.447 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -60.69 -39.32 88.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 110.58 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mt -86.35 168.5 13.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.225 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.402 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 6.8 pt -160.66 -43.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.031 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' A' ' 106' ' ' LEU . 1.0 OUTLIER 178.16 78.34 0.14 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.473 ' O ' HG22 ' A' ' 107' ' ' ILE . 52.2 Cg_endo -69.12 -38.8 8.65 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.623 2.216 . . . . 0.0 112.474 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.77 -23.94 45.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.242 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.411 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -83.94 -40.9 17.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.259 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.2 tp -57.37 -46.48 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.239 0.542 . . . . 0.0 111.473 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.9 24.75 12.49 Favored Glycine 0 C--N 1.319 -0.392 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.565 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.43 173.79 14.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 0.0 110.965 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -81.39 155.67 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.845 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.485 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.1 110.0 7.64 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.3 mtm180 -81.23 119.87 24.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.816 0.817 . . . . 0.0 111.242 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.45 ' CG2' ' CE1' ' A' ' 85' ' ' PHE . 48.9 t -111.88 129.89 66.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.162 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.456 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 75.9 p -123.98 137.74 54.56 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.249 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.428 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.53 172.89 12.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.343 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -134.41 133.3 40.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.23 134.65 55.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.251 0.548 . . . . 0.0 112.337 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.68 -3.55 22.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.284 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.458 ' CB ' ' HB2' ' A' ' 174' ' ' TRP . . . -123.26 -51.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.958 0.409 . . . . 0.0 111.476 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.408 ' CG2' HG23 ' A' ' 170' ' ' THR . 1.4 p -84.99 -29.44 25.03 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.002 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.02 4.97 79.27 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.219 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . . . -59.11 150.77 60.48 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 1.1 Cg_endo -82.54 104.11 1.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.561 2.174 . . . . 0.0 111.093 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.428 ' CG2' ' CB ' ' A' ' 115' ' ' SER . 35.9 m -97.71 144.28 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.985 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.0 p -150.6 142.35 23.72 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.439 0.637 . . . . 0.0 110.856 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -139.61 151.64 46.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.815 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 52.4 m -107.88 113.91 27.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.419 ' CG2' HG21 ' A' ' 113' ' ' VAL . 46.2 t -96.0 111.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.087 0.47 . . . . 0.0 111.403 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.487 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -106.79 177.83 1.24 Allowed Pre-proline 0 N--CA 1.453 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.638 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 56.6 Cg_endo -72.55 -20.1 23.91 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 121.961 1.774 . . . . 0.0 112.87 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 26.8 t -109.96 -28.06 8.92 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 131' ' ' SER . 11.8 pt-20 177.63 -162.73 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.11 0.481 . . . . 0.0 110.08 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -95.72 143.96 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.8 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -129.41 21.82 5.61 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.399 0.619 . . . . 0.0 112.295 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.66 87.65 0.1 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.225 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.6 t -104.55 115.59 46.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.332 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -146.37 124.24 6.16 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.652 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.79 157.08 95.24 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.207 0.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.85 79.04 0.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.123 0.487 . . . . 0.0 110.611 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 143.15 19.22 0.23 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.184 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.476 ' HG3' HG23 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -57.73 156.78 8.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.939 0.4 . . . . 0.0 111.577 -179.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -129.5 152.21 49.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.123 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.46 ' CG2' ' CZ ' ' A' ' 164' ' ' PHE . 21.1 t -115.35 151.03 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.412 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 51.6 p -116.81 141.43 48.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.712 0.292 . . . . 0.0 110.405 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.6 mp -138.16 176.09 9.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.018 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.965 179.737 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 96' ' ' CYS . 8.9 p . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 121.063 0.459 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -125.65 169.26 12.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.48 0.657 . . . . 0.0 109.973 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.469 ' CD1' ' CB ' ' A' ' 97' ' ' ALA . 2.7 m-85 -113.01 129.72 56.4 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.728 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 142' ' ' ALA . 42.9 m-85 -108.6 140.76 41.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.46 0.647 . . . . 0.0 110.722 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.28 -26.17 1.87 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.978 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.49 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 10.8 t -163.99 169.55 17.84 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.086 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 84.6 t -68.78 -35.11 6.04 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.403 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.5 Cg_exo -72.19 -37.28 4.75 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.83 2.354 . . . . 0.0 110.192 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.545 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -75.95 -41.22 52.22 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.538 178.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.76 -45.57 93.35 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.606 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.0 mt-10 -78.78 -27.96 44.64 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.21 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.3 t70 -70.82 -55.97 7.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.604 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.458 ' HB2' ' CB ' ' A' ' 119' ' ' ALA . 64.2 t-105 -64.83 -28.83 69.83 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -61.22 -40.98 96.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.196 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -46.13 65.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.246 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -98.02 25.6 5.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.068 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -153.03 33.62 0.48 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.0 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 179.742 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.735 0.302 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.55 149.0 40.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.999 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.45 HG22 ' HB3' ' A' ' 171' ' ' ALA . 19.2 mm -102.9 161.73 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.57 156.69 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 112.051 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.8 OUTLIER -82.64 122.11 27.7 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.142 178.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.476 HG23 ' HG3' ' A' ' 141' ' ' MET . 0.9 OUTLIER -41.29 -29.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.549 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -64.47 -46.13 84.36 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -82.2 -20.8 37.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.841 178.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.91 -25.82 61.19 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -81.65 -24.91 36.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.557 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.75 -28.3 39.02 Favored Glycine 0 CA--C 1.509 -0.326 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 21.1 tp -82.06 -28.38 32.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.06 -28.85 29.93 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.405 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -76.19 -21.96 55.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.964 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.01 -22.86 39.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.15 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -51.85 -37.4 51.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.15 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.98 -55.19 38.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.641 0.257 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.06 -29.18 40.53 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.411 2.074 . . . . 0.0 112.312 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.53 -57.36 12.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.041 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.0 mt -57.3 -27.05 61.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.397 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -65.72 -53.24 43.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.087 0.47 . . . . 0.0 109.887 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -77.12 -28.31 54.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.533 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.77 -52.13 22.66 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.98 -25.67 22.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.043 0.449 . . . . 0.0 110.981 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -68.71 -21.8 64.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.224 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.27 46.81 93.59 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.026 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -130.0 158.6 73.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 0.0 110.815 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.96 110.76 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.499 2.132 . . . . 0.0 112.065 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.412 ' CG2' HG21 ' A' ' 41' ' ' THR . 11.6 p -118.98 111.0 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.36 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 p -75.85 -178.7 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.967 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -77.94 -35.86 49.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.253 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -66.23 -24.88 66.68 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.195 179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -86.13 -42.84 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 tp -63.63 -36.25 83.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -74.17 -42.48 59.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.492 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 40' ' ' THR . . . -68.8 -29.02 72.65 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.546 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.1 mt -79.06 -41.45 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 121.17 0.51 . . . . 0.0 110.074 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.15 -9.92 59.07 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.354 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 t70 61.46 21.35 11.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -110.08 158.32 35.42 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.23 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.63 143.27 56.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.611 2.208 . . . . 0.0 111.917 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.3 -16.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -32.0 41.52 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.967 0.413 . . . . 0.0 111.146 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.98 -41.66 77.61 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.95 -46.44 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.56 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.71 -50.07 69.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.575 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.13 -35.78 27.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.5 t -68.75 -31.05 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.081 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.9 mp -81.08 -17.21 50.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.319 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -58.52 -19.24 35.8 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.256 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.66 17.91 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.705 0.288 . . . . 0.0 111.173 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.12 71.11 0.73 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.803 0.811 . . . . 0.0 110.635 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.1 p -63.88 -15.27 58.59 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.415 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.1 t -95.19 34.68 1.37 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.91 110.93 23.04 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -82.3 126.51 32.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.1 0.476 . . . . 0.0 111.997 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 69' ' ' GLY . 5.8 m-85 -110.83 160.3 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.14 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.13 143.9 25.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 0.0 111.498 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.1 -100.44 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.854 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -93.82 -10.46 34.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.411 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 125.07 33.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.939 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -93.99 154.24 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.3 mt -79.79 125.19 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.979 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.706 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.844 0.354 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.9 t -102.38 159.09 15.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.9 tt -82.21 -40.9 21.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -96.8 153.63 17.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 110.979 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -66.25 126.66 29.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.5 p -110.59 -172.47 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.109 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.27 -32.87 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.38 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.405 ' OH ' ' CD2' ' A' ' 163' ' ' HIS . 62.0 m-85 -79.34 110.75 14.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.751 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG23 ' CE1' ' A' ' 93' ' ' TYR . 25.1 t -104.73 135.0 44.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.964 0.412 . . . . 0.0 111.045 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 55.1 t80 -127.55 106.6 9.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.579 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -101.5 132.59 47.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.329 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.5 pt -140.03 123.1 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 111.825 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.6 t70 60.97 -69.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.381 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 87' ' ' ILE . 1.8 t70 -166.24 35.33 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.348 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -136.45 111.96 9.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.013 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -77.91 120.63 23.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.2 mt -117.15 165.08 13.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 84' ' ' VAL . 6.0 m-85 -133.44 165.16 25.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.362 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.415 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -150.85 173.01 14.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.118 0.485 . . . . 0.0 111.95 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -108.29 -5.67 16.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.832 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.6 p -160.09 163.08 34.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.13 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.468 ' CB ' ' CE2' ' A' ' 164' ' ' PHE . . . -51.7 -23.1 4.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -88.76 -51.59 5.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.715 0.293 . . . . 0.0 111.349 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.415 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 1.9 m-20 -39.7 -28.81 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -59.72 -35.42 74.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.64 0.257 . . . . 0.0 110.812 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.501 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . 14.8 tp -156.93 160.22 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.553 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 mt -113.52 -31.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.07 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 200' ' ' ASN . 4.1 m-85 -161.81 99.27 1.2 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.964 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.518 ' O ' HG22 ' A' ' 107' ' ' ILE . 59.7 Cg_endo -71.77 -26.35 19.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.578 2.185 . . . . 0.0 112.335 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 130' ' ' PRO . . . -79.36 -23.5 43.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.338 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 tp -81.7 -40.5 22.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.573 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.7 tp -54.39 -48.34 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.171 0.51 . . . . 0.0 111.595 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.22 20.71 22.32 Favored Glycine 0 C--N 1.319 -0.41 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.799 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 173.04 14.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.949 0.404 . . . . 0.0 111.023 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -78.28 152.79 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.644 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.465 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -137.15 109.88 7.56 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -83.71 120.57 26.17 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.79 0.805 . . . . 0.0 111.056 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.6 t -111.82 130.59 65.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.014 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 m -122.45 136.24 54.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.101 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.99 173.17 11.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.684 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.412 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 71.6 m80 -134.56 136.64 43.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 165' ' ' PHE . 28.5 t -64.76 134.44 54.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.179 0.514 . . . . 0.0 112.175 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.32 -5.76 34.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.819 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.461 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -126.89 -50.91 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.407 HG23 ' N ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -74.41 -33.6 63.05 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.217 0.532 . . . . 0.0 110.026 -179.104 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.17 34.92 57.67 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.373 -0.918 . . . . 0.0 110.818 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' HIS . . . -100.34 160.32 27.34 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.178 -0.511 . . . . 0.0 109.994 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -87.78 108.02 0.62 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.731 2.287 . . . . 0.0 111.257 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.401 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 35.9 m -104.41 144.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.157 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 85.4 p -147.22 142.79 27.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.51 0.671 . . . . 0.0 110.631 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -136.63 152.38 50.37 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.56 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 21.1 m -112.26 113.98 26.51 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.417 HG11 ' CE2' ' A' ' 193' ' ' PHE . 23.8 t -96.3 111.91 27.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.84 0.353 . . . . 0.0 111.586 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.47 167.21 9.88 Favored Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.211 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 105' ' ' ALA . 22.7 Cg_exo -64.79 -16.54 55.84 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.521 2.147 . . . . 0.0 113.051 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 27.2 t -116.72 -25.6 7.28 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 131' ' ' SER . 12.5 pt-20 178.94 -162.41 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.123 0.487 . . . . 0.0 109.854 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -96.05 160.14 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.878 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -147.01 18.64 1.25 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.422 0.629 . . . . 0.0 112.409 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.95 86.56 0.08 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.643 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.07 120.79 56.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.848 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -145.23 126.16 7.49 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.985 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.22 165.53 84.12 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.475 -1.469 . . . . 0.0 112.271 -0.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.77 78.01 0.86 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.148 0.499 . . . . 0.0 110.656 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.7 19.32 0.18 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.171 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.404 ' CE ' ' HG ' ' A' ' 126' ' ' LEU . 10.4 ptm -61.03 160.91 9.16 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.949 0.404 . . . . 0.0 111.396 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -126.89 152.19 47.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.381 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.461 ' CG1' ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -113.76 147.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.863 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 56.3 p -117.29 137.52 52.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.697 0.284 . . . . 0.0 110.659 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.11 176.18 9.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.801 179.678 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.902 0.382 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.405 ' CD2' ' OH ' ' A' ' 83' ' ' TYR . 5.4 m80 -120.5 165.96 14.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.58 0.705 . . . . 0.0 110.152 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.468 ' CE2' ' CB ' ' A' ' 97' ' ' ALA . 40.9 m-85 -115.52 140.67 48.94 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.536 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 57.0 m-85 -117.6 137.94 52.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.228 0.537 . . . . 0.0 110.287 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.38 -26.13 0.5 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.656 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.483 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 30.8 p -167.52 170.65 11.05 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.73 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.603 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 90.5 t -68.03 -34.37 6.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.32 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.707 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.8 Cg_exo -72.33 -37.41 4.46 Favored 'Trans proline' 0 CA--C 1.503 -1.06 0 C-N-CA 122.58 2.187 . . . . 0.0 110.321 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.561 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.34 -40.45 51.24 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.84 -46.38 89.73 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.674 ' HA ' ' HB1' ' A' ' 175' ' ' ALA . 2.3 mm-40 -79.09 -27.43 42.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.425 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 169' ' ' PRO . 17.6 t70 -69.8 -55.77 8.93 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.168 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.461 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 54.7 t-105 -65.87 -28.76 69.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.652 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.674 ' HB1' ' HA ' ' A' ' 172' ' ' GLU . . . -64.47 -39.05 93.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.213 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.5 t -51.98 -45.32 64.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.386 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 22.33 7.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.345 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.75 37.77 0.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.903 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.326 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.82 0.343 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.33 150.1 40.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 111.015 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.457 HG21 ' CB ' ' A' ' 171' ' ' ALA . 12.3 mm -102.42 159.99 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.923 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.09 162.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.175 0.512 . . . . 0.0 111.782 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.9 OUTLIER -88.77 125.68 34.99 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.792 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.403 HG23 ' CD2' ' A' ' 126' ' ' LEU . 0.4 OUTLIER -46.98 -20.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.596 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -69.27 -43.16 74.44 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -82.53 -24.49 34.04 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.249 178.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.91 -25.28 61.84 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.417 ' CE2' HG11 ' A' ' 128' ' ' VAL . 2.8 t80 -81.76 -31.38 31.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.145 0.498 . . . . 0.0 110.511 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.16 -30.45 31.06 Favored Glycine 0 CA--C 1.51 -0.253 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.359 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.01 -28.26 35.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.92 -29.07 29.75 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.62 -22.82 34.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.377 -0.411 . . . . 0.0 110.962 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -78.9 -22.8 45.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.23 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.76 -28.71 16.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.201 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . 0.413 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . 63.6 t-20 -81.1 -41.6 22.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.4 t . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.637 0.256 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.18 -43.62 4.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.565 2.176 . . . . 0.0 112.659 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.95 -57.03 10.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.7 mt -63.25 -26.83 68.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.011 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 -60.34 -53.1 61.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.933 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 24.8 mm-40 -75.32 -22.05 57.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.582 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tp -75.15 -52.15 11.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.254 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.0 -36.3 62.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.966 0.412 . . . . 0.0 112.003 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 30' ' ' GLU . 6.5 ptmt -68.23 -19.52 64.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.155 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.32 56.88 13.14 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.228 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.9 165.76 25.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.653 0.263 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.57 114.41 3.93 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.546 2.164 . . . . 0.0 112.24 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.0 t -126.91 110.45 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.428 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 82.1 p -89.97 -169.84 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -78.04 -37.88 45.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.361 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -29.13 69.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.907 0.384 . . . . 0.0 110.174 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.437 HG22 ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -83.41 -42.76 16.62 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.15 -36.76 82.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.406 ' HB1' HG23 ' A' ' 53' ' ' VAL . . . -71.28 -43.02 67.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.788 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.83 -31.84 70.16 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.86 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.437 ' CD1' HG22 ' A' ' 41' ' ' THR . 6.7 mt -77.42 -45.44 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 120.885 0.374 . . . . 0.0 110.722 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.81 -8.51 57.46 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.567 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 t0 60.5 24.27 13.9 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.411 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 5.3 m95 -111.37 139.8 22.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.181 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.85 144.48 20.79 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.556 2.17 . . . . 0.0 112.252 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.46 -16.69 2.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -77.2 -34.88 56.11 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.427 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.7 mtt85 -67.71 -41.33 83.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.406 HG23 ' HB1' ' A' ' 43' ' ' ALA . 2.1 t -63.82 -47.99 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.389 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.4 -52.53 59.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.299 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.98 -34.99 10.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.891 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.1 t -63.97 -32.29 56.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.015 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.63 -34.65 78.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.758 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -56.03 -34.08 65.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.549 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -96.19 -18.36 20.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.737 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.6 35.96 1.44 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.438 0.637 . . . . 0.0 111.098 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.6 p -58.75 -18.16 29.26 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.269 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 m -112.77 38.12 2.89 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.785 0.326 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.425 HG22 ' CZ ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -101.24 141.58 33.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.102 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.62 126.79 31.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.092 0.472 . . . . 0.0 111.257 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.425 ' CZ ' HG22 ' A' ' 63' ' ' THR . 61.1 m-85 -117.2 173.15 6.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.369 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.64 146.75 26.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.027 0.441 . . . . 0.0 111.333 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.9 tttm 66.7 -103.33 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.813 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -87.92 -11.46 47.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.21 26.96 2.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.128 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -81.49 169.43 17.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.953 0.406 . . . . 0.0 109.914 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.69 120.13 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.652 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 179.666 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.796 0.332 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.1 p -109.88 159.1 17.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -92.2 42.74 1.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -155.06 123.61 6.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' THR . 14.8 pm0 -57.46 -19.76 26.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.43 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 80' ' ' GLU . 54.4 p 36.88 -165.83 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -110.0 -26.26 9.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.426 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 28.1 m-85 -87.83 117.37 26.62 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.596 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.413 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.7 t -110.1 145.08 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.024 0.44 . . . . 0.0 111.521 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 17.4 t80 -134.13 107.46 7.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.016 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -102.51 133.03 48.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 0.0 111.843 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.48 ' CG2' ' CE1' ' A' ' 85' ' ' PHE . 3.8 pt -140.1 124.37 18.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.255 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.5 t70 63.12 -68.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.216 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.3 t0 -166.92 36.15 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.413 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -135.76 114.72 12.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.938 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.1 85.77 7.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.233 0.539 . . . . 0.0 110.885 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -74.13 165.05 25.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.08 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -134.88 165.28 25.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.365 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.407 ' CB ' ' N ' ' A' ' 100' ' ' THR . . . -151.56 169.75 21.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 0.0 111.919 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 17.8 m0 -88.24 -25.22 22.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.828 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.426 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 3.9 p -147.57 173.0 13.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.388 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.455 ' CB ' ' CE1' ' A' ' 164' ' ' PHE . . . -56.6 -20.87 23.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.826 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.2 mt -87.31 -51.66 5.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -50.12 -24.65 2.87 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.457 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -60.7 -39.48 88.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.719 0.295 . . . . 0.0 110.651 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 pp -112.08 178.42 4.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 111.106 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.42 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 4.3 tt -157.93 -45.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.11 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CG ' ' O ' ' A' ' 102' ' ' ILE . 8.0 m-85 -164.4 90.89 1.04 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.07 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.46 ' O ' HG21 ' A' ' 107' ' ' ILE . 60.1 Cg_endo -72.86 -33.69 7.59 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.522 2.148 . . . . 0.0 112.456 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.92 47.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.391 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 tp -84.84 -42.73 14.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.223 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.46 HG21 ' O ' ' A' ' 104' ' ' PRO . 0.6 OUTLIER -54.7 -48.6 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.175 0.512 . . . . 0.0 111.419 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.74 21.6 15.94 Favored Glycine 0 C--N 1.319 -0.408 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.921 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.77 177.36 10.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.053 0.454 . . . . 0.0 111.109 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -83.52 153.74 24.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.926 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.489 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . . . -137.09 109.87 7.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -82.75 121.05 26.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.778 0.799 . . . . 0.0 111.034 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.0 t -113.18 132.61 61.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.811 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 60.5 p -120.77 139.09 53.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.066 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 m -140.73 172.9 12.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.26 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -133.61 130.56 38.5 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 21.8 m -57.33 123.26 14.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.044 0.45 . . . . 0.0 111.803 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.34 -9.3 39.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.695 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.441 ' CB ' ' HB2' ' A' ' 174' ' ' TRP . . . -122.54 -50.59 1.98 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.506 HG23 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -75.74 -21.21 57.69 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.965 0.412 . . . . 0.0 110.848 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.45 33.96 86.61 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.118 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.506 ' CB ' HG23 ' A' ' 120' ' ' THR . . . -102.41 167.8 9.86 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.43 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -93.22 110.05 0.2 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.954 2.436 . . . . 0.0 111.28 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.409 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 35.0 m -108.5 148.32 12.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.547 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 79.4 p -149.21 141.44 24.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.406 0.622 . . . . 0.0 110.795 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -132.6 153.78 50.69 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.53 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 21.2 m -110.99 114.46 27.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.828 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.419 HG11 ' CE2' ' A' ' 193' ' ' PHE . 38.4 t -96.47 111.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.4 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -106.65 168.9 7.44 Favored Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.958 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.2 Cg_endo -66.09 -19.27 57.33 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.229 1.953 . . . . 0.0 112.891 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 34.6 p -112.89 -26.12 8.69 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 131' ' ' SER . 11.1 pt-20 178.09 -162.23 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.131 0.491 . . . . 0.0 110.099 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.35 158.76 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.752 178.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -146.19 20.43 1.4 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.387 0.613 . . . . 0.0 112.299 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.67 86.47 0.09 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.646 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.4 t -102.87 113.51 39.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.375 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -146.26 121.94 5.61 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.498 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.571 ' HD2' ' HE3' ' A' ' 141' ' ' MET . 55.6 Cg_endo -69.28 157.6 90.53 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.459 -1.475 . . . . 0.0 112.737 -0.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.02 80.33 1.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.54 16.64 0.15 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.351 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.571 ' HE3' ' HD2' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -61.16 159.24 12.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.033 0.444 . . . . 0.0 111.571 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.03 152.1 48.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.515 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.42 HG11 ' CD1' ' A' ' 164' ' ' PHE . 4.6 t -115.31 152.97 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.88 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.419 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 23.5 m -120.0 141.08 50.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.582 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.2 mp -142.23 176.27 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.985 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 36.4 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.811 179.73 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 96' ' ' CYS . 2.6 p . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 121.068 0.461 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.41 ' CE1' ' OH ' ' A' ' 83' ' ' TYR . 3.6 m-70 -126.96 169.38 13.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.555 0.693 . . . . 0.0 110.05 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.455 ' CE1' ' CB ' ' A' ' 97' ' ' ALA . 1.9 m-85 -108.61 150.69 27.16 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.796 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.456 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 37.9 m-85 -132.96 136.26 45.99 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.361 0.601 . . . . 0.0 110.564 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.19 -28.67 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.142 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 30.5 t -171.7 176.78 3.58 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.796 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 85.3 t -69.05 -34.3 4.92 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.552 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.7 Cg_exo -72.55 -38.38 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.813 2.342 . . . . 0.0 110.396 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.571 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.52 -39.84 51.77 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.546 177.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.496 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.33 -45.37 94.69 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.603 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 96.6 mt-10 -79.19 -27.56 42.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.179 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 169' ' ' PRO . 8.8 t70 -70.24 -55.86 8.21 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.421 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.501 ' CZ2' ' CD2' ' A' ' 178' ' ' HIS . 57.4 t90 -65.17 -28.05 69.13 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.8 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -66.73 -37.04 83.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.323 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 t -53.09 -46.51 68.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.404 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -95.16 22.79 6.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.211 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.501 ' CD2' ' CZ2' ' A' ' 174' ' ' TRP . 79.5 m80 -152.8 45.43 0.69 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.952 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.739 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.11 41.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.021 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.433 HG22 ' CB ' ' A' ' 171' ' ' ALA . 10.0 mm -99.78 159.45 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.864 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.12 162.03 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.361 0.6 . . . . 0.0 111.967 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -90.8 129.64 36.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.778 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.418 HG12 ' HG2' ' A' ' 141' ' ' MET . 1.5 m -46.98 -19.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.75 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 8.7 m80 -71.76 -41.84 67.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.798 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.21 -24.22 34.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.364 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.9 61.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.175 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.419 ' CE2' HG11 ' A' ' 128' ' ' VAL . 5.4 t80 -81.3 -25.57 36.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.682 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.76 -30.25 32.92 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 -28.22 32.48 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.14 -28.32 31.2 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.414 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -82.28 -23.99 34.95 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.883 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.08 -23.04 57.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.146 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -51.89 -33.08 35.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.144 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.99 -25.08 37.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.948 179.976 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.852 0.358 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.49 -26.23 27.86 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.482 2.122 . . . . 0.0 112.219 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.13 -57.37 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.352 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 mt -80.17 -27.28 39.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.55 -53.22 51.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.548 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.03 -23.28 66.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.291 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -38.38 77.53 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.07 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.08 -25.63 13.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.001 0.429 . . . . 0.0 111.174 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.01 -20.87 65.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.073 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.56 42.46 95.61 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.267 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -133.36 165.85 33.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.704 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.55 114.28 3.78 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.502 2.135 . . . . 0.0 112.016 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.8 t -115.57 110.19 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.421 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.7 p -88.03 -171.65 3.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.746 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -77.99 -36.64 48.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.313 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -29.42 69.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.276 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.421 HG21 ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -83.52 -42.65 16.61 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 12.6 mt -62.53 -36.56 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.414 ' CB ' ' CG2' ' A' ' 53' ' ' VAL . . . -72.87 -43.01 63.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.646 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.28 -31.65 77.76 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.477 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.421 ' CD1' HG21 ' A' ' 41' ' ' THR . 6.9 mt -79.54 -38.52 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 121.061 0.458 . . . . 0.0 110.231 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 6.4 mp -78.13 -10.01 59.43 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.178 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 59.38 22.54 10.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.442 ' CD1' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -102.77 137.06 19.21 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.189 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.442 ' HD2' ' CD1' ' A' ' 48' ' ' TRP . 10.1 Cg_endo -53.04 142.81 52.8 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.697 2.265 . . . . 0.0 112.207 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HA ' HG22 ' A' ' 53' ' ' VAL . . . -51.8 -20.64 2.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.55 -39.95 36.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.121 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -67.93 -38.28 82.7 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.414 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 2.5 t -65.73 -48.1 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.89 -54.37 30.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.177 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.14 64.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.898 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 t -65.06 -31.73 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.747 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.21 -35.12 79.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.49 -22.82 46.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.851 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -96.42 -20.68 18.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.38 31.89 2.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.55 0.69 . . . . 0.0 110.916 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.1 p -71.61 -27.65 63.26 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.761 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.8 m -75.86 -25.51 56.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.35 141.25 56.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.042 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -78.92 133.77 36.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.046 0.45 . . . . 0.0 111.274 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.411 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 55.2 m-85 -105.19 173.42 6.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.48 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -149.82 145.97 26.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.969 0.414 . . . . 0.0 111.499 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 tttp 65.6 -105.03 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.634 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -86.91 -11.51 50.46 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.713 0.292 . . . . 0.0 111.561 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.411 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 122.67 25.87 1.86 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.228 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -78.02 158.79 29.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 110.006 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.74 126.32 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.574 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 121.027 0.442 . . . . 0.0 111.021 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.794 0.33 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -113.72 140.86 47.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -59.75 -23.87 63.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.078 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -92.97 123.61 36.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 111.096 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.2 pt-20 -60.64 -16.76 42.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.461 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 80' ' ' GLU . 0.5 OUTLIER 37.46 -167.97 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.08 -24.88 12.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.113 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -80.78 114.85 19.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.55 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.82 136.14 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.015 0.436 . . . . 0.0 111.423 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.479 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 56.5 t80 -128.16 104.6 7.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.177 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -98.6 131.12 45.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.396 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -140.06 122.95 17.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.07 -72.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 87' ' ' ILE . 18.3 t0 -159.26 37.11 0.2 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -139.8 145.95 38.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.56 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.96 86.49 2.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.871 0.367 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 85' ' ' PHE . 4.3 mm? -71.27 164.79 25.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.589 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -131.12 160.08 35.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.356 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.466 ' HB3' ' N ' ' A' ' 100' ' ' THR . . . -146.55 161.44 40.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.737 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -90.61 -24.7 20.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.409 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.411 ' HB3' ' CG1' ' A' ' 162' ' ' VAL . 5.6 m -146.97 172.37 13.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.974 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.443 ' HB1' ' CE2' ' A' ' 164' ' ' PHE . . . -53.77 -21.53 7.51 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tp -86.8 -51.53 6.03 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.401 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -45.57 -25.39 0.45 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.466 ' N ' ' HB3' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -60.31 -36.73 78.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.688 0.28 . . . . 0.0 110.87 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.441 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.9 pt? -137.5 166.18 24.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.004 0.431 . . . . 0.0 111.386 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.1 mp -143.62 -46.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.834 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -141.1 65.83 23.45 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.664 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.507 ' O ' HG22 ' A' ' 107' ' ' ILE . 34.3 Cg_exo -57.83 -30.61 89.99 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.742 2.295 . . . . 0.0 112.531 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.36 -23.61 43.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.455 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.94 -34.04 20.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.143 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.4 tp -54.51 -47.61 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.174 0.511 . . . . 0.0 111.687 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.91 20.85 25.0 Favored Glycine 0 C--N 1.32 -0.351 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.733 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 173.42 14.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 111.011 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -78.87 151.8 31.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.479 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.14 109.75 7.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 112.001 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -82.35 119.64 24.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.818 0.818 . . . . 0.0 111.198 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.429 HG21 ' CD1' ' A' ' 85' ' ' PHE . 39.6 t -111.61 130.47 65.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.137 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.0 m -122.29 137.04 54.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.093 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.418 ' CB ' HG22 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.62 172.8 12.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.209 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.417 ' CE1' ' HA ' ' A' ' 123' ' ' PRO . 0.7 OUTLIER -136.68 135.06 37.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 26.4 t -61.77 132.14 52.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.227 0.537 . . . . 0.0 112.147 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.48 -3.84 23.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.935 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.445 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -122.58 -50.6 1.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.616 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.487 HG21 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -88.98 -24.23 22.45 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.247 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.36 5.03 76.05 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.179 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.487 ' CB ' HG21 ' A' ' 120' ' ' THR . . . -57.74 151.17 43.54 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.504 0.193 . . . . 0.0 110.579 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.417 ' HA ' ' CE1' ' A' ' 116' ' ' HIS . 2.5 Cg_endo -84.54 105.8 1.06 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.736 2.29 . . . . 0.0 110.898 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.418 HG22 ' CB ' ' A' ' 115' ' ' SER . 35.2 m -103.29 145.49 12.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.419 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 72.8 p -151.49 141.62 22.22 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.443 0.64 . . . . 0.0 110.699 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -134.82 152.92 52.14 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.306 178.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 82.7 m -111.34 113.31 25.69 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.424 HG13 ' CZ ' ' A' ' 193' ' ' PHE . 19.7 t -95.86 111.73 26.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.631 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.14 175.63 2.07 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.401 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.78 -15.62 37.11 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.695 2.263 . . . . 0.0 112.971 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 50.1 m -120.11 -26.03 5.61 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 131' ' ' SER . 14.6 pt-20 179.74 -162.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.169 0.509 . . . . 0.0 110.186 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -96.62 161.36 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.992 178.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -149.31 19.25 0.95 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.298 0.57 . . . . 0.0 112.253 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.09 86.23 0.08 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.593 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.4 t -105.02 118.35 52.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.138 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -146.21 117.12 4.82 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.47 146.99 83.12 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.643 -1.399 . . . . 0.0 112.28 0.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.18 -33.83 54.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.642 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.93 28.98 12.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.957 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.453 ' CE ' ' CD1' ' A' ' 164' ' ' PHE . 1.9 ppp? -64.9 156.55 30.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.126 0.489 . . . . 0.0 111.529 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.72 152.32 48.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.616 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.447 ' CG2' ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -112.49 150.67 14.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.965 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 23.0 p -119.86 140.37 50.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.757 0.313 . . . . 0.0 111.026 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.4 mt -139.02 176.28 8.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.873 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.051 179.741 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 96' ' ' CYS . 8.0 p . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 121.13 0.491 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.447 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 2.5 m-70 -126.81 169.24 13.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.609 0.719 . . . . 0.0 110.076 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.453 ' CD1' ' CE ' ' A' ' 141' ' ' MET . 11.9 m-85 -106.11 151.71 24.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.62 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 49.2 m-85 -131.13 136.3 48.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.495 0.664 . . . . 0.0 110.502 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -43.42 -26.42 0.2 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.67 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.471 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 22.3 p -169.24 172.76 7.1 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.941 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 81.5 t -69.01 -34.04 4.7 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.389 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.76 -37.35 3.91 Favored 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 122.669 2.246 . . . . 0.0 110.24 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.56 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.6 -40.42 49.54 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.578 178.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.49 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -62.0 -45.59 92.96 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.607 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.6 mt-10 -78.92 -27.56 43.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.119 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 25.3 t70 -70.77 -55.94 7.47 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.451 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.445 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 41.6 t-105 -65.03 -28.28 69.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.632 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.607 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -63.59 -40.7 97.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.221 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.2 p -51.85 -43.56 63.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.354 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.82 21.01 7.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.358 0.599 . . . . 0.0 111.353 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -125.94 27.39 6.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.811 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.757 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.9 tt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.735 0.302 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.65 149.76 41.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.429 HG22 ' HB3' ' A' ' 171' ' ' ALA . 12.9 mm -99.78 159.59 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.954 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.09 147.81 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.815 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.5 OUTLIER -77.41 124.49 27.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.467 177.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.446 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 1.0 OUTLIER -46.93 -20.67 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.644 179.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.37 -39.63 77.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.7 mt-10 -82.46 -28.38 31.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.036 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.69 -24.69 67.88 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.116 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.458 ' CZ ' HG21 ' A' ' 133' ' ' ILE . 0.6 OUTLIER -81.15 -24.72 37.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.032 0.444 . . . . 0.0 110.818 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.56 -30.3 33.45 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.17 -28.47 32.07 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -27.87 32.77 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.601 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -82.17 -25.85 33.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 110.951 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -73.88 -23.32 59.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.089 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -55.84 -43.3 76.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.128 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -81.01 -50.07 10.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.253 -179.864 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.84 0.352 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.02 -21.81 27.13 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.595 2.197 . . . . 0.0 112.484 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.46 -57.44 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 111.363 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -80.12 -27.43 39.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.227 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -53.22 14.53 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.888 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.88 -24.52 66.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.506 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.4 tp -69.45 -28.93 66.53 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.73 -22.56 9.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.351 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -69.11 -21.7 64.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.192 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.95 39.51 94.94 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.399 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -133.25 166.04 32.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.572 0.225 . . . . 0.0 110.833 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.64 114.12 3.58 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.468 2.112 . . . . 0.0 111.952 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.408 ' CG2' HG21 ' A' ' 41' ' ' THR . 11.1 p -111.59 109.87 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.438 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.3 p -85.99 -170.47 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -78.04 -37.52 46.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.465 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -27.91 68.66 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.199 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.53 -42.34 15.61 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -36.6 83.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -73.04 -42.74 62.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.604 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.74 -30.19 72.7 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.643 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.0 mt -79.03 -43.51 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.055 0.455 . . . . 0.0 110.397 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.75 -9.83 58.95 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.506 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.5 t70 60.63 21.77 11.64 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.441 ' CD1' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -104.47 137.79 19.33 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.068 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HD2' ' CD1' ' A' ' 48' ' ' TRP . 10.7 Cg_endo -53.66 140.01 66.56 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.597 2.198 . . . . 0.0 112.012 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.19 -17.89 1.28 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.6 -32.61 47.66 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.258 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HD2' ' CD1' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -67.17 -39.87 86.53 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.05 -48.14 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.586 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.87 57.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.389 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.2 -42.77 66.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.891 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.9 t -67.76 -31.17 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.95 -35.37 80.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.758 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.25 -45.12 88.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.755 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -88.05 -7.88 56.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.62 74.98 1.04 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.765 0.793 . . . . 0.0 110.133 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -106.66 -16.09 14.6 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.42 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -73.87 -28.13 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.17 141.33 50.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.448 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -78.79 126.94 31.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.313 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -103.37 171.78 7.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.463 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 70' ' ' ASN . 1.6 t70 -92.16 -172.76 3.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.479 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -67.55 -35.42 79.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -91.73 12.24 21.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.648 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.28 17.33 74.23 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.156 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 66' ' ' ASP . 24.3 m120 -91.49 165.62 13.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.983 0.392 . . . . 0.0 110.04 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.2 mp -79.84 127.8 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.546 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.022 179.696 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.742 0.306 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.7 p -97.82 159.05 15.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.5 -41.41 85.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.979 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.9 mtt-85 -110.31 150.29 28.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 4.5 tt0 -57.05 132.34 52.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.925 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.8 p -108.44 -173.67 2.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.046 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.413 ' CB ' ' NE2' ' A' ' 116' ' ' HIS . 70.2 m -94.94 -38.54 10.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.016 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.424 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 32.6 m-85 -79.52 111.09 15.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.507 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.62 138.13 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.502 ' CE1' ' HB1' ' A' ' 111' ' ' ALA . 69.4 t80 -123.51 106.73 10.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.544 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -98.06 125.77 43.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.279 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -139.59 122.91 18.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.853 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 t70 59.4 -72.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.159 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 87' ' ' ILE . 35.1 t0 -165.74 34.15 0.05 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.313 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.3 mmp_? -136.64 111.82 9.06 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.751 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -77.87 120.63 23.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.909 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.95 164.78 11.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 111.022 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.417 ' CZ ' ' HG3' ' A' ' 80' ' ' GLU . 28.4 m-85 -131.49 155.39 47.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.355 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.39 168.41 24.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.973 0.416 . . . . 0.0 111.614 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -100.21 -6.97 25.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.189 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.424 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.5 OUTLIER 178.03 -179.28 0.27 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.827 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.443 ' HB3' ' CD1' ' A' ' 164' ' ' PHE . . . -55.09 164.36 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.729 0.3 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 tt 70.21 -52.92 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.103 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -47.3 -29.27 2.38 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.834 0.349 . . . . 0.0 110.867 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.491 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 2.7 p -60.02 -39.44 85.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.717 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER 169.92 153.45 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.554 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.491 ' CG2' ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -143.33 48.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.867 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CG ' ' O ' ' A' ' 102' ' ' ILE . 16.9 m-85 -166.27 59.27 0.54 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.992 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.487 ' O ' HG21 ' A' ' 107' ' ' ILE . 61.2 Cg_endo -73.14 -37.67 3.28 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.596 2.197 . . . . 0.0 112.253 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 130' ' ' PRO . . . -79.08 -23.8 43.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.218 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.72 -41.06 19.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.26 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.487 HG21 ' O ' ' A' ' 104' ' ' PRO . 1.3 tp -57.68 -46.6 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.177 0.513 . . . . 0.0 111.422 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.88 24.29 15.68 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.636 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -152.55 173.53 15.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.003 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -80.09 153.42 28.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.772 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -137.06 109.78 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -83.19 120.26 25.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.781 0.8 . . . . 0.0 111.23 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 94.6 t -112.79 130.68 66.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.013 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 m -122.78 136.91 55.02 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.202 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 t -141.81 173.0 11.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.36 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.455 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -133.53 137.23 45.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 34.0 t -66.65 134.0 51.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.086 0.47 . . . . 0.0 112.234 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.52 -3.98 27.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.102 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.452 ' HB1' ' CD2' ' A' ' 174' ' ' TRP . . . -121.59 -51.34 2.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.928 0.395 . . . . 0.0 111.529 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.515 HG21 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.37 -24.18 22.01 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.356 -179.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.15 6.09 73.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.114 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.515 ' CB ' HG21 ' A' ' 120' ' ' THR . . . -59.39 150.69 63.37 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.552 0.215 . . . . 0.0 110.501 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.0 104.39 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.652 2.235 . . . . 0.0 110.77 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.0 m -99.22 144.35 12.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.299 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.9 p -150.48 141.95 23.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.448 0.642 . . . . 0.0 110.639 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -138.26 151.28 47.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.026 179.072 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 39.2 m -107.1 113.76 27.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.732 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.424 HG12 ' CE1' ' A' ' 193' ' ' PHE . 36.2 t -96.15 111.72 26.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.382 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.23 167.68 9.09 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.793 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 105' ' ' ALA . 34.5 Cg_endo -65.62 -19.16 60.15 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.084 1.856 . . . . 0.0 112.884 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 4.4 m -112.79 -26.73 8.43 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 131' ' ' SER . 2.9 pt-20 178.37 -162.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.15 0.5 . . . . 0.0 110.159 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -96.23 157.75 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.014 178.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -144.85 19.05 1.64 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.367 0.603 . . . . 0.0 112.241 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.9 86.56 0.08 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.326 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.8 t -104.99 115.92 47.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.431 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.35 124.32 6.2 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.575 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.65 154.79 95.81 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.874 -1.302 . . . . 0.0 112.247 0.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.42 79.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.106 0.479 . . . . 0.0 110.434 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 141.82 20.46 0.27 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.017 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.475 ' HG3' HG13 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -61.06 160.32 10.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.035 0.445 . . . . 0.0 111.298 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -129.24 152.29 48.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.091 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.484 ' CG1' ' CE1' ' A' ' 164' ' ' PHE . 40.5 t -113.98 150.67 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.624 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.8 p -117.81 138.77 51.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.865 0.364 . . . . 0.0 110.912 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 pp -149.93 176.63 10.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.599 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 0.0 110.88 179.69 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.83 0.348 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -113.99 164.81 13.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.717 0.77 . . . . 0.0 110.469 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.484 ' CE1' ' CG1' ' A' ' 143' ' ' VAL . 3.3 m-85 -122.3 129.83 52.56 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.559 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.479 ' CG ' ' HA ' ' A' ' 171' ' ' ALA . 44.8 m-85 -108.54 140.95 41.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.45 0.643 . . . . 0.0 110.771 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.38 -25.66 1.71 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.78 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.551 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 32.1 m -162.36 165.84 25.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.663 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.625 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 74.9 t -67.66 -33.91 5.94 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.955 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.63 -36.92 4.44 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.669 2.246 . . . . 0.0 110.262 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.65 -40.37 49.33 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.468 177.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.72 -45.79 92.44 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.676 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 3.1 mm-40 -78.88 -27.06 43.97 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.351 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 169' ' ' PRO . 25.9 t0 -70.62 -55.91 7.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.452 ' CD2' ' HB1' ' A' ' 119' ' ' ALA . 31.8 t-105 -65.23 -28.97 69.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.635 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.676 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -63.43 -39.93 95.8 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.346 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.8 m -52.22 -44.54 64.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.327 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.408 ' O ' ' CD2' ' A' ' 178' ' ' HIS . 0.0 OUTLIER -96.15 22.33 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.259 0.552 . . . . 0.0 111.235 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.436 ' NE2' ' CE2' ' A' ' 174' ' ' TRP . 15.8 m-70 -145.46 40.75 1.22 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.084 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.575 179.835 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.639 0.257 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.04 143.65 46.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.949 0.404 . . . . 0.0 111.225 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.501 HG23 ' HB3' ' A' ' 171' ' ' ALA . 15.9 mm -103.52 161.56 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.94 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.402 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.99 164.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.363 0.601 . . . . 0.0 112.012 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.424 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -92.97 133.83 35.73 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.49 178.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.475 HG13 ' HG3' ' A' ' 141' ' ' MET . 18.3 m -47.43 -18.68 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 120.879 0.371 . . . . 0.0 110.838 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.424 ' N ' ' C ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -73.83 -43.08 59.85 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.037 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -20.98 36.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.327 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.38 -25.2 59.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.087 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.424 ' CE1' HG12 ' A' ' 128' ' ' VAL . 1.2 t80 -81.42 -24.82 36.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.762 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.85 -30.63 31.52 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.4 mt -82.05 -27.62 32.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.05 -25.84 39.28 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -82.19 -22.95 35.74 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.56 -0.32 . . . . 0.0 111.116 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -79.67 -24.8 41.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.141 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -53.88 -30.47 45.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 111.189 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -55.63 -54.98 37.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.061 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.157 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.738 0.304 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.78 -26.38 19.25 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.517 2.145 . . . . 0.0 112.435 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -54.16 -57.49 10.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.042 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.2 mt -63.19 -26.91 69.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -68.68 -53.25 23.45 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.118 0.485 . . . . 0.0 109.907 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -30.76 64.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.297 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.8 tt -70.81 -49.76 42.9 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.825 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.8 -27.64 30.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 0.0 110.973 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -21.1 65.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.136 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 45.9 94.97 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.068 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.86 152.6 80.87 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.622 0.248 . . . . 0.0 110.834 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.89 89.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.643 2.229 . . . . 0.0 112.346 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.2 t -97.61 110.7 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 p -85.34 -172.98 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.007 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -78.07 -35.51 49.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.339 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -27.19 68.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.954 0.407 . . . . 0.0 110.331 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -85.19 -42.68 14.49 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 tp -63.05 -35.91 81.82 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -73.31 -43.0 61.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.59 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.12 -31.49 74.97 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.7 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 41' ' ' THR . 6.7 mt -78.81 -44.38 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-O 120.873 0.368 . . . . 0.0 110.535 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.57 -9.66 58.82 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.434 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t0 59.3 22.15 10.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -105.01 144.82 29.51 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.274 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.3 140.0 81.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.457 2.104 . . . . 0.0 112.033 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.15 -18.39 1.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -78.36 -32.38 48.96 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.203 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -40.95 86.84 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.401 HG22 ' HB1' ' A' ' 43' ' ' ALA . 2.1 t -61.98 -48.54 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.646 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.68 -53.18 55.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.232 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.62 -46.93 77.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.837 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.0 t -66.4 -31.84 55.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.714 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 mt -62.1 -32.2 72.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.613 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -24.48 50.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.741 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -96.22 -17.88 20.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.72 32.77 3.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.478 0.656 . . . . 0.0 110.816 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.2 p -67.52 -13.71 62.29 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.212 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 p -88.44 -22.65 23.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.778 0.323 . . . . 0.0 111.368 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.54 141.32 48.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.027 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -79.1 127.0 31.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.05 0.452 . . . . 0.0 111.414 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.431 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.8 m-85 -101.74 173.13 6.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.263 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -151.46 146.95 26.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.941 0.4 . . . . 0.0 111.492 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm 66.68 -102.54 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.865 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -91.85 -10.05 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 120.95 30.42 1.35 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.028 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.01 170.65 10.93 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.1 mp -79.84 114.28 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.239 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.246 179.898 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.833 0.349 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 t -101.19 159.04 15.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.35 -43.79 85.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.992 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -103.59 147.46 27.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.966 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.8 128.59 37.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.1 p -106.9 -174.46 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.4 -34.45 12.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 52.2 m-85 -81.15 110.48 16.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.606 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.57 137.25 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.481 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 36.4 t80 -126.82 105.6 8.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.567 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -98.58 126.55 44.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.685 0.279 . . . . 0.0 110.984 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.465 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.07 127.19 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 59.18 -77.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.296 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' ILE . 19.4 t0 -160.11 35.34 0.17 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.483 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -138.42 114.05 9.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.503 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -77.82 86.4 4.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 110.894 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -71.73 164.84 25.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.704 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -136.76 162.89 31.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.327 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.405 ' HB2' ' CB ' ' A' ' 99' ' ' ASP . . . -149.59 167.22 26.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.011 0.434 . . . . 0.0 112.068 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -98.88 -8.96 24.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.126 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.422 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -161.15 172.77 16.16 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.983 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.449 ' CB ' ' CE2' ' A' ' 164' ' ' PHE . . . -55.35 -24.2 28.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.273 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.445 HD21 ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -94.62 -38.03 11.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.175 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.445 ' N ' HD21 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -53.84 -22.0 8.8 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.444 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -60.12 -35.07 74.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.739 0.304 . . . . 0.0 110.482 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.457 ' CD2' ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -169.66 147.12 3.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.988 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 tt -107.29 -43.09 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -129.57 72.47 81.95 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.05 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.465 ' O ' HG21 ' A' ' 107' ' ' ILE . 26.8 Cg_exo -62.47 -21.06 72.29 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.642 2.228 . . . . 0.0 112.426 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.63 -23.3 42.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.894 0.378 . . . . 0.0 111.407 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.5 tp -86.02 -24.42 26.43 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.465 HG21 ' O ' ' A' ' 104' ' ' PRO . 1.3 tp -57.99 -47.99 85.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.133 0.492 . . . . 0.0 111.679 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.73 19.29 27.49 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.785 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.17 175.49 12.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 111.001 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -78.79 150.15 32.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.799 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.481 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.15 110.03 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -81.26 120.19 24.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.852 0.834 . . . . 0.0 111.114 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.448 HG22 ' CD1' ' A' ' 85' ' ' PHE . 33.4 t -111.53 131.01 64.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.024 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.3 m -119.57 137.57 53.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.947 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.74 172.6 12.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.442 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -135.45 131.76 36.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.681 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 21.0 m -57.12 123.6 15.84 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.863 0.363 . . . . 0.0 111.963 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -68.06 -9.01 42.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.615 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.44 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -122.49 -50.6 1.98 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.494 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -76.8 -20.36 56.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 110.935 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.49 33.28 84.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.168 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.494 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -101.4 168.67 8.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.426 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -94.55 111.13 0.16 Allowed 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 123.043 2.495 . . . . 0.0 111.529 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.5 m -110.57 149.32 13.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.569 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 76.0 p -149.36 141.82 24.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.337 0.589 . . . . 0.0 110.731 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -133.37 152.42 51.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.131 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 60.6 m -112.02 113.06 25.14 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.426 ' CG1' ' CB ' ' A' ' 104' ' ' PRO . 23.3 t -96.31 111.88 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.626 -0.429 . . . . 0.0 111.351 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.3 p -106.47 175.88 1.89 Allowed Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.212 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.11 -13.4 33.74 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.562 2.174 . . . . 0.0 113.192 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.1 t -120.31 -27.7 5.18 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.73 -162.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.023 0.439 . . . . 0.0 110.201 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -96.67 155.08 3.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.863 178.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -142.87 19.39 1.98 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.347 0.594 . . . . 0.0 112.589 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.15 86.18 0.08 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.686 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.5 t -104.83 122.07 57.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.106 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -146.13 124.19 6.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.869 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.3 158.65 96.9 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.226 0.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.31 78.43 0.54 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.224 0.535 . . . . 0.0 110.645 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.41 18.14 0.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.195 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 166' ' ' ALA . 0.5 OUTLIER -60.78 161.14 8.37 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.047 0.423 . . . . 0.0 111.225 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.21 152.09 51.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.776 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.444 ' CG2' ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -110.15 150.49 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.372 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.421 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 68.3 m -123.51 147.45 47.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.92 0.391 . . . . 0.0 111.203 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.6 tt -129.28 157.81 40.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.515 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.904 179.709 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.7 t . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -124.67 169.25 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.574 0.702 . . . . 0.0 109.756 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.449 ' CE2' ' CB ' ' A' ' 97' ' ' ALA . 6.2 m-85 -110.63 152.53 26.37 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.982 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 18.1 m-85 -134.62 137.06 43.36 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.42 0.629 . . . . 0.0 110.31 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -37.93 -30.67 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.739 -1.118 . . . . 0.0 113.109 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.466 ' O ' ' HB1' ' A' ' 171' ' ' ALA . 18.7 m -172.6 -179.97 2.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.157 0.503 . . . . 0.0 111.65 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 84.2 t -69.69 -33.49 3.75 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.563 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.1 Cg_exo -72.94 -39.05 2.5 Favored 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 122.604 2.203 . . . . 0.0 110.5 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.566 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.48 -39.69 52.45 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.122 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.502 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.61 -45.81 92.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.607 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.3 mt-10 -78.99 -27.39 43.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.316 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.6 t70 -70.51 -55.86 7.93 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.355 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.44 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 41.7 t-105 -64.91 -28.31 69.44 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.786 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.607 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -66.83 -38.68 86.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.264 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.8 t -51.45 -42.53 61.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.454 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -94.25 20.48 8.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.363 0.602 . . . . 0.0 111.458 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -129.62 29.46 5.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.759 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.1 tp . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.863 0.363 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.83 150.14 39.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 111.518 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.435 HG22 ' CB ' ' A' ' 171' ' ' ALA . 11.9 mm -99.84 160.32 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.611 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.49 157.72 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.367 0.603 . . . . 0.0 112.198 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.9 OUTLIER -88.41 125.47 34.74 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.542 178.325 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.416 HG13 ' HG3' ' A' ' 141' ' ' MET . 0.3 OUTLIER -45.9 -21.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.556 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.407 ' N ' ' C ' ' A' ' 188' ' ' SER . 47.7 m170 -67.58 -40.1 84.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.2 mt-10 -82.32 -27.7 32.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.094 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.8 -24.71 67.03 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.413 ' CZ ' HG12 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -79.31 -24.76 42.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.625 179.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.94 -29.71 33.8 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.27 -28.55 31.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.97 -27.92 32.82 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -82.19 -25.48 34.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.816 0.341 . . . . 0.0 110.839 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -81.05 -22.97 38.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.193 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.82 -39.64 59.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.217 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -76.15 -49.35 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.4 m . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.584 0.231 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.84 -21.07 31.41 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.45 2.1 . . . . 0.0 112.484 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.6 tp -53.39 -57.48 10.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.995 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.26 -26.78 65.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.183 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.29 -53.35 37.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.032 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -28.8 56.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.398 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tt -70.57 -52.05 24.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.733 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.54 -26.4 21.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.142 0.496 . . . . 0.0 111.058 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -68.21 -21.63 64.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.172 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.04 45.72 95.44 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.067 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -133.07 150.16 74.76 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.678 0.275 . . . . 0.0 110.767 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.85 106.08 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.63 2.22 . . . . 0.0 112.342 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.7 p -113.51 109.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.176 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 p -85.85 -172.2 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 43' ' ' ALA . 6.2 ptt180 -78.03 -35.32 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.227 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -26.52 67.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.845 0.355 . . . . 0.0 110.206 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -85.59 -42.45 14.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 tp -63.2 -36.0 82.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -73.45 -42.94 61.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.543 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.29 -30.94 73.73 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.694 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.0 mt -78.68 -44.59 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 121.0 0.429 . . . . 0.0 110.498 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.26 -10.08 59.13 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.405 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.03 21.76 10.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.441 ' CH2' ' CZ ' ' A' ' 52' ' ' ARG . 10.6 m95 -107.57 136.77 19.59 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.265 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.2 142.41 16.44 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.5 2.133 . . . . 0.0 112.286 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.77 -16.86 1.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.88 -34.46 51.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.325 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' CZ ' ' CH2' ' A' ' 48' ' ' TRP . 7.5 tpt180 -67.01 -40.64 87.34 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.405 HG23 ' HB1' ' A' ' 43' ' ' ALA . 2.1 t -62.62 -48.11 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.613 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.43 -53.38 52.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.354 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.94 -45.1 71.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.877 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.5 t -71.48 -30.23 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.723 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.06 -39.81 82.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.738 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.68 -45.04 86.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.66 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -66.9 -14.97 63.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.027 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.14 70.43 0.71 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.67 0.748 . . . . 0.0 110.759 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.7 p -83.95 -3.87 58.29 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.247 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.0 p -96.41 -20.0 18.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.713 0.292 . . . . 0.0 111.333 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.77 141.23 21.82 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.033 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.73 126.69 31.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.154 0.502 . . . . 0.0 111.65 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.425 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 5.0 m-85 -102.92 163.06 12.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.287 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -148.3 133.79 18.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 111.711 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.405 ' HB3' ' H ' ' A' ' 68' ' ' ASP . 1.3 tptt 70.28 -94.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.177 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.405 ' H ' ' HB3' ' A' ' 67' ' ' LYS . 2.0 m-20 -98.23 -15.06 20.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 127.95 34.48 0.55 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.124 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -92.67 159.6 15.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.368 . . . . 0.0 110.193 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.6 mp -79.85 114.45 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.235 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.5 tt . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 121.038 0.447 . . . . 0.0 111.446 179.766 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.783 0.325 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.1 p -98.96 159.07 15.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -78.4 -50.12 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.07 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -97.02 156.71 16.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.993 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -67.46 129.59 40.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.6 p -111.76 -174.48 2.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.404 ' OG ' ' CD2' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -91.82 -29.67 16.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.147 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.09 111.53 18.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.603 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 t -105.91 139.51 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.019 0.437 . . . . 0.0 111.156 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.498 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 68.9 t80 -129.42 106.63 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.649 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -102.0 128.89 48.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.3 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.6 pt -138.52 124.64 24.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.583 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.82 -68.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.24 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 87' ' ' ILE . 1.3 p30 -169.33 35.21 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.253 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -137.06 113.18 9.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.1 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.409 ' O ' ' CD ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -81.0 124.69 29.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.63 165.07 14.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.102 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 93' ' ' TYR . 1.5 m-85 -129.22 165.21 21.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.206 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.63 169.58 21.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.12 0.486 . . . . 0.0 111.984 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -99.3 -11.83 20.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.061 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 162' ' ' VAL . 0.9 OUTLIER -154.44 162.09 41.34 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.978 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.79 -22.28 3.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.769 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.86 -51.5 5.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.693 0.282 . . . . 0.0 111.288 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.55 -26.39 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.7 -32.34 70.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.309 . . . . 0.0 110.764 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . 12.3 tp -148.76 167.35 25.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.36 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.1 tp -118.61 -41.19 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.958 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -162.89 102.77 1.03 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.778 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.485 ' O ' HG23 ' A' ' 107' ' ' ILE . 15.6 Cg_exo -68.16 -25.78 36.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.75 2.3 . . . . 0.0 112.556 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.64 48.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.524 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 tt -83.05 -42.17 17.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.615 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 104' ' ' PRO . 1.6 tp -53.85 -48.73 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.192 0.52 . . . . 0.0 111.631 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.52 21.53 24.04 Favored Glycine 0 C--N 1.319 -0.396 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.764 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.32 173.52 14.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.955 0.407 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -78.33 151.54 32.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.868 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.47 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . . . -136.67 109.72 7.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.3 mtt-85 -82.28 119.76 24.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.761 0.791 . . . . 0.0 111.08 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.2 t -110.07 127.46 66.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.513 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.6 m -116.41 137.23 52.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.248 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.42 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 1.5 m -140.97 172.91 12.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.379 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.404 ' CD2' ' OG ' ' A' ' 82' ' ' SER . 2.6 p80 -133.58 130.23 38.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 21.3 m -56.76 122.53 12.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.943 0.402 . . . . 0.0 111.841 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.17 -9.72 42.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.615 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.461 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -121.81 -51.14 2.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.963 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.5 HG21 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -75.5 -21.8 57.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.836 0.351 . . . . 0.0 110.728 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.12 34.06 87.83 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.948 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.5 ' CB ' HG21 ' A' ' 120' ' ' THR . . . -103.09 166.26 12.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.516 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -91.6 111.23 0.31 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.996 2.464 . . . . 0.0 111.196 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.42 ' CG2' ' CB ' ' A' ' 115' ' ' SER . 22.0 m -107.7 146.42 13.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.485 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 93.2 p -144.91 142.59 29.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.394 0.616 . . . . 0.0 110.216 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -132.91 154.13 50.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.539 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 22.4 m -110.79 112.38 24.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.376 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.423 ' CG1' ' CG ' ' A' ' 104' ' ' PRO . 2.8 t -96.87 111.99 28.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.913 0.387 . . . . 0.0 111.423 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 m -108.31 160.73 25.96 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.167 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.23 -16.44 40.5 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.516 2.144 . . . . 0.0 112.968 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 78.1 p -114.35 -27.31 7.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 131' ' ' SER . 0.4 OUTLIER 178.95 -162.83 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.165 0.507 . . . . 0.0 110.061 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -94.8 166.24 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.657 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -155.17 19.39 0.43 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.14 85.79 0.07 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.973 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 51.5 t -100.37 114.87 40.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.522 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -146.37 125.24 6.47 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.235 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.99 155.68 97.46 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 123.515 -1.452 . . . . 0.0 111.847 -0.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.7 161.32 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 67.41 11.68 59.87 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.132 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 166' ' ' ALA . 12.6 ptp -61.55 156.59 19.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.151 0.501 . . . . 0.0 111.844 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.03 152.38 49.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.183 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.463 ' CG2' HG11 ' A' ' 189' ' ' VAL . 11.4 t -113.25 151.64 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.688 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.468 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 14.8 p -120.62 139.51 52.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.795 0.331 . . . . 0.0 110.769 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.06 176.34 8.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.832 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.938 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 96' ' ' CYS . 15.1 t . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.958 0.409 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -128.34 169.39 14.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.676 0.75 . . . . 0.0 110.387 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.453 ' CZ ' ' CG2' ' A' ' 143' ' ' VAL . 3.2 m-85 -110.48 151.54 27.42 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.678 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.47 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 17.8 m-85 -129.15 137.36 51.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.559 0.695 . . . . 0.0 110.358 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -42.7 -28.26 0.22 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.125 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.721 ' HB3' ' HD2' ' A' ' 169' ' ' PRO . 1.0 OUTLIER -166.72 171.62 11.33 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.754 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.587 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 92.6 t -68.96 -36.44 7.65 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.341 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.721 ' HD2' ' HB3' ' A' ' 167' ' ' SER . 11.4 Cg_exo -71.37 -37.14 6.02 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.749 2.299 . . . . 0.0 110.063 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.15 -40.22 53.11 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -62.04 -45.96 91.27 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.671 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 1.4 mm-40 -78.99 -27.66 43.38 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.452 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.709 ' N ' ' O ' ' A' ' 169' ' ' PRO . 13.5 t0 -70.43 -55.61 8.61 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.461 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 30.4 t-105 -65.28 -28.98 69.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.712 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.671 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -64.44 -39.97 94.85 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.394 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.41 -43.7 62.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.396 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -96.02 22.77 7.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.113 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.442 ' CE1' ' NE1' ' A' ' 174' ' ' TRP . 0.3 OUTLIER -132.82 29.16 4.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.928 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.879 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.9 tp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.872 0.367 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.43 149.91 41.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.118 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.455 HG22 ' CB ' ' A' ' 171' ' ' ALA . 15.4 mm -102.11 160.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.955 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.408 ' N ' HG21 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.95 163.16 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.221 0.534 . . . . 0.0 111.89 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -86.31 127.97 34.86 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.774 178.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.463 HG11 ' CG2' ' A' ' 143' ' ' VAL . 0.9 OUTLIER -45.16 -22.27 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.685 179.344 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.408 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.8 t-160 -71.9 -43.3 65.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.185 0.517 . . . . 0.0 109.785 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.3 OUTLIER -82.15 -21.0 36.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.353 179.036 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.45 -25.31 64.04 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.776 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.421 ' CE2' HG12 ' A' ' 128' ' ' VAL . 2.4 m-85 -81.35 -24.89 36.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.111 0.481 . . . . 0.0 110.664 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.99 -31.01 29.98 Favored Glycine 0 CA--C 1.51 -0.273 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.314 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.9 tp -81.06 -29.66 34.96 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -81.23 -26.15 52.98 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -82.18 -21.76 36.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.963 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.99 -23.01 41.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.247 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -51.76 -37.46 51.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.063 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.98 -40.82 23.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.035 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.685 0.278 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.55 -40.43 54.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.676 2.25 . . . . 0.0 112.422 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 mp -52.79 -57.18 11.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.308 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.3 -27.16 42.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.051 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -67.52 -53.36 29.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.08 -26.5 66.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 tp -71.8 -36.77 70.39 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.802 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.26 -29.33 32.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.229 0.538 . . . . 0.0 110.836 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -19.31 65.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.142 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.18 51.75 50.15 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.061 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.6 mtp85 -127.47 165.91 26.57 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.743 0.306 . . . . 0.0 110.741 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.19 111.55 2.05 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.399 2.066 . . . . 0.0 112.097 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.409 ' CG2' HG23 ' A' ' 41' ' ' THR . 8.1 p -125.85 109.76 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.272 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t -94.99 -170.06 2.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.965 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' ALA . 20.0 ptt-85 -72.55 -38.69 67.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.608 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -31.0 71.73 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.244 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -83.1 -41.91 18.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 9.3 tp -62.18 -36.69 82.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -72.41 -43.19 64.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.646 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.57 -31.68 76.96 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.587 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 41' ' ' THR . 6.9 mt -78.95 -44.07 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.106 0.479 . . . . 0.0 110.423 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 6.9 mp -76.75 -9.38 58.63 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.518 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.2 t70 60.08 21.84 11.04 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -100.27 155.86 35.92 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.223 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.58 139.96 35.18 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.551 2.167 . . . . 0.0 112.132 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.14 -19.2 1.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -77.84 -35.49 51.1 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 111.279 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -40.34 88.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.39 -48.47 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.54 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.1 -53.93 43.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.259 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.67 75.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.3 t -68.6 -31.01 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.711 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.35 -35.62 80.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.679 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.43 -44.95 85.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.701 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -76.75 -9.78 58.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.038 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.4 73.62 0.89 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.723 0.773 . . . . 0.0 110.397 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.5 p -96.99 -24.33 15.86 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.138 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -70.26 -25.46 63.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.216 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.48 141.16 31.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.242 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.92 126.9 31.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.063 0.459 . . . . 0.0 111.376 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.405 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 64.1 m-85 -104.29 170.85 7.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.323 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -156.12 145.43 20.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.031 0.443 . . . . 0.0 111.344 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp 66.74 -103.78 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.8 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -92.3 -13.57 30.13 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 125.92 30.76 0.85 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.154 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -87.34 163.44 16.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.79 118.28 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.187 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.208 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.408 ' CD1' ' CD1' ' A' ' 92' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.777 0.322 . . . . 0.0 110.736 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.44 HG21 ' CD1' ' A' ' 95' ' ' TRP . 18.0 p -126.43 159.61 32.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.2 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -48.18 -86.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.583 0.23 . . . . 0.0 110.804 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.433 ' HG3' ' CD1' ' A' ' 93' ' ' TYR . 4.6 mtp180 -173.71 98.96 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.78 23.54 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.614 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.7 p -120.08 -173.66 2.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.13 0.491 . . . . 0.0 111.648 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 p -101.07 -25.82 13.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.209 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 97' ' ' ALA . 30.0 m-85 -87.49 116.33 25.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 110.613 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.16 144.89 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.066 0.46 . . . . 0.0 111.439 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.491 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 67.9 t80 -131.66 105.85 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.516 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -97.25 129.89 44.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.655 0.264 . . . . 0.0 111.269 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.438 ' CG2' ' HB2' ' A' ' 111' ' ' ALA . 1.0 OUTLIER -140.07 125.61 20.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.69 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 87' ' ' ILE . 17.0 t0 -154.35 37.46 0.43 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.664 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -141.48 145.85 35.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.297 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.04 86.59 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.904 0.383 . . . . 0.0 110.867 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -71.1 164.55 25.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.433 ' CD1' ' HG3' ' A' ' 79' ' ' ARG . 2.1 m-85 -135.36 161.68 34.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.548 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.423 ' HB2' ' N ' ' A' ' 100' ' ' THR . . . -148.1 163.72 36.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.057 0.456 . . . . 0.0 111.592 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.44 ' CD1' HG21 ' A' ' 77' ' ' THR . 21.7 m0 -84.24 -20.25 32.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.509 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -158.59 -177.38 6.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.091 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.453 ' N ' ' CD2' ' A' ' 83' ' ' TYR . . . -61.38 -16.45 46.58 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.5 tt -86.62 -51.64 6.02 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.08 -21.24 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.483 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -66.1 -39.58 90.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.592 0.234 . . . . 0.0 111.491 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.414 ' O ' ' HB ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -92.1 -83.92 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 101' ' ' LEU . 25.5 mm 78.25 -59.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.654 0.264 . . . . 0.0 111.113 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.4 ' N ' ' HD3' ' A' ' 104' ' ' PRO . 7.2 m-85 -151.25 65.95 6.89 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 111.056 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.501 ' O ' HG21 ' A' ' 107' ' ' ILE . 12.3 Cg_exo -71.3 -28.72 18.0 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.969 2.446 . . . . 0.0 112.551 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.6 -23.48 42.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.94 0.4 . . . . 0.0 111.584 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.93 -31.29 31.4 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.501 HG21 ' O ' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -56.64 -46.36 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.998 0.428 . . . . 0.0 111.662 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.16 19.36 21.56 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.828 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 177.23 10.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 110.865 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -75.1 150.87 38.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.665 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.491 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.09 109.82 7.55 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -84.25 120.99 26.87 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.779 0.8 . . . . 0.0 110.915 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.51 130.94 65.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.005 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.7 m -122.22 137.61 54.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.133 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.404 ' CB ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -141.21 172.86 12.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.031 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.421 ' CD2' ' HA ' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -132.1 131.37 42.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 34.0 m -58.15 125.85 24.98 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.03 0.443 . . . . 0.0 112.165 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.421 ' HB1' ' CZ ' ' A' ' 165' ' ' PHE . . . -68.75 -8.03 39.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.049 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HB3' ' CE3' ' A' ' 174' ' ' TRP . . . -119.0 -51.62 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 0.0 111.189 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.48 ' CG2' HG22 ' A' ' 170' ' ' THR . 0.9 OUTLIER -82.66 -23.9 34.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.465 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 116' ' ' HIS . . . 69.82 6.81 57.31 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.923 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.8 160.08 71.08 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 120.609 0.243 . . . . 0.0 110.671 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.421 ' HA ' ' CD2' ' A' ' 116' ' ' HIS . 6.1 Cg_endo -86.55 106.79 0.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.92 2.413 . . . . 0.0 111.033 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.516 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 26.9 m -103.78 146.59 11.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.1 p -152.42 142.17 21.95 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.333 0.587 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -131.96 153.22 50.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.447 178.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 24.0 m -110.02 113.01 25.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.447 HG12 ' CE2' ' A' ' 193' ' ' PHE . 51.5 t -96.53 114.12 32.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.088 0.471 . . . . 0.0 111.955 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.4 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.8 OUTLIER -107.32 169.03 7.16 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.734 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 35.5 Cg_endo -65.86 -19.32 58.67 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.197 1.931 . . . . 0.0 112.885 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -110.68 -27.54 8.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.433 ' HA ' ' CE1' ' A' ' 193' ' ' PHE . 3.7 pt-20 178.85 -164.68 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.069 0.462 . . . . 0.0 110.007 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.73 152.12 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.708 178.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.31 21.89 2.77 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.308 0.575 . . . . 0.0 112.445 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.77 87.4 0.09 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.814 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.72 115.05 44.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.347 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.405 ' O ' ' CE ' ' A' ' 141' ' ' MET . 19.3 tt0 -143.13 123.76 8.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.486 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' HE3' ' A' ' 141' ' ' MET . 57.8 Cg_endo -70.95 162.25 87.84 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 123.502 -1.457 . . . . 0.0 112.544 -0.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.19 79.91 1.79 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.16 18.5 0.2 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.268 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.516 ' CE ' ' HB ' ' A' ' 124' ' ' VAL . 0.4 OUTLIER -63.57 164.22 9.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.06 0.457 . . . . 0.0 111.708 -179.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.13 152.09 49.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.439 HG11 ' CD1' ' A' ' 164' ' ' PHE . 3.3 t -115.8 152.05 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.701 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.402 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 8.2 m -120.84 143.1 49.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.958 0.408 . . . . 0.0 111.242 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -123.39 159.53 28.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.604 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.103 179.836 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.879 0.371 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -116.69 169.15 9.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.692 . . . . 0.0 110.336 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.439 ' CD1' HG11 ' A' ' 143' ' ' VAL . 4.7 m-85 -118.64 153.52 34.17 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.076 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.459 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 59.2 m-85 -132.59 136.14 46.35 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.038 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -41.87 -27.68 0.13 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.091 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.511 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 74.0 m -165.5 173.67 10.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.194 0.521 . . . . 0.0 111.936 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.8 t -70.0 -33.75 3.75 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.346 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.19 -37.32 3.47 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.688 2.259 . . . . 0.0 110.289 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.563 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.91 -40.27 47.91 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.483 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 167' ' ' SER . . . -61.2 -44.88 96.57 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.595 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.0 mt-10 -78.97 -27.22 43.46 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.232 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.69 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.2 t70 -71.04 -55.94 7.2 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.429 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.416 ' CE3' ' HB3' ' A' ' 119' ' ' ALA . 41.3 t-105 -64.59 -28.0 69.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.726 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.595 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -65.01 -40.37 94.8 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.359 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.25 -43.26 61.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.382 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -95.77 21.86 7.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.374 0.607 . . . . 0.0 111.194 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.71 27.42 5.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.78 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.77 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.871 0.367 . . . . 0.0 110.764 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.89 150.09 41.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.077 0.465 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.442 HG23 ' CB ' ' A' ' 171' ' ' ALA . 12.9 mm -100.91 160.41 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.832 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.54 159.16 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.809 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.5 OUTLIER -86.03 124.96 33.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.908 178.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -47.83 -20.59 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.608 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -69.35 -41.41 76.63 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.6 mt-10 -82.6 -26.46 32.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.058 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.02 64.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.447 ' CE2' HG12 ' A' ' 128' ' ' VAL . 7.9 t80 -81.61 -26.17 35.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.689 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.93 -30.06 32.84 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.1 mt -82.11 -27.35 32.88 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.11 -26.75 35.88 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.444 ' CG ' ' CE1' ' A' ' 193' ' ' PHE . 46.6 mm-40 -81.91 -24.86 35.4 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.041 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 -22.96 61.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -51.97 -42.4 62.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.272 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -81.18 -29.57 34.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.005 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.233 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.784 0.326 . . . . 0.0 111.096 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.71 -46.19 35.22 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.589 2.193 . . . . 0.0 112.355 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.95 -57.24 10.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 mt -72.7 -27.11 61.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.814 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.52 -53.22 55.29 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.598 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -69.91 -26.51 64.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.163 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tp -70.68 -44.2 67.49 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.686 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.22 -28.54 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.138 0.494 . . . . 0.0 110.89 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -64.77 -20.44 66.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.181 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.37 54.05 25.57 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.296 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -133.04 165.36 37.33 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.298 . . . . 0.0 110.719 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.38 113.5 3.33 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.464 2.109 . . . . 0.0 112.088 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.7 t -117.98 109.88 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.458 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.2 p -87.97 179.63 6.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.836 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -70.13 -37.46 75.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.306 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -30.11 70.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 110.074 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -82.92 -41.96 18.25 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.401 ' CD1' ' CD1' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -62.49 -37.02 84.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -71.64 -43.29 66.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.626 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.68 -31.03 72.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.807 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' THR . 6.8 mt -78.59 -43.98 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-O 120.997 0.427 . . . . 0.0 110.519 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.06 -10.18 59.21 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.387 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 61.0 21.41 11.75 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.427 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 29.6 m95 -107.26 138.78 19.98 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.018 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.34 140.54 34.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.74 2.294 . . . . 0.0 112.053 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.33 -16.88 0.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -78.86 -31.86 45.78 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.292 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.427 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -68.61 -40.86 80.21 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.64 -47.62 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.635 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.83 -52.35 57.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.352 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.22 -43.09 67.0 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.786 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.7 -33.58 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.756 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.2 mt -61.75 -35.88 79.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.657 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -57.55 -26.33 61.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.717 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -90.49 -16.46 28.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.028 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.61 33.58 2.24 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.398 0.618 . . . . 0.0 111.006 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 65.6 p -58.93 -20.88 56.02 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.009 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 p -88.76 -22.94 23.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.352 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.41 141.21 55.15 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.327 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.37 132.16 34.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 111.685 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.412 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 76.9 m-85 -105.73 173.23 6.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -150.37 146.8 26.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.047 0.451 . . . . 0.0 111.535 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 tptt 66.28 -102.64 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.853 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -90.36 -10.46 43.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 119.94 29.56 1.65 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.951 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -86.01 171.31 11.51 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.401 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 4.1 mp -79.76 116.8 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.316 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 tt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.252 179.916 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.836 0.35 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.8 t -111.01 159.0 18.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.27 -25.82 64.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -102.86 146.99 27.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.005 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -63.56 129.63 40.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.9 p -106.36 -176.47 3.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.011 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.1 m -89.57 -31.83 17.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.439 ' CE2' ' N ' ' A' ' 97' ' ' ALA . 5.3 m-85 -89.53 117.67 28.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.446 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.8 t -108.75 139.12 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.078 0.466 . . . . 0.0 111.114 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.518 ' CE1' ' HB1' ' A' ' 111' ' ' ALA . 30.3 t80 -123.1 106.92 11.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.887 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.2 124.08 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.741 0.305 . . . . 0.0 111.144 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.482 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.15 126.29 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.62 -77.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.317 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.0 t70 -156.11 37.0 0.34 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.633 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -141.45 147.44 37.91 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.578 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.2 86.41 2.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 0.0 110.752 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 85' ' ' PHE . 3.9 mm? -71.46 164.49 25.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.628 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -131.88 158.9 40.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.749 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.52 163.03 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.281 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -88.33 -5.64 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.137 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.0 OUTLIER 176.06 -175.2 0.11 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.006 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.453 ' CB ' ' CD1' ' A' ' 164' ' ' PHE . . . -61.3 149.42 38.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.76 0.315 . . . . 0.0 110.761 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 97' ' ' ALA . 20.0 mt 82.62 -52.32 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.05 -25.09 1.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.937 0.399 . . . . 0.0 111.166 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.494 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 3.1 p -60.15 -39.32 85.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.759 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 22.9 tp -131.4 165.17 24.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.228 0.537 . . . . 0.0 111.842 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.452 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 3.3 pt -121.92 -37.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.885 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.452 ' CE2' ' CD1' ' A' ' 102' ' ' ILE . 2.4 p90 -165.61 103.29 0.74 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.507 ' O ' HG23 ' A' ' 107' ' ' ILE . 74.0 Cg_endo -75.15 -27.58 9.65 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.745 2.297 . . . . 0.0 112.897 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.17 -23.65 54.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.703 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.71 -40.99 16.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.58 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.507 HG23 ' O ' ' A' ' 104' ' ' PRO . 1.8 tp -56.0 -49.22 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.183 0.516 . . . . 0.0 111.531 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.04 24.02 18.34 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.768 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -152.41 173.24 15.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 111.037 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.79 151.8 28.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.862 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.518 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -137.4 110.16 7.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -81.44 120.23 24.73 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.719 0.771 . . . . 0.0 111.448 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.433 HG23 ' CG2' ' A' ' 128' ' ' VAL . 58.6 t -112.55 129.63 67.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.79 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 m -122.49 137.15 54.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.393 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.438 ' HB2' ' CG2' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -141.76 173.1 11.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.179 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -134.85 135.44 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 36.2 t -64.35 133.83 53.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.532 . . . . 0.0 112.132 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.43 -4.05 24.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.214 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.442 ' HB1' ' CD2' ' A' ' 174' ' ' TRP . . . -123.37 -51.04 1.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 111.673 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.525 HG23 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -87.38 -25.1 24.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.016 -179.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.21 5.58 72.01 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.094 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.525 ' CB ' HG23 ' A' ' 120' ' ' THR . . . -58.7 147.19 72.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.618 0.247 . . . . 0.0 110.513 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.35 104.7 1.66 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.56 2.174 . . . . 0.0 110.422 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.483 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 35.3 m -101.4 145.65 11.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.397 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.1 p -152.53 142.07 21.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.484 0.659 . . . . 0.0 110.929 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -134.88 153.12 52.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.464 178.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 21.2 m -109.36 113.09 25.61 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.433 ' CG2' HG23 ' A' ' 113' ' ' VAL . 29.2 t -96.1 111.86 27.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.118 0.485 . . . . 0.0 111.819 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.59 175.51 2.03 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.975 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.43 -6.25 18.76 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.548 2.166 . . . . 0.0 113.286 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m -122.77 -31.31 3.71 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.405 ' HA ' ' CE2' ' A' ' 193' ' ' PHE . 14.5 pt-20 -179.7 -162.3 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 110.005 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -91.78 144.3 9.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.563 178.234 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -133.6 18.2 3.93 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.392 0.615 . . . . 0.0 112.412 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.03 86.34 0.08 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.523 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 37.2 t -105.65 120.62 56.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.898 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -146.21 122.14 5.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.08 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -68.23 167.73 63.35 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.626 -1.406 . . . . 0.0 112.951 -0.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.7 83.7 7.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.97 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 140.87 21.08 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.046 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.483 ' CE ' ' HB ' ' A' ' 124' ' ' VAL . 9.1 mtp -60.98 164.72 4.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.144 0.497 . . . . 0.0 111.968 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -131.92 151.87 51.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.82 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.47 HG13 ' CD1' ' A' ' 164' ' ' PHE . 7.6 t -112.77 148.98 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.417 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.444 ' O ' ' HB ' ' A' ' 162' ' ' VAL . 64.4 m -118.29 143.53 46.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.77 0.319 . . . . 0.0 110.854 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.408 ' HA ' ' CG1' ' A' ' 162' ' ' VAL . 0.6 OUTLIER -99.9 147.23 25.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.954 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.971 179.816 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 144' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 111.38 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -113.68 159.45 19.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.679 0.752 . . . . 0.0 110.177 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.47 ' CD1' HG13 ' A' ' 143' ' ' VAL . 2.3 m-85 -116.9 129.74 56.26 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.837 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 142' ' ' ALA . 29.8 m-85 -108.53 142.39 39.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.449 0.642 . . . . 0.0 110.796 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.19 -26.15 2.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.888 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.556 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 50.7 m -163.3 167.68 21.54 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.862 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 75.1 t -67.92 -33.64 5.35 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.07 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.713 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.4 Cg_exo -73.01 -37.49 3.49 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.667 2.244 . . . . 0.0 110.336 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.566 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.16 -40.59 52.19 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.492 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.8 -45.94 91.67 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.611 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.9 mt-10 -78.81 -27.39 44.4 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.313 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.713 ' N ' ' O ' ' A' ' 169' ' ' PRO . 9.5 t70 -70.65 -55.86 7.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.383 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.442 ' CD2' ' HB1' ' A' ' 119' ' ' ALA . 41.9 t-105 -64.91 -28.62 69.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.765 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.611 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -64.9 -40.72 95.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.317 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 40.7 t -50.85 -42.55 58.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.369 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.1 20.87 8.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.308 0.575 . . . . 0.0 111.271 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.5 25.01 7.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.788 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.787 0.327 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.17 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.455 HG23 ' HB2' ' A' ' 171' ' ' ALA . 14.5 mm -102.32 162.01 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.937 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.69 166.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.265 0.555 . . . . 0.0 111.794 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -89.59 128.13 35.99 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.014 178.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.421 HG13 ' CE2' ' A' ' 164' ' ' PHE . 1.4 m -45.88 -21.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.621 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.402 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.8 t60 -71.47 -42.72 67.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.215 0.531 . . . . 0.0 109.98 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -82.28 -21.58 36.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -73.86 -25.23 59.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.092 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.408 ' O ' ' CB ' ' A' ' 197' ' ' GLN . 72.7 t80 -81.6 -24.77 36.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.585 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.84 -29.11 35.86 Favored Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.3 mp -82.06 -28.4 32.44 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.32 -28.84 29.26 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.543 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 1.3 tm0? -82.24 -25.26 34.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.575 -0.312 . . . . 0.0 111.28 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -76.86 -22.79 52.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.124 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -51.82 -33.63 36.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.963 0.411 . . . . 0.0 111.082 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -81.06 -53.78 6.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.964 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.91 -17.02 46.57 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.583 2.189 . . . . 0.0 112.552 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tp -52.76 -57.41 10.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.368 . . . . 0.0 111.01 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.09 -27.05 64.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.76 -53.22 60.53 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.611 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.34 -23.7 61.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.272 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 tt -63.13 -49.03 75.99 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.479 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.0 18.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.34 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -24.33 61.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.126 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.64 39.58 96.76 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.34 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -133.32 150.06 74.2 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.696 0.284 . . . . 0.0 110.755 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.67 107.07 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.559 2.172 . . . . 0.0 111.978 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.0 p -99.23 112.1 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.519 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 p -93.32 175.62 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.422 ' O ' ' N ' ' A' ' 43' ' ' ALA . 2.1 mpp_? -65.26 -40.33 93.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.302 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -25.09 67.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.869 0.366 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -86.11 -43.3 13.17 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -36.28 82.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -73.2 -43.0 62.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.595 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.79 -30.7 72.58 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.697 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 41' ' ' THR . 6.9 mt -78.42 -44.75 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 120.999 0.428 . . . . 0.0 110.563 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -75.65 -9.85 58.93 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.491 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t70 59.72 21.92 10.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.446 ' CZ2' ' NH1' ' A' ' 52' ' ' ARG . 1.8 m0 -109.27 146.02 33.03 Favored Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.217 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.13 143.18 52.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.557 2.171 . . . . 0.0 112.063 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.19 -16.9 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.65 -33.61 47.04 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.236 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.446 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -67.95 -41.2 82.83 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.417 HG23 ' HB1' ' A' ' 43' ' ' ALA . 2.1 t -63.29 -47.65 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.544 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.49 -52.32 59.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.269 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.67 -36.65 25.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.019 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.9 t -59.4 -35.81 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.035 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 mp -60.93 -32.43 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.873 0.368 . . . . 0.0 110.723 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -58.65 -34.8 71.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.467 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -100.19 -20.42 15.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.87 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.59 33.44 3.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.476 0.655 . . . . 0.0 110.742 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.1 p -66.99 -13.87 62.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.343 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 p -88.02 -23.57 23.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.325 . . . . 0.0 111.359 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.22 141.47 50.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.016 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.68 126.99 31.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 111.326 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -102.1 173.13 6.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.465 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -97.18 -172.88 2.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -34.5 76.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.955 0.407 . . . . 0.0 111.128 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.28 1.7 55.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.343 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.05 14.45 60.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.267 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -86.79 146.82 26.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.491 0.645 . . . . 0.0 109.881 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 72' ' ' ILE . 1.7 mp -79.76 143.28 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.905 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.448 ' CB ' ' O ' ' A' ' 71' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.466 0.331 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.692 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 mt . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.983 0.42 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.01 159.53 17.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.72 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.72 24.96 1.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.619 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 51.56 96.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.808 0.337 . . . . 0.0 111.505 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -156.21 -84.76 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.483 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.37 163.7 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.844 0.354 . . . . 0.0 111.592 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.3 m -82.18 -5.88 58.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.97 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -66.21 96.77 0.35 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 110.293 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -109.69 144.71 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.369 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.472 ' CZ ' ' CG2' ' A' ' 87' ' ' ILE . 33.5 t80 -131.16 107.57 9.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.086 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -102.72 132.46 48.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.517 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' ASP . 2.3 pt -138.74 123.0 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.396 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.12 -67.5 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.134 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.6 m-20 -168.54 34.82 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.304 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -135.57 112.49 10.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.968 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -82.11 124.63 30.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.971 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 85' ' ' PHE . 2.8 mm? -115.57 165.1 13.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -129.75 165.21 22.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.994 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 99' ' ' ASP . . . -153.48 170.97 19.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.939 0.4 . . . . 0.0 111.705 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -95.25 -17.95 21.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.679 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 98.9 m -152.54 166.48 31.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.255 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.469 ' CB ' ' CE1' ' A' ' 164' ' ' PHE . . . -54.21 -21.08 8.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.93 -51.73 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 41.4 t0 -50.1 -23.23 2.0 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.409 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -60.11 -32.67 71.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.676 0.274 . . . . 0.0 110.688 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 85' ' ' PHE . 50.9 tp -140.84 162.22 35.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 111.296 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.24 -39.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.28 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.424 ' CG ' ' HB2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -163.19 103.22 1.0 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.099 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.493 ' O ' HG21 ' A' ' 107' ' ' ILE . 74.4 Cg_endo -74.91 -31.76 6.1 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.575 2.184 . . . . 0.0 112.609 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 130' ' ' PRO . . . -79.08 -23.83 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.456 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.424 ' HB2' ' CG ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -82.43 -40.89 20.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.36 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 104' ' ' PRO . 1.3 tp -56.1 -47.15 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.154 0.502 . . . . 0.0 111.556 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.04 21.41 20.72 Favored Glycine 0 C--N 1.32 -0.338 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.836 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 174.68 13.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.01 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -79.46 151.77 30.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.671 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.464 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . . . -137.02 109.95 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 65.0 mtm-85 -82.22 121.63 26.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.745 0.783 . . . . 0.0 110.975 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.4 t -113.6 130.76 67.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.961 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.8 m -121.18 137.48 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.735 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.403 ' HB3' HG22 ' A' ' 124' ' ' VAL . 3.1 t -141.06 173.01 11.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.347 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -131.14 130.74 43.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 23.3 m -56.68 123.97 16.75 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.95 0.405 . . . . 0.0 111.811 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.42 ' HB1' ' CE1' ' A' ' 165' ' ' PHE . . . -67.8 -9.44 44.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.617 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.471 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -122.14 -50.64 2.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.507 HG21 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -77.12 -21.05 54.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.815 0.34 . . . . 0.0 110.895 -178.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.87 33.58 85.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.157 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.507 ' CB ' HG21 ' A' ' 120' ' ' THR . . . -102.0 169.12 8.02 Favored Pre-proline 0 N--CA 1.453 -0.324 0 CA-C-N 115.459 -0.37 . . . . 0.0 110.372 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -92.98 108.23 0.19 Allowed 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.92 2.413 . . . . 0.0 111.454 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.427 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 35.7 m -105.43 146.26 12.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.45 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.8 p -148.99 142.49 25.32 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.397 0.618 . . . . 0.0 110.695 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -139.08 151.85 47.06 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.852 178.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 40.3 m -107.64 114.09 27.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.053 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.7 t -96.56 111.83 27.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.853 0.358 . . . . 0.0 111.412 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -106.69 172.18 4.09 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.009 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 105' ' ' ALA . 14.9 Cg_exo -68.83 -14.64 39.34 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.42 2.08 . . . . 0.0 112.995 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 1.1 t -117.86 -26.46 6.48 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 131' ' ' SER . 21.1 pt-20 178.65 -162.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.124 0.488 . . . . 0.0 110.01 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.88 159.2 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.849 178.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -145.67 19.34 1.49 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.402 0.62 . . . . 0.0 112.274 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.91 86.45 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.493 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.2 t -102.42 116.06 45.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.087 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -146.36 121.49 5.47 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.721 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.5 155.35 98.95 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.542 -1.441 . . . . 0.0 112.243 -0.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.29 78.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 147.76 15.84 0.13 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.503 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.427 ' CE ' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -60.69 157.88 13.79 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.187 0.494 . . . . 0.0 111.227 -179.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.63 151.98 48.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.917 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.445 ' CG1' ' CE1' ' A' ' 164' ' ' PHE . 4.6 t -113.83 150.41 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.307 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.04 146.29 46.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.906 0.384 . . . . 0.0 111.078 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -122.08 158.12 29.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.651 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.269 179.935 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.998 0.428 . . . . 0.0 111.595 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -115.37 169.14 9.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.611 0.719 . . . . 0.0 109.677 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 97' ' ' ALA . 3.2 m-85 -117.23 153.51 32.75 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.293 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.483 ' HB3' HG23 ' A' ' 170' ' ' THR . 42.3 m-85 -133.16 137.32 46.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.166 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -38.9 -29.05 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.869 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 5.0 p -172.02 178.55 2.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.04 0.448 . . . . 0.0 111.54 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.606 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 77.8 t -69.13 -33.14 3.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.583 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.685 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.3 Cg_exo -72.98 -39.31 2.34 Favored 'Trans proline' 0 CA--C 1.505 -0.936 0 C-N-CA 122.731 2.288 . . . . 0.0 110.586 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.542 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.34 -39.44 53.92 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.508 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.86 -46.04 91.16 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.6 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.3 mt-10 -78.81 -27.66 44.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.225 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.685 ' N ' ' O ' ' A' ' 169' ' ' PRO . 22.7 t0 -71.04 -55.74 7.63 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.43 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.471 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 8.1 t-105 -64.79 -28.49 69.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.702 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.6 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -64.96 -40.33 94.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.249 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.55 -42.79 55.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.402 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.407 ' O ' ' CD2' ' A' ' 178' ' ' HIS . 0.2 OUTLIER -97.1 23.7 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.338 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.407 ' CD2' ' O ' ' A' ' 177' ' ' LYS . 11.1 m170 -152.87 45.12 0.68 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.926 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.872 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 29.6 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.734 0.302 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.14 142.64 46.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.141 0.496 . . . . 0.0 111.3 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.461 HG22 ' CB ' ' A' ' 171' ' ' ALA . 16.0 mm -101.69 160.85 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.758 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.71 157.47 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.233 0.54 . . . . 0.0 112.013 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.5 OUTLIER -86.02 127.98 34.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.767 178.461 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.422 HG12 ' CE2' ' A' ' 164' ' ' PHE . 2.1 m -46.43 -20.93 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.874 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.4 ' N ' ' C ' ' A' ' 188' ' ' SER . 1.8 t-80 -73.67 -43.3 59.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.208 0.527 . . . . 0.0 109.761 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.38 -20.86 36.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.378 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.2 -25.36 61.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.972 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -81.81 -30.96 31.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.252 0.548 . . . . 0.0 110.37 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.07 -33.48 23.52 Favored Glycine 0 CA--C 1.509 -0.31 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.336 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.2 tt -76.65 -29.65 56.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.58 -26.88 37.26 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -82.71 -22.69 34.4 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.445 -0.377 . . . . 0.0 110.87 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.38 -22.95 43.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.424 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -51.95 -26.87 11.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 111.168 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -81.18 -54.31 5.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.155 -179.861 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.684 0.278 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.04 -35.68 4.0 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.452 2.101 . . . . 0.0 112.384 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 mt -53.9 -57.47 10.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.194 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.44 -26.87 44.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.259 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -63.72 -53.21 54.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.152 0.501 . . . . 0.0 109.982 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -78.88 -27.47 44.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.627 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 tt -69.78 -52.42 25.37 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.794 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.63 -25.93 63.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 110.822 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -70.0 -23.3 63.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.047 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.63 48.8 82.3 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.147 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -133.09 150.17 74.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.715 0.293 . . . . 0.0 110.855 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.64 106.36 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.536 2.157 . . . . 0.0 112.397 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.32 109.9 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.221 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 p -84.15 -175.01 5.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.962 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 43' ' ' ALA . 9.3 mtp180 -76.93 -35.97 56.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.471 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -25.83 67.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.894 0.378 . . . . 0.0 110.348 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -86.05 -42.74 13.69 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.43 -35.92 82.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -74.06 -42.57 60.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.425 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.95 -30.98 74.54 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.567 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.0 mt -79.09 -43.0 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.04 0.448 . . . . 0.0 110.432 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mp -78.16 -7.75 57.45 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.509 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.66 23.41 6.15 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.63 145.4 31.22 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.264 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.07 139.61 70.95 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.415 2.077 . . . . 0.0 111.961 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.79 -17.46 0.94 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -78.56 -32.49 47.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.285 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 mmt85 -67.66 -41.27 84.02 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.0 -48.07 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.516 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.01 -51.79 62.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.469 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.64 -37.47 18.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.6 t -60.21 -33.06 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.754 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.06 -26.51 36.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.057 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -56.63 -22.7 36.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.197 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -1.67 11.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.231 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.77 72.19 0.78 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.819 0.819 . . . . 0.0 110.618 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.3 p -77.79 -3.96 44.02 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.376 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.2 m -113.14 39.92 2.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.061 0.458 . . . . 0.0 110.706 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.44 141.43 29.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.081 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.79 126.58 30.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.067 0.46 . . . . 0.0 111.237 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 69' ' ' GLY . 31.8 m-85 -119.51 160.83 21.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.402 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.52 145.6 22.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 111.289 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 tptt 66.06 -102.71 0.08 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.68 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.86 -14.04 32.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.728 0.299 . . . . 0.0 111.767 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 122.79 30.08 1.18 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.145 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -87.39 170.01 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.069 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.0 mt -79.7 117.37 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.355 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.109 -179.99 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.777 0.322 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.8 p -132.42 159.06 40.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt -85.24 5.72 29.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.476 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.44 113.26 24.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -55.77 -23.15 27.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.332 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER 35.66 -166.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 m -104.82 -25.92 12.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.4 ' OH ' ' CD2' ' A' ' 163' ' ' HIS . 4.8 m-85 -85.5 117.19 24.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.454 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.43 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.6 t -109.09 142.54 21.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.001 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.494 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 54.5 t80 -130.05 106.95 8.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.62 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -99.53 126.51 45.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.167 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -135.47 122.73 35.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.847 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t0 61.02 -69.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.319 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 87' ' ' ILE . 7.5 t70 -167.48 35.29 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.196 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.0 mmt-85 -137.6 113.24 9.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.986 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.55 121.9 25.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.501 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.93 164.69 13.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.323 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -129.03 165.0 22.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.038 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HB3' ' N ' ' A' ' 100' ' ' THR . . . -152.65 169.03 23.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.987 0.422 . . . . 0.0 112.105 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.3 m95 -95.03 -19.59 20.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.783 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.48 166.64 30.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.091 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.48 ' CB ' ' CD1' ' A' ' 164' ' ' PHE . . . -51.93 -23.28 4.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tp -86.38 -51.65 6.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.745 0.307 . . . . 0.0 111.434 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.03 -28.28 0.67 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.972 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -60.46 -39.56 88.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 0.0 110.725 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 pp -111.08 -173.45 2.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 0.0 111.232 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 tp -165.22 -42.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.052 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -162.98 76.15 1.91 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.023 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.484 ' O ' HG22 ' A' ' 107' ' ' ILE . 25.7 Cg_exo -62.96 -34.78 69.87 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.632 2.221 . . . . 0.0 112.374 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.18 -23.66 43.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.472 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -84.15 -39.23 19.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.409 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -58.05 -45.97 88.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.098 0.475 . . . . 0.0 111.371 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.94 24.03 16.23 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.474 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.26 173.73 14.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 111.038 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -80.65 155.3 26.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.494 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.11 109.83 7.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -81.9 119.8 24.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.771 0.796 . . . . 0.0 111.178 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.423 HG22 ' CG2' ' A' ' 128' ' ' VAL . 96.6 t -112.69 130.22 66.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.061 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.43 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 59.6 p -121.97 137.78 54.67 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.208 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.423 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 1.1 m -141.37 173.01 11.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.319 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -135.21 134.72 40.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . 0.406 ' O ' ' HA2' ' A' ' 121' ' ' GLY . 35.5 t -62.09 128.84 38.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.142 0.496 . . . . 0.0 111.89 -178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 165' ' ' PHE . . . -69.65 -5.52 25.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.84 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.462 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -121.47 -50.11 2.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.845 0.355 . . . . 0.0 111.682 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.478 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.51 -24.4 21.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.058 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 117' ' ' CYS . . . 74.94 6.78 79.94 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.135 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.478 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -58.19 147.82 64.8 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.643 0.259 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.32 105.73 1.48 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.676 2.251 . . . . 0.0 110.448 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.494 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 27.7 m -103.32 145.7 12.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.945 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.408 ' O ' HD13 ' A' ' 126' ' ' LEU . 77.3 p -153.29 141.3 20.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.237 0.541 . . . . 0.0 110.421 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -136.72 153.6 50.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.258 178.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 89.5 m -105.75 112.57 25.69 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.654 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.423 ' CG2' HG22 ' A' ' 113' ' ' VAL . 62.1 t -96.21 111.95 27.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.935 0.398 . . . . 0.0 111.46 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.44 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -106.14 171.0 5.18 Favored Pre-proline 0 N--CA 1.453 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.853 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 37.7 Cg_endo -67.16 -19.22 51.1 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.028 1.819 . . . . 0.0 112.965 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 8.5 m -109.25 -29.41 8.5 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 131' ' ' SER . 10.5 pt-20 178.63 -161.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.198 0.523 . . . . 0.0 110.101 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -94.26 163.6 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.602 178.424 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -153.07 21.07 0.58 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.295 0.569 . . . . 0.0 112.448 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.95 86.32 0.08 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.445 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.431 ' HA ' HD13 ' A' ' 126' ' ' LEU . 39.5 t -101.59 107.69 22.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.451 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -146.82 119.77 4.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.812 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.63 145.95 83.04 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.582 -1.424 . . . . 0.0 112.222 0.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.94 165.47 5.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.746 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 66.89 13.18 61.15 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.312 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.494 ' CE ' ' HB ' ' A' ' 124' ' ' VAL . 0.5 OUTLIER -61.43 158.3 15.03 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.983 0.42 . . . . 0.0 111.613 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.05 152.35 49.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.241 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.466 HG21 ' CZ ' ' A' ' 164' ' ' PHE . 21.3 t -111.92 151.24 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.575 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.506 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 3.3 p -120.18 140.76 50.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.79 0.328 . . . . 0.0 110.804 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.96 154.71 39.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.914 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.925 179.561 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.5 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.835 0.35 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.4 ' CD2' ' OH ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -117.03 169.23 9.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.602 0.715 . . . . 0.0 110.182 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.48 ' CD1' ' CB ' ' A' ' 97' ' ' ALA . 1.8 m-85 -120.48 132.26 55.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.915 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 144' ' ' SER . 54.5 m-85 -108.65 136.15 48.72 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.144 0.497 . . . . 0.0 110.001 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -46.89 -25.79 0.85 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 40.1 m -163.09 167.49 22.22 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.825 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 77.4 t -68.1 -34.43 6.09 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.97 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.0 Cg_exo -72.69 -36.8 4.48 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 122.753 2.302 . . . . 0.0 110.001 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.75 -40.27 48.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.465 178.007 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.483 ' HA ' ' CG ' ' A' ' 165' ' ' PHE . . . -61.45 -45.24 95.1 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.6 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 95.1 mt-10 -78.93 -27.94 43.77 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.249 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 169' ' ' PRO . 28.3 t70 -70.19 -55.89 8.19 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.457 0.646 . . . . 0.0 109.475 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.469 ' CE2' ' CE1' ' A' ' 178' ' ' HIS . 29.8 t-105 -64.88 -27.74 69.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.83 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.6 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -65.54 -40.27 92.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.265 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -42.29 63.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.471 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -95.11 20.46 9.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.271 0.558 . . . . 0.0 111.435 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.469 ' CE1' ' CE2' ' A' ' 174' ' ' TRP . 0.1 OUTLIER -127.84 29.25 5.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.721 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.802 179.944 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.24 149.9 40.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.447 HG23 ' CB ' ' A' ' 171' ' ' ALA . 10.6 mm -100.29 158.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.937 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.46 161.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.219 0.533 . . . . 0.0 112.016 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -88.08 127.97 35.41 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.652 178.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.467 HG12 ' HG3' ' A' ' 141' ' ' MET . 2.1 m -48.01 -19.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.405 ' N ' ' C ' ' A' ' 188' ' ' SER . 23.6 m-70 -73.02 -44.39 60.96 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -22.3 35.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.524 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.89 -25.18 58.76 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.282 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -81.51 -24.86 36.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.942 0.401 . . . . 0.0 110.666 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.86 -29.81 33.81 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -28.3 31.8 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.04 -28.17 31.89 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -82.15 -21.88 36.37 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.44 -0.38 . . . . 0.0 110.995 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -81.12 -22.84 38.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.126 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.65 -28.32 20.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.129 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -52.39 -55.08 24.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.031 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.618 0.247 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.99 -19.83 64.74 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.49 2.127 . . . . 0.0 112.403 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.5 tt -55.27 -57.62 11.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.447 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.27 -27.36 38.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.334 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.7 ttt-85 -70.86 -53.31 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.941 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -66.5 -25.52 66.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.499 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 tp -72.02 -30.56 65.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.714 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.38 -27.87 26.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.146 0.498 . . . . 0.0 110.944 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -64.76 -19.96 66.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.245 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.64 47.52 89.98 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.134 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.06 143.93 51.46 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.601 0.239 . . . . 0.0 110.676 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -51.46 91.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.458 2.106 . . . . 0.0 112.306 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.1 t -93.17 112.08 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.281 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.9 p -86.73 -176.57 5.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.688 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -75.71 -36.73 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.248 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -27.3 67.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.206 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.94 -42.52 14.88 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -36.7 83.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.412 ' HB3' HG23 ' A' ' 53' ' ' VAL . . . -72.43 -43.02 64.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.625 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.23 -31.72 75.01 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.591 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.1 mt -78.02 -46.15 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 120.968 0.413 . . . . 0.0 110.409 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.58 -9.51 58.64 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.543 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 60.31 21.65 11.14 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -102.0 160.43 26.45 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.25 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.16 138.99 34.54 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.608 2.205 . . . . 0.0 111.925 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.54 -20.27 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -32.25 47.35 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.045 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -67.39 -40.66 85.69 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.447 ' O ' HG11 ' A' ' 56' ' ' VAL . 2.0 t -62.98 -47.85 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.518 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.26 -52.46 58.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.164 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.98 79.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.154 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -66.62 -26.81 38.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.922 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.06 -31.77 66.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.632 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -56.17 -23.18 33.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -88.54 -16.36 32.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.96 33.35 1.92 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.381 0.61 . . . . 0.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.6 p -59.01 -20.76 56.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.01 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.6 m -90.21 -21.43 22.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.366 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.75 141.24 57.13 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.354 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.0 131.09 36.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 0.0 111.62 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.434 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.6 m-85 -104.06 173.06 6.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.169 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -152.73 146.52 25.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 111.541 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tptt 65.95 -103.54 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.799 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.95 -12.29 33.81 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 124.6 31.15 0.91 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.006 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -85.75 168.05 14.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.179 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.91 115.76 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.469 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.3 tt . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.164 179.921 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.716 0.293 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.8 p -102.8 159.01 15.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.867 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.63 -48.03 82.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -110.65 155.43 22.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.02 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -57.21 129.44 41.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -109.23 -172.68 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.985 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 m -94.34 -41.33 9.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -78.58 108.52 12.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.644 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.86 140.97 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.509 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 28.3 t80 -131.03 108.01 9.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.632 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -101.75 136.71 41.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -138.78 122.98 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.76 -68.94 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.466 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 87' ' ' ILE . 11.0 t0 -164.94 35.05 0.06 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.447 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -137.83 111.67 8.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.793 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -77.91 120.11 22.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.785 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 10.4 mt -109.86 164.86 12.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -133.27 165.05 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.131 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.23 169.95 21.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.057 0.456 . . . . 0.0 111.815 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -106.44 -7.42 17.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.876 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 76.6 m -152.74 159.94 43.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.331 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' A' ' 162' ' ' VAL . . . -51.5 -25.37 6.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.527 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 tt -87.86 -50.27 6.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.12 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.25 -22.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.474 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -59.0 -32.38 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.475 ' CD2' ' CZ ' ' A' ' 85' ' ' PHE . 2.2 tp 178.65 149.19 0.22 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 111.218 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.417 HG21 ' CE2' ' A' ' 103' ' ' PHE . 5.1 mt -128.45 128.42 68.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.701 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 102' ' ' ILE . 13.1 m-85 66.84 66.91 0.66 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.864 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.455 ' O ' HG12 ' A' ' 107' ' ' ILE . 24.2 Cg_exo -63.65 -20.92 69.98 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.842 2.361 . . . . 0.0 112.404 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.75 -23.67 59.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.916 0.388 . . . . 0.0 111.278 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.7 mt -78.6 -29.75 46.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.24 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 104' ' ' PRO . 3.7 mm -53.17 -61.08 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.006 0.908 . . . . 0.0 111.051 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.89 18.61 26.77 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.294 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.37 -179.95 7.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.714 0.292 . . . . 0.0 110.597 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.54 149.0 26.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.509 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.09 110.34 7.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -79.56 119.08 22.03 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.849 0.833 . . . . 0.0 111.223 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.437 HG23 ' CE1' ' A' ' 85' ' ' PHE . 12.2 t -110.49 131.53 61.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.983 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 m -122.61 137.33 54.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.246 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.404 ' CB ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -140.94 172.77 12.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.062 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -131.84 130.83 42.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.829 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 29.5 m -56.02 123.84 15.72 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.029 0.443 . . . . 0.0 111.979 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.39 -6.95 33.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.788 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.449 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -119.47 -50.6 2.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.696 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.16 -13.75 37.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.996 -179.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 64.23 10.34 40.81 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.746 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.492 ' H ' HG22 ' A' ' 120' ' ' THR . . . -71.2 168.99 16.78 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.808 0.337 . . . . 0.0 110.647 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -93.69 108.71 0.17 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.073 2.515 . . . . 0.0 111.629 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.404 HG22 ' CB ' ' A' ' 115' ' ' SER . 34.3 m -106.53 146.84 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.341 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.2 p -151.66 142.8 23.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.375 0.607 . . . . 0.0 110.771 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -134.43 151.74 51.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.484 178.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 30.2 m -107.62 113.59 26.99 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.434 HG12 ' CE1' ' A' ' 193' ' ' PHE . 36.2 t -96.51 111.69 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.968 0.413 . . . . 0.0 111.489 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -105.76 169.8 6.58 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.15 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.58 -14.52 44.33 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.456 2.104 . . . . 0.0 112.982 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 p -118.19 -27.01 6.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.52 -163.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.112 0.482 . . . . 0.0 109.999 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.592 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -95.3 162.29 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.717 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -151.41 19.98 0.74 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.04 86.14 0.08 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.791 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.15 122.74 53.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.707 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -146.12 119.3 5.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.98 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.71 162.3 92.97 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 123.435 -1.485 . . . . 0.0 112.274 0.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.82 78.24 1.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.151 0.5 . . . . 0.0 110.737 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 147.4 15.91 0.13 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.576 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.451 ' HG3' HG12 ' A' ' 189' ' ' VAL . 10.2 ptp -62.51 160.82 12.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.079 0.439 . . . . 0.0 111.534 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -130.65 152.06 50.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.942 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.462 ' CG2' ' CE2' ' A' ' 164' ' ' PHE . 2.5 t -117.44 154.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.443 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 55.6 p -121.16 146.8 46.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.842 0.353 . . . . 0.0 110.921 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.0 pp -113.47 158.4 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.993 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.571 ' HA ' ' HB1' ' A' ' 97' ' ' ALA . 7.2 p . . . . . 0 CA--C 1.526 0.052 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -107.19 148.5 28.8 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.65 0.738 . . . . 0.0 109.979 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.462 ' CE2' ' CG2' ' A' ' 143' ' ' VAL . 40.4 m-85 -109.9 150.67 28.11 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.238 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 49.7 m-85 -131.83 136.09 47.21 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.557 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.75 -28.32 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.243 -0.889 . . . . 0.0 113.141 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 11.4 p -170.59 176.45 4.31 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.655 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.61 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 79.6 t -69.4 -34.27 4.61 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.369 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.88 -37.55 3.62 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.763 2.309 . . . . 0.0 110.313 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.569 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -77.21 -39.78 47.42 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.471 178.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 167' ' ' SER . . . -61.37 -44.56 96.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 177.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.606 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 95.6 mt-10 -79.07 -27.95 43.08 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.099 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.3 t70 -69.92 -56.03 8.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.466 0.651 . . . . 0.0 109.395 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.449 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 35.6 t-105 -64.87 -27.88 69.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.817 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.606 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -66.54 -38.51 87.3 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.218 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -44.32 63.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.302 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -94.95 22.47 6.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.031 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.33 30.57 0.68 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.69 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.936 179.995 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -143.24 150.32 39.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.452 HG21 ' CB ' ' A' ' 171' ' ' ALA . 11.7 mm -99.66 160.82 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.938 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.61 162.9 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.474 0.654 . . . . 0.0 112.197 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.9 OUTLIER -89.16 130.26 35.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.905 178.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.451 HG12 ' HG3' ' A' ' 141' ' ' MET . 1.2 m -46.49 -20.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 2.1 m-70 -72.65 -43.36 63.29 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.761 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -21.02 36.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.347 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.75 -25.21 58.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.434 ' CE1' HG12 ' A' ' 128' ' ' VAL . 9.7 t80 -81.42 -24.86 36.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.703 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.66 -29.98 34.02 Favored Glycine 0 CA--C 1.509 -0.3 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.8 mt -81.59 -27.85 34.06 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.01 -26.52 37.01 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -81.99 -22.02 36.8 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.517 -0.342 . . . . 0.0 111.026 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -74.11 -24.37 59.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -54.06 -39.53 66.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.107 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.17 -24.95 37.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.039 -179.854 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.41 ' CG1' ' CD2' ' A' ' 28' ' ' LEU . 9.7 p . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.15 -20.0 22.69 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.693 2.262 . . . . 0.0 112.851 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.8 mp -52.01 -57.4 9.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.747 0.308 . . . . 0.0 111.227 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.41 ' CD2' ' CG1' ' A' ' 25' ' ' VAL . 3.9 pp -66.42 -26.98 67.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.138 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.2 mtp85 -68.84 -53.32 22.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.846 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -72.86 -30.32 63.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.318 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 tp -72.57 -43.16 63.79 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.837 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.11 -26.74 17.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.074 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -66.62 -20.62 66.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.188 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.91 47.41 89.07 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.136 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -133.07 148.58 69.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.622 0.249 . . . . 0.0 110.814 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.01 105.46 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.556 2.171 . . . . 0.0 112.31 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 p -107.23 110.0 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.36 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 94.1 p -86.83 -179.54 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.744 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.4 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -71.96 -36.36 69.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.246 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -27.39 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 0.0 110.117 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -85.33 -41.61 15.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.53 -36.51 84.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 176.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 39' ' ' ARG . . . -73.21 -42.6 62.46 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.463 177.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.26 -31.09 73.98 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.617 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.0 mt -78.78 -44.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-O 120.998 0.428 . . . . 0.0 110.518 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.72 -9.75 58.89 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.412 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 59.36 22.24 10.62 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 7.8 m0 -104.99 144.75 29.37 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.337 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.7 138.23 80.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.455 2.103 . . . . 0.0 112.012 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.95 -18.94 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.7 -32.03 46.77 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.106 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -67.21 -40.53 86.44 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.26 -48.23 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.667 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.64 -52.74 58.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.516 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.64 -45.73 73.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.1 t -68.83 -29.3 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.728 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.17 -38.52 69.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.95 -45.16 87.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -64.5 -17.18 63.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.36 67.59 0.7 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.748 0.785 . . . . 0.0 110.847 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 p -72.41 -8.64 56.09 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.335 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.0 m -114.51 40.81 2.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.179 0.514 . . . . 0.0 110.781 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.66 141.4 33.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.164 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.77 126.74 31.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.033 0.444 . . . . 0.0 111.16 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.405 ' CD1' ' O ' ' A' ' 69' ' ' GLY . 43.9 m-85 -115.16 165.6 12.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.349 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -154.22 144.3 21.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 111.286 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 tptt 66.42 -103.2 0.08 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.733 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -91.55 -13.47 32.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.751 0.31 . . . . 0.0 111.818 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 124.36 30.65 0.98 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.134 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -86.55 168.79 13.36 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.8 121.53 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.413 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.005 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.682 0.277 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.8 p -113.39 159.55 19.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.709 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.31 48.99 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.622 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 43.47 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.985 0.421 . . . . 0.0 112.067 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -156.99 -88.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.475 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -38.63 157.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.958 0.408 . . . . 0.0 111.996 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 t -75.07 -10.64 59.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.89 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 97' ' ' ALA . 23.2 m-85 -70.87 101.2 2.09 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.404 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 9.2 t -110.23 143.61 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.398 . . . . 0.0 111.186 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 111' ' ' ALA . 32.5 t80 -134.33 109.25 8.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.352 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.84 125.22 39.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.995 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.477 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -136.31 122.99 31.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.87 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.5 -76.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.063 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.9 p-10 -159.15 36.7 0.21 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.461 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -140.94 115.66 9.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.636 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -77.76 85.89 4.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.86 0.362 . . . . 0.0 110.989 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 51.5 mt -71.97 165.0 25.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.84 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -138.45 165.15 27.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.312 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.405 ' HB2' ' HA ' ' A' ' 100' ' ' THR . . . -144.14 162.04 37.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.866 0.365 . . . . 0.0 111.861 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -85.31 -27.43 25.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.402 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.89 159.04 37.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.754 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.488 ' CB ' ' CE1' ' A' ' 164' ' ' PHE . . . -61.98 -11.87 15.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.0 mt -103.64 -20.76 13.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -82.5 -3.6 56.13 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.433 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -60.54 -39.1 86.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 0.0 110.341 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.445 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -98.33 173.77 6.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -154.92 -45.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.133 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -163.06 79.12 1.72 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.016 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.449 ' O ' HG21 ' A' ' 107' ' ' ILE . 59.3 Cg_endo -71.92 -32.84 10.71 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.591 2.194 . . . . 0.0 112.294 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.15 -23.78 43.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.263 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.89 -40.08 17.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.38 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.449 HG21 ' O ' ' A' ' 104' ' ' PRO . 1.1 tp -57.94 -45.34 87.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.263 0.554 . . . . 0.0 111.372 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.19 24.26 15.09 Favored Glycine 0 C--N 1.319 -0.385 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.484 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -151.42 173.62 14.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.065 0.459 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -83.84 157.18 22.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.971 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.07 110.06 7.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.2 mtt-85 -80.91 119.03 22.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.732 0.777 . . . . 0.0 111.178 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 85' ' ' PHE . 13.4 t -108.27 129.54 62.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.847 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.404 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 1.5 p -124.49 137.62 54.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.318 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.403 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.1 172.96 11.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.986 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 121' ' ' GLY . 0.8 OUTLIER -130.13 130.94 45.42 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 21.1 m -57.76 123.06 14.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.873 0.368 . . . . 0.0 111.927 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.78 -8.28 34.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.783 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.474 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -122.43 -50.54 1.99 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.507 HG21 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -77.9 -21.15 51.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 111.198 -178.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.401 ' O ' ' CE1' ' A' ' 116' ' ' HIS . . . 63.31 33.28 86.83 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.01 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.507 ' CB ' HG21 ' A' ' 120' ' ' THR . . . -102.93 169.69 7.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.432 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.413 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 58.6 Cg_endo -93.86 107.49 0.16 Allowed 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.922 2.415 . . . . 0.0 111.681 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.403 ' CG2' ' CB ' ' A' ' 115' ' ' SER . 33.8 m -102.54 146.26 10.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.235 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.0 p -151.87 141.49 21.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.457 0.646 . . . . 0.0 111.196 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -134.18 153.14 52.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.001 178.48 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 23.6 m -110.05 114.95 28.89 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.2 111.52 26.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.999 0.428 . . . . 0.0 110.869 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -108.29 176.51 1.57 Allowed Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.461 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 129' ' ' SER . 13.3 Cg_exo -70.33 -12.69 32.25 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.727 2.285 . . . . 0.0 113.112 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 0.8 OUTLIER -121.91 -27.91 4.54 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.076 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 131' ' ' SER . 13.4 pt-20 179.63 -161.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.13 0.49 . . . . 0.0 110.374 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -91.38 156.39 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.758 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -146.31 17.16 1.35 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.99 85.04 0.07 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.882 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.1 t -98.88 123.16 51.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.834 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.17 117.09 4.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.018 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.12 161.85 93.56 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.423 -1.491 . . . . 0.0 112.087 -0.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.01 78.0 1.69 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.117 0.484 . . . . 0.0 110.674 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.86 18.76 0.18 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.388 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.453 ' HG3' ' CG1' ' A' ' 189' ' ' VAL . 6.7 ptm -64.38 161.45 16.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.969 0.385 . . . . 0.0 111.2 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -125.55 152.36 45.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.07 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' A' ' 164' ' ' PHE . 61.2 t -114.09 148.9 16.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.424 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 50.3 m -120.19 140.87 50.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.769 0.319 . . . . 0.0 110.372 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -144.01 176.11 9.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.071 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.967 179.686 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 26.0 t . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.882 0.372 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 163' ' ' HIS . 3.2 m-70 -128.14 169.25 14.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.314 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.488 ' CE1' ' CB ' ' A' ' 97' ' ' ALA . 10.5 m-30 -110.73 152.95 25.97 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.812 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.469 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 27.1 m-85 -132.54 138.13 47.38 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.582 0.706 . . . . 0.0 110.238 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -42.66 -28.84 0.26 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.141 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.505 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 71.4 m -166.96 174.7 8.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.121 0.486 . . . . 0.0 111.685 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.601 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.4 t -69.53 -33.84 4.15 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.199 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.4 Cg_exo -73.33 -37.92 2.97 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.81 2.34 . . . . 0.0 110.361 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.545 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.6 -39.63 51.93 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.53 177.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -62.06 -45.63 92.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.598 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.2 mt-10 -78.9 -27.68 43.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.34 178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.688 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.5 t70 -71.11 -56.0 7.04 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.301 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.474 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 36.0 t-105 -64.45 -28.91 69.99 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.675 178.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.598 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -64.02 -39.76 94.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.145 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -43.88 63.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.372 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.75 21.92 7.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.177 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.79 23.89 5.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.881 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.716 179.93 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 8.1 tt . . . . . 0 C--O 1.231 0.099 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -144.98 150.13 36.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.153 0.502 . . . . 0.0 111.815 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.485 HG23 ' CB ' ' A' ' 171' ' ' ALA . 12.0 mm -103.95 162.04 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.506 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.35 162.31 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.578 0.704 . . . . 0.0 112.313 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -94.97 133.34 38.83 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.375 178.079 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.453 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 2.8 m -47.35 -18.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.879 0.371 . . . . 0.0 110.817 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 11.6 m170 -73.67 -44.87 55.54 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.18 0.514 . . . . 0.0 109.69 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.41 -20.91 36.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.478 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.51 -24.79 62.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.97 -24.73 37.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.74 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.71 -31.28 30.19 Favored Glycine 0 CA--C 1.509 -0.338 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.3 mp -80.8 -28.42 36.3 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.92 -24.31 45.67 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.614 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -82.13 -22.01 36.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.805 0.336 . . . . 0.0 111.092 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.21 -23.15 43.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.186 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -54.24 -38.72 66.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 111.105 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.73 -54.73 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.996 -179.943 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.685 0.279 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.57 -37.28 5.61 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.551 2.168 . . . . 0.0 112.317 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.73 -57.14 11.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -60.23 -26.82 66.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.427 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -53.42 23.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.027 0.441 . . . . 0.0 110.274 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.37 -30.1 57.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.419 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 28' ' ' LEU . 49.1 tp -70.36 -49.94 44.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.71 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.48 -25.31 15.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.997 0.427 . . . . 0.0 111.133 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -22.39 64.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.137 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.21 48.14 77.83 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.297 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -133.18 155.11 81.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.659 0.266 . . . . 0.0 110.854 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.9 108.99 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.518 2.145 . . . . 0.0 111.973 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -113.58 109.84 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 120.954 0.407 . . . . 0.0 111.394 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 p -87.62 -169.79 2.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.8 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 43' ' ' ALA . 15.8 ttm180 -78.07 -36.84 47.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.406 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -26.96 68.04 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.363 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -85.56 -42.15 14.65 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.413 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.29 -36.29 83.17 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -73.83 -42.7 60.49 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.494 177.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.81 -30.84 74.75 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.612 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.0 mt -79.14 -42.48 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 120.949 0.404 . . . . 0.0 110.468 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.94 -7.43 58.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.505 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 55.37 23.5 5.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.422 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -98.89 153.12 37.98 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.272 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.02 137.1 36.75 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.592 2.195 . . . . 0.0 111.923 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.91 -22.18 0.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -78.57 -35.47 45.86 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.876 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 mmt-85 -66.84 -40.84 88.08 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.11 -48.2 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.544 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.15 -53.47 50.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.383 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.7 -49.82 75.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.898 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.7 t -63.57 -30.66 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.642 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 tp -62.16 -32.13 72.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.675 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.82 -22.26 46.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.948 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -95.93 -18.3 20.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.149 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.95 32.57 3.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.448 0.642 . . . . 0.0 110.85 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.9 p -67.48 -27.99 67.47 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.956 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.4 t -75.93 -25.56 56.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.254 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.56 141.4 43.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.073 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -78.43 126.87 31.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -102.49 173.08 6.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.583 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.17 -172.77 2.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.564 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.25 -36.99 85.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.516 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -88.46 10.8 18.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.739 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.76 13.11 82.78 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.262 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -89.03 161.77 16.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.233 0.517 . . . . 0.0 109.827 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.76 124.83 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.401 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 tt . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.204 179.766 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.849 0.356 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.5 p -123.57 159.55 28.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.39 -25.02 0.58 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.664 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.421 ' HD2' ' CD1' ' A' ' 93' ' ' TYR . 18.9 mtm180 79.9 92.03 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.889 0.376 . . . . 0.0 110.922 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.87 25.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.021 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 p -122.24 -138.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.959 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 p -129.65 -31.12 2.02 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.588 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 96' ' ' CYS . 12.4 m-85 -72.1 104.19 3.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.534 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.54 141.09 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.347 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.49 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 20.4 t80 -133.78 107.44 7.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.145 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -102.33 134.67 45.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.446 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.465 ' CG2' ' CE1' ' A' ' 85' ' ' PHE . 2.6 pt -140.06 123.91 18.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.724 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 t0 63.32 -66.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.43 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 87' ' ' ILE . 16.0 m-20 -168.0 35.28 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.499 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -135.61 113.23 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.895 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -80.21 86.17 5.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.083 0.468 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.404 ' CB ' ' O ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -73.65 164.63 26.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.114 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.421 ' CD1' ' HD2' ' A' ' 79' ' ' ARG . 7.9 m-85 -135.49 165.2 26.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.228 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.37 173.44 15.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.073 0.463 . . . . 0.0 111.946 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.411 ' O ' ' CE2' ' A' ' 83' ' ' TYR . 12.0 m0 -97.02 -17.58 19.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.008 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.43 ' HA ' ' CE2' ' A' ' 83' ' ' TYR . 1.2 m -153.96 165.91 34.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.155 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.438 ' CB ' ' CE1' ' A' ' 164' ' ' PHE . . . -52.46 -22.8 5.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.666 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.2 mt -85.22 -51.67 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.593 0.235 . . . . 0.0 111.292 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.4 -27.4 4.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.704 0.287 . . . . 0.0 111.542 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.42 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -60.48 -29.81 69.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.454 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.445 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 1.8 pt? -154.65 126.3 7.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.471 HG22 HD11 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -96.22 -36.68 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 106' ' ' LEU . 1.6 m-85 -124.76 78.0 64.61 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.724 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.45 ' O ' ' CG2' ' A' ' 107' ' ' ILE . 36.1 Cg_exo -61.2 -51.42 4.5 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.631 2.221 . . . . 0.0 112.327 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.85 -23.41 41.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.567 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -90.35 -15.84 30.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.45 ' CG2' ' O ' ' A' ' 104' ' ' PRO . 2.9 tp -47.84 -53.31 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 111.993 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.3 0.73 50.7 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.966 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.95 177.88 10.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 110.399 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.35 143.94 44.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.49 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . . . -137.18 109.88 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -81.33 120.05 24.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.75 0.786 . . . . 0.0 111.467 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.17 130.9 65.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.827 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.4 m -126.02 137.97 53.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.326 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.43 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 0.6 OUTLIER -141.34 172.91 12.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.075 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -133.97 135.67 43.64 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.2 t -64.59 131.97 48.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.29 -3.4 23.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.936 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.442 ' HB3' ' CG ' ' A' ' 174' ' ' TRP . . . -121.91 -50.5 2.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.87 0.367 . . . . 0.0 111.543 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.5 HG23 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -90.32 -23.62 21.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.457 -179.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.56 6.18 75.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.251 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.5 ' CB ' HG23 ' A' ' 120' ' ' THR . . . -60.03 155.55 43.2 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-O 120.604 0.24 . . . . 0.0 110.457 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -87.97 104.27 0.51 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.719 2.279 . . . . 0.0 111.383 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.43 ' CG2' ' CB ' ' A' ' 115' ' ' SER . 33.9 m -98.1 145.14 10.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.1 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.3 p -155.59 142.69 19.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.581 0.705 . . . . 0.0 111.26 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.5 OUTLIER -135.16 153.32 52.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.685 178.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 32.2 m -108.26 113.84 27.25 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 111' ' ' ALA . 41.1 t -95.9 111.51 26.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.026 0.441 . . . . 0.0 111.696 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.401 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.8 OUTLIER -105.86 169.01 7.45 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.744 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 33.3 Cg_endo -65.42 -18.82 60.87 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.14 1.893 . . . . 0.0 112.844 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.8 m -112.59 -28.2 7.92 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 179.54 -163.3 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.237 0.541 . . . . 0.0 110.139 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -95.2 158.66 2.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.753 178.605 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -147.23 19.33 1.22 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.23 86.19 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.632 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.3 t -105.03 117.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.024 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.44 117.38 4.77 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.087 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 141' ' ' MET . 16.7 Cg_exo -67.57 145.91 75.38 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.73 -1.363 . . . . 0.0 112.443 0.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.35 -33.19 52.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.867 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -101.43 30.14 11.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.245 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.56 ' HG3' HG13 ' A' ' 189' ' ' VAL . 5.4 ptp -65.22 157.22 29.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 0.0 111.889 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.8 152.44 50.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.318 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.448 HG21 ' CZ ' ' A' ' 164' ' ' PHE . 11.4 t -113.41 153.08 15.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.776 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.413 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 4.4 m -121.7 143.04 49.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.741 0.305 . . . . 0.0 110.608 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 187' ' ' VAL . 5.3 mp -145.3 176.08 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.109 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.4 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.837 179.725 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.908 0.385 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.411 ' CD2' ' OH ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -126.03 169.31 12.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.738 0.78 . . . . 0.0 109.765 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 143' ' ' VAL . 2.0 m-85 -113.0 152.35 29.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.912 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.472 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 60.6 m-85 -131.44 136.83 48.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.766 0.793 . . . . 0.0 110.578 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -47.88 -25.17 1.22 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.797 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.544 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 44.7 m -164.73 167.62 18.79 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.643 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.62 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.3 t -68.12 -34.45 6.08 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.896 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.3 Cg_exo -72.45 -37.03 4.6 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.768 2.312 . . . . 0.0 110.103 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.557 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.19 -40.57 52.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.52 -46.15 91.21 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.683 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 1.7 mm-40 -78.97 -27.22 43.48 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.331 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.709 ' N ' ' O ' ' A' ' 169' ' ' PRO . 26.5 t70 -70.06 -55.76 8.66 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.192 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.442 ' CG ' ' HB3' ' A' ' 119' ' ' ALA . 51.4 t-105 -65.99 -28.29 68.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.723 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.683 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -64.24 -39.45 93.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.13 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.0 t -53.71 -42.25 67.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.428 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 18.46 9.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.382 0.61 . . . . 0.0 111.38 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . 0.438 ' CD2' ' CD1' ' A' ' 174' ' ' TRP . 0.1 OUTLIER -120.31 24.15 10.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.727 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.768 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.9 tt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.757 0.313 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.55 150.17 40.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.11 0.481 . . . . 0.0 111.369 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.476 HG22 ' HB2' ' A' ' 171' ' ' ALA . 15.5 mm -101.56 161.31 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.747 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.401 ' N ' HG21 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -159.89 159.79 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.277 0.56 . . . . 0.0 112.15 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 190' ' ' HIS . 42.2 p -89.83 128.59 36.19 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.669 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.56 HG13 ' HG3' ' A' ' 141' ' ' MET . 2.4 m -47.72 -19.15 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.993 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.407 ' N ' ' C ' ' A' ' 188' ' ' SER . 59.5 t-80 -72.82 -42.03 64.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.155 0.502 . . . . 0.0 109.821 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -82.16 -26.18 33.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.177 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.22 -24.91 66.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.927 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.421 ' CE2' HG12 ' A' ' 128' ' ' VAL . 1.3 t80 -81.34 -25.58 36.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.68 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.04 -31.76 27.96 Favored Glycine 0 CA--C 1.509 -0.3 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.1 tp -80.83 -28.55 36.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -82.84 -24.77 52.04 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.2 -22.28 36.04 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.969 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -77.74 -22.77 49.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.255 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.13 -39.5 60.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.868 0.366 . . . . 0.0 111.092 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -81.09 -44.34 18.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.072 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.709 0.29 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.02 -24.55 19.83 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.593 2.195 . . . . 0.0 112.407 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -57.23 12.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.328 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.49 -27.36 62.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.251 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -64.42 -53.28 50.85 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.138 0.494 . . . . 0.0 109.824 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -70.91 -25.01 62.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.409 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.6 -40.27 84.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.947 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.23 -25.2 13.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.573 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -70.36 -20.19 62.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.173 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.13 47.69 86.18 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.354 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -133.21 158.3 76.09 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.725 0.297 . . . . 0.0 110.74 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.7 91.63 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.566 2.177 . . . . 0.0 112.262 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.96 114.92 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.353 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.4 p -77.44 -179.62 5.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.847 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -78.2 -32.55 50.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.631 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -68.34 -30.77 69.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.681 0.277 . . . . 0.0 110.642 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.31 -38.51 20.32 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.31 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.785 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.3 tp -63.16 -41.71 99.29 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.427 ' CB ' HG21 ' A' ' 53' ' ' VAL . . . -69.74 -42.96 73.26 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.774 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 40' ' ' THR . . . -67.47 -25.84 73.71 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.254 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.1 mt -76.54 -40.18 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.245 -0.478 . . . . 0.0 110.457 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.785 ' HG ' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -80.22 -6.5 57.93 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.568 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 62.95 30.15 16.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -116.99 149.64 44.52 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.624 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.16 143.72 99.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.626 2.218 . . . . 0.0 112.006 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 53' ' ' VAL . . . -54.48 -16.45 2.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.95 -31.58 45.11 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.586 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -70.18 -40.0 74.92 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.427 HG21 ' CB ' ' A' ' 43' ' ' ALA . 1.8 t -65.63 -46.36 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.36 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.38 -51.7 57.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.112 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.72 -43.24 80.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.7 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.7 t -70.59 -32.45 49.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.577 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.9 mt -61.39 -32.52 72.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.499 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.63 -24.35 56.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.701 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -96.18 -14.43 22.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.11 32.86 3.73 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.466 0.65 . . . . 0.0 110.598 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.0 p -66.89 -14.39 62.7 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.233 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 t -86.78 -23.9 25.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 111.346 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.81 141.23 39.48 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.047 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.99 126.79 31.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.038 0.447 . . . . 0.0 111.474 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -100.64 168.81 9.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.267 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -153.87 143.61 21.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.549 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.7 tttp 66.9 -102.64 0.07 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.824 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.32 -13.04 28.64 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.74 31.86 0.79 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.051 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.67 169.03 11.65 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.0 mp -79.8 114.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.27 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.112 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.3 p -107.66 159.05 16.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.35 -30.8 60.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -102.8 147.57 26.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -64.52 122.27 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.9 p -106.91 -174.72 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.2 p -92.65 -37.29 12.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -87.24 113.97 23.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.08 142.73 20.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.466 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 59.8 t80 -124.72 105.19 9.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.346 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -98.62 126.23 44.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.323 . . . . 0.0 111.42 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 89' ' ' ASP . 6.9 pt -118.76 177.89 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.396 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 87' ' ' ILE . 8.6 t0 -14.52 -53.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 87' ' ' ILE . 21.7 p30 -165.74 35.48 0.05 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.033 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 12.1 mmt180 -142.03 113.07 7.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.72 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.64 119.39 21.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.791 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.3 164.88 12.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.268 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -133.95 165.14 25.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.099 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 99' ' ' ASP . . . -153.45 171.39 18.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.115 0.483 . . . . 0.0 111.855 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -94.37 -20.27 19.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.007 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.3 m -157.51 179.81 8.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.668 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.52 -21.89 29.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tp -89.18 -51.92 5.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.401 ' CB ' ' HB2' ' A' ' 94' ' ' ALA . 4.8 m-20 -46.95 -26.54 1.03 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.36 -36.26 77.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.666 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.449 ' CD1' ' CE2' ' A' ' 85' ' ' PHE . 3.3 tp -176.78 152.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 102' ' ' ILE . 15.5 pt -122.82 -39.24 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.519 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.451 ' CZ ' ' ND2' ' A' ' 200' ' ' ASN . 9.2 m-85 -119.7 81.7 25.56 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.168 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.414 ' O ' HG12 ' A' ' 107' ' ' ILE . 7.3 Cg_exo -72.58 -29.0 13.69 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.797 2.331 . . . . 0.0 112.215 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.09 -23.76 59.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.249 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.74 -29.91 45.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.906 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 104' ' ' PRO . 3.9 mm -54.16 -60.55 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.082 0.944 . . . . 0.0 110.988 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.29 25.21 Favored Glycine 0 C--N 1.316 -0.545 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.301 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.16 -177.27 5.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.357 . . . . 0.0 110.462 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.09 148.5 27.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.24 110.01 7.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -80.8 121.05 25.46 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.714 0.768 . . . . 0.0 110.86 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.5 t -113.8 131.78 64.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.934 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.6 p -119.42 138.25 53.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.712 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.67 172.8 12.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.42 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.15 131.32 36.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.54 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 21.3 m -57.41 124.45 18.98 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.918 0.389 . . . . 0.0 111.902 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.12 -9.49 46.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.628 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.469 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -121.67 -51.2 2.05 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.499 HG21 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -76.24 -20.83 57.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.917 0.389 . . . . 0.0 110.767 -179.024 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.3 33.69 85.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.108 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.499 ' CB ' HG21 ' A' ' 120' ' ' THR . . . -100.91 168.01 9.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.437 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -93.89 110.27 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 123.024 2.483 . . . . 0.0 111.313 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.3 m -109.51 148.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.492 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 86.0 p -147.62 142.43 26.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.509 0.671 . . . . 0.0 110.567 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.615 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -135.19 152.13 51.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.743 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 42.8 m -111.25 112.31 24.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 32.6 t -96.93 114.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.008 0.432 . . . . 0.0 112.137 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.413 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -105.72 170.19 6.15 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.702 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.9 Cg_endo -66.64 -19.51 53.9 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.158 1.905 . . . . 0.0 113.001 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 6.9 t -108.87 -27.41 9.73 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 131' ' ' SER . 14.9 pt-20 178.05 -162.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.64 162.84 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.472 178.248 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -150.09 21.28 0.87 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.434 0.635 . . . . 0.0 112.326 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.95 87.4 0.09 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.44 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 t -104.1 119.88 53.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.156 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.18 122.9 5.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.796 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.24 159.63 97.03 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.382 -1.507 . . . . 0.0 112.322 0.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.92 79.37 0.64 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.134 0.492 . . . . 0.0 110.658 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.26 18.02 0.17 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.282 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.427 ' HE3' ' CE1' ' A' ' 164' ' ' PHE . 9.8 ptm -60.98 157.82 14.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.019 0.438 . . . . 0.0 111.395 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.13 152.01 47.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.326 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.468 HG23 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -117.93 152.34 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.991 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.422 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 53.1 p -117.47 143.74 45.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.766 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.54 176.05 9.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.819 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.9 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 179.92 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.8 t . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -118.91 169.35 9.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.558 0.694 . . . . 0.0 109.773 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.468 ' CE1' HG23 ' A' ' 143' ' ' VAL . 0.4 OUTLIER -111.05 151.14 28.38 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.036 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 45.6 m-85 -135.83 134.6 39.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.251 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -38.93 -29.68 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.146 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 35.2 m -170.49 178.0 3.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.062 0.458 . . . . 0.0 111.575 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.61 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 90.5 t -69.57 -33.77 4.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.491 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.5 Cg_exo -72.64 -38.78 3.0 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.563 2.175 . . . . 0.0 110.41 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.536 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.23 -39.65 54.05 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.88 -46.81 87.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.672 ' HA ' ' HB1' ' A' ' 175' ' ' ALA . 2.3 mm-40 -78.99 -26.98 43.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.5 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 169' ' ' PRO . 4.8 t70 -70.89 -55.72 7.82 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.469 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 32.3 t-105 -65.03 -29.75 70.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.787 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.672 ' HB1' ' HA ' ' A' ' 172' ' ' GLU . . . -63.33 -39.6 95.0 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.242 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -44.43 62.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.338 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.16 23.87 6.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.172 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -136.41 33.38 2.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.037 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.675 179.893 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.9 tp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.771 0.32 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -140.28 148.89 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.022 0.439 . . . . 0.0 111.121 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.448 HG21 ' CB ' ' A' ' 171' ' ' ALA . 17.1 mm -100.71 160.53 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.987 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.408 ' N ' HG23 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -162.79 150.66 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.144 0.497 . . . . 0.0 111.969 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -78.98 126.07 30.2 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.635 178.082 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.432 ' HA ' HG22 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -46.54 -20.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.885 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -72.24 -45.1 61.63 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.0 OUTLIER -82.73 -22.41 34.44 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.141 178.175 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -67.83 -25.61 65.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.729 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 197' ' ' GLN . 0.2 OUTLIER -81.75 -24.94 35.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.627 179.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.08 -31.52 28.43 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -29.73 31.53 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -82.27 -28.46 40.38 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.409 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 37.5 tt0 -82.47 -22.57 35.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.866 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -81.09 -25.23 37.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.85 -29.76 20.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 0.0 111.291 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . 0.451 ' ND2' ' CZ ' ' A' ' 103' ' ' PHE . 6.6 m120 -80.43 -55.13 5.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 -179.879 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.707 0.289 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.413 ' CG ' ' CD1' ' A' ' 46' ' ' LEU . 43.0 Cg_endo -67.83 -27.12 37.74 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.525 2.15 . . . . 0.0 112.371 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 mp -52.66 -57.44 10.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.232 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 pp -80.07 -27.3 39.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.066 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.6 ttt85 -64.83 -53.29 49.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -65.78 -23.78 66.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.287 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -37.59 81.53 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.773 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.19 -26.41 17.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 111.03 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -20.97 66.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.226 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.63 48.3 82.63 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.153 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.06 157.26 78.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.724 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.3 91.02 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.516 2.144 . . . . 0.0 112.121 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -93.01 113.5 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.38 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.8 p -87.0 -174.16 4.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.718 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 43' ' ' ALA . 9.3 ptp180 -77.93 -36.23 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.321 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -28.72 69.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.907 0.384 . . . . 0.0 110.09 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.46 -41.82 16.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.345 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 tp -62.63 -36.5 83.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' A' ' 53' ' ' VAL . . . -72.92 -43.27 62.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.589 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -30.89 74.95 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.689 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.0 mt -79.09 -42.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.067 0.461 . . . . 0.0 110.376 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.413 ' CD1' ' CG ' ' A' ' 26' ' ' PRO . 7.1 mp -76.44 -9.66 58.82 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.41 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.1 t0 60.34 21.64 11.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.418 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 5.3 m95 -107.48 158.1 34.07 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.171 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.02 144.09 62.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.607 2.205 . . . . 0.0 112.114 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.0 -16.92 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -78.64 -35.04 46.01 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.208 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -67.6 -41.1 84.59 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.417 HG21 ' HB1' ' A' ' 43' ' ' ALA . 2.1 t -63.03 -47.73 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.483 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.26 -53.11 55.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.206 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.77 -46.92 77.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.794 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 t -67.65 -32.03 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.724 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -33.26 75.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.657 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -58.16 -22.06 49.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.88 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -90.85 -17.47 26.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.06 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.18 33.09 2.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.367 0.603 . . . . 0.0 111.121 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.1 p -60.1 -20.63 59.15 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.912 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.56 -22.6 21.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.411 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.46 141.06 52.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.523 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -78.85 126.9 31.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 0.0 111.604 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.418 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 62.5 m-85 -103.43 173.17 6.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.192 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -153.53 147.87 25.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.416 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.7 tttp 66.28 -102.01 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.782 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.23 -13.05 33.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.97 30.76 1.18 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.92 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -85.92 164.83 17.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.957 0.408 . . . . 0.0 110.189 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.96 109.61 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.336 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.642 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.764 0.316 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.5 p -99.75 159.08 15.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.812 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.73 -32.66 25.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -96.53 144.23 26.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.1 122.09 17.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.3 p -107.36 -177.05 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.451 ' CB ' ' CE1' ' A' ' 116' ' ' HIS . 53.1 m -93.08 -30.47 15.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.904 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.472 ' CE2' ' N ' ' A' ' 97' ' ' ALA . 20.6 m-85 -86.68 117.35 25.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.362 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.01 142.31 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.488 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 111' ' ' ALA . 46.2 t80 -125.58 105.21 8.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.717 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.14 121.01 34.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.173 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.454 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -139.03 122.93 19.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.617 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 58.3 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.327 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.0 t70 -159.38 35.83 0.2 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.432 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -139.79 113.88 8.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.641 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -77.78 86.32 4.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.979 0.418 . . . . 0.0 111.02 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 85' ' ' PHE . 3.4 mm? -71.77 164.64 25.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.439 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -137.46 162.2 34.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.821 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.03 164.09 32.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.119 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -81.31 -33.37 32.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.441 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 59.7 m -152.92 -177.8 6.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.056 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 98' ' ' LEU . . . -61.84 148.86 41.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.706 0.289 . . . . 0.0 110.917 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.48 ' CB ' ' O ' ' A' ' 97' ' ' ALA . 1.7 tt 88.11 -51.48 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.666 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -54.58 -21.61 10.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.208 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 1.3 p -60.45 -39.51 87.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.381 . . . . 0.0 110.544 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.433 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -110.34 -172.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.174 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.447 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 3.3 pt -161.76 -43.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.975 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.447 ' CE2' ' CD1' ' A' ' 102' ' ' ILE . 2.2 p90 -163.0 93.64 1.16 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.762 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 107' ' ' ILE . 74.1 Cg_endo -74.45 -35.07 4.0 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.7 2.266 . . . . 0.0 112.368 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.69 -23.99 53.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.8 tp -84.89 -42.41 15.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.338 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.3 tp -57.18 -46.95 84.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.295 0.569 . . . . 0.0 111.417 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.52 23.64 18.31 Favored Glycine 0 C--N 1.318 -0.423 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.699 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 173.46 15.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.893 0.378 . . . . 0.0 111.077 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -80.81 152.91 28.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.897 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.51 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . . . -137.16 109.77 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -83.03 120.64 26.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.78 0.8 . . . . 0.0 111.158 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.44 129.44 67.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.963 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.7 m -119.72 137.93 53.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.029 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.435 ' OG ' ' CD2' ' A' ' 83' ' ' TYR . 3.1 m -141.25 172.8 12.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.478 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . 0.451 ' CE1' ' CB ' ' A' ' 82' ' ' SER . 17.6 p-80 -137.82 132.67 32.98 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 23.0 t -61.15 130.8 48.09 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.152 0.501 . . . . 0.0 112.16 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.91 -3.14 20.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.756 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.456 ' CB ' ' HB2' ' A' ' 174' ' ' TRP . . . -121.14 -50.46 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 0.0 111.601 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.483 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -90.14 -24.67 21.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.29 -179.465 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.09 81.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.108 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.483 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -58.29 158.68 13.48 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 120.581 0.229 . . . . 0.0 110.483 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -91.49 106.16 0.26 Allowed 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.757 2.305 . . . . 0.0 111.246 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 115' ' ' SER . 32.2 m -103.92 145.66 12.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.277 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 64.3 p -151.47 141.47 22.09 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.386 0.612 . . . . 0.0 110.79 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -135.22 153.07 52.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.434 178.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 54.7 m -110.57 113.52 26.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.814 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.401 ' CG1' ' HG3' ' A' ' 104' ' ' PRO . 24.2 t -96.04 111.63 26.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.482 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.79 171.17 4.94 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.282 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.34 -14.93 46.32 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.503 2.135 . . . . 0.0 113.087 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.9 p -119.88 -27.23 5.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -179.97 -163.57 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.166 0.508 . . . . 0.0 110.17 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -95.88 158.94 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.97 178.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -147.34 18.75 1.21 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.404 0.621 . . . . 0.0 112.555 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.32 85.83 0.07 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.466 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.46 118.13 53.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.334 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -146.45 116.28 4.64 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.691 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.55 145.25 76.15 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.726 -1.364 . . . . 0.0 112.32 0.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.25 -29.31 22.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.698 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.55 33.7 6.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.776 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.569 ' HG3' HG13 ' A' ' 189' ' ' VAL . 1.1 ptm -66.26 159.74 25.9 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.068 0.434 . . . . 0.0 111.13 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -131.58 152.74 50.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.063 0.459 . . . . 0.0 111.604 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.464 HG23 ' CE1' ' A' ' 164' ' ' PHE . 44.4 t -111.12 146.16 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.314 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.454 ' O ' ' HB ' ' A' ' 162' ' ' VAL . 47.4 m -114.8 141.26 48.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.689 0.281 . . . . 0.0 110.653 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.417 ' HA ' ' CG1' ' A' ' 162' ' ' VAL . 6.8 mt -103.18 149.07 25.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.081 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.011 179.812 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 97' ' ' ALA . 3.5 m . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.882 0.372 . . . . 0.0 111.872 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -116.03 166.81 11.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.525 0.679 . . . . 0.0 109.762 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.471 ' CE1' ' CB ' ' A' ' 97' ' ' ALA . 18.3 m-30 -117.84 129.67 55.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.768 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.459 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 19.4 m-85 -108.68 142.58 38.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.401 0.619 . . . . 0.0 110.608 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -46.08 -26.72 0.79 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.825 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.499 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 25.7 p -169.94 170.8 7.47 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.82 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 72.0 t -67.76 -33.41 5.23 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.32 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.2 Cg_exo -72.7 -37.89 3.6 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.724 2.283 . . . . 0.0 110.292 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.557 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.08 -40.39 53.23 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.97 -45.97 91.31 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.601 ' HA ' ' HB1' ' A' ' 175' ' ' ALA . 97.6 mt-10 -78.96 -27.63 43.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.244 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 169' ' ' PRO . 9.4 t70 -70.79 -55.94 7.44 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.59 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.456 ' HB2' ' CB ' ' A' ' 119' ' ' ALA . 77.2 t-105 -65.15 -27.84 69.0 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.685 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.601 ' HB1' ' HA ' ' A' ' 172' ' ' GLU . . . -62.4 -38.99 91.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.215 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.3 t -54.68 -47.78 73.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.442 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -95.48 21.6 7.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.258 0.551 . . . . 0.0 111.034 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -132.77 29.75 4.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.951 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.604 179.843 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.3 tp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.641 0.258 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -143.64 150.51 38.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.109 0.481 . . . . 0.0 111.539 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.433 HG22 ' CB ' ' A' ' 171' ' ' ALA . 12.5 mm -100.7 161.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.638 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.48 165.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.398 0.618 . . . . 0.0 112.11 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.5 OUTLIER -93.79 132.79 37.84 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.539 178.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.569 HG13 ' HG3' ' A' ' 141' ' ' MET . 3.6 m -48.27 -17.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.878 0.37 . . . . 0.0 110.927 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 0.6 OUTLIER -73.33 -44.51 58.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.134 0.492 . . . . 0.0 109.753 179.075 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.38 -21.61 35.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.53 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -76.49 -25.37 54.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.278 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.414 ' CE2' ' HG3' ' A' ' 197' ' ' GLN . 85.8 t80 -81.7 -25.89 35.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 110.722 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.79 -30.25 32.81 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.59 -27.74 34.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -27.33 34.29 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.414 ' HG3' ' CE2' ' A' ' 193' ' ' PHE . 1.5 mm100 -82.33 -23.21 35.22 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.495 -0.352 . . . . 0.0 111.023 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -79.28 -23.08 43.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.229 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -52.2 -32.01 34.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -81.14 -55.03 5.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -179.897 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 120.444 0.164 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.51 -28.65 17.42 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.403 2.069 . . . . 0.0 112.359 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.27 -57.18 10.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.56 -27.14 58.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.921 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -53.45 57.38 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -24.3 62.26 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.126 178.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.8 tt -66.2 -48.24 71.26 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.759 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.49 -26.09 19.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.61 -22.11 65.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.27 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 47.03 92.97 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.147 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -127.42 163.95 39.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.694 0.283 . . . . 0.0 110.86 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.34 111.61 2.1 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.553 2.169 . . . . 0.0 112.107 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.35 111.04 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.398 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 p -91.39 179.62 5.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.688 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -69.22 -40.99 77.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.213 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -24.64 66.83 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.279 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -85.96 -44.16 12.59 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -36.29 82.67 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HB3' HG23 ' A' ' 53' ' ' VAL . . . -72.95 -42.83 63.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.57 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.51 -31.56 73.98 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.652 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.3 mt -78.32 -46.08 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 120.965 0.412 . . . . 0.0 110.528 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.413 HD22 ' CE3' ' A' ' 48' ' ' TRP . 7.7 mp -75.73 -9.61 58.73 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.614 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 59.91 21.78 10.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.413 ' CE3' HD22 ' A' ' 46' ' ' LEU . 16.4 m0 -103.68 160.06 27.32 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.175 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.93 138.79 41.42 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.595 2.197 . . . . 0.0 111.91 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.03 -20.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.55 -32.28 47.78 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.059 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -40.98 85.27 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.402 HG23 ' HB3' ' A' ' 43' ' ' ALA . 2.1 t -62.69 -48.02 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.616 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.75 -52.05 61.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.488 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.22 -38.79 27.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.38 -30.06 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.782 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.0 -23.62 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.873 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.9 -23.49 31.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.091 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -126.64 5.83 6.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.229 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -123.17 76.94 1.42 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.722 0.772 . . . . 0.0 110.441 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.9 p -99.3 -22.44 15.59 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.118 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 p -70.5 -26.08 63.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.192 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.46 141.38 42.7 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -78.85 126.77 31.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 111.354 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -104.03 171.7 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.491 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 70' ' ' ASN . 1.9 t0 -92.45 -172.85 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.376 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -37.71 86.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.58 9.52 29.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.718 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.76 18.76 62.93 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.065 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 66' ' ' ASP . 56.8 m-20 -92.03 167.34 12.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.076 0.438 . . . . 0.0 110.091 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.82 119.18 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.329 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 tt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.028 179.932 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.701 0.286 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.423 HG23 ' CD1' ' A' ' 95' ' ' TRP . 12.3 p -126.06 159.33 33.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.501 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.97 52.44 2.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 0.0 111.096 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.421 ' HA ' ' CD1' ' A' ' 93' ' ' TYR . 27.4 mtm-85 49.38 95.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.088 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.1 tp10 -169.15 -144.09 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.635 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 80' ' ' GLU . 0.7 OUTLIER 41.19 -173.36 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 178.413 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 p -107.34 -19.65 13.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.364 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -76.87 111.25 12.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.688 0.28 . . . . 0.0 110.485 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.0 137.65 41.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 111.388 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 87' ' ' ILE . 34.6 t80 -126.79 105.07 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.162 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -96.82 124.83 40.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.14 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.46 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.15 128.72 26.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.998 0.428 . . . . 0.0 112.109 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 61.13 -77.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.318 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 87' ' ' ILE . 7.6 t70 -156.3 37.39 0.33 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.65 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -141.78 149.65 40.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.781 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 86.22 2.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.013 0.435 . . . . 0.0 110.673 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 85' ' ' PHE . 8.5 mp -71.39 164.64 25.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.975 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.421 ' CD1' ' HA ' ' A' ' 79' ' ' ARG . 88.9 m-85 -133.48 165.18 25.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.973 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.435 ' HB1' ' N ' ' A' ' 100' ' ' THR . . . -150.91 166.24 31.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.001 0.429 . . . . 0.0 111.962 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.423 ' CD1' HG23 ' A' ' 77' ' ' THR . 12.0 m0 -90.75 -23.17 20.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.403 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 65.2 m -153.81 174.83 14.05 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.941 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 164' ' ' PHE . . . -53.83 -21.49 7.65 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -51.78 6.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -49.36 -25.65 2.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.435 ' N ' ' HB1' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.07 -28.97 68.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.952 0.406 . . . . 0.0 110.5 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.426 ' O ' ' CE1' ' A' ' 85' ' ' PHE . 5.1 tp 70.48 155.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.069 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.1 pt -158.84 77.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CE1' HD23 ' A' ' 101' ' ' LEU . 14.8 p90 -121.2 54.13 4.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.457 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.8 Cg_endo -62.7 -37.61 55.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.696 2.264 . . . . 0.0 112.235 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 130' ' ' PRO . . . -64.03 -30.33 71.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.581 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.89 -47.69 13.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.457 ' CG2' ' HA ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -67.73 -41.09 84.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 111.285 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.82 28.47 8.29 Favored Glycine 0 C--N 1.319 -0.38 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.171 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.14 177.39 10.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.051 0.453 . . . . 0.0 110.895 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 m -87.28 160.28 18.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.993 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.442 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . . . -136.55 109.84 7.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.869 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -82.96 119.43 24.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.818 0.818 . . . . 0.0 111.185 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.424 HG21 ' CG2' ' A' ' 128' ' ' VAL . 42.0 t -109.98 128.92 65.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.878 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.1 m -121.75 136.72 54.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.961 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.401 ' HB2' HG21 ' A' ' 124' ' ' VAL . 3.4 m -141.5 172.98 11.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -131.06 130.93 43.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 30.9 m -56.29 125.6 22.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.95 0.405 . . . . 0.0 112.041 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.21 -7.0 38.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.429 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -119.39 -50.56 2.33 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.475 HG21 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.35 -13.96 36.7 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.898 -179.166 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 63.8 11.24 42.46 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.674 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.475 ' H ' HG21 ' A' ' 120' ' ' THR . . . -71.83 164.38 58.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.697 0.284 . . . . 0.0 110.691 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.49 107.98 0.42 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 123.037 2.491 . . . . 0.0 111.328 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 115' ' ' SER . 33.5 m -104.95 146.27 12.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.421 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 60.6 p -151.45 141.69 22.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.384 0.611 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -134.3 152.58 51.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.137 178.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 20.8 m -111.55 114.3 27.28 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.424 ' CG2' HG21 ' A' ' 113' ' ' VAL . 39.7 t -96.09 111.79 27.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.016 0.436 . . . . 0.0 111.243 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.477 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -105.68 172.9 3.59 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.215 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 41.2 Cg_endo -67.57 -19.82 47.95 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.271 1.981 . . . . 0.0 113.097 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 0.4 OUTLIER -112.57 -26.7 8.53 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.117 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 131' ' ' SER . 19.9 pt-20 178.62 -161.02 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.19 0.519 . . . . 0.0 110.108 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -91.79 160.5 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.565 178.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -150.18 17.87 0.85 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.07 85.12 0.07 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.102 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 t -99.6 122.86 51.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.637 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -146.06 118.8 5.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.95 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.42 159.65 95.8 Favored 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 123.396 -1.502 . . . . 0.0 112.094 -0.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.26 78.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.103 0.478 . . . . 0.0 110.673 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.13 18.47 0.17 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.692 -0.765 . . . . 0.0 113.288 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.493 ' CE ' ' CD1' ' A' ' 164' ' ' PHE . 6.5 ptm -67.4 164.43 18.67 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.968 0.384 . . . . 0.0 111.303 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -125.0 152.16 44.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.172 0.511 . . . . 0.0 111.049 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.434 ' CG1' ' CE1' ' A' ' 164' ' ' PHE . 2.5 t -113.08 150.42 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 20.3 p -118.29 140.19 50.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.851 0.358 . . . . 0.0 110.835 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.23 176.52 10.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.723 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.901 179.73 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.881 0.372 . . . . 0.0 111.583 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -120.84 169.44 10.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.565 0.698 . . . . 0.0 109.777 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.493 ' CD1' ' CE ' ' A' ' 141' ' ' MET . 49.8 m-85 -115.08 152.67 32.11 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.382 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 37.9 m-85 -134.09 137.84 44.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.181 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -43.85 -27.92 0.39 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.255 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.517 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 67.8 m -165.98 172.3 11.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.118 0.485 . . . . 0.0 111.577 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 76.2 t -69.38 -34.16 4.53 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.02 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.3 -37.41 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.645 2.23 . . . . 0.0 110.136 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.547 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.59 -40.02 50.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.085 -0.962 . . . . 0.0 108.415 177.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.29 -45.75 93.16 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.603 ' HA ' ' HB1' ' A' ' 175' ' ' ALA . 95.8 mt-10 -78.79 -27.47 44.48 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.291 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 169' ' ' PRO . 28.8 t70 -71.05 -55.92 7.23 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.517 0.675 . . . . 0.0 109.308 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.429 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 32.9 t-105 -64.59 -28.66 69.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.806 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.603 ' HB1' ' HA ' ' A' ' 172' ' ' GLU . . . -65.39 -38.55 90.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.349 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.2 t -52.07 -46.42 65.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.469 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -97.55 24.36 6.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.017 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -156.68 45.81 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.691 179.802 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 CA--C 1.528 0.127 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -131.34 141.19 49.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.101 0.477 . . . . 0.0 111.353 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.484 HG23 ' HB2' ' A' ' 171' ' ' ALA . 18.3 mm -104.44 160.95 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.019 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.409 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -160.62 162.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.373 0.606 . . . . 0.0 111.775 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 190' ' ' HIS . 1.7 m -92.13 133.99 35.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.475 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.449 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 1.7 m -45.87 -20.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.882 0.373 . . . . 0.0 110.654 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.425 ' N ' ' C ' ' A' ' 188' ' ' SER . 93.9 m-70 -70.77 -45.2 65.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.818 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.42 -20.89 36.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.656 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -76.69 -25.36 53.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.228 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -81.41 -24.85 36.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.687 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.84 -29.26 35.44 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.7 mp -82.33 -28.45 31.62 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.05 -28.33 31.43 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -80.84 -21.95 40.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.996 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -75.75 -22.94 56.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.103 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -52.09 -37.87 55.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.932 0.396 . . . . 0.0 111.168 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -69.64 -24.85 63.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.132 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.441 ' N ' ' HD3' ' A' ' 26' ' ' PRO . 7.3 p . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 111.583 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 25' ' ' VAL . 48.9 Cg_exo -55.78 -30.05 74.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.558 2.172 . . . . 0.0 112.54 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.94 -57.5 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.068 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.3 mt -60.87 -27.05 67.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -60.04 -53.18 60.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 0.0 109.673 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -76.75 -25.09 53.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.39 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.28 -52.15 44.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.21 -23.68 15.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.254 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -70.84 -23.58 62.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.186 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.1 49.15 77.81 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.174 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -132.98 166.02 32.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.48 115.16 3.92 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.515 2.144 . . . . 0.0 111.927 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.403 ' CG2' HG21 ' A' ' 41' ' ' THR . 9.3 p -124.21 109.87 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.487 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.9 p -79.15 -176.19 5.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -78.04 -33.44 51.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.315 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -28.11 68.25 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.132 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.59 -41.42 16.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.228 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -36.81 84.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -73.36 -42.94 61.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.409 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.88 -29.64 73.78 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.463 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 41' ' ' THR . 6.9 mt -78.86 -42.21 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 121.2 0.524 . . . . 0.0 109.903 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.82 -9.82 58.94 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.445 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 t70 61.77 21.29 12.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.413 ' CD1' ' HD2' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -101.6 152.47 38.06 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.132 -179.535 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.72 139.02 35.98 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.503 2.135 . . . . 0.0 112.027 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.62 -19.22 0.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.25 -31.2 49.06 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.237 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HD2' ' CD1' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -67.62 -40.36 84.69 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -61.73 -48.07 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.735 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.16 -52.61 58.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.461 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.47 -43.51 68.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.923 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.6 t -75.12 -29.3 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.856 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.5 tp -68.78 -38.86 80.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.816 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.75 -45.11 86.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.616 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -74.22 -8.23 55.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.111 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.04 70.98 0.73 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.766 0.793 . . . . 0.0 110.531 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.9 p -76.51 -6.36 51.51 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.424 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.51 37.9 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 0.0 110.852 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -92.8 141.2 28.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.181 179.607 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -78.88 126.63 30.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 111.28 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 63' ' ' THR . 27.0 m-85 -124.4 154.01 41.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.343 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -153.14 146.11 24.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.233 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 tttm 66.04 -101.68 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.672 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -89.96 -14.4 34.15 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.11 29.23 1.68 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.989 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -87.41 172.65 9.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.1 mt -79.59 105.84 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.845 0.355 . . . . 0.0 110.999 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 tt . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.555 -179.69 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.112 0 CA-C-O 121.061 0.457 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -144.08 159.39 42.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.566 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -83.12 52.76 2.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 111.053 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? 57.84 113.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -177.71 -28.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.497 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.8 p -89.41 -178.23 5.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.945 0.402 . . . . 0.0 111.332 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.75 -26.98 14.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.345 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.447 ' HB3' HG22 ' A' ' 100' ' ' THR . 81.7 m-85 -76.56 110.79 11.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.628 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.26 139.12 31.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.169 0.509 . . . . 0.0 111.573 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.481 ' CE1' ' CG2' ' A' ' 87' ' ' ILE . 14.5 t80 -136.38 108.19 7.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.847 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -103.7 137.12 42.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.806 0.336 . . . . 0.0 111.552 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.481 ' CG2' ' CE1' ' A' ' 85' ' ' PHE . 2.2 pt -140.03 123.35 17.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.572 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 t0 63.65 -66.68 0.1 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.189 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.5 t70 -168.0 35.2 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.401 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -134.07 113.48 12.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.927 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.21 86.2 5.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 111.0 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -76.0 164.92 25.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.016 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -136.2 165.45 25.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.263 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.401 ' HB3' ' CB ' ' A' ' 99' ' ' ASP . . . -150.73 169.98 20.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.922 0.391 . . . . 0.0 111.879 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 15.0 m0 -92.93 -23.5 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.931 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 50.9 m -147.44 167.08 25.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.283 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.47 ' CB ' ' CZ ' ' A' ' 164' ' ' PHE . . . -51.97 -22.44 3.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.011 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.4 tp -86.26 -51.55 6.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.401 ' CB ' ' HB3' ' A' ' 94' ' ' ALA . 2.7 m-20 -48.14 -25.94 1.68 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.447 HG22 ' HB3' ' A' ' 83' ' ' TYR . 0.1 OUTLIER -60.26 -39.1 85.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.515 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.18 166.56 11.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.7 pt -158.03 -43.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.422 ' CD1' ' HB2' ' A' ' 106' ' ' LEU . 1.5 m-85 -162.58 64.46 1.55 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.501 ' O ' HG22 ' A' ' 107' ' ' ILE . 37.8 Cg_exo -60.22 -43.04 37.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.747 2.298 . . . . 0.0 112.416 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.19 -23.76 43.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.376 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.422 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -84.09 -38.74 20.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.509 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.4 tp -57.16 -45.7 84.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.146 0.498 . . . . 0.0 111.309 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.56 25.31 10.09 Favored Glycine 0 C--N 1.319 -0.372 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.508 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.65 174.15 14.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 110.939 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.0 m -81.08 158.14 25.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.756 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . . . -136.77 109.67 7.63 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -81.61 119.78 24.23 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.765 0.793 . . . . 0.0 111.015 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.17 129.86 66.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.084 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.4 m -124.21 137.35 54.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.045 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.417 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 1.4 m -141.6 173.09 11.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.377 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -134.09 133.24 40.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.6 t -62.44 133.37 54.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.216 0.532 . . . . 0.0 112.213 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.98 -3.81 24.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.891 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.45 ' CB ' ' HB2' ' A' ' 174' ' ' TRP . . . -122.68 -50.94 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.786 0.327 . . . . 0.0 111.662 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.514 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.45 -24.13 21.94 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.306 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.76 5.15 73.44 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.144 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.514 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -58.07 149.41 56.46 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-O 120.544 0.212 . . . . 0.0 110.631 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.31 103.85 1.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.667 2.244 . . . . 0.0 110.807 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.418 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 35.8 m -99.14 144.72 11.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.311 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.5 p -151.87 141.72 21.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.431 0.634 . . . . 0.0 110.836 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -138.82 151.39 46.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.875 178.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 21.2 m -105.94 115.21 29.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.639 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.425 HG12 ' CE2' ' A' ' 193' ' ' PHE . 38.8 t -96.11 111.73 26.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.853 0.359 . . . . 0.0 111.505 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.411 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -107.22 169.5 6.67 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.938 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.411 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.4 Cg_endo -66.23 -19.25 56.52 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.198 1.932 . . . . 0.0 112.816 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 19.6 p -112.66 -26.97 8.37 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 131' ' ' SER . 0.4 OUTLIER 178.39 -162.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.133 0.492 . . . . 0.0 110.043 -179.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -93.68 158.46 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.922 178.578 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -144.66 19.49 1.67 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.448 0.642 . . . . 0.0 112.154 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.83 86.81 0.08 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.238 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 36.3 t -103.25 113.64 40.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.334 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -146.5 122.72 5.67 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.48 155.83 95.05 Favored 'Cis proline' 0 C--N 1.348 0.517 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.26 0.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.39 79.46 0.38 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.178 0.514 . . . . 0.0 110.497 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.01 17.61 0.18 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.597 -0.728 . . . . 0.0 113.243 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.468 ' HG3' ' CG1' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -58.61 158.47 7.76 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.964 0.412 . . . . 0.0 111.441 -179.393 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.49 152.32 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.052 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.416 HG23 ' CE1' ' A' ' 164' ' ' PHE . 46.1 t -111.74 147.72 15.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.543 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 32.0 m -120.77 144.91 48.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.804 0.335 . . . . 0.0 110.946 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.04 175.03 9.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.828 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.3 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 -179.983 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.885 0.374 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 163' ' ' HIS . 2.2 m-70 -118.93 159.14 24.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.535 0.683 . . . . 0.0 109.919 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.47 ' CZ ' ' CB ' ' A' ' 97' ' ' ALA . 15.9 m-30 -111.12 130.6 55.57 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.526 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 39.4 m-85 -108.48 140.69 41.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.397 0.618 . . . . 0.0 110.545 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.33 -27.64 0.7 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.76 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 68.2 m -164.95 171.48 13.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.225 0.536 . . . . 0.0 111.746 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 73.0 t -69.23 -32.84 3.52 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.298 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.22 -37.76 3.16 Favored 'Trans proline' 0 CA--C 1.504 -0.983 0 C-N-CA 122.739 2.292 . . . . 0.0 110.389 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.556 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.71 -40.17 49.6 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.146 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.474 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.9 -45.49 93.49 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 97.2 mt-10 -78.96 -27.37 43.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.288 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 169' ' ' PRO . 13.8 t70 -70.75 -55.78 7.86 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.457 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' TRP . . . . . 0.45 ' HB2' ' CB ' ' A' ' 119' ' ' ALA . 39.2 t-105 -64.64 -28.58 69.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.616 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.605 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -63.85 -41.58 97.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.311 178.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.56 -42.23 55.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.228 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.6 22.75 7.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.294 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.66 31.73 1.46 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.889 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.289 179.882 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.811 0.339 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.4 150.08 40.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.221 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.462 HG23 ' HB2' ' A' ' 171' ' ' ALA . 17.2 mm -103.14 161.71 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.961 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.56 162.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.099 0.476 . . . . 0.0 111.833 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.412 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -90.15 128.09 36.26 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.896 178.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.468 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 2.2 m -46.78 -20.14 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.915 0.388 . . . . 0.0 110.758 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' HIS . . . . . 0.412 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.0 m170 -71.5 -41.68 68.97 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.126 0.488 . . . . 0.0 109.709 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.7 OUTLIER -82.12 -25.66 34.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.412 179.097 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.83 -24.86 62.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.043 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 128' ' ' VAL . 5.0 t80 -81.15 -24.98 37.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.8 -29.82 33.98 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 9.6 mp -82.4 -28.27 31.52 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -28.36 31.4 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.402 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 9.1 tt0 -80.55 -22.99 40.29 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.897 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -73.46 -22.89 60.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.102 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.03 -36.95 51.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.959 0.409 . . . . 0.0 111.246 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -73.07 -24.81 60.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.108 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.794 0.33 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -139.59 173.69 11.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.2 mt -151.74 111.44 4.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.949 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.43 35.69 1.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t 59.81 64.25 2.91 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.71 -21.99 50.4 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.519 2.146 . . . . 0.0 112.292 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 2.6 mt -52.0 -57.3 9.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.244 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.55 -27.09 62.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -61.0 -53.27 59.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.653 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.9 -25.07 62.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.298 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -67.0 -47.65 70.82 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.824 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.39 -25.85 17.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -67.74 -22.26 65.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.212 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.6 47.99 88.44 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.039 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.14 153.1 81.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.768 0.318 . . . . 0.0 110.928 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.01 109.08 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.596 2.197 . . . . 0.0 111.987 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 p -115.56 110.17 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.334 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 57.5 p -85.14 177.6 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.677 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.09 -37.17 72.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.192 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -26.46 67.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.814 0.34 . . . . 0.0 110.136 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -85.4 -42.65 14.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.11 -36.38 83.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.2 -43.0 62.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.492 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.01 -30.61 74.18 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.734 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 41' ' ' THR . 6.7 mt -79.16 -41.58 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.055 0.455 . . . . 0.0 110.297 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.5 mp -77.17 -9.66 58.91 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.336 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 t70 59.88 21.95 10.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -109.95 158.31 35.36 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.162 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.68 142.75 71.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.533 2.155 . . . . 0.0 112.02 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.64 -16.82 1.04 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -78.95 -34.34 44.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.062 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -41.58 84.39 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.36 -46.99 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.482 177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.91 -51.35 61.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.383 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.96 -37.65 20.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.719 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 t -63.6 -53.01 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.793 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.52 -16.92 61.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.968 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -58.12 -19.58 33.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.049 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.85 12.57 12.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.825 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -123.06 76.5 1.38 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.771 0.796 . . . . 0.0 110.48 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 p -87.43 -26.95 23.02 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.762 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.25 -21.29 63.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.76 141.2 53.6 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.431 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -84.68 126.96 33.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 111.642 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -100.36 173.14 6.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.163 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -153.11 143.3 22.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 111.504 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 tptp 66.06 -104.06 0.09 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.82 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -92.73 -13.05 29.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.715 0.293 . . . . 0.0 111.782 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.64 31.98 0.63 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.14 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -87.14 170.56 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.82 0.343 . . . . 0.0 110.166 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.7 mp -79.7 109.43 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.159 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.505 HG21 HD12 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -68.3 -33.66 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.107 0.479 . . . . 0.0 111.002 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.83 -130.47 10.24 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.63 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 102' ' ' ILE . 1.1 m-85 -103.44 -170.61 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.847 0.356 . . . . 0.0 110.954 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.01 -29.72 0.15 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.51 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 65.16 -85.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 111.032 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -129.43 159.62 35.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.6 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.8 mt -77.91 51.13 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.266 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 4.7 ttt-85 44.47 85.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.635 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.07 23.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.469 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.1 p -119.17 -171.07 2.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.114 0.483 . . . . 0.0 111.599 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 p -104.08 -29.14 11.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.301 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 95' ' ' TRP . 10.8 m-85 -79.27 111.83 15.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.628 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.57 140.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.059 0.457 . . . . 0.0 111.098 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.465 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 43.8 t80 -129.95 106.38 8.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.588 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -100.17 130.54 46.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.921 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.503 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -140.03 124.62 19.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.16 -70.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.283 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -166.94 34.39 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.251 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -137.71 111.94 8.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.906 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.42 121.56 24.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.837 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 85' ' ' PHE . 3.8 mm? -114.43 164.8 13.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.969 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.408 ' CZ ' ' HG3' ' A' ' 79' ' ' ARG . 24.8 m-85 -130.78 165.09 23.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.112 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.41 ' HB1' ' N ' ' A' ' 100' ' ' THR . . . -151.79 170.17 20.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.106 0.479 . . . . 0.0 111.848 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.405 ' O ' ' CE1' ' A' ' 83' ' ' TYR . 5.3 m95 -98.81 -18.67 17.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.684 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 28.1 m -147.61 162.55 38.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.924 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.463 ' CB ' ' CE1' ' A' ' 164' ' ' PHE . . . -52.03 -22.62 4.2 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 tp -85.79 -51.53 6.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.656 0.265 . . . . 0.0 111.305 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -45.16 -28.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.416 ' CG2' ' HB2' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -60.41 -39.1 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 110.549 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.3 pt? -121.87 174.9 6.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.059 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 74' ' ' TYR . 19.2 mt -151.31 -46.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.044 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -156.92 79.02 3.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.742 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.407 ' HA ' HG12 ' A' ' 107' ' ' ILE . 20.3 Cg_endo -60.78 -40.13 56.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.703 2.269 . . . . 0.0 112.41 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.24 -25.94 67.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.547 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.3 tp -79.9 -26.47 40.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 104' ' ' PRO . 4.5 mm -64.5 -58.88 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.117 0.961 . . . . 0.0 111.013 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.54 22.14 13.22 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.637 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.07 -177.03 5.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.925 0.393 . . . . 0.0 110.344 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.54 154.11 20.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.227 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.465 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . . . -136.85 110.06 7.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.639 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -80.38 119.91 23.71 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.767 0.794 . . . . 0.0 111.277 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.434 HG22 ' CD1' ' A' ' 85' ' ' PHE . 47.2 t -112.05 129.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.947 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 m -122.87 137.56 54.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.114 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.411 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 0.6 OUTLIER -141.4 172.82 12.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.317 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -134.54 133.88 40.79 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . 0.407 ' O ' ' HA2' ' A' ' 121' ' ' GLY . 30.5 t -62.29 130.38 45.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.047 0.451 . . . . 0.0 112.037 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.95 -3.59 23.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.974 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.435 ' HB3' ' CG ' ' A' ' 174' ' ' TRP . . . -121.54 -49.85 2.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 111.545 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.476 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -91.77 -24.62 19.36 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.281 -179.522 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 117' ' ' CYS . . . 76.28 5.55 81.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.195 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -57.93 148.92 57.51 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-O 120.528 0.204 . . . . 0.0 110.636 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.31 104.1 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.686 2.258 . . . . 0.0 110.806 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.426 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 30.5 m -100.16 144.91 11.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.4 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.0 p -151.64 141.49 21.97 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.415 0.626 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -138.55 151.92 47.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.83 178.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 53.8 m -106.52 113.49 27.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.871 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.433 HG12 ' CE2' ' A' ' 193' ' ' PHE . 47.9 t -96.31 111.79 27.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.902 0.382 . . . . 0.0 111.474 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.25 168.53 8.05 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.08 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.75 -14.55 45.2 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.49 2.126 . . . . 0.0 113.015 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -118.84 -26.91 5.93 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 179.6 -163.29 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.16 0.505 . . . . 0.0 110.017 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -96.61 160.47 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.879 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -148.21 20.75 1.09 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.468 0.651 . . . . 0.0 112.194 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.94 86.69 0.08 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.408 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.2 t -103.54 115.4 45.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.193 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -146.27 122.28 5.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.74 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.87 157.0 99.14 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 123.523 -1.449 . . . . 0.0 112.283 0.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.42 79.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 0.0 110.553 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.58 16.61 0.15 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.407 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.428 ' HG3' ' CG1' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -60.13 156.49 15.01 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.065 0.459 . . . . 0.0 111.313 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -125.43 151.87 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.734 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.475 ' CG1' ' CE1' ' A' ' 164' ' ' PHE . 18.4 t -113.0 152.22 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.793 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.524 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 1.6 p -120.72 140.98 50.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.938 0.399 . . . . 0.0 110.945 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.7 tp -135.84 175.13 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.871 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.06 158.88 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.083 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.1 mt -89.23 149.45 42.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.964 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 129.32 17.28 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.637 2.225 . . . . 0.0 112.256 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -114.01 147.28 38.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.826 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.96 35.47 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.834 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.31 39.12 0.73 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -123.08 162.48 22.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 36.7 p30 -59.37 -176.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.1 m -107.18 125.13 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.235 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.29 -50.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.681 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -163.4 -46.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.816 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.3 m 57.24 45.21 20.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.001 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 61.42 66.59 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.825 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.75 -26.38 45.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.071 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 51.2 m -143.5 -75.32 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 55.67 38.18 29.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.736 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.5 110.88 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.499 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -117.1 169.05 9.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.602 0.715 . . . . 0.0 109.801 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.475 ' CE1' ' CG1' ' A' ' 143' ' ' VAL . 2.5 m-85 -119.38 152.9 36.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.127 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.524 ' CE2' ' HB3' ' A' ' 144' ' ' SER . 49.1 m-85 -129.35 133.67 47.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.845 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -41.48 -27.51 0.09 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.491 ' O ' ' HB1' ' A' ' 171' ' ' ALA . 10.8 p -168.84 174.36 6.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.015 0.436 . . . . 0.0 111.511 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.6 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 85.6 t -68.6 -33.53 4.6 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.673 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.683 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.6 Cg_exo -72.51 -38.17 3.61 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.718 2.279 . . . . 0.0 110.371 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.553 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.54 -39.47 52.75 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.495 ' HA ' ' CG ' ' A' ' 165' ' ' PHE . . . -62.44 -46.02 90.42 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.584 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.7 mt-10 -78.78 -28.12 44.61 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.323 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 169' ' ' PRO . 12.3 t70 -71.33 -55.81 7.26 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.384 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.435 ' CG ' ' HB3' ' A' ' 119' ' ' ALA . 58.3 t-105 -64.04 -28.48 69.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.739 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -62.99 -42.22 99.79 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.166 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 71.1 m -51.37 -41.74 60.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.399 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 21.04 9.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.421 0.629 . . . . 0.0 111.298 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.42 ' CD2' HD21 ' A' ' 184' ' ' LEU . 2.8 t60 -128.4 28.74 5.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.864 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -91.45 171.07 9.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.709 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 97.12 -27.52 18.04 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.424 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.415 HD13 ' CE1' ' A' ' 178' ' ' HIS . 14.3 mt -63.76 -176.18 0.17 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.765 0.317 . . . . 0.0 110.86 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.74 66.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.777 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 91.16 -86.28 1.31 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.431 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.42 HD21 ' CD2' ' A' ' 178' ' ' HIS . 6.0 tp 62.65 122.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.29 150.08 42.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.037 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.454 HG21 ' CB ' ' A' ' 171' ' ' ALA . 10.6 mm -100.14 159.04 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.035 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.02 162.56 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.289 0.566 . . . . 0.0 112.076 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.415 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -88.53 129.52 35.45 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.669 178.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.428 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 2.2 m -46.44 -20.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.832 0.349 . . . . 0.0 110.717 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.415 ' N ' ' C ' ' A' ' 188' ' ' SER . 1.8 t-160 -73.82 -42.07 61.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.784 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -82.25 -21.2 36.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.25 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.4 -24.93 63.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.813 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.433 ' CE2' HG12 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -81.11 -24.91 37.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.72 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.81 -31.26 29.91 Favored Glycine 0 CA--C 1.509 -0.317 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.7 tp -82.13 -29.25 31.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -83.12 -27.43 40.59 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -82.28 -21.93 35.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.938 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -81.03 -26.21 36.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -52.68 -30.52 32.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.115 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.67 -54.46 27.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -58.46 -31.81 68.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -72.47 -40.43 66.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 mt -79.54 -30.24 41.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.012 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.4 tt -56.82 -30.83 64.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.072 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -66.02 121.34 14.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.9 t -59.73 -46.6 88.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.54 156.83 26.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.57 165.23 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.79 87.24 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -93.04 116.83 29.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.431 ' CB ' ' CD ' ' A' ' 212' ' ' PRO . 1.1 m -176.47 -62.91 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.029 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 211' ' ' THR . 19.0 Cg_endo . . . . . 0 C--O 1.25 1.121 0 C-N-CA 122.34 2.027 . . . . 0.0 112.353 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.87 0.367 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -174.74 149.89 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.7 mt -59.92 -29.88 68.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 62.19 -166.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.7 m 42.51 53.88 8.92 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.695 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.2 -16.97 45.08 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.695 2.263 . . . . 0.0 112.456 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -54.25 -57.44 11.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.949 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 31' ' ' LEU . 9.2 tp -63.7 -27.05 68.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.982 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -68.43 -53.33 24.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.719 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -72.61 -29.72 63.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.318 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HB3' ' HA ' ' A' ' 28' ' ' LEU . 9.2 tt -67.25 -45.71 75.9 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.56 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.08 -23.06 18.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -22.75 62.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.005 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.3 39.72 98.09 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.26 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -133.38 166.09 31.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.595 0.236 . . . . 0.0 110.673 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.64 112.65 2.92 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.517 2.145 . . . . 0.0 112.201 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.4 t -112.22 109.92 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.331 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -90.46 -168.4 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.835 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.458 ' O ' ' N ' ' A' ' 43' ' ' ALA . 27.9 ptt180 -78.07 -38.44 44.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.513 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -25.31 68.06 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.45 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -86.1 -43.56 12.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 tp -63.01 -35.46 80.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -74.24 -42.94 58.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.496 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.13 -30.96 74.11 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.579 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.3 mt -78.7 -44.44 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 120.995 0.426 . . . . 0.0 110.584 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.81 -9.8 58.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.421 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.6 t70 58.21 22.88 9.65 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -97.81 139.62 21.43 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.461 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -56.07 137.37 79.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.445 2.097 . . . . 0.0 111.797 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.85 -22.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -78.33 -36.12 46.73 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 110.951 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -67.07 -40.41 87.02 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -63.01 -47.98 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.487 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.04 -53.69 46.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.117 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.39 -48.28 77.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.836 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.31 -31.95 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.664 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.14 -31.4 71.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.581 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -58.17 -21.83 48.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -96.13 -19.57 19.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.002 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.75 32.07 3.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.466 0.651 . . . . 0.0 110.88 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.2 p -69.43 -13.04 62.14 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.173 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.7 p -90.91 -23.11 20.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 111.266 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.49 141.23 43.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.77 126.96 31.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.397 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.404 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 66.8 m-85 -102.14 173.25 6.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.505 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -152.77 147.09 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.948 0.404 . . . . 0.0 111.441 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.41 -104.01 0.09 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.745 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.65 -11.1 46.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.726 0.298 . . . . 0.0 111.726 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.04 27.69 1.82 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.076 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -86.64 168.47 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.5 mp -79.64 120.41 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.379 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.3 tt -108.2 -28.0 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.17 -156.05 30.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.617 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.22 90.83 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.959 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.95 -44.63 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.412 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.75 150.51 29.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 0.0 110.748 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -100.32 152.6 20.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.88 -45.95 76.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -103.47 147.72 26.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.946 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.406 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 3.1 tt0 -59.43 132.21 53.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.2 p -110.09 -173.6 2.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.6 p -93.62 -35.74 12.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.928 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -79.15 109.72 13.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.385 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.55 137.51 34.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.139 0.495 . . . . 0.0 111.377 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 111' ' ' ALA . 21.7 t80 -132.58 105.77 7.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.103 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -102.52 135.26 44.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.387 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.463 ' CG2' ' CE1' ' A' ' 85' ' ' PHE . 2.8 pt -140.14 126.54 22.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t0 61.89 -72.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -158.05 37.7 0.25 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -140.34 148.74 41.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.611 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.88 86.19 2.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.094 0.473 . . . . 0.0 110.571 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.6 164.69 25.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.091 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.406 ' CZ ' ' HG3' ' A' ' 80' ' ' GLU . 9.7 m-85 -134.31 165.16 25.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.113 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.16 167.24 28.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.152 0.501 . . . . 0.0 111.849 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -101.09 -10.54 20.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.751 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.406 ' HB3' ' CG1' ' A' ' 162' ' ' VAL . 11.9 m -153.31 160.0 42.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.854 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.442 ' CB ' ' CE2' ' A' ' 164' ' ' PHE . . . -51.81 -22.46 3.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.93 -51.34 6.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.674 0.273 . . . . 0.0 111.172 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -44.38 -27.66 0.46 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.442 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -60.28 -39.2 86.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.892 0.377 . . . . 0.0 110.544 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 mt -93.45 -176.1 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.032 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 tp -174.67 -40.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -172.02 65.48 0.39 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.797 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.51 ' O ' HG23 ' A' ' 107' ' ' ILE . 33.6 Cg_exo -59.85 -42.04 48.94 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.73 2.287 . . . . 0.0 112.351 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 130' ' ' PRO . . . -79.07 -23.91 43.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.332 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -85.11 -38.33 19.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.481 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -57.19 -45.82 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 111.394 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.61 23.37 16.19 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.568 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.41 173.61 13.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.036 0.446 . . . . 0.0 110.954 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m -81.61 156.51 25.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.901 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.469 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . . . -136.76 109.96 7.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.847 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -81.28 120.07 24.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.717 0.77 . . . . 0.0 111.232 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.3 t -111.07 127.29 68.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.626 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.3 m -122.36 137.6 54.8 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.317 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.426 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 1.0 OUTLIER -141.5 172.85 12.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.265 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -134.32 133.23 40.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 22.6 t -62.77 131.84 50.23 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.248 0.547 . . . . 0.0 112.222 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.17 -3.59 20.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.988 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.473 ' CB ' ' HB2' ' A' ' 174' ' ' TRP . . . -123.27 -51.07 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.631 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.524 HG21 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -87.68 -24.57 23.85 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.208 -179.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.44 5.45 72.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.114 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 120' ' ' THR . . . -59.94 152.27 60.78 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-O 120.591 0.234 . . . . 0.0 110.515 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -84.71 105.03 0.97 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.683 2.255 . . . . 0.0 110.947 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.435 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 35.3 m -99.36 144.46 11.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.364 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 82.4 p -151.64 141.68 22.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.424 0.631 . . . . 0.0 110.936 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -138.64 152.09 47.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.724 178.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 20.1 m -106.73 115.23 29.83 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.4 t -96.18 111.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.843 0.354 . . . . 0.0 111.211 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.97 175.79 1.9 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.32 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 105' ' ' ALA . 12.1 Cg_exo -70.77 -15.5 33.33 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.629 2.219 . . . . 0.0 112.978 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 18.0 t -118.96 -25.7 6.19 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.415 ' HB3' ' O ' ' A' ' 131' ' ' SER . 10.7 pt-20 178.56 -162.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.158 0.504 . . . . 0.0 110.036 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -93.44 156.49 3.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.94 178.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.72 18.59 2.0 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.469 0.652 . . . . 0.0 112.279 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.57 86.45 0.09 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.421 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 39.7 t -102.29 115.82 44.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.063 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -146.3 122.25 5.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.748 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.11 160.17 94.37 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.495 -1.461 . . . . 0.0 112.362 -0.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.64 78.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.673 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.0 16.92 0.16 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.33 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.472 ' HG3' ' CG1' ' A' ' 189' ' ' VAL . 0.4 OUTLIER -58.67 155.03 13.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 111.619 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.88 151.9 44.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.977 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.465 ' CG2' ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -112.93 149.32 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.666 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.415 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 9.8 m -120.54 141.39 50.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.544 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.411 ' CD2' ' CG2' ' A' ' 187' ' ' VAL . 0.7 OUTLIER -146.79 176.64 9.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.031 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.75 131.19 72.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.811 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.427 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . 1.5 mp -70.46 -63.29 1.74 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.114 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 73.2 Cg_endo -75.75 -168.23 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.434 2.09 . . . . 0.0 112.379 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -174.27 115.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -149.19 30.87 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -174.91 36.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.036 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.37 74.73 1.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.087 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -156.74 31.7 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.9 m -73.76 -30.24 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -160.32 -74.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.83 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -140.81 39.4 1.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 m -99.32 111.41 23.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.08 -68.38 0.79 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 18.1 m -81.09 -45.99 15.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 5.4 t 80.03 -50.79 0.37 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.31 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -109.06 48.05 0.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.944 0.402 . . . . 0.0 111.112 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.406 ' CG1' ' HB3' ' A' ' 96' ' ' CYS . 3.2 p -106.34 110.46 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.451 . . . . 0.0 110.948 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.4 169.33 14.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.454 0.645 . . . . 0.0 110.379 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.465 ' CE1' ' CG2' ' A' ' 143' ' ' VAL . 14.0 m-85 -107.54 129.66 54.95 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.425 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.459 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 43.7 m-85 -108.78 139.73 43.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.347 0.594 . . . . 0.0 110.589 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -47.65 -26.64 1.58 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.797 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.541 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 49.0 m -164.43 168.99 17.87 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.836 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 82.1 t -68.47 -34.13 5.35 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.019 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.1 Cg_exo -72.5 -37.22 4.37 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.629 2.22 . . . . 0.0 110.27 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.44 -40.39 50.75 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.81 -46.43 89.54 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.68 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 3.0 mm-40 -78.98 -27.87 43.47 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.462 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.5 t70 -69.7 -55.85 8.84 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.165 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.473 ' HB2' ' CB ' ' A' ' 119' ' ' ALA . 71.5 t-105 -65.73 -28.3 68.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.795 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.68 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -63.96 -39.95 95.31 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.054 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.96 -43.66 63.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.249 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.51 22.43 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.289 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.411 ' CE1' HD11 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -145.79 29.89 1.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.911 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -108.41 -16.92 14.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.167 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.32 -21.25 25.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.411 HD11 ' CE1' ' A' ' 178' ' ' HIS . 4.1 mt -57.07 -176.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.831 0.348 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -101.29 36.73 1.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.976 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 149.33 117.62 0.89 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.614 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -178.7 127.22 0.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.379 . . . . 0.0 110.992 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.57 149.09 40.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.815 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.447 HG23 ' HB3' ' A' ' 171' ' ' ALA . 16.3 mm -102.13 160.48 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.08 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.411 ' CG2' ' CD2' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -161.05 164.17 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.257 0.551 . . . . 0.0 112.067 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.413 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -89.61 127.99 35.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.744 178.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.472 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 2.0 m -46.63 -20.5 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.824 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.413 ' N ' ' C ' ' A' ' 188' ' ' SER . 2.4 m-70 -72.76 -42.88 63.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.211 0.529 . . . . 0.0 109.746 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.28 -21.92 35.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.153 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.11 61.88 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.832 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -81.06 -24.95 37.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.688 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.89 -29.91 33.42 Favored Glycine 0 CA--C 1.51 -0.277 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -28.49 32.32 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.81 -27.97 33.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.22 -22.02 36.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.99 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.06 -23.1 55.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.213 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -51.92 -37.17 51.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -81.08 -28.31 35.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.832 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -58.13 -28.35 64.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -57.88 -48.52 79.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.976 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.36 -39.4 87.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.75 -43.87 85.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 59.79 -176.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.919 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 p -71.37 80.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 2.8 ttm -172.14 126.64 0.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.17 -68.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.4 t -158.15 130.39 7.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.37 35.64 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.986 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.617 ' N ' ' CD ' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -70.96 -34.63 3.62 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.795 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 211' ' ' THR . 63.5 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 121.972 1.781 . . . . 0.0 112.498 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 t0 61.89 152.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.8 mp -148.97 160.86 42.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.7 mt -146.49 -75.99 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.58 77.61 2.43 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.078 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.48 -24.77 22.03 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.518 2.145 . . . . 0.0 112.502 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.5 mt -54.89 -57.55 11.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.374 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.22 -27.36 38.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -53.23 15.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.966 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.92 -26.12 66.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.49 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 mt -73.68 -30.3 62.81 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.746 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.34 -28.77 30.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.199 0.524 . . . . 0.0 110.909 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -64.23 -19.46 65.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.208 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.0 48.49 83.05 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.038 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -129.78 164.92 36.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.658 0.266 . . . . 0.0 110.71 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.52 111.41 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.482 2.121 . . . . 0.0 112.2 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.5 t -120.32 109.98 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.358 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 p -91.51 -172.72 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.699 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -74.61 -37.85 62.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.192 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -28.25 68.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.973 0.416 . . . . 0.0 110.246 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.5 -42.36 15.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -62.53 -36.74 83.54 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB2' HG23 ' A' ' 53' ' ' VAL . . . -72.62 -42.95 63.91 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.589 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -31.98 77.09 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.613 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.0 mt -78.66 -43.36 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 120.936 0.398 . . . . 0.0 110.478 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 7.5 mp -78.52 -7.41 57.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.485 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 54.91 23.64 5.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.416 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 18.0 m0 -101.02 152.03 37.77 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.285 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -65.18 137.05 50.33 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.433 2.089 . . . . 0.0 111.92 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.22 -21.29 0.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.15 -36.69 47.4 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.959 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.416 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -66.71 -40.52 88.46 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.84 -47.97 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.423 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.7 -53.7 43.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.239 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.82 73.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.849 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.7 t -64.36 -34.63 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.744 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -61.88 -32.63 73.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.607 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -57.9 -22.49 48.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -94.26 -19.85 20.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.997 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.77 32.22 2.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.435 0.636 . . . . 0.0 111.041 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 38.8 p -62.16 -19.13 62.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.888 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 m -90.09 -21.99 22.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.37 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.61 141.23 55.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.384 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . 4.0 tt0 -78.86 131.06 36.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 111.634 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.433 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.7 m-85 -105.26 173.18 6.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.278 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.54 146.68 26.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 111.43 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.5 -103.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.77 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -89.88 -11.02 43.11 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.63 29.37 1.43 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.975 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -87.55 172.14 9.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.835 0.35 . . . . 0.0 110.143 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.9 mp -79.58 118.42 27.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.272 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.488 HD13 HG23 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -97.96 -33.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.004 0.431 . . . . 0.0 110.958 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.88 -179.19 19.12 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.512 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -147.86 -173.87 4.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 110.891 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.74 27.85 7.74 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.567 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp -145.43 151.33 38.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.747 0.308 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.6 p -104.25 159.08 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.811 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.7 mt -91.73 49.21 1.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -178.29 137.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.08 121.32 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.7 p -109.24 -174.89 2.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.083 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -93.0 -34.35 13.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.974 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.415 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 7.7 m-85 -83.76 112.41 20.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.316 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.456 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.5 t -107.84 144.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.985 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.485 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 38.4 t80 -133.93 105.36 6.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.144 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -97.47 131.9 43.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.052 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.05 124.29 18.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 -71.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.537 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -161.22 35.44 0.14 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.601 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -137.62 142.28 41.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.295 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.94 86.28 2.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 110.74 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.62 164.7 25.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.781 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -134.91 164.18 28.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.161 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.413 ' HB3' ' N ' ' A' ' 100' ' ' THR . . . -151.02 167.03 28.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.014 0.435 . . . . 0.0 111.881 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.4 m0 -95.09 -18.92 20.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.62 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.443 ' HB3' ' CG1' ' A' ' 162' ' ' VAL . 1.7 m -150.11 166.61 29.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.154 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.469 ' CB ' ' CD1' ' A' ' 164' ' ' PHE . . . -53.76 -21.81 8.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.8 mp -84.67 -51.59 6.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.561 0.22 . . . . 0.0 111.536 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.403 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -47.96 -28.16 2.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.447 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -60.69 -39.32 88.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 110.58 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mt -86.35 168.5 13.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.225 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.402 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 6.8 pt -160.66 -43.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.031 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' A' ' 106' ' ' LEU . 1.0 OUTLIER 178.16 78.34 0.14 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.473 ' O ' HG22 ' A' ' 107' ' ' ILE . 52.2 Cg_endo -69.12 -38.8 8.65 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.623 2.216 . . . . 0.0 112.474 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.77 -23.94 45.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.242 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.411 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -83.94 -40.9 17.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.259 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.2 tp -57.37 -46.48 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.239 0.542 . . . . 0.0 111.473 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.9 24.75 12.49 Favored Glycine 0 C--N 1.319 -0.392 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.565 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.43 173.79 14.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 0.0 110.965 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -81.39 155.67 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.845 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.485 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.1 110.0 7.64 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.3 mtm180 -81.23 119.87 24.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.816 0.817 . . . . 0.0 111.242 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.45 ' CG2' ' CE1' ' A' ' 85' ' ' PHE . 48.9 t -111.88 129.89 66.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.162 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.456 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 75.9 p -123.98 137.74 54.56 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.249 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.428 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.53 172.89 12.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.343 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -134.41 133.3 40.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.23 134.65 55.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.251 0.548 . . . . 0.0 112.337 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.68 -3.55 22.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.284 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.458 ' CB ' ' HB2' ' A' ' 174' ' ' TRP . . . -123.26 -51.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.958 0.409 . . . . 0.0 111.476 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.408 ' CG2' HG23 ' A' ' 170' ' ' THR . 1.4 p -84.99 -29.44 25.03 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.002 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.02 4.97 79.27 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.219 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . . . -59.11 150.77 60.48 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 1.1 Cg_endo -82.54 104.11 1.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.561 2.174 . . . . 0.0 111.093 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.428 ' CG2' ' CB ' ' A' ' 115' ' ' SER . 35.9 m -97.71 144.28 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.985 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.0 p -150.6 142.35 23.72 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.439 0.637 . . . . 0.0 110.856 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -139.61 151.64 46.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.815 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 52.4 m -107.88 113.91 27.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.419 ' CG2' HG21 ' A' ' 113' ' ' VAL . 46.2 t -96.0 111.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.087 0.47 . . . . 0.0 111.403 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.487 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -106.79 177.83 1.24 Allowed Pre-proline 0 N--CA 1.453 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.638 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 56.6 Cg_endo -72.55 -20.1 23.91 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 121.961 1.774 . . . . 0.0 112.87 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 26.8 t -109.96 -28.06 8.92 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 131' ' ' SER . 11.8 pt-20 177.63 -162.73 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.11 0.481 . . . . 0.0 110.08 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -95.72 143.96 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.8 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -129.41 21.82 5.61 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.399 0.619 . . . . 0.0 112.295 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.66 87.65 0.1 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.225 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.6 t -104.55 115.59 46.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.332 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -146.37 124.24 6.16 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.652 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.79 157.08 95.24 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.207 0.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.85 79.04 0.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.123 0.487 . . . . 0.0 110.611 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 143.15 19.22 0.23 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.184 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.476 ' HG3' HG23 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -57.73 156.78 8.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.939 0.4 . . . . 0.0 111.577 -179.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -129.5 152.21 49.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.123 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.46 ' CG2' ' CZ ' ' A' ' 164' ' ' PHE . 21.1 t -115.35 151.03 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.412 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 51.6 p -116.81 141.43 48.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.712 0.292 . . . . 0.0 110.405 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.6 mp -138.16 176.09 9.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.018 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.99 120.16 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.965 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.421 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . 6.5 mp -57.23 -61.9 6.26 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.012 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 68.9 Cg_endo -74.69 -168.18 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.465 2.11 . . . . 0.0 112.267 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.53 115.24 2.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -141.27 146.35 36.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 60.14 31.23 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.59 77.96 1.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -131.69 82.41 2.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.7 p -127.82 -44.97 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.035 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.91 -53.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -165.65 34.15 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.3 p -71.76 123.69 23.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -83.54 -73.55 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 59.1 m -77.42 -46.0 24.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.5 t 76.48 0.11 3.14 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.589 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -158.86 63.05 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.956 0.408 . . . . 0.0 110.944 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 96' ' ' CYS . 8.9 p -114.74 120.88 65.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -125.65 169.26 12.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.48 0.657 . . . . 0.0 109.973 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.469 ' CD1' ' CB ' ' A' ' 97' ' ' ALA . 2.7 m-85 -113.01 129.72 56.4 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.728 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 142' ' ' ALA . 42.9 m-85 -108.6 140.76 41.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.46 0.647 . . . . 0.0 110.722 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.28 -26.17 1.87 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.978 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.49 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 10.8 t -163.99 169.55 17.84 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.086 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 84.6 t -68.78 -35.11 6.04 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.403 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.5 Cg_exo -72.19 -37.28 4.75 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.83 2.354 . . . . 0.0 110.192 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.545 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -75.95 -41.22 52.22 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.538 178.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.76 -45.57 93.35 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.606 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.0 mt-10 -78.78 -27.96 44.64 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.21 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.3 t70 -70.82 -55.97 7.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.604 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.458 ' HB2' ' CB ' ' A' ' 119' ' ' ALA . 64.2 t-105 -64.83 -28.83 69.83 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -61.22 -40.98 96.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.196 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -46.13 65.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.246 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -98.02 25.6 5.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.068 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.44 ' CE1' ' CD1' ' A' ' 181' ' ' LEU . 1.9 t-160 -153.03 33.62 0.48 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.0 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -99.75 -16.04 18.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.13 -19.93 33.27 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.567 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.44 ' CD1' ' CE1' ' A' ' 178' ' ' HIS . 16.0 mt -66.69 71.45 0.08 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.831 0.348 . . . . 0.0 111.202 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 54.34 28.31 9.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 102.92 -67.23 0.34 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.518 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 6.7 tp 62.82 147.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.831 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.55 149.0 40.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.999 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.45 HG22 ' HB3' ' A' ' 171' ' ' ALA . 19.2 mm -102.9 161.73 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.57 156.69 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 112.051 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.8 OUTLIER -82.64 122.11 27.7 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.142 178.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.476 HG23 ' HG3' ' A' ' 141' ' ' MET . 0.9 OUTLIER -41.29 -29.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.549 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -64.47 -46.13 84.36 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -82.2 -20.8 37.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.841 178.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.91 -25.82 61.19 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -81.65 -24.91 36.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.557 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.75 -28.3 39.02 Favored Glycine 0 CA--C 1.509 -0.326 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 21.1 tp -82.06 -28.38 32.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.06 -28.85 29.93 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.405 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -76.19 -21.96 55.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.964 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.01 -22.86 39.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.15 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -51.85 -37.4 51.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.15 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.98 -55.19 38.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -27.08 68.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -55.07 -35.62 64.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.138 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.55 -50.18 10.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.3 tp -59.86 -50.81 72.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -139.26 -174.62 3.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.37 166.83 19.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.957 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -65.29 79.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.31 96.0 6.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.0 m -74.77 172.78 11.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -131.58 -178.97 5.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.831 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.442 HG23 ' N ' ' A' ' 212' ' ' PRO . 1.1 m -176.33 -63.0 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.973 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.442 ' N ' HG23 ' A' ' 211' ' ' THR . 19.6 Cg_endo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.391 2.06 . . . . 0.0 112.342 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.842 0.353 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -140.75 78.68 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tt -177.02 -40.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mt -76.37 -179.36 5.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 m -100.21 96.46 5.08 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.06 -29.18 40.53 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.411 2.074 . . . . 0.0 112.312 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.53 -57.36 12.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.041 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.0 mt -57.3 -27.05 61.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.397 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -65.72 -53.24 43.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.087 0.47 . . . . 0.0 109.887 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -77.12 -28.31 54.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.533 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.77 -52.13 22.66 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.84 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.98 -25.67 22.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.043 0.449 . . . . 0.0 110.981 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -68.71 -21.8 64.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.224 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.27 46.81 93.59 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.026 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -130.0 158.6 73.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 0.0 110.815 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.96 110.76 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.499 2.132 . . . . 0.0 112.065 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.412 ' CG2' HG21 ' A' ' 41' ' ' THR . 11.6 p -118.98 111.0 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.36 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 p -75.85 -178.7 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.967 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -77.94 -35.86 49.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.253 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -66.23 -24.88 66.68 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.195 179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -86.13 -42.84 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 tp -63.63 -36.25 83.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -74.17 -42.48 59.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.492 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 40' ' ' THR . . . -68.8 -29.02 72.65 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.546 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.1 mt -79.06 -41.45 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 121.17 0.51 . . . . 0.0 110.074 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mp -77.15 -9.92 59.07 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.354 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 t70 61.46 21.35 11.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -110.08 158.32 35.42 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.23 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.63 143.27 56.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.611 2.208 . . . . 0.0 111.917 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.3 -16.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -32.0 41.52 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.967 0.413 . . . . 0.0 111.146 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.98 -41.66 77.61 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.95 -46.44 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.56 178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.71 -50.07 69.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.575 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.13 -35.78 27.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.5 t -68.75 -31.05 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.081 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.9 mp -81.08 -17.21 50.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.319 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -58.52 -19.24 35.8 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.256 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.66 17.91 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.705 0.288 . . . . 0.0 111.173 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.12 71.11 0.73 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.803 0.811 . . . . 0.0 110.635 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.1 p -63.88 -15.27 58.59 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.415 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.1 t -95.19 34.68 1.37 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.91 110.93 23.04 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.416 ' HB3' ' CA ' ' A' ' 73' ' ' GLY . 2.2 tt0 -82.3 126.51 32.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.1 0.476 . . . . 0.0 111.997 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 69' ' ' GLY . 5.8 m-85 -110.83 160.3 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.14 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.13 143.9 25.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 0.0 111.498 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.1 -100.44 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.854 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -93.82 -10.46 34.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.411 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 125.07 33.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.939 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -93.99 154.24 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.3 mt -79.79 125.19 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.979 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -168.43 -36.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.706 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.416 ' CA ' ' HB3' ' A' ' 64' ' ' GLU . . . -60.93 137.99 48.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.264 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -175.99 -164.76 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 0.0 110.888 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.42 24.27 1.79 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.764 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.7 -82.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.844 0.354 . . . . 0.0 111.202 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.9 t -102.38 159.09 15.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.9 tt -82.21 -40.9 21.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -96.8 153.63 17.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 110.979 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -66.25 126.66 29.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 35.5 p -110.59 -172.47 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.109 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.27 -32.87 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.38 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.405 ' OH ' ' CD2' ' A' ' 163' ' ' HIS . 62.0 m-85 -79.34 110.75 14.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.751 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG23 ' CE1' ' A' ' 93' ' ' TYR . 25.1 t -104.73 135.0 44.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.964 0.412 . . . . 0.0 111.045 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 55.1 t80 -127.55 106.6 9.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.579 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -101.5 132.59 47.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.329 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.5 pt -140.03 123.1 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 111.825 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.6 t70 60.97 -69.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.381 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 87' ' ' ILE . 1.8 t70 -166.24 35.33 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.348 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -136.45 111.96 9.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.013 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -77.91 120.63 23.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 23.2 mt -117.15 165.08 13.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.412 ' CE1' HG23 ' A' ' 84' ' ' VAL . 6.0 m-85 -133.44 165.16 25.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.362 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.415 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -150.85 173.01 14.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.118 0.485 . . . . 0.0 111.95 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -108.29 -5.67 16.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.832 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.6 p -160.09 163.08 34.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.13 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.468 ' CB ' ' CE2' ' A' ' 164' ' ' PHE . . . -51.7 -23.1 4.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -88.76 -51.59 5.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.715 0.293 . . . . 0.0 111.349 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.415 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 1.9 m-20 -39.7 -28.81 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.455 ' CG2' ' HB2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -59.72 -35.42 74.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.64 0.257 . . . . 0.0 110.812 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.501 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . 14.8 tp -156.93 160.22 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.553 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 mt -113.52 -31.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.07 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 200' ' ' ASN . 4.1 m-85 -161.81 99.27 1.2 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.964 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.518 ' O ' HG22 ' A' ' 107' ' ' ILE . 59.7 Cg_endo -71.77 -26.35 19.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.578 2.185 . . . . 0.0 112.335 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 130' ' ' PRO . . . -79.36 -23.5 43.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.338 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 tp -81.7 -40.5 22.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.573 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.7 tp -54.39 -48.34 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.171 0.51 . . . . 0.0 111.595 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.22 20.71 22.32 Favored Glycine 0 C--N 1.319 -0.41 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.799 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 173.04 14.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.949 0.404 . . . . 0.0 111.023 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -78.28 152.79 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.644 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.465 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . . . -137.15 109.88 7.56 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -83.71 120.57 26.17 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.79 0.805 . . . . 0.0 111.056 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.6 t -111.82 130.59 65.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.014 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 m -122.45 136.24 54.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.101 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.99 173.17 11.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.684 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.412 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 71.6 m80 -134.56 136.64 43.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' A' ' 165' ' ' PHE . 28.5 t -64.76 134.44 54.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.179 0.514 . . . . 0.0 112.175 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.32 -5.76 34.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.819 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.461 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -126.89 -50.91 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.407 HG23 ' N ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -74.41 -33.6 63.05 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.217 0.532 . . . . 0.0 110.026 -179.104 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.17 34.92 57.67 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.373 -0.918 . . . . 0.0 110.818 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' HIS . . . -100.34 160.32 27.34 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.178 -0.511 . . . . 0.0 109.994 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -87.78 108.02 0.62 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.731 2.287 . . . . 0.0 111.257 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.401 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 35.9 m -104.41 144.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.157 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 85.4 p -147.22 142.79 27.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.51 0.671 . . . . 0.0 110.631 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.509 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -136.63 152.38 50.37 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.56 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 21.1 m -112.26 113.98 26.51 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.417 HG11 ' CE2' ' A' ' 193' ' ' PHE . 23.8 t -96.3 111.91 27.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.84 0.353 . . . . 0.0 111.586 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.47 167.21 9.88 Favored Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.211 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 105' ' ' ALA . 22.7 Cg_exo -64.79 -16.54 55.84 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.521 2.147 . . . . 0.0 113.051 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 27.2 t -116.72 -25.6 7.28 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 131' ' ' SER . 12.5 pt-20 178.94 -162.41 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.123 0.487 . . . . 0.0 109.854 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -96.05 160.14 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.878 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -147.01 18.64 1.25 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.422 0.629 . . . . 0.0 112.409 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.95 86.56 0.08 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.643 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.0 t -105.07 120.79 56.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.848 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -145.23 126.16 7.49 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.985 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.22 165.53 84.12 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.475 -1.469 . . . . 0.0 112.271 -0.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.77 78.01 0.86 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.148 0.499 . . . . 0.0 110.656 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.7 19.32 0.18 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.171 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.404 ' CE ' ' HG ' ' A' ' 126' ' ' LEU . 10.4 ptm -61.03 160.91 9.16 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.949 0.404 . . . . 0.0 111.396 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -126.89 152.19 47.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.381 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.461 ' CG1' ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -113.76 147.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.863 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 56.3 p -117.29 137.52 52.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.697 0.284 . . . . 0.0 110.659 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.11 176.18 9.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.5 p -125.18 106.78 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.801 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.415 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.2 OUTLIER -57.99 -52.25 75.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 147' ' ' LEU . 44.9 Cg_exo -56.27 160.98 9.81 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.545 2.163 . . . . 0.0 112.299 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 62.54 146.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.958 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -108.05 -24.53 11.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.016 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -112.48 -22.6 10.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.309 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 57.22 55.84 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.091 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.59 115.91 19.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.8 m -159.01 -48.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -176.44 -66.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -68.66 -48.96 62.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.6 m -104.48 133.91 48.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -125.6 -51.48 1.6 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.99 -46.04 15.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.043 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 179.33 -36.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.165 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 70.96 60.66 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.691 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.15 124.62 69.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.233 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.405 ' CD2' ' OH ' ' A' ' 83' ' ' TYR . 5.4 m80 -120.5 165.96 14.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.58 0.705 . . . . 0.0 110.152 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.468 ' CE2' ' CB ' ' A' ' 97' ' ' ALA . 40.9 m-85 -115.52 140.67 48.94 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.536 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 57.0 m-85 -117.6 137.94 52.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.228 0.537 . . . . 0.0 110.287 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.38 -26.13 0.5 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.656 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.483 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 30.8 p -167.52 170.65 11.05 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.73 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.603 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 90.5 t -68.03 -34.37 6.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.32 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.707 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.8 Cg_exo -72.33 -37.41 4.46 Favored 'Trans proline' 0 CA--C 1.503 -1.06 0 C-N-CA 122.58 2.187 . . . . 0.0 110.321 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.561 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.34 -40.45 51.24 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.84 -46.38 89.73 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.674 ' HA ' ' HB1' ' A' ' 175' ' ' ALA . 2.3 mm-40 -79.09 -27.43 42.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.425 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 169' ' ' PRO . 17.6 t70 -69.8 -55.77 8.93 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.168 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.461 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 54.7 t-105 -65.87 -28.76 69.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.652 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.674 ' HB1' ' HA ' ' A' ' 172' ' ' GLU . . . -64.47 -39.05 93.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.213 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.5 t -51.98 -45.32 64.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.386 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 22.33 7.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.345 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.75 37.77 0.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.903 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.03 -10.96 16.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.326 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.44 24.57 24.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.559 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 47.5 mt -85.85 56.07 3.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.797 0.332 . . . . 0.0 110.764 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 60.31 28.59 18.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.656 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 131.51 -105.64 0.63 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.371 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.4 tt 63.4 130.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 110.998 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.33 150.1 40.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 111.015 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.457 HG21 ' CB ' ' A' ' 171' ' ' ALA . 12.3 mm -102.42 159.99 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.923 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.09 162.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.175 0.512 . . . . 0.0 111.782 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.9 OUTLIER -88.77 125.68 34.99 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.792 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.403 HG23 ' CD2' ' A' ' 126' ' ' LEU . 0.4 OUTLIER -46.98 -20.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.596 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -69.27 -43.16 74.44 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -82.53 -24.49 34.04 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.249 178.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.91 -25.28 61.84 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.417 ' CE2' HG11 ' A' ' 128' ' ' VAL . 2.8 t80 -81.76 -31.38 31.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.145 0.498 . . . . 0.0 110.511 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.16 -30.45 31.06 Favored Glycine 0 CA--C 1.51 -0.253 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.359 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.01 -28.26 35.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.92 -29.07 29.75 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.62 -22.82 34.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.377 -0.411 . . . . 0.0 110.962 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -78.9 -22.8 45.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.23 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.76 -28.71 16.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.201 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . 0.413 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . 63.6 t-20 -81.1 -41.6 22.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.44 -49.16 78.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -72.93 -30.52 63.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 mt -66.45 -19.94 65.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.81 -51.92 8.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.862 0.363 . . . . 0.0 110.944 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -60.16 159.69 9.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -167.21 88.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.799 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 25.0 ttm -56.8 -57.11 13.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.049 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.02 94.51 5.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.9 p -140.1 134.38 31.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 60.26 31.78 20.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.442 HG21 ' N ' ' A' ' 212' ' ' PRO . 1.1 m -67.58 -62.78 3.13 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.041 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.442 ' N ' HG21 ' A' ' 211' ' ' THR . 19.5 Cg_endo . . . . . 0 C--O 1.248 1.018 0 C-N-CA 122.397 2.064 . . . . 0.0 112.372 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.786 0.327 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -130.53 87.81 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.993 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mt -106.94 -32.27 7.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.13 177.48 4.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.4 t -104.12 90.59 3.17 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.071 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.18 -43.62 4.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.565 2.176 . . . . 0.0 112.659 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.95 -57.03 10.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.7 mt -63.25 -26.83 68.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.011 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 -60.34 -53.1 61.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.933 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 33' ' ' LYS . 24.8 mm-40 -75.32 -22.05 57.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.582 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tp -75.15 -52.15 11.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.254 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.0 -36.3 62.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.966 0.412 . . . . 0.0 112.003 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 30' ' ' GLU . 6.5 ptmt -68.23 -19.52 64.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.155 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.32 56.88 13.14 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.228 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.9 165.76 25.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.653 0.263 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.57 114.41 3.93 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.546 2.164 . . . . 0.0 112.24 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.0 t -126.91 110.45 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.428 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 82.1 p -89.97 -169.84 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -78.04 -37.88 45.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.361 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -29.13 69.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.907 0.384 . . . . 0.0 110.174 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.437 HG22 ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -83.41 -42.76 16.62 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.15 -36.76 82.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.406 ' HB1' HG23 ' A' ' 53' ' ' VAL . . . -71.28 -43.02 67.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.788 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.83 -31.84 70.16 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.86 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.437 ' CD1' HG22 ' A' ' 41' ' ' THR . 6.7 mt -77.42 -45.44 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 120.885 0.374 . . . . 0.0 110.722 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.81 -8.51 57.46 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.567 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 t0 60.5 24.27 13.9 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.411 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 5.3 m95 -111.37 139.8 22.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.181 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.85 144.48 20.79 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.556 2.17 . . . . 0.0 112.252 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.46 -16.69 2.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -77.2 -34.88 56.11 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.427 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.7 mtt85 -67.71 -41.33 83.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.406 HG23 ' HB1' ' A' ' 43' ' ' ALA . 2.1 t -63.82 -47.99 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.389 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.4 -52.53 59.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.299 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.98 -34.99 10.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.891 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.1 t -63.97 -32.29 56.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.015 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.63 -34.65 78.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.758 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -56.03 -34.08 65.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.549 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -96.19 -18.36 20.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.737 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.6 35.96 1.44 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.438 0.637 . . . . 0.0 111.098 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.6 p -58.75 -18.16 29.26 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.269 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 m -112.77 38.12 2.89 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.785 0.326 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.425 HG22 ' CZ ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -101.24 141.58 33.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.102 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -78.62 126.79 31.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.092 0.472 . . . . 0.0 111.257 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.425 ' CZ ' HG22 ' A' ' 63' ' ' THR . 61.1 m-85 -117.2 173.15 6.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.369 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -151.64 146.75 26.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.027 0.441 . . . . 0.0 111.333 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.9 tttm 66.7 -103.33 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.813 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -87.92 -11.46 47.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.21 26.96 2.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.128 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -81.49 169.43 17.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.953 0.406 . . . . 0.0 109.914 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.69 120.13 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.652 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 tt -107.26 -27.29 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 47.17 -150.01 2.38 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.982 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.41 ' CE1' HD12 ' A' ' 87' ' ' ILE . 0.3 OUTLIER 62.39 113.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.779 0.323 . . . . 0.0 111.041 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.66 65.12 0.83 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.479 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.44 145.28 27.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 110.933 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.1 p -109.88 159.1 17.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -92.2 42.74 1.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -155.06 123.61 6.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' THR . 14.8 pm0 -57.46 -19.76 26.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.43 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 80' ' ' GLU . 54.4 p 36.88 -165.83 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -110.0 -26.26 9.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.426 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 28.1 m-85 -87.83 117.37 26.62 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.596 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.413 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.7 t -110.1 145.08 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.024 0.44 . . . . 0.0 111.521 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 17.4 t80 -134.13 107.46 7.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.016 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -102.51 133.03 48.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 0.0 111.843 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.48 ' CG2' ' CE1' ' A' ' 85' ' ' PHE . 3.8 pt -140.1 124.37 18.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.255 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.5 t70 63.12 -68.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.216 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.3 t0 -166.92 36.15 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.413 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -135.76 114.72 12.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.938 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.1 85.77 7.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.233 0.539 . . . . 0.0 110.885 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -74.13 165.05 25.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.08 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -134.88 165.28 25.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.365 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.407 ' CB ' ' N ' ' A' ' 100' ' ' THR . . . -151.56 169.75 21.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 0.0 111.919 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 17.8 m0 -88.24 -25.22 22.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.828 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.426 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 3.9 p -147.57 173.0 13.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.388 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.455 ' CB ' ' CE1' ' A' ' 164' ' ' PHE . . . -56.6 -20.87 23.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.826 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 14.2 mt -87.31 -51.66 5.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -50.12 -24.65 2.87 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.457 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -60.7 -39.48 88.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.719 0.295 . . . . 0.0 110.651 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 pp -112.08 178.42 4.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 111.106 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.42 ' O ' ' CG ' ' A' ' 103' ' ' PHE . 4.3 tt -157.93 -45.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.11 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.42 ' CG ' ' O ' ' A' ' 102' ' ' ILE . 8.0 m-85 -164.4 90.89 1.04 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.07 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.46 ' O ' HG21 ' A' ' 107' ' ' ILE . 60.1 Cg_endo -72.86 -33.69 7.59 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.522 2.148 . . . . 0.0 112.456 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.92 47.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.391 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 tp -84.84 -42.73 14.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.223 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.46 HG21 ' O ' ' A' ' 104' ' ' PRO . 0.6 OUTLIER -54.7 -48.6 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.175 0.512 . . . . 0.0 111.419 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.74 21.6 15.94 Favored Glycine 0 C--N 1.319 -0.408 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.921 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.77 177.36 10.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.053 0.454 . . . . 0.0 111.109 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -83.52 153.74 24.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.926 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.489 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . . . -137.09 109.87 7.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -82.75 121.05 26.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.778 0.799 . . . . 0.0 111.034 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.0 t -113.18 132.61 61.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.811 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 60.5 p -120.77 139.09 53.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.066 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 m -140.73 172.9 12.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.26 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -133.61 130.56 38.5 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 21.8 m -57.33 123.26 14.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.044 0.45 . . . . 0.0 111.803 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.34 -9.3 39.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.695 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.441 ' CB ' ' HB2' ' A' ' 174' ' ' TRP . . . -122.54 -50.59 1.98 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.506 HG23 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -75.74 -21.21 57.69 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.965 0.412 . . . . 0.0 110.848 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.45 33.96 86.61 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.118 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.506 ' CB ' HG23 ' A' ' 120' ' ' THR . . . -102.41 167.8 9.86 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.43 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -93.22 110.05 0.2 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.954 2.436 . . . . 0.0 111.28 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.409 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 35.0 m -108.5 148.32 12.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.547 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 79.4 p -149.21 141.44 24.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.406 0.622 . . . . 0.0 110.795 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -132.6 153.78 50.69 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.53 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 21.2 m -110.99 114.46 27.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.828 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.419 HG11 ' CE2' ' A' ' 193' ' ' PHE . 38.4 t -96.47 111.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.4 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -106.65 168.9 7.44 Favored Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.958 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.2 Cg_endo -66.09 -19.27 57.33 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.229 1.953 . . . . 0.0 112.891 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 34.6 p -112.89 -26.12 8.69 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 131' ' ' SER . 11.1 pt-20 178.09 -162.23 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.131 0.491 . . . . 0.0 110.099 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.35 158.76 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.752 178.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -146.19 20.43 1.4 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.387 0.613 . . . . 0.0 112.299 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.67 86.47 0.09 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.646 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.4 t -102.87 113.51 39.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.375 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -146.26 121.94 5.61 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.498 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.571 ' HD2' ' HE3' ' A' ' 141' ' ' MET . 55.6 Cg_endo -69.28 157.6 90.53 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.459 -1.475 . . . . 0.0 112.737 -0.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.02 80.33 1.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.54 16.64 0.15 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.351 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.571 ' HE3' ' HD2' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -61.16 159.24 12.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.033 0.444 . . . . 0.0 111.571 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.03 152.1 48.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.515 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.42 HG11 ' CD1' ' A' ' 164' ' ' PHE . 4.6 t -115.31 152.97 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.88 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.419 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 23.5 m -120.0 141.08 50.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.582 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.2 mp -142.23 176.27 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.985 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.452 ' CG2' ' CD2' ' A' ' 161' ' ' HIS . 36.4 t -125.21 144.11 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.811 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 pp -59.25 160.88 11.07 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.893 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.45 -62.11 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.703 2.269 . . . . 0.0 112.621 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.92 -172.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -139.39 55.37 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -179.99 -35.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.974 0.416 . . . . 0.0 111.219 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -106.77 135.71 47.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -60.63 171.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.933 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.1 p -110.74 -30.27 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.052 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 -40.08 6.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.983 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.39 78.06 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.997 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.422 ' HB2' ' CD2' ' A' ' 161' ' ' HIS . 9.1 t -60.84 -80.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -134.9 -76.18 0.46 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 5.0 m -81.04 -45.96 15.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.895 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 161' ' ' HIS . 1.8 t -162.82 -62.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.452 ' CD2' ' CG2' ' A' ' 146' ' ' VAL . 0.3 OUTLIER 80.79 -50.49 0.31 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.32 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.425 ' CG1' ' HB2' ' A' ' 96' ' ' CYS . 2.6 p -107.13 115.81 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.068 0.461 . . . . 0.0 111.155 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.41 ' CE1' ' OH ' ' A' ' 83' ' ' TYR . 3.6 m-70 -126.96 169.38 13.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.555 0.693 . . . . 0.0 110.05 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.455 ' CE1' ' CB ' ' A' ' 97' ' ' ALA . 1.9 m-85 -108.61 150.69 27.16 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.796 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.456 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 37.9 m-85 -132.96 136.26 45.99 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.361 0.601 . . . . 0.0 110.564 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.19 -28.67 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.142 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 30.5 t -171.7 176.78 3.58 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.796 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 85.3 t -69.05 -34.3 4.92 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.552 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.7 Cg_exo -72.55 -38.38 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.813 2.342 . . . . 0.0 110.396 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.571 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.52 -39.84 51.77 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.546 177.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.496 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.33 -45.37 94.69 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.603 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 96.6 mt-10 -79.19 -27.56 42.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.179 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 169' ' ' PRO . 8.8 t70 -70.24 -55.86 8.21 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.421 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.501 ' CZ2' ' CD2' ' A' ' 178' ' ' HIS . 57.4 t90 -65.17 -28.05 69.13 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.8 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -66.73 -37.04 83.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.323 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 t -53.09 -46.51 68.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.404 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -95.16 22.79 6.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.211 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.501 ' CD2' ' CZ2' ' A' ' 174' ' ' TRP . 79.5 m80 -152.8 45.43 0.69 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.952 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -179.38 3.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.739 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 58.02 29.41 62.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.486 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.0 mt -97.05 61.76 1.79 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.931 0.396 . . . . 0.0 110.901 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 55.75 26.5 9.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.929 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 114.73 128.39 4.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.438 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.1 tp -176.92 129.49 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.11 41.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.021 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.433 HG22 ' CB ' ' A' ' 171' ' ' ALA . 10.0 mm -99.78 159.45 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.864 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.12 162.03 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.361 0.6 . . . . 0.0 111.967 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -90.8 129.64 36.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.778 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.418 HG12 ' HG2' ' A' ' 141' ' ' MET . 1.5 m -46.98 -19.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.75 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 8.7 m80 -71.76 -41.84 67.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.798 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.21 -24.22 34.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.364 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.9 61.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.175 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.419 ' CE2' HG11 ' A' ' 128' ' ' VAL . 5.4 t80 -81.3 -25.57 36.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.682 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.76 -30.25 32.92 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 -28.22 32.48 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.14 -28.32 31.2 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.414 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -82.28 -23.99 34.95 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.883 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.08 -23.04 57.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.146 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -51.89 -33.08 35.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.144 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.99 -25.08 37.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -57.28 -48.45 78.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.948 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -80.07 -31.27 39.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.754 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.42 -24.68 62.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.078 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.04 -51.79 8.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.956 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -161.18 80.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.7 t -82.92 -37.25 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 10.0 mtp -153.22 137.7 16.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.25 146.58 30.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.96 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.7 t 60.66 178.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -89.17 -170.44 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.972 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.428 HG21 ' N ' ' A' ' 212' ' ' PRO . 0.9 OUTLIER 178.4 -55.2 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.848 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.428 ' N ' HG21 ' A' ' 211' ' ' THR . 74.1 Cg_exo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.516 2.144 . . . . 0.0 112.436 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.99 100.36 9.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.826 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -176.07 -171.31 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.936 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 tp 63.13 162.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.0 m 41.95 61.12 8.66 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.823 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.49 -26.23 27.86 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.482 2.122 . . . . 0.0 112.219 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.13 -57.37 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.352 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 mt -80.17 -27.28 39.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.55 -53.22 51.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.548 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -66.03 -23.28 66.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.291 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.52 -38.38 77.53 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.07 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.08 -25.63 13.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.001 0.429 . . . . 0.0 111.174 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.01 -20.87 65.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.073 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.56 42.46 95.61 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.267 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -133.36 165.85 33.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.704 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.55 114.28 3.78 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.502 2.135 . . . . 0.0 112.016 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.8 t -115.57 110.19 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.421 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.7 p -88.03 -171.65 3.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.746 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -77.99 -36.64 48.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.313 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -29.42 69.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.276 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.421 HG21 ' CD1' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -83.52 -42.65 16.61 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 12.6 mt -62.53 -36.56 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.414 ' CB ' ' CG2' ' A' ' 53' ' ' VAL . . . -72.87 -43.01 63.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.646 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.28 -31.65 77.76 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.477 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.421 ' CD1' HG21 ' A' ' 41' ' ' THR . 6.9 mt -79.54 -38.52 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 121.061 0.458 . . . . 0.0 110.231 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 6.4 mp -78.13 -10.01 59.43 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.178 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 59.38 22.54 10.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.442 ' CD1' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -102.77 137.06 19.21 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.189 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.442 ' HD2' ' CD1' ' A' ' 48' ' ' TRP . 10.1 Cg_endo -53.04 142.81 52.8 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.697 2.265 . . . . 0.0 112.207 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.409 ' HA ' HG22 ' A' ' 53' ' ' VAL . . . -51.8 -20.64 2.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.55 -39.95 36.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.121 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -67.93 -38.28 82.7 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.414 ' CG2' ' CB ' ' A' ' 43' ' ' ALA . 2.5 t -65.73 -48.1 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.89 -54.37 30.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.177 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.14 64.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.898 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 t -65.06 -31.73 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.747 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.21 -35.12 79.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -57.49 -22.82 46.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.851 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -96.42 -20.68 18.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.38 31.89 2.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.55 0.69 . . . . 0.0 110.916 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 21.1 p -71.61 -27.65 63.26 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.761 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.8 m -75.86 -25.51 56.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.35 141.25 56.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.042 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -78.92 133.77 36.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.046 0.45 . . . . 0.0 111.274 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.411 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 55.2 m-85 -105.19 173.42 6.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.48 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -149.82 145.97 26.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.969 0.414 . . . . 0.0 111.499 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 tttp 65.6 -105.03 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.634 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -86.91 -11.51 50.46 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.713 0.292 . . . . 0.0 111.561 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.411 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 122.67 25.87 1.86 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.228 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -78.02 158.79 29.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 110.006 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.9 mp -79.74 126.32 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.574 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -28.97 30.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.027 0.442 . . . . 0.0 111.021 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.62 -106.62 3.13 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.677 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.415 ' CD2' ' HG ' ' A' ' 92' ' ' LEU . 0.8 OUTLIER -53.91 161.77 1.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.877 0.37 . . . . 0.0 111.156 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.5 125.58 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.654 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tp -124.63 149.51 47.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.33 . . . . 0.0 110.76 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -113.72 140.86 47.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -59.75 -23.87 63.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.078 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -92.97 123.61 36.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 111.096 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.2 pt-20 -60.64 -16.76 42.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.461 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 80' ' ' GLU . 0.5 OUTLIER 37.46 -167.97 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.08 -24.88 12.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.113 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -80.78 114.85 19.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.55 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.82 136.14 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.015 0.436 . . . . 0.0 111.423 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.479 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 56.5 t80 -128.16 104.6 7.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.177 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -98.6 131.12 45.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.396 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -140.06 122.95 17.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.07 -72.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 87' ' ' ILE . 18.3 t0 -159.26 37.11 0.2 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -139.8 145.95 38.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.56 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.96 86.49 2.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.871 0.367 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' HG ' ' CD2' ' A' ' 74' ' ' TYR . 4.3 mm? -71.27 164.79 25.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.589 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -131.12 160.08 35.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.356 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.466 ' HB3' ' N ' ' A' ' 100' ' ' THR . . . -146.55 161.44 40.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.737 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -90.61 -24.7 20.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.409 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.411 ' HB3' ' CG1' ' A' ' 162' ' ' VAL . 5.6 m -146.97 172.37 13.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.974 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.443 ' HB1' ' CE2' ' A' ' 164' ' ' PHE . . . -53.77 -21.53 7.51 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tp -86.8 -51.53 6.03 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.401 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -45.57 -25.39 0.45 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.466 ' N ' ' HB3' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -60.31 -36.73 78.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.688 0.28 . . . . 0.0 110.87 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.441 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.9 pt? -137.5 166.18 24.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.004 0.431 . . . . 0.0 111.386 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.1 mp -143.62 -46.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.834 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -141.1 65.83 23.45 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.664 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.507 ' O ' HG22 ' A' ' 107' ' ' ILE . 34.3 Cg_exo -57.83 -30.61 89.99 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.742 2.295 . . . . 0.0 112.531 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.36 -23.61 43.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.455 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.94 -34.04 20.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.143 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.4 tp -54.51 -47.61 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.174 0.511 . . . . 0.0 111.687 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.91 20.85 25.0 Favored Glycine 0 C--N 1.32 -0.351 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.733 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 173.42 14.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 111.011 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -78.87 151.8 31.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.479 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.14 109.75 7.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 112.001 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -82.35 119.64 24.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.818 0.818 . . . . 0.0 111.198 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.429 HG21 ' CD1' ' A' ' 85' ' ' PHE . 39.6 t -111.61 130.47 65.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.137 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.0 m -122.29 137.04 54.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.093 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.418 ' CB ' HG22 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.62 172.8 12.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.209 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.417 ' CE1' ' HA ' ' A' ' 123' ' ' PRO . 0.7 OUTLIER -136.68 135.06 37.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 26.4 t -61.77 132.14 52.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.227 0.537 . . . . 0.0 112.147 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.48 -3.84 23.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.935 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.445 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -122.58 -50.6 1.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.616 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.487 HG21 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -88.98 -24.23 22.45 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.247 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.36 5.03 76.05 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.179 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.487 ' CB ' HG21 ' A' ' 120' ' ' THR . . . -57.74 151.17 43.54 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.504 0.193 . . . . 0.0 110.579 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.417 ' HA ' ' CE1' ' A' ' 116' ' ' HIS . 2.5 Cg_endo -84.54 105.8 1.06 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.736 2.29 . . . . 0.0 110.898 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.418 HG22 ' CB ' ' A' ' 115' ' ' SER . 35.2 m -103.29 145.49 12.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.419 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 72.8 p -151.49 141.62 22.22 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.443 0.64 . . . . 0.0 110.699 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.455 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -134.82 152.92 52.14 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.306 178.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 82.7 m -111.34 113.31 25.69 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.424 HG13 ' CZ ' ' A' ' 193' ' ' PHE . 19.7 t -95.86 111.73 26.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.631 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.14 175.63 2.07 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.401 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.78 -15.62 37.11 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.695 2.263 . . . . 0.0 112.971 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 50.1 m -120.11 -26.03 5.61 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 131' ' ' SER . 14.6 pt-20 179.74 -162.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.169 0.509 . . . . 0.0 110.186 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -96.62 161.36 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.992 178.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -149.31 19.25 0.95 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.298 0.57 . . . . 0.0 112.253 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.09 86.23 0.08 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.593 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.4 t -105.02 118.35 52.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.138 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -146.21 117.12 4.82 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.47 146.99 83.12 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.643 -1.399 . . . . 0.0 112.28 0.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.18 -33.83 54.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.642 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.93 28.98 12.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.957 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.453 ' CE ' ' CD1' ' A' ' 164' ' ' PHE . 1.9 ppp? -64.9 156.55 30.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.126 0.489 . . . . 0.0 111.529 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.72 152.32 48.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.616 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.447 ' CG2' ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -112.49 150.67 14.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.965 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 23.0 p -119.86 140.37 50.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.757 0.313 . . . . 0.0 111.026 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.4 mt -139.02 176.28 8.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.873 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.5 m -125.04 154.39 33.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.051 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.47 96.19 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.839 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.32 -19.36 43.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.489 2.126 . . . . 0.0 112.581 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -53.95 137.86 38.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.834 0.349 . . . . 0.0 111.061 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.34 -25.15 68.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -110.48 -29.15 8.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 51.74 29.61 5.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.309 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 59.83 -175.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.849 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.45 70.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.98 0.419 . . . . 0.0 111.228 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -153.43 24.3 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.122 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 54.37 88.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.095 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.65 68.41 1.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.049 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -162.15 -55.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.743 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 43.6 t -81.31 -15.85 54.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 42.2 t -49.55 -34.59 17.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.396 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -151.91 65.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.779 0.323 . . . . 0.0 111.357 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 96' ' ' CYS . 8.0 p -108.15 114.56 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.13 0.491 . . . . 0.0 110.865 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.447 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 2.5 m-70 -126.81 169.24 13.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.609 0.719 . . . . 0.0 110.076 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.453 ' CD1' ' CE ' ' A' ' 141' ' ' MET . 11.9 m-85 -106.11 151.71 24.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.62 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.452 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 49.2 m-85 -131.13 136.3 48.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.495 0.664 . . . . 0.0 110.502 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -43.42 -26.42 0.2 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.67 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.471 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 22.3 p -169.24 172.76 7.1 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.941 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 81.5 t -69.01 -34.04 4.7 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.389 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.76 -37.35 3.91 Favored 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 122.669 2.246 . . . . 0.0 110.24 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.56 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.6 -40.42 49.54 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.578 178.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.49 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -62.0 -45.59 92.96 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.607 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.6 mt-10 -78.92 -27.56 43.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.119 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 25.3 t70 -70.77 -55.94 7.47 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.451 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.445 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 41.6 t-105 -65.03 -28.28 69.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.632 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.607 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -63.59 -40.7 97.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.221 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.2 p -51.85 -43.56 63.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.354 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.82 21.01 7.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.358 0.599 . . . . 0.0 111.353 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -125.94 27.39 6.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.811 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -97.91 -178.75 4.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.757 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.6 -28.38 13.66 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.465 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.94 -174.94 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.94 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -97.94 33.41 2.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.849 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 145.76 126.51 1.82 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.525 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.9 tt -176.66 116.76 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.65 149.76 41.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.429 HG22 ' HB3' ' A' ' 171' ' ' ALA . 12.9 mm -99.78 159.59 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.954 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.09 147.81 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.815 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.5 OUTLIER -77.41 124.49 27.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.467 177.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.446 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 1.0 OUTLIER -46.93 -20.67 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.644 179.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.37 -39.63 77.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.7 mt-10 -82.46 -28.38 31.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.036 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.69 -24.69 67.88 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.116 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.458 ' CZ ' HG21 ' A' ' 133' ' ' ILE . 0.6 OUTLIER -81.15 -24.72 37.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.032 0.444 . . . . 0.0 110.818 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.56 -30.3 33.45 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.17 -28.47 32.07 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -27.87 32.77 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.601 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -82.17 -25.85 33.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 110.951 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 202' ' ' HIS . 4.0 mt-10 -73.88 -23.32 59.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.089 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -55.84 -43.3 76.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.128 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -81.01 -50.07 10.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -56.52 -28.85 61.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.253 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . 0.419 ' CE1' ' HB3' ' A' ' 198' ' ' GLU . 2.9 m80 -66.33 -48.49 70.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.16 -42.74 18.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.005 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -74.56 -51.9 13.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 60.29 -169.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.0 t -60.4 147.52 40.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.961 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 3.5 ptp -113.16 -175.4 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.2 m -125.88 175.69 7.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.4 m -111.56 -33.99 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 61.16 112.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.439 HG21 ' N ' ' A' ' 212' ' ' PRO . 1.1 m -65.64 -62.71 4.1 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.987 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.439 ' N ' HG21 ' A' ' 211' ' ' THR . 19.2 Cg_endo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.379 2.053 . . . . 0.0 112.262 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.774 0.321 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 60.45 165.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.978 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mp -96.43 104.24 16.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -113.72 77.99 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 p -171.18 54.18 0.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.078 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.02 -21.81 27.13 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.595 2.197 . . . . 0.0 112.484 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.46 -57.44 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 111.363 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -80.12 -27.43 39.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.227 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -53.22 14.53 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.888 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.88 -24.52 66.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.506 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.4 tp -69.45 -28.93 66.53 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.73 -22.56 9.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.351 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -69.11 -21.7 64.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.192 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.95 39.51 94.94 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.399 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -133.25 166.04 32.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.572 0.225 . . . . 0.0 110.833 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.64 114.12 3.58 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.468 2.112 . . . . 0.0 111.952 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.408 ' CG2' HG21 ' A' ' 41' ' ' THR . 11.1 p -111.59 109.87 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.438 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.3 p -85.99 -170.47 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.432 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -78.04 -37.52 46.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.465 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -27.91 68.66 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.199 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.53 -42.34 15.61 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -36.6 83.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 176.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -73.04 -42.74 62.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.604 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.74 -30.19 72.7 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.643 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.0 mt -79.03 -43.51 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.055 0.455 . . . . 0.0 110.397 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.75 -9.83 58.95 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.506 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.5 t70 60.63 21.77 11.64 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.441 ' CD1' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -104.47 137.79 19.33 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.068 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HD2' ' CD1' ' A' ' 48' ' ' TRP . 10.7 Cg_endo -53.66 140.01 66.56 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.597 2.198 . . . . 0.0 112.012 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.19 -17.89 1.28 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.6 -32.61 47.66 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.258 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HD2' ' CD1' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -67.17 -39.87 86.53 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.05 -48.14 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.586 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.87 57.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.389 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.2 -42.77 66.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.891 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.9 t -67.76 -31.17 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.95 -35.37 80.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.758 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.25 -45.12 88.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.755 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -88.05 -7.88 56.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.62 74.98 1.04 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.765 0.793 . . . . 0.0 110.133 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -106.66 -16.09 14.6 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.42 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -73.87 -28.13 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.17 141.33 50.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.448 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -78.79 126.94 31.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.313 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -103.37 171.78 7.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.463 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 70' ' ' ASN . 1.6 t70 -92.16 -172.76 3.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.479 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -67.55 -35.42 79.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -91.73 12.24 21.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.648 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.28 17.33 74.23 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.156 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 66' ' ' ASP . 24.3 m120 -91.49 165.62 13.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.983 0.392 . . . . 0.0 110.04 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.2 mp -79.84 127.8 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.546 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.4 tt -85.32 -24.95 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.022 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.36 11.95 57.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.035 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 51.45 -176.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.793 0.33 . . . . 0.0 111.092 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.36 -87.3 0.43 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.578 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.54 138.07 46.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 110.895 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.7 p -97.82 159.05 15.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.5 -41.41 85.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.979 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.9 mtt-85 -110.31 150.29 28.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 4.5 tt0 -57.05 132.34 52.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.925 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.8 p -108.44 -173.67 2.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.046 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.413 ' CB ' ' NE2' ' A' ' 116' ' ' HIS . 70.2 m -94.94 -38.54 10.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.016 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.424 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 32.6 m-85 -79.52 111.09 15.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.507 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.62 138.13 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.502 ' CE1' ' HB1' ' A' ' 111' ' ' ALA . 69.4 t80 -123.51 106.73 10.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.544 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -98.06 125.77 43.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.279 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -139.59 122.91 18.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.853 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 t70 59.4 -72.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.159 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 87' ' ' ILE . 35.1 t0 -165.74 34.15 0.05 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.313 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.3 mmp_? -136.64 111.82 9.06 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.751 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -77.87 120.63 23.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.909 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.95 164.78 11.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 111.022 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.417 ' CZ ' ' HG3' ' A' ' 80' ' ' GLU . 28.4 m-85 -131.49 155.39 47.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.355 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.39 168.41 24.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.973 0.416 . . . . 0.0 111.614 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -100.21 -6.97 25.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.189 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.424 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.5 OUTLIER 178.03 -179.28 0.27 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.827 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.443 ' HB3' ' CD1' ' A' ' 164' ' ' PHE . . . -55.09 164.36 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.729 0.3 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 tt 70.21 -52.92 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.103 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -47.3 -29.27 2.38 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.834 0.349 . . . . 0.0 110.867 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.491 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 2.7 p -60.02 -39.44 85.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.717 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER 169.92 153.45 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.554 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.491 ' CG2' ' O ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -143.33 48.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.867 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CG ' ' O ' ' A' ' 102' ' ' ILE . 16.9 m-85 -166.27 59.27 0.54 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.992 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.487 ' O ' HG21 ' A' ' 107' ' ' ILE . 61.2 Cg_endo -73.14 -37.67 3.28 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.596 2.197 . . . . 0.0 112.253 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 130' ' ' PRO . . . -79.08 -23.8 43.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.218 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.72 -41.06 19.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.26 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.487 HG21 ' O ' ' A' ' 104' ' ' PRO . 1.3 tp -57.68 -46.6 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.177 0.513 . . . . 0.0 111.422 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.88 24.29 15.68 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.636 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -152.55 173.53 15.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.003 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -80.09 153.42 28.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.772 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -137.06 109.78 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -83.19 120.26 25.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.781 0.8 . . . . 0.0 111.23 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 94.6 t -112.79 130.68 66.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.013 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 m -122.78 136.91 55.02 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.202 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.0 t -141.81 173.0 11.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.36 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.455 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -133.53 137.23 45.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 34.0 t -66.65 134.0 51.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.086 0.47 . . . . 0.0 112.234 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.52 -3.98 27.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.102 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.452 ' HB1' ' CD2' ' A' ' 174' ' ' TRP . . . -121.59 -51.34 2.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.928 0.395 . . . . 0.0 111.529 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.515 HG21 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.37 -24.18 22.01 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.356 -179.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.15 6.09 73.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.114 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.515 ' CB ' HG21 ' A' ' 120' ' ' THR . . . -59.39 150.69 63.37 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.552 0.215 . . . . 0.0 110.501 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.0 104.39 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.652 2.235 . . . . 0.0 110.77 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.0 m -99.22 144.35 12.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.299 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.9 p -150.48 141.95 23.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.448 0.642 . . . . 0.0 110.639 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -138.26 151.28 47.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.026 179.072 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 39.2 m -107.1 113.76 27.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.732 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.424 HG12 ' CE1' ' A' ' 193' ' ' PHE . 36.2 t -96.15 111.72 26.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.382 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.23 167.68 9.09 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.793 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 105' ' ' ALA . 34.5 Cg_endo -65.62 -19.16 60.15 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.084 1.856 . . . . 0.0 112.884 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 4.4 m -112.79 -26.73 8.43 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 131' ' ' SER . 2.9 pt-20 178.37 -162.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.15 0.5 . . . . 0.0 110.159 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -96.23 157.75 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.014 178.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -144.85 19.05 1.64 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.367 0.603 . . . . 0.0 112.241 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.9 86.56 0.08 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.326 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.8 t -104.99 115.92 47.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.431 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.35 124.32 6.2 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.575 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.65 154.79 95.81 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.874 -1.302 . . . . 0.0 112.247 0.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.42 79.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.106 0.479 . . . . 0.0 110.434 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 141.82 20.46 0.27 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.017 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.475 ' HG3' HG13 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -61.06 160.32 10.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.035 0.445 . . . . 0.0 111.298 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -129.24 152.29 48.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.091 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.484 ' CG1' ' CE1' ' A' ' 164' ' ' PHE . 40.5 t -113.98 150.67 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.624 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 2.8 p -117.81 138.77 51.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.865 0.364 . . . . 0.0 110.912 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 pp -149.93 176.63 10.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.599 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.9 p -108.09 104.18 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 0.0 110.88 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.423 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . 0.4 OUTLIER -72.71 -62.39 1.38 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.246 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 38.2 Cg_endo -66.56 83.65 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.514 2.143 . . . . 0.0 112.468 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -175.0 122.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.683 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -140.39 116.89 10.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 59.7 40.51 19.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -97.84 30.33 3.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.058 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -177.5 -56.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.1 m -158.95 -47.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.068 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -152.78 -74.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -80.28 -34.52 36.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.0 t 63.15 124.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.052 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 59.24 31.16 20.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.905 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 29.4 p -72.65 -28.21 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.929 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.8 m -86.69 -19.75 28.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.169 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -87.44 53.84 2.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 25.2 t -111.7 127.49 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.047 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -113.99 164.81 13.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.717 0.77 . . . . 0.0 110.469 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.484 ' CE1' ' CG1' ' A' ' 143' ' ' VAL . 3.3 m-85 -122.3 129.83 52.56 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.559 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.479 ' CG ' ' HA ' ' A' ' 171' ' ' ALA . 44.8 m-85 -108.54 140.95 41.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.45 0.643 . . . . 0.0 110.771 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.38 -25.66 1.71 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.78 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.551 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 32.1 m -162.36 165.84 25.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.663 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.625 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 74.9 t -67.66 -33.91 5.94 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.955 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.63 -36.92 4.44 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.669 2.246 . . . . 0.0 110.262 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.65 -40.37 49.33 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.468 177.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.72 -45.79 92.44 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.676 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 3.1 mm-40 -78.88 -27.06 43.97 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.351 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 169' ' ' PRO . 25.9 t0 -70.62 -55.91 7.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.452 ' CD2' ' HB1' ' A' ' 119' ' ' ALA . 31.8 t-105 -65.23 -28.97 69.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.635 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.676 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -63.43 -39.93 95.8 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.346 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.8 m -52.22 -44.54 64.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.327 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.408 ' O ' ' CD2' ' A' ' 178' ' ' HIS . 0.0 OUTLIER -96.15 22.33 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.259 0.552 . . . . 0.0 111.235 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.436 ' NE2' ' CE2' ' A' ' 174' ' ' TRP . 15.8 m-70 -145.46 40.75 1.22 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.084 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -81.53 136.69 35.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.575 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 97.19 -25.5 26.76 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.174 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 mt -66.76 -175.49 0.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.728 0.299 . . . . 0.0 110.871 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.86 -25.37 11.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.051 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -103.76 52.51 0.76 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.182 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -26.96 51.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.639 0.257 . . . . 0.0 111.14 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.04 143.65 46.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.949 0.404 . . . . 0.0 111.225 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.501 HG23 ' HB3' ' A' ' 171' ' ' ALA . 15.9 mm -103.52 161.56 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.94 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.402 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.99 164.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.363 0.601 . . . . 0.0 112.012 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.424 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -92.97 133.83 35.73 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.49 178.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.475 HG13 ' HG3' ' A' ' 141' ' ' MET . 18.3 m -47.43 -18.68 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 120.879 0.371 . . . . 0.0 110.838 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.424 ' N ' ' C ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -73.83 -43.08 59.85 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.037 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -20.98 36.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.327 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.38 -25.2 59.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.087 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.424 ' CE1' HG12 ' A' ' 128' ' ' VAL . 1.2 t80 -81.42 -24.82 36.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.762 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.85 -30.63 31.52 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.4 mt -82.05 -27.62 32.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.05 -25.84 39.28 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -82.19 -22.95 35.74 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.56 -0.32 . . . . 0.0 111.116 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -79.67 -24.8 41.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.141 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -53.88 -30.47 45.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 111.189 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -55.63 -54.98 37.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.061 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -54.65 -43.08 72.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.157 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -36.22 82.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.06 -27.61 32.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.037 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -80.97 -42.13 21.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -58.96 146.41 38.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.917 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.5 t -131.81 -51.81 0.98 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.08 37.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.8 m -95.92 133.4 40.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.998 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.87 -74.81 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.957 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 60.3 106.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.624 ' N ' ' CD ' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -78.79 -34.52 0.99 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.881 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 211' ' ' THR . 63.7 Cg_exo . . . . . 0 C--O 1.248 1.015 0 C-N-CA 121.971 1.78 . . . . 0.0 112.419 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.13 175.36 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.924 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 mt -137.98 -178.72 5.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -156.43 30.92 0.33 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m -152.84 70.16 7.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.033 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.78 -26.38 19.25 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.517 2.145 . . . . 0.0 112.435 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -54.16 -57.49 10.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.042 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.2 mt -63.19 -26.91 69.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -68.68 -53.25 23.45 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.118 0.485 . . . . 0.0 109.907 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -30.76 64.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.297 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.8 tt -70.81 -49.76 42.9 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.825 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.8 -27.64 30.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 0.0 110.973 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -21.1 65.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.136 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 45.9 94.97 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.068 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.86 152.6 80.87 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.622 0.248 . . . . 0.0 110.834 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.89 89.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.643 2.229 . . . . 0.0 112.346 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.2 t -97.61 110.7 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 p -85.34 -172.98 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.007 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.409 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -78.07 -35.51 49.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.339 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -27.19 68.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.954 0.407 . . . . 0.0 110.331 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -85.19 -42.68 14.49 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 tp -63.05 -35.91 81.82 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -73.31 -43.0 61.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.59 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.12 -31.49 74.97 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.7 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.425 ' N ' ' O ' ' A' ' 41' ' ' THR . 6.7 mt -78.81 -44.38 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-O 120.873 0.368 . . . . 0.0 110.535 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.57 -9.66 58.82 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.434 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t0 59.3 22.15 10.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -105.01 144.82 29.51 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.274 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.3 140.0 81.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.457 2.104 . . . . 0.0 112.033 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.15 -18.39 1.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -78.36 -32.38 48.96 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.203 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.14 -40.95 86.84 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.401 HG22 ' HB1' ' A' ' 43' ' ' ALA . 2.1 t -61.98 -48.54 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.646 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.68 -53.18 55.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.232 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.62 -46.93 77.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.837 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 37.0 t -66.4 -31.84 55.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.714 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 mt -62.1 -32.2 72.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.613 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.78 -24.48 50.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.741 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -96.22 -17.88 20.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.72 32.77 3.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.478 0.656 . . . . 0.0 110.816 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.2 p -67.52 -13.71 62.29 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.212 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 p -88.44 -22.65 23.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.778 0.323 . . . . 0.0 111.368 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.54 141.32 48.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.027 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -79.1 127.0 31.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.05 0.452 . . . . 0.0 111.414 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.431 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.8 m-85 -101.74 173.13 6.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.263 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -151.46 146.95 26.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.941 0.4 . . . . 0.0 111.492 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm 66.68 -102.54 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.865 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -91.85 -10.05 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 120.95 30.42 1.35 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.028 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.01 170.65 10.93 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.1 mp -79.84 114.28 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.239 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.6 tt -109.82 -28.93 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.246 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.43 -179.16 35.93 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.471 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -149.63 67.17 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.67 25.82 10.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.555 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.8 mp -149.17 156.16 41.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.833 0.349 . . . . 0.0 110.955 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.3 t -101.19 159.04 15.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.35 -43.79 85.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.992 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -103.59 147.46 27.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.966 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.8 128.59 37.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.1 p -106.9 -174.46 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.4 -34.45 12.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 52.2 m-85 -81.15 110.48 16.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.606 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.57 137.25 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.481 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 36.4 t80 -126.82 105.6 8.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.567 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -98.58 126.55 44.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.685 0.279 . . . . 0.0 110.984 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.465 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.07 127.19 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 59.18 -77.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.296 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' ILE . 19.4 t0 -160.11 35.34 0.17 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.483 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -138.42 114.05 9.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.503 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -77.82 86.4 4.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 110.894 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -71.73 164.84 25.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.704 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -136.76 162.89 31.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.327 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.405 ' HB2' ' CB ' ' A' ' 99' ' ' ASP . . . -149.59 167.22 26.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.011 0.434 . . . . 0.0 112.068 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -98.88 -8.96 24.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.126 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.422 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -161.15 172.77 16.16 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.983 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.449 ' CB ' ' CE2' ' A' ' 164' ' ' PHE . . . -55.35 -24.2 28.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.273 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.445 HD21 ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -94.62 -38.03 11.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.175 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.445 ' N ' HD21 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -53.84 -22.0 8.8 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.444 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -60.12 -35.07 74.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.739 0.304 . . . . 0.0 110.482 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.457 ' CD2' ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -169.66 147.12 3.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.988 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 tt -107.29 -43.09 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -129.57 72.47 81.95 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.05 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.465 ' O ' HG21 ' A' ' 107' ' ' ILE . 26.8 Cg_exo -62.47 -21.06 72.29 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.642 2.228 . . . . 0.0 112.426 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.63 -23.3 42.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.894 0.378 . . . . 0.0 111.407 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.5 tp -86.02 -24.42 26.43 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.465 HG21 ' O ' ' A' ' 104' ' ' PRO . 1.3 tp -57.99 -47.99 85.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.133 0.492 . . . . 0.0 111.679 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.73 19.29 27.49 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.785 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.17 175.49 12.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 111.001 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -78.79 150.15 32.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.799 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.481 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.15 110.03 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -81.26 120.19 24.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.852 0.834 . . . . 0.0 111.114 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.448 HG22 ' CD1' ' A' ' 85' ' ' PHE . 33.4 t -111.53 131.01 64.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.024 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.3 m -119.57 137.57 53.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.947 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.74 172.6 12.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.442 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -135.45 131.76 36.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.681 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 21.0 m -57.12 123.6 15.84 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.863 0.363 . . . . 0.0 111.963 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -68.06 -9.01 42.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.615 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.44 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -122.49 -50.6 1.98 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.494 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -76.8 -20.36 56.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 110.935 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.49 33.28 84.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.168 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.494 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -101.4 168.67 8.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.426 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -94.55 111.13 0.16 Allowed 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 123.043 2.495 . . . . 0.0 111.529 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.5 m -110.57 149.32 13.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.569 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 76.0 p -149.36 141.82 24.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.337 0.589 . . . . 0.0 110.731 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -133.37 152.42 51.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.131 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 60.6 m -112.02 113.06 25.14 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.426 ' CG1' ' CB ' ' A' ' 104' ' ' PRO . 23.3 t -96.31 111.88 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.626 -0.429 . . . . 0.0 111.351 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.3 p -106.47 175.88 1.89 Allowed Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.212 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.11 -13.4 33.74 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.562 2.174 . . . . 0.0 113.192 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.1 t -120.31 -27.7 5.18 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.73 -162.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.023 0.439 . . . . 0.0 110.201 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -96.67 155.08 3.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.863 178.674 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -142.87 19.39 1.98 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.347 0.594 . . . . 0.0 112.589 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.15 86.18 0.08 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.686 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 24.5 t -104.83 122.07 57.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.106 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -146.13 124.19 6.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.869 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.3 158.65 96.9 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.226 0.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.31 78.43 0.54 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.224 0.535 . . . . 0.0 110.645 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.41 18.14 0.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.195 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 166' ' ' ALA . 0.5 OUTLIER -60.78 161.14 8.37 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.047 0.423 . . . . 0.0 111.225 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -132.21 152.09 51.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.776 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.444 ' CG2' ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -110.15 150.49 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.372 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.421 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 68.3 m -123.51 147.45 47.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.92 0.391 . . . . 0.0 111.203 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.6 tt -129.28 157.81 40.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.515 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.427 ' HB ' ' CD2' ' A' ' 161' ' ' HIS . 20.0 t -125.56 142.12 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.904 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.32 68.69 26.77 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.993 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -87.82 146.25 6.79 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.922 2.415 . . . . 0.0 112.466 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 59.28 20.84 9.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.462 0.649 . . . . 0.0 111.457 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 63.19 86.46 0.12 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.779 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 63.48 106.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.84 93.45 4.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.075 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.87 -68.36 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.841 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.8 p -143.31 123.22 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.28 -68.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -157.52 33.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 53.7 m -145.16 81.89 1.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -139.6 28.93 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.107 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 17.0 p -77.29 -42.74 35.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.387 . . . . 0.0 110.674 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 161' ' ' HIS . 1.8 m -163.19 -78.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.455 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.428 ' CB ' ' O ' ' A' ' 160' ' ' CYS . 0.8 OUTLIER 83.69 -51.58 0.14 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.725 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.59 110.95 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -124.67 169.25 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.574 0.702 . . . . 0.0 109.756 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.449 ' CE2' ' CB ' ' A' ' 97' ' ' ALA . 6.2 m-85 -110.63 152.53 26.37 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.982 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 18.1 m-85 -134.62 137.06 43.36 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.42 0.629 . . . . 0.0 110.31 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -37.93 -30.67 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.739 -1.118 . . . . 0.0 113.109 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.466 ' O ' ' HB1' ' A' ' 171' ' ' ALA . 18.7 m -172.6 -179.97 2.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.157 0.503 . . . . 0.0 111.65 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 84.2 t -69.69 -33.49 3.75 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.563 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.1 Cg_exo -72.94 -39.05 2.5 Favored 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 122.604 2.203 . . . . 0.0 110.5 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.566 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.48 -39.69 52.45 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.122 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.502 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.61 -45.81 92.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.607 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.3 mt-10 -78.99 -27.39 43.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.316 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.6 t70 -70.51 -55.86 7.93 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.355 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.44 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 41.7 t-105 -64.91 -28.31 69.44 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.786 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.607 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -66.83 -38.68 86.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.264 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.8 t -51.45 -42.53 61.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.454 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -94.25 20.48 8.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.363 0.602 . . . . 0.0 111.458 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -129.62 29.46 5.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.759 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -91.51 -166.62 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.48 -32.98 5.98 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.385 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.7 mt -59.17 -175.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.738 0.304 . . . . 0.0 110.793 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -97.99 33.52 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.833 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 163.15 -105.43 0.25 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.419 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.1 tp 62.15 118.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.363 . . . . 0.0 110.761 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.83 150.14 39.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 111.518 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.435 HG22 ' CB ' ' A' ' 171' ' ' ALA . 11.9 mm -99.84 160.32 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.611 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.49 157.72 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.367 0.603 . . . . 0.0 112.198 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.9 OUTLIER -88.41 125.47 34.74 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.542 178.325 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.416 HG13 ' HG3' ' A' ' 141' ' ' MET . 0.3 OUTLIER -45.9 -21.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.556 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.407 ' N ' ' C ' ' A' ' 188' ' ' SER . 47.7 m170 -67.58 -40.1 84.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.2 mt-10 -82.32 -27.7 32.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.094 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -61.8 -24.71 67.03 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.413 ' CZ ' HG12 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -79.31 -24.76 42.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.625 179.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.94 -29.71 33.8 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.27 -28.55 31.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.97 -27.92 32.82 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -82.19 -25.48 34.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.816 0.341 . . . . 0.0 110.839 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -81.05 -22.97 38.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.193 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.82 -39.64 59.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.217 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -76.15 -49.35 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -56.27 -39.45 72.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -44.79 19.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.951 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 16.7 tp -59.04 -23.13 61.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.165 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.0 tp -81.0 -52.14 7.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -100.66 88.98 3.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.02 -47.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.88 177.05 8.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 54.8 m 60.67 108.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.5 m -75.68 84.75 2.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 110.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.938 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.632 ' N ' ' CD ' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -70.99 -34.56 3.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.753 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' A' ' 211' ' ' THR . 60.5 Cg_exo . . . . . 0 C--O 1.249 1.062 0 C-N-CA 121.973 1.782 . . . . 0.0 112.475 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.718 0.294 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -148.37 81.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.76 -179.18 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 mt -137.85 174.24 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.805 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.4 m -57.86 109.33 1.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.219 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.84 -21.07 31.41 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.45 2.1 . . . . 0.0 112.484 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.6 tp -53.39 -57.48 10.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.995 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.26 -26.78 65.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.183 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.29 -53.35 37.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.032 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -28.8 56.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.398 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tt -70.57 -52.05 24.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.733 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.54 -26.4 21.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.142 0.496 . . . . 0.0 111.058 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -68.21 -21.63 64.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.172 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.04 45.72 95.44 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.067 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -133.07 150.16 74.76 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.678 0.275 . . . . 0.0 110.767 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.85 106.08 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.63 2.22 . . . . 0.0 112.342 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.7 p -113.51 109.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.176 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 p -85.85 -172.2 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 43' ' ' ALA . 6.2 ptt180 -78.03 -35.32 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.227 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -26.52 67.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.845 0.355 . . . . 0.0 110.206 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -85.59 -42.45 14.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.341 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 tp -63.2 -36.0 82.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -73.45 -42.94 61.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.543 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.29 -30.94 73.73 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.694 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.0 mt -78.68 -44.59 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 121.0 0.429 . . . . 0.0 110.498 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.26 -10.08 59.13 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.405 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.03 21.76 10.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.441 ' CH2' ' CZ ' ' A' ' 52' ' ' ARG . 10.6 m95 -107.57 136.77 19.59 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.265 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.2 142.41 16.44 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.5 2.133 . . . . 0.0 112.286 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.77 -16.86 1.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.88 -34.46 51.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.325 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' CZ ' ' CH2' ' A' ' 48' ' ' TRP . 7.5 tpt180 -67.01 -40.64 87.34 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.405 HG23 ' HB1' ' A' ' 43' ' ' ALA . 2.1 t -62.62 -48.11 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.613 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.43 -53.38 52.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.354 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.94 -45.1 71.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.877 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.5 t -71.48 -30.23 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.723 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 13.0 mt -68.06 -39.81 82.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.738 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.68 -45.04 86.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.66 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -66.9 -14.97 63.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.027 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.14 70.43 0.71 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.67 0.748 . . . . 0.0 110.759 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.7 p -83.95 -3.87 58.29 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.247 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.0 p -96.41 -20.0 18.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.713 0.292 . . . . 0.0 111.333 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.77 141.23 21.82 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.033 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.73 126.69 31.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.154 0.502 . . . . 0.0 111.65 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.425 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 5.0 m-85 -102.92 163.06 12.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.287 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -148.3 133.79 18.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 111.711 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.405 ' HB3' ' H ' ' A' ' 68' ' ' ASP . 1.3 tptt 70.28 -94.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.177 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.405 ' H ' ' HB3' ' A' ' 67' ' ' LYS . 2.0 m-20 -98.23 -15.06 20.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 127.95 34.48 0.55 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.124 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -92.67 159.6 15.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.368 . . . . 0.0 110.193 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.6 mp -79.85 114.45 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.235 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.5 tt -178.08 -44.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.038 0.447 . . . . 0.0 111.446 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 66.53 -91.64 0.17 Allowed Glycine 0 C--N 1.32 -0.306 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.456 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.403 ' CE2' ' O ' ' A' ' 76' ' ' LEU . 8.0 p90 -166.89 -178.49 4.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 0.0 110.894 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.34 76.96 0.13 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.616 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.403 ' O ' ' CE2' ' A' ' 74' ' ' TYR . 8.5 mt 58.71 -86.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.783 0.325 . . . . 0.0 111.082 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.1 p -98.96 159.07 15.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -78.4 -50.12 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.07 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -97.02 156.71 16.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.993 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -67.46 129.59 40.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.6 p -111.76 -174.48 2.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.404 ' OG ' ' CD2' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -91.82 -29.67 16.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.147 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.09 111.53 18.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.603 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 t -105.91 139.51 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.019 0.437 . . . . 0.0 111.156 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.498 ' CE1' ' HB2' ' A' ' 101' ' ' LEU . 68.9 t80 -129.42 106.63 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.649 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -102.0 128.89 48.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.3 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.6 pt -138.52 124.64 24.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.583 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.82 -68.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.24 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 87' ' ' ILE . 1.3 p30 -169.33 35.21 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.253 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -137.06 113.18 9.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.1 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.409 ' O ' ' CD ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -81.0 124.69 29.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.63 165.07 14.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.102 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 93' ' ' TYR . 1.5 m-85 -129.22 165.21 21.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.206 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.63 169.58 21.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.12 0.486 . . . . 0.0 111.984 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -99.3 -11.83 20.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.061 178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 162' ' ' VAL . 0.9 OUTLIER -154.44 162.09 41.34 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.978 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.79 -22.28 3.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.769 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.86 -51.5 5.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.693 0.282 . . . . 0.0 111.288 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.55 -26.39 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.7 -32.34 70.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.309 . . . . 0.0 110.764 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.498 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . 12.3 tp -148.76 167.35 25.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.36 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.1 tp -118.61 -41.19 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.958 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -162.89 102.77 1.03 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.778 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.485 ' O ' HG23 ' A' ' 107' ' ' ILE . 15.6 Cg_exo -68.16 -25.78 36.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.75 2.3 . . . . 0.0 112.556 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.64 48.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.524 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 tt -83.05 -42.17 17.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.615 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.485 HG23 ' O ' ' A' ' 104' ' ' PRO . 1.6 tp -53.85 -48.73 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.192 0.52 . . . . 0.0 111.631 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.52 21.53 24.04 Favored Glycine 0 C--N 1.319 -0.396 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.764 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.32 173.52 14.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.955 0.407 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -78.33 151.54 32.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.868 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.47 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . . . -136.67 109.72 7.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.3 mtt-85 -82.28 119.76 24.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.761 0.791 . . . . 0.0 111.08 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.2 t -110.07 127.46 66.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.513 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.6 m -116.41 137.23 52.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.248 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.42 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 1.5 m -140.97 172.91 12.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.379 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.404 ' CD2' ' OG ' ' A' ' 82' ' ' SER . 2.6 p80 -133.58 130.23 38.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 21.3 m -56.76 122.53 12.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.943 0.402 . . . . 0.0 111.841 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.17 -9.72 42.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.615 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.461 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -121.81 -51.14 2.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.963 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.5 HG21 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -75.5 -21.8 57.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.836 0.351 . . . . 0.0 110.728 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.12 34.06 87.83 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.948 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.5 ' CB ' HG21 ' A' ' 120' ' ' THR . . . -103.09 166.26 12.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.516 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -91.6 111.23 0.31 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.996 2.464 . . . . 0.0 111.196 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.42 ' CG2' ' CB ' ' A' ' 115' ' ' SER . 22.0 m -107.7 146.42 13.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.485 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 93.2 p -144.91 142.59 29.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.394 0.616 . . . . 0.0 110.216 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -132.91 154.13 50.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.539 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 22.4 m -110.79 112.38 24.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.376 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.423 ' CG1' ' CG ' ' A' ' 104' ' ' PRO . 2.8 t -96.87 111.99 28.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.913 0.387 . . . . 0.0 111.423 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 m -108.31 160.73 25.96 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.167 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.23 -16.44 40.5 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.516 2.144 . . . . 0.0 112.968 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 78.1 p -114.35 -27.31 7.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 131' ' ' SER . 0.4 OUTLIER 178.95 -162.83 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.165 0.507 . . . . 0.0 110.061 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -94.8 166.24 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.657 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -155.17 19.39 0.43 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.14 85.79 0.07 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.973 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 51.5 t -100.37 114.87 40.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.522 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -146.37 125.24 6.47 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.235 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.99 155.68 97.46 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 123.515 -1.452 . . . . 0.0 111.847 -0.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.7 161.32 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 67.41 11.68 59.87 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.132 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 166' ' ' ALA . 12.6 ptp -61.55 156.59 19.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.151 0.501 . . . . 0.0 111.844 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.03 152.38 49.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.183 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.463 ' CG2' HG11 ' A' ' 189' ' ' VAL . 11.4 t -113.25 151.64 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.688 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.468 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 14.8 p -120.62 139.51 52.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.795 0.331 . . . . 0.0 110.769 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.06 176.34 8.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.832 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.8 t -112.89 151.23 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.938 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 tp -56.98 109.01 1.42 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.013 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.4 135.84 29.9 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.526 2.151 . . . . 0.0 112.315 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -147.59 145.8 29.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -97.27 23.13 7.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.074 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -113.7 -19.72 11.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.373 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.26 -69.18 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.033 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -157.96 -176.54 5.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.93 31.05 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.3 mtp180 -119.03 -59.21 1.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.819 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -176.65 -52.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.9 m 61.83 116.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.053 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' A' ' 182' ' ' GLU . 75.6 m-85 61.99 35.27 16.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.007 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -33.52 33.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.774 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 45.4 t -84.43 -0.46 52.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.437 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.407 ' CE1' HD11 ' A' ' 181' ' ' LEU . 8.2 t-80 -94.93 26.87 3.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.687 0.28 . . . . 0.0 111.304 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 96' ' ' CYS . 15.1 t -105.08 113.96 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 110.801 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -128.34 169.39 14.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.676 0.75 . . . . 0.0 110.387 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.453 ' CZ ' ' CG2' ' A' ' 143' ' ' VAL . 3.2 m-85 -110.48 151.54 27.42 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.678 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.47 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 17.8 m-85 -129.15 137.36 51.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.559 0.695 . . . . 0.0 110.358 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -42.7 -28.26 0.22 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.125 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.721 ' HB3' ' HD2' ' A' ' 169' ' ' PRO . 1.0 OUTLIER -166.72 171.62 11.33 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.754 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.587 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 92.6 t -68.96 -36.44 7.65 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.341 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.721 ' HD2' ' HB3' ' A' ' 167' ' ' SER . 11.4 Cg_exo -71.37 -37.14 6.02 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.749 2.299 . . . . 0.0 110.063 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.15 -40.22 53.11 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -62.04 -45.96 91.27 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.671 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 1.4 mm-40 -78.99 -27.66 43.38 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.452 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.709 ' N ' ' O ' ' A' ' 169' ' ' PRO . 13.5 t0 -70.43 -55.61 8.61 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.461 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 30.4 t-105 -65.28 -28.98 69.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.712 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.671 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -64.44 -39.97 94.85 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.394 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.41 -43.7 62.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.396 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -96.02 22.77 7.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.113 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.442 ' CE1' ' NE1' ' A' ' 174' ' ' TRP . 0.3 OUTLIER -132.82 29.16 4.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.928 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -90.66 145.63 24.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 121.36 -26.11 6.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.454 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' A' ' 161' ' ' HIS . 5.0 mt -69.21 68.51 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.937 0.399 . . . . 0.0 111.052 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.419 ' HG3' ' CE2' ' A' ' 158' ' ' PHE . 0.1 OUTLIER 56.99 30.78 18.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 106.32 -70.47 0.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.551 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.9 tp 63.68 131.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.872 0.367 . . . . 0.0 110.917 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.43 149.91 41.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.118 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.455 HG22 ' CB ' ' A' ' 171' ' ' ALA . 15.4 mm -102.11 160.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.955 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.408 ' N ' HG21 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.95 163.16 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.221 0.534 . . . . 0.0 111.89 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -86.31 127.97 34.86 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.774 178.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.463 HG11 ' CG2' ' A' ' 143' ' ' VAL . 0.9 OUTLIER -45.16 -22.27 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.685 179.344 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.408 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.8 t-160 -71.9 -43.3 65.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.185 0.517 . . . . 0.0 109.785 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.3 OUTLIER -82.15 -21.0 36.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.353 179.036 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.45 -25.31 64.04 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.776 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.421 ' CE2' HG12 ' A' ' 128' ' ' VAL . 2.4 m-85 -81.35 -24.89 36.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.111 0.481 . . . . 0.0 110.664 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.99 -31.01 29.98 Favored Glycine 0 CA--C 1.51 -0.273 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.314 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.9 tp -81.06 -29.66 34.96 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -81.23 -26.15 52.98 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -82.18 -21.76 36.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.963 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.99 -23.01 41.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.247 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -51.76 -37.46 51.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.063 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.98 -40.82 23.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -30.88 65.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.035 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.19 -36.67 84.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.923 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -49.32 78.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.83 -30.73 65.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.984 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -75.01 -31.55 61.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.2 m -94.67 121.26 36.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.972 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.34 116.32 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 12.2 p 59.27 108.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.9 p -97.06 77.9 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? 61.92 116.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.999 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.617 ' N ' ' CD ' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -71.22 -34.39 3.32 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.744 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 211' ' ' THR . 66.0 Cg_exo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 121.96 1.774 . . . . 0.0 112.475 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.891 0.376 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -60.35 -179.72 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.982 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -157.5 -179.93 8.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.957 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mp 61.01 160.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.896 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.3 m -130.41 90.58 40.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.02 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.55 -40.43 54.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.676 2.25 . . . . 0.0 112.422 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 mp -52.79 -57.18 11.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.308 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tt -79.3 -27.16 42.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.051 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -67.52 -53.36 29.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.08 -26.5 66.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 tp -71.8 -36.77 70.39 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.802 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.26 -29.33 32.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.229 0.538 . . . . 0.0 110.836 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -19.31 65.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.142 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.18 51.75 50.15 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.061 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.6 mtp85 -127.47 165.91 26.57 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.743 0.306 . . . . 0.0 110.741 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.19 111.55 2.05 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.399 2.066 . . . . 0.0 112.097 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.409 ' CG2' HG23 ' A' ' 41' ' ' THR . 8.1 p -125.85 109.76 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.272 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t -94.99 -170.06 2.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.965 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' ALA . 20.0 ptt-85 -72.55 -38.69 67.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.608 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -31.0 71.73 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.244 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -83.1 -41.91 18.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 9.3 tp -62.18 -36.69 82.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -72.41 -43.19 64.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.646 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.57 -31.68 76.96 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.587 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 41' ' ' THR . 6.9 mt -78.95 -44.07 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.106 0.479 . . . . 0.0 110.423 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 6.9 mp -76.75 -9.38 58.63 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.518 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.2 t70 60.08 21.84 11.04 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -100.27 155.86 35.92 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.223 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.58 139.96 35.18 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.551 2.167 . . . . 0.0 112.132 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.14 -19.2 1.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -77.84 -35.49 51.1 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 111.279 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -40.34 88.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.39 -48.47 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.54 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.1 -53.93 43.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.259 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.67 75.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.3 t -68.6 -31.01 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.711 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.35 -35.62 80.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.679 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.43 -44.95 85.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.701 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -76.75 -9.78 58.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.038 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.4 73.62 0.89 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.723 0.773 . . . . 0.0 110.397 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.5 p -96.99 -24.33 15.86 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.138 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -70.26 -25.46 63.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.216 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.48 141.16 31.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.242 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -78.92 126.9 31.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.063 0.459 . . . . 0.0 111.376 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.405 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 64.1 m-85 -104.29 170.85 7.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.323 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -156.12 145.43 20.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.031 0.443 . . . . 0.0 111.344 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp 66.74 -103.78 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.8 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -92.3 -13.57 30.13 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 125.92 30.76 0.85 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.154 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -87.34 163.44 16.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.79 118.28 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.187 -179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -26.01 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.208 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.68 -170.79 13.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.5 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -162.9 171.17 17.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.919 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.3 -59.04 1.38 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.408 ' CD1' ' CD1' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -85.43 166.48 16.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.777 0.322 . . . . 0.0 110.736 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.44 HG21 ' CD1' ' A' ' 95' ' ' TRP . 18.0 p -126.43 159.61 32.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.2 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -48.18 -86.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.583 0.23 . . . . 0.0 110.804 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.433 ' HG3' ' CD1' ' A' ' 93' ' ' TYR . 4.6 mtp180 -173.71 98.96 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.78 23.54 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.614 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.7 p -120.08 -173.66 2.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.13 0.491 . . . . 0.0 111.648 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 p -101.07 -25.82 13.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.209 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 97' ' ' ALA . 30.0 m-85 -87.49 116.33 25.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 110.613 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.16 144.89 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.066 0.46 . . . . 0.0 111.439 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.491 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 67.9 t80 -131.66 105.85 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.516 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -97.25 129.89 44.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.655 0.264 . . . . 0.0 111.269 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.438 ' CG2' ' HB2' ' A' ' 111' ' ' ALA . 1.0 OUTLIER -140.07 125.61 20.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.69 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 87' ' ' ILE . 17.0 t0 -154.35 37.46 0.43 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.664 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -141.48 145.85 35.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.297 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.04 86.59 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.904 0.383 . . . . 0.0 110.867 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 85' ' ' PHE . 0.9 OUTLIER -71.1 164.55 25.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.433 ' CD1' ' HG3' ' A' ' 79' ' ' ARG . 2.1 m-85 -135.36 161.68 34.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.548 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.423 ' HB2' ' N ' ' A' ' 100' ' ' THR . . . -148.1 163.72 36.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.057 0.456 . . . . 0.0 111.592 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.44 ' CD1' HG21 ' A' ' 77' ' ' THR . 21.7 m0 -84.24 -20.25 32.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.509 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -158.59 -177.38 6.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.091 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.453 ' N ' ' CD2' ' A' ' 83' ' ' TYR . . . -61.38 -16.45 46.58 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.5 tt -86.62 -51.64 6.02 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.08 -21.24 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.483 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -66.1 -39.58 90.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.592 0.234 . . . . 0.0 111.491 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.414 ' O ' ' HB ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -92.1 -83.92 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 101' ' ' LEU . 25.5 mm 78.25 -59.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.654 0.264 . . . . 0.0 111.113 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.4 ' N ' ' HD3' ' A' ' 104' ' ' PRO . 7.2 m-85 -151.25 65.95 6.89 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 111.056 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.501 ' O ' HG21 ' A' ' 107' ' ' ILE . 12.3 Cg_exo -71.3 -28.72 18.0 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.969 2.446 . . . . 0.0 112.551 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.6 -23.48 42.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.94 0.4 . . . . 0.0 111.584 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.93 -31.29 31.4 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.501 HG21 ' O ' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -56.64 -46.36 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.998 0.428 . . . . 0.0 111.662 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.16 19.36 21.56 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.828 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 177.23 10.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 110.865 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -75.1 150.87 38.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.665 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.491 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.09 109.82 7.55 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -84.25 120.99 26.87 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.779 0.8 . . . . 0.0 110.915 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.8 t -112.51 130.94 65.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.005 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.7 m -122.22 137.61 54.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.133 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.404 ' CB ' HG21 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -141.21 172.86 12.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.031 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.421 ' CD2' ' HA ' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -132.1 131.37 42.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 34.0 m -58.15 125.85 24.98 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.03 0.443 . . . . 0.0 112.165 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.421 ' HB1' ' CZ ' ' A' ' 165' ' ' PHE . . . -68.75 -8.03 39.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.049 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.416 ' HB3' ' CE3' ' A' ' 174' ' ' TRP . . . -119.0 -51.62 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 0.0 111.189 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.48 ' CG2' HG22 ' A' ' 170' ' ' THR . 0.9 OUTLIER -82.66 -23.9 34.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.465 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.407 ' O ' ' CE1' ' A' ' 116' ' ' HIS . . . 69.82 6.81 57.31 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.923 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.8 160.08 71.08 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 120.609 0.243 . . . . 0.0 110.671 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.421 ' HA ' ' CD2' ' A' ' 116' ' ' HIS . 6.1 Cg_endo -86.55 106.79 0.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.92 2.413 . . . . 0.0 111.033 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.516 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 26.9 m -103.78 146.59 11.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.1 p -152.42 142.17 21.95 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.333 0.587 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -131.96 153.22 50.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.447 178.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 24.0 m -110.02 113.01 25.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.447 HG12 ' CE2' ' A' ' 193' ' ' PHE . 51.5 t -96.53 114.12 32.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.088 0.471 . . . . 0.0 111.955 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.4 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.8 OUTLIER -107.32 169.03 7.16 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.734 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 35.5 Cg_endo -65.86 -19.32 58.67 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.197 1.931 . . . . 0.0 112.885 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -110.68 -27.54 8.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.433 ' HA ' ' CE1' ' A' ' 193' ' ' PHE . 3.7 pt-20 178.85 -164.68 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.069 0.462 . . . . 0.0 110.007 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.73 152.12 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.708 178.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.31 21.89 2.77 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.308 0.575 . . . . 0.0 112.445 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.77 87.4 0.09 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.814 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.72 115.05 44.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.347 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.405 ' O ' ' CE ' ' A' ' 141' ' ' MET . 19.3 tt0 -143.13 123.76 8.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.486 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.465 ' HD2' ' HE3' ' A' ' 141' ' ' MET . 57.8 Cg_endo -70.95 162.25 87.84 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 123.502 -1.457 . . . . 0.0 112.544 -0.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.19 79.91 1.79 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.16 18.5 0.2 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.268 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.516 ' CE ' ' HB ' ' A' ' 124' ' ' VAL . 0.4 OUTLIER -63.57 164.22 9.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.06 0.457 . . . . 0.0 111.708 -179.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.13 152.09 49.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.439 HG11 ' CD1' ' A' ' 164' ' ' PHE . 3.3 t -115.8 152.05 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.701 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.402 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 8.2 m -120.84 143.1 49.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.958 0.408 . . . . 0.0 111.242 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -123.39 159.53 28.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.604 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.3 t -125.45 131.52 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.103 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 tt 57.68 87.57 0.14 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.016 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.58 75.02 1.6 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.539 2.16 . . . . 0.0 112.318 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -104.21 167.09 9.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -109.0 -21.67 12.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.74 -82.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.58 -169.27 0.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.115 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 61.28 31.6 19.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.976 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.2 m -84.75 -32.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.18 -41.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.09 67.9 0.49 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -175.43 1.04 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -113.45 29.8 7.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.006 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.88 -15.97 60.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 97.4 m -92.4 0.63 57.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.302 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -102.22 48.18 0.88 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 110.818 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.14 113.6 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.265 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -116.69 169.15 9.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.692 . . . . 0.0 110.336 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.439 ' CD1' HG11 ' A' ' 143' ' ' VAL . 4.7 m-85 -118.64 153.52 34.17 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.076 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.459 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 59.2 m-85 -132.59 136.14 46.35 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.038 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -41.87 -27.68 0.13 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.091 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.511 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 74.0 m -165.5 173.67 10.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.194 0.521 . . . . 0.0 111.936 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.8 t -70.0 -33.75 3.75 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.346 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.19 -37.32 3.47 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.688 2.259 . . . . 0.0 110.289 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.563 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.91 -40.27 47.91 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.483 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.491 ' HB1' ' O ' ' A' ' 167' ' ' SER . . . -61.2 -44.88 96.57 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.595 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.0 mt-10 -78.97 -27.22 43.46 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.232 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.69 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.2 t70 -71.04 -55.94 7.2 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.429 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.416 ' CE3' ' HB3' ' A' ' 119' ' ' ALA . 41.3 t-105 -64.59 -28.0 69.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.726 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.595 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -65.01 -40.37 94.8 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.359 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.25 -43.26 61.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.382 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -95.77 21.86 7.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.374 0.607 . . . . 0.0 111.194 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -127.71 27.42 5.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.78 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -98.91 178.06 5.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.77 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.93 -27.35 18.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.448 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.2 mt -64.84 -176.79 0.29 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.804 0.335 . . . . 0.0 110.948 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.72 58.32 4.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 100.57 143.44 14.18 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.517 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.05 125.27 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.871 0.367 . . . . 0.0 110.764 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.89 150.09 41.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.077 0.465 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.442 HG23 ' CB ' ' A' ' 171' ' ' ALA . 12.9 mm -100.91 160.41 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.832 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.54 159.16 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.809 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.5 OUTLIER -86.03 124.96 33.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.908 178.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -47.83 -20.59 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.608 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -69.35 -41.41 76.63 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.6 mt-10 -82.6 -26.46 32.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.058 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -68.75 -25.02 64.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.447 ' CE2' HG12 ' A' ' 128' ' ' VAL . 7.9 t80 -81.61 -26.17 35.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.689 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.93 -30.06 32.84 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.1 mt -82.11 -27.35 32.88 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.11 -26.75 35.88 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.444 ' CG ' ' CE1' ' A' ' 193' ' ' PHE . 46.6 mm-40 -81.91 -24.86 35.4 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.041 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 -22.96 61.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -51.97 -42.4 62.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.272 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -81.18 -29.57 34.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.005 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.66 -27.71 29.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.233 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -57.98 -29.73 65.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.958 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.5 tp -81.95 -30.01 31.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.28 -37.45 80.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 61.22 170.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.6 t -157.43 173.82 16.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.912 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 17.9 mtt 60.24 80.71 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 74.5 p -115.12 147.76 39.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.3 t -98.66 33.72 2.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 31.54 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 212' ' ' PRO . 1.1 m -67.74 -62.8 3.05 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.983 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.425 ' N ' HG22 ' A' ' 211' ' ' THR . 19.2 Cg_endo . . . . . 0 C--O 1.25 1.107 0 C-N-CA 122.418 2.079 . . . . 0.0 112.367 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.825 0.345 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 65.34 -77.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tp -143.92 -47.64 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.868 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tp -115.62 157.34 24.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.1 m -133.19 81.54 56.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.71 -46.19 35.22 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.589 2.193 . . . . 0.0 112.355 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.95 -57.24 10.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 mt -72.7 -27.11 61.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.814 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.52 -53.22 55.29 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.598 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -69.91 -26.51 64.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.163 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tp -70.68 -44.2 67.49 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.686 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.22 -28.54 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.138 0.494 . . . . 0.0 110.89 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -64.77 -20.44 66.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.181 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.37 54.05 25.57 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.296 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -133.04 165.36 37.33 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.298 . . . . 0.0 110.719 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.38 113.5 3.33 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.464 2.109 . . . . 0.0 112.088 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.7 t -117.98 109.88 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.458 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.2 p -87.97 179.63 6.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.836 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -70.13 -37.46 75.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.306 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -30.11 70.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 110.074 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -82.92 -41.96 18.25 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.401 ' CD1' ' CD1' ' A' ' 71' ' ' ILE . 0.1 OUTLIER -62.49 -37.02 84.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -71.64 -43.29 66.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.626 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.68 -31.03 72.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.807 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 41' ' ' THR . 6.8 mt -78.59 -43.98 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-O 120.997 0.427 . . . . 0.0 110.519 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.06 -10.18 59.21 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.387 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 61.0 21.41 11.75 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.427 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 29.6 m95 -107.26 138.78 19.98 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.018 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.34 140.54 34.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.74 2.294 . . . . 0.0 112.053 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.33 -16.88 0.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -78.86 -31.86 45.78 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.292 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.427 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.2 OUTLIER -68.61 -40.86 80.21 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.64 -47.62 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.635 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.83 -52.35 57.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.352 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.22 -43.09 67.0 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.786 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.8 t -69.7 -33.58 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.756 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.2 mt -61.75 -35.88 79.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.657 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -57.55 -26.33 61.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.717 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -90.49 -16.46 28.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.028 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.61 33.58 2.24 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.398 0.618 . . . . 0.0 111.006 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 65.6 p -58.93 -20.88 56.02 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.009 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 p -88.76 -22.94 23.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.352 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.41 141.21 55.15 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.327 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.37 132.16 34.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 111.685 -179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.412 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 76.9 m-85 -105.73 173.23 6.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -150.37 146.8 26.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.047 0.451 . . . . 0.0 111.535 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 tptt 66.28 -102.64 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.853 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -90.36 -10.46 43.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 119.94 29.56 1.65 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.951 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -86.01 171.31 11.51 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.401 ' CD1' ' CD1' ' A' ' 42' ' ' LEU . 4.1 mp -79.76 116.8 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.316 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 tt -86.49 -25.54 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.252 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.64 152.22 27.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.441 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -108.65 159.39 16.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.85 -50.56 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.56 156.1 16.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.836 0.35 . . . . 0.0 110.926 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.8 t -111.01 159.0 18.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.27 -25.82 64.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -102.86 146.99 27.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.005 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -63.56 129.63 40.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.9 p -106.36 -176.47 3.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.011 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.1 m -89.57 -31.83 17.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.439 ' CE2' ' N ' ' A' ' 97' ' ' ALA . 5.3 m-85 -89.53 117.67 28.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.446 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.8 t -108.75 139.12 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.078 0.466 . . . . 0.0 111.114 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.518 ' CE1' ' HB1' ' A' ' 111' ' ' ALA . 30.3 t80 -123.1 106.92 11.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.887 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.2 124.08 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.741 0.305 . . . . 0.0 111.144 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.482 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.15 126.29 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.62 -77.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.317 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.0 t70 -156.11 37.0 0.34 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.633 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -141.45 147.44 37.91 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.578 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.2 86.41 2.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 0.0 110.752 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 85' ' ' PHE . 3.9 mm? -71.46 164.49 25.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.628 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -131.88 158.9 40.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.749 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.52 163.03 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.281 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -88.33 -5.64 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.137 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.0 OUTLIER 176.06 -175.2 0.11 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.006 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.453 ' CB ' ' CD1' ' A' ' 164' ' ' PHE . . . -61.3 149.42 38.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.76 0.315 . . . . 0.0 110.761 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 97' ' ' ALA . 20.0 mt 82.62 -52.32 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.05 -25.09 1.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.937 0.399 . . . . 0.0 111.166 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.494 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 3.1 p -60.15 -39.32 85.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.759 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 22.9 tp -131.4 165.17 24.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.228 0.537 . . . . 0.0 111.842 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.452 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 3.3 pt -121.92 -37.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.885 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.452 ' CE2' ' CD1' ' A' ' 102' ' ' ILE . 2.4 p90 -165.61 103.29 0.74 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.507 ' O ' HG23 ' A' ' 107' ' ' ILE . 74.0 Cg_endo -75.15 -27.58 9.65 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.745 2.297 . . . . 0.0 112.897 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.17 -23.65 54.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.703 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.71 -40.99 16.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.58 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.507 HG23 ' O ' ' A' ' 104' ' ' PRO . 1.8 tp -56.0 -49.22 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.183 0.516 . . . . 0.0 111.531 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.04 24.02 18.34 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.768 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -152.41 173.24 15.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 111.037 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.79 151.8 28.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.862 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.518 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -137.4 110.16 7.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -81.44 120.23 24.73 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.719 0.771 . . . . 0.0 111.448 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.433 HG23 ' CG2' ' A' ' 128' ' ' VAL . 58.6 t -112.55 129.63 67.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.79 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 m -122.49 137.15 54.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.393 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.438 ' HB2' ' CG2' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -141.76 173.1 11.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.179 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -134.85 135.44 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 36.2 t -64.35 133.83 53.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.532 . . . . 0.0 112.132 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.43 -4.05 24.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.214 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.442 ' HB1' ' CD2' ' A' ' 174' ' ' TRP . . . -123.37 -51.04 1.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 111.673 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.525 HG23 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -87.38 -25.1 24.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.016 -179.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.21 5.58 72.01 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.094 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.525 ' CB ' HG23 ' A' ' 120' ' ' THR . . . -58.7 147.19 72.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.618 0.247 . . . . 0.0 110.513 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.35 104.7 1.66 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.56 2.174 . . . . 0.0 110.422 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.483 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 35.3 m -101.4 145.65 11.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.397 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 71.1 p -152.53 142.07 21.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.484 0.659 . . . . 0.0 110.929 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.1 OUTLIER -134.88 153.12 52.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.464 178.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 21.2 m -109.36 113.09 25.61 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.433 ' CG2' HG23 ' A' ' 113' ' ' VAL . 29.2 t -96.1 111.86 27.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.118 0.485 . . . . 0.0 111.819 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.59 175.51 2.03 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.975 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.43 -6.25 18.76 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.548 2.166 . . . . 0.0 113.286 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m -122.77 -31.31 3.71 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.405 ' HA ' ' CE2' ' A' ' 193' ' ' PHE . 14.5 pt-20 -179.7 -162.3 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 110.005 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -91.78 144.3 9.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.563 178.234 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -133.6 18.2 3.93 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.392 0.615 . . . . 0.0 112.412 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.03 86.34 0.08 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.523 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 37.2 t -105.65 120.62 56.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.898 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -146.21 122.14 5.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.08 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -68.23 167.73 63.35 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.626 -1.406 . . . . 0.0 112.951 -0.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.7 83.7 7.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.97 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 140.87 21.08 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.046 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.483 ' CE ' ' HB ' ' A' ' 124' ' ' VAL . 9.1 mtp -60.98 164.72 4.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.144 0.497 . . . . 0.0 111.968 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -131.92 151.87 51.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.82 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.47 HG13 ' CD1' ' A' ' 164' ' ' PHE . 7.6 t -112.77 148.98 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.417 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.444 ' O ' ' HB ' ' A' ' 162' ' ' VAL . 64.4 m -118.29 143.53 46.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.77 0.319 . . . . 0.0 110.854 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.408 ' HA ' ' CG1' ' A' ' 162' ' ' VAL . 0.6 OUTLIER -99.9 147.23 25.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.954 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.12 107.92 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.971 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 62.49 84.96 0.18 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.31 158.38 57.75 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.57 2.18 . . . . 0.0 112.246 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -146.28 138.74 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -100.68 -21.08 15.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -156.61 77.66 0.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.102 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -171.89 146.27 2.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.058 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -176.11 37.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.2 p -109.17 -36.27 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -169.16 -42.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.954 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -59.27 -31.81 69.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.978 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.0 t -68.02 118.78 11.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.007 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -123.89 28.9 6.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.976 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 29.7 p -81.01 -23.85 38.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.075 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 37.3 t -65.44 -22.48 66.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.251 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 161' ' ' HIS . 3.1 m-70 -112.78 54.54 0.72 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.813 0.34 . . . . 0.0 111.037 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 144' ' ' SER . 0.7 OUTLIER -83.01 174.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.38 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -113.68 159.45 19.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.679 0.752 . . . . 0.0 110.177 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.47 ' CD1' HG13 ' A' ' 143' ' ' VAL . 2.3 m-85 -116.9 129.74 56.26 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.837 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 142' ' ' ALA . 29.8 m-85 -108.53 142.39 39.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.449 0.642 . . . . 0.0 110.796 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.19 -26.15 2.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.888 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.556 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 50.7 m -163.3 167.68 21.54 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.862 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 75.1 t -67.92 -33.64 5.35 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.07 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.713 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.4 Cg_exo -73.01 -37.49 3.49 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.667 2.244 . . . . 0.0 110.336 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.566 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.16 -40.59 52.19 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.006 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.492 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.8 -45.94 91.67 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.611 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.9 mt-10 -78.81 -27.39 44.4 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.313 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.713 ' N ' ' O ' ' A' ' 169' ' ' PRO . 9.5 t70 -70.65 -55.86 7.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.383 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.442 ' CD2' ' HB1' ' A' ' 119' ' ' ALA . 41.9 t-105 -64.91 -28.62 69.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.765 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.611 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -64.9 -40.72 95.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.317 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 40.7 t -50.85 -42.55 58.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.369 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.1 20.87 8.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.308 0.575 . . . . 0.0 111.271 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.5 25.01 7.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.788 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -95.12 -176.04 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.83 -29.85 9.29 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.424 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 mt -64.5 -175.14 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.86 0.362 . . . . 0.0 110.852 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.02 -20.51 58.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.259 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 147.92 135.0 2.55 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.585 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.3 mp -147.59 146.8 29.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 110.869 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.17 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.455 HG23 ' HB2' ' A' ' 171' ' ' ALA . 14.5 mm -102.32 162.01 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.937 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -161.69 166.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.265 0.555 . . . . 0.0 111.794 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -89.59 128.13 35.99 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.014 178.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.421 HG13 ' CE2' ' A' ' 164' ' ' PHE . 1.4 m -45.88 -21.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.621 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.402 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.8 t60 -71.47 -42.72 67.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.215 0.531 . . . . 0.0 109.98 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -82.28 -21.58 36.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -73.86 -25.23 59.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.092 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.408 ' O ' ' CB ' ' A' ' 197' ' ' GLN . 72.7 t80 -81.6 -24.77 36.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.585 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.84 -29.11 35.86 Favored Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.3 mp -82.06 -28.4 32.44 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.32 -28.84 29.26 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.543 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 1.3 tm0? -82.24 -25.26 34.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.575 -0.312 . . . . 0.0 111.28 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -76.86 -22.79 52.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.124 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -51.82 -33.63 36.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.963 0.411 . . . . 0.0 111.082 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -81.06 -53.78 6.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -55.03 -29.39 57.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -59.05 -30.57 68.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.911 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 8.4 mp -66.55 -40.93 89.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.02 -35.86 75.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.836 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -98.27 36.53 1.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.1 p -61.4 150.35 35.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.913 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 6.6 ptp -141.28 120.69 13.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.31 135.82 40.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.6 m -137.72 -70.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.91 34.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 212' ' ' PRO . 1.1 m -176.43 -63.02 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.031 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.433 ' N ' HG23 ' A' ' 211' ' ' THR . 19.6 Cg_endo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.397 2.065 . . . . 0.0 112.37 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.783 0.325 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -109.4 -61.91 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 mt -103.36 113.78 27.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.36 -41.33 85.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.4 m 41.17 83.37 0.21 Allowed Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.717 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.91 -17.02 46.57 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.583 2.189 . . . . 0.0 112.552 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tp -52.76 -57.41 10.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.368 . . . . 0.0 111.01 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -70.09 -27.05 64.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.76 -53.22 60.53 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.611 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.34 -23.7 61.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.272 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.0 tt -63.13 -49.03 75.99 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.479 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.0 18.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.34 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -24.33 61.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.126 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.64 39.58 96.76 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.34 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -133.32 150.06 74.2 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.696 0.284 . . . . 0.0 110.755 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.67 107.07 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.559 2.172 . . . . 0.0 111.978 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.0 p -99.23 112.1 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.519 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 p -93.32 175.62 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.422 ' O ' ' N ' ' A' ' 43' ' ' ALA . 2.1 mpp_? -65.26 -40.33 93.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.302 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -25.09 67.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.869 0.366 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.471 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -86.11 -43.3 13.17 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.79 -36.28 82.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -73.2 -43.0 62.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.595 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.79 -30.7 72.58 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.697 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.471 ' N ' ' O ' ' A' ' 41' ' ' THR . 6.9 mt -78.42 -44.75 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 120.999 0.428 . . . . 0.0 110.563 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -75.65 -9.85 58.93 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.491 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t70 59.72 21.92 10.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.446 ' CZ2' ' NH1' ' A' ' 52' ' ' ARG . 1.8 m0 -109.27 146.02 33.03 Favored Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.217 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.13 143.18 52.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.557 2.171 . . . . 0.0 112.063 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.19 -16.9 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.65 -33.61 47.04 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.236 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.446 ' NH1' ' CZ2' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -67.95 -41.2 82.83 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.417 HG23 ' HB1' ' A' ' 43' ' ' ALA . 2.1 t -63.29 -47.65 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.544 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.49 -52.32 59.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.269 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.67 -36.65 25.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.019 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.9 t -59.4 -35.81 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.035 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 mp -60.93 -32.43 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.873 0.368 . . . . 0.0 110.723 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -58.65 -34.8 71.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.467 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -100.19 -20.42 15.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.87 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.59 33.44 3.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.476 0.655 . . . . 0.0 110.742 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.1 p -66.99 -13.87 62.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.343 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 p -88.02 -23.57 23.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.325 . . . . 0.0 111.359 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.22 141.47 50.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.016 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.68 126.99 31.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 111.326 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -102.1 173.13 6.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.465 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -97.18 -172.88 2.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -34.5 76.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.955 0.407 . . . . 0.0 111.128 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.28 1.7 55.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.343 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.05 14.45 60.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.267 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -86.79 146.82 26.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.491 0.645 . . . . 0.0 109.881 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 72' ' ' ILE . 1.7 mp -79.76 143.28 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.905 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.448 ' CB ' ' O ' ' A' ' 71' ' ' ILE . 0.4 OUTLIER 90.5 -23.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.692 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.91 -91.73 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.613 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -131.9 -45.78 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.63 -160.49 9.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 mt -110.68 -33.37 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.983 0.42 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.01 159.53 17.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.72 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.72 24.96 1.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.619 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 51.56 96.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.808 0.337 . . . . 0.0 111.505 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -156.21 -84.76 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.483 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.37 163.7 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.844 0.354 . . . . 0.0 111.592 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 65.3 m -82.18 -5.88 58.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.97 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -66.21 96.77 0.35 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 110.293 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -109.69 144.71 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.369 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.472 ' CZ ' ' CG2' ' A' ' 87' ' ' ILE . 33.5 t80 -131.16 107.57 9.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.086 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -102.72 132.46 48.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.517 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' ASP . 2.3 pt -138.74 123.0 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.396 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.12 -67.5 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.134 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.6 m-20 -168.54 34.82 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.304 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -135.57 112.49 10.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.968 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -82.11 124.63 30.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.971 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 85' ' ' PHE . 2.8 mm? -115.57 165.1 13.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -129.75 165.21 22.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.994 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 99' ' ' ASP . . . -153.48 170.97 19.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.939 0.4 . . . . 0.0 111.705 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 49.6 m0 -95.25 -17.95 21.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.679 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 98.9 m -152.54 166.48 31.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.255 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.469 ' CB ' ' CE1' ' A' ' 164' ' ' PHE . . . -54.21 -21.08 8.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.93 -51.73 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 41.4 t0 -50.1 -23.23 2.0 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.409 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -60.11 -32.67 71.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.676 0.274 . . . . 0.0 110.688 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 85' ' ' PHE . 50.9 tp -140.84 162.22 35.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 111.296 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -125.24 -39.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.28 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.424 ' CG ' ' HB2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -163.19 103.22 1.0 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.099 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.493 ' O ' HG21 ' A' ' 107' ' ' ILE . 74.4 Cg_endo -74.91 -31.76 6.1 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.575 2.184 . . . . 0.0 112.609 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 130' ' ' PRO . . . -79.08 -23.83 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.456 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.424 ' HB2' ' CG ' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -82.43 -40.89 20.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.36 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.493 HG21 ' O ' ' A' ' 104' ' ' PRO . 1.3 tp -56.1 -47.15 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.154 0.502 . . . . 0.0 111.556 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.04 21.41 20.72 Favored Glycine 0 C--N 1.32 -0.338 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.836 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 174.68 13.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.01 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -79.46 151.77 30.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.671 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.464 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . . . -137.02 109.95 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 65.0 mtm-85 -82.22 121.63 26.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.745 0.783 . . . . 0.0 110.975 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.4 t -113.6 130.76 67.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.961 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.8 m -121.18 137.48 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.735 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.403 ' HB3' HG22 ' A' ' 124' ' ' VAL . 3.1 t -141.06 173.01 11.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.347 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -131.14 130.74 43.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 23.3 m -56.68 123.97 16.75 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.95 0.405 . . . . 0.0 111.811 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.42 ' HB1' ' CE1' ' A' ' 165' ' ' PHE . . . -67.8 -9.44 44.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.617 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.471 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -122.14 -50.64 2.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.507 HG21 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -77.12 -21.05 54.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.815 0.34 . . . . 0.0 110.895 -178.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.87 33.58 85.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.157 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.507 ' CB ' HG21 ' A' ' 120' ' ' THR . . . -102.0 169.12 8.02 Favored Pre-proline 0 N--CA 1.453 -0.324 0 CA-C-N 115.459 -0.37 . . . . 0.0 110.372 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -92.98 108.23 0.19 Allowed 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.92 2.413 . . . . 0.0 111.454 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.427 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 35.7 m -105.43 146.26 12.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.45 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.8 p -148.99 142.49 25.32 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.397 0.618 . . . . 0.0 110.695 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -139.08 151.85 47.06 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.852 178.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 40.3 m -107.64 114.09 27.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.053 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 10.7 t -96.56 111.83 27.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.853 0.358 . . . . 0.0 111.412 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -106.69 172.18 4.09 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.009 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 105' ' ' ALA . 14.9 Cg_exo -68.83 -14.64 39.34 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.42 2.08 . . . . 0.0 112.995 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 1.1 t -117.86 -26.46 6.48 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 131' ' ' SER . 21.1 pt-20 178.65 -162.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.124 0.488 . . . . 0.0 110.01 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.88 159.2 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.849 178.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -145.67 19.34 1.49 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.402 0.62 . . . . 0.0 112.274 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.91 86.45 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.493 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.2 t -102.42 116.06 45.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.087 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -146.36 121.49 5.47 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.721 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.5 155.35 98.95 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.542 -1.441 . . . . 0.0 112.243 -0.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.29 78.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 147.76 15.84 0.13 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.503 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.427 ' CE ' ' HB ' ' A' ' 124' ' ' VAL . 0.0 OUTLIER -60.69 157.88 13.79 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.187 0.494 . . . . 0.0 111.227 -179.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.63 151.98 48.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.917 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.445 ' CG1' ' CE1' ' A' ' 164' ' ' PHE . 4.6 t -113.83 150.41 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.307 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.04 146.29 46.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.906 0.384 . . . . 0.0 111.078 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -122.08 158.12 29.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.651 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 34.6 m -125.24 143.71 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.269 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.44 ' CB ' ' HD3' ' A' ' 148' ' ' PRO . 2.7 tp -91.64 -52.59 0.28 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.89 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 147' ' ' LEU . 17.2 Cg_exo -66.73 -158.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.601 2.201 . . . . 0.0 112.127 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -118.3 -179.39 3.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.749 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -171.18 110.93 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 58.01 83.76 0.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.405 ' CB ' ' CB ' ' A' ' 157' ' ' SER . . . -159.63 176.16 12.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.199 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -113.15 -34.7 5.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.415 ' CG1' ' CB ' ' A' ' 157' ' ' SER . 12.0 p -67.06 159.05 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.038 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.18 -50.79 72.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.232 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -121.95 69.0 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.05 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.415 ' CB ' ' CG1' ' A' ' 154' ' ' VAL . 0.9 OUTLIER -69.04 151.54 46.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -177.28 53.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.2 m -61.3 -46.27 91.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 75.8 m -152.42 -75.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.775 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 50.1 m80 48.86 38.05 11.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.2 t -115.88 127.61 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.595 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -115.37 169.14 9.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.611 0.719 . . . . 0.0 109.677 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.469 ' CE1' ' CB ' ' A' ' 97' ' ' ALA . 3.2 m-85 -117.23 153.51 32.75 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.293 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.483 ' HB3' HG23 ' A' ' 170' ' ' THR . 42.3 m-85 -133.16 137.32 46.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.166 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -38.9 -29.05 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.869 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 5.0 p -172.02 178.55 2.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.04 0.448 . . . . 0.0 111.54 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.606 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 77.8 t -69.13 -33.14 3.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.583 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.685 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.3 Cg_exo -72.98 -39.31 2.34 Favored 'Trans proline' 0 CA--C 1.505 -0.936 0 C-N-CA 122.731 2.288 . . . . 0.0 110.586 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.542 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.34 -39.44 53.92 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.508 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.86 -46.04 91.16 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.6 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.3 mt-10 -78.81 -27.66 44.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.225 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.685 ' N ' ' O ' ' A' ' 169' ' ' PRO . 22.7 t0 -71.04 -55.74 7.63 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.43 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.471 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 8.1 t-105 -64.79 -28.49 69.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.702 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.6 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -64.96 -40.33 94.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.249 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.55 -42.79 55.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.402 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.407 ' O ' ' CD2' ' A' ' 178' ' ' HIS . 0.2 OUTLIER -97.1 23.7 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.338 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.407 ' CD2' ' O ' ' A' ' 177' ' ' LYS . 11.1 m170 -152.87 45.12 0.68 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.926 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -112.04 -12.57 13.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.68 -23.65 22.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.441 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.9 mt -71.51 65.82 0.47 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 58.71 26.45 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.972 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.16 81.5 0.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.588 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 29.6 mt -66.87 173.38 3.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.734 0.302 . . . . 0.0 110.698 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.14 142.64 46.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.141 0.496 . . . . 0.0 111.3 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.461 HG22 ' CB ' ' A' ' 171' ' ' ALA . 16.0 mm -101.69 160.85 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.758 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.71 157.47 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.233 0.54 . . . . 0.0 112.013 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.5 OUTLIER -86.02 127.98 34.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.767 178.461 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.422 HG12 ' CE2' ' A' ' 164' ' ' PHE . 2.1 m -46.43 -20.93 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.874 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.4 ' N ' ' C ' ' A' ' 188' ' ' SER . 1.8 t-80 -73.67 -43.3 59.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.208 0.527 . . . . 0.0 109.761 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.38 -20.86 36.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.378 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.2 -25.36 61.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.972 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -81.81 -30.96 31.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.252 0.548 . . . . 0.0 110.37 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.07 -33.48 23.52 Favored Glycine 0 CA--C 1.509 -0.31 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.336 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.2 tt -76.65 -29.65 56.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.58 -26.88 37.26 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -82.71 -22.69 34.4 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.445 -0.377 . . . . 0.0 110.87 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.38 -22.95 43.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.424 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -51.95 -26.87 11.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 111.168 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -81.18 -54.31 5.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -66.09 -44.91 83.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.155 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -54.14 -30.1 47.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.99 -29.49 68.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.952 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.6 tp -69.62 -32.01 70.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.986 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 61.71 165.91 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.88 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.1 p -141.43 -177.96 5.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -169.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 6.3 t -123.7 -43.49 2.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.868 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 62.1 p -59.62 -175.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.994 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 60.88 87.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.63 ' N ' ' CD ' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -78.58 -34.47 1.02 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.76 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.63 ' CD ' ' N ' ' A' ' 211' ' ' THR . 65.2 Cg_exo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.015 1.81 . . . . 0.0 112.421 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -146.05 -178.84 6.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.72 -169.0 2.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -156.13 150.28 25.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.0 m -63.13 143.09 97.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.022 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.04 -35.68 4.0 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.452 2.101 . . . . 0.0 112.384 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 mt -53.9 -57.47 10.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.194 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.44 -26.87 44.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.259 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -63.72 -53.21 54.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.152 0.501 . . . . 0.0 109.982 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -78.88 -27.47 44.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.627 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 tt -69.78 -52.42 25.37 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.794 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.63 -25.93 63.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 110.822 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -70.0 -23.3 63.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.047 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.63 48.8 82.3 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.147 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -133.09 150.17 74.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.715 0.293 . . . . 0.0 110.855 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.64 106.36 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.536 2.157 . . . . 0.0 112.397 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.32 109.9 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.221 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 p -84.15 -175.01 5.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.962 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 43' ' ' ALA . 9.3 mtp180 -76.93 -35.97 56.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.471 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -25.83 67.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.894 0.378 . . . . 0.0 110.348 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -86.05 -42.74 13.69 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.2 tp -63.43 -35.92 82.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -74.06 -42.57 60.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.425 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.95 -30.98 74.54 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.567 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.0 mt -79.09 -43.0 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.04 0.448 . . . . 0.0 110.432 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.9 mp -78.16 -7.75 57.45 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.509 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.66 23.41 6.15 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.63 145.4 31.22 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.264 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.07 139.61 70.95 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.415 2.077 . . . . 0.0 111.961 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.79 -17.46 0.94 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -78.56 -32.49 47.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.285 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 mmt85 -67.66 -41.27 84.02 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 t -63.0 -48.07 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.516 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.01 -51.79 62.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.469 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.64 -37.47 18.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.6 t -60.21 -33.06 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.754 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.06 -26.51 36.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.057 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -56.63 -22.7 36.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.197 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -1.67 11.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.231 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.77 72.19 0.78 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.819 0.819 . . . . 0.0 110.618 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.3 p -77.79 -3.96 44.02 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.376 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.2 m -113.14 39.92 2.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.061 0.458 . . . . 0.0 110.706 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.44 141.43 29.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.081 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.79 126.58 30.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.067 0.46 . . . . 0.0 111.237 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.4 ' CD1' ' O ' ' A' ' 69' ' ' GLY . 31.8 m-85 -119.51 160.83 21.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.402 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -154.52 145.6 22.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 111.289 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 tptt 66.06 -102.71 0.08 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.68 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.86 -14.04 32.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.728 0.299 . . . . 0.0 111.767 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 122.79 30.08 1.18 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.145 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -87.39 170.01 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.069 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.0 mt -79.7 117.37 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.355 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 tt -89.88 -27.33 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.54 139.06 9.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.571 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -100.99 177.0 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.353 . . . . 0.0 110.857 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.97 -43.75 2.12 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.414 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.93 155.4 27.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.777 0.322 . . . . 0.0 110.829 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.8 p -132.42 159.06 40.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt -85.24 5.72 29.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.476 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.44 113.26 24.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -55.77 -23.15 27.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.332 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER 35.66 -166.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 m -104.82 -25.92 12.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.4 ' OH ' ' CD2' ' A' ' 163' ' ' HIS . 4.8 m-85 -85.5 117.19 24.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.454 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.43 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.6 t -109.09 142.54 21.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.001 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.494 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 54.5 t80 -130.05 106.95 8.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.62 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -99.53 126.51 45.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.167 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -135.47 122.73 35.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.847 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t0 61.02 -69.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.319 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 87' ' ' ILE . 7.5 t70 -167.48 35.29 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.196 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.0 mmt-85 -137.6 113.24 9.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.986 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.55 121.9 25.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.501 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.93 164.69 13.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.323 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -129.03 165.0 22.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.038 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HB3' ' N ' ' A' ' 100' ' ' THR . . . -152.65 169.03 23.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.987 0.422 . . . . 0.0 112.105 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.3 m95 -95.03 -19.59 20.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.783 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.48 166.64 30.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.091 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.48 ' CB ' ' CD1' ' A' ' 164' ' ' PHE . . . -51.93 -23.28 4.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tp -86.38 -51.65 6.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.745 0.307 . . . . 0.0 111.434 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.03 -28.28 0.67 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.972 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -60.46 -39.56 88.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 0.0 110.725 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.2 pp -111.08 -173.45 2.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 0.0 111.232 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.5 tp -165.22 -42.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.052 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -162.98 76.15 1.91 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.023 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.484 ' O ' HG22 ' A' ' 107' ' ' ILE . 25.7 Cg_exo -62.96 -34.78 69.87 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.632 2.221 . . . . 0.0 112.374 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.18 -23.66 43.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.472 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.418 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -84.15 -39.23 19.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.409 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.484 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -58.05 -45.97 88.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.098 0.475 . . . . 0.0 111.371 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.94 24.03 16.23 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.474 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.26 173.73 14.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 111.038 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -80.65 155.3 26.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.494 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.11 109.83 7.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -81.9 119.8 24.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.771 0.796 . . . . 0.0 111.178 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.423 HG22 ' CG2' ' A' ' 128' ' ' VAL . 96.6 t -112.69 130.22 66.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.061 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.43 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 59.6 p -121.97 137.78 54.67 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.208 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.423 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 1.1 m -141.37 173.01 11.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.319 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -135.21 134.72 40.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . 0.406 ' O ' ' HA2' ' A' ' 121' ' ' GLY . 35.5 t -62.09 128.84 38.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.142 0.496 . . . . 0.0 111.89 -178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 165' ' ' PHE . . . -69.65 -5.52 25.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.84 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.462 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -121.47 -50.11 2.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.845 0.355 . . . . 0.0 111.682 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.478 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.51 -24.4 21.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.058 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 117' ' ' CYS . . . 74.94 6.78 79.94 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.135 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.478 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -58.19 147.82 64.8 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.643 0.259 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.32 105.73 1.48 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.676 2.251 . . . . 0.0 110.448 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.494 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 27.7 m -103.32 145.7 12.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.945 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.408 ' O ' HD13 ' A' ' 126' ' ' LEU . 77.3 p -153.29 141.3 20.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.237 0.541 . . . . 0.0 110.421 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -136.72 153.6 50.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.258 178.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 89.5 m -105.75 112.57 25.69 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.654 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.423 ' CG2' HG22 ' A' ' 113' ' ' VAL . 62.1 t -96.21 111.95 27.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.935 0.398 . . . . 0.0 111.46 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.44 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -106.14 171.0 5.18 Favored Pre-proline 0 N--CA 1.453 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.853 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 37.7 Cg_endo -67.16 -19.22 51.1 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.028 1.819 . . . . 0.0 112.965 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 8.5 m -109.25 -29.41 8.5 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.416 ' HB3' ' O ' ' A' ' 131' ' ' SER . 10.5 pt-20 178.63 -161.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.198 0.523 . . . . 0.0 110.101 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -94.26 163.6 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.602 178.424 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -153.07 21.07 0.58 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.295 0.569 . . . . 0.0 112.448 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.95 86.32 0.08 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.445 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.431 ' HA ' HD13 ' A' ' 126' ' ' LEU . 39.5 t -101.59 107.69 22.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.451 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -146.82 119.77 4.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.812 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.63 145.95 83.04 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.582 -1.424 . . . . 0.0 112.222 0.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.94 165.47 5.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.746 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 66.89 13.18 61.15 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.312 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.494 ' CE ' ' HB ' ' A' ' 124' ' ' VAL . 0.5 OUTLIER -61.43 158.3 15.03 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.983 0.42 . . . . 0.0 111.613 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.05 152.35 49.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.241 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.466 HG21 ' CZ ' ' A' ' 164' ' ' PHE . 21.3 t -111.92 151.24 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.575 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.506 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 3.3 p -120.18 140.76 50.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.79 0.328 . . . . 0.0 110.804 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.96 154.71 39.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.914 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.3 t -125.61 159.38 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.925 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.4 mt -92.39 148.71 37.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.701 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.58 149.37 79.57 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.512 2.142 . . . . 0.0 112.323 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -108.91 -171.93 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.832 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.16 -20.63 12.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -108.03 51.75 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -168.84 -173.14 1.76 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 60.81 36.47 19.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.4 m -109.98 -38.75 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.067 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.3 mtp180 -130.96 -60.41 0.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -176.07 83.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.89 126.76 0.22 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 1.3 t80 60.52 40.44 16.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.8 t -59.83 -31.09 69.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.3 t -165.39 -43.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 62.34 67.62 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.5 t -110.94 123.39 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.4 ' CD2' ' OH ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -117.03 169.23 9.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.602 0.715 . . . . 0.0 110.182 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.48 ' CD1' ' CB ' ' A' ' 97' ' ' ALA . 1.8 m-85 -120.48 132.26 55.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.915 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 144' ' ' SER . 54.5 m-85 -108.65 136.15 48.72 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.144 0.497 . . . . 0.0 110.001 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -46.89 -25.79 0.85 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 40.1 m -163.09 167.49 22.22 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.825 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 77.4 t -68.1 -34.43 6.09 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.97 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.0 Cg_exo -72.69 -36.8 4.48 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 122.753 2.302 . . . . 0.0 110.001 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.75 -40.27 48.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.465 178.007 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.483 ' HA ' ' CG ' ' A' ' 165' ' ' PHE . . . -61.45 -45.24 95.1 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.6 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 95.1 mt-10 -78.93 -27.94 43.77 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.249 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 169' ' ' PRO . 28.3 t70 -70.19 -55.89 8.19 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.457 0.646 . . . . 0.0 109.475 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.469 ' CE2' ' CE1' ' A' ' 178' ' ' HIS . 29.8 t-105 -64.88 -27.74 69.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.83 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.6 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -65.54 -40.27 92.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.265 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -42.29 63.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.471 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -95.11 20.46 9.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.271 0.558 . . . . 0.0 111.435 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.469 ' CE1' ' CE2' ' A' ' 174' ' ' TRP . 0.1 OUTLIER -127.84 29.25 5.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.721 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -96.81 -173.06 2.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.802 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.99 -31.24 7.49 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.443 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.8 mt -62.67 -174.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.712 0.292 . . . . 0.0 110.854 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -97.62 34.15 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 165.01 -117.58 0.76 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.614 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.2 tt 62.5 114.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.24 149.9 40.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.447 HG23 ' CB ' ' A' ' 171' ' ' ALA . 10.6 mm -100.29 158.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.937 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.46 161.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.219 0.533 . . . . 0.0 112.016 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -88.08 127.97 35.41 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.652 178.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.467 HG12 ' HG3' ' A' ' 141' ' ' MET . 2.1 m -48.01 -19.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.405 ' N ' ' C ' ' A' ' 188' ' ' SER . 23.6 m-70 -73.02 -44.39 60.96 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -22.3 35.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.524 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.89 -25.18 58.76 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.282 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -81.51 -24.86 36.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.942 0.401 . . . . 0.0 110.666 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.86 -29.81 33.81 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.3 -28.3 31.8 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.04 -28.17 31.89 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -82.15 -21.88 36.37 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.44 -0.38 . . . . 0.0 110.995 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -81.12 -22.84 38.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.126 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.451 ' CD2' ' CD1' ' A' ' 203' ' ' LEU . 0.5 OUTLIER -52.65 -28.32 20.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.129 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -52.39 -55.08 24.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -58.03 -30.76 66.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.031 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -55.92 5.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.978 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.451 ' CD1' ' CD2' ' A' ' 199' ' ' PHE . 9.9 mt -64.88 -35.21 80.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.973 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.69 -49.67 44.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -71.24 79.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.5 m -84.65 101.65 12.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.905 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 7.5 tpp -63.3 147.52 50.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 59.2 p -142.13 144.79 33.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.6 t -130.93 35.15 3.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.7 157.63 31.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.442 HG23 ' N ' ' A' ' 212' ' ' PRO . 1.1 m -59.53 -62.93 4.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.978 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.442 ' N ' HG23 ' A' ' 211' ' ' THR . 19.6 Cg_endo . . . . . 0 C--O 1.249 1.043 0 C-N-CA 122.363 2.042 . . . . 0.0 112.362 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.857 0.36 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 61.01 112.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp 60.26 158.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.2 mt -100.68 155.02 18.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.39 107.41 0.87 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.172 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.99 -19.83 64.74 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.49 2.127 . . . . 0.0 112.403 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.5 tt -55.27 -57.62 11.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.447 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.27 -27.36 38.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.334 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.7 ttt-85 -70.86 -53.31 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.941 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -66.5 -25.52 66.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.499 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 tp -72.02 -30.56 65.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.714 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.38 -27.87 26.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.146 0.498 . . . . 0.0 110.944 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -64.76 -19.96 66.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.245 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.64 47.52 89.98 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.134 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.06 143.93 51.46 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.601 0.239 . . . . 0.0 110.676 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -51.46 91.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.458 2.106 . . . . 0.0 112.306 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.1 t -93.17 112.08 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.281 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.9 p -86.73 -176.57 5.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.688 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -75.71 -36.73 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.248 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -27.3 67.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.206 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.94 -42.52 14.88 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -36.7 83.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.412 ' HB3' HG23 ' A' ' 53' ' ' VAL . . . -72.43 -43.02 64.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.625 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.23 -31.72 75.01 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.591 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.1 mt -78.02 -46.15 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 120.968 0.413 . . . . 0.0 110.409 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.58 -9.51 58.64 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.543 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 60.31 21.65 11.14 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -102.0 160.43 26.45 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.25 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.16 138.99 34.54 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.608 2.205 . . . . 0.0 111.925 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.54 -20.27 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -32.25 47.35 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.045 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -67.39 -40.66 85.69 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.447 ' O ' HG11 ' A' ' 56' ' ' VAL . 2.0 t -62.98 -47.85 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.518 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.26 -52.46 58.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.164 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.98 79.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.154 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -66.62 -26.81 38.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.922 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.06 -31.77 66.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.632 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -56.17 -23.18 33.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -88.54 -16.36 32.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.96 33.35 1.92 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.381 0.61 . . . . 0.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.6 p -59.01 -20.76 56.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.01 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.6 m -90.21 -21.43 22.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.366 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.75 141.24 57.13 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.354 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -79.0 131.09 36.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 0.0 111.62 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.434 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.6 m-85 -104.06 173.06 6.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.169 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -152.73 146.52 25.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 111.541 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tptt 65.95 -103.54 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.799 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.95 -12.29 33.81 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 124.6 31.15 0.91 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.006 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -85.75 168.05 14.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.179 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.91 115.76 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.469 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.3 tt -110.1 -26.02 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.164 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.99 -133.64 11.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.572 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -176.34 93.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.869 0.366 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.07 22.06 1.76 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.585 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.3 mt -147.09 144.04 28.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.716 0.293 . . . . 0.0 110.952 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.8 p -102.8 159.01 15.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.867 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.63 -48.03 82.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -110.65 155.43 22.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.02 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -57.21 129.44 41.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -109.23 -172.68 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.985 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 m -94.34 -41.33 9.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -78.58 108.52 12.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.644 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.86 140.97 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.509 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 28.3 t80 -131.03 108.01 9.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.632 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -101.75 136.71 41.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -138.78 122.98 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.76 -68.94 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.466 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 87' ' ' ILE . 11.0 t0 -164.94 35.05 0.06 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.447 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -137.83 111.67 8.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.793 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -77.91 120.11 22.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.785 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.402 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 10.4 mt -109.86 164.86 12.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -133.27 165.05 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.131 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.23 169.95 21.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.057 0.456 . . . . 0.0 111.815 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -106.44 -7.42 17.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.876 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 76.6 m -152.74 159.94 43.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.331 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' A' ' 162' ' ' VAL . . . -51.5 -25.37 6.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.527 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 tt -87.86 -50.27 6.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.12 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -43.25 -22.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.474 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -59.0 -32.38 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.475 ' CD2' ' CZ ' ' A' ' 85' ' ' PHE . 2.2 tp 178.65 149.19 0.22 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 111.218 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.417 HG21 ' CE2' ' A' ' 103' ' ' PHE . 5.1 mt -128.45 128.42 68.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.701 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 102' ' ' ILE . 13.1 m-85 66.84 66.91 0.66 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.864 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.455 ' O ' HG12 ' A' ' 107' ' ' ILE . 24.2 Cg_exo -63.65 -20.92 69.98 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.842 2.361 . . . . 0.0 112.404 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.75 -23.67 59.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.916 0.388 . . . . 0.0 111.278 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.7 mt -78.6 -29.75 46.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.24 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 104' ' ' PRO . 3.7 mm -53.17 -61.08 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.006 0.908 . . . . 0.0 111.051 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.89 18.61 26.77 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.294 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.37 -179.95 7.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.714 0.292 . . . . 0.0 110.597 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.54 149.0 26.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.509 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.09 110.34 7.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -79.56 119.08 22.03 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.849 0.833 . . . . 0.0 111.223 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.437 HG23 ' CE1' ' A' ' 85' ' ' PHE . 12.2 t -110.49 131.53 61.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.983 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 m -122.61 137.33 54.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.246 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.404 ' CB ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -140.94 172.77 12.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.062 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -131.84 130.83 42.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.829 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 29.5 m -56.02 123.84 15.72 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.029 0.443 . . . . 0.0 111.979 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.39 -6.95 33.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.788 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.449 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -119.47 -50.6 2.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.696 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.16 -13.75 37.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.996 -179.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 64.23 10.34 40.81 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.746 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.492 ' H ' HG22 ' A' ' 120' ' ' THR . . . -71.2 168.99 16.78 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.808 0.337 . . . . 0.0 110.647 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -93.69 108.71 0.17 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.073 2.515 . . . . 0.0 111.629 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.404 HG22 ' CB ' ' A' ' 115' ' ' SER . 34.3 m -106.53 146.84 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.341 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.2 p -151.66 142.8 23.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.375 0.607 . . . . 0.0 110.771 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -134.43 151.74 51.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.484 178.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 30.2 m -107.62 113.59 26.99 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.434 HG12 ' CE1' ' A' ' 193' ' ' PHE . 36.2 t -96.51 111.69 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.968 0.413 . . . . 0.0 111.489 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -105.76 169.8 6.58 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.15 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.58 -14.52 44.33 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.456 2.104 . . . . 0.0 112.982 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 p -118.19 -27.01 6.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.52 -163.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.112 0.482 . . . . 0.0 109.999 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.592 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -95.3 162.29 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.717 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -151.41 19.98 0.74 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.04 86.14 0.08 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.791 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.15 122.74 53.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.707 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -146.12 119.3 5.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.98 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.71 162.3 92.97 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 123.435 -1.485 . . . . 0.0 112.274 0.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.82 78.24 1.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.151 0.5 . . . . 0.0 110.737 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 147.4 15.91 0.13 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.576 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.451 ' HG3' HG12 ' A' ' 189' ' ' VAL . 10.2 ptp -62.51 160.82 12.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.079 0.439 . . . . 0.0 111.534 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.401 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -130.65 152.06 50.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.942 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.462 ' CG2' ' CE2' ' A' ' 164' ' ' PHE . 2.5 t -117.44 154.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.443 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 55.6 p -121.16 146.8 46.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.842 0.353 . . . . 0.0 110.921 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 4.0 pp -113.47 158.4 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.993 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.1 p -125.18 112.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.416 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . 1.8 mt -77.01 -61.96 0.64 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.246 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 47.4 Cg_endo -69.98 -50.47 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.475 2.117 . . . . 0.0 112.479 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 62.94 145.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.866 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -109.05 -21.5 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.73 31.68 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.093 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -118.62 98.14 6.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.045 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -99.41 35.5 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.5 m -118.67 -44.37 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 9.6 ttt180 -173.08 -68.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.979 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -154.79 -45.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.992 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 m 61.8 158.64 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.963 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -170.18 79.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.873 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 8.9 m -56.59 -26.91 56.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.6 t 76.43 0.09 3.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.585 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.406 ' HB2' ' CG1' ' A' ' 143' ' ' VAL . 8.3 p80 178.04 84.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.549 0.214 . . . . 0.0 110.732 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.571 ' HA ' ' HB1' ' A' ' 97' ' ' ALA . 7.2 p -101.27 -44.89 11.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -107.19 148.5 28.8 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.65 0.738 . . . . 0.0 109.979 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.462 ' CE2' ' CG2' ' A' ' 143' ' ' VAL . 40.4 m-85 -109.9 150.67 28.11 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.238 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 49.7 m-85 -131.83 136.09 47.21 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.557 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -39.75 -28.32 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.243 -0.889 . . . . 0.0 113.141 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 11.4 p -170.59 176.45 4.31 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.655 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.61 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 79.6 t -69.4 -34.27 4.61 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.369 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.88 -37.55 3.62 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.763 2.309 . . . . 0.0 110.313 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.569 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -77.21 -39.78 47.42 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.471 178.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 167' ' ' SER . . . -61.37 -44.56 96.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 177.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.606 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 95.6 mt-10 -79.07 -27.95 43.08 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.099 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.3 t70 -69.92 -56.03 8.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.466 0.651 . . . . 0.0 109.395 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.449 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 35.6 t-105 -64.87 -27.88 69.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.817 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.606 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -66.54 -38.51 87.3 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.218 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -44.32 63.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.302 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -94.95 22.47 6.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.031 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.33 30.57 0.68 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.69 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -108.6 -176.09 2.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 59.32 25.67 60.65 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.492 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 36.7 mt -96.57 44.18 1.07 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 110.827 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 63.07 30.87 16.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 110.724 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 143.05 -127.38 3.1 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.378 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.5 tt 62.87 123.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -143.24 150.32 39.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.452 HG21 ' CB ' ' A' ' 171' ' ' ALA . 11.7 mm -99.66 160.82 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.938 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -165.61 162.9 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.474 0.654 . . . . 0.0 112.197 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.9 OUTLIER -89.16 130.26 35.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.905 178.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.451 HG12 ' HG3' ' A' ' 141' ' ' MET . 1.2 m -46.49 -20.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 2.1 m-70 -72.65 -43.36 63.29 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.761 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -21.02 36.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.347 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.75 -25.21 58.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.434 ' CE1' HG12 ' A' ' 128' ' ' VAL . 9.7 t80 -81.42 -24.86 36.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.703 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.66 -29.98 34.02 Favored Glycine 0 CA--C 1.509 -0.3 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.8 mt -81.59 -27.85 34.06 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.01 -26.52 37.01 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -81.99 -22.02 36.8 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.517 -0.342 . . . . 0.0 111.026 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -74.11 -24.37 59.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -54.06 -39.53 66.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.107 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.17 -24.95 37.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -54.93 -42.91 72.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.039 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -80.01 -30.83 39.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.98 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 7.0 tp -78.29 -19.99 52.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.278 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.05 -52.01 7.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.818 0.342 . . . . 0.0 110.92 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -74.16 -177.03 2.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.4 t -71.07 160.7 32.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -110.57 -177.05 3.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.1 158.5 11.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.5 m -105.73 105.38 15.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.44 -81.18 0.23 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.438 HG21 ' N ' ' A' ' 212' ' ' PRO . 1.1 m -59.98 -62.75 5.27 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.98 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.438 ' N ' HG21 ' A' ' 211' ' ' THR . 19.5 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.425 2.084 . . . . 0.0 112.307 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.843 0.354 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -112.28 -43.09 3.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mt -109.95 -31.43 7.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.12 167.79 27.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.41 ' CG1' ' CD2' ' A' ' 28' ' ' LEU . 9.7 p -108.71 99.71 35.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.932 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.15 -20.0 22.69 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.693 2.262 . . . . 0.0 112.851 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.8 mp -52.01 -57.4 9.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.747 0.308 . . . . 0.0 111.227 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.41 ' CD2' ' CG1' ' A' ' 25' ' ' VAL . 3.9 pp -66.42 -26.98 67.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.138 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 41.2 mtp85 -68.84 -53.32 22.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.846 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -72.86 -30.32 63.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.318 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 tp -72.57 -43.16 63.79 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.837 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.11 -26.74 17.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.074 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -66.62 -20.62 66.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.188 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.91 47.41 89.07 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.136 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -133.07 148.58 69.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.622 0.249 . . . . 0.0 110.814 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.01 105.46 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.556 2.171 . . . . 0.0 112.31 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.1 p -107.23 110.0 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.36 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 94.1 p -86.83 -179.54 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.744 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.4 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -71.96 -36.36 69.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.246 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -27.39 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 0.0 110.117 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -85.33 -41.61 15.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.8 tp -63.53 -36.51 84.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 176.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 39' ' ' ARG . . . -73.21 -42.6 62.46 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.463 177.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.26 -31.09 73.98 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.617 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.0 mt -78.78 -44.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-O 120.998 0.428 . . . . 0.0 110.518 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.4 mp -76.72 -9.75 58.89 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.412 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 59.36 22.24 10.62 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.418 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 7.8 m0 -104.99 144.75 29.37 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.337 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.7 138.23 80.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.455 2.103 . . . . 0.0 112.012 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.95 -18.94 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.7 -32.03 46.77 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.106 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' HG2' ' CE3' ' A' ' 48' ' ' TRP . 0.3 OUTLIER -67.21 -40.53 86.44 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.26 -48.23 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.667 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.64 -52.74 58.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.516 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.64 -45.73 73.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.1 t -68.83 -29.3 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.728 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -72.17 -38.52 69.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.95 -45.16 87.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -64.5 -17.18 63.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.36 67.59 0.7 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.748 0.785 . . . . 0.0 110.847 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 p -72.41 -8.64 56.09 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.335 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.0 m -114.51 40.81 2.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.179 0.514 . . . . 0.0 110.781 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.66 141.4 33.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.164 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.456 ' CG ' ' CZ ' ' A' ' 74' ' ' TYR . 1.9 mm-40 -78.77 126.74 31.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.033 0.444 . . . . 0.0 111.16 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.405 ' CD1' ' O ' ' A' ' 69' ' ' GLY . 43.9 m-85 -115.16 165.6 12.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.349 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -154.22 144.3 21.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 111.286 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 tptt 66.42 -103.2 0.08 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.733 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -91.55 -13.47 32.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.751 0.31 . . . . 0.0 111.818 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 124.36 30.65 0.98 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.134 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -86.55 168.79 13.36 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.8 121.53 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.413 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -29.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.005 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.76 171.64 18.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.64 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.456 ' CZ ' ' CG ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -151.65 -174.02 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 110.802 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.79 -48.28 3.26 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.575 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -57.6 174.26 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.682 0.277 . . . . 0.0 110.953 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 15.8 p -113.39 159.55 19.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.709 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.31 48.99 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.622 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 43.47 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.985 0.421 . . . . 0.0 112.067 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -156.99 -88.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.475 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -38.63 157.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.958 0.408 . . . . 0.0 111.996 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.0 t -75.07 -10.64 59.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.89 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 97' ' ' ALA . 23.2 m-85 -70.87 101.2 2.09 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.404 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 9.2 t -110.23 143.61 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.398 . . . . 0.0 111.186 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.495 ' CZ ' ' HB2' ' A' ' 111' ' ' ALA . 32.5 t80 -134.33 109.25 8.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.352 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.84 125.22 39.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.995 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.477 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -136.31 122.99 31.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.87 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.5 -76.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.063 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.9 p-10 -159.15 36.7 0.21 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.461 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -140.94 115.66 9.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.636 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -77.76 85.89 4.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.86 0.362 . . . . 0.0 110.989 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 51.5 mt -71.97 165.0 25.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.84 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -138.45 165.15 27.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.312 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.405 ' HB2' ' HA ' ' A' ' 100' ' ' THR . . . -144.14 162.04 37.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.866 0.365 . . . . 0.0 111.861 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -85.31 -27.43 25.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.402 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -129.89 159.04 37.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.754 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.488 ' CB ' ' CE1' ' A' ' 164' ' ' PHE . . . -61.98 -11.87 15.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.0 mt -103.64 -20.76 13.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -82.5 -3.6 56.13 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.433 ' O ' ' CD2' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -60.54 -39.1 86.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 0.0 110.341 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.445 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -98.33 173.77 6.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -154.92 -45.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.133 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -163.06 79.12 1.72 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.016 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.449 ' O ' HG21 ' A' ' 107' ' ' ILE . 59.3 Cg_endo -71.92 -32.84 10.71 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.591 2.194 . . . . 0.0 112.294 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.15 -23.78 43.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.263 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.89 -40.08 17.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.38 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.449 HG21 ' O ' ' A' ' 104' ' ' PRO . 1.1 tp -57.94 -45.34 87.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.263 0.554 . . . . 0.0 111.372 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.19 24.26 15.09 Favored Glycine 0 C--N 1.319 -0.385 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.484 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -151.42 173.62 14.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.065 0.459 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -83.84 157.18 22.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.971 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.495 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.07 110.06 7.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.2 mtt-85 -80.91 119.03 22.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.732 0.777 . . . . 0.0 111.178 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.431 HG22 ' CD1' ' A' ' 85' ' ' PHE . 13.4 t -108.27 129.54 62.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.847 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.404 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 1.5 p -124.49 137.62 54.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.318 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.403 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.1 172.96 11.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.986 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 121' ' ' GLY . 0.8 OUTLIER -130.13 130.94 45.42 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 21.1 m -57.76 123.06 14.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.873 0.368 . . . . 0.0 111.927 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.78 -8.28 34.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.783 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.474 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -122.43 -50.54 1.99 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.507 HG21 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -77.9 -21.15 51.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 111.198 -178.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.401 ' O ' ' CE1' ' A' ' 116' ' ' HIS . . . 63.31 33.28 86.83 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.01 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.507 ' CB ' HG21 ' A' ' 120' ' ' THR . . . -102.93 169.69 7.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.432 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.413 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 58.6 Cg_endo -93.86 107.49 0.16 Allowed 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.922 2.415 . . . . 0.0 111.681 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.403 ' CG2' ' CB ' ' A' ' 115' ' ' SER . 33.8 m -102.54 146.26 10.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.235 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.0 p -151.87 141.49 21.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.457 0.646 . . . . 0.0 111.196 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -134.18 153.14 52.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.001 178.48 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 23.6 m -110.05 114.95 28.89 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 47.8 t -96.2 111.52 26.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.999 0.428 . . . . 0.0 110.869 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -108.29 176.51 1.57 Allowed Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.461 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 129' ' ' SER . 13.3 Cg_exo -70.33 -12.69 32.25 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.727 2.285 . . . . 0.0 113.112 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 0.8 OUTLIER -121.91 -27.91 4.54 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.076 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 131' ' ' SER . 13.4 pt-20 179.63 -161.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.13 0.49 . . . . 0.0 110.374 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -91.38 156.39 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.758 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -146.31 17.16 1.35 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.99 85.04 0.07 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.882 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.1 t -98.88 123.16 51.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.834 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.17 117.09 4.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.018 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.12 161.85 93.56 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.423 -1.491 . . . . 0.0 112.087 -0.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.01 78.0 1.69 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.117 0.484 . . . . 0.0 110.674 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.86 18.76 0.18 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.388 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.453 ' HG3' ' CG1' ' A' ' 189' ' ' VAL . 6.7 ptm -64.38 161.45 16.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.969 0.385 . . . . 0.0 111.2 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -125.55 152.36 45.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.07 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' A' ' 164' ' ' PHE . 61.2 t -114.09 148.9 16.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.424 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 50.3 m -120.19 140.87 50.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.769 0.319 . . . . 0.0 110.372 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.4 ' CD1' ' CD1' ' A' ' 147' ' ' LEU . 2.0 pt? -144.01 176.11 9.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.071 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.44 93.79 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.967 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.408 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . 0.9 OUTLIER -72.11 -60.86 2.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.911 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 74.4 Cg_endo -75.16 148.56 34.86 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.608 2.205 . . . . 0.0 112.367 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -152.96 121.06 6.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.96 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -112.92 -23.35 10.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.166 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.68 106.17 5.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.021 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -178.35 -36.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.349 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -56.05 100.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.176 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 35.0 m -156.39 -44.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.003 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.2 tpt85 -144.32 -47.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.682 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -124.64 -62.66 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.715 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 p 56.9 33.31 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.178 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -176.53 37.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.977 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.5 p -63.72 -46.15 86.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.812 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -176.29 -88.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.029 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 32.0 m80 60.52 17.52 7.42 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.444 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 26.0 t -113.21 121.84 66.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.882 0.372 . . . . 0.0 111.235 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 163' ' ' HIS . 3.2 m-70 -128.14 169.25 14.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.314 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.488 ' CE1' ' CB ' ' A' ' 97' ' ' ALA . 10.5 m-30 -110.73 152.95 25.97 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.812 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.469 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 27.1 m-85 -132.54 138.13 47.38 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.582 0.706 . . . . 0.0 110.238 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -42.66 -28.84 0.26 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.141 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.505 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 71.4 m -166.96 174.7 8.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.121 0.486 . . . . 0.0 111.685 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.601 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.4 t -69.53 -33.84 4.15 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.199 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.4 Cg_exo -73.33 -37.92 2.97 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.81 2.34 . . . . 0.0 110.361 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.545 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.6 -39.63 51.93 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.53 177.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -62.06 -45.63 92.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.598 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.2 mt-10 -78.9 -27.68 43.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.34 178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.688 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.5 t70 -71.11 -56.0 7.04 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.301 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.474 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 36.0 t-105 -64.45 -28.91 69.99 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.675 178.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.598 ' HB3' ' HA ' ' A' ' 172' ' ' GLU . . . -64.02 -39.76 94.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.145 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -43.88 63.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.372 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.75 21.92 7.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.177 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.79 23.89 5.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.881 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -81.9 -176.13 5.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.716 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.94 -32.67 6.38 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.363 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.2 mt -71.74 61.66 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.902 0.382 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.4 16.73 6.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.456 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 113.07 -63.29 0.29 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.962 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 8.1 tt 65.27 151.62 0.05 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.584 0.192 . . . . 0.0 110.513 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -144.98 150.13 36.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.153 0.502 . . . . 0.0 111.815 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.485 HG23 ' CB ' ' A' ' 171' ' ' ALA . 12.0 mm -103.95 162.04 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.506 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -157.35 162.31 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.578 0.704 . . . . 0.0 112.313 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -94.97 133.34 38.83 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.375 178.079 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.453 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 2.8 m -47.35 -18.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.879 0.371 . . . . 0.0 110.817 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 11.6 m170 -73.67 -44.87 55.54 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.18 0.514 . . . . 0.0 109.69 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.41 -20.91 36.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.478 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.51 -24.79 62.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.97 -24.73 37.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.74 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.71 -31.28 30.19 Favored Glycine 0 CA--C 1.509 -0.338 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.3 mp -80.8 -28.42 36.3 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.92 -24.31 45.67 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.614 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -82.13 -22.01 36.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.805 0.336 . . . . 0.0 111.092 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.21 -23.15 43.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.186 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -54.24 -38.72 66.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 111.105 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.73 -54.73 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -57.87 -31.28 66.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.996 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -76.09 -31.48 58.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.27 -48.5 81.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.4 mt -60.77 -37.44 81.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.948 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -74.55 169.36 17.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.0 t -155.16 35.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 6.5 mtm -131.64 103.4 6.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.7 -46.83 51.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.27 137.37 48.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -170.61 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.431 HG23 ' N ' ' A' ' 212' ' ' PRO . 1.1 m -176.37 -62.95 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.008 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.431 ' N ' HG23 ' A' ' 211' ' ' THR . 19.4 Cg_endo . . . . . 0 C--O 1.249 1.06 0 C-N-CA 122.372 2.048 . . . . 0.0 112.342 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.82 0.343 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.6 t0 60.42 104.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.864 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 60.9 112.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tp -166.45 82.89 0.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 m -59.81 148.85 74.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.062 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.57 -37.28 5.61 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.551 2.168 . . . . 0.0 112.317 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.73 -57.14 11.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -60.23 -26.82 66.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.427 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -53.42 23.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.027 0.441 . . . . 0.0 110.274 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.37 -30.1 57.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.419 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.418 ' HB3' ' HA ' ' A' ' 28' ' ' LEU . 49.1 tp -70.36 -49.94 44.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.71 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.48 -25.31 15.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.997 0.427 . . . . 0.0 111.133 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -22.39 64.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.137 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.21 48.14 77.83 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.297 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -133.18 155.11 81.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.659 0.266 . . . . 0.0 110.854 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.9 108.99 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.518 2.145 . . . . 0.0 111.973 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 p -113.58 109.84 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 120.954 0.407 . . . . 0.0 111.394 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 p -87.62 -169.79 2.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.8 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 43' ' ' ALA . 15.8 ttm180 -78.07 -36.84 47.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.406 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -26.96 68.04 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.363 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.487 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -85.56 -42.15 14.65 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.413 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.29 -36.29 83.17 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -73.83 -42.7 60.49 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.494 177.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.81 -30.84 74.75 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.612 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.487 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.0 mt -79.14 -42.48 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 120.949 0.404 . . . . 0.0 110.468 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.94 -7.43 58.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.505 178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 55.37 23.5 5.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.422 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -98.89 153.12 37.98 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.272 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.02 137.1 36.75 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.592 2.195 . . . . 0.0 111.923 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.91 -22.18 0.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -78.57 -35.47 45.86 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.876 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.2 mmt-85 -66.84 -40.84 88.08 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.11 -48.2 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.544 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.15 -53.47 50.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.383 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.7 -49.82 75.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.898 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.7 t -63.57 -30.66 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.642 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 tp -62.16 -32.13 72.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.675 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -57.82 -22.26 46.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.948 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -95.93 -18.3 20.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.149 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.95 32.57 3.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.448 0.642 . . . . 0.0 110.85 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.9 p -67.48 -27.99 67.47 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.956 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.4 t -75.93 -25.56 56.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.254 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.56 141.4 43.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.073 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -78.43 126.87 31.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -102.49 173.08 6.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.583 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.17 -172.77 2.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.564 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.25 -36.99 85.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.516 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -88.46 10.8 18.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.739 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.76 13.11 82.78 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.262 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -89.03 161.77 16.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.233 0.517 . . . . 0.0 109.827 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.76 124.83 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.401 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 tt -92.73 -21.12 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.204 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.14 116.07 0.56 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.602 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.413 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 44.9 p90 -60.31 111.87 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 0.0 110.889 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.29 -66.16 0.17 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.31 141.43 58.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.356 . . . . 0.0 110.857 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.5 p -123.57 159.55 28.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.39 -25.02 0.58 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.664 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.421 ' HD2' ' CD1' ' A' ' 93' ' ' TYR . 18.9 mtm180 79.9 92.03 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.889 0.376 . . . . 0.0 110.922 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.87 25.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.021 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 p -122.24 -138.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.959 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 p -129.65 -31.12 2.02 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.588 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 96' ' ' CYS . 12.4 m-85 -72.1 104.19 3.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.534 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.54 141.09 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.347 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.49 ' CE2' ' HB2' ' A' ' 111' ' ' ALA . 20.4 t80 -133.78 107.44 7.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.145 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -102.33 134.67 45.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.446 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.465 ' CG2' ' CE1' ' A' ' 85' ' ' PHE . 2.6 pt -140.06 123.91 18.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.724 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 t0 63.32 -66.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.43 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 87' ' ' ILE . 16.0 m-20 -168.0 35.28 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.499 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -135.61 113.23 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.895 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -80.21 86.17 5.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.083 0.468 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.404 ' CB ' ' O ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -73.65 164.63 26.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.114 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.421 ' CD1' ' HD2' ' A' ' 79' ' ' ARG . 7.9 m-85 -135.49 165.2 26.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.228 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -153.37 173.44 15.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.073 0.463 . . . . 0.0 111.946 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.411 ' O ' ' CE2' ' A' ' 83' ' ' TYR . 12.0 m0 -97.02 -17.58 19.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.008 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.43 ' HA ' ' CE2' ' A' ' 83' ' ' TYR . 1.2 m -153.96 165.91 34.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.155 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.438 ' CB ' ' CE1' ' A' ' 164' ' ' PHE . . . -52.46 -22.8 5.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.666 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.2 mt -85.22 -51.67 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.593 0.235 . . . . 0.0 111.292 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.4 -27.4 4.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.704 0.287 . . . . 0.0 111.542 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.42 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -60.48 -29.81 69.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.454 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.445 ' HB3' ' CE2' ' A' ' 85' ' ' PHE . 1.8 pt? -154.65 126.3 7.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.471 HG22 HD11 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -96.22 -36.68 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 106' ' ' LEU . 1.6 m-85 -124.76 78.0 64.61 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.724 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.45 ' O ' ' CG2' ' A' ' 107' ' ' ILE . 36.1 Cg_exo -61.2 -51.42 4.5 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.631 2.221 . . . . 0.0 112.327 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.85 -23.41 41.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.567 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -90.35 -15.84 30.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.45 ' CG2' ' O ' ' A' ' 104' ' ' PRO . 2.9 tp -47.84 -53.31 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 111.993 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.3 0.73 50.7 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.966 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.95 177.88 10.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 110.399 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.35 143.94 44.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.49 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . . . -137.18 109.88 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -81.33 120.05 24.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.75 0.786 . . . . 0.0 111.467 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.17 130.9 65.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.827 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.4 m -126.02 137.97 53.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.326 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.43 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 0.6 OUTLIER -141.34 172.91 12.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.075 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -133.97 135.67 43.64 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.2 t -64.59 131.97 48.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.29 -3.4 23.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.936 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.442 ' HB3' ' CG ' ' A' ' 174' ' ' TRP . . . -121.91 -50.5 2.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.87 0.367 . . . . 0.0 111.543 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.5 HG23 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -90.32 -23.62 21.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.457 -179.346 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.56 6.18 75.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.251 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.5 ' CB ' HG23 ' A' ' 120' ' ' THR . . . -60.03 155.55 43.2 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-O 120.604 0.24 . . . . 0.0 110.457 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -87.97 104.27 0.51 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.719 2.279 . . . . 0.0 111.383 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.43 ' CG2' ' CB ' ' A' ' 115' ' ' SER . 33.9 m -98.1 145.14 10.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.1 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.3 p -155.59 142.69 19.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.581 0.705 . . . . 0.0 111.26 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.5 OUTLIER -135.16 153.32 52.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.685 178.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.608 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 32.2 m -108.26 113.84 27.25 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 111' ' ' ALA . 41.1 t -95.9 111.51 26.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.026 0.441 . . . . 0.0 111.696 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.401 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.8 OUTLIER -105.86 169.01 7.45 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.744 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 33.3 Cg_endo -65.42 -18.82 60.87 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.14 1.893 . . . . 0.0 112.844 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 70.8 m -112.59 -28.2 7.92 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 179.54 -163.3 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.237 0.541 . . . . 0.0 110.139 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -95.2 158.66 2.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.753 178.605 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -147.23 19.33 1.22 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.23 86.19 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.632 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.3 t -105.03 117.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.024 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.44 117.38 4.77 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.087 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 141' ' ' MET . 16.7 Cg_exo -67.57 145.91 75.38 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.73 -1.363 . . . . 0.0 112.443 0.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.35 -33.19 52.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.867 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -101.43 30.14 11.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.245 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.56 ' HG3' HG13 ' A' ' 189' ' ' VAL . 5.4 ptp -65.22 157.22 29.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 0.0 111.889 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -130.8 152.44 50.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.318 -178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.448 HG21 ' CZ ' ' A' ' 164' ' ' PHE . 11.4 t -113.41 153.08 15.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.776 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.413 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 4.4 m -121.7 143.04 49.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.741 0.305 . . . . 0.0 110.608 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.4 ' CD1' ' CG2' ' A' ' 187' ' ' VAL . 5.3 mp -145.3 176.08 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.109 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.4 t -125.35 132.49 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.837 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.412 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . 2.5 mp -78.28 -61.66 0.55 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.932 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 78.1 Cg_endo -77.04 -168.07 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.595 2.197 . . . . 0.0 112.416 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -174.6 114.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.935 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.52 -21.25 10.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.286 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -128.82 79.44 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.363 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -179.02 59.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.998 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -177.25 -40.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.97 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 28.6 m -61.6 -45.23 99.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.156 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 75.6 mtm-85 -135.64 31.06 3.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.949 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 60.46 44.71 11.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.0 m -70.42 138.44 51.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -177.76 62.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -57.73 -41.2 81.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.721 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 161' ' ' HIS . 0.8 OUTLIER -177.95 -87.4 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.743 179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 160' ' ' CYS . 9.6 m170 75.93 -47.83 0.58 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.9 t -95.09 103.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.908 0.385 . . . . 0.0 111.52 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.411 ' CD2' ' OH ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -126.03 169.31 12.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.738 0.78 . . . . 0.0 109.765 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 143' ' ' VAL . 2.0 m-85 -113.0 152.35 29.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.912 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.472 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 60.6 m-85 -131.44 136.83 48.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.766 0.793 . . . . 0.0 110.578 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -47.88 -25.17 1.22 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.797 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.544 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 44.7 m -164.73 167.62 18.79 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.643 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.62 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.3 t -68.12 -34.45 6.08 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.896 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.3 Cg_exo -72.45 -37.03 4.6 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.768 2.312 . . . . 0.0 110.103 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.557 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.19 -40.57 52.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.52 -46.15 91.21 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.683 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 1.7 mm-40 -78.97 -27.22 43.48 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.331 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.709 ' N ' ' O ' ' A' ' 169' ' ' PRO . 26.5 t70 -70.06 -55.76 8.66 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.192 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.442 ' CG ' ' HB3' ' A' ' 119' ' ' ALA . 51.4 t-105 -65.99 -28.29 68.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.723 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.683 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -64.24 -39.45 93.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.13 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.0 t -53.71 -42.25 67.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.428 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 18.46 9.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.382 0.61 . . . . 0.0 111.38 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.438 ' CD2' ' CD1' ' A' ' 174' ' ' TRP . 0.1 OUTLIER -120.31 24.15 10.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.727 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -93.38 -176.71 4.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.768 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.52 -32.22 6.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.355 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.5 mt -63.56 -174.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.323 . . . . 0.0 110.723 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.36 -27.14 67.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.849 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 170.09 159.94 17.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.497 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.9 tt -179.03 137.68 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.757 0.313 . . . . 0.0 110.751 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.55 150.17 40.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.11 0.481 . . . . 0.0 111.369 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.476 HG22 ' HB2' ' A' ' 171' ' ' ALA . 15.5 mm -101.56 161.31 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.747 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.401 ' N ' HG21 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -159.89 159.79 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.277 0.56 . . . . 0.0 112.15 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 190' ' ' HIS . 42.2 p -89.83 128.59 36.19 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.669 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.56 HG13 ' HG3' ' A' ' 141' ' ' MET . 2.4 m -47.72 -19.15 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.993 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.407 ' N ' ' C ' ' A' ' 188' ' ' SER . 59.5 t-80 -72.82 -42.03 64.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.155 0.502 . . . . 0.0 109.821 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -82.16 -26.18 33.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.177 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.22 -24.91 66.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.927 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.421 ' CE2' HG12 ' A' ' 128' ' ' VAL . 1.3 t80 -81.34 -25.58 36.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.68 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.04 -31.76 27.96 Favored Glycine 0 CA--C 1.509 -0.3 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.1 tp -80.83 -28.55 36.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -82.84 -24.77 52.04 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.2 -22.28 36.04 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.969 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -77.74 -22.77 49.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.255 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.13 -39.5 60.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.868 0.366 . . . . 0.0 111.092 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -81.09 -44.34 18.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -35.16 71.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.072 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -30.28 68.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.61 -46.77 89.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -65.59 -52.09 54.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 59.09 31.51 21.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 7.2 t -100.72 116.51 32.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -157.09 36.35 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.947 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.4 m -160.35 174.05 14.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.0 p -161.48 -68.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.962 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -70.96 -177.83 1.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.417 HG22 ' N ' ' A' ' 212' ' ' PRO . 0.9 OUTLIER 178.8 -55.11 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.417 ' N ' HG22 ' A' ' 211' ' ' THR . 78.0 Cg_exo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.43 2.087 . . . . 0.0 112.447 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.891 0.377 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -168.44 157.36 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 mt -95.13 125.79 40.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.799 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tt -85.0 -56.7 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 m -158.82 80.68 2.8 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.155 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.02 -24.55 19.83 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.593 2.195 . . . . 0.0 112.407 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.93 -57.23 12.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.328 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.49 -27.36 62.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.251 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -64.42 -53.28 50.85 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.138 0.494 . . . . 0.0 109.824 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -70.91 -25.01 62.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.409 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.6 -40.27 84.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.947 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.23 -25.2 13.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.573 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -70.36 -20.19 62.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.173 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.13 47.69 86.18 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.354 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -133.21 158.3 76.09 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.725 0.297 . . . . 0.0 110.74 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.7 91.63 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.566 2.177 . . . . 0.0 112.262 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.96 114.92 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.353 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.4 p -77.44 -179.62 5.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.847 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -78.2 -32.55 50.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.631 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -68.34 -30.77 69.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.681 0.277 . . . . 0.0 110.642 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.31 -38.51 20.32 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.31 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.785 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.3 tp -63.16 -41.71 99.29 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' CB ' HG21 ' A' ' 53' ' ' VAL . . . -69.74 -42.96 73.26 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.774 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 40' ' ' THR . . . -67.47 -25.84 73.71 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.254 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.1 mt -76.54 -40.18 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.245 -0.478 . . . . 0.0 110.457 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.785 ' HG ' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -80.22 -6.5 57.93 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.568 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 62.95 30.15 16.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -116.99 149.64 44.52 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.624 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.16 143.72 99.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.626 2.218 . . . . 0.0 112.006 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.418 ' HA ' HG22 ' A' ' 53' ' ' VAL . . . -54.48 -16.45 2.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.95 -31.58 45.11 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.586 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.5 mtp180 -70.18 -40.0 74.92 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.427 HG21 ' CB ' ' A' ' 43' ' ' ALA . 1.8 t -65.63 -46.36 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.36 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.38 -51.7 57.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.112 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.72 -43.24 80.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.7 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.7 t -70.59 -32.45 49.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.577 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 15.9 mt -61.39 -32.52 72.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.499 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -57.63 -24.35 56.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.701 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -96.18 -14.43 22.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.11 32.86 3.73 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.466 0.65 . . . . 0.0 110.598 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.0 p -66.89 -14.39 62.7 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.233 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 t -86.78 -23.9 25.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 111.346 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.81 141.23 39.48 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.047 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.99 126.79 31.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.038 0.447 . . . . 0.0 111.474 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -100.64 168.81 9.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.267 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -153.87 143.61 21.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.549 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.7 tttp 66.9 -102.64 0.07 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.824 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.32 -13.04 28.64 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.74 31.86 0.79 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.051 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.67 169.03 11.65 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.0 mp -79.8 114.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.27 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -103.28 -27.46 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.112 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.401 ' N ' HG22 ' A' ' 72' ' ' ILE . . . 90.17 162.32 38.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.516 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.404 ' O ' ' CG ' ' A' ' 74' ' ' TYR . 11.9 t80 -111.23 31.44 6.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.808 0.337 . . . . 0.0 110.909 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.11 -62.44 1.43 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.556 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -78.73 147.94 33.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.3 p -107.66 159.05 16.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.35 -30.8 60.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -102.8 147.57 26.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -64.52 122.27 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.9 p -106.91 -174.72 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.2 p -92.65 -37.29 12.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -87.24 113.97 23.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.08 142.73 20.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.466 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 59.8 t80 -124.72 105.19 9.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.346 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -98.62 126.23 44.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.323 . . . . 0.0 111.42 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 89' ' ' ASP . 6.9 pt -118.76 177.89 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.396 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 87' ' ' ILE . 8.6 t0 -14.52 -53.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 87' ' ' ILE . 21.7 p30 -165.74 35.48 0.05 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.033 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 12.1 mmt180 -142.03 113.07 7.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.72 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.64 119.39 21.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.791 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.3 164.88 12.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.268 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -133.95 165.14 25.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.099 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 99' ' ' ASP . . . -153.45 171.39 18.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.115 0.483 . . . . 0.0 111.855 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -94.37 -20.27 19.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.007 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 2.3 m -157.51 179.81 8.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.668 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -56.52 -21.89 29.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tp -89.18 -51.92 5.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.401 ' CB ' ' HB2' ' A' ' 94' ' ' ALA . 4.8 m-20 -46.95 -26.54 1.03 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.36 -36.26 77.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.666 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.449 ' CD1' ' CE2' ' A' ' 85' ' ' PHE . 3.3 tp -176.78 152.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 102' ' ' ILE . 15.5 pt -122.82 -39.24 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.519 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.451 ' CZ ' ' ND2' ' A' ' 200' ' ' ASN . 9.2 m-85 -119.7 81.7 25.56 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.168 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.414 ' O ' HG12 ' A' ' 107' ' ' ILE . 7.3 Cg_exo -72.58 -29.0 13.69 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.797 2.331 . . . . 0.0 112.215 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.09 -23.76 59.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.249 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.74 -29.91 45.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.906 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.414 HG12 ' O ' ' A' ' 104' ' ' PRO . 3.9 mm -54.16 -60.55 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.082 0.944 . . . . 0.0 110.988 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.29 25.21 Favored Glycine 0 C--N 1.316 -0.545 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.301 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.16 -177.27 5.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.357 . . . . 0.0 110.462 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.09 148.5 27.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.466 ' CB ' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.24 110.01 7.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -80.8 121.05 25.46 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.714 0.768 . . . . 0.0 110.86 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.5 t -113.8 131.78 64.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.934 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.6 p -119.42 138.25 53.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.712 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.67 172.8 12.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.42 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.15 131.32 36.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.54 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 21.3 m -57.41 124.45 18.98 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.918 0.389 . . . . 0.0 111.902 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.12 -9.49 46.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.628 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.469 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -121.67 -51.2 2.05 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.499 HG21 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -76.24 -20.83 57.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.917 0.389 . . . . 0.0 110.767 -179.024 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.3 33.69 85.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.108 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.499 ' CB ' HG21 ' A' ' 120' ' ' THR . . . -100.91 168.01 9.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.437 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -93.89 110.27 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 123.024 2.483 . . . . 0.0 111.313 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.3 m -109.51 148.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.492 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 86.0 p -147.62 142.43 26.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.509 0.671 . . . . 0.0 110.567 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.615 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -135.19 152.13 51.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.743 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 42.8 m -111.25 112.31 24.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 32.6 t -96.93 114.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.008 0.432 . . . . 0.0 112.137 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.413 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -105.72 170.19 6.15 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.702 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.9 Cg_endo -66.64 -19.51 53.9 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.158 1.905 . . . . 0.0 113.001 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 6.9 t -108.87 -27.41 9.73 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 131' ' ' SER . 14.9 pt-20 178.05 -162.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.64 162.84 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.472 178.248 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -150.09 21.28 0.87 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.434 0.635 . . . . 0.0 112.326 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.95 87.4 0.09 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.44 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 t -104.1 119.88 53.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.156 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.18 122.9 5.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.796 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.24 159.63 97.03 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.382 -1.507 . . . . 0.0 112.322 0.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.92 79.37 0.64 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.134 0.492 . . . . 0.0 110.658 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.26 18.02 0.17 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.282 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.427 ' HE3' ' CE1' ' A' ' 164' ' ' PHE . 9.8 ptm -60.98 157.82 14.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.019 0.438 . . . . 0.0 111.395 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -127.13 152.01 47.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.326 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.468 HG23 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -117.93 152.34 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.991 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.422 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 53.1 p -117.47 143.74 45.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.766 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.54 176.05 9.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.819 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 29.9 m -120.42 159.72 21.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.9 mt -89.36 149.32 42.48 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.08 -45.92 35.85 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.588 2.192 . . . . 0.0 112.338 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 61.15 158.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -92.82 -21.4 19.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.179 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -87.14 -20.13 27.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.366 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.87 167.67 20.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -130.82 -67.93 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.5 m -159.21 -45.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -81.57 -30.59 32.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -100.97 58.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' A' ' 158' ' ' PHE . 13.3 t -154.5 -81.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.432 ' CG ' ' O ' ' A' ' 157' ' ' SER . 42.4 p90 43.53 36.46 1.18 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.364 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 17.2 m -73.8 -46.05 47.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.78 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.5 m -115.3 -37.12 4.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.405 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 1.3 t60 63.58 28.29 15.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.053 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 75.8 t 57.82 110.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.047 0.451 . . . . 0.0 111.611 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -118.91 169.35 9.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.558 0.694 . . . . 0.0 109.773 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.468 ' CE1' HG23 ' A' ' 143' ' ' VAL . 0.4 OUTLIER -111.05 151.14 28.38 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.036 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.458 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 45.6 m-85 -135.83 134.6 39.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.251 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -38.93 -29.68 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.146 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 171' ' ' ALA . 35.2 m -170.49 178.0 3.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.062 0.458 . . . . 0.0 111.575 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.61 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 90.5 t -69.57 -33.77 4.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.491 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.5 Cg_exo -72.64 -38.78 3.0 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.563 2.175 . . . . 0.0 110.41 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.536 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.23 -39.65 54.05 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.88 -46.81 87.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.672 ' HA ' ' HB1' ' A' ' 175' ' ' ALA . 2.3 mm-40 -78.99 -26.98 43.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.5 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 169' ' ' PRO . 4.8 t70 -70.89 -55.72 7.82 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.469 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 32.3 t-105 -65.03 -29.75 70.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.787 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.672 ' HB1' ' HA ' ' A' ' 172' ' ' GLU . . . -63.33 -39.6 95.0 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.242 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -44.43 62.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.338 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.16 23.87 6.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.172 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . 0.425 ' CE1' HD11 ' A' ' 181' ' ' LEU . 2.3 t-160 -136.41 33.38 2.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.037 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -95.32 143.79 26.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.675 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 125.54 -24.45 5.83 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.573 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.425 HD11 ' CE1' ' A' ' 178' ' ' HIS . 3.6 mt -68.24 69.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 55.88 28.64 12.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 75.6 72.54 1.05 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.515 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.9 tp -75.0 152.66 38.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.771 0.32 . . . . 0.0 110.903 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -140.28 148.89 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.022 0.439 . . . . 0.0 111.121 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.448 HG21 ' CB ' ' A' ' 171' ' ' ALA . 17.1 mm -100.71 160.53 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.987 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.408 ' N ' HG23 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -162.79 150.66 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.144 0.497 . . . . 0.0 111.969 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -78.98 126.07 30.2 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.635 178.082 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.432 ' HA ' HG22 ' A' ' 143' ' ' VAL . 0.2 OUTLIER -46.54 -20.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.885 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -72.24 -45.1 61.63 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.0 OUTLIER -82.73 -22.41 34.44 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.141 178.175 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -67.83 -25.61 65.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.729 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 197' ' ' GLN . 0.2 OUTLIER -81.75 -24.94 35.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.627 179.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.08 -31.52 28.43 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -29.73 31.53 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -82.27 -28.46 40.38 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.409 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 37.5 tt0 -82.47 -22.57 35.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.866 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -81.09 -25.23 37.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.85 -29.76 20.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 0.0 111.291 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . 0.451 ' ND2' ' CZ ' ' A' ' 103' ' ' PHE . 6.6 m120 -80.43 -55.13 5.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -63.24 -30.57 71.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -80.02 -45.07 19.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.005 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.82 -41.18 86.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.956 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -44.87 83.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -87.38 144.05 26.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.13 -39.97 6.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -113.58 159.96 19.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.5 m -93.2 111.38 23.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.936 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.0 t -151.82 -66.0 0.18 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.47 167.51 22.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 212' ' ' PRO . 1.1 m -176.4 -63.09 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.993 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.445 ' N ' HG23 ' A' ' 211' ' ' THR . 19.5 Cg_endo . . . . . 0 C--O 1.247 0.943 0 C-N-CA 122.348 2.032 . . . . 0.0 112.34 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.81 0.338 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -65.89 165.62 12.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.0 tp -99.03 98.95 9.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.64 150.21 39.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -110.3 86.8 5.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.136 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.413 ' CG ' ' CD1' ' A' ' 46' ' ' LEU . 43.0 Cg_endo -67.83 -27.12 37.74 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.525 2.15 . . . . 0.0 112.371 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 mp -52.66 -57.44 10.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.232 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.417 ' HB3' ' CE1' ' A' ' 74' ' ' TYR . 3.9 pp -80.07 -27.3 39.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.066 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.6 ttt85 -64.83 -53.29 49.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -65.78 -23.78 66.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.287 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.04 -37.59 81.53 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.773 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.19 -26.41 17.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 111.03 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -20.97 66.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.226 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.63 48.3 82.63 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.153 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.06 157.26 78.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.724 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.3 91.02 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.516 2.144 . . . . 0.0 112.121 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.5 t -93.01 113.5 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.38 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.8 p -87.0 -174.16 4.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.718 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 43' ' ' ALA . 9.3 ptp180 -77.93 -36.23 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.321 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -28.72 69.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.907 0.384 . . . . 0.0 110.09 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.46 -41.82 16.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.345 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 tp -62.63 -36.5 83.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HB1' HG21 ' A' ' 53' ' ' VAL . . . -72.92 -43.27 62.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.589 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -30.89 74.95 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.689 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.43 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.0 mt -79.09 -42.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.067 0.461 . . . . 0.0 110.376 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.413 ' CD1' ' CG ' ' A' ' 26' ' ' PRO . 7.1 mp -76.44 -9.66 58.82 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.41 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.1 t0 60.34 21.64 11.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.418 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 5.3 m95 -107.48 158.1 34.07 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.171 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.02 144.09 62.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.607 2.205 . . . . 0.0 112.114 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.0 -16.92 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -78.64 -35.04 46.01 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.208 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -67.6 -41.1 84.59 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.417 HG21 ' HB1' ' A' ' 43' ' ' ALA . 2.1 t -63.03 -47.73 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.483 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.26 -53.11 55.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.206 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.77 -46.92 77.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.794 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.9 t -67.65 -32.03 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.724 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -33.26 75.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.657 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -58.16 -22.06 49.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.88 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -90.85 -17.47 26.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.06 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.18 33.09 2.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.367 0.603 . . . . 0.0 111.121 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.1 p -60.1 -20.63 59.15 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.912 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.56 -22.6 21.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.411 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.46 141.06 52.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.523 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -78.85 126.9 31.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 0.0 111.604 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.418 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 62.5 m-85 -103.43 173.17 6.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.192 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -153.53 147.87 25.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.416 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.7 tttp 66.28 -102.01 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.782 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.23 -13.05 33.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.97 30.76 1.18 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.92 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -85.92 164.83 17.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.957 0.408 . . . . 0.0 110.189 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.96 109.61 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.336 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.407 HG23 ' N ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER -123.51 -26.88 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.642 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 72' ' ' ILE . . . -101.84 174.36 24.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.578 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 28' ' ' LEU . 46.7 t80 -173.88 -51.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.05 46.83 0.71 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.553 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.15 150.96 49.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.764 0.316 . . . . 0.0 110.96 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.5 p -99.75 159.08 15.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.812 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.73 -32.66 25.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -96.53 144.23 26.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.1 122.09 17.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.3 p -107.36 -177.05 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.451 ' CB ' ' CE1' ' A' ' 116' ' ' HIS . 53.1 m -93.08 -30.47 15.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.904 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.472 ' CE2' ' N ' ' A' ' 97' ' ' ALA . 20.6 m-85 -86.68 117.35 25.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.362 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.01 142.31 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.488 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 111' ' ' ALA . 46.2 t80 -125.58 105.21 8.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.717 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.14 121.01 34.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.173 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.454 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -139.03 122.93 19.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.617 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 58.3 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.327 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.0 t70 -159.38 35.83 0.2 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.432 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -139.79 113.88 8.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.641 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -77.78 86.32 4.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.979 0.418 . . . . 0.0 111.02 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 85' ' ' PHE . 3.4 mm? -71.77 164.64 25.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.439 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -137.46 162.2 34.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.821 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.03 164.09 32.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.119 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -81.31 -33.37 32.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.441 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 59.7 m -152.92 -177.8 6.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.056 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 98' ' ' LEU . . . -61.84 148.86 41.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.706 0.289 . . . . 0.0 110.917 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.48 ' CB ' ' O ' ' A' ' 97' ' ' ALA . 1.7 tt 88.11 -51.48 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.666 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -54.58 -21.61 10.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.208 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 1.3 p -60.45 -39.51 87.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.381 . . . . 0.0 110.544 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.433 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -110.34 -172.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.174 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.447 ' CD1' ' CE2' ' A' ' 103' ' ' PHE . 3.3 pt -161.76 -43.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.975 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.447 ' CE2' ' CD1' ' A' ' 102' ' ' ILE . 2.2 p90 -163.0 93.64 1.16 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.762 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 107' ' ' ILE . 74.1 Cg_endo -74.45 -35.07 4.0 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.7 2.266 . . . . 0.0 112.368 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.69 -23.99 53.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.8 tp -84.89 -42.41 15.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.338 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.3 tp -57.18 -46.95 84.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.295 0.569 . . . . 0.0 111.417 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.52 23.64 18.31 Favored Glycine 0 C--N 1.318 -0.423 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.699 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 173.46 15.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.893 0.378 . . . . 0.0 111.077 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -80.81 152.91 28.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.897 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.51 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . . . -137.16 109.77 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -83.03 120.64 26.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.78 0.8 . . . . 0.0 111.158 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.44 129.44 67.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.963 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.7 m -119.72 137.93 53.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.029 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.435 ' OG ' ' CD2' ' A' ' 83' ' ' TYR . 3.1 m -141.25 172.8 12.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.478 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.451 ' CE1' ' CB ' ' A' ' 82' ' ' SER . 17.6 p-80 -137.82 132.67 32.98 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 23.0 t -61.15 130.8 48.09 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.152 0.501 . . . . 0.0 112.16 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.91 -3.14 20.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.756 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.456 ' CB ' ' HB2' ' A' ' 174' ' ' TRP . . . -121.14 -50.46 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 0.0 111.601 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.483 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -90.14 -24.67 21.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.29 -179.465 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.09 81.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.108 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.483 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -58.29 158.68 13.48 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 120.581 0.229 . . . . 0.0 110.483 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -91.49 106.16 0.26 Allowed 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.757 2.305 . . . . 0.0 111.246 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 115' ' ' SER . 32.2 m -103.92 145.66 12.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.277 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 64.3 p -151.47 141.47 22.09 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.386 0.612 . . . . 0.0 110.79 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -135.22 153.07 52.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.434 178.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 54.7 m -110.57 113.52 26.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.814 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.401 ' CG1' ' HG3' ' A' ' 104' ' ' PRO . 24.2 t -96.04 111.63 26.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.482 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.79 171.17 4.94 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.282 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.34 -14.93 46.32 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.503 2.135 . . . . 0.0 113.087 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.9 p -119.88 -27.23 5.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -179.97 -163.57 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.166 0.508 . . . . 0.0 110.17 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -95.88 158.94 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.97 178.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -147.34 18.75 1.21 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.404 0.621 . . . . 0.0 112.555 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.32 85.83 0.07 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.466 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.46 118.13 53.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.334 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -146.45 116.28 4.64 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.691 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.55 145.25 76.15 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.726 -1.364 . . . . 0.0 112.32 0.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.25 -29.31 22.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.698 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.55 33.7 6.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.776 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.569 ' HG3' HG13 ' A' ' 189' ' ' VAL . 1.1 ptm -66.26 159.74 25.9 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.068 0.434 . . . . 0.0 111.13 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -131.58 152.74 50.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.063 0.459 . . . . 0.0 111.604 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.464 HG23 ' CE1' ' A' ' 164' ' ' PHE . 44.4 t -111.12 146.16 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.314 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.454 ' O ' ' HB ' ' A' ' 162' ' ' VAL . 47.4 m -114.8 141.26 48.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.689 0.281 . . . . 0.0 110.653 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.417 ' HA ' ' CG1' ' A' ' 162' ' ' VAL . 6.8 mt -103.18 149.07 25.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.081 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.6 p -125.11 137.55 57.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.011 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -134.9 73.53 66.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.91 -39.84 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.513 2.142 . . . . 0.0 112.37 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -176.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.95 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -101.71 -20.58 14.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.092 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -179.91 -35.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.222 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.75 -174.11 0.11 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.14 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -141.97 -62.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.945 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.6 m -158.77 -44.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -57.76 -30.86 65.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.986 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -125.63 61.29 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.03 0.443 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.2 p -171.73 94.81 0.16 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -161.84 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 60.7 m -81.07 -46.01 15.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.905 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 28.9 m 74.18 -1.0 3.19 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.857 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 51.44 43.22 29.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 111.015 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 97' ' ' ALA . 3.5 m -62.04 169.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.872 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -116.03 166.81 11.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.525 0.679 . . . . 0.0 109.762 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.471 ' CE1' ' CB ' ' A' ' 97' ' ' ALA . 18.3 m-30 -117.84 129.67 55.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.768 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.459 ' CD2' ' HA ' ' A' ' 171' ' ' ALA . 19.4 m-85 -108.68 142.58 38.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.401 0.619 . . . . 0.0 110.608 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -46.08 -26.72 0.79 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.825 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.499 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 25.7 p -169.94 170.8 7.47 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.82 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 72.0 t -67.76 -33.41 5.23 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.32 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.2 Cg_exo -72.7 -37.89 3.6 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.724 2.283 . . . . 0.0 110.292 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.557 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.08 -40.39 53.23 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.97 -45.97 91.31 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.601 ' HA ' ' HB1' ' A' ' 175' ' ' ALA . 97.6 mt-10 -78.96 -27.63 43.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.244 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 169' ' ' PRO . 9.4 t70 -70.79 -55.94 7.44 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.59 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.456 ' HB2' ' CB ' ' A' ' 119' ' ' ALA . 77.2 t-105 -65.15 -27.84 69.0 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.685 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.601 ' HB1' ' HA ' ' A' ' 172' ' ' GLU . . . -62.4 -38.99 91.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.215 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.3 t -54.68 -47.78 73.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.442 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -95.48 21.6 7.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.258 0.551 . . . . 0.0 111.034 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -132.77 29.75 4.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.951 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -87.49 132.72 33.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.604 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.02 -25.72 22.47 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.864 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 183' ' ' GLY . 5.3 mt -83.67 -162.82 0.68 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.595 0.236 . . . . 0.0 110.666 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -59.77 82.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.93 0.395 . . . . 0.0 110.845 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 181' ' ' LEU . . . 175.86 -167.88 39.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.093 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.3 tp -176.48 -58.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 111.406 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -143.64 150.51 38.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.109 0.481 . . . . 0.0 111.539 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.433 HG22 ' CB ' ' A' ' 171' ' ' ALA . 12.5 mm -100.7 161.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.638 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.48 165.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.398 0.618 . . . . 0.0 112.11 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.5 OUTLIER -93.79 132.79 37.84 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.539 178.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.569 HG13 ' HG3' ' A' ' 141' ' ' MET . 3.6 m -48.27 -17.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.878 0.37 . . . . 0.0 110.927 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 0.6 OUTLIER -73.33 -44.51 58.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.134 0.492 . . . . 0.0 109.753 179.075 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.38 -21.61 35.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.53 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -76.49 -25.37 54.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.278 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.414 ' CE2' ' HG3' ' A' ' 197' ' ' GLN . 85.8 t80 -81.7 -25.89 35.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 110.722 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.79 -30.25 32.81 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.59 -27.74 34.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -27.33 34.29 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.414 ' HG3' ' CE2' ' A' ' 193' ' ' PHE . 1.5 mm100 -82.33 -23.21 35.22 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.495 -0.352 . . . . 0.0 111.023 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -79.28 -23.08 43.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.229 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -52.2 -32.01 34.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -81.14 -55.03 5.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -58.98 -45.9 89.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -58.94 -31.09 68.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.14 -48.52 17.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.2 mt -61.24 -51.99 66.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -60.55 146.78 43.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.6 m -143.7 117.42 9.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 15.4 mtp -81.43 -38.75 25.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.6 p -72.8 142.24 48.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 14.5 p -93.83 121.46 35.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.926 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.6 110.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 212' ' ' PRO . 1.1 m -176.3 -63.0 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.444 ' N ' HG23 ' A' ' 211' ' ' THR . 19.5 Cg_endo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.444 2.096 . . . . 0.0 112.294 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.826 0.346 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.34 34.45 3.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mp 63.71 -79.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.998 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 pp -130.88 133.2 45.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.89 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 p -68.36 120.99 78.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.022 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.51 -28.65 17.42 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.403 2.069 . . . . 0.0 112.359 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.27 -57.18 10.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -75.56 -27.14 58.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.921 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -53.45 57.38 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -24.3 62.26 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.126 178.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.403 HD22 ' CE2' ' A' ' 74' ' ' TYR . 8.8 tt -66.2 -48.24 71.26 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.759 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.49 -26.09 19.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.61 -22.11 65.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.27 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 47.03 92.97 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.147 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -127.42 163.95 39.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.694 0.283 . . . . 0.0 110.86 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.34 111.61 2.1 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.553 2.169 . . . . 0.0 112.107 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.35 111.04 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.398 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 p -91.39 179.62 5.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.688 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -69.22 -40.99 77.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.213 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -24.64 66.83 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.279 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -85.96 -44.16 12.59 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.8 -36.29 82.67 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HB3' HG23 ' A' ' 53' ' ' VAL . . . -72.95 -42.83 63.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.57 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.51 -31.56 73.98 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.652 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 41' ' ' THR . 7.3 mt -78.32 -46.08 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 120.965 0.412 . . . . 0.0 110.528 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.413 HD22 ' CE3' ' A' ' 48' ' ' TRP . 7.7 mp -75.73 -9.61 58.73 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.614 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 59.91 21.78 10.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.413 ' CE3' HD22 ' A' ' 46' ' ' LEU . 16.4 m0 -103.68 160.06 27.32 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.175 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.93 138.79 41.42 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.595 2.197 . . . . 0.0 111.91 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.03 -20.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.55 -32.28 47.78 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.059 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.48 -40.98 85.27 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.402 HG23 ' HB3' ' A' ' 43' ' ' ALA . 2.1 t -62.69 -48.02 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.616 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.75 -52.05 61.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.488 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.22 -38.79 27.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.38 -30.06 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.782 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.2 mp -81.0 -23.62 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.873 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.9 -23.49 31.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.091 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -126.64 5.83 6.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.229 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -123.17 76.94 1.42 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.722 0.772 . . . . 0.0 110.441 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.9 p -99.3 -22.44 15.59 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.118 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 p -70.5 -26.08 63.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.192 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.46 141.38 42.7 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -78.85 126.77 31.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 111.354 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -104.03 171.7 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.491 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 70' ' ' ASN . 1.9 t0 -92.45 -172.85 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.376 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -37.71 86.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.58 9.52 29.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.718 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.76 18.76 62.93 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.065 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 66' ' ' ASP . 56.8 m-20 -92.03 167.34 12.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.076 0.438 . . . . 0.0 110.091 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.82 119.18 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.329 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 tt -102.49 -27.26 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.028 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.54 -174.03 15.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.605 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.428 ' CZ ' ' HG3' ' A' ' 90' ' ' ARG . 87.3 m-85 61.0 155.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.881 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.06 -98.5 0.13 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.632 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.6 mp 60.71 -87.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.701 0.286 . . . . 0.0 110.68 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.423 HG23 ' CD1' ' A' ' 95' ' ' TRP . 12.3 p -126.06 159.33 33.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.501 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.97 52.44 2.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 0.0 111.096 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.421 ' HA ' ' CD1' ' A' ' 93' ' ' TYR . 27.4 mtm-85 49.38 95.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.088 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.1 tp10 -169.15 -144.09 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.635 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.433 ' O ' ' O ' ' A' ' 80' ' ' GLU . 0.7 OUTLIER 41.19 -173.36 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 178.413 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 p -107.34 -19.65 13.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.364 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -76.87 111.25 12.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.688 0.28 . . . . 0.0 110.485 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.0 137.65 41.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 111.388 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 87' ' ' ILE . 34.6 t80 -126.79 105.07 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.162 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -96.82 124.83 40.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.14 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.46 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.15 128.72 26.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.998 0.428 . . . . 0.0 112.109 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 61.13 -77.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.318 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 87' ' ' ILE . 7.6 t70 -156.3 37.39 0.33 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.65 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 74' ' ' TYR . 4.2 mmm180 -141.78 149.65 40.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.781 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 86.22 2.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.013 0.435 . . . . 0.0 110.673 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 85' ' ' PHE . 8.5 mp -71.39 164.64 25.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.975 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.421 ' CD1' ' HA ' ' A' ' 79' ' ' ARG . 88.9 m-85 -133.48 165.18 25.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.973 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.435 ' HB1' ' N ' ' A' ' 100' ' ' THR . . . -150.91 166.24 31.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.001 0.429 . . . . 0.0 111.962 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.423 ' CD1' HG23 ' A' ' 77' ' ' THR . 12.0 m0 -90.75 -23.17 20.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.403 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 65.2 m -153.81 174.83 14.05 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.941 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.485 ' HB3' ' CZ ' ' A' ' 164' ' ' PHE . . . -53.83 -21.49 7.65 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -51.78 6.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -49.36 -25.65 2.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.435 ' N ' ' HB1' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.07 -28.97 68.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.952 0.406 . . . . 0.0 110.5 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.426 ' O ' ' CE1' ' A' ' 85' ' ' PHE . 5.1 tp 70.48 155.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.069 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.1 pt -158.84 77.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CE1' HD23 ' A' ' 101' ' ' LEU . 14.8 p90 -121.2 54.13 4.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.457 ' HA ' ' CG2' ' A' ' 107' ' ' ILE . 28.8 Cg_endo -62.7 -37.61 55.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.696 2.264 . . . . 0.0 112.235 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 130' ' ' PRO . . . -64.03 -30.33 71.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.581 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.89 -47.69 13.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.457 ' CG2' ' HA ' ' A' ' 104' ' ' PRO . 0.5 OUTLIER -67.73 -41.09 84.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 111.285 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.82 28.47 8.29 Favored Glycine 0 C--N 1.319 -0.38 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.171 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.14 177.39 10.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.051 0.453 . . . . 0.0 110.895 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 m -87.28 160.28 18.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.993 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.442 ' HB2' ' CE1' ' A' ' 85' ' ' PHE . . . -136.55 109.84 7.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.869 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -82.96 119.43 24.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.818 0.818 . . . . 0.0 111.185 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.424 HG21 ' CG2' ' A' ' 128' ' ' VAL . 42.0 t -109.98 128.92 65.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.878 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.1 m -121.75 136.72 54.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.961 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.401 ' HB2' HG21 ' A' ' 124' ' ' VAL . 3.4 m -141.5 172.98 11.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -131.06 130.93 43.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 30.9 m -56.29 125.6 22.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.95 0.405 . . . . 0.0 112.041 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.21 -7.0 38.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.429 ' CB ' ' CG ' ' A' ' 174' ' ' TRP . . . -119.39 -50.56 2.33 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.475 HG21 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.35 -13.96 36.7 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.898 -179.166 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 63.8 11.24 42.46 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.674 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.475 ' H ' HG21 ' A' ' 120' ' ' THR . . . -71.83 164.38 58.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.697 0.284 . . . . 0.0 110.691 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.49 107.98 0.42 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 123.037 2.491 . . . . 0.0 111.328 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 115' ' ' SER . 33.5 m -104.95 146.27 12.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.421 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 60.6 p -151.45 141.69 22.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.384 0.611 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.502 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -134.3 152.58 51.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.137 178.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 20.8 m -111.55 114.3 27.28 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.424 ' CG2' HG21 ' A' ' 113' ' ' VAL . 39.7 t -96.09 111.79 27.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.016 0.436 . . . . 0.0 111.243 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.477 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -105.68 172.9 3.59 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.215 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 41.2 Cg_endo -67.57 -19.82 47.95 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.271 1.981 . . . . 0.0 113.097 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 0.4 OUTLIER -112.57 -26.7 8.53 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.117 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 131' ' ' SER . 19.9 pt-20 178.62 -161.02 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.19 0.519 . . . . 0.0 110.108 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -91.79 160.5 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.565 178.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -150.18 17.87 0.85 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -172.07 85.12 0.07 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.102 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 t -99.6 122.86 51.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.637 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -146.06 118.8 5.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.95 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.42 159.65 95.8 Favored 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 123.396 -1.502 . . . . 0.0 112.094 -0.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.26 78.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.103 0.478 . . . . 0.0 110.673 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.13 18.47 0.17 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.692 -0.765 . . . . 0.0 113.288 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.493 ' CE ' ' CD1' ' A' ' 164' ' ' PHE . 6.5 ptm -67.4 164.43 18.67 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.968 0.384 . . . . 0.0 111.303 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -125.0 152.16 44.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.172 0.511 . . . . 0.0 111.049 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.434 ' CG1' ' CE1' ' A' ' 164' ' ' PHE . 2.5 t -113.08 150.42 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.436 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 20.3 p -118.29 140.19 50.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.851 0.358 . . . . 0.0 110.835 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -149.23 176.52 10.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.723 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.08 112.77 40.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.901 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.423 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . 2.7 mt -58.14 -61.76 6.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.423 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 56.1 Cg_endo -70.4 145.86 54.64 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.515 2.144 . . . . 0.0 112.339 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -145.34 115.09 7.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.44 -21.26 15.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.205 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.06 74.52 1.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.032 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -153.55 -68.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.035 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.4 t70 68.58 -68.37 0.18 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.3 m -142.54 -47.12 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.158 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 -160.67 52.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.868 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -94.3 -34.74 12.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.1 t -73.63 -174.42 1.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.931 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -140.94 -50.32 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.95 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -46.21 15.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 6.0 t 78.36 -3.25 2.32 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.589 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.415 ' CD2' ' HA ' ' A' ' 182' ' ' GLU . 4.1 m-70 48.44 42.61 18.73 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.884 0.373 . . . . 0.0 111.287 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.4 t -104.97 110.62 31.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.583 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -120.84 169.44 10.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.565 0.698 . . . . 0.0 109.777 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.493 ' CD1' ' CE ' ' A' ' 141' ' ' MET . 49.8 m-85 -115.08 152.67 32.11 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.382 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 37.9 m-85 -134.09 137.84 44.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.181 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -43.85 -27.92 0.39 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.255 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.517 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 67.8 m -165.98 172.3 11.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.118 0.485 . . . . 0.0 111.577 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 76.2 t -69.38 -34.16 4.53 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.02 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.3 -37.41 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.645 2.23 . . . . 0.0 110.136 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.547 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.59 -40.02 50.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.085 -0.962 . . . . 0.0 108.415 177.916 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.29 -45.75 93.16 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.603 ' HA ' ' HB1' ' A' ' 175' ' ' ALA . 95.8 mt-10 -78.79 -27.47 44.48 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.291 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 169' ' ' PRO . 28.8 t70 -71.05 -55.92 7.23 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.517 0.675 . . . . 0.0 109.308 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.429 ' CG ' ' CB ' ' A' ' 119' ' ' ALA . 32.9 t-105 -64.59 -28.66 69.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.806 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.603 ' HB1' ' HA ' ' A' ' 172' ' ' GLU . . . -65.39 -38.55 90.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.349 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.2 t -52.07 -46.42 65.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.469 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -97.55 24.36 6.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.017 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -156.68 45.81 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -88.56 125.39 34.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.691 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 91.32 -19.99 43.54 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.261 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.8 mt -86.86 87.11 7.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.733 0.301 . . . . 0.0 111.104 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.415 ' HA ' ' CD2' ' A' ' 161' ' ' HIS . 18.8 mt-10 57.62 69.36 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.945 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 110.51 91.83 2.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.367 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.403 ' CD2' ' CG ' ' A' ' 148' ' ' PRO . 3.7 pp -94.67 -3.93 48.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -131.34 141.19 49.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.101 0.477 . . . . 0.0 111.353 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.484 HG23 ' HB2' ' A' ' 171' ' ' ALA . 18.3 mm -104.44 160.95 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.019 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.409 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -160.62 162.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.373 0.606 . . . . 0.0 111.775 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 190' ' ' HIS . 1.7 m -92.13 133.99 35.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.475 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.449 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 1.7 m -45.87 -20.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.882 0.373 . . . . 0.0 110.654 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.425 ' N ' ' C ' ' A' ' 188' ' ' SER . 93.9 m-70 -70.77 -45.2 65.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.818 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.42 -20.89 36.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.656 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -76.69 -25.36 53.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.228 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -81.41 -24.85 36.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.687 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.84 -29.26 35.44 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.7 mp -82.33 -28.45 31.62 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.05 -28.33 31.43 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -80.84 -21.95 40.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.996 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -75.75 -22.94 56.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.103 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -52.09 -37.87 55.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.932 0.396 . . . . 0.0 111.168 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -69.64 -24.85 63.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.132 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -46.67 85.24 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -80.02 -35.21 37.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.6 tp -61.29 -31.19 71.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.4 tp -59.39 -39.22 82.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 60.08 108.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.923 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 73.3 p -141.54 79.07 1.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 3.5 tpt -99.22 -58.65 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.0 p -159.17 -174.04 4.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.8 m 60.56 105.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.76 31.49 4.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.95 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.421 HG23 ' N ' ' A' ' 212' ' ' PRO . 0.9 OUTLIER 178.55 -54.94 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.421 ' N ' HG23 ' A' ' 211' ' ' THR . 78.1 Cg_exo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.471 2.114 . . . . 0.0 112.368 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.81 0.338 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -87.56 110.27 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 mt -132.1 127.85 36.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -120.47 77.43 1.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.441 ' N ' ' HD3' ' A' ' 26' ' ' PRO . 7.3 p 42.92 59.98 10.69 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.583 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 25' ' ' VAL . 48.9 Cg_exo -55.78 -30.05 74.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.558 2.172 . . . . 0.0 112.54 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.94 -57.5 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.068 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.3 mt -60.87 -27.05 67.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -60.04 -53.18 60.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 0.0 109.673 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -76.75 -25.09 53.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.39 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.28 -52.15 44.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.21 -23.68 15.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.254 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -70.84 -23.58 62.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.186 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.1 49.15 77.81 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.174 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -132.98 166.02 32.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.48 115.16 3.92 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.515 2.144 . . . . 0.0 111.927 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.403 ' CG2' HG21 ' A' ' 41' ' ' THR . 9.3 p -124.21 109.87 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.487 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.9 p -79.15 -176.19 5.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -78.04 -33.44 51.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.315 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -28.11 68.25 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.132 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.501 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.59 -41.42 16.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.228 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -36.81 84.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 39' ' ' ARG . . . -73.36 -42.94 61.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.409 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.88 -29.64 73.78 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.463 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.501 ' N ' ' O ' ' A' ' 41' ' ' THR . 6.9 mt -78.86 -42.21 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 121.2 0.524 . . . . 0.0 109.903 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.5 mp -76.82 -9.82 58.94 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.445 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 t70 61.77 21.29 12.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.413 ' CD1' ' HD2' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -101.6 152.47 38.06 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.132 -179.535 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.72 139.02 35.98 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.503 2.135 . . . . 0.0 112.027 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.62 -19.22 0.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.25 -31.2 49.06 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.237 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HD2' ' CD1' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -67.62 -40.36 84.69 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.1 t -61.73 -48.07 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.735 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.16 -52.61 58.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.461 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.47 -43.51 68.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.923 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.6 t -75.12 -29.3 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.856 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.5 tp -68.78 -38.86 80.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.816 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.75 -45.11 86.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.616 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -74.22 -8.23 55.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.111 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.04 70.98 0.73 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.766 0.793 . . . . 0.0 110.531 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.9 p -76.51 -6.36 51.51 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.424 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.51 37.9 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 0.0 110.852 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -92.8 141.2 28.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.181 179.607 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -78.88 126.63 30.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 111.28 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 63' ' ' THR . 27.0 m-85 -124.4 154.01 41.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.343 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -153.14 146.11 24.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.233 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 tttm 66.04 -101.68 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.672 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -89.96 -14.4 34.15 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.11 29.23 1.68 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.989 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -87.41 172.65 9.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.1 mt -79.59 105.84 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.845 0.355 . . . . 0.0 110.999 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.7 tt -103.78 -19.99 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.555 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -44.39 95.62 0.01 OUTLIER Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.919 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -83.16 -79.38 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 0.0 110.94 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.52 -148.42 23.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.492 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.9 -41.29 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.061 0.457 . . . . 0.0 110.911 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -144.08 159.39 42.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.566 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -83.12 52.76 2.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 111.053 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? 57.84 113.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -177.71 -28.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.497 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.8 p -89.41 -178.23 5.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.945 0.402 . . . . 0.0 111.332 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.75 -26.98 14.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.345 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.447 ' HB3' HG22 ' A' ' 100' ' ' THR . 81.7 m-85 -76.56 110.79 11.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.628 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.26 139.12 31.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.169 0.509 . . . . 0.0 111.573 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.481 ' CE1' ' CG2' ' A' ' 87' ' ' ILE . 14.5 t80 -136.38 108.19 7.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.847 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -103.7 137.12 42.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.806 0.336 . . . . 0.0 111.552 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.481 ' CG2' ' CE1' ' A' ' 85' ' ' PHE . 2.2 pt -140.03 123.35 17.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.572 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 t0 63.65 -66.68 0.1 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.189 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.5 t70 -168.0 35.2 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.401 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -134.07 113.48 12.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.927 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.21 86.2 5.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 111.0 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -76.0 164.92 25.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.016 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -136.2 165.45 25.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.263 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.401 ' HB3' ' CB ' ' A' ' 99' ' ' ASP . . . -150.73 169.98 20.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.922 0.391 . . . . 0.0 111.879 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 15.0 m0 -92.93 -23.5 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.931 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 50.9 m -147.44 167.08 25.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.283 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.47 ' CB ' ' CZ ' ' A' ' 164' ' ' PHE . . . -51.97 -22.44 3.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.011 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.4 tp -86.26 -51.55 6.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.401 ' CB ' ' HB3' ' A' ' 94' ' ' ALA . 2.7 m-20 -48.14 -25.94 1.68 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.447 HG22 ' HB3' ' A' ' 83' ' ' TYR . 0.1 OUTLIER -60.26 -39.1 85.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.515 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.18 166.56 11.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.7 pt -158.03 -43.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.422 ' CD1' ' HB2' ' A' ' 106' ' ' LEU . 1.5 m-85 -162.58 64.46 1.55 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.501 ' O ' HG22 ' A' ' 107' ' ' ILE . 37.8 Cg_exo -60.22 -43.04 37.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.747 2.298 . . . . 0.0 112.416 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.19 -23.76 43.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.376 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.422 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -84.09 -38.74 20.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.509 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.4 tp -57.16 -45.7 84.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.146 0.498 . . . . 0.0 111.309 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.56 25.31 10.09 Favored Glycine 0 C--N 1.319 -0.372 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.508 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.65 174.15 14.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 110.939 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.0 m -81.08 158.14 25.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.756 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 85' ' ' PHE . . . -136.77 109.67 7.63 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -81.61 119.78 24.23 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.765 0.793 . . . . 0.0 111.015 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.6 t -112.17 129.86 66.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.084 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.4 m -124.21 137.35 54.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.045 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.417 ' CB ' ' CG2' ' A' ' 124' ' ' VAL . 1.4 m -141.6 173.09 11.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.377 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -134.09 133.24 40.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.6 t -62.44 133.37 54.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.216 0.532 . . . . 0.0 112.213 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.98 -3.81 24.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.891 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.45 ' CB ' ' HB2' ' A' ' 174' ' ' TRP . . . -122.68 -50.94 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.786 0.327 . . . . 0.0 111.662 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.514 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.45 -24.13 21.94 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.306 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.76 5.15 73.44 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.144 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.514 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -58.07 149.41 56.46 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-O 120.544 0.212 . . . . 0.0 110.631 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.31 103.85 1.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.667 2.244 . . . . 0.0 110.807 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.418 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 35.8 m -99.14 144.72 11.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.311 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.5 p -151.87 141.72 21.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.431 0.634 . . . . 0.0 110.836 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -138.82 151.39 46.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.875 178.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 133' ' ' ILE . 21.2 m -105.94 115.21 29.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.639 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.425 HG12 ' CE2' ' A' ' 193' ' ' PHE . 38.8 t -96.11 111.73 26.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.853 0.359 . . . . 0.0 111.505 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.411 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -107.22 169.5 6.67 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.938 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.411 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.4 Cg_endo -66.23 -19.25 56.52 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.198 1.932 . . . . 0.0 112.816 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 19.6 p -112.66 -26.97 8.37 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 131' ' ' SER . 0.4 OUTLIER 178.39 -162.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.133 0.492 . . . . 0.0 110.043 -179.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -93.68 158.46 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.922 178.578 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -144.66 19.49 1.67 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.448 0.642 . . . . 0.0 112.154 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 126' ' ' LEU . . . -171.83 86.81 0.08 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.238 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 36.3 t -103.25 113.64 40.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.334 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -146.5 122.72 5.67 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.48 155.83 95.05 Favored 'Cis proline' 0 C--N 1.348 0.517 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.26 0.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.39 79.46 0.38 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.178 0.514 . . . . 0.0 110.497 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.01 17.61 0.18 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.597 -0.728 . . . . 0.0 113.243 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.468 ' HG3' ' CG1' ' A' ' 189' ' ' VAL . 0.2 OUTLIER -58.61 158.47 7.76 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.964 0.412 . . . . 0.0 111.441 -179.393 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -128.49 152.32 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.052 -178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.416 HG23 ' CE1' ' A' ' 164' ' ' PHE . 46.1 t -111.74 147.72 15.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.543 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 32.0 m -120.77 144.91 48.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.804 0.335 . . . . 0.0 110.946 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.04 175.03 9.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.828 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.3 m -125.04 120.14 57.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 33.0 mt 60.05 87.84 0.13 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.79 63.75 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.54 2.16 . . . . 0.0 112.307 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -63.54 131.71 48.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -112.33 33.99 4.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.84 30.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -169.78 -73.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.209 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.5 t0 58.28 29.96 18.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.9 m -159.08 174.69 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.111 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 59.9 64.9 1.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 58.86 31.46 21.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.1 t -60.16 -81.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -133.7 8.81 3.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.394 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.407 ' HA ' ' CG2' ' A' ' 162' ' ' VAL . 52.9 t -81.13 -15.83 54.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.649 0.262 . . . . 0.0 111.485 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 94.2 m -79.76 -0.74 35.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -154.76 54.76 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.743 0.306 . . . . 0.0 111.505 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.407 ' CG2' ' HA ' ' A' ' 159' ' ' CYS . 22.0 t -104.26 109.76 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.495 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 163' ' ' HIS . 2.2 m-70 -118.93 159.14 24.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.535 0.683 . . . . 0.0 109.919 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.47 ' CZ ' ' CB ' ' A' ' 97' ' ' ALA . 15.9 m-30 -111.12 130.6 55.57 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.526 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 39.4 m-85 -108.48 140.69 41.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.397 0.618 . . . . 0.0 110.545 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.33 -27.64 0.7 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.76 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 68.2 m -164.95 171.48 13.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.225 0.536 . . . . 0.0 111.746 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 73.0 t -69.23 -32.84 3.52 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.298 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.22 -37.76 3.16 Favored 'Trans proline' 0 CA--C 1.504 -0.983 0 C-N-CA 122.739 2.292 . . . . 0.0 110.389 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.556 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.71 -40.17 49.6 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.146 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.474 ' O ' ' CB ' ' A' ' 175' ' ' ALA . . . -61.9 -45.49 93.49 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 175' ' ' ALA . 97.2 mt-10 -78.96 -27.37 43.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.288 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 169' ' ' PRO . 13.8 t70 -70.75 -55.78 7.86 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.457 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' TRP . . . . . 0.45 ' HB2' ' CB ' ' A' ' 119' ' ' ALA . 39.2 t-105 -64.64 -28.58 69.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.616 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.605 ' HB2' ' HA ' ' A' ' 172' ' ' GLU . . . -63.85 -41.58 97.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.311 178.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.56 -42.23 55.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.228 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.6 22.75 7.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.294 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.66 31.73 1.46 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.889 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -107.89 -15.41 14.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.289 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.55 -22.49 24.65 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.472 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 18.2 mt -59.56 -176.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.924 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -87.39 54.73 3.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 110.15 139.89 8.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.536 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.4 tt -177.19 133.57 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.762 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.4 150.08 40.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.221 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.462 HG23 ' HB2' ' A' ' 171' ' ' ALA . 17.2 mm -103.14 161.71 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.961 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.56 162.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.099 0.476 . . . . 0.0 111.833 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.412 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -90.15 128.09 36.26 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.896 178.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.468 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 2.2 m -46.78 -20.14 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.915 0.388 . . . . 0.0 110.758 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.412 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.0 m170 -71.5 -41.68 68.97 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.126 0.488 . . . . 0.0 109.709 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.7 OUTLIER -82.12 -25.66 34.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.412 179.097 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.83 -24.86 62.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.043 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PHE . . . . . 0.425 ' CE2' HG12 ' A' ' 128' ' ' VAL . 5.0 t80 -81.15 -24.98 37.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.8 -29.82 33.98 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 9.6 mp -82.4 -28.27 31.52 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -28.36 31.4 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.402 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 9.1 tt0 -80.55 -22.99 40.29 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.897 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -73.46 -22.89 60.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.102 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.03 -36.95 51.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.959 0.409 . . . . 0.0 111.246 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -73.07 -24.81 60.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.108 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -49.71 -29.71 7.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -80.01 -31.64 39.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.941 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.5 mt -82.09 -22.17 36.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.07 -28.17 66.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.002 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 60.84 99.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.948 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 28.9 m -155.89 79.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 5.3 mtm -59.86 -59.09 5.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.829 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 18.4 m -128.57 162.56 26.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 60.7 p -100.96 141.78 33.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -78.02 -171.0 2.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.984 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 212' ' ' PRO . 1.1 m -176.36 -63.01 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.007 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' PRO . . . . . 0.441 ' N ' HG22 ' A' ' 211' ' ' THR . 19.8 Cg_endo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.442 2.095 . . . . 0.0 112.268 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.828 0.347 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.71 -21.99 50.4 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.519 2.146 . . . . 0.0 112.292 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.688 ' CD2' HD21 ' A' ' 42' ' ' LEU . 2.6 mt -52.0 -57.3 9.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.244 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.55 -27.09 62.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -61.0 -53.27 59.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.653 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.9 -25.07 62.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.298 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.464 ' HA ' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -67.0 -47.65 70.82 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.824 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.39 -25.85 17.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -67.74 -22.26 65.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.212 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.6 47.99 88.44 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.039 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.14 153.1 81.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.768 0.318 . . . . 0.0 110.928 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.01 109.08 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.596 2.197 . . . . 0.0 111.987 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.686 HG23 HG22 ' A' ' 41' ' ' THR . 11.0 p -115.56 110.17 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.334 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 57.5 p -85.14 177.6 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.677 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.09 -37.17 72.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.192 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -26.46 67.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.814 0.34 . . . . 0.0 110.136 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.686 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.4 -42.65 14.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.688 HD21 ' CD2' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -63.11 -36.38 83.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.2 -43.0 62.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.492 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.01 -30.61 74.18 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.734 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.586 HD12 HG23 ' A' ' 41' ' ' THR . 6.7 mt -79.16 -41.58 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.055 0.455 . . . . 0.0 110.297 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.443 HD12 HG22 ' A' ' 45' ' ' ILE . 6.5 mp -77.17 -9.66 58.91 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.336 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 t70 59.88 21.95 10.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.408 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 6.5 m95 -109.95 158.31 35.36 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.162 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.68 142.75 71.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.533 2.155 . . . . 0.0 112.02 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.64 -16.82 1.04 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -78.95 -34.34 44.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.062 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -67.47 -41.58 84.39 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.0 t -63.36 -46.99 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.482 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.91 -51.35 61.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.383 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.96 -37.65 20.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.719 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 52' ' ' ARG . 23.2 t -63.6 -53.01 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.793 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 58' ' ' GLU . 3.9 pp -73.52 -16.92 61.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.968 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.598 ' N ' HD12 ' A' ' 57' ' ' LEU . 59.2 tt0 -58.12 -19.58 33.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.049 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.85 12.57 12.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.825 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -123.06 76.5 1.38 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.771 0.796 . . . . 0.0 110.48 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 p -87.43 -26.95 23.02 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.762 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.25 -21.29 63.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.76 141.2 53.6 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.431 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.61 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -84.68 126.96 33.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 111.642 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.408 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 14.8 m-85 -100.36 173.14 6.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.163 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -153.11 143.3 22.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 111.504 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 tptp 66.06 -104.06 0.09 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.82 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -92.73 -13.05 29.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.715 0.293 . . . . 0.0 111.782 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 128.64 31.98 0.63 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.14 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -87.14 170.56 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.82 0.343 . . . . 0.0 110.166 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.67 HD13 HD12 ' A' ' 42' ' ' LEU . 3.7 mp -79.7 109.43 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.159 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.866 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.107 0.479 . . . . 0.0 111.002 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 76' ' ' LEU . 3.1 mm? . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.864 0.364 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -129.43 159.62 35.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.6 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.8 mt -77.91 51.13 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.266 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 4.7 ttt-85 44.47 85.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.635 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.07 23.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.469 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.1 p -119.17 -171.07 2.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.114 0.483 . . . . 0.0 111.599 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 p -104.08 -29.14 11.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.301 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 95' ' ' TRP . 10.8 m-85 -79.27 111.83 15.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.628 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.57 140.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.059 0.457 . . . . 0.0 111.098 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.826 ' CD1' HG22 ' A' ' 113' ' ' VAL . 43.8 t80 -129.95 106.38 8.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.588 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -100.17 130.54 46.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.921 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.503 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -140.03 124.62 19.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.16 -70.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.283 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -166.94 34.39 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.251 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -137.71 111.94 8.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.906 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.413 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -78.42 121.56 24.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.837 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 92' ' ' LEU . 3.8 mm? -114.43 164.8 13.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.969 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 79' ' ' ARG . 24.8 m-85 -130.78 165.09 23.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.112 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.632 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -151.79 170.17 20.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.106 0.479 . . . . 0.0 111.848 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.405 ' O ' ' CE1' ' A' ' 83' ' ' TYR . 5.3 m95 -98.81 -18.67 17.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.684 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 28.1 m -147.61 162.55 38.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.924 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -52.03 -22.62 4.2 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 tp -85.79 -51.53 6.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.656 0.265 . . . . 0.0 111.305 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.617 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -45.16 -28.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.632 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -60.41 -39.1 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 110.549 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.44 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.3 pt? -121.87 174.9 6.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.059 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.2 mt -151.31 -46.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.044 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -156.92 79.02 3.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.742 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.517 ' HA ' HG12 ' A' ' 107' ' ' ILE . 20.3 Cg_endo -60.78 -40.13 56.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.703 2.269 . . . . 0.0 112.41 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.24 -25.94 67.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.547 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.3 tp -79.9 -26.47 40.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 104' ' ' PRO . 4.5 mm -64.5 -58.88 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.117 0.961 . . . . 0.0 111.013 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.54 22.14 13.22 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.637 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.07 -177.03 5.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.925 0.393 . . . . 0.0 110.344 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.54 154.11 20.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.227 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.779 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -136.85 110.06 7.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.639 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -80.38 119.91 23.71 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.767 0.794 . . . . 0.0 111.277 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.826 HG22 ' CD1' ' A' ' 85' ' ' PHE . 47.2 t -112.05 129.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.947 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 m -122.87 137.56 54.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.114 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.546 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.6 OUTLIER -141.4 172.82 12.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.317 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -134.54 133.88 40.79 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.407 ' HB3' ' H ' ' A' ' 121' ' ' GLY . 30.5 t -62.29 130.38 45.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.047 0.451 . . . . 0.0 112.037 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.95 -3.59 23.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.974 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.885 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.54 -49.85 2.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 111.545 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.686 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -91.77 -24.62 19.36 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.281 -179.522 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 117' ' ' CYS . . . 76.28 5.55 81.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.195 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.686 ' H ' HG22 ' A' ' 120' ' ' THR . . . -57.93 148.92 57.51 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-O 120.528 0.204 . . . . 0.0 110.636 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 1.0 OUTLIER -82.31 104.1 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.686 2.258 . . . . 0.0 110.806 179.327 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 115' ' ' SER . 30.5 m -100.16 144.91 11.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.4 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.0 p -151.64 141.49 21.97 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.415 0.626 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -138.55 151.92 47.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.83 178.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.857 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 53.8 m -106.52 113.49 27.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.871 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.69 HG13 ' CE2' ' A' ' 193' ' ' PHE . 47.9 t -96.31 111.79 27.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.902 0.382 . . . . 0.0 111.474 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.25 168.53 8.05 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.08 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.75 -14.55 45.2 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.49 2.126 . . . . 0.0 113.015 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -118.84 -26.91 5.93 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 179.6 -163.29 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.16 0.505 . . . . 0.0 110.017 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -96.61 160.47 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.879 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -148.21 20.75 1.09 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.468 0.651 . . . . 0.0 112.194 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.857 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.94 86.69 0.08 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.408 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.577 HG13 ' SD ' ' A' ' 141' ' ' MET . 39.2 t -103.54 115.4 45.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.193 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -146.27 122.28 5.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.74 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.87 157.0 99.14 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 123.523 -1.449 . . . . 0.0 112.283 0.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.42 79.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 0.0 110.553 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.58 16.61 0.15 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.407 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.868 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -60.13 156.49 15.01 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.065 0.459 . . . . 0.0 111.313 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -125.43 151.87 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.734 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.739 HG13 ' CE1' ' A' ' 164' ' ' PHE . 18.4 t -113.0 152.22 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.793 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 1.6 p -120.72 140.98 50.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.938 0.399 . . . . 0.0 110.945 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.664 HD12 HG22 ' A' ' 162' ' ' VAL . 5.7 tp -135.84 175.13 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.871 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.083 179.81 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.664 HG22 HD12 ' A' ' 145' ' ' LEU . 22.4 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.84 0.353 . . . . 0.0 111.499 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -117.1 169.05 9.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.602 0.715 . . . . 0.0 109.801 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.739 ' CE1' HG13 ' A' ' 143' ' ' VAL . 2.5 m-85 -119.38 152.9 36.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.127 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.619 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 49.1 m-85 -129.35 133.67 47.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.845 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -41.48 -27.51 0.09 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 10.8 p -168.84 174.36 6.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.015 0.436 . . . . 0.0 111.511 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.6 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 85.6 t -68.6 -33.53 4.6 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.673 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.683 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.6 Cg_exo -72.51 -38.17 3.61 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.718 2.279 . . . . 0.0 110.371 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.57 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.54 -39.47 52.75 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.44 -46.02 90.42 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.7 mt-10 -78.78 -28.12 44.61 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.323 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 169' ' ' PRO . 12.3 t70 -71.33 -55.81 7.26 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.384 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.885 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 58.3 t-105 -64.04 -28.48 69.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.739 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -62.99 -42.22 99.79 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.166 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 71.1 m -51.37 -41.74 60.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.399 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 21.04 9.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.421 0.629 . . . . 0.0 111.298 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -128.4 28.74 5.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.864 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.709 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 6.0 tp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.817 0.341 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.29 150.08 42.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.037 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.571 ' CG2' ' HB1' ' A' ' 171' ' ' ALA . 10.6 mm -100.14 159.04 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.035 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.444 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -162.02 162.56 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.289 0.566 . . . . 0.0 112.076 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.415 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -88.53 129.52 35.45 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.669 178.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.868 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.2 m -46.44 -20.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.832 0.349 . . . . 0.0 110.717 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.415 ' N ' ' C ' ' A' ' 188' ' ' SER . 1.8 t-160 -73.82 -42.07 61.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.784 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -82.25 -21.2 36.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.25 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.4 -24.93 63.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.813 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.69 ' CE2' HG13 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -81.11 -24.91 37.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.72 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.81 -31.26 29.91 Favored Glycine 0 CA--C 1.509 -0.317 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.7 tp -82.13 -29.25 31.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -83.12 -27.43 40.59 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -82.28 -21.93 35.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.938 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -81.03 -26.21 36.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -52.68 -30.52 32.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.115 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.67 -54.46 27.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.016 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.7 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.857 0.361 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.2 -16.97 45.08 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.695 2.263 . . . . 0.0 112.456 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.589 HD23 HG21 ' A' ' 71' ' ' ILE . 2.0 tm? -54.25 -57.44 11.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.949 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.497 ' N ' HD13 ' A' ' 27' ' ' LEU . 9.2 tp -63.7 -27.05 68.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.982 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -68.43 -53.33 24.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.719 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.889 ' HB3' HG21 ' A' ' 37' ' ' VAL . 2.7 mm-40 -72.61 -29.72 63.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.318 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.548 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.2 tt -67.25 -45.71 75.9 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.56 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.08 -23.06 18.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -22.75 62.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.005 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.3 39.72 98.09 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.26 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -133.38 166.09 31.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.595 0.236 . . . . 0.0 110.673 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.64 112.65 2.92 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.517 2.145 . . . . 0.0 112.201 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.889 HG21 ' HB3' ' A' ' 30' ' ' GLU . 33.4 t -112.22 109.92 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.331 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -90.46 -168.4 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.835 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -78.07 -38.44 44.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.513 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -25.31 68.06 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.45 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.722 ' CG2' HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.1 -43.56 12.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.391 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.422 HD13 HD13 ' A' ' 71' ' ' ILE . 1.5 tp -63.01 -35.46 80.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.664 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -74.24 -42.94 58.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.496 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.13 -30.96 74.11 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.579 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.603 HD12 HG23 ' A' ' 41' ' ' THR . 7.3 mt -78.7 -44.44 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 120.995 0.426 . . . . 0.0 110.584 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.577 HD12 HG22 ' A' ' 45' ' ' ILE . 7.3 mp -76.81 -9.8 58.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.421 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.6 t70 58.21 22.88 9.65 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -97.81 139.62 21.43 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.461 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.508 ' O ' HG23 ' A' ' 53' ' ' VAL . 44.4 Cg_exo -56.07 137.37 79.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.445 2.097 . . . . 0.0 111.797 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.85 -22.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -78.33 -36.12 46.73 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 110.951 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.2 mtt-85 -67.07 -40.41 87.02 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -63.01 -47.98 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.487 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.04 -53.69 46.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.117 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.39 -48.28 77.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.836 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 52' ' ' ARG . 41.1 t -64.31 -31.95 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.664 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.14 -31.4 71.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.581 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 61' ' ' THR . 5.5 tt0 -58.17 -21.83 48.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -96.13 -19.57 19.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.002 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.558 ' HB1' ' HG1' ' A' ' 63' ' ' THR . . . -99.75 32.07 3.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.466 0.651 . . . . 0.0 110.88 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 58' ' ' GLU . 25.2 p -69.43 -13.04 62.14 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.173 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.7 p -90.91 -23.11 20.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 111.266 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.558 ' HG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -56.49 141.23 43.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -78.77 126.96 31.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.397 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 66.8 m-85 -102.14 173.25 6.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.505 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD2' HD13 ' A' ' 72' ' ' ILE . 14.0 t0 -152.77 147.09 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.948 0.404 . . . . 0.0 111.441 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.41 -104.01 0.09 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.745 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.65 -11.1 46.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.726 0.298 . . . . 0.0 111.726 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.04 27.69 1.82 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.076 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -86.64 168.47 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.589 HG21 HD23 ' A' ' 27' ' ' LEU . 2.5 mp -79.64 120.41 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.379 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.524 HD13 ' OD2' ' A' ' 66' ' ' ASP . 2.3 tt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.556 HD21 HD11 ' A' ' 92' ' ' LEU . 3.3 mm? . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.854 0.359 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.519 HG21 HG23 ' A' ' 81' ' ' THR . 1.4 t -100.32 152.6 20.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.88 -45.95 76.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -103.47 147.72 26.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.946 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.424 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 3.1 tt0 -59.43 132.21 53.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.519 HG23 HG21 ' A' ' 77' ' ' THR . 35.2 p -110.09 -173.6 2.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.6 p -93.62 -35.74 12.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.928 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.424 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 4.9 m-85 -79.15 109.72 13.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.385 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.55 137.51 34.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.139 0.495 . . . . 0.0 111.377 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.758 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 21.7 t80 -132.58 105.77 7.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.103 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -102.52 135.26 44.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.387 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.48 HG23 ' CE1' ' A' ' 85' ' ' PHE . 2.8 pt -140.14 126.54 22.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t0 61.89 -72.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 87' ' ' ILE . 13.4 t0 -158.05 37.7 0.25 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -140.34 148.74 41.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.611 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.88 86.19 2.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.094 0.473 . . . . 0.0 110.571 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.556 HD11 HD21 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -71.6 164.69 25.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.091 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.424 ' CZ ' ' HG3' ' A' ' 80' ' ' GLU . 9.7 m-85 -134.31 165.16 25.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.113 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.625 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -151.16 167.24 28.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.152 0.501 . . . . 0.0 111.849 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -101.09 -10.54 20.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.751 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 11.9 m -153.31 160.0 42.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.854 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.842 ' HB1' ' CE2' ' A' ' 164' ' ' PHE . . . -51.81 -22.46 3.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -85.93 -51.34 6.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.674 0.273 . . . . 0.0 111.172 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.625 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 1.9 m-20 -44.38 -27.66 0.46 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -60.28 -39.2 86.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.892 0.377 . . . . 0.0 110.544 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.857 HD21 HG21 ' A' ' 128' ' ' VAL . 5.3 mt -93.45 -176.1 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.032 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 103' ' ' PHE . 7.5 tp -174.67 -40.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.84 ' O ' HG22 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -172.02 65.48 0.39 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.797 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.417 ' HG3' HD22 ' A' ' 101' ' ' LEU . 33.6 Cg_exo -59.85 -42.04 48.94 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.73 2.287 . . . . 0.0 112.351 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.07 -23.91 43.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.332 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.439 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -85.11 -38.33 19.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.481 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -57.19 -45.82 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 111.394 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.61 23.37 16.19 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.568 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.41 173.61 13.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.036 0.446 . . . . 0.0 110.954 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m -81.61 156.51 25.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.901 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.758 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -136.76 109.96 7.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.847 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -81.28 120.07 24.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.717 0.77 . . . . 0.0 111.232 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.3 t -111.07 127.29 68.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.626 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.3 m -122.36 137.6 54.8 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.317 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.595 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.0 OUTLIER -141.5 172.85 12.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.265 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -134.32 133.23 40.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 22.6 t -62.77 131.84 50.23 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.248 0.547 . . . . 0.0 112.222 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.17 -3.59 20.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.988 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.866 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -123.27 -51.07 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.631 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -87.68 -24.57 23.85 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.208 -179.572 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.44 5.45 72.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.114 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.715 ' H ' HG22 ' A' ' 120' ' ' THR . . . -59.94 152.27 60.78 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-O 120.591 0.234 . . . . 0.0 110.515 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -84.71 105.03 0.97 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.683 2.255 . . . . 0.0 110.947 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.595 HG22 ' C ' ' A' ' 115' ' ' SER . 35.3 m -99.36 144.46 11.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.364 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.427 ' O ' ' HE1' ' A' ' 141' ' ' MET . 82.4 p -151.64 141.68 22.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.424 0.631 . . . . 0.0 110.936 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -138.64 152.09 47.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.724 178.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.815 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 20.1 m -106.73 115.23 29.83 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.857 HG21 HD21 ' A' ' 101' ' ' LEU . 42.4 t -96.18 111.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.843 0.354 . . . . 0.0 111.211 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.97 175.79 1.9 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.32 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.77 -15.5 33.33 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.629 2.219 . . . . 0.0 112.978 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 18.0 t -118.96 -25.7 6.19 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 131' ' ' SER . 10.7 pt-20 178.56 -162.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.158 0.504 . . . . 0.0 110.036 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -93.44 156.49 3.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.94 178.572 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.72 18.59 2.0 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.469 0.652 . . . . 0.0 112.279 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.815 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.57 86.45 0.09 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.421 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.536 HG13 ' SD ' ' A' ' 141' ' ' MET . 39.7 t -102.29 115.82 44.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.063 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -146.3 122.25 5.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.748 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.11 160.17 94.37 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.495 -1.461 . . . . 0.0 112.362 -0.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.64 78.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.673 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.0 16.92 0.16 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.33 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.921 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -58.67 155.03 13.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 111.619 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -124.88 151.9 44.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.977 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.799 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -112.93 149.32 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.666 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 162' ' ' VAL . 9.8 m -120.54 141.39 50.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.544 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.415 ' CD2' HG22 ' A' ' 187' ' ' VAL . 0.7 OUTLIER -146.79 176.64 9.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.031 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.811 179.64 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 144' ' ' SER . 3.2 p . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.048 0.451 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.4 169.33 14.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.454 0.645 . . . . 0.0 110.379 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.842 ' CE2' ' HB1' ' A' ' 97' ' ' ALA . 14.0 m-85 -107.54 129.66 54.95 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.425 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.568 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 43.7 m-85 -108.78 139.73 43.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.347 0.594 . . . . 0.0 110.589 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -47.65 -26.64 1.58 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.797 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.591 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 49.0 m -164.43 168.99 17.87 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.836 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 82.1 t -68.47 -34.13 5.35 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.019 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.1 Cg_exo -72.5 -37.22 4.37 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.629 2.22 . . . . 0.0 110.27 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.44 -40.39 50.75 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.731 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.81 -46.43 89.54 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 3.0 mm-40 -78.98 -27.87 43.47 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.462 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.5 t70 -69.7 -55.85 8.84 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.165 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.866 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 71.5 t-105 -65.73 -28.3 68.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.795 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.96 -39.95 95.31 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.054 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.96 -43.66 63.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.249 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.51 22.43 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.289 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.417 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -145.79 29.89 1.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.911 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.167 179.799 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 178' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.895 0.379 . . . . 0.0 110.992 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.57 149.09 40.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.815 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 175' ' ' ALA . 16.3 mm -102.13 160.48 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.08 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.481 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.05 164.17 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.257 0.551 . . . . 0.0 112.067 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.413 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -89.61 127.99 35.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.744 178.552 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.921 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.0 m -46.63 -20.5 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.824 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.413 ' N ' ' C ' ' A' ' 188' ' ' SER . 2.4 m-70 -72.76 -42.88 63.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.211 0.529 . . . . 0.0 109.746 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.28 -21.92 35.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.153 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.11 61.88 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.832 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.825 ' CE2' HG13 ' A' ' 128' ' ' VAL . 3.3 t80 -81.06 -24.95 37.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.688 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.89 -29.91 33.42 Favored Glycine 0 CA--C 1.51 -0.277 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -28.49 32.32 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.81 -27.97 33.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.22 -22.02 36.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.99 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.06 -23.1 55.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.213 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -51.92 -37.17 51.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -81.08 -28.31 35.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.832 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.832 0.349 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.664 ' CG ' HD11 ' A' ' 46' ' ' LEU . 57.7 Cg_endo -71.48 -24.77 22.03 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.518 2.145 . . . . 0.0 112.502 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.5 mt -54.89 -57.55 11.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.374 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.22 -27.36 38.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -53.23 15.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.966 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.92 -26.12 66.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.49 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.596 HD11 ' CG2' ' A' ' 71' ' ' ILE . 9.5 mt -73.68 -30.3 62.81 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.746 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.34 -28.77 30.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.199 0.524 . . . . 0.0 110.909 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -64.23 -19.46 65.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.208 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.0 48.49 83.05 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.038 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.42 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -129.78 164.92 36.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.658 0.266 . . . . 0.0 110.71 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.52 111.41 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.482 2.121 . . . . 0.0 112.2 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 41' ' ' THR . 24.5 t -120.32 109.98 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.358 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 p -91.51 -172.72 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.699 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -74.61 -37.85 62.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.192 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -28.25 68.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.973 0.416 . . . . 0.0 110.246 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.724 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.5 -42.36 15.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 71' ' ' ILE . 0.6 OUTLIER -62.53 -36.74 83.54 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.62 -42.95 63.91 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.589 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -31.98 77.09 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.613 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.616 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -78.66 -43.36 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 120.936 0.398 . . . . 0.0 110.478 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.664 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.5 mp -78.52 -7.41 57.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.485 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 54.91 23.64 5.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 18.0 m0 -101.02 152.03 37.77 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.285 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 53' ' ' VAL . 35.5 Cg_endo -65.18 137.05 50.33 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.433 2.089 . . . . 0.0 111.92 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.22 -21.29 0.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.15 -36.69 47.4 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.959 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.71 -40.52 88.46 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.466 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.726 ' O ' HD23 ' A' ' 57' ' ' LEU . 2.1 t -62.84 -47.97 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.423 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.7 -53.7 43.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.239 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.82 73.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.849 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 52' ' ' ARG . 36.7 t -64.36 -34.63 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.744 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 53' ' ' VAL . 3.8 mm? -61.88 -32.63 73.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 61' ' ' THR . 5.7 tt0 -57.9 -22.49 48.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -94.26 -19.85 20.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.997 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.77 32.22 2.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.435 0.636 . . . . 0.0 111.041 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 58' ' ' GLU . 38.8 p -62.16 -19.13 62.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.888 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 m -90.09 -21.99 22.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.37 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.61 141.23 55.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.384 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.512 ' O ' HG22 ' A' ' 72' ' ' ILE . 4.0 tt0 -78.86 131.06 36.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 111.634 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.452 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.7 m-85 -105.26 173.18 6.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.278 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.54 146.68 26.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 111.43 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.5 -103.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.77 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -89.88 -11.02 43.11 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.63 29.37 1.43 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.975 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -87.55 172.14 9.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.835 0.35 . . . . 0.0 110.143 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 42' ' ' LEU . 2.9 mp -79.58 118.42 27.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.272 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.865 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.004 0.431 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--O 1.23 0.03 0 CA-C-O 120.747 0.308 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.452 HG21 ' CD1' ' A' ' 95' ' ' TRP . 30.6 p -104.25 159.08 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.811 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.7 mt -91.73 49.21 1.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -178.29 137.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.08 121.32 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.7 p -109.24 -174.89 2.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.083 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -93.0 -34.35 13.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.974 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.416 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 7.7 m-85 -83.76 112.41 20.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.316 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.469 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.5 t -107.84 144.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.985 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.919 ' CD1' HG22 ' A' ' 113' ' ' VAL . 38.4 t80 -133.93 105.36 6.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.144 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -97.47 131.9 43.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.052 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.05 124.29 18.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 -71.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.537 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -161.22 35.44 0.14 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.601 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -137.62 142.28 41.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.295 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.94 86.28 2.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 110.74 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -71.62 164.7 25.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.781 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -134.91 164.18 28.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.161 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.615 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -151.02 167.03 28.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.014 0.435 . . . . 0.0 111.881 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.452 ' CD1' HG21 ' A' ' 77' ' ' THR . 8.4 m0 -95.09 -18.92 20.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.62 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.449 ' HB3' HG13 ' A' ' 162' ' ' VAL . 1.7 m -150.11 166.61 29.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.154 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.594 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -53.76 -21.81 8.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.845 HD13 HG11 ' A' ' 162' ' ' VAL . 10.8 mp -84.67 -51.59 6.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.561 0.22 . . . . 0.0 111.536 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.599 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -47.96 -28.16 2.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -60.69 -39.32 88.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 110.58 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.042 HD21 HG11 ' A' ' 128' ' ' VAL . 1.5 mt -86.35 168.5 13.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.225 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 101' ' ' LEU . 6.8 pt -160.66 -43.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.031 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.808 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.0 OUTLIER 178.16 78.34 0.14 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.453 ' CB ' HG12 ' A' ' 128' ' ' VAL . 52.2 Cg_endo -69.12 -38.8 8.65 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.623 2.216 . . . . 0.0 112.474 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.77 -23.94 45.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.242 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -83.94 -40.9 17.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.259 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.808 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.2 tp -57.37 -46.48 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.239 0.542 . . . . 0.0 111.473 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.9 24.75 12.49 Favored Glycine 0 C--N 1.319 -0.392 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.565 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.43 173.79 14.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 0.0 110.965 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -81.39 155.67 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.845 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.1 110.0 7.64 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.3 mtm180 -81.23 119.87 24.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.816 0.817 . . . . 0.0 111.242 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.919 HG22 ' CD1' ' A' ' 85' ' ' PHE . 48.9 t -111.88 129.89 66.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.162 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.469 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 75.9 p -123.98 137.74 54.56 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.249 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.578 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.53 172.89 12.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.343 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -134.41 133.3 40.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.23 134.65 55.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.251 0.548 . . . . 0.0 112.337 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.68 -3.55 22.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.284 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.882 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -123.26 -51.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.958 0.409 . . . . 0.0 111.476 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.44 HG23 HG21 ' A' ' 170' ' ' THR . 1.4 p -84.99 -29.44 25.03 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.002 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.02 4.97 79.27 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.219 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . . . -59.11 150.77 60.48 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 1.1 Cg_endo -82.54 104.11 1.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.561 2.174 . . . . 0.0 111.093 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.578 HG22 ' C ' ' A' ' 115' ' ' SER . 35.9 m -97.71 144.28 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.985 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.0 p -150.6 142.35 23.72 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.439 0.637 . . . . 0.0 110.856 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -139.61 151.64 46.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.815 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.843 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 52.4 m -107.88 113.91 27.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 1.042 HG11 HD21 ' A' ' 101' ' ' LEU . 46.2 t -96.0 111.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.087 0.47 . . . . 0.0 111.403 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.502 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -106.79 177.83 1.24 Allowed Pre-proline 0 N--CA 1.453 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.638 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 56.6 Cg_endo -72.55 -20.1 23.91 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 121.961 1.774 . . . . 0.0 112.87 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 26.8 t -109.96 -28.06 8.92 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 131' ' ' SER . 11.8 pt-20 177.63 -162.73 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.11 0.481 . . . . 0.0 110.08 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.69 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -95.72 143.96 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.8 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -129.41 21.82 5.61 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.399 0.619 . . . . 0.0 112.295 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.843 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.66 87.65 0.1 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.225 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.577 HG13 ' SD ' ' A' ' 141' ' ' MET . 41.6 t -104.55 115.59 46.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.332 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -146.37 124.24 6.16 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.652 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.79 157.08 95.24 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.207 0.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.85 79.04 0.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.123 0.487 . . . . 0.0 110.611 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 143.15 19.22 0.23 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.184 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.745 ' HG3' HG21 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -57.73 156.78 8.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.939 0.4 . . . . 0.0 111.577 -179.346 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -129.5 152.21 49.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.123 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.669 HG13 ' CD1' ' A' ' 164' ' ' PHE . 21.1 t -115.35 151.03 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.825 ' O ' HG23 ' A' ' 162' ' ' VAL . 51.6 p -116.81 141.43 48.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.712 0.292 . . . . 0.0 110.405 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 184' ' ' LEU . 1.6 mp -138.16 176.09 9.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 146' ' ' VAL . 27.0 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.965 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.845 HG11 HD13 ' A' ' 98' ' ' LEU . 8.9 p . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 121.063 0.459 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.54 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 3.5 m-70 -125.65 169.26 12.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.48 0.657 . . . . 0.0 109.973 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.669 ' CD1' HG13 ' A' ' 143' ' ' VAL . 2.7 m-85 -113.01 129.72 56.4 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.728 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.613 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 42.9 m-85 -108.6 140.76 41.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.46 0.647 . . . . 0.0 110.722 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.28 -26.17 1.87 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.978 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.538 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 10.8 t -163.99 169.55 17.84 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.086 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 84.6 t -68.78 -35.11 6.04 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.403 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.5 Cg_exo -72.19 -37.28 4.75 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.83 2.354 . . . . 0.0 110.192 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.571 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -75.95 -41.22 52.22 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.538 178.054 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.759 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.76 -45.57 93.35 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.0 mt-10 -78.78 -27.96 44.64 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.21 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.3 t70 -70.82 -55.97 7.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.604 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.882 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 64.2 t-105 -64.83 -28.83 69.83 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -61.22 -40.98 96.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.196 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -46.13 65.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.246 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -98.02 25.6 5.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.068 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.4 ' O ' HD22 ' A' ' 184' ' ' LEU . 1.9 t-160 -153.03 33.62 0.48 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.0 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 179.742 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 145' ' ' LEU . 6.7 tp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.735 0.302 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.55 149.0 40.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.999 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 175' ' ' ALA . 19.2 mm -102.9 161.73 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.503 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -157.57 156.69 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 112.051 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.8 OUTLIER -82.64 122.11 27.7 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.142 178.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.745 HG21 ' HG3' ' A' ' 141' ' ' MET . 0.9 OUTLIER -41.29 -29.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.549 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -64.47 -46.13 84.36 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -82.2 -20.8 37.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.841 178.052 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.669 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -72.91 -25.82 61.19 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -81.65 -24.91 36.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.557 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.75 -28.3 39.02 Favored Glycine 0 CA--C 1.509 -0.326 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 21.1 tp -82.06 -28.38 32.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.06 -28.85 29.93 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.405 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -76.19 -21.96 55.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.964 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.01 -22.86 39.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.15 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -51.85 -37.4 51.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.15 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.98 -55.19 38.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.515 HG21 HD12 ' A' ' 28' ' ' LEU . 6.2 m . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.641 0.257 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.577 ' CG ' HD11 ' A' ' 46' ' ' LEU . 39.6 Cg_endo -67.06 -29.18 40.53 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.411 2.074 . . . . 0.0 112.312 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.53 -57.36 12.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.041 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.515 HD12 HG21 ' A' ' 25' ' ' VAL . 12.0 mt -57.3 -27.05 61.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.397 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -65.72 -53.24 43.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.087 0.47 . . . . 0.0 109.887 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -77.12 -28.31 54.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.533 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 31' ' ' LEU . 1.7 tm? -70.77 -52.13 22.66 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.84 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.98 -25.67 22.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.043 0.449 . . . . 0.0 110.981 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -68.71 -21.8 64.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.224 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.27 46.81 93.59 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.026 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -130.0 158.6 73.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 0.0 110.815 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.96 110.76 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.499 2.132 . . . . 0.0 112.065 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.654 HG23 ' CG2' ' A' ' 41' ' ' THR . 11.6 p -118.98 111.0 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.36 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 p -75.85 -178.7 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.967 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -77.94 -35.86 49.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.253 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -24.88 66.68 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.195 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.654 ' CG2' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.13 -42.84 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.326 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 46' ' ' LEU . 10.3 tp -63.63 -36.25 83.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 176.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -74.17 -42.48 59.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.492 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.8 -29.02 72.65 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.546 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 41' ' ' THR . 7.1 mt -79.06 -41.45 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 121.17 0.51 . . . . 0.0 110.074 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 26' ' ' PRO . 6.9 mp -77.15 -9.92 59.07 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.354 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 t70 61.46 21.35 11.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -110.08 158.32 35.42 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.23 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.63 143.27 56.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.611 2.208 . . . . 0.0 111.917 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.3 -16.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -32.0 41.52 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.967 0.413 . . . . 0.0 111.146 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -68.98 -41.66 77.61 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.643 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.0 t -63.95 -46.44 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.56 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.71 -50.07 69.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.575 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.13 -35.78 27.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 52' ' ' ARG . 28.5 t -68.75 -31.05 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.081 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 53' ' ' VAL . 4.9 mp -81.08 -17.21 50.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.319 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -58.52 -19.24 35.8 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.256 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.66 17.91 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.705 0.288 . . . . 0.0 111.173 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . . . -113.12 71.11 0.73 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.803 0.811 . . . . 0.0 110.635 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.1 p -63.88 -15.27 58.59 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.415 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.1 t -95.19 34.68 1.37 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.5 HG21 HD23 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -95.91 110.93 23.04 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.795 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -82.3 126.51 32.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.1 0.476 . . . . 0.0 111.997 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 69' ' ' GLY . 5.8 m-85 -110.83 160.3 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.14 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.13 143.9 25.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 0.0 111.498 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.1 -100.44 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.854 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -93.82 -10.46 34.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.411 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 125.07 33.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.939 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -93.99 154.24 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 37' ' ' VAL . 4.3 mt -79.79 125.19 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.979 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.706 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.771 HD13 ' O ' ' A' ' 93' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.844 0.354 . . . . 0.0 111.202 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.465 HG21 HG23 ' A' ' 81' ' ' THR . 12.9 t -102.38 159.09 15.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.938 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.503 ' C ' HD23 ' A' ' 78' ' ' LEU . 9.9 tt -82.21 -40.9 21.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 77' ' ' THR . 4.1 mtt180 -96.8 153.63 17.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 110.979 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -66.25 126.66 29.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.465 HG23 HG21 ' A' ' 77' ' ' THR . 35.5 p -110.59 -172.47 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.109 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.27 -32.87 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.38 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -79.34 110.75 14.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.751 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.829 HG22 ' CE1' ' A' ' 93' ' ' TYR . 25.1 t -104.73 135.0 44.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.964 0.412 . . . . 0.0 111.045 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.936 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 55.1 t80 -127.55 106.6 9.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.579 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -101.5 132.59 47.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.329 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.5 pt -140.03 123.1 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 111.825 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.6 t70 60.97 -69.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.381 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 87' ' ' ILE . 1.8 t70 -166.24 35.33 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.348 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -136.45 111.96 9.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.013 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -77.91 120.63 23.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.639 HD12 ' CD2' ' A' ' 85' ' ' PHE . 23.2 mt -117.15 165.08 13.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.829 ' CE1' HG22 ' A' ' 84' ' ' VAL . 6.0 m-85 -133.44 165.16 25.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.362 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.679 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -150.85 173.01 14.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.118 0.485 . . . . 0.0 111.95 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -108.29 -5.67 16.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.832 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.6 p -160.09 163.08 34.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.13 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.625 ' HB1' ' CZ ' ' A' ' 164' ' ' PHE . . . -51.7 -23.1 4.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -88.76 -51.59 5.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.715 0.293 . . . . 0.0 111.349 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.679 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 1.9 m-20 -39.7 -28.81 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -59.72 -35.42 74.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.64 0.257 . . . . 0.0 110.812 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.936 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 14.8 tp -156.93 160.22 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.553 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 mt -113.52 -31.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.07 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 200' ' ' ASN . 4.1 m-85 -161.81 99.27 1.2 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.964 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.543 ' CB ' HG12 ' A' ' 128' ' ' VAL . 59.7 Cg_endo -71.77 -26.35 19.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.578 2.185 . . . . 0.0 112.335 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.36 -23.5 43.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.338 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 tp -81.7 -40.5 22.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.573 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.7 tp -54.39 -48.34 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.171 0.51 . . . . 0.0 111.595 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.22 20.71 22.32 Favored Glycine 0 C--N 1.319 -0.41 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.799 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 173.04 14.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.949 0.404 . . . . 0.0 111.023 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -78.28 152.79 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.644 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.819 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -137.15 109.88 7.56 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -83.71 120.57 26.17 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.79 0.805 . . . . 0.0 111.056 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.451 HG22 ' HD1' ' A' ' 85' ' ' PHE . 93.6 t -111.82 130.59 65.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.014 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 m -122.45 136.24 54.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.101 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.548 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -141.99 173.17 11.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.684 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 71.6 m80 -134.56 136.64 43.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 165' ' ' PHE . 28.5 t -64.76 134.44 54.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.179 0.514 . . . . 0.0 112.175 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.32 -5.76 34.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.819 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.895 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -126.89 -50.91 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.471 ' CG2' ' HB2' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -74.41 -33.6 63.05 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.217 0.532 . . . . 0.0 110.026 -179.104 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.17 34.92 57.67 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.373 -0.918 . . . . 0.0 110.818 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.471 ' HB2' ' CG2' ' A' ' 120' ' ' THR . . . -100.34 160.32 27.34 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.178 -0.511 . . . . 0.0 109.994 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -87.78 108.02 0.62 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.731 2.287 . . . . 0.0 111.257 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.548 HG22 ' C ' ' A' ' 115' ' ' SER . 35.9 m -104.41 144.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.157 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 85.4 p -147.22 142.79 27.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.51 0.671 . . . . 0.0 110.631 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -136.63 152.38 50.37 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.56 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.873 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.1 m -112.26 113.98 26.51 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 23.8 t -96.3 111.91 27.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.84 0.353 . . . . 0.0 111.586 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.47 167.21 9.88 Favored Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.211 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.79 -16.54 55.84 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.521 2.147 . . . . 0.0 113.051 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 27.2 t -116.72 -25.6 7.28 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 131' ' ' SER . 12.5 pt-20 178.94 -162.41 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.123 0.487 . . . . 0.0 109.854 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -96.05 160.14 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.878 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -147.01 18.64 1.25 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.422 0.629 . . . . 0.0 112.409 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.873 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.95 86.56 0.08 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.643 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.464 HG13 ' SD ' ' A' ' 141' ' ' MET . 41.0 t -105.07 120.79 56.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.848 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -145.23 126.16 7.49 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.985 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.22 165.53 84.12 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.475 -1.469 . . . . 0.0 112.271 -0.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.77 78.01 0.86 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.148 0.499 . . . . 0.0 110.656 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.7 19.32 0.18 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.171 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.682 ' CG ' HG11 ' A' ' 189' ' ' VAL . 10.4 ptm -61.03 160.91 9.16 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.949 0.404 . . . . 0.0 111.396 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -126.89 152.19 47.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.381 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.722 HG13 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -113.76 147.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.863 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.747 ' O ' HG13 ' A' ' 162' ' ' VAL . 56.3 p -117.29 137.52 52.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.697 0.284 . . . . 0.0 110.659 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 146' ' ' VAL . 0.3 OUTLIER -144.11 176.18 9.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 146' ' ' VAL . 8.5 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.801 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 144' ' ' SER . 21.9 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.902 0.382 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.473 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 8.8 m-70 -120.5 165.96 14.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.58 0.705 . . . . 0.0 110.152 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.722 ' CE1' HG13 ' A' ' 143' ' ' VAL . 40.9 m-85 -115.52 140.67 48.94 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.536 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.591 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 57.0 m-85 -117.6 137.94 52.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.228 0.537 . . . . 0.0 110.287 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.38 -26.13 0.5 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.656 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 30.8 p -167.52 170.65 11.05 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.73 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.603 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 90.5 t -68.03 -34.37 6.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.32 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.707 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.8 Cg_exo -72.33 -37.41 4.46 Favored 'Trans proline' 0 CA--C 1.503 -1.06 0 C-N-CA 122.58 2.187 . . . . 0.0 110.321 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.584 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.34 -40.45 51.24 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.733 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.84 -46.38 89.73 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.561 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 2.3 mm-40 -79.09 -27.43 42.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.425 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 169' ' ' PRO . 17.6 t70 -69.8 -55.77 8.93 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.168 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.895 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 54.7 t-105 -65.87 -28.76 69.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.652 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.733 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.47 -39.05 93.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.213 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.5 t -51.98 -45.32 64.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.386 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 22.33 7.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.345 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.75 37.77 0.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.903 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.326 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.82 0.343 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.33 150.1 40.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 111.015 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.3 mm -102.42 159.99 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.923 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.454 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.09 162.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.175 0.512 . . . . 0.0 111.782 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.9 OUTLIER -88.77 125.68 34.99 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.792 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.706 HG21 HD23 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -46.98 -20.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.596 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -69.27 -43.16 74.44 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -82.53 -24.49 34.04 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.249 178.473 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -71.91 -25.28 61.84 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.534 ' CE2' HG23 ' A' ' 133' ' ' ILE . 2.8 t80 -81.76 -31.38 31.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.145 0.498 . . . . 0.0 110.511 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.16 -30.45 31.06 Favored Glycine 0 CA--C 1.51 -0.253 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.359 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.01 -28.26 35.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.92 -29.07 29.75 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.62 -22.82 34.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.377 -0.411 . . . . 0.0 110.962 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -78.9 -22.8 45.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.23 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.76 -28.71 16.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.201 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . 63.6 t-20 -81.1 -41.6 22.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.715 HG11 HD12 ' A' ' 28' ' ' LEU . 6.4 t . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.637 0.256 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.532 ' HG3' HD11 ' A' ' 46' ' ' LEU . 43.4 Cg_endo -68.18 -43.62 4.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.565 2.176 . . . . 0.0 112.659 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.596 HD12 ' HG ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -51.95 -57.03 10.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.715 HD12 HG11 ' A' ' 25' ' ' VAL . 15.7 mt -63.25 -26.83 68.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.011 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 -60.34 -53.1 61.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.933 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.745 ' HB3' HG21 ' A' ' 37' ' ' VAL . 24.8 mm-40 -75.32 -22.05 57.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.582 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tp -75.15 -52.15 11.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.254 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.0 -36.3 62.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.966 0.412 . . . . 0.0 112.003 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 30' ' ' GLU . 6.5 ptmt -68.23 -19.52 64.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.155 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.32 56.88 13.14 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.228 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.9 165.76 25.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.653 0.263 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.57 114.41 3.93 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.546 2.164 . . . . 0.0 112.24 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.745 HG21 ' HB3' ' A' ' 30' ' ' GLU . 25.0 t -126.91 110.45 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.428 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 82.1 p -89.97 -169.84 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -78.04 -37.88 45.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.361 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -29.13 69.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.907 0.384 . . . . 0.0 110.174 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.708 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -83.41 -42.76 16.62 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.393 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.653 ' CD1' HD13 ' A' ' 71' ' ' ILE . 10.2 mt -62.15 -36.76 82.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -71.28 -43.02 67.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.788 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.83 -31.84 70.16 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.86 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.617 HD12 HG23 ' A' ' 41' ' ' THR . 6.7 mt -77.42 -45.44 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 120.885 0.374 . . . . 0.0 110.722 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 42' ' ' LEU . 2.0 mm? -76.81 -8.51 57.46 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.567 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 t0 60.5 24.27 13.9 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.425 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 5.3 m95 -111.37 139.8 22.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.181 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.85 144.48 20.79 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.556 2.17 . . . . 0.0 112.252 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.46 -16.69 2.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -77.2 -34.88 56.11 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.427 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.603 ' O ' HG23 ' A' ' 56' ' ' VAL . 9.7 mtt85 -67.71 -41.33 83.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.636 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -63.82 -47.99 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.389 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.4 -52.53 59.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.299 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.98 -34.99 10.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.891 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 52' ' ' ARG . 36.1 t -63.97 -32.29 56.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.015 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 3.6 mm? -66.63 -34.65 78.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.758 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 61' ' ' THR . 4.4 tt0 -56.03 -34.08 65.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.549 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -96.19 -18.36 20.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.737 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . . . -96.6 35.96 1.44 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.438 0.637 . . . . 0.0 111.098 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 58' ' ' GLU . 72.6 p -58.75 -18.16 29.26 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.269 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 m -112.77 38.12 2.89 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.785 0.326 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 60' ' ' ALA . 0.9 OUTLIER -101.24 141.58 33.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.102 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.503 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -78.62 126.79 31.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.092 0.472 . . . . 0.0 111.257 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CZ ' HG22 ' A' ' 63' ' ' THR . 61.1 m-85 -117.2 173.15 6.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.369 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.595 ' OD1' HD13 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -151.64 146.75 26.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.027 0.441 . . . . 0.0 111.333 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.9 tttm 66.7 -103.33 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.813 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -87.92 -11.46 47.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.21 26.96 2.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.128 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -81.49 169.43 17.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.953 0.406 . . . . 0.0 109.914 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.653 HD13 ' CD1' ' A' ' 42' ' ' LEU . 3.9 mp -79.69 120.13 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.652 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.595 HD13 ' OD1' ' A' ' 66' ' ' ASP . 2.4 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.796 0.332 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.1 p -109.88 159.1 17.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -92.2 42.74 1.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -155.06 123.61 6.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' THR . 14.8 pm0 -57.46 -19.76 26.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.43 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 80' ' ' GLU . 54.4 p 36.88 -165.83 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -110.0 -26.26 9.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 28.1 m-85 -87.83 117.37 26.62 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.596 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.424 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.7 t -110.1 145.08 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.024 0.44 . . . . 0.0 111.521 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.797 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 17.4 t80 -134.13 107.46 7.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.016 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -102.51 133.03 48.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 0.0 111.843 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.486 HG23 ' CE1' ' A' ' 85' ' ' PHE . 3.8 pt -140.1 124.37 18.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.255 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.5 t70 63.12 -68.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.216 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.3 t0 -166.92 36.15 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.413 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -135.76 114.72 12.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.938 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.443 ' CD ' ' H ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -83.1 85.77 7.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.233 0.539 . . . . 0.0 110.885 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -74.13 165.05 25.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.08 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -134.88 165.28 25.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.365 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.683 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -151.56 169.75 21.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 0.0 111.919 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 17.8 m0 -88.24 -25.22 22.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.828 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.903 ' HB2' HG13 ' A' ' 162' ' ' VAL . 3.9 p -147.57 173.0 13.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.388 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.527 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -56.6 -20.87 23.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.826 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.821 HD12 HG11 ' A' ' 162' ' ' VAL . 14.2 mt -87.31 -51.66 5.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.59 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 5.3 m-20 -50.12 -24.65 2.87 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.683 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.7 -39.48 88.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.719 0.295 . . . . 0.0 110.651 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.532 HD12 ' C ' ' A' ' 101' ' ' LEU . 4.2 pp -112.08 178.42 4.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 111.106 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 101' ' ' LEU . 4.3 tt -157.93 -45.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.11 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.651 ' O ' HG22 ' A' ' 107' ' ' ILE . 8.0 m-85 -164.4 90.89 1.04 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.07 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.666 ' HB3' HG12 ' A' ' 128' ' ' VAL . 60.1 Cg_endo -72.86 -33.69 7.59 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.522 2.148 . . . . 0.0 112.456 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.411 ' HA ' ' CB ' ' A' ' 130' ' ' PRO . . . -78.05 -23.92 47.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.391 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.401 ' CB ' ' HB3' ' A' ' 103' ' ' PHE . 1.9 tp -84.84 -42.73 14.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.223 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -54.7 -48.6 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.175 0.512 . . . . 0.0 111.419 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.74 21.6 15.94 Favored Glycine 0 C--N 1.319 -0.408 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.921 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.77 177.36 10.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.053 0.454 . . . . 0.0 111.109 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -83.52 153.74 24.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.926 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.797 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -137.09 109.87 7.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -82.75 121.05 26.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.778 0.799 . . . . 0.0 111.034 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.455 HG22 ' HD2' ' A' ' 85' ' ' PHE . 99.0 t -113.18 132.61 61.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.811 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.424 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 60.5 p -120.77 139.09 53.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.066 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.553 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.3 m -140.73 172.9 12.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.26 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -133.61 130.56 38.5 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.8 m -57.33 123.26 14.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.044 0.45 . . . . 0.0 111.803 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.34 -9.3 39.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.695 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.693 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.54 -50.59 1.98 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.558 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -75.74 -21.21 57.69 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.965 0.412 . . . . 0.0 110.848 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.45 33.96 86.61 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.118 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.558 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -102.41 167.8 9.86 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.43 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.409 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 37.7 Cg_endo -93.22 110.05 0.2 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.954 2.436 . . . . 0.0 111.28 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.553 HG22 ' C ' ' A' ' 115' ' ' SER . 35.0 m -108.5 148.32 12.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.547 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.861 ' C ' HD13 ' A' ' 126' ' ' LEU . 79.4 p -149.21 141.44 24.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.406 0.622 . . . . 0.0 110.795 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.861 HD13 ' C ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -132.6 153.78 50.69 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.53 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.811 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.2 m -110.99 114.46 27.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.828 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.765 HG13 ' CE2' ' A' ' 193' ' ' PHE . 38.4 t -96.47 111.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.412 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -106.65 168.9 7.44 Favored Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.958 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.2 Cg_endo -66.09 -19.27 57.33 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.229 1.953 . . . . 0.0 112.891 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 34.6 p -112.89 -26.12 8.69 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 131' ' ' SER . 11.1 pt-20 178.09 -162.23 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.131 0.491 . . . . 0.0 110.099 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.695 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.35 158.76 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.752 178.408 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -146.19 20.43 1.4 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.387 0.613 . . . . 0.0 112.299 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.811 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.67 86.47 0.09 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.646 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.631 HG13 ' SD ' ' A' ' 141' ' ' MET . 58.4 t -102.87 113.51 39.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.375 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.447 ' O ' ' HE1' ' A' ' 141' ' ' MET . 4.2 tm-20 -146.26 121.94 5.61 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.498 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.608 ' HD2' ' HE3' ' A' ' 141' ' ' MET . 55.6 Cg_endo -69.28 157.6 90.53 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.459 -1.475 . . . . 0.0 112.737 -0.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.02 80.33 1.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.54 16.64 0.15 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.351 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.811 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -61.16 159.24 12.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.033 0.444 . . . . 0.0 111.571 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -129.03 152.1 48.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.515 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.697 HG13 ' CD1' ' A' ' 164' ' ' PHE . 4.6 t -115.31 152.97 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.88 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 162' ' ' VAL . 23.5 m -120.0 141.08 50.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.582 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.534 HD13 HG21 ' A' ' 187' ' ' VAL . 5.2 mp -142.23 176.27 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.985 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 1.012 HG22 HD12 ' A' ' 184' ' ' LEU . 36.4 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.811 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.903 HG13 ' HB2' ' A' ' 96' ' ' CYS . 2.6 p . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 121.068 0.461 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.41 ' CE1' ' OH ' ' A' ' 83' ' ' TYR . 3.6 m-70 -126.96 169.38 13.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.555 0.693 . . . . 0.0 110.05 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.697 ' CD1' HG13 ' A' ' 143' ' ' VAL . 1.9 m-85 -108.61 150.69 27.16 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.796 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 37.9 m-85 -132.96 136.26 45.99 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.361 0.601 . . . . 0.0 110.564 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.641 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -39.19 -28.67 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.142 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.498 ' HB3' ' HD2' ' A' ' 169' ' ' PRO . 30.5 t -171.7 176.78 3.58 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.796 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 85.3 t -69.05 -34.3 4.92 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.552 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.7 Cg_exo -72.55 -38.38 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.813 2.342 . . . . 0.0 110.396 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.595 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.52 -39.84 51.77 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.546 177.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.706 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.33 -45.37 94.69 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.6 mt-10 -79.19 -27.56 42.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.179 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 169' ' ' PRO . 8.8 t70 -70.24 -55.86 8.21 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.421 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.693 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 57.4 t90 -65.17 -28.05 69.13 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.8 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -66.73 -37.04 83.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.323 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 t -53.09 -46.51 68.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.404 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -95.16 22.79 6.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.211 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.501 ' CD2' ' CZ2' ' A' ' 174' ' ' TRP . 79.5 m80 -152.8 45.43 0.69 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.952 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.739 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 1.012 HD12 HG22 ' A' ' 146' ' ' VAL . 1.1 tp . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.11 41.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.021 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 175' ' ' ALA . 10.0 mm -99.78 159.45 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.864 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -161.12 162.03 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.361 0.6 . . . . 0.0 111.967 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -90.8 129.64 36.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.778 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.811 HG11 ' HG3' ' A' ' 141' ' ' MET . 1.5 m -46.98 -19.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.75 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 8.7 m80 -71.76 -41.84 67.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.798 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.21 -24.22 34.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.364 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.9 61.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.175 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.765 ' CE2' HG13 ' A' ' 128' ' ' VAL . 5.4 t80 -81.3 -25.57 36.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.682 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.76 -30.25 32.92 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 -28.22 32.48 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.14 -28.32 31.2 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.414 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -82.28 -23.99 34.95 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.883 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.08 -23.04 57.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.146 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -51.89 -33.08 35.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.144 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -80.99 -25.08 37.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.948 179.976 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.623 HG21 HD22 ' A' ' 106' ' ' LEU . 17.0 m . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.852 0.358 . . . . 0.0 111.823 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.607 ' HG2' HD11 ' A' ' 46' ' ' LEU . 52.9 Cg_exo -52.49 -26.23 27.86 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.482 2.122 . . . . 0.0 112.219 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.623 HD21 ' CG2' ' A' ' 71' ' ' ILE . 1.0 OUTLIER -52.13 -57.37 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.352 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 mt -80.17 -27.28 39.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.55 -53.22 51.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.548 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.584 ' HG2' HD13 ' A' ' 45' ' ' ILE . 3.0 mp0 -66.03 -23.28 66.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.291 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.609 HD21 ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -69.52 -38.38 77.53 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.07 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.08 -25.63 13.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.001 0.429 . . . . 0.0 111.174 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.01 -20.87 65.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.073 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.56 42.46 95.61 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.267 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -133.36 165.85 33.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.704 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.55 114.28 3.78 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.502 2.135 . . . . 0.0 112.016 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.696 HG12 ' HG ' ' A' ' 42' ' ' LEU . 20.8 t -115.57 110.19 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.421 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.7 p -88.03 -171.65 3.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.746 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -77.99 -36.64 48.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.313 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -29.42 69.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.276 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.651 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -83.52 -42.65 16.61 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.696 ' HG ' HG12 ' A' ' 37' ' ' VAL . 12.6 mt -62.53 -36.56 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.975 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.87 -43.01 63.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.646 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.28 -31.65 77.76 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.477 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.634 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -79.54 -38.52 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 121.061 0.458 . . . . 0.0 110.231 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.607 HD11 ' HG2' ' A' ' 26' ' ' PRO . 6.4 mp -78.13 -10.01 59.43 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.178 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 59.38 22.54 10.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.439 ' CD1' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -102.77 137.06 19.21 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.189 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.731 ' O ' HG23 ' A' ' 53' ' ' VAL . 10.1 Cg_endo -53.04 142.81 52.8 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.697 2.265 . . . . 0.0 112.207 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.8 -20.64 2.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.55 -39.95 36.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.121 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.896 ' O ' HG23 ' A' ' 56' ' ' VAL . 13.0 mmt180 -67.93 -38.28 82.7 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.975 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.5 t -65.73 -48.1 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.89 -54.37 30.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.177 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.14 64.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.898 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 52' ' ' ARG . 35.9 t -65.06 -31.73 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.747 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.21 -35.12 79.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.59 ' O ' HG23 ' A' ' 61' ' ' THR . 1.8 mp0 -57.49 -22.82 46.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.851 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -96.42 -20.68 18.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.38 31.89 2.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.55 0.69 . . . . 0.0 110.916 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 58' ' ' GLU . 21.1 p -71.61 -27.65 63.26 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.8 m -75.86 -25.51 56.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.35 141.25 56.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.042 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.6 ' CG ' HG21 ' A' ' 72' ' ' ILE . 14.5 pt-20 -78.92 133.77 36.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.046 0.45 . . . . 0.0 111.274 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.426 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 55.2 m-85 -105.19 173.42 6.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.48 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -149.82 145.97 26.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.969 0.414 . . . . 0.0 111.499 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 tttp 65.6 -105.03 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.634 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -86.91 -11.51 50.46 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.713 0.292 . . . . 0.0 111.561 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 122.67 25.87 1.86 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.228 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -78.02 158.79 29.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 110.006 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.669 HD13 ' CD1' ' A' ' 42' ' ' LEU . 1.9 mp -79.74 126.32 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.574 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.819 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 121.027 0.442 . . . . 0.0 111.021 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.794 0.33 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -113.72 140.86 47.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.579 ' H ' HD12 ' A' ' 78' ' ' LEU . 5.1 mp -59.75 -23.87 63.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -92.97 123.61 36.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 111.096 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.2 pt-20 -60.64 -16.76 42.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.461 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.756 HG21 ' HA ' ' A' ' 95' ' ' TRP . 0.5 OUTLIER 37.46 -167.97 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.596 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.08 -24.88 12.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.113 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -80.78 114.85 19.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.55 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.82 136.14 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.015 0.436 . . . . 0.0 111.423 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.819 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 56.5 t80 -128.16 104.6 7.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.177 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -98.6 131.12 45.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.396 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -140.06 122.95 17.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.07 -72.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 87' ' ' ILE . 18.3 t0 -159.26 37.11 0.2 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -139.8 145.95 38.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.56 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.96 86.49 2.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.871 0.367 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 85' ' ' PHE . 4.3 mm? -71.27 164.79 25.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.589 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.41 ' CD2' ' HA ' ' A' ' 80' ' ' GLU . 5.1 m-85 -131.12 160.08 35.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.356 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.549 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -146.55 161.44 40.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.737 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.756 ' HA ' HG21 ' A' ' 81' ' ' THR . 7.7 m0 -90.61 -24.7 20.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.409 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.436 ' HB3' ' CG1' ' A' ' 162' ' ' VAL . 5.6 m -146.97 172.37 13.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.974 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.716 ' HB1' ' CE2' ' A' ' 164' ' ' PHE . . . -53.77 -21.53 7.51 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.432 ' HB2' HG11 ' A' ' 162' ' ' VAL . 2.1 tp -86.8 -51.53 6.03 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.549 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -45.57 -25.39 0.45 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -60.31 -36.73 78.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.688 0.28 . . . . 0.0 110.87 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.866 HD12 ' CG ' ' A' ' 104' ' ' PRO . 1.9 pt? -137.5 166.18 24.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.004 0.431 . . . . 0.0 111.386 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.405 HG22 ' CZ ' ' A' ' 103' ' ' PHE . 4.1 mp -143.62 -46.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.405 ' CZ ' HG22 ' A' ' 102' ' ' ILE . 38.5 m-85 -141.1 65.83 23.45 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.664 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.866 ' CG ' HD12 ' A' ' 101' ' ' LEU . 34.3 Cg_exo -57.83 -30.61 89.99 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.742 2.295 . . . . 0.0 112.531 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.36 -23.61 43.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.455 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.623 HD22 HG21 ' A' ' 25' ' ' VAL . 1.1 tt -85.94 -34.04 20.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.143 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 tp -54.51 -47.61 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.174 0.511 . . . . 0.0 111.687 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.91 20.85 25.0 Favored Glycine 0 C--N 1.32 -0.351 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.733 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 173.42 14.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 111.011 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -78.87 151.8 31.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.819 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.14 109.75 7.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 112.001 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -82.35 119.64 24.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.818 0.818 . . . . 0.0 111.198 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.768 HG22 ' CD1' ' A' ' 85' ' ' PHE . 39.6 t -111.61 130.47 65.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.137 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.0 m -122.29 137.04 54.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.093 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.548 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.62 172.8 12.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.209 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.44 ' CD2' ' HA ' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -136.68 135.06 37.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 26.4 t -61.77 132.14 52.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.227 0.537 . . . . 0.0 112.147 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.48 -3.84 23.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.935 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.915 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.58 -50.6 1.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.616 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -88.98 -24.23 22.45 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.247 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.36 5.03 76.05 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.179 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.689 ' H ' HG22 ' A' ' 120' ' ' THR . . . -57.74 151.17 43.54 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.504 0.193 . . . . 0.0 110.579 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.44 ' HA ' ' CD2' ' A' ' 116' ' ' HIS . 2.5 Cg_endo -84.54 105.8 1.06 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.736 2.29 . . . . 0.0 110.898 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.65 HG12 ' CD ' ' A' ' 138' ' ' PRO . 35.2 m -103.29 145.49 12.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.419 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.906 ' O ' HD13 ' A' ' 126' ' ' LEU . 72.8 p -151.49 141.62 22.22 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.443 0.64 . . . . 0.0 110.699 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.906 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -134.82 152.92 52.14 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.306 178.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.882 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 82.7 m -111.34 113.31 25.69 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.541 HG22 ' HZ ' ' A' ' 193' ' ' PHE . 19.7 t -95.86 111.73 26.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.631 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.14 175.63 2.07 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.401 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.78 -15.62 37.11 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.695 2.263 . . . . 0.0 112.971 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 50.1 m -120.11 -26.03 5.61 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 131' ' ' SER . 14.6 pt-20 179.74 -162.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.169 0.509 . . . . 0.0 110.186 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.777 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -96.62 161.36 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.992 178.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -149.31 19.25 0.95 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.298 0.57 . . . . 0.0 112.253 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.882 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.09 86.23 0.08 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.593 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.557 HG13 HD12 ' A' ' 126' ' ' LEU . 24.4 t -105.02 118.35 52.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.138 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -146.21 117.12 4.82 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.65 ' CD ' HG12 ' A' ' 124' ' ' VAL . 13.9 Cg_exo -69.47 146.99 83.12 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.643 -1.399 . . . . 0.0 112.28 0.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.18 -33.83 54.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.642 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.93 28.98 12.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.957 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.759 ' HE1' HD21 ' A' ' 126' ' ' LEU . 1.9 ppp? -64.9 156.55 30.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.126 0.489 . . . . 0.0 111.529 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -128.72 152.32 48.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.616 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.844 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -112.49 150.67 14.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.965 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 162' ' ' VAL . 23.0 p -119.86 140.37 50.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.757 0.313 . . . . 0.0 111.026 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.4 mt -139.02 176.28 8.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.873 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.051 179.741 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 144' ' ' SER . 8.0 p . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 121.13 0.491 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.447 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 2.5 m-70 -126.81 169.24 13.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.609 0.719 . . . . 0.0 110.076 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.844 ' CE1' HG22 ' A' ' 143' ' ' VAL . 11.9 m-85 -106.11 151.71 24.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.62 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 49.2 m-85 -131.13 136.3 48.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.495 0.664 . . . . 0.0 110.502 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -43.42 -26.42 0.2 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.67 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.526 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 22.3 p -169.24 172.76 7.1 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.941 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 81.5 t -69.01 -34.04 4.7 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.389 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.76 -37.35 3.91 Favored 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 122.669 2.246 . . . . 0.0 110.24 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.587 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.6 -40.42 49.54 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.578 178.077 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.73 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.0 -45.59 92.96 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.6 mt-10 -78.92 -27.56 43.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.119 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 25.3 t70 -70.77 -55.94 7.47 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.451 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.915 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.6 t-105 -65.03 -28.28 69.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.632 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.59 -40.7 97.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.221 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.2 p -51.85 -43.56 63.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.354 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.82 21.01 7.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.358 0.599 . . . . 0.0 111.353 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.468 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -125.94 27.39 6.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.811 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.757 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 178' ' ' HIS . 2.9 tt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.735 0.302 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.65 149.76 41.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.659 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.9 mm -99.78 159.59 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.954 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -160.09 147.81 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.815 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.5 OUTLIER -77.41 124.49 27.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.467 177.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.635 HG11 ' HG3' ' A' ' 141' ' ' MET . 1.0 OUTLIER -46.93 -20.67 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.644 179.316 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.37 -39.63 77.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.7 mt-10 -82.46 -28.38 31.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.036 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.436 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -63.69 -24.69 67.88 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.116 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.777 ' CZ ' HG23 ' A' ' 133' ' ' ILE . 0.6 OUTLIER -81.15 -24.72 37.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.032 0.444 . . . . 0.0 110.818 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.56 -30.3 33.45 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.17 -28.47 32.07 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -27.87 32.77 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.601 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -82.17 -25.85 33.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 110.951 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -73.88 -23.32 59.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.089 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -55.84 -43.3 76.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.128 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -81.01 -50.07 10.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.253 -179.864 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 25' ' ' VAL . 11.2 p . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.84 0.352 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.626 ' HG3' HD11 ' A' ' 46' ' ' LEU . 57.0 Cg_endo -71.02 -21.81 27.13 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.595 2.197 . . . . 0.0 112.484 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.711 ' HG ' HG21 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -56.46 -57.44 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 111.363 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -80.12 -27.43 39.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.227 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.426 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -71.54 -53.22 14.53 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.888 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.88 -24.52 66.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.506 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.4 tp -69.45 -28.93 66.53 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.73 -22.56 9.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.351 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -69.11 -21.7 64.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.192 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.95 39.51 94.94 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.399 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -133.25 166.04 32.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.572 0.225 . . . . 0.0 110.833 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.64 114.12 3.58 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.468 2.112 . . . . 0.0 111.952 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.782 HG23 HG22 ' A' ' 41' ' ' THR . 11.1 p -111.59 109.87 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.438 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.3 p -85.99 -170.47 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.723 ' NH1' HD11 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -78.04 -37.52 46.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.465 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -27.91 68.66 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.199 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.782 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.53 -42.34 15.61 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.324 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -62.74 -36.6 83.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 176.61 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.04 -42.74 62.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.604 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.74 -30.19 72.7 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.643 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.556 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.03 -43.51 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.055 0.455 . . . . 0.0 110.397 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.626 HD11 ' HG3' ' A' ' 26' ' ' PRO . 7.2 mp -76.75 -9.83 58.95 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.506 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.5 t70 60.63 21.77 11.64 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.442 ' CD1' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -104.47 137.79 19.33 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.068 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.442 ' HD2' ' CD1' ' A' ' 48' ' ' TRP . 10.7 Cg_endo -53.66 140.01 66.56 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.597 2.198 . . . . 0.0 112.012 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.19 -17.89 1.28 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.6 -32.61 47.66 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.258 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.791 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.17 -39.87 86.53 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.05 -48.14 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.586 177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.87 57.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.389 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.2 -42.77 66.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.891 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 52' ' ' ARG . 26.9 t -67.76 -31.17 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.539 ' C ' HD23 ' A' ' 57' ' ' LEU . 9.2 tt -63.95 -35.37 80.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.758 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.25 -45.12 88.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.755 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -88.05 -7.88 56.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.62 74.98 1.04 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.765 0.793 . . . . 0.0 110.133 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -106.66 -16.09 14.6 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.42 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -73.87 -28.13 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.17 141.33 50.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.448 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.822 ' O ' HG22 ' A' ' 72' ' ' ILE . 23.9 mt-10 -78.79 126.94 31.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.313 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -103.37 171.78 7.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.463 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 70' ' ' ASN . 1.6 t70 -92.16 -172.76 3.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.479 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -67.55 -35.42 79.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -91.73 12.24 21.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.648 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.28 17.33 74.23 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.156 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 66' ' ' ASP . 24.3 m120 -91.49 165.62 13.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.983 0.392 . . . . 0.0 110.04 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.776 HD13 HD13 ' A' ' 42' ' ' LEU . 3.2 mp -79.84 127.8 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.546 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.822 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.4 tt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.022 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.742 0.306 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.572 HG21 ' CD1' ' A' ' 95' ' ' TRP . 81.7 p -97.82 159.05 15.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.5 -41.41 85.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.979 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.9 mtt-85 -110.31 150.29 28.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 4.5 tt0 -57.05 132.34 52.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.925 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.8 p -108.44 -173.67 2.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.046 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 70.2 m -94.94 -38.54 10.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.016 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.431 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 32.6 m-85 -79.52 111.09 15.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.507 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.62 138.13 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.762 ' HD1' HG22 ' A' ' 113' ' ' VAL . 69.4 t80 -123.51 106.73 10.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.544 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -98.06 125.77 43.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.279 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -139.59 122.91 18.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.853 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 t70 59.4 -72.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.159 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 87' ' ' ILE . 35.1 t0 -165.74 34.15 0.05 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.313 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.3 mmp_? -136.64 111.82 9.06 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.751 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -77.87 120.63 23.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.909 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.95 164.78 11.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 111.022 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.435 ' CZ ' ' HG3' ' A' ' 80' ' ' GLU . 28.4 m-85 -131.49 155.39 47.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.355 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.768 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -150.39 168.41 24.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.973 0.416 . . . . 0.0 111.614 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.572 ' CD1' HG21 ' A' ' 77' ' ' THR . 6.3 m95 -100.21 -6.97 25.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.189 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.431 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.5 OUTLIER 178.03 -179.28 0.27 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.827 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 164' ' ' PHE . . . -55.09 164.36 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.729 0.3 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 tt 70.21 -52.92 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.103 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.768 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 8.8 t0 -47.3 -29.27 2.38 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.834 0.349 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.481 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 2.7 p -60.02 -39.44 85.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.717 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER 169.92 153.45 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.554 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.755 ' O ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -143.33 48.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.867 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.705 ' O ' HG22 ' A' ' 107' ' ' ILE . 16.9 m-85 -166.27 59.27 0.54 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.992 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.583 ' HB3' HG12 ' A' ' 128' ' ' VAL . 61.2 Cg_endo -73.14 -37.67 3.28 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.596 2.197 . . . . 0.0 112.253 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.08 -23.8 43.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.218 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -82.72 -41.06 19.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.26 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.3 tp -57.68 -46.6 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.177 0.513 . . . . 0.0 111.422 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.88 24.29 15.68 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.636 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -152.55 173.53 15.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.003 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -80.09 153.42 28.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.772 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.752 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -137.06 109.78 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -83.19 120.26 25.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.781 0.8 . . . . 0.0 111.23 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.762 HG22 ' HD1' ' A' ' 85' ' ' PHE . 94.6 t -112.79 130.68 66.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.013 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 m -122.78 136.91 55.02 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.202 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.598 ' HB3' HG23 ' A' ' 124' ' ' VAL . 2.0 t -141.81 173.0 11.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.36 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.455 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -133.53 137.23 45.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.208 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 34.0 t -66.65 134.0 51.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.086 0.47 . . . . 0.0 112.234 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -72.52 -3.98 27.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.102 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.888 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.59 -51.34 2.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.928 0.395 . . . . 0.0 111.529 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.37 -24.18 22.01 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.356 -179.448 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.15 6.09 73.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.114 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.716 ' H ' HG22 ' A' ' 120' ' ' THR . . . -59.39 150.69 63.37 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.552 0.215 . . . . 0.0 110.501 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.0 104.39 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.652 2.235 . . . . 0.0 110.77 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.598 HG23 ' HB3' ' A' ' 115' ' ' SER . 35.0 m -99.22 144.35 12.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.299 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.9 p -150.48 141.95 23.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.448 0.642 . . . . 0.0 110.639 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.675 HD21 HG11 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -138.26 151.28 47.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.026 179.072 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.871 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 39.2 m -107.1 113.76 27.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.732 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.583 HG12 ' HB3' ' A' ' 104' ' ' PRO . 36.2 t -96.15 111.72 26.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.382 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.23 167.68 9.09 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.793 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.62 -19.16 60.15 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.084 1.856 . . . . 0.0 112.884 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 4.4 m -112.79 -26.73 8.43 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 131' ' ' SER . 2.9 pt-20 178.37 -162.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.15 0.5 . . . . 0.0 110.159 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -96.23 157.75 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.014 178.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -144.85 19.05 1.64 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.367 0.603 . . . . 0.0 112.241 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.871 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.9 86.56 0.08 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.326 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.574 HG13 ' SD ' ' A' ' 141' ' ' MET . 23.8 t -104.99 115.92 47.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.431 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.35 124.32 6.2 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.575 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.65 154.79 95.81 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.874 -1.302 . . . . 0.0 112.247 0.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.42 79.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.106 0.479 . . . . 0.0 110.434 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 141.82 20.46 0.27 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.017 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.574 ' SD ' HG13 ' A' ' 136' ' ' VAL . 0.4 OUTLIER -61.06 160.32 10.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.035 0.445 . . . . 0.0 111.298 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -129.24 152.29 48.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.091 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.641 HG13 ' CD1' ' A' ' 164' ' ' PHE . 40.5 t -113.98 150.67 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.624 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.745 ' O ' HG13 ' A' ' 162' ' ' VAL . 2.8 p -117.81 138.77 51.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.865 0.364 . . . . 0.0 110.912 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.868 HD21 HG21 ' A' ' 187' ' ' VAL . 1.3 pp -149.93 176.63 10.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.599 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 146' ' ' VAL . 8.9 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 0.0 110.88 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 144' ' ' SER . 25.2 t . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.83 0.348 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -113.99 164.81 13.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.717 0.77 . . . . 0.0 110.469 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.641 ' CD1' HG13 ' A' ' 143' ' ' VAL . 3.3 m-85 -122.3 129.83 52.56 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.559 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 44.8 m-85 -108.54 140.95 41.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.45 0.643 . . . . 0.0 110.771 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.38 -25.66 1.71 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.78 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.599 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 32.1 m -162.36 165.84 25.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.663 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.625 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 74.9 t -67.66 -33.91 5.94 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.955 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.63 -36.92 4.44 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.669 2.246 . . . . 0.0 110.262 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.65 -40.37 49.33 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.468 177.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.72 -45.79 92.44 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.547 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 3.1 mm-40 -78.88 -27.06 43.97 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.351 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 169' ' ' PRO . 25.9 t0 -70.62 -55.91 7.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.888 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 31.8 t-105 -65.23 -28.97 69.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.635 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.43 -39.93 95.8 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.346 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.8 m -52.22 -44.54 64.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.327 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.408 ' O ' ' CD2' ' A' ' 178' ' ' HIS . 0.0 OUTLIER -96.15 22.33 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.259 0.552 . . . . 0.0 111.235 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.436 ' NE2' ' CE2' ' A' ' 174' ' ' TRP . 15.8 m-70 -145.46 40.75 1.22 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.084 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.575 179.835 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.591 ' CD1' HG23 ' A' ' 146' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.639 0.257 . . . . 0.0 111.14 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.04 143.65 46.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.949 0.404 . . . . 0.0 111.225 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 175' ' ' ALA . 15.9 mm -103.52 161.56 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.94 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.868 HG21 HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -161.99 164.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.363 0.601 . . . . 0.0 112.012 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.424 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -92.97 133.83 35.73 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.49 178.209 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.675 HG11 HD21 ' A' ' 126' ' ' LEU . 18.3 m -47.43 -18.68 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 120.879 0.371 . . . . 0.0 110.838 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.424 ' N ' ' C ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -73.83 -43.08 59.85 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.037 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -20.98 36.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.327 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.38 -25.2 59.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.087 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -81.42 -24.82 36.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.762 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.85 -30.63 31.52 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.4 mt -82.05 -27.62 32.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.05 -25.84 39.28 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -82.19 -22.95 35.74 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.56 -0.32 . . . . 0.0 111.116 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -79.67 -24.8 41.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.141 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -53.88 -30.47 45.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 111.189 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -55.63 -54.98 37.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.061 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.157 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.738 0.304 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.833 ' CG ' HD11 ' A' ' 46' ' ' LEU . 58.6 Cg_endo -71.78 -26.38 19.25 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.517 2.145 . . . . 0.0 112.435 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -54.16 -57.49 10.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.042 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 31' ' ' LEU . 9.2 mt -63.19 -26.91 69.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -68.68 -53.25 23.45 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.118 0.485 . . . . 0.0 109.907 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.769 ' HB3' HG21 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -72.67 -30.76 64.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.297 178.52 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 28' ' ' LEU . 9.8 tt -70.81 -49.76 42.9 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.825 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.8 -27.64 30.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 0.0 110.973 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -21.1 65.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.136 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 45.9 94.97 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.068 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.656 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -130.86 152.6 80.87 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.622 0.248 . . . . 0.0 110.834 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.89 89.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.643 2.229 . . . . 0.0 112.346 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.769 HG21 ' HB3' ' A' ' 30' ' ' GLU . 39.2 t -97.61 110.7 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 p -85.34 -172.98 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.007 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.673 ' HE ' HG23 ' A' ' 40' ' ' THR . 0.2 OUTLIER -78.07 -35.51 49.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.339 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.673 HG23 ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -65.74 -27.19 68.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.954 0.407 . . . . 0.0 110.331 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.657 ' CG2' HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.19 -42.68 14.49 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.342 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 tp -63.05 -35.91 81.82 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.604 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.31 -43.0 61.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.59 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.12 -31.49 74.97 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.7 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.604 HD12 HG23 ' A' ' 41' ' ' THR . 6.7 mt -78.81 -44.38 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-O 120.873 0.368 . . . . 0.0 110.535 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.833 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.2 mp -76.57 -9.66 58.82 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.434 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t0 59.3 22.15 10.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.438 ' HE3' HD23 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -105.01 144.82 29.51 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.274 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.3 140.0 81.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.457 2.104 . . . . 0.0 112.033 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.15 -18.39 1.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -78.36 -32.38 48.96 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.203 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -67.14 -40.95 86.84 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.48 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.604 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -61.98 -48.54 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.646 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.68 -53.18 55.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.232 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.62 -46.93 77.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.837 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 52' ' ' ARG . 37.0 t -66.4 -31.84 55.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.714 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 mt -62.1 -32.2 72.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.613 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -56.78 -24.48 50.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.741 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -96.22 -17.88 20.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.49 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -101.72 32.77 3.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.478 0.656 . . . . 0.0 110.816 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 58' ' ' GLU . 27.2 p -67.52 -13.71 62.29 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.212 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 p -88.44 -22.65 23.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.778 0.323 . . . . 0.0 111.368 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.49 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -57.54 141.32 48.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.027 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.5 ' O ' HG22 ' A' ' 72' ' ' ILE . 3.4 mt-10 -79.1 127.0 31.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.05 0.452 . . . . 0.0 111.414 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.447 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.8 m-85 -101.74 173.13 6.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.263 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -151.46 146.95 26.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.941 0.4 . . . . 0.0 111.492 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm 66.68 -102.54 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.865 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -91.85 -10.05 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 120.95 30.42 1.35 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.028 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.01 170.65 10.93 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 37' ' ' VAL . 3.1 mp -79.84 114.28 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.239 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.6 tt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.246 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.833 0.349 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.721 HG21 HG23 ' A' ' 81' ' ' THR . 1.3 t -101.19 159.04 15.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.35 -43.79 85.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.992 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -103.59 147.46 27.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.966 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.8 128.59 37.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.721 HG23 HG21 ' A' ' 77' ' ' THR . 32.1 p -106.9 -174.46 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.4 -34.45 12.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 52.2 m-85 -81.15 110.48 16.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.606 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.57 137.25 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.844 ' CE2' HD23 ' A' ' 101' ' ' LEU . 36.4 t80 -126.82 105.6 8.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.567 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -98.58 126.55 44.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.685 0.279 . . . . 0.0 110.984 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.546 HG21 ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.07 127.19 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 59.18 -77.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.296 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' ILE . 19.4 t0 -160.11 35.34 0.17 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.483 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -138.42 114.05 9.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.503 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -77.82 86.4 4.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 110.894 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -71.73 164.84 25.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.704 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -136.76 162.89 31.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.327 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -149.59 167.22 26.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.011 0.434 . . . . 0.0 112.068 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -98.88 -8.96 24.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.126 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.432 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -161.15 172.77 16.16 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.983 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.673 ' HB1' ' CE2' ' A' ' 164' ' ' PHE . . . -55.35 -24.2 28.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.273 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.904 HD22 ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -94.62 -38.03 11.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.175 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.904 ' N ' HD22 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -53.84 -22.0 8.8 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.708 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -60.12 -35.07 74.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.739 0.304 . . . . 0.0 110.482 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.844 HD23 ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -169.66 147.12 3.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.988 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.699 ' H ' HD13 ' A' ' 101' ' ' LEU . 2.8 tt -107.29 -43.09 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.45 ' N ' HG23 ' A' ' 102' ' ' ILE . 22.6 m-85 -129.57 72.47 81.95 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.05 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.593 ' N ' HD12 ' A' ' 101' ' ' LEU . 26.8 Cg_exo -62.47 -21.06 72.29 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.642 2.228 . . . . 0.0 112.426 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.63 -23.3 42.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.894 0.378 . . . . 0.0 111.407 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.5 tp -86.02 -24.42 26.43 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.3 tp -57.99 -47.99 85.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.133 0.492 . . . . 0.0 111.679 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.73 19.29 27.49 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.785 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.17 175.49 12.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 111.001 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -78.79 150.15 32.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.799 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.793 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.15 110.03 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -81.26 120.19 24.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.852 0.834 . . . . 0.0 111.114 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.807 HG22 ' CD1' ' A' ' 85' ' ' PHE . 33.4 t -111.53 131.01 64.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.024 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.3 m -119.57 137.57 53.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.947 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.529 ' HB2' HG23 ' A' ' 124' ' ' VAL . 1.0 OUTLIER -140.74 172.6 12.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.442 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -135.45 131.76 36.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.681 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.0 m -57.12 123.6 15.84 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.863 0.363 . . . . 0.0 111.963 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -68.06 -9.01 42.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.615 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.681 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.49 -50.6 1.98 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.545 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -76.8 -20.36 56.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 110.935 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.49 33.28 84.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.168 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.545 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -101.4 168.67 8.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.426 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.422 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 41.6 Cg_endo -94.55 111.13 0.16 Allowed 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 123.043 2.495 . . . . 0.0 111.529 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.752 HG12 ' CD ' ' A' ' 138' ' ' PRO . 34.5 m -110.57 149.32 13.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.569 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.859 ' O ' HD13 ' A' ' 126' ' ' LEU . 76.0 p -149.36 141.82 24.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.337 0.589 . . . . 0.0 110.731 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.859 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -133.37 152.42 51.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.131 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.867 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 60.6 m -112.02 113.06 25.14 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.552 HG22 ' HZ ' ' A' ' 193' ' ' PHE . 23.3 t -96.31 111.88 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.626 -0.429 . . . . 0.0 111.351 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.3 p -106.47 175.88 1.89 Allowed Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.212 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.11 -13.4 33.74 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.562 2.174 . . . . 0.0 113.192 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.1 t -120.31 -27.7 5.18 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.73 -162.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.023 0.439 . . . . 0.0 110.201 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.725 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -96.67 155.08 3.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.863 178.674 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -142.87 19.39 1.98 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.347 0.594 . . . . 0.0 112.589 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.867 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.15 86.18 0.08 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.686 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.517 HG13 HD12 ' A' ' 126' ' ' LEU . 24.5 t -104.83 122.07 57.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.106 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -146.13 124.19 6.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.869 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.752 ' CD ' HG12 ' A' ' 124' ' ' VAL . 60.1 Cg_endo -72.3 158.65 96.9 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.226 0.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.31 78.43 0.54 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.224 0.535 . . . . 0.0 110.645 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.41 18.14 0.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.195 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.661 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.5 OUTLIER -60.78 161.14 8.37 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.047 0.423 . . . . 0.0 111.225 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -132.21 152.09 51.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.776 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.929 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -110.15 150.49 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.372 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.3 m -123.51 147.45 47.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.92 0.391 . . . . 0.0 111.203 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 146' ' ' VAL . 2.6 tt -129.28 157.81 40.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.515 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.62 ' N ' HD23 ' A' ' 145' ' ' LEU . 20.0 t . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.904 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.7 t . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -124.67 169.25 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.574 0.702 . . . . 0.0 109.756 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.929 ' CE1' HG22 ' A' ' 143' ' ' VAL . 6.2 m-85 -110.63 152.53 26.37 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.982 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 118' ' ' ALA . 18.1 m-85 -134.62 137.06 43.36 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.42 0.629 . . . . 0.0 110.31 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.635 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -37.93 -30.67 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.739 -1.118 . . . . 0.0 113.109 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.52 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 18.7 m -172.6 -179.97 2.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.157 0.503 . . . . 0.0 111.65 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 84.2 t -69.69 -33.49 3.75 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.563 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.1 Cg_exo -72.94 -39.05 2.5 Favored 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 122.604 2.203 . . . . 0.0 110.5 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.601 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.48 -39.69 52.45 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.122 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.61 -45.81 92.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.3 mt-10 -78.99 -27.39 43.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.316 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.6 t70 -70.51 -55.86 7.93 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.355 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.681 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.7 t-105 -64.91 -28.31 69.44 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.786 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -66.83 -38.68 86.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.264 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.8 t -51.45 -42.53 61.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.454 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -94.25 20.48 8.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.363 0.602 . . . . 0.0 111.458 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.55 ' O ' HD22 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -129.62 29.46 5.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.759 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.55 HD22 ' O ' ' A' ' 178' ' ' HIS . 5.1 tp . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.863 0.363 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.83 150.14 39.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 111.518 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.571 HD11 ' HB2' ' A' ' 175' ' ' ALA . 11.9 mm -99.84 160.32 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.611 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.694 HG23 ' HB ' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -157.49 157.72 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.367 0.603 . . . . 0.0 112.198 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.9 OUTLIER -88.41 125.47 34.74 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.542 178.325 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.661 HG11 ' HG3' ' A' ' 141' ' ' MET . 0.3 OUTLIER -45.9 -21.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.556 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.407 ' N ' ' C ' ' A' ' 188' ' ' SER . 47.7 m170 -67.58 -40.1 84.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.2 mt-10 -82.32 -27.7 32.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.094 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -61.8 -24.71 67.03 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.725 ' CZ ' HG23 ' A' ' 133' ' ' ILE . 0.6 OUTLIER -79.31 -24.76 42.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.625 179.299 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.94 -29.71 33.8 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.27 -28.55 31.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.97 -27.92 32.82 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -82.19 -25.48 34.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.816 0.341 . . . . 0.0 110.839 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -81.05 -22.97 38.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.193 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.82 -39.64 59.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.217 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -76.15 -49.35 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.546 ' O ' HG23 ' A' ' 25' ' ' VAL . 23.4 m . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.584 0.231 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.715 ' HB2' HD11 ' A' ' 46' ' ' LEU . 48.9 Cg_exo -55.84 -21.07 31.41 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.45 2.1 . . . . 0.0 112.484 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.608 HD11 HG21 ' A' ' 71' ' ' ILE . 8.6 tp -53.39 -57.48 10.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.995 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.776 HD11 HG21 ' A' ' 102' ' ' ILE . 1.3 tt -59.26 -26.78 65.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.183 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.29 -53.35 37.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.032 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -28.8 56.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.398 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 28' ' ' LEU . 8.1 tt -70.57 -52.05 24.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.733 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HB2' HD23 ' A' ' 28' ' ' LEU . . . -53.54 -26.4 21.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.142 0.496 . . . . 0.0 111.058 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -68.21 -21.63 64.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.172 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.04 45.72 95.44 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.067 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -133.07 150.16 74.76 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.678 0.275 . . . . 0.0 110.767 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.85 106.08 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.63 2.22 . . . . 0.0 112.342 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.715 HG23 HG22 ' A' ' 41' ' ' THR . 10.7 p -113.51 109.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.176 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 p -85.85 -172.2 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 43' ' ' ALA . 6.2 ptt180 -78.03 -35.32 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.227 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -26.52 67.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.845 0.355 . . . . 0.0 110.206 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.715 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.59 -42.45 14.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.341 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.434 ' HA ' HD12 ' A' ' 42' ' ' LEU . 10.0 tp -63.2 -36.0 82.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.639 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.45 -42.94 61.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.543 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.29 -30.94 73.73 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.694 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.592 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -78.68 -44.59 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 121.0 0.429 . . . . 0.0 110.498 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 26' ' ' PRO . 7.2 mp -76.26 -10.08 59.13 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.405 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.03 21.76 10.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.441 ' CH2' ' CZ ' ' A' ' 52' ' ' ARG . 10.6 m95 -107.57 136.77 19.59 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.265 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.2 142.41 16.44 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.5 2.133 . . . . 0.0 112.286 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.77 -16.86 1.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.88 -34.46 51.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.325 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.753 ' O ' HG23 ' A' ' 56' ' ' VAL . 7.5 tpt180 -67.01 -40.64 87.34 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.62 -48.11 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.613 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 57' ' ' LEU . . . -53.43 -53.38 52.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.354 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.94 -45.1 71.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.877 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 52' ' ' ARG . 32.5 t -71.48 -30.23 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.723 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 54' ' ' ALA . 13.0 mt -68.06 -39.81 82.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.738 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.68 -45.04 86.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.66 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -66.9 -14.97 63.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.027 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.584 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -112.14 70.43 0.71 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.67 0.748 . . . . 0.0 110.759 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.7 p -83.95 -3.87 58.29 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.247 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.0 p -96.41 -20.0 18.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.713 0.292 . . . . 0.0 111.333 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.584 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -52.77 141.23 21.82 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.033 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.73 126.69 31.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.154 0.502 . . . . 0.0 111.65 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.428 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 5.0 m-85 -102.92 163.06 12.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.287 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -148.3 133.79 18.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 111.711 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 tptt 70.28 -94.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.177 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.23 -15.06 20.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 127.95 34.48 0.55 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.124 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -92.67 159.6 15.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.368 . . . . 0.0 110.193 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.608 HG21 HD11 ' A' ' 27' ' ' LEU . 2.6 mp -79.85 114.45 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.235 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.5 tt . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 121.038 0.447 . . . . 0.0 111.446 179.766 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 92' ' ' LEU . 8.5 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.783 0.325 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.468 HG21 ' HD1' ' A' ' 95' ' ' TRP . 20.1 p -98.96 159.07 15.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -78.4 -50.12 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.07 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -97.02 156.71 16.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.993 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -67.46 129.59 40.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.6 p -111.76 -174.48 2.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.532 ' HG ' ' CE1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -91.82 -29.67 16.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.147 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.415 ' OH ' ' CD2' ' A' ' 163' ' ' HIS . 26.4 m-85 -82.09 111.53 18.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.603 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 t -105.91 139.51 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.019 0.437 . . . . 0.0 111.156 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.941 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 68.9 t80 -129.42 106.63 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.649 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -102.0 128.89 48.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.3 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.6 pt -138.52 124.64 24.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.583 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.82 -68.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.24 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 87' ' ' ILE . 1.3 p30 -169.33 35.21 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.253 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -137.06 113.18 9.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.1 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.409 ' CD ' ' O ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -81.0 124.69 29.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 76' ' ' LEU . 1.7 mm? -118.63 165.07 14.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.102 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.72 ' O ' HD13 ' A' ' 76' ' ' LEU . 1.5 m-85 -129.22 165.21 21.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.206 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.65 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -151.63 169.58 21.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.12 0.486 . . . . 0.0 111.984 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.468 ' HD1' HG21 ' A' ' 77' ' ' THR . 7.2 m0 -99.3 -11.83 20.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.061 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 162' ' ' VAL . 0.9 OUTLIER -154.44 162.09 41.34 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.978 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.79 -22.28 3.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.769 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.86 -51.5 5.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.693 0.282 . . . . 0.0 111.288 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.65 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -41.55 -26.39 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.529 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -59.7 -32.34 70.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.309 . . . . 0.0 110.764 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.941 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 12.3 tp -148.76 167.35 25.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.36 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.776 HG21 HD11 ' A' ' 28' ' ' LEU . 1.1 tp -118.61 -41.19 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.958 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.431 ' N ' HG23 ' A' ' 102' ' ' ILE . 1.2 t80 -162.89 102.77 1.03 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.778 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.759 ' HG3' HD23 ' A' ' 101' ' ' LEU . 15.6 Cg_exo -68.16 -25.78 36.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.75 2.3 . . . . 0.0 112.556 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.64 48.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.524 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 tt -83.05 -42.17 17.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.615 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 tp -53.85 -48.73 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.192 0.52 . . . . 0.0 111.631 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.52 21.53 24.04 Favored Glycine 0 C--N 1.319 -0.396 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.764 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.32 173.52 14.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.955 0.407 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -78.33 151.54 32.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.868 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.822 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -136.67 109.72 7.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.3 mtt-85 -82.28 119.76 24.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.761 0.791 . . . . 0.0 111.08 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.2 t -110.07 127.46 66.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.513 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.6 m -116.41 137.23 52.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.248 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.664 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.5 m -140.97 172.91 12.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.379 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.532 ' CE1' ' HG ' ' A' ' 82' ' ' SER . 2.6 p80 -133.58 130.23 38.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.3 m -56.76 122.53 12.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.943 0.402 . . . . 0.0 111.841 -178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.17 -9.72 42.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.615 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.72 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.81 -51.14 2.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.963 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.552 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -75.5 -21.8 57.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.836 0.351 . . . . 0.0 110.728 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.12 34.06 87.83 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.948 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -103.09 166.26 12.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.516 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -91.6 111.23 0.31 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.996 2.464 . . . . 0.0 111.196 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.796 HG12 ' HD2' ' A' ' 138' ' ' PRO . 22.0 m -107.7 146.42 13.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.485 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.722 ' C ' HD23 ' A' ' 126' ' ' LEU . 93.2 p -144.91 142.59 29.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.394 0.616 . . . . 0.0 110.216 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 125' ' ' SER . 0.1 OUTLIER -132.91 154.13 50.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.539 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.839 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 22.4 m -110.79 112.38 24.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.376 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.723 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 2.8 t -96.87 111.99 28.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.913 0.387 . . . . 0.0 111.423 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 m -108.31 160.73 25.96 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.167 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.23 -16.44 40.5 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.516 2.144 . . . . 0.0 112.968 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 78.1 p -114.35 -27.31 7.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 131' ' ' SER . 0.4 OUTLIER 178.95 -162.83 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.165 0.507 . . . . 0.0 110.061 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.632 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -94.8 166.24 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.657 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -155.17 19.39 0.43 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.839 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.14 85.79 0.07 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.973 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.56 HG13 ' SD ' ' A' ' 141' ' ' MET . 51.5 t -100.37 114.87 40.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.522 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -146.37 125.24 6.47 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.235 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.796 ' HD2' HG12 ' A' ' 124' ' ' VAL . 71.6 Cg_endo -76.99 155.68 97.46 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 123.515 -1.452 . . . . 0.0 111.847 -0.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.7 161.32 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 67.41 11.68 59.87 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.132 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.658 ' SD ' HD22 ' A' ' 126' ' ' LEU . 12.6 ptp -61.55 156.59 19.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.151 0.501 . . . . 0.0 111.844 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.03 152.38 49.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.183 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.685 HG13 ' CD1' ' A' ' 164' ' ' PHE . 11.4 t -113.25 151.64 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.688 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.477 ' C ' HD12 ' A' ' 145' ' ' LEU . 14.8 p -120.62 139.51 52.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.795 0.331 . . . . 0.0 110.769 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 144' ' ' SER . 5.3 mp -139.06 176.34 8.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.832 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.938 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 96' ' ' CYS . 15.1 t . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.958 0.409 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.415 ' CD2' ' OH ' ' A' ' 83' ' ' TYR . 24.7 m80 -128.34 169.39 14.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.676 0.75 . . . . 0.0 110.387 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.685 ' CD1' HG13 ' A' ' 143' ' ' VAL . 3.2 m-85 -110.48 151.54 27.42 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.678 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 118' ' ' ALA . 17.8 m-85 -129.15 137.36 51.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.559 0.695 . . . . 0.0 110.358 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.689 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -42.7 -28.26 0.22 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.125 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.738 ' HB3' ' HD2' ' A' ' 169' ' ' PRO . 1.0 OUTLIER -166.72 171.62 11.33 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.754 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.587 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 92.6 t -68.96 -36.44 7.65 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.341 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' ' 167' ' ' SER . 11.4 Cg_exo -71.37 -37.14 6.02 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.749 2.299 . . . . 0.0 110.063 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.15 -40.22 53.11 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.757 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.04 -45.96 91.27 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.544 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 1.4 mm-40 -78.99 -27.66 43.38 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.452 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 169' ' ' PRO . 13.5 t0 -70.43 -55.61 8.61 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.72 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 30.4 t-105 -65.28 -28.98 69.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.712 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.44 -39.97 94.85 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.394 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.41 -43.7 62.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.396 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -96.02 22.77 7.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.113 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.456 ' O ' HD22 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -132.82 29.16 4.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.928 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.879 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.456 HD22 ' O ' ' A' ' 178' ' ' HIS . 7.9 tp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.872 0.367 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.43 149.91 41.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.118 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.616 HD11 ' HB2' ' A' ' 175' ' ' ALA . 15.4 mm -102.11 160.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.955 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.48 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.95 163.16 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.221 0.534 . . . . 0.0 111.89 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -86.31 127.97 34.86 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.774 178.463 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.478 HG12 ' CG2' ' A' ' 143' ' ' VAL . 0.9 OUTLIER -45.16 -22.27 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.685 179.344 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.408 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.8 t-160 -71.9 -43.3 65.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.185 0.517 . . . . 0.0 109.785 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.3 OUTLIER -82.15 -21.0 36.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.353 179.036 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.45 -25.31 64.04 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.776 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.574 ' CE2' HG23 ' A' ' 133' ' ' ILE . 2.4 m-85 -81.35 -24.89 36.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.111 0.481 . . . . 0.0 110.664 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.99 -31.01 29.98 Favored Glycine 0 CA--C 1.51 -0.273 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.314 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.9 tp -81.06 -29.66 34.96 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -81.23 -26.15 52.98 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -82.18 -21.76 36.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.963 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.99 -23.01 41.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.247 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -51.76 -37.46 51.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.063 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.98 -40.82 23.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.035 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 25' ' ' VAL . 5.3 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.685 0.278 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 29' ' ' ARG . 76.3 Cg_exo -50.55 -40.43 54.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.676 2.25 . . . . 0.0 112.422 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.731 HD11 HD21 ' A' ' 46' ' ' LEU . 6.0 mp -52.79 -57.18 11.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.308 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.485 ' O ' HD23 ' A' ' 28' ' ' LEU . 5.0 tt -79.3 -27.16 42.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.051 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.41 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 3.3 ttt180 -67.52 -53.36 29.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.08 -26.5 66.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 tp -71.8 -36.77 70.39 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.802 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.26 -29.33 32.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.229 0.538 . . . . 0.0 110.836 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -19.31 65.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.142 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.18 51.75 50.15 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.061 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.6 mtp85 -127.47 165.91 26.57 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.743 0.306 . . . . 0.0 110.741 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.19 111.55 2.05 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.399 2.066 . . . . 0.0 112.097 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.872 HG23 HG22 ' A' ' 41' ' ' THR . 8.1 p -125.85 109.76 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.272 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t -94.99 -170.06 2.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.965 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' ALA . 20.0 ptt-85 -72.55 -38.69 67.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.608 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -31.0 71.73 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.244 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.872 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -83.1 -41.91 18.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.389 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.426 HD22 HD12 ' A' ' 71' ' ' ILE . 9.3 tp -62.18 -36.69 82.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.41 -43.19 64.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.646 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.57 -31.68 76.96 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.587 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.617 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -78.95 -44.07 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.106 0.479 . . . . 0.0 110.423 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.731 HD21 HD11 ' A' ' 27' ' ' LEU . 6.9 mp -76.75 -9.38 58.63 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.518 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.2 t70 60.08 21.84 11.04 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.416 ' CG ' ' HD2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -100.27 155.86 35.92 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.223 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 48' ' ' TRP . 57.8 Cg_endo -71.58 139.96 35.18 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.551 2.167 . . . . 0.0 112.132 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.14 -19.2 1.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -77.84 -35.49 51.1 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 111.279 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.846 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.7 -40.34 88.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.56 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.39 -48.47 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.54 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.1 -53.93 43.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.259 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.67 75.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 52' ' ' ARG . 27.3 t -68.6 -31.01 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.711 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.412 HD23 HG12 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -66.35 -35.62 80.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.679 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.43 -44.95 85.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.701 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -76.75 -9.78 58.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.038 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.4 73.62 0.89 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.723 0.773 . . . . 0.0 110.397 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.5 p -96.99 -24.33 15.86 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.138 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -70.26 -25.46 63.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.216 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.48 141.16 31.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.242 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.602 ' O ' HG22 ' A' ' 72' ' ' ILE . 3.4 mt-10 -78.92 126.9 31.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.063 0.459 . . . . 0.0 111.376 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.421 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 64.1 m-85 -104.29 170.85 7.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.323 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -156.12 145.43 20.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.031 0.443 . . . . 0.0 111.344 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp 66.74 -103.78 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.8 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -92.3 -13.57 30.13 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 125.92 30.76 0.85 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.154 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -87.34 163.44 16.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.816 HG12 HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -79.79 118.28 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.187 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.208 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.03 HD13 HD11 ' A' ' 92' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.777 0.322 . . . . 0.0 110.736 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.75 HG21 ' HE1' ' A' ' 95' ' ' TRP . 18.0 p -126.43 159.61 32.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.2 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -48.18 -86.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.583 0.23 . . . . 0.0 110.804 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.458 ' HG3' ' CD1' ' A' ' 93' ' ' TYR . 4.6 mtp180 -173.71 98.96 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.78 23.54 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.614 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.7 p -120.08 -173.66 2.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.13 0.491 . . . . 0.0 111.648 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 p -101.07 -25.82 13.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.209 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 97' ' ' ALA . 30.0 m-85 -87.49 116.33 25.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 110.613 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.16 144.89 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.066 0.46 . . . . 0.0 111.439 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.834 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 67.9 t80 -131.66 105.85 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.516 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -97.25 129.89 44.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.655 0.264 . . . . 0.0 111.269 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -140.07 125.61 20.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.69 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 87' ' ' ILE . 17.0 t0 -154.35 37.46 0.43 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.664 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -141.48 145.85 35.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.297 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.04 86.59 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.904 0.383 . . . . 0.0 110.867 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.03 HD11 HD13 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -71.1 164.55 25.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CD1' ' HG3' ' A' ' 79' ' ' ARG . 2.1 m-85 -135.36 161.68 34.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.548 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.772 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -148.1 163.72 36.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.057 0.456 . . . . 0.0 111.592 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.75 ' HE1' HG21 ' A' ' 77' ' ' THR . 21.7 m0 -84.24 -20.25 32.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.509 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.599 ' HG ' ' N ' ' A' ' 162' ' ' VAL . 0.8 OUTLIER -158.59 -177.38 6.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.091 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.604 ' O ' HD21 ' A' ' 101' ' ' LEU . . . -61.38 -16.45 46.58 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.57 HD12 HG21 ' A' ' 162' ' ' VAL . 1.5 tt -86.62 -51.64 6.02 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.856 ' HA ' HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -57.08 -21.24 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -178.589 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -66.1 -39.58 90.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.592 0.234 . . . . 0.0 111.491 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.604 HD21 ' O ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -92.1 -83.92 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.856 HD11 ' HA ' ' A' ' 99' ' ' ASP . 25.5 mm 78.25 -59.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.654 0.264 . . . . 0.0 111.113 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -151.25 65.95 6.89 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 111.056 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.513 ' CB ' HG11 ' A' ' 128' ' ' VAL . 12.3 Cg_exo -71.3 -28.72 18.0 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.969 2.446 . . . . 0.0 112.551 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.6 -23.48 42.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.94 0.4 . . . . 0.0 111.584 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 106' ' ' LEU . 0.9 OUTLIER -81.93 -31.29 31.4 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.476 ' O ' HD12 ' A' ' 107' ' ' ILE . 1.0 OUTLIER -56.64 -46.36 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.998 0.428 . . . . 0.0 111.662 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.16 19.36 21.56 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.828 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 177.23 10.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 110.865 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -75.1 150.87 38.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.665 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.834 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.09 109.82 7.55 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -84.25 120.99 26.87 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.779 0.8 . . . . 0.0 110.915 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.789 HG22 ' CD1' ' A' ' 85' ' ' PHE . 46.8 t -112.51 130.94 65.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.005 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.7 m -122.22 137.61 54.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.133 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.522 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -141.21 172.86 12.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.031 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 121' ' ' GLY . 0.1 OUTLIER -132.1 131.37 42.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.626 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 34.0 m -58.15 125.85 24.98 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.03 0.443 . . . . 0.0 112.165 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -68.75 -8.03 39.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.049 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.622 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -119.0 -51.62 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 0.0 111.189 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.612 HG21 ' HB3' ' A' ' 166' ' ' ALA . 0.9 OUTLIER -82.66 -23.9 34.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.465 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 117' ' ' CYS . . . 69.82 6.81 57.31 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.923 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.8 160.08 71.08 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 120.609 0.243 . . . . 0.0 110.671 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -86.55 106.79 0.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.92 2.413 . . . . 0.0 111.033 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.527 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 26.9 m -103.78 146.59 11.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.822 ' C ' HD13 ' A' ' 126' ' ' LEU . 62.1 p -152.42 142.17 21.95 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.333 0.587 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.822 HD13 ' C ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -131.96 153.22 50.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.447 178.507 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.842 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 24.0 m -110.02 113.01 25.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.513 HG11 ' CB ' ' A' ' 104' ' ' PRO . 51.5 t -96.53 114.12 32.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.088 0.471 . . . . 0.0 111.955 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.41 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.8 OUTLIER -107.32 169.03 7.16 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.734 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 35.5 Cg_endo -65.86 -19.32 58.67 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.197 1.931 . . . . 0.0 112.885 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -110.68 -27.54 8.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.437 ' HA ' ' CE1' ' A' ' 193' ' ' PHE . 3.7 pt-20 178.85 -164.68 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.069 0.462 . . . . 0.0 110.007 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.742 HG23 ' CE2' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -94.73 152.12 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.708 178.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.31 21.89 2.77 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.308 0.575 . . . . 0.0 112.445 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.842 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.77 87.4 0.09 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.814 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.498 HG13 ' SD ' ' A' ' 141' ' ' MET . 60.9 t -103.72 115.05 44.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.347 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.405 ' O ' ' CE ' ' A' ' 141' ' ' MET . 19.3 tt0 -143.13 123.76 8.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.486 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.499 ' HD2' ' HE3' ' A' ' 141' ' ' MET . 57.8 Cg_endo -70.95 162.25 87.84 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 123.502 -1.457 . . . . 0.0 112.544 -0.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.19 79.91 1.79 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.16 18.5 0.2 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.268 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.733 ' CG ' HG11 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -63.57 164.22 9.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.06 0.457 . . . . 0.0 111.708 -179.436 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -129.13 152.09 49.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.69 HG13 ' CD1' ' A' ' 164' ' ' PHE . 3.3 t -115.8 152.05 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.701 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.2 m -120.84 143.1 49.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.958 0.408 . . . . 0.0 111.242 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.54 HD13 HG22 ' A' ' 162' ' ' VAL . 1.6 mm? -123.39 159.53 28.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.604 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.103 179.836 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.599 ' N ' ' HG ' ' A' ' 96' ' ' CYS . 22.0 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.879 0.371 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -116.69 169.15 9.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.692 . . . . 0.0 110.336 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.69 ' CD1' HG13 ' A' ' 143' ' ' VAL . 4.7 m-85 -118.64 153.52 34.17 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.076 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.612 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 59.2 m-85 -132.59 136.14 46.35 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.038 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.612 ' HB3' HG21 ' A' ' 120' ' ' THR . . . -41.87 -27.68 0.13 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.091 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.564 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 74.0 m -165.5 173.67 10.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.194 0.521 . . . . 0.0 111.936 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.8 t -70.0 -33.75 3.75 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.346 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.19 -37.32 3.47 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.688 2.259 . . . . 0.0 110.289 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.602 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.91 -40.27 47.91 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.483 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.726 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.2 -44.88 96.57 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.0 mt-10 -78.97 -27.22 43.46 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.232 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.69 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.2 t70 -71.04 -55.94 7.2 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.429 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.622 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.3 t-105 -64.59 -28.0 69.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.726 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -65.01 -40.37 94.8 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.359 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.25 -43.26 61.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.382 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -95.77 21.86 7.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.374 0.607 . . . . 0.0 111.194 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.461 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -127.71 27.42 5.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.78 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.77 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 178' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.871 0.367 . . . . 0.0 110.764 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.89 150.09 41.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.077 0.465 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.645 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.9 mm -100.91 160.41 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.832 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.463 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -160.54 159.16 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.809 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.5 OUTLIER -86.03 124.96 33.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.908 178.571 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.733 HG11 ' CG ' ' A' ' 141' ' ' MET . 0.7 OUTLIER -47.83 -20.59 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.608 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -69.35 -41.41 76.63 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.6 mt-10 -82.6 -26.46 32.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.058 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -68.75 -25.02 64.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.742 ' CE2' HG23 ' A' ' 133' ' ' ILE . 7.9 t80 -81.61 -26.17 35.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.689 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.93 -30.06 32.84 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.1 mt -82.11 -27.35 32.88 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.11 -26.75 35.88 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.444 ' CG ' ' CE1' ' A' ' 193' ' ' PHE . 46.6 mm-40 -81.91 -24.86 35.4 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.041 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 -22.96 61.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -51.97 -42.4 62.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.272 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -81.18 -29.57 34.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.005 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.233 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.574 ' O ' HG23 ' A' ' 25' ' ' VAL . 19.1 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.784 0.326 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.71 -46.19 35.22 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.589 2.193 . . . . 0.0 112.355 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -51.95 -57.24 10.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 27' ' ' LEU . 2.1 mt -72.7 -27.11 61.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.814 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.52 -53.22 55.29 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.598 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -69.91 -26.51 64.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.163 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tp -70.68 -44.2 67.49 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.686 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.22 -28.54 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.138 0.494 . . . . 0.0 110.89 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -64.77 -20.44 66.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.181 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.37 54.05 25.57 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.296 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -133.04 165.36 37.33 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.298 . . . . 0.0 110.719 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.38 113.5 3.33 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.464 2.109 . . . . 0.0 112.088 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.717 HG13 HG22 ' A' ' 41' ' ' THR . 31.7 t -117.98 109.88 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.458 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.2 p -87.97 179.63 6.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.836 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -70.13 -37.46 75.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.306 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -30.11 70.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 110.074 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.717 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -82.92 -41.96 18.25 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.319 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.738 ' CD1' HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -62.49 -37.02 84.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.643 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.63 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -71.64 -43.29 66.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.626 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.68 -31.03 72.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.807 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.585 HD12 HG23 ' A' ' 41' ' ' THR . 6.8 mt -78.59 -43.98 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-O 120.997 0.427 . . . . 0.0 110.519 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.539 HD12 HG22 ' A' ' 45' ' ' ILE . 7.2 mp -76.06 -10.18 59.21 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.387 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 61.0 21.41 11.75 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.412 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 29.6 m95 -107.26 138.78 19.98 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.018 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.34 140.54 34.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.74 2.294 . . . . 0.0 112.053 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.33 -16.88 0.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -78.86 -31.86 45.78 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.292 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.76 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -68.61 -40.86 80.21 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.63 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.64 -47.62 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.635 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.83 -52.35 57.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.352 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.22 -43.09 67.0 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.786 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 52' ' ' ARG . 21.8 t -69.7 -33.58 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.756 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.2 mt -61.75 -35.88 79.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.657 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.685 ' O ' HG23 ' A' ' 61' ' ' THR . 5.6 tt0 -57.55 -26.33 61.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.717 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -90.49 -16.46 28.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.028 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' A' ' 63' ' ' THR . . . -98.61 33.58 2.24 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.398 0.618 . . . . 0.0 111.006 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 58' ' ' GLU . 65.6 p -58.93 -20.88 56.02 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.009 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 p -88.76 -22.94 23.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.352 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.404 ' HB ' ' HB1' ' A' ' 60' ' ' ALA . 0.8 OUTLIER -59.41 141.21 55.15 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.327 179.52 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.842 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -85.37 132.16 34.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 111.685 -179.276 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.43 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 76.9 m-85 -105.73 173.23 6.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -150.37 146.8 26.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.047 0.451 . . . . 0.0 111.535 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 tptt 66.28 -102.64 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.853 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -90.36 -10.46 43.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 119.94 29.56 1.65 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.951 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -86.01 171.31 11.51 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.738 HD13 ' CD1' ' A' ' 42' ' ' LEU . 4.1 mp -79.76 116.8 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.316 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.7 tt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.252 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.774 HD22 ' CD1' ' A' ' 92' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.836 0.35 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 79' ' ' ARG . 4.8 t -111.01 159.0 18.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.27 -25.82 64.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.745 ' O ' HG23 ' A' ' 77' ' ' THR . 1.0 OUTLIER -102.86 146.99 27.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.005 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -63.56 129.63 40.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.533 HG23 HG21 ' A' ' 77' ' ' THR . 27.9 p -106.36 -176.47 3.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.011 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.1 m -89.57 -31.83 17.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.439 ' CE2' ' N ' ' A' ' 97' ' ' ALA . 5.3 m-85 -89.53 117.67 28.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.446 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.8 t -108.75 139.12 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.078 0.466 . . . . 0.0 111.114 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.876 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 30.3 t80 -123.1 106.92 11.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.887 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.2 124.08 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.741 0.305 . . . . 0.0 111.144 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.623 HG21 ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.15 126.29 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.62 -77.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.317 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.0 t70 -156.11 37.0 0.34 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.633 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -141.45 147.44 37.91 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.578 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.2 86.41 2.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 0.0 110.752 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.774 ' CD1' HD22 ' A' ' 76' ' ' LEU . 3.9 mm? -71.46 164.49 25.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.628 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -131.88 158.9 40.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.749 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.509 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -143.52 163.03 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.281 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -88.33 -5.64 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.137 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.43 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.0 OUTLIER 176.06 -175.2 0.11 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.006 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.453 ' CB ' ' CD1' ' A' ' 164' ' ' PHE . . . -61.3 149.42 38.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.76 0.315 . . . . 0.0 110.761 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 97' ' ' ALA . 20.0 mt 82.62 -52.32 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.509 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -48.05 -25.09 1.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.937 0.399 . . . . 0.0 111.166 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.493 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 3.1 p -60.15 -39.32 85.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.759 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.876 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 22.9 tp -131.4 165.17 24.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.228 0.537 . . . . 0.0 111.842 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.753 HD12 ' CE2' ' A' ' 103' ' ' PHE . 3.3 pt -121.92 -37.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.885 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.753 ' CE2' HD12 ' A' ' 102' ' ' ILE . 2.4 p90 -165.61 103.29 0.74 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.631 ' HB3' HG12 ' A' ' 128' ' ' VAL . 74.0 Cg_endo -75.15 -27.58 9.65 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.745 2.297 . . . . 0.0 112.897 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.17 -23.65 54.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.703 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.71 -40.99 16.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.58 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 tp -56.0 -49.22 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.183 0.516 . . . . 0.0 111.531 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.04 24.02 18.34 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.768 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -152.41 173.24 15.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 111.037 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.411 HG23 ' OG ' ' A' ' 129' ' ' SER . 0.9 OUTLIER -80.79 151.8 28.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.862 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.832 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.4 110.16 7.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -81.44 120.23 24.73 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.719 0.771 . . . . 0.0 111.448 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.745 HG22 ' HD1' ' A' ' 85' ' ' PHE . 58.6 t -112.55 129.63 67.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.79 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 m -122.49 137.15 54.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.393 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.554 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -141.76 173.1 11.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.179 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -134.85 135.44 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 36.2 t -64.35 133.83 53.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.532 . . . . 0.0 112.132 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -71.43 -4.05 24.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.214 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.897 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -123.37 -51.04 1.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 111.673 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.732 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -87.38 -25.1 24.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.016 -179.599 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.21 5.58 72.01 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.094 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.732 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.7 147.19 72.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.618 0.247 . . . . 0.0 110.513 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.35 104.7 1.66 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.56 2.174 . . . . 0.0 110.422 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.554 HG22 ' C ' ' A' ' 115' ' ' SER . 35.3 m -101.4 145.65 11.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.397 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.89 ' O ' HD13 ' A' ' 126' ' ' LEU . 71.1 p -152.53 142.07 21.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.484 0.659 . . . . 0.0 110.929 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.986 HD11 ' CE ' ' A' ' 141' ' ' MET . 0.1 OUTLIER -134.88 153.12 52.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.464 178.79 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.873 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.2 m -109.36 113.09 25.61 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' A' ' 104' ' ' PRO . 29.2 t -96.1 111.86 27.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.118 0.485 . . . . 0.0 111.819 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.411 ' OG ' HG23 ' A' ' 110' ' ' THR . 0.4 OUTLIER -106.59 175.51 2.03 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.975 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.43 -6.25 18.76 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.548 2.166 . . . . 0.0 113.286 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m -122.77 -31.31 3.71 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 193' ' ' PHE . 14.5 pt-20 -179.7 -162.3 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 110.005 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -91.78 144.3 9.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.563 178.234 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -133.6 18.2 3.93 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.392 0.615 . . . . 0.0 112.412 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.873 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.03 86.34 0.08 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.523 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.668 HG13 HD12 ' A' ' 126' ' ' LEU . 37.2 t -105.65 120.62 56.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.898 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -146.21 122.14 5.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.08 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.458 ' HD2' HG12 ' A' ' 124' ' ' VAL . 53.2 Cg_endo -68.23 167.73 63.35 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.626 -1.406 . . . . 0.0 112.951 -0.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.7 83.7 7.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.97 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 140.87 21.08 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.046 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.986 ' CE ' HD11 ' A' ' 126' ' ' LEU . 9.1 mtp -60.98 164.72 4.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.144 0.497 . . . . 0.0 111.968 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -131.92 151.87 51.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.82 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.702 HG13 ' CD1' ' A' ' 164' ' ' PHE . 7.6 t -112.77 148.98 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.417 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 162' ' ' VAL . 64.4 m -118.29 143.53 46.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.77 0.319 . . . . 0.0 110.854 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 162' ' ' VAL . 0.6 OUTLIER -99.9 147.23 25.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.954 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 146' ' ' VAL . 9.0 p . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.971 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 144' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 111.38 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -113.68 159.45 19.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.679 0.752 . . . . 0.0 110.177 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.702 ' CD1' HG13 ' A' ' 143' ' ' VAL . 2.3 m-85 -116.9 129.74 56.26 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.837 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 29.8 m-85 -108.53 142.39 39.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.449 0.642 . . . . 0.0 110.796 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.19 -26.15 2.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.888 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.608 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 50.7 m -163.3 167.68 21.54 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.862 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 75.1 t -67.92 -33.64 5.35 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.07 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.704 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.4 Cg_exo -73.01 -37.49 3.49 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.667 2.244 . . . . 0.0 110.336 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.586 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.16 -40.59 52.19 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.006 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.716 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.8 -45.94 91.67 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.9 mt-10 -78.81 -27.39 44.4 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.313 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 169' ' ' PRO . 9.5 t70 -70.65 -55.86 7.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.383 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.897 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.9 t-105 -64.91 -28.62 69.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.765 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.9 -40.72 95.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.317 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 40.7 t -50.85 -42.55 58.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.369 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.1 20.87 8.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.308 0.575 . . . . 0.0 111.271 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.5 25.01 7.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.788 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.787 0.327 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.17 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.684 HD11 ' HB2' ' A' ' 175' ' ' ALA . 14.5 mm -102.32 162.01 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.937 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.487 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.69 166.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.265 0.555 . . . . 0.0 111.794 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -89.59 128.13 35.99 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.014 178.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.445 HG12 ' CG2' ' A' ' 143' ' ' VAL . 1.4 m -45.88 -21.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.621 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.402 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.8 t60 -71.47 -42.72 67.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.215 0.531 . . . . 0.0 109.98 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -82.28 -21.58 36.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -73.86 -25.23 59.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.092 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 132' ' ' GLU . 72.7 t80 -81.6 -24.77 36.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.585 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.84 -29.11 35.86 Favored Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.3 mp -82.06 -28.4 32.44 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.32 -28.84 29.26 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.543 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 1.3 tm0? -82.24 -25.26 34.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.575 -0.312 . . . . 0.0 111.28 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -76.86 -22.79 52.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.124 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -51.82 -33.63 36.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.963 0.411 . . . . 0.0 111.082 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -81.06 -53.78 6.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.964 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.759 ' CG ' HD11 ' A' ' 46' ' ' LEU . 43.9 Cg_endo -67.91 -17.02 46.57 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.583 2.189 . . . . 0.0 112.552 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 71' ' ' ILE . 6.0 tp -52.76 -57.41 10.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.368 . . . . 0.0 111.01 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 31' ' ' LEU . 4.4 mm? -70.09 -27.05 64.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.76 -53.22 60.53 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.611 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.34 -23.7 61.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.272 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 28' ' ' LEU . 9.0 tt -63.13 -49.03 75.99 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.479 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.0 18.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.34 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -24.33 61.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.126 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.64 39.58 96.76 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.34 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -133.32 150.06 74.2 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.696 0.284 . . . . 0.0 110.755 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.67 107.07 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.559 2.172 . . . . 0.0 111.978 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.726 HG23 HG22 ' A' ' 41' ' ' THR . 14.0 p -99.23 112.1 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.519 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 p -93.32 175.62 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.422 ' O ' ' N ' ' A' ' 43' ' ' ALA . 2.1 mpp_? -65.26 -40.33 93.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.302 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -25.09 67.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.869 0.366 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.726 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.11 -43.3 13.17 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.352 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -62.79 -36.28 82.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.629 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.691 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.2 -43.0 62.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.595 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.79 -30.7 72.58 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.697 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.588 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -78.42 -44.75 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 120.999 0.428 . . . . 0.0 110.563 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.759 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.2 mp -75.65 -9.85 58.93 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.491 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t70 59.72 21.92 10.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.446 ' CZ2' ' NH1' ' A' ' 52' ' ' ARG . 1.8 m0 -109.27 146.02 33.03 Favored Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.217 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.13 143.18 52.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.557 2.171 . . . . 0.0 112.063 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.19 -16.9 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.65 -33.61 47.04 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.236 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.632 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.95 -41.2 82.83 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.851 HG13 HD23 ' A' ' 42' ' ' LEU . 2.1 t -63.29 -47.65 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.544 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.579 ' HA ' HD13 ' A' ' 57' ' ' LEU . . . -53.49 -52.32 59.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.269 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.67 -36.65 25.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.019 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 52' ' ' ARG . 28.9 t -59.4 -35.81 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.035 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.579 HD13 ' HA ' ' A' ' 54' ' ' ALA . 3.7 mp -60.93 -32.43 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.873 0.368 . . . . 0.0 110.723 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.423 ' O ' HG23 ' A' ' 61' ' ' THR . 1.9 tp10 -58.65 -34.8 71.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.467 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -100.19 -20.42 15.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.87 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.494 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -102.59 33.44 3.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.476 0.655 . . . . 0.0 110.742 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 58' ' ' GLU . 32.1 p -66.99 -13.87 62.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.343 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 p -88.02 -23.57 23.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.325 . . . . 0.0 111.359 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.494 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -58.22 141.47 50.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.016 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.68 126.99 31.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 111.326 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -102.1 173.13 6.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.465 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.409 ' HB2' ' ND2' ' A' ' 70' ' ' ASN . 6.6 t0 -97.18 -172.88 2.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -34.5 76.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.955 0.407 . . . . 0.0 111.128 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.28 1.7 55.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.343 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.05 14.45 60.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.267 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 66' ' ' ASP . 1.1 p-10 -86.79 146.82 26.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.491 0.645 . . . . 0.0 109.881 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.579 ' O ' HG22 ' A' ' 72' ' ' ILE . 1.7 mp -79.76 143.28 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.905 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 71' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.466 0.331 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.692 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 mt . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.983 0.42 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.615 HG22 ' CD1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -111.01 159.53 17.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.72 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.72 24.96 1.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.619 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 51.56 96.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.808 0.337 . . . . 0.0 111.505 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -156.21 -84.76 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.483 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.37 163.7 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.844 0.354 . . . . 0.0 111.592 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 84' ' ' VAL . 65.3 m -82.18 -5.88 58.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.97 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -66.21 96.77 0.35 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 110.293 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 82' ' ' SER . 17.8 t -109.69 144.71 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.369 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.966 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 33.5 t80 -131.16 107.57 9.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.086 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -102.72 132.46 48.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.517 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' ASP . 2.3 pt -138.74 123.0 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.396 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.12 -67.5 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.134 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.6 m-20 -168.54 34.82 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.304 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -135.57 112.49 10.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.968 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.628 ' C ' HD22 ' A' ' 92' ' ' LEU . 9.3 mpt_? -82.11 124.63 30.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.971 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.628 HD22 ' C ' ' A' ' 91' ' ' ARG . 2.8 mm? -115.57 165.1 13.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -129.75 165.21 22.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.994 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.787 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -153.48 170.97 19.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.939 0.4 . . . . 0.0 111.705 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.615 ' CD1' HG22 ' A' ' 77' ' ' THR . 49.6 m0 -95.25 -17.95 21.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.679 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 98.9 m -152.54 166.48 31.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.255 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.548 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -54.21 -21.08 8.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.93 -51.73 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.787 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 41.4 t0 -50.1 -23.23 2.0 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -60.11 -32.67 71.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.676 0.274 . . . . 0.0 110.688 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.966 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 50.9 tp -140.84 162.22 35.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 111.296 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.795 HD12 ' HB2' ' A' ' 103' ' ' PHE . 2.7 pp -125.24 -39.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.28 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.795 ' HB2' HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -163.19 103.22 1.0 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.099 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.563 ' CB ' HG12 ' A' ' 128' ' ' VAL . 74.4 Cg_endo -74.91 -31.76 6.1 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.575 2.184 . . . . 0.0 112.609 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.08 -23.83 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.456 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -82.43 -40.89 20.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.36 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 tp -56.1 -47.15 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.154 0.502 . . . . 0.0 111.556 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.04 21.41 20.72 Favored Glycine 0 C--N 1.32 -0.338 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.836 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 174.68 13.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.01 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -79.46 151.77 30.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.671 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.824 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -137.02 109.95 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 65.0 mtm-85 -82.22 121.63 26.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.745 0.783 . . . . 0.0 110.975 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.4 t -113.6 130.76 67.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.961 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.8 m -121.18 137.48 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.735 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.58 ' HB3' HG23 ' A' ' 124' ' ' VAL . 3.1 t -141.06 173.01 11.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.347 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -131.14 130.74 43.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 23.3 m -56.68 123.97 16.75 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.95 0.405 . . . . 0.0 111.811 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.855 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . . . -67.8 -9.44 44.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.617 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.736 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.14 -50.64 2.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.559 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -77.12 -21.05 54.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.815 0.34 . . . . 0.0 110.895 -178.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.87 33.58 85.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.157 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.559 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -102.0 169.12 8.02 Favored Pre-proline 0 N--CA 1.453 -0.324 0 CA-C-N 115.459 -0.37 . . . . 0.0 110.372 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.426 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 51.1 Cg_endo -92.98 108.23 0.19 Allowed 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.92 2.413 . . . . 0.0 111.454 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.58 HG23 ' HB3' ' A' ' 115' ' ' SER . 35.7 m -105.43 146.26 12.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.45 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.8 p -148.99 142.49 25.32 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.397 0.618 . . . . 0.0 110.695 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -139.08 151.85 47.06 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.852 178.914 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.795 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 40.3 m -107.64 114.09 27.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.053 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.563 HG12 ' CB ' ' A' ' 104' ' ' PRO . 10.7 t -96.56 111.83 27.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.853 0.358 . . . . 0.0 111.412 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -106.69 172.18 4.09 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.009 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -68.83 -14.64 39.34 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.42 2.08 . . . . 0.0 112.995 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 1.1 t -117.86 -26.46 6.48 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 131' ' ' SER . 21.1 pt-20 178.65 -162.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.124 0.488 . . . . 0.0 110.01 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.69 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.88 159.2 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.849 178.562 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -145.67 19.34 1.49 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.402 0.62 . . . . 0.0 112.274 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.795 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.91 86.45 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.493 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.569 HG13 ' SD ' ' A' ' 141' ' ' MET . 45.2 t -102.42 116.06 45.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -146.36 121.49 5.47 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.721 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.5 155.35 98.95 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.542 -1.441 . . . . 0.0 112.243 -0.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.29 78.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 147.76 15.84 0.13 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.503 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.885 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -60.69 157.88 13.79 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.187 0.494 . . . . 0.0 111.227 -179.508 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -128.63 151.98 48.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.917 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.7 HG13 ' CD1' ' A' ' 164' ' ' PHE . 4.6 t -113.83 150.41 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.307 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.783 ' O ' HG13 ' A' ' 162' ' ' VAL . 0.1 OUTLIER -120.04 146.29 46.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.906 0.384 . . . . 0.0 111.078 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.687 HD22 ' C ' ' A' ' 144' ' ' SER . 3.8 mm? -122.08 158.12 29.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.651 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.741 ' HA ' HD22 ' A' ' 184' ' ' LEU . 34.6 m . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.269 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.783 HG13 ' O ' ' A' ' 144' ' ' SER . 24.2 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.998 0.428 . . . . 0.0 111.595 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -115.37 169.14 9.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.611 0.719 . . . . 0.0 109.677 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.7 ' CD1' HG13 ' A' ' 143' ' ' VAL . 3.2 m-85 -117.23 153.51 32.75 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.293 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.855 ' CE1' ' HB3' ' A' ' 118' ' ' ALA . 42.3 m-85 -133.16 137.32 46.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.166 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.635 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -38.9 -29.05 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.869 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.492 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 5.0 p -172.02 178.55 2.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.04 0.448 . . . . 0.0 111.54 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.606 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 77.8 t -69.13 -33.14 3.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.583 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.669 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.3 Cg_exo -72.98 -39.31 2.34 Favored 'Trans proline' 0 CA--C 1.505 -0.936 0 C-N-CA 122.731 2.288 . . . . 0.0 110.586 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.569 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.34 -39.44 53.92 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.728 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.86 -46.04 91.16 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.466 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.3 mt-10 -78.81 -27.66 44.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.225 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 169' ' ' PRO . 22.7 t0 -71.04 -55.74 7.63 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.43 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.736 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 8.1 t-105 -64.79 -28.49 69.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.702 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.96 -40.33 94.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.249 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.55 -42.79 55.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.402 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.407 ' O ' ' CD2' ' A' ' 178' ' ' HIS . 0.2 OUTLIER -97.1 23.7 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.338 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.46 ' O ' HD12 ' A' ' 184' ' ' LEU . 11.1 m170 -152.87 45.12 0.68 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.926 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.872 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 146' ' ' VAL . 29.6 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.734 0.302 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.14 142.64 46.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.141 0.496 . . . . 0.0 111.3 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.685 HD11 ' HB2' ' A' ' 175' ' ' ALA . 16.0 mm -101.69 160.85 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.758 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.461 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -158.71 157.47 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.233 0.54 . . . . 0.0 112.013 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.5 OUTLIER -86.02 127.98 34.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.767 178.461 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.885 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.1 m -46.43 -20.93 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.874 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.4 ' N ' ' C ' ' A' ' 188' ' ' SER . 1.8 t-80 -73.67 -43.3 59.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.208 0.527 . . . . 0.0 109.761 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.38 -20.86 36.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.378 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.2 -25.36 61.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.972 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.45 ' CZ ' HG22 ' A' ' 128' ' ' VAL . 3.5 m-85 -81.81 -30.96 31.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.252 0.548 . . . . 0.0 110.37 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.07 -33.48 23.52 Favored Glycine 0 CA--C 1.509 -0.31 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.336 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.413 ' O ' HD23 ' A' ' 195' ' ' LEU . 4.2 tt -76.65 -29.65 56.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.58 -26.88 37.26 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -82.71 -22.69 34.4 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.445 -0.377 . . . . 0.0 110.87 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.38 -22.95 43.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.424 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -51.95 -26.87 11.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 111.168 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -81.18 -54.31 5.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.155 -179.861 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 28' ' ' LEU . 19.0 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.684 0.278 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.544 ' CG ' HD11 ' A' ' 46' ' ' LEU . 66.2 Cg_endo -74.04 -35.68 4.0 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.452 2.101 . . . . 0.0 112.384 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 mt -53.9 -57.47 10.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.194 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.463 HD23 ' HB2' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -55.44 -26.87 44.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.259 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -63.72 -53.21 54.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.152 0.501 . . . . 0.0 109.982 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -78.88 -27.47 44.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.627 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.487 ' O ' HD23 ' A' ' 31' ' ' LEU . 3.4 tt -69.78 -52.42 25.37 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.794 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HB2' HD23 ' A' ' 28' ' ' LEU . . . -58.63 -25.93 63.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 110.822 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -70.0 -23.3 63.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.047 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.63 48.8 82.3 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.147 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -133.09 150.17 74.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.715 0.293 . . . . 0.0 110.855 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.64 106.36 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.536 2.157 . . . . 0.0 112.397 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.647 HG23 ' CG2' ' A' ' 41' ' ' THR . 11.2 p -112.32 109.9 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.221 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 p -84.15 -175.01 5.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.962 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 43' ' ' ALA . 9.3 mtp180 -76.93 -35.97 56.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.471 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -25.83 67.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.894 0.378 . . . . 0.0 110.348 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.647 ' CG2' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.05 -42.74 13.69 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.402 ' O ' HD13 ' A' ' 46' ' ' LEU . 5.2 tp -63.43 -35.92 82.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.559 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -74.06 -42.57 60.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.425 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.95 -30.98 74.54 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.567 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.59 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.09 -43.0 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.04 0.448 . . . . 0.0 110.432 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.544 HD11 ' CG ' ' A' ' 26' ' ' PRO . 6.9 mp -78.16 -7.75 57.45 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.509 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.66 23.41 6.15 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.63 145.4 31.22 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.264 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.07 139.61 70.95 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.415 2.077 . . . . 0.0 111.961 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.79 -17.46 0.94 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -78.56 -32.49 47.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.285 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.603 ' O ' HG23 ' A' ' 56' ' ' VAL . 4.1 mmt85 -67.66 -41.27 84.02 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.559 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.0 t -63.0 -48.07 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.516 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.01 -51.79 62.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.469 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.64 -37.47 18.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 52' ' ' ARG . 41.6 t -60.21 -33.06 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.754 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.6 mm? -81.06 -26.51 36.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.057 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -56.63 -22.7 36.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.197 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -1.67 11.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.231 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.77 72.19 0.78 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.819 0.819 . . . . 0.0 110.618 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.3 p -77.79 -3.96 44.02 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.376 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.2 m -113.14 39.92 2.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.061 0.458 . . . . 0.0 110.706 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.44 141.43 29.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.081 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.79 126.58 30.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.067 0.46 . . . . 0.0 111.237 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.413 ' OH ' HD12 ' A' ' 57' ' ' LEU . 31.8 m-85 -119.51 160.83 21.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.402 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.458 ' OD1' HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -154.52 145.6 22.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 111.289 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 tptt 66.06 -102.71 0.08 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.68 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.86 -14.04 32.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.728 0.299 . . . . 0.0 111.767 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 122.79 30.08 1.18 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.145 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -87.39 170.01 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.069 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.44 HD12 ' O ' ' A' ' 37' ' ' VAL . 2.0 mt -79.7 117.37 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.355 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.458 HD13 ' OD1' ' A' ' 66' ' ' ASP . 2.1 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.887 HD23 HD21 ' A' ' 92' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.777 0.322 . . . . 0.0 110.829 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.8 p -132.42 159.06 40.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt -85.24 5.72 29.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.476 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.44 113.26 24.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -55.77 -23.15 27.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.332 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER 35.66 -166.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 m -104.82 -25.92 12.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.561 ' OH ' ' CE1' ' A' ' 163' ' ' HIS . 4.8 m-85 -85.5 117.19 24.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.454 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.441 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.6 t -109.09 142.54 21.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.001 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.838 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 54.5 t80 -130.05 106.95 8.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.62 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -99.53 126.51 45.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.167 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -135.47 122.73 35.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.847 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t0 61.02 -69.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.319 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 87' ' ' ILE . 7.5 t70 -167.48 35.29 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.196 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.0 mmt-85 -137.6 113.24 9.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.986 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.55 121.9 25.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.501 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.887 HD21 HD23 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -114.93 164.69 13.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.323 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -129.03 165.0 22.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.038 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.679 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -152.65 169.03 23.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.987 0.422 . . . . 0.0 112.105 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.446 ' HA ' HG21 ' A' ' 81' ' ' THR . 18.3 m95 -95.03 -19.59 20.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.783 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.48 166.64 30.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.091 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -51.93 -23.28 4.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tp -86.38 -51.65 6.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.745 0.307 . . . . 0.0 111.434 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.622 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -45.03 -28.28 0.67 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.972 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.679 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -60.46 -39.56 88.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 0.0 110.725 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 102' ' ' ILE . 4.2 pp -111.08 -173.45 2.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 0.0 111.232 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 101' ' ' LEU . 7.5 tp -165.22 -42.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.052 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.562 ' O ' HG22 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -162.98 76.15 1.91 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.023 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.422 ' CB ' HG12 ' A' ' 128' ' ' VAL . 25.7 Cg_exo -62.96 -34.78 69.87 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.632 2.221 . . . . 0.0 112.374 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.18 -23.66 43.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.472 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -84.15 -39.23 19.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.409 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -58.05 -45.97 88.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.098 0.475 . . . . 0.0 111.371 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.94 24.03 16.23 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.474 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.26 173.73 14.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 111.038 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -80.65 155.3 26.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.838 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.11 109.83 7.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -81.9 119.8 24.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.771 0.796 . . . . 0.0 111.178 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.793 HG22 ' HD1' ' A' ' 85' ' ' PHE . 96.6 t -112.69 130.22 66.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.061 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.441 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 59.6 p -121.97 137.78 54.67 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.208 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.624 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.1 m -141.37 173.01 11.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.319 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -135.21 134.72 40.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.403 ' O ' ' HA2' ' A' ' 121' ' ' GLY . 35.5 t -62.09 128.84 38.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.142 0.496 . . . . 0.0 111.89 -178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.569 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . . . -69.65 -5.52 25.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.84 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.909 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.47 -50.11 2.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.845 0.355 . . . . 0.0 111.682 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.674 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.51 -24.4 21.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.058 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 117' ' ' CYS . . . 74.94 6.78 79.94 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.135 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.674 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.19 147.82 64.8 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.643 0.259 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.32 105.73 1.48 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.676 2.251 . . . . 0.0 110.448 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.729 HG12 ' HD2' ' A' ' 138' ' ' PRO . 27.7 m -103.32 145.7 12.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.945 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.955 ' O ' HD13 ' A' ' 126' ' ' LEU . 77.3 p -153.29 141.3 20.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.237 0.541 . . . . 0.0 110.421 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 1.008 HD21 ' HE1' ' A' ' 141' ' ' MET . 0.2 OUTLIER -136.72 153.6 50.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.258 178.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.772 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 89.5 m -105.75 112.57 25.69 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.654 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 62.1 t -96.21 111.95 27.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.935 0.398 . . . . 0.0 111.46 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.453 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -106.14 171.0 5.18 Favored Pre-proline 0 N--CA 1.453 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.853 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 37.7 Cg_endo -67.16 -19.22 51.1 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.028 1.819 . . . . 0.0 112.965 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 8.5 m -109.25 -29.41 8.5 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 131' ' ' SER . 10.5 pt-20 178.63 -161.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.198 0.523 . . . . 0.0 110.101 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -94.26 163.6 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.602 178.424 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -153.07 21.07 0.58 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.295 0.569 . . . . 0.0 112.448 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.772 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.95 86.32 0.08 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.445 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 139' ' ' ALA . 39.5 t -101.59 107.69 22.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.451 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -146.82 119.77 4.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.812 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.729 ' HD2' HG12 ' A' ' 124' ' ' VAL . 73.1 Cg_endo -76.63 145.95 83.04 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.582 -1.424 . . . . 0.0 112.222 0.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 136' ' ' VAL . . . -61.94 165.47 5.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.746 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 66.89 13.18 61.15 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.312 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' MET . . . . . 1.008 ' HE1' HD21 ' A' ' 126' ' ' LEU . 0.5 OUTLIER -61.43 158.3 15.03 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.983 0.42 . . . . 0.0 111.613 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.582 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.05 152.35 49.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.241 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.878 ' CG2' HG12 ' A' ' 189' ' ' VAL . 21.3 t -111.92 151.24 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.575 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.772 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.3 p -120.18 140.76 50.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.79 0.328 . . . . 0.0 110.804 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.96 154.71 39.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.914 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.925 179.561 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 144' ' ' SER . 30.5 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.835 0.35 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.561 ' CE1' ' OH ' ' A' ' 83' ' ' TYR . 0.1 OUTLIER -117.03 169.23 9.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.602 0.715 . . . . 0.0 110.182 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.666 ' CE1' HG13 ' A' ' 143' ' ' VAL . 1.8 m-85 -120.48 132.26 55.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.915 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.625 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 54.5 m-85 -108.65 136.15 48.72 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.144 0.497 . . . . 0.0 110.001 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -46.89 -25.79 0.85 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.594 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 40.1 m -163.09 167.49 22.22 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.825 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 77.4 t -68.1 -34.43 6.09 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.97 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.0 Cg_exo -72.69 -36.8 4.48 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 122.753 2.302 . . . . 0.0 110.001 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.593 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.75 -40.27 48.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.465 178.007 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.7 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.45 -45.24 95.1 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.1 mt-10 -78.93 -27.94 43.77 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.249 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 169' ' ' PRO . 28.3 t70 -70.19 -55.89 8.19 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.457 0.646 . . . . 0.0 109.475 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.909 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 29.8 t-105 -64.88 -27.74 69.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.83 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -65.54 -40.27 92.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.265 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -42.29 63.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.471 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -95.11 20.46 9.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.271 0.558 . . . . 0.0 111.435 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.494 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -127.84 29.25 5.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.721 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.802 179.944 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 178' ' ' HIS . 1.2 tt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.423 ' N ' HD23 ' A' ' 184' ' ' LEU . . . -142.24 149.9 40.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 175' ' ' ALA . 10.6 mm -100.29 158.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.937 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -162.46 161.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.219 0.533 . . . . 0.0 112.016 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -88.08 127.97 35.41 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.652 178.529 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.955 HG11 ' SD ' ' A' ' 141' ' ' MET . 2.1 m -48.01 -19.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.405 ' N ' ' C ' ' A' ' 188' ' ' SER . 23.6 m-70 -73.02 -44.39 60.96 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -22.3 35.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.524 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -74.89 -25.18 58.76 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.282 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -81.51 -24.86 36.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.942 0.401 . . . . 0.0 110.666 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.86 -29.81 33.81 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -82.3 -28.3 31.8 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.435 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.04 -28.17 31.89 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -82.15 -21.88 36.37 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.44 -0.38 . . . . 0.0 110.995 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -81.12 -22.84 38.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.126 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.65 -28.32 20.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.129 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -52.39 -55.08 24.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.031 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.618 0.247 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.747 ' HB2' HD11 ' A' ' 46' ' ' LEU . 37.1 Cg_exo -60.99 -19.83 64.74 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.49 2.127 . . . . 0.0 112.403 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.5 tt -55.27 -57.62 11.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.447 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -80.27 -27.36 38.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.334 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 8.7 ttt-85 -70.86 -53.31 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.941 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -66.5 -25.52 66.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.499 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.755 HD11 ' C ' ' A' ' 72' ' ' ILE . 4.4 tp -72.02 -30.56 65.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.714 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.38 -27.87 26.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.146 0.498 . . . . 0.0 110.944 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -64.76 -19.96 66.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.245 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.64 47.52 89.98 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.134 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.766 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -131.06 143.93 51.46 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.601 0.239 . . . . 0.0 110.676 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -51.46 91.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.458 2.106 . . . . 0.0 112.306 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 35' ' ' ARG . 23.1 t -93.17 112.08 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.281 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.9 p -86.73 -176.57 5.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.688 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -75.71 -36.73 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.248 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -27.3 67.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.206 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.64 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.94 -42.52 14.88 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.367 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.752 ' CD1' HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -62.73 -36.7 83.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.608 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.62 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.43 -43.02 64.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.625 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.23 -31.72 75.01 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.591 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.606 HG22 HD12 ' A' ' 46' ' ' LEU . 7.1 mt -78.02 -46.15 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 120.968 0.413 . . . . 0.0 110.409 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 26' ' ' PRO . 7.9 mp -75.58 -9.51 58.64 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.543 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 60.31 21.65 11.14 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -102.0 160.43 26.45 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.25 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.16 138.99 34.54 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.608 2.205 . . . . 0.0 111.925 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.54 -20.27 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -32.25 47.35 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.045 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -67.39 -40.66 85.69 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.0 t -62.98 -47.85 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.518 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.26 -52.46 58.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.164 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.98 79.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.154 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -66.62 -26.81 38.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.922 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.443 HD23 HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -72.06 -31.77 66.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.632 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.735 ' O ' HG23 ' A' ' 61' ' ' THR . 7.6 mt-10 -56.17 -23.18 33.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -88.54 -16.36 32.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 63' ' ' THR . . . -96.96 33.35 1.92 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.381 0.61 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.735 HG23 ' O ' ' A' ' 58' ' ' GLU . 80.6 p -59.01 -20.76 56.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.01 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.6 m -90.21 -21.43 22.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.366 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HB1' ' A' ' 60' ' ' ALA . 0.8 OUTLIER -60.75 141.24 57.13 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.354 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.627 ' O ' HG22 ' A' ' 72' ' ' ILE . 2.1 mt-10 -79.0 131.09 36.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 0.0 111.62 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.45 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.6 m-85 -104.06 173.06 6.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.169 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -152.73 146.52 25.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 111.541 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tptt 65.95 -103.54 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.799 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.95 -12.29 33.81 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 124.6 31.15 0.91 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.006 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -85.75 168.05 14.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.179 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.752 HD13 ' CD1' ' A' ' 42' ' ' LEU . 3.6 mp -79.91 115.76 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.469 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.755 ' C ' HD11 ' A' ' 31' ' ' LEU . 2.3 tt . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.164 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.716 0.293 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.8 p -102.8 159.01 15.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.867 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.63 -48.03 82.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -110.65 155.43 22.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.02 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -57.21 129.44 41.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -109.23 -172.68 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.985 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 m -94.34 -41.33 9.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -78.58 108.52 12.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.644 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.86 140.97 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.898 ' CZ ' HD22 ' A' ' 101' ' ' LEU . 28.3 t80 -131.03 108.01 9.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.632 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -101.75 136.71 41.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -138.78 122.98 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.76 -68.94 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.466 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 87' ' ' ILE . 11.0 t0 -164.94 35.05 0.06 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.447 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -137.83 111.67 8.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.793 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -77.91 120.11 22.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.785 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.631 HD12 ' HD2' ' A' ' 85' ' ' PHE . 10.4 mt -109.86 164.86 12.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -133.27 165.05 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.131 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -153.23 169.95 21.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.057 0.456 . . . . 0.0 111.815 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -106.44 -7.42 17.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.876 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.888 ' HB3' HG23 ' A' ' 162' ' ' VAL . 76.6 m -152.74 159.94 43.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.331 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.719 ' HB2' ' O ' ' A' ' 162' ' ' VAL . . . -51.5 -25.37 6.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.527 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.417 HD21 HG12 ' A' ' 102' ' ' ILE . 3.6 tt -87.86 -50.27 6.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.12 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.617 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -43.25 -22.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.529 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -59.0 -32.38 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.898 HD22 ' CZ ' ' A' ' 85' ' ' PHE . 2.2 tp 178.65 149.19 0.22 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 111.218 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.417 HG12 HD21 ' A' ' 98' ' ' LEU . 5.1 mt -128.45 128.42 68.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.701 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.64 ' HB3' HD12 ' A' ' 106' ' ' LEU . 13.1 m-85 66.84 66.91 0.66 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.864 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.474 ' O ' HG12 ' A' ' 107' ' ' ILE . 24.2 Cg_exo -63.65 -20.92 69.98 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.842 2.361 . . . . 0.0 112.404 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.75 -23.67 59.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.916 0.388 . . . . 0.0 111.278 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.64 HD12 ' HB3' ' A' ' 103' ' ' PHE . 7.7 mt -78.6 -29.75 46.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.24 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 104' ' ' PRO . 3.7 mm -53.17 -61.08 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.006 0.908 . . . . 0.0 111.051 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.89 18.61 26.77 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.294 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.37 -179.95 7.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.714 0.292 . . . . 0.0 110.597 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.54 149.0 26.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.729 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.09 110.34 7.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -79.56 119.08 22.03 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.849 0.833 . . . . 0.0 111.223 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.773 HG22 ' CD1' ' A' ' 85' ' ' PHE . 12.2 t -110.49 131.53 61.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.983 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 m -122.61 137.33 54.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.246 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.547 ' OG ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -140.94 172.77 12.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.062 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -131.84 130.83 42.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.829 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 29.5 m -56.02 123.84 15.72 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.029 0.443 . . . . 0.0 111.979 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.39 -6.95 33.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.788 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.625 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -119.47 -50.6 2.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.696 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.16 -13.75 37.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.996 -179.172 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 117' ' ' CYS . . . 64.23 10.34 40.81 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.746 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.554 ' H ' HG22 ' A' ' 120' ' ' THR . . . -71.2 168.99 16.78 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.808 0.337 . . . . 0.0 110.647 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.461 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 53.8 Cg_endo -93.69 108.71 0.17 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.073 2.515 . . . . 0.0 111.629 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.547 HG23 ' OG ' ' A' ' 115' ' ' SER . 34.3 m -106.53 146.84 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.341 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.2 p -151.66 142.8 23.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.375 0.607 . . . . 0.0 110.771 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -134.43 151.74 51.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.484 178.686 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.888 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 30.2 m -107.62 113.59 26.99 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.485 HG23 ' CG2' ' A' ' 113' ' ' VAL . 36.2 t -96.51 111.69 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.968 0.413 . . . . 0.0 111.489 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -105.76 169.8 6.58 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.15 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.58 -14.52 44.33 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.456 2.104 . . . . 0.0 112.982 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 p -118.19 -27.01 6.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.52 -163.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.112 0.482 . . . . 0.0 109.999 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -95.3 162.29 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.717 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -151.41 19.98 0.74 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.888 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.04 86.14 0.08 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.791 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.15 122.74 53.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.707 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -146.12 119.3 5.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.98 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.425 ' HD2' HG12 ' A' ' 124' ' ' VAL . 70.8 Cg_endo -74.71 162.3 92.97 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 123.435 -1.485 . . . . 0.0 112.274 0.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.82 78.24 1.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.151 0.5 . . . . 0.0 110.737 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 147.4 15.91 0.13 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.576 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 126' ' ' LEU . 10.2 ptp -62.51 160.82 12.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.079 0.439 . . . . 0.0 111.534 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.65 152.06 50.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.942 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.757 HG22 ' CE2' ' A' ' 164' ' ' PHE . 2.5 t -117.44 154.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.443 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 55.6 p -121.16 146.8 46.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.842 0.353 . . . . 0.0 110.921 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.856 HD21 ' HB3' ' A' ' 185' ' ' ALA . 4.0 pp -113.47 158.4 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.993 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 146' ' ' VAL . 11.1 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.888 HG23 ' HB3' ' A' ' 96' ' ' CYS . 7.2 p . . . . . 0 CA--C 1.526 0.052 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.467 ' N ' HG13 ' A' ' 162' ' ' VAL . 16.0 m-70 -107.19 148.5 28.8 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.65 0.738 . . . . 0.0 109.979 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.757 ' CE2' HG22 ' A' ' 143' ' ' VAL . 40.4 m-85 -109.9 150.67 28.11 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.238 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 49.7 m-85 -131.83 136.09 47.21 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.557 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.568 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -39.75 -28.32 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.243 -0.889 . . . . 0.0 113.141 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.499 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 11.4 p -170.59 176.45 4.31 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.655 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.61 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 79.6 t -69.4 -34.27 4.61 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.369 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.88 -37.55 3.62 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.763 2.309 . . . . 0.0 110.313 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.592 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -77.21 -39.78 47.42 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.471 178.045 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.701 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.37 -44.56 96.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 177.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.6 mt-10 -79.07 -27.95 43.08 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.099 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.3 t70 -69.92 -56.03 8.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.466 0.651 . . . . 0.0 109.395 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.625 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 35.6 t-105 -64.87 -27.88 69.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.817 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -66.54 -38.51 87.3 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.218 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -44.32 63.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.302 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -94.95 22.47 6.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.031 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.33 30.57 0.68 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.69 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.936 179.995 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.856 ' HB3' HD21 ' A' ' 145' ' ' LEU . . . -143.24 150.32 39.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.002 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.541 HD11 ' HB2' ' A' ' 175' ' ' ALA . 11.7 mm -99.66 160.82 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.938 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.476 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -165.61 162.9 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.474 0.654 . . . . 0.0 112.197 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.9 OUTLIER -89.16 130.26 35.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.905 178.456 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.538 HG12 ' CG2' ' A' ' 143' ' ' VAL . 1.2 m -46.49 -20.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 2.1 m-70 -72.65 -43.36 63.29 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.761 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -21.02 36.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.347 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.75 -25.21 58.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 128' ' ' VAL . 9.7 t80 -81.42 -24.86 36.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.703 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.66 -29.98 34.02 Favored Glycine 0 CA--C 1.509 -0.3 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.8 mt -81.59 -27.85 34.06 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.01 -26.52 37.01 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -81.99 -22.02 36.8 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.517 -0.342 . . . . 0.0 111.026 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -74.11 -24.37 59.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -54.06 -39.53 66.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.107 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.17 -24.95 37.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.039 -179.854 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.648 HG22 ' HB2' ' A' ' 27' ' ' LEU . 9.7 p . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.564 ' HB2' HD11 ' A' ' 46' ' ' LEU . 52.3 Cg_exo -55.15 -20.0 22.69 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.693 2.262 . . . . 0.0 112.851 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.648 ' HB2' HG22 ' A' ' 25' ' ' VAL . 4.8 mp -52.01 -57.4 9.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.747 0.308 . . . . 0.0 111.227 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.623 HD23 ' CG1' ' A' ' 25' ' ' VAL . 3.9 pp -66.42 -26.98 67.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.138 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.451 ' N ' HD12 ' A' ' 28' ' ' LEU . 41.2 mtp85 -68.84 -53.32 22.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.846 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -72.86 -30.32 63.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.318 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 72' ' ' ILE . 5.7 tp -72.57 -43.16 63.79 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.837 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.11 -26.74 17.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.074 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -66.62 -20.62 66.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.188 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.91 47.41 89.07 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.136 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -133.07 148.58 69.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.622 0.249 . . . . 0.0 110.814 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.01 105.46 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.556 2.171 . . . . 0.0 112.31 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.739 HG23 HG22 ' A' ' 41' ' ' THR . 11.1 p -107.23 110.0 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.36 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 94.1 p -86.83 -179.54 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.744 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.4 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -71.96 -36.36 69.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.246 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -27.39 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 0.0 110.117 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.739 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.33 -41.61 15.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.488 HD22 ' CD1' ' A' ' 71' ' ' ILE . 7.8 tp -63.53 -36.51 84.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 176.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.21 -42.6 62.46 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.463 177.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.26 -31.09 73.98 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.617 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.574 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -78.78 -44.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-O 120.998 0.428 . . . . 0.0 110.518 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.567 HD12 HG22 ' A' ' 45' ' ' ILE . 7.4 mp -76.72 -9.75 58.89 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.412 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 59.36 22.24 10.62 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.442 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 7.8 m0 -104.99 144.75 29.37 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.337 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.7 138.23 80.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.455 2.103 . . . . 0.0 112.012 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.95 -18.94 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.7 -32.03 46.77 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.106 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.779 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -67.21 -40.53 86.44 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.581 ' O ' HD23 ' A' ' 57' ' ' LEU . 2.1 t -62.26 -48.23 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.667 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.64 -52.74 58.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.516 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.64 -45.73 73.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 52' ' ' ARG . 30.1 t -68.83 -29.3 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.728 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.837 HD12 ' OH ' ' A' ' 65' ' ' TYR . 2.2 mm? -72.17 -38.52 69.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.95 -45.16 87.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -64.5 -17.18 63.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.36 67.59 0.7 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.748 0.785 . . . . 0.0 110.847 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 p -72.41 -8.64 56.09 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.335 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.0 m -114.51 40.81 2.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.179 0.514 . . . . 0.0 110.781 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.66 141.4 33.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.164 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.77 126.74 31.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.033 0.444 . . . . 0.0 111.16 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.837 ' OH ' HD12 ' A' ' 57' ' ' LEU . 43.9 m-85 -115.16 165.6 12.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.349 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -154.22 144.3 21.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 111.286 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 tptt 66.42 -103.2 0.08 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.733 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -91.55 -13.47 32.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.751 0.31 . . . . 0.0 111.818 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 124.36 30.65 0.98 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.134 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -86.55 168.79 13.36 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.488 ' CD1' HD22 ' A' ' 42' ' ' LEU . 2.1 mp -79.8 121.53 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.413 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.817 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.005 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.604 HD11 HD22 ' A' ' 92' ' ' LEU . 3.2 mm? . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.682 0.277 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.464 HG21 ' C ' ' A' ' 94' ' ' ALA . 15.8 p -113.39 159.55 19.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.709 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.31 48.99 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.622 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 43.47 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.985 0.421 . . . . 0.0 112.067 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -156.99 -88.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.475 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -38.63 157.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.958 0.408 . . . . 0.0 111.996 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.437 ' O ' HG23 ' A' ' 84' ' ' VAL . 15.0 t -75.07 -10.64 59.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.89 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 97' ' ' ALA . 23.2 m-85 -70.87 101.2 2.09 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG13 ' CE1' ' A' ' 93' ' ' TYR . 9.2 t -110.23 143.61 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.398 . . . . 0.0 111.186 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.862 ' CD1' HG22 ' A' ' 113' ' ' VAL . 32.5 t80 -134.33 109.25 8.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.352 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.84 125.22 39.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.995 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.477 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -136.31 122.99 31.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.87 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.5 -76.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.063 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.9 p-10 -159.15 36.7 0.21 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.461 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -140.94 115.66 9.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.636 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -77.76 85.89 4.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.86 0.362 . . . . 0.0 110.989 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 76' ' ' LEU . 51.5 mt -71.97 165.0 25.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.84 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.558 ' CE1' HG13 ' A' ' 84' ' ' VAL . 50.6 m-85 -138.45 165.15 27.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.312 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 100' ' ' THR . . . -144.14 162.04 37.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.866 0.365 . . . . 0.0 111.861 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -85.31 -27.43 25.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.402 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.438 ' HB2' ' HB ' ' A' ' 162' ' ' VAL . 0.5 OUTLIER -129.89 159.04 37.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.754 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.674 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -61.98 -11.87 15.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.83 HD12 HG11 ' A' ' 162' ' ' VAL . 9.0 mt -103.64 -20.76 13.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.49 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 14.7 t70 -82.5 -3.6 56.13 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.706 ' HA ' ' HB2' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.54 -39.1 86.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 0.0 110.341 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.648 ' H ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -98.33 173.77 6.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.719 HD12 ' N ' ' A' ' 103' ' ' PHE . 2.5 pp -154.92 -45.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.133 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.719 ' N ' HD12 ' A' ' 102' ' ' ILE . 11.3 m-85 -163.06 79.12 1.72 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.016 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.466 ' CB ' HG12 ' A' ' 128' ' ' VAL . 59.3 Cg_endo -71.92 -32.84 10.71 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.591 2.194 . . . . 0.0 112.294 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.15 -23.78 43.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.263 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.89 -40.08 17.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.38 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.1 tp -57.94 -45.34 87.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.263 0.554 . . . . 0.0 111.372 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.19 24.26 15.09 Favored Glycine 0 C--N 1.319 -0.385 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.484 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -151.42 173.62 14.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.065 0.459 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -83.84 157.18 22.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.971 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.575 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.07 110.06 7.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.2 mtt-85 -80.91 119.03 22.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.732 0.777 . . . . 0.0 111.178 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.862 HG22 ' CD1' ' A' ' 85' ' ' PHE . 13.4 t -108.27 129.54 62.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.847 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.415 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 1.5 p -124.49 137.62 54.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.318 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.591 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.1 172.96 11.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.986 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -130.13 130.94 45.42 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.571 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.1 m -57.76 123.06 14.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.873 0.368 . . . . 0.0 111.927 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.78 -8.28 34.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.783 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.703 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.43 -50.54 1.99 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.563 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -77.9 -21.15 51.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 111.198 -178.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 63.31 33.28 86.83 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.01 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.563 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -102.93 169.69 7.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.432 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.444 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 58.6 Cg_endo -93.86 107.49 0.16 Allowed 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.922 2.415 . . . . 0.0 111.681 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.591 HG22 ' C ' ' A' ' 115' ' ' SER . 33.8 m -102.54 146.26 10.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.235 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.897 ' O ' HD13 ' A' ' 126' ' ' LEU . 67.0 p -151.87 141.49 21.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.457 0.646 . . . . 0.0 111.196 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.897 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -134.18 153.14 52.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.001 178.48 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.906 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 23.6 m -110.05 114.95 28.89 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.469 HG23 ' CG2' ' A' ' 113' ' ' VAL . 47.8 t -96.2 111.52 26.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.999 0.428 . . . . 0.0 110.869 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -108.29 176.51 1.57 Allowed Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.461 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 129' ' ' SER . 13.3 Cg_exo -70.33 -12.69 32.25 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.727 2.285 . . . . 0.0 113.112 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 0.8 OUTLIER -121.91 -27.91 4.54 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.076 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 131' ' ' SER . 13.4 pt-20 179.63 -161.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.13 0.49 . . . . 0.0 110.374 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -91.38 156.39 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.758 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -146.31 17.16 1.35 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.906 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.99 85.04 0.07 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.882 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.472 HG13 HD12 ' A' ' 126' ' ' LEU . 23.1 t -98.88 123.16 51.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.834 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.17 117.09 4.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.018 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.12 161.85 93.56 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.423 -1.491 . . . . 0.0 112.087 -0.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.01 78.0 1.69 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.117 0.484 . . . . 0.0 110.674 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.86 18.76 0.18 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.388 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.836 ' SD ' HD11 ' A' ' 126' ' ' LEU . 6.7 ptm -64.38 161.45 16.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.969 0.385 . . . . 0.0 111.2 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -125.55 152.36 45.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.07 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.516 HG22 ' CE1' ' A' ' 164' ' ' PHE . 61.2 t -114.09 148.9 16.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.775 ' O ' HG13 ' A' ' 162' ' ' VAL . 50.3 m -120.19 140.87 50.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.769 0.319 . . . . 0.0 110.372 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -144.01 176.11 9.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.071 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.967 179.686 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.83 HG11 HD12 ' A' ' 98' ' ' LEU . 26.0 t . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.882 0.372 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 163' ' ' HIS . 3.2 m-70 -128.14 169.25 14.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.314 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.674 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 10.5 m-30 -110.73 152.95 25.97 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.812 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.595 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 27.1 m-85 -132.54 138.13 47.38 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.582 0.706 . . . . 0.0 110.238 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.571 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -42.66 -28.84 0.26 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.141 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.552 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 71.4 m -166.96 174.7 8.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.121 0.486 . . . . 0.0 111.685 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.601 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.4 t -69.53 -33.84 4.15 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.199 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.4 Cg_exo -73.33 -37.92 2.97 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.81 2.34 . . . . 0.0 110.361 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.577 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.6 -39.63 51.93 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.53 177.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.734 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.06 -45.63 92.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.2 mt-10 -78.9 -27.68 43.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.34 178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.688 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.5 t70 -71.11 -56.0 7.04 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.301 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.703 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 36.0 t-105 -64.45 -28.91 69.99 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.675 178.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.02 -39.76 94.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.145 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -43.88 63.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.372 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.75 21.92 7.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.177 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.79 23.89 5.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.881 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.716 179.93 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.554 HD23 ' N ' ' A' ' 185' ' ' ALA . 8.1 tt . . . . . 0 C--O 1.231 0.099 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.554 ' N ' HD23 ' A' ' 184' ' ' LEU . . . -144.98 150.13 36.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.153 0.502 . . . . 0.0 111.815 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.0 mm -103.95 162.04 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.506 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.462 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -157.35 162.31 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.578 0.704 . . . . 0.0 112.313 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -94.97 133.34 38.83 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.375 178.079 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.464 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 2.8 m -47.35 -18.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.879 0.371 . . . . 0.0 110.817 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 11.6 m170 -73.67 -44.87 55.54 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.18 0.514 . . . . 0.0 109.69 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.576 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.7 OUTLIER -82.41 -20.91 36.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.478 179.152 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.51 -24.79 62.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.97 -24.73 37.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.74 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.71 -31.28 30.19 Favored Glycine 0 CA--C 1.509 -0.338 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 191' ' ' GLU . 8.3 mp -80.8 -28.42 36.3 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.92 -24.31 45.67 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.614 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -82.13 -22.01 36.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.805 0.336 . . . . 0.0 111.092 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.21 -23.15 43.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.186 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -54.24 -38.72 66.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 111.105 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.73 -54.73 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.996 -179.943 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.685 0.279 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.416 ' CG ' HD11 ' A' ' 46' ' ' LEU . 58.4 Cg_endo -71.57 -37.28 5.61 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.551 2.168 . . . . 0.0 112.317 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.73 -57.14 11.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.568 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -60.23 -26.82 66.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.427 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -53.42 23.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.027 0.441 . . . . 0.0 110.274 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.37 -30.1 57.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.419 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.487 HD23 HD22 ' A' ' 28' ' ' LEU . 49.1 tp -70.36 -49.94 44.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.71 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB2' HD13 ' A' ' 28' ' ' LEU . . . -53.48 -25.31 15.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.997 0.427 . . . . 0.0 111.133 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -22.39 64.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.137 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.21 48.14 77.83 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.297 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -133.18 155.11 81.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.659 0.266 . . . . 0.0 110.854 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.9 108.99 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.518 2.145 . . . . 0.0 111.973 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.768 HG13 HG12 ' A' ' 71' ' ' ILE . 9.6 p -113.58 109.84 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 120.954 0.407 . . . . 0.0 111.394 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 p -87.62 -169.79 2.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.8 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 43' ' ' ALA . 15.8 ttm180 -78.07 -36.84 47.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.406 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -26.96 68.04 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.363 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.76 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.56 -42.15 14.65 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.413 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.29 -36.29 83.17 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.83 -42.7 60.49 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.494 177.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.81 -30.84 74.75 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.612 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.582 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.14 -42.48 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 120.949 0.404 . . . . 0.0 110.468 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.546 HD12 HG22 ' A' ' 45' ' ' ILE . 7.1 mp -78.94 -7.43 58.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.505 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 55.37 23.5 5.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.421 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -98.89 153.12 37.98 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.272 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.433 ' O ' HG23 ' A' ' 53' ' ' VAL . 49.4 Cg_endo -69.02 137.1 36.75 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.592 2.195 . . . . 0.0 111.923 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.91 -22.18 0.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -78.57 -35.47 45.86 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.876 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.85 ' O ' HG23 ' A' ' 56' ' ' VAL . 32.2 mmt-85 -66.84 -40.84 88.08 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.11 -48.2 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.544 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.15 -53.47 50.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.383 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.7 -49.82 75.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.898 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 52' ' ' ARG . 39.7 t -63.57 -30.66 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.642 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.493 HD11 ' OH ' ' A' ' 65' ' ' TYR . 1.8 tp -62.16 -32.13 72.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.675 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.607 ' O ' HG23 ' A' ' 61' ' ' THR . 3.3 tt0 -57.82 -22.26 46.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -95.93 -18.3 20.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.149 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.448 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -100.95 32.57 3.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.448 0.642 . . . . 0.0 110.85 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 58' ' ' GLU . 26.9 p -67.48 -27.99 67.47 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.956 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.4 t -75.93 -25.56 56.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.254 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.448 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -56.56 141.4 43.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.073 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.711 ' O ' HG22 ' A' ' 72' ' ' ILE . 31.5 mt-10 -78.43 126.87 31.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.493 ' OH ' HD11 ' A' ' 57' ' ' LEU . 39.8 m-85 -102.49 173.08 6.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.583 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.17 -172.77 2.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.564 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.25 -36.99 85.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.516 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -88.46 10.8 18.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.739 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.76 13.11 82.78 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.262 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -89.03 161.77 16.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.233 0.517 . . . . 0.0 109.827 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.768 HG12 HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -79.76 124.83 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.401 -179.15 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.84 HD11 HD11 ' A' ' 76' ' ' LEU . 2.2 tt . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.204 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.84 HD11 HD11 ' A' ' 72' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.849 0.356 . . . . 0.0 110.857 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.5 p -123.57 159.55 28.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.39 -25.02 0.58 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.664 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.433 ' HD2' ' CD1' ' A' ' 93' ' ' TYR . 18.9 mtm180 79.9 92.03 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.889 0.376 . . . . 0.0 110.922 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.87 25.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.021 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 p -122.24 -138.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.959 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 p -129.65 -31.12 2.02 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.588 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 96' ' ' CYS . 12.4 m-85 -72.1 104.19 3.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.534 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.54 141.09 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.347 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.818 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 20.4 t80 -133.78 107.44 7.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.145 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -102.33 134.67 45.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.446 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.479 HG23 ' CE1' ' A' ' 85' ' ' PHE . 2.6 pt -140.06 123.91 18.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.724 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 t0 63.32 -66.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.43 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 87' ' ' ILE . 16.0 m-20 -168.0 35.28 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.499 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -135.61 113.23 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.895 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -80.21 86.17 5.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.083 0.468 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.404 ' CB ' ' O ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -73.65 164.63 26.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.114 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.433 ' CD1' ' HD2' ' A' ' 79' ' ' ARG . 7.9 m-85 -135.49 165.2 26.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.228 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -153.37 173.44 15.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.073 0.463 . . . . 0.0 111.946 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.411 ' O ' ' CE2' ' A' ' 83' ' ' TYR . 12.0 m0 -97.02 -17.58 19.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.008 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.43 ' HA ' ' CE2' ' A' ' 83' ' ' TYR . 1.2 m -153.96 165.91 34.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.155 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -52.46 -22.8 5.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.666 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.2 mt -85.22 -51.67 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.593 0.235 . . . . 0.0 111.292 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.593 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -49.4 -27.4 4.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.704 0.287 . . . . 0.0 111.542 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.627 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.48 -29.81 69.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.454 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.529 ' N ' HD23 ' A' ' 101' ' ' LEU . 1.8 pt? -154.65 126.3 7.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.773 HD13 ' O ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -96.22 -36.68 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 106' ' ' LEU . 1.6 m-85 -124.76 78.0 64.61 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.724 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.812 ' O ' HG22 ' A' ' 107' ' ' ILE . 36.1 Cg_exo -61.2 -51.42 4.5 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.631 2.221 . . . . 0.0 112.327 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.85 -23.41 41.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.567 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -90.35 -15.84 30.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 104' ' ' PRO . 2.9 tp -47.84 -53.31 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 111.993 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.443 ' H ' HG23 ' A' ' 107' ' ' ILE . . . 102.3 0.73 50.7 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.966 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.95 177.88 10.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 110.399 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.35 143.94 44.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.818 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -137.18 109.88 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -81.33 120.05 24.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.75 0.786 . . . . 0.0 111.467 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.17 130.9 65.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.827 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.4 m -126.02 137.97 53.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.326 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.594 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.6 OUTLIER -141.34 172.91 12.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.075 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -133.97 135.67 43.64 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.2 t -64.59 131.97 48.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.29 -3.4 23.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.936 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.897 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.91 -50.5 2.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.87 0.367 . . . . 0.0 111.543 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.688 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -90.32 -23.62 21.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.457 -179.346 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.56 6.18 75.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.251 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.688 ' H ' HG22 ' A' ' 120' ' ' THR . . . -60.03 155.55 43.2 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-O 120.604 0.24 . . . . 0.0 110.457 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -87.97 104.27 0.51 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.719 2.279 . . . . 0.0 111.383 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.594 HG22 ' C ' ' A' ' 115' ' ' SER . 33.9 m -98.1 145.14 10.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.1 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.3 p -155.59 142.69 19.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.581 0.705 . . . . 0.0 111.26 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.585 HD21 ' SD ' ' A' ' 141' ' ' MET . 0.5 OUTLIER -135.16 153.32 52.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.685 178.349 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.874 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 32.2 m -108.26 113.84 27.25 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.723 HG13 ' CZ ' ' A' ' 193' ' ' PHE . 41.1 t -95.9 111.51 26.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.026 0.441 . . . . 0.0 111.696 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.409 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.8 OUTLIER -105.86 169.01 7.45 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.744 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 33.3 Cg_endo -65.42 -18.82 60.87 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.14 1.893 . . . . 0.0 112.844 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 70.8 m -112.59 -28.2 7.92 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 131' ' ' SER . 22.1 pt-20 179.54 -163.3 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.237 0.541 . . . . 0.0 110.139 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -95.2 158.66 2.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.753 178.605 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -147.23 19.33 1.22 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.874 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.23 86.19 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.632 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.3 t -105.03 117.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.024 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.44 117.38 4.77 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.087 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.436 ' CD ' HG12 ' A' ' 124' ' ' VAL . 16.7 Cg_exo -67.57 145.91 75.38 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.73 -1.363 . . . . 0.0 112.443 0.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.35 -33.19 52.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.867 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -101.43 30.14 11.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.245 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.873 ' SD ' HG11 ' A' ' 189' ' ' VAL . 5.4 ptp -65.22 157.22 29.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 0.0 111.889 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.8 152.44 50.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.318 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.747 ' CG2' HG12 ' A' ' 189' ' ' VAL . 11.4 t -113.41 153.08 15.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.776 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.404 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 4.4 m -121.7 143.04 49.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.741 0.305 . . . . 0.0 110.608 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.508 HD13 HG21 ' A' ' 187' ' ' VAL . 5.3 mp -145.3 176.08 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.109 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.4 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.837 179.725 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.908 0.385 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.03 169.31 12.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.738 0.78 . . . . 0.0 109.765 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.708 ' CD1' HG13 ' A' ' 143' ' ' VAL . 2.0 m-85 -113.0 152.35 29.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.912 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 60.6 m-85 -131.44 136.83 48.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.766 0.793 . . . . 0.0 110.578 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 122' ' ' ALA . . . -47.88 -25.17 1.22 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.797 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.596 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 44.7 m -164.73 167.62 18.79 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.643 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.62 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.3 t -68.12 -34.45 6.08 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.896 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.3 Cg_exo -72.45 -37.03 4.6 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.768 2.312 . . . . 0.0 110.103 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.583 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.19 -40.57 52.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.731 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.52 -46.15 91.21 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 1.7 mm-40 -78.97 -27.22 43.48 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.331 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.709 ' N ' ' O ' ' A' ' 169' ' ' PRO . 26.5 t70 -70.06 -55.76 8.66 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.192 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.897 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 51.4 t-105 -65.99 -28.29 68.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.723 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.24 -39.45 93.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.13 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.0 t -53.71 -42.25 67.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.428 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 18.46 9.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.382 0.61 . . . . 0.0 111.38 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.438 ' CD2' ' CD1' ' A' ' 174' ' ' TRP . 0.1 OUTLIER -120.31 24.15 10.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.727 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.768 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 185' ' ' ALA . 1.9 tt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.757 0.313 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.589 ' N ' HD23 ' A' ' 184' ' ' LEU . . . -142.55 150.17 40.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.11 0.481 . . . . 0.0 111.369 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 175' ' ' ALA . 15.5 mm -101.56 161.31 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.747 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.716 HG12 ' CD ' ' A' ' 191' ' ' GLU . 0.0 OUTLIER -159.89 159.79 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.277 0.56 . . . . 0.0 112.15 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 190' ' ' HIS . 42.2 p -89.83 128.59 36.19 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.669 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.873 HG11 ' SD ' ' A' ' 141' ' ' MET . 2.4 m -47.72 -19.15 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.993 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.407 ' N ' ' C ' ' A' ' 188' ' ' SER . 59.5 t-80 -72.82 -42.03 64.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.155 0.502 . . . . 0.0 109.821 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.716 ' CD ' HG12 ' A' ' 187' ' ' VAL . 1.1 pt-20 -82.16 -26.18 33.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.177 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.22 -24.91 66.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.927 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.723 ' CZ ' HG13 ' A' ' 128' ' ' VAL . 1.3 t80 -81.34 -25.58 36.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.68 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.04 -31.76 27.96 Favored Glycine 0 CA--C 1.509 -0.3 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.1 tp -80.83 -28.55 36.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -82.84 -24.77 52.04 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.2 -22.28 36.04 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.969 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -77.74 -22.77 49.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.255 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.13 -39.5 60.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.868 0.366 . . . . 0.0 111.092 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -81.09 -44.34 18.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.072 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 25' ' ' VAL . 6.1 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.709 0.29 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.467 ' HA ' ' HB2' ' A' ' 29' ' ' ARG . 53.6 Cg_exo -52.02 -24.55 19.83 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.593 2.195 . . . . 0.0 112.407 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.083 HD12 HD12 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.93 -57.23 12.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.328 -179.432 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.083 HD12 HD12 ' A' ' 27' ' ' LEU . 1.1 mp -72.49 -27.36 62.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.251 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.467 ' HB2' ' HA ' ' A' ' 26' ' ' PRO . 5.3 mmt85 -64.42 -53.28 50.85 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.138 0.494 . . . . 0.0 109.824 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -70.91 -25.01 62.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.409 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.6 -40.27 84.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.947 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.23 -25.2 13.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.573 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' NZ ' HG22 ' A' ' 37' ' ' VAL . 1.3 ptpt -70.36 -20.19 62.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.173 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.13 47.69 86.18 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.354 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -133.21 158.3 76.09 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.725 0.297 . . . . 0.0 110.74 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.7 91.63 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.566 2.177 . . . . 0.0 112.262 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.614 ' O ' HD12 ' A' ' 71' ' ' ILE . 21.9 t -92.96 114.92 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.353 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.4 p -77.44 -179.62 5.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.847 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -78.2 -32.55 50.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.631 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -68.34 -30.77 69.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.681 0.277 . . . . 0.0 110.642 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.31 -38.51 20.32 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.31 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.805 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.3 tp -63.16 -41.71 99.29 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.977 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -69.74 -42.96 73.26 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.774 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 40' ' ' THR . . . -67.47 -25.84 73.71 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.254 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.795 HG22 HD23 ' A' ' 46' ' ' LEU . 7.1 mt -76.54 -40.18 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.245 -0.478 . . . . 0.0 110.457 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.805 ' HG ' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -80.22 -6.5 57.93 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.568 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 62.95 30.15 16.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -116.99 149.64 44.52 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.624 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.16 143.72 99.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.626 2.218 . . . . 0.0 112.006 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.48 -16.45 2.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.95 -31.58 45.11 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.586 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.82 ' O ' HG23 ' A' ' 56' ' ' VAL . 13.5 mtp180 -70.18 -40.0 74.92 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.977 HG21 ' HB2' ' A' ' 43' ' ' ALA . 1.8 t -65.63 -46.36 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.36 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.38 -51.7 57.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.112 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.72 -43.24 80.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.7 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 52' ' ' ARG . 27.7 t -70.59 -32.45 49.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.577 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.562 HD22 ' OH ' ' A' ' 65' ' ' TYR . 15.9 mt -61.39 -32.52 72.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.499 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.606 ' O ' HG23 ' A' ' 61' ' ' THR . 3.0 tt0 -57.63 -24.35 56.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.701 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -96.18 -14.43 22.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.482 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -104.11 32.86 3.73 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.466 0.65 . . . . 0.0 110.598 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 58' ' ' GLU . 27.0 p -66.89 -14.39 62.7 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.233 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 t -86.78 -23.9 25.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 111.346 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.482 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -55.81 141.23 39.48 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.047 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.543 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -78.99 126.79 31.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.038 0.447 . . . . 0.0 111.474 -179.397 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.562 ' OH ' HD22 ' A' ' 57' ' ' LEU . 13.1 m-85 -100.64 168.81 9.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.267 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -153.87 143.61 21.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.549 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.7 tttp 66.9 -102.64 0.07 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.824 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.32 -13.04 28.64 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.74 31.86 0.79 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.051 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.67 169.03 11.65 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 37' ' ' VAL . 4.0 mp -79.8 114.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.27 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.782 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.112 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.3 p -107.66 159.05 16.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.35 -30.8 60.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -102.8 147.57 26.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -64.52 122.27 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.9 p -106.91 -174.72 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.2 p -92.65 -37.29 12.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 45.6 m-85 -87.24 113.97 23.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.08 142.73 20.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.984 ' CE2' HD13 ' A' ' 101' ' ' LEU . 59.8 t80 -124.72 105.19 9.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.346 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -98.62 126.23 44.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.323 . . . . 0.0 111.42 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.621 HD11 ' HB2' ' A' ' 90' ' ' ARG . 6.9 pt -118.76 177.89 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.396 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 87' ' ' ILE . 8.6 t0 -14.52 -53.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 87' ' ' ILE . 21.7 p30 -165.74 35.48 0.05 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.033 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.621 ' HB2' HD11 ' A' ' 87' ' ' ILE . 12.1 mmt180 -142.03 113.07 7.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.72 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.64 119.39 21.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.791 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.3 164.88 12.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.268 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -133.95 165.14 25.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.099 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.63 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -153.45 171.39 18.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.115 0.483 . . . . 0.0 111.855 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -94.37 -20.27 19.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.007 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.407 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 2.3 m -157.51 179.81 8.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.668 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB2' ' HD2' ' A' ' 164' ' ' PHE . . . -56.52 -21.89 29.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tp -89.18 -51.92 5.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.63 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 4.8 m-20 -46.95 -26.54 1.03 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -60.36 -36.26 77.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.666 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.984 HD13 ' CE2' ' A' ' 85' ' ' PHE . 3.3 tp -176.78 152.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.5 pt -122.82 -39.24 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.519 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -119.7 81.7 25.56 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.168 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.633 ' HA ' HD21 ' A' ' 101' ' ' LEU . 7.3 Cg_exo -72.58 -29.0 13.69 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.797 2.331 . . . . 0.0 112.215 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.09 -23.76 59.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.249 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -78.74 -29.91 45.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.906 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 104' ' ' PRO . 3.9 mm -54.16 -60.55 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.082 0.944 . . . . 0.0 110.988 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.29 25.21 Favored Glycine 0 C--N 1.316 -0.545 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.301 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.16 -177.27 5.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.357 . . . . 0.0 110.462 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.09 148.5 27.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.795 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.24 110.01 7.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -80.8 121.05 25.46 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.714 0.768 . . . . 0.0 110.86 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.822 HG22 ' CD1' ' A' ' 85' ' ' PHE . 90.5 t -113.8 131.78 64.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.934 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.6 p -119.42 138.25 53.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.712 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.535 ' OG ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -140.67 172.8 12.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.42 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -135.15 131.32 36.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.54 178.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.662 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.3 m -57.41 124.45 18.98 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.918 0.389 . . . . 0.0 111.902 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.12 -9.49 46.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.628 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.701 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.67 -51.2 2.05 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.557 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -76.24 -20.83 57.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.917 0.389 . . . . 0.0 110.767 -179.024 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.3 33.69 85.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.108 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.557 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -100.91 168.01 9.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.437 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.418 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 46.3 Cg_endo -93.89 110.27 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 123.024 2.483 . . . . 0.0 111.313 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.535 HG23 ' OG ' ' A' ' 115' ' ' SER . 35.3 m -109.51 148.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.492 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 86.0 p -147.62 142.43 26.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.509 0.671 . . . . 0.0 110.567 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -135.19 152.13 51.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.743 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.801 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 42.8 m -111.25 112.31 24.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 104' ' ' PRO . 32.6 t -96.93 114.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.008 0.432 . . . . 0.0 112.137 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.42 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -105.72 170.19 6.15 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.702 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.9 Cg_endo -66.64 -19.51 53.9 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.158 1.905 . . . . 0.0 113.001 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 6.9 t -108.87 -27.41 9.73 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 131' ' ' SER . 14.9 pt-20 178.05 -162.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.64 162.84 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.472 178.248 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -150.09 21.28 0.87 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.434 0.635 . . . . 0.0 112.326 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.801 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.95 87.4 0.09 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.44 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 t -104.1 119.88 53.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.156 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.18 122.9 5.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.796 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.506 ' CD ' HG12 ' A' ' 124' ' ' VAL . 61.9 Cg_endo -73.24 159.63 97.03 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.382 -1.507 . . . . 0.0 112.322 0.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.92 79.37 0.64 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.134 0.492 . . . . 0.0 110.658 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.26 18.02 0.17 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.282 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.593 ' CG ' HG11 ' A' ' 189' ' ' VAL . 9.8 ptm -60.98 157.82 14.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.019 0.438 . . . . 0.0 111.395 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.492 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -127.13 152.01 47.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.326 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.939 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -117.93 152.34 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.991 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.423 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 53.1 p -117.47 143.74 45.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.766 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 146' ' ' VAL . 0.2 OUTLIER -136.54 176.05 9.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.819 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.722 HG12 ' CD1' ' A' ' 184' ' ' LEU . 29.9 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 145' ' ' LEU . 75.8 t . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 111.611 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -118.91 169.35 9.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.558 0.694 . . . . 0.0 109.773 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.939 ' CE1' HG22 ' A' ' 143' ' ' VAL . 0.4 OUTLIER -111.05 151.14 28.38 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.036 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 45.6 m-85 -135.83 134.6 39.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.251 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.662 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -38.93 -29.68 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.146 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 35.2 m -170.49 178.0 3.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.062 0.458 . . . . 0.0 111.575 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.61 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 90.5 t -69.57 -33.77 4.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.491 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.5 Cg_exo -72.64 -38.78 3.0 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.563 2.175 . . . . 0.0 110.41 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.556 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.23 -39.65 54.05 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.035 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.751 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.88 -46.81 87.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 2.3 mm-40 -78.99 -26.98 43.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.5 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 169' ' ' PRO . 4.8 t70 -70.89 -55.72 7.82 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.701 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 32.3 t-105 -65.03 -29.75 70.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.787 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.33 -39.6 95.0 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.242 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -44.43 62.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.338 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.16 23.87 6.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.172 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 174' ' ' TRP . 2.3 t-160 -136.41 33.38 2.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.037 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.675 179.893 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.722 ' CD1' HG12 ' A' ' 146' ' ' VAL . 7.9 tp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.771 0.32 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -140.28 148.89 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.022 0.439 . . . . 0.0 111.121 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.662 HD11 ' HB2' ' A' ' 175' ' ' ALA . 17.1 mm -100.71 160.53 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.987 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.473 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -162.79 150.66 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.144 0.497 . . . . 0.0 111.969 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -78.98 126.07 30.2 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.635 178.082 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.612 ' HA ' ' HB3' ' A' ' 192' ' ' ALA . 0.2 OUTLIER -46.54 -20.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.885 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -72.24 -45.1 61.63 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.0 OUTLIER -82.73 -22.41 34.44 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.141 178.175 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -67.83 -25.61 65.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.729 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 197' ' ' GLN . 0.2 OUTLIER -81.75 -24.94 35.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.627 179.147 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.08 -31.52 28.43 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -29.73 31.53 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -82.27 -28.46 40.38 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.409 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 37.5 tt0 -82.47 -22.57 35.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.866 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -81.09 -25.23 37.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.85 -29.76 20.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 0.0 111.291 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -80.43 -55.13 5.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.902 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 -179.879 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.76 HG11 HD23 ' A' ' 28' ' ' LEU . 21.5 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.707 0.289 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.796 ' CG ' HD11 ' A' ' 46' ' ' LEU . 43.0 Cg_endo -67.83 -27.12 37.74 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.525 2.15 . . . . 0.0 112.371 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.709 ' HG ' HD21 ' A' ' 42' ' ' LEU . 5.2 mp -52.66 -57.44 10.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.232 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.76 HD23 HG11 ' A' ' 25' ' ' VAL . 3.9 pp -80.07 -27.3 39.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.066 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.429 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 10.6 ttt85 -64.83 -53.29 49.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -65.78 -23.78 66.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.287 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.677 HD11 ' O ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -68.04 -37.59 81.53 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.773 179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.19 -26.41 17.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 111.03 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -20.97 66.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.226 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.63 48.3 82.63 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.153 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -133.06 157.26 78.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.724 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.3 91.02 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.516 2.144 . . . . 0.0 112.121 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.644 HG13 HG22 ' A' ' 41' ' ' THR . 21.5 t -93.01 113.5 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.38 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.8 p -87.0 -174.16 4.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.718 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -77.93 -36.23 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.321 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -28.72 69.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.907 0.384 . . . . 0.0 110.09 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.644 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.46 -41.82 16.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.345 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.709 HD21 ' HG ' ' A' ' 27' ' ' LEU . 2.2 tp -62.63 -36.5 83.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.92 -43.27 62.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.589 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -30.89 74.95 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.689 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.588 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.09 -42.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.067 0.461 . . . . 0.0 110.376 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.796 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.1 mp -76.44 -9.66 58.82 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.41 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.1 t0 60.34 21.64 11.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.43 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 5.3 m95 -107.48 158.1 34.07 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.171 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.02 144.09 62.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.607 2.205 . . . . 0.0 112.114 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.0 -16.92 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -78.64 -35.04 46.01 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.208 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.828 ' O ' HG23 ' A' ' 56' ' ' VAL . 3.6 ttt-85 -67.6 -41.1 84.59 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.645 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -63.03 -47.73 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.483 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.26 -53.11 55.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.206 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.77 -46.92 77.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.794 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 52' ' ' ARG . 30.9 t -67.65 -32.03 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.724 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -64.22 -33.26 75.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.657 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 61' ' ' THR . 6.0 tp10 -58.16 -22.06 49.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.88 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -90.85 -17.47 26.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.06 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HB1' ' HB ' ' A' ' 63' ' ' THR . . . -97.18 33.09 2.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.367 0.603 . . . . 0.0 111.121 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.694 HG23 ' O ' ' A' ' 58' ' ' GLU . 73.1 p -60.1 -20.63 59.15 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.912 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.56 -22.6 21.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.411 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB1' ' A' ' 60' ' ' ALA . 0.8 OUTLIER -58.46 141.06 52.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.523 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -78.85 126.9 31.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 0.0 111.604 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.433 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 62.5 m-85 -103.43 173.17 6.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.192 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.824 ' HB2' HG21 ' A' ' 72' ' ' ILE . 22.5 t70 -153.53 147.87 25.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.416 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.7 tttp 66.28 -102.01 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.782 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.23 -13.05 33.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.97 30.76 1.18 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.92 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -85.92 164.83 17.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.957 0.408 . . . . 0.0 110.189 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -79.96 109.61 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.336 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.824 HG21 ' HB2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.642 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.617 HD12 HD13 ' A' ' 92' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.764 0.316 . . . . 0.0 110.96 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.571 ' N ' HD23 ' A' ' 76' ' ' LEU . 67.5 p -99.75 159.08 15.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.812 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.73 -32.66 25.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -96.53 144.23 26.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.1 122.09 17.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.3 p -107.36 -177.05 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.1 m -93.08 -30.47 15.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.904 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.544 ' HE2' ' HB2' ' A' ' 97' ' ' ALA . 20.6 m-85 -86.68 117.35 25.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.362 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.458 HG22 ' HE1' ' A' ' 93' ' ' TYR . 21.2 t -110.01 142.31 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.488 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.83 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 46.2 t80 -125.58 105.21 8.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.717 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.14 121.01 34.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.173 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.608 HD11 HD23 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -139.03 122.93 19.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.617 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 58.3 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.327 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.0 t70 -159.38 35.83 0.2 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.432 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -139.79 113.88 8.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.641 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -77.78 86.32 4.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.979 0.418 . . . . 0.0 111.02 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.617 HD13 HD12 ' A' ' 76' ' ' LEU . 3.4 mm? -71.77 164.64 25.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.439 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.458 ' HE1' HG22 ' A' ' 84' ' ' VAL . 40.5 m-85 -137.46 162.2 34.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.821 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 100' ' ' THR . . . -145.03 164.09 32.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.119 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -81.31 -33.37 32.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.45 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 59.7 m -152.92 -177.8 6.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.056 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.874 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -61.84 148.86 41.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.706 0.289 . . . . 0.0 110.917 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.48 ' CB ' ' O ' ' A' ' 97' ' ' ALA . 1.7 tt 88.11 -51.48 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.666 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -54.58 -21.61 10.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.208 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 1.3 p -60.45 -39.51 87.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.381 . . . . 0.0 110.544 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.627 ' O ' HG23 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -110.34 -172.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.174 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.8 HD12 ' CE2' ' A' ' 103' ' ' PHE . 3.3 pt -161.76 -43.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.975 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 102' ' ' ILE . 2.2 p90 -163.0 93.64 1.16 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.762 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.672 ' HB3' HG12 ' A' ' 128' ' ' VAL . 74.1 Cg_endo -74.45 -35.07 4.0 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.7 2.266 . . . . 0.0 112.368 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.69 -23.99 53.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.8 tp -84.89 -42.41 15.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.338 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.3 tp -57.18 -46.95 84.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.295 0.569 . . . . 0.0 111.417 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.52 23.64 18.31 Favored Glycine 0 C--N 1.318 -0.423 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.699 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 173.46 15.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.893 0.378 . . . . 0.0 111.077 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -80.81 152.91 28.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.897 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.83 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.16 109.77 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -83.03 120.64 26.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.78 0.8 . . . . 0.0 111.158 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.75 HG22 ' HD1' ' A' ' 85' ' ' PHE . 60.3 t -112.44 129.44 67.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.963 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.7 m -119.72 137.93 53.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.029 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.695 ' HB2' HG23 ' A' ' 124' ' ' VAL . 3.1 m -141.25 172.8 12.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.478 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 3.8 p80 -137.82 132.67 32.98 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 23.0 t -61.15 130.8 48.09 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.152 0.501 . . . . 0.0 112.16 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.91 -3.14 20.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.756 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.823 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.14 -50.46 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 0.0 111.601 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -90.14 -24.67 21.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.29 -179.465 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.09 81.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.108 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.689 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.29 158.68 13.48 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 120.581 0.229 . . . . 0.0 110.483 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -91.49 106.16 0.26 Allowed 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.757 2.305 . . . . 0.0 111.246 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.7 HG12 ' CD ' ' A' ' 138' ' ' PRO . 32.2 m -103.92 145.66 12.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.277 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.926 ' O ' HD13 ' A' ' 126' ' ' LEU . 64.3 p -151.47 141.47 22.09 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.386 0.612 . . . . 0.0 110.79 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.926 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -135.22 153.07 52.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.434 178.854 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.864 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 54.7 m -110.57 113.52 26.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.814 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.672 HG12 ' HB3' ' A' ' 104' ' ' PRO . 24.2 t -96.04 111.63 26.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.482 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.79 171.17 4.94 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.282 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.34 -14.93 46.32 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.503 2.135 . . . . 0.0 113.087 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.9 p -119.88 -27.23 5.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -179.97 -163.57 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.166 0.508 . . . . 0.0 110.17 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -95.88 158.94 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.97 178.784 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -147.34 18.75 1.21 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.404 0.621 . . . . 0.0 112.555 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.864 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.32 85.83 0.07 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.466 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.815 HG13 HD12 ' A' ' 126' ' ' LEU . 21.3 t -106.46 118.13 53.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.334 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -146.45 116.28 4.64 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.691 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.7 ' CD ' HG12 ' A' ' 124' ' ' VAL . 15.4 Cg_exo -68.55 145.25 76.15 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.726 -1.364 . . . . 0.0 112.32 0.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.25 -29.31 22.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.698 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.55 33.7 6.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.776 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.781 ' SD ' HD11 ' A' ' 126' ' ' LEU . 1.1 ptm -66.26 159.74 25.9 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.068 0.434 . . . . 0.0 111.13 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -131.58 152.74 50.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.063 0.459 . . . . 0.0 111.604 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.677 ' CG2' HG12 ' A' ' 189' ' ' VAL . 44.4 t -111.12 146.16 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.314 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.468 ' O ' ' HB ' ' A' ' 162' ' ' VAL . 47.4 m -114.8 141.26 48.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.689 0.281 . . . . 0.0 110.653 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.612 ' HA ' HG12 ' A' ' 162' ' ' VAL . 6.8 mt -103.18 149.07 25.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.081 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.011 179.812 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 145' ' ' LEU . 3.5 m . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.882 0.372 . . . . 0.0 111.872 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -116.03 166.81 11.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.525 0.679 . . . . 0.0 109.762 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.874 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.3 m-30 -117.84 129.67 55.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.768 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.509 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 19.4 m-85 -108.68 142.58 38.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.401 0.619 . . . . 0.0 110.608 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -46.08 -26.72 0.79 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.825 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.556 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 25.7 p -169.94 170.8 7.47 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.82 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 72.0 t -67.76 -33.41 5.23 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.32 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.2 Cg_exo -72.7 -37.89 3.6 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.724 2.283 . . . . 0.0 110.292 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.08 -40.39 53.23 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.876 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.97 -45.97 91.31 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.6 mt-10 -78.96 -27.63 43.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.244 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 169' ' ' PRO . 9.4 t70 -70.79 -55.94 7.44 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.59 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.823 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 77.2 t-105 -65.15 -27.84 69.0 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.685 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -62.4 -38.99 91.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.215 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.3 t -54.68 -47.78 73.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.442 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -95.48 21.6 7.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.258 0.551 . . . . 0.0 111.034 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -132.77 29.75 4.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.951 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.604 179.843 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.3 tp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.641 0.258 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -143.64 150.51 38.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.109 0.481 . . . . 0.0 111.539 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.5 mm -100.7 161.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.638 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.471 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -164.48 165.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.398 0.618 . . . . 0.0 112.11 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.5 OUTLIER -93.79 132.79 37.84 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.539 178.442 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.763 HG11 ' SD ' ' A' ' 141' ' ' MET . 3.6 m -48.27 -17.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.878 0.37 . . . . 0.0 110.927 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 0.6 OUTLIER -73.33 -44.51 58.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.134 0.492 . . . . 0.0 109.753 179.075 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.38 -21.61 35.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.53 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -76.49 -25.37 54.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.278 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.42 ' CE2' ' HG3' ' A' ' 197' ' ' GLN . 85.8 t80 -81.7 -25.89 35.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 110.722 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.79 -30.25 32.81 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -81.59 -27.74 34.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.482 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -27.33 34.29 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.42 ' HG3' ' CE2' ' A' ' 193' ' ' PHE . 1.5 mm100 -82.33 -23.21 35.22 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.495 -0.352 . . . . 0.0 111.023 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -79.28 -23.08 43.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.229 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -52.2 -32.01 34.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -81.14 -55.03 5.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -179.897 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 25' ' ' VAL . 10.8 p . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 120.444 0.164 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.604 ' CG ' HD11 ' A' ' 46' ' ' LEU . 58.7 Cg_endo -71.51 -28.65 17.42 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.403 2.069 . . . . 0.0 112.359 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 27' ' ' LEU . 5.8 mp -52.27 -57.18 10.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.632 HD13 HD13 ' A' ' 31' ' ' LEU . 4.0 mm? -75.56 -27.14 58.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.921 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -53.45 57.38 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.629 ' OE2' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -71.12 -24.3 62.26 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.126 178.165 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.632 HD13 HD13 ' A' ' 28' ' ' LEU . 8.8 tt -66.2 -48.24 71.26 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.759 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.49 -26.09 19.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.61 -22.11 65.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.27 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 47.03 92.97 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.147 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -127.42 163.95 39.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.694 0.283 . . . . 0.0 110.86 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.34 111.61 2.1 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.553 2.169 . . . . 0.0 112.107 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.692 HG13 HG22 ' A' ' 41' ' ' THR . 22.6 t -116.35 111.04 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.398 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 p -91.39 179.62 5.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.688 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -69.22 -40.99 77.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.213 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -24.64 66.83 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.279 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.692 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.96 -44.16 12.59 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.383 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.73 HD12 HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -62.8 -36.29 82.67 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.664 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.95 -42.83 63.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.57 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.51 -31.56 73.98 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.652 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.604 HD12 HG23 ' A' ' 41' ' ' THR . 7.3 mt -78.32 -46.08 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 120.965 0.412 . . . . 0.0 110.528 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.604 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.7 mp -75.73 -9.61 58.73 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.614 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 59.91 21.78 10.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.456 ' CE3' HD23 ' A' ' 46' ' ' LEU . 16.4 m0 -103.68 160.06 27.32 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.175 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.93 138.79 41.42 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.595 2.197 . . . . 0.0 111.91 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.03 -20.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.55 -32.28 47.78 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.059 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.615 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.48 -40.98 85.27 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.578 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.69 -48.02 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.616 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.75 -52.05 61.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.488 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.22 -38.79 27.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 52' ' ' ARG . 39.1 t -58.38 -30.06 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.782 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 57' ' ' LEU . 7.2 mp -81.0 -23.62 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.873 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.9 -23.49 31.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.091 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -126.64 5.83 6.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.229 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -123.17 76.94 1.42 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.722 0.772 . . . . 0.0 110.441 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.9 p -99.3 -22.44 15.59 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.118 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 p -70.5 -26.08 63.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.192 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.46 141.38 42.7 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.5 ' O ' HG22 ' A' ' 72' ' ' ILE . 1.7 tt0 -78.85 126.77 31.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 111.354 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -104.03 171.7 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.491 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 70' ' ' ASN . 1.9 t0 -92.45 -172.85 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.376 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -37.71 86.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.58 9.52 29.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.718 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.76 18.76 62.93 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.065 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 66' ' ' ASP . 56.8 m-20 -92.03 167.34 12.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.076 0.438 . . . . 0.0 110.091 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.73 HD13 HD12 ' A' ' 42' ' ' LEU . 4.1 mp -79.82 119.18 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.329 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.7 tt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.028 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.591 HD13 ' CD2' ' A' ' 92' ' ' LEU . 4.6 mp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.701 0.286 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.476 HG21 ' HD1' ' A' ' 95' ' ' TRP . 12.3 p -126.06 159.33 33.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.501 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.504 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.9 OUTLIER -83.97 52.44 2.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 0.0 111.096 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.428 ' HA ' ' CD1' ' A' ' 93' ' ' TYR . 27.4 mtm-85 49.38 95.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.088 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.1 tp10 -169.15 -144.09 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.635 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.884 HG21 ' HA ' ' A' ' 95' ' ' TRP . 0.7 OUTLIER 41.19 -173.36 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 178.413 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 p -107.34 -19.65 13.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.364 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -76.87 111.25 12.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.688 0.28 . . . . 0.0 110.485 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.0 137.65 41.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 111.388 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.851 ' CD1' HG22 ' A' ' 113' ' ' VAL . 34.6 t80 -126.79 105.07 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.162 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -96.82 124.83 40.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.14 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.548 HG21 ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.15 128.72 26.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.998 0.428 . . . . 0.0 112.109 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 61.13 -77.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.318 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 87' ' ' ILE . 7.6 t70 -156.3 37.39 0.33 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.65 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -141.78 149.65 40.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.781 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 86.22 2.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.013 0.435 . . . . 0.0 110.673 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.591 ' CD2' HD13 ' A' ' 76' ' ' LEU . 8.5 mp -71.39 164.64 25.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.975 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 79' ' ' ARG . 88.9 m-85 -133.48 165.18 25.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.973 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -150.91 166.24 31.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.001 0.429 . . . . 0.0 111.962 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.884 ' HA ' HG21 ' A' ' 81' ' ' THR . 12.0 m0 -90.75 -23.17 20.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.403 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 65.2 m -153.81 174.83 14.05 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.941 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB1' ' CZ ' ' A' ' 164' ' ' PHE . . . -53.83 -21.49 7.65 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -51.78 6.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.622 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -49.36 -25.65 2.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.696 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -60.07 -28.97 68.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.952 0.406 . . . . 0.0 110.5 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 102' ' ' ILE . 5.1 tp 70.48 155.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.069 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.719 ' HB ' HG11 ' A' ' 128' ' ' VAL . 2.1 pt -158.84 77.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.789 ' O ' HG22 ' A' ' 107' ' ' ILE . 14.8 p90 -121.2 54.13 4.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.947 ' HG3' HG12 ' A' ' 128' ' ' VAL . 28.8 Cg_endo -62.7 -37.61 55.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.696 2.264 . . . . 0.0 112.235 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 130' ' ' PRO . . . -64.03 -30.33 71.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.581 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.89 -47.69 13.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -67.73 -41.09 84.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 111.285 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.82 28.47 8.29 Favored Glycine 0 C--N 1.319 -0.38 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.171 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.14 177.39 10.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.051 0.453 . . . . 0.0 110.895 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 m -87.28 160.28 18.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.993 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.663 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -136.55 109.84 7.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.869 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -82.96 119.43 24.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.818 0.818 . . . . 0.0 111.185 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.851 HG22 ' CD1' ' A' ' 85' ' ' PHE . 42.0 t -109.98 128.92 65.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.878 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.1 m -121.75 136.72 54.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.961 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.625 ' HB2' HG23 ' A' ' 124' ' ' VAL . 3.4 m -141.5 172.98 11.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -131.06 130.93 43.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 30.9 m -56.29 125.6 22.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.95 0.405 . . . . 0.0 112.041 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.21 -7.0 38.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.62 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -119.39 -50.56 2.33 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.35 -13.96 36.7 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.898 -179.166 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 63.8 11.24 42.46 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.674 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.547 ' H ' HG22 ' A' ' 120' ' ' THR . . . -71.83 164.38 58.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.697 0.284 . . . . 0.0 110.691 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.49 107.98 0.42 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 123.037 2.491 . . . . 0.0 111.328 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' A' ' 115' ' ' SER . 33.5 m -104.95 146.27 12.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.421 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.891 ' O ' HD13 ' A' ' 126' ' ' LEU . 60.6 p -151.45 141.69 22.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.384 0.611 . . . . 0.0 110.883 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -134.3 152.58 51.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.137 178.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.843 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 20.8 m -111.55 114.3 27.28 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.947 HG12 ' HG3' ' A' ' 104' ' ' PRO . 39.7 t -96.09 111.79 27.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.016 0.436 . . . . 0.0 111.243 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.491 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -105.68 172.9 3.59 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.215 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 41.2 Cg_endo -67.57 -19.82 47.95 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.271 1.981 . . . . 0.0 113.097 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 0.4 OUTLIER -112.57 -26.7 8.53 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.117 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 131' ' ' SER . 19.9 pt-20 178.62 -161.02 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.19 0.519 . . . . 0.0 110.108 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -91.79 160.5 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.565 178.532 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -150.18 17.87 0.85 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.843 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.07 85.12 0.07 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.102 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.407 HG13 HD12 ' A' ' 126' ' ' LEU . 32.9 t -99.6 122.86 51.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.637 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -146.06 118.8 5.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.95 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.413 ' HD2' HG12 ' A' ' 124' ' ' VAL . 60.0 Cg_endo -72.42 159.65 95.8 Favored 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 123.396 -1.502 . . . . 0.0 112.094 -0.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.26 78.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.103 0.478 . . . . 0.0 110.673 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.13 18.47 0.17 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.692 -0.765 . . . . 0.0 113.288 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.873 ' SD ' HD11 ' A' ' 126' ' ' LEU . 6.5 ptm -67.4 164.43 18.67 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.968 0.384 . . . . 0.0 111.303 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -125.0 152.16 44.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.172 0.511 . . . . 0.0 111.049 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.738 HG13 ' CD1' ' A' ' 164' ' ' PHE . 2.5 t -113.08 150.42 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 20.3 p -118.29 140.19 50.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.851 0.358 . . . . 0.0 110.835 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.404 HD21 HG21 ' A' ' 187' ' ' VAL . 0.8 OUTLIER -149.23 176.52 10.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.723 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 146' ' ' VAL . 11.8 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.901 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.46 HG12 ' HB3' ' A' ' 97' ' ' ALA . 12.4 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.881 0.372 . . . . 0.0 111.583 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -120.84 169.44 10.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.565 0.698 . . . . 0.0 109.777 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.738 ' CD1' HG13 ' A' ' 143' ' ' VAL . 49.8 m-85 -115.08 152.67 32.11 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.382 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 37.9 m-85 -134.09 137.84 44.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.181 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.626 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -43.85 -27.92 0.39 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.255 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.569 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 67.8 m -165.98 172.3 11.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.118 0.485 . . . . 0.0 111.577 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 76.2 t -69.38 -34.16 4.53 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.02 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.3 -37.41 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.645 2.23 . . . . 0.0 110.136 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.59 -40.02 50.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.085 -0.962 . . . . 0.0 108.415 177.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.724 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.29 -45.75 93.16 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.8 mt-10 -78.79 -27.47 44.48 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.291 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 169' ' ' PRO . 28.8 t70 -71.05 -55.92 7.23 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.517 0.675 . . . . 0.0 109.308 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.62 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 32.9 t-105 -64.59 -28.66 69.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.806 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -65.39 -38.55 90.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.349 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.2 t -52.07 -46.42 65.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.469 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -97.55 24.36 6.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.017 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -156.68 45.81 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.691 179.802 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 CA--C 1.528 0.127 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -131.34 141.19 49.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.101 0.477 . . . . 0.0 111.353 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 175' ' ' ALA . 18.3 mm -104.44 160.95 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.019 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -160.62 162.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.373 0.606 . . . . 0.0 111.775 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 190' ' ' HIS . 1.7 m -92.13 133.99 35.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.475 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.536 HG11 ' HG3' ' A' ' 141' ' ' MET . 1.7 m -45.87 -20.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.882 0.373 . . . . 0.0 110.654 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.425 ' N ' ' C ' ' A' ' 188' ' ' SER . 93.9 m-70 -70.77 -45.2 65.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.818 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.631 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.4 OUTLIER -82.42 -20.89 36.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.656 179.254 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -76.69 -25.36 53.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.228 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -81.41 -24.85 36.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.687 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.84 -29.26 35.44 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.631 HD13 ' O ' ' A' ' 191' ' ' GLU . 6.7 mp -82.33 -28.45 31.62 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.05 -28.33 31.43 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -80.84 -21.95 40.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.996 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -75.75 -22.94 56.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.103 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -52.09 -37.87 55.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.932 0.396 . . . . 0.0 111.168 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -69.64 -24.85 63.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.132 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.953 HG21 HD12 ' A' ' 28' ' ' LEU . 7.3 p . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 111.583 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HB2' HD11 ' A' ' 46' ' ' LEU . 48.9 Cg_exo -55.78 -30.05 74.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.558 2.172 . . . . 0.0 112.54 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.706 HD12 ' HG ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -52.94 -57.5 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.068 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.953 HD12 HG21 ' A' ' 25' ' ' VAL . 82.3 mt -60.87 -27.05 67.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -60.04 -53.18 60.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 0.0 109.673 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -76.75 -25.09 53.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.39 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.28 -52.15 44.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.21 -23.68 15.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.254 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -70.84 -23.58 62.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.186 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.1 49.15 77.81 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.174 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -132.98 166.02 32.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.48 115.16 3.92 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.515 2.144 . . . . 0.0 111.927 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.685 HG23 ' CG2' ' A' ' 41' ' ' THR . 9.3 p -124.21 109.87 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.487 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.9 p -79.15 -176.19 5.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -78.04 -33.44 51.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.315 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -28.11 68.25 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.132 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.685 ' CG2' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.59 -41.42 16.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.228 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -63.35 -36.81 84.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.613 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.36 -42.94 61.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.409 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.88 -29.64 73.78 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.463 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -78.86 -42.21 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 121.2 0.524 . . . . 0.0 109.903 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 26' ' ' PRO . 6.5 mp -76.82 -9.82 58.94 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.445 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 t70 61.77 21.29 12.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.421 ' CD1' ' HD2' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -101.6 152.47 38.06 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.132 -179.535 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.72 139.02 35.98 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.503 2.135 . . . . 0.0 112.027 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.62 -19.22 0.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.25 -31.2 49.06 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.237 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.62 -40.36 84.69 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.518 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -61.73 -48.07 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.735 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.16 -52.61 58.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.461 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.47 -43.51 68.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.923 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 52' ' ' ARG . 27.6 t -75.12 -29.3 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.856 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.643 HD21 ' OH ' ' A' ' 65' ' ' TYR . 6.5 tp -68.78 -38.86 80.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.816 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.75 -45.11 86.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.616 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -74.22 -8.23 55.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.111 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.04 70.98 0.73 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.766 0.793 . . . . 0.0 110.531 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.9 p -76.51 -6.36 51.51 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.424 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.51 37.9 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 0.0 110.852 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.8 141.2 28.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.181 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -78.88 126.63 30.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 111.28 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.643 ' OH ' HD21 ' A' ' 57' ' ' LEU . 27.0 m-85 -124.4 154.01 41.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.343 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.625 ' HB2' HG21 ' A' ' 72' ' ' ILE . 26.8 t70 -153.14 146.11 24.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.233 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 tttm 66.04 -101.68 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.672 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -89.96 -14.4 34.15 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.11 29.23 1.68 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.989 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -87.41 172.65 9.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.1 mt -79.59 105.84 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.845 0.355 . . . . 0.0 110.999 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.625 HG21 ' HB2' ' A' ' 66' ' ' ASP . 2.7 tt . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.555 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.112 0 CA-C-O 121.061 0.457 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.583 HG23 ' HB2' ' A' ' 93' ' ' TYR . 1.4 t -144.08 159.39 42.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.566 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 78' ' ' LEU . 5.1 mp -83.12 52.76 2.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 111.053 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HG2' ' CZ ' ' A' ' 93' ' ' TYR . 7.3 tmm_? 57.84 113.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -177.71 -28.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.497 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.433 HG21 ' HA ' ' A' ' 95' ' ' TRP . 4.8 p -89.41 -178.23 5.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.945 0.402 . . . . 0.0 111.332 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.75 -26.98 14.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.345 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 81.7 m-85 -76.56 110.79 11.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.628 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.4 HG22 ' CE1' ' A' ' 93' ' ' TYR . 25.0 t -108.26 139.12 31.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.169 0.509 . . . . 0.0 111.573 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.781 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 14.5 t80 -136.38 108.19 7.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.847 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -103.7 137.12 42.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.806 0.336 . . . . 0.0 111.552 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.542 HG23 ' CE1' ' A' ' 85' ' ' PHE . 2.2 pt -140.03 123.35 17.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.572 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 t0 63.65 -66.68 0.1 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.189 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.5 t70 -168.0 35.2 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.401 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -134.07 113.48 12.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.927 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.21 86.2 5.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 111.0 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -76.0 164.92 25.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.016 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.583 ' HB2' HG23 ' A' ' 77' ' ' THR . 61.0 m-85 -136.2 165.45 25.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.263 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.615 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -150.73 169.98 20.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.922 0.391 . . . . 0.0 111.879 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.433 ' HA ' HG21 ' A' ' 81' ' ' THR . 15.0 m0 -92.93 -23.5 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.931 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.427 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 50.9 m -147.44 167.08 25.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.283 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.998 ' HB1' ' CZ ' ' A' ' 164' ' ' PHE . . . -51.97 -22.44 3.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.011 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.457 ' HA ' HD21 ' A' ' 101' ' ' LEU . 2.4 tp -86.26 -51.55 6.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.615 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 2.7 m-20 -48.14 -25.94 1.68 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.26 -39.1 85.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.515 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -99.18 166.56 11.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 101' ' ' LEU . 12.7 pt -158.03 -43.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.838 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.5 m-85 -162.58 64.46 1.55 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 103' ' ' PHE . 37.8 Cg_exo -60.22 -43.04 37.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.747 2.298 . . . . 0.0 112.416 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.19 -23.76 43.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.376 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -84.09 -38.74 20.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.509 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.838 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.4 tp -57.16 -45.7 84.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.146 0.498 . . . . 0.0 111.309 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.56 25.31 10.09 Favored Glycine 0 C--N 1.319 -0.372 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.508 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.65 174.15 14.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 110.939 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.0 m -81.08 158.14 25.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.756 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -136.77 109.67 7.63 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -81.61 119.78 24.23 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.765 0.793 . . . . 0.0 111.015 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.409 HG22 ' HD2' ' A' ' 85' ' ' PHE . 57.6 t -112.17 129.86 66.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.084 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.4 m -124.21 137.35 54.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.045 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.594 ' HB2' HG23 ' A' ' 124' ' ' VAL . 1.4 m -141.6 173.09 11.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.377 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -134.09 133.24 40.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.6 t -62.44 133.37 54.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.216 0.532 . . . . 0.0 112.213 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.98 -3.81 24.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.891 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.918 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.68 -50.94 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.786 0.327 . . . . 0.0 111.662 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.45 -24.13 21.94 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.306 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.76 5.15 73.44 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.144 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.705 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.07 149.41 56.46 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-O 120.544 0.212 . . . . 0.0 110.631 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 1.0 OUTLIER -82.31 103.85 1.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.667 2.244 . . . . 0.0 110.807 179.324 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 115' ' ' SER . 35.8 m -99.14 144.72 11.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.311 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.419 ' O ' ' HE1' ' A' ' 141' ' ' MET . 81.5 p -151.87 141.72 21.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.431 0.634 . . . . 0.0 110.836 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -138.82 151.39 46.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.875 178.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.802 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.2 m -105.94 115.21 29.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.639 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.915 HG13 ' CE2' ' A' ' 193' ' ' PHE . 38.8 t -96.11 111.73 26.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.853 0.359 . . . . 0.0 111.505 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.422 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -107.22 169.5 6.67 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.938 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.4 Cg_endo -66.23 -19.25 56.52 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.198 1.932 . . . . 0.0 112.816 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 19.6 p -112.66 -26.97 8.37 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 131' ' ' SER . 0.4 OUTLIER 178.39 -162.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.133 0.492 . . . . 0.0 110.043 -179.363 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -93.68 158.46 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.922 178.578 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -144.66 19.49 1.67 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.448 0.642 . . . . 0.0 112.154 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.802 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.83 86.81 0.08 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.238 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.544 HG13 ' SD ' ' A' ' 141' ' ' MET . 36.3 t -103.25 113.64 40.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.334 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -146.5 122.72 5.67 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.48 155.83 95.05 Favored 'Cis proline' 0 C--N 1.348 0.517 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.26 0.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.39 79.46 0.38 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.178 0.514 . . . . 0.0 110.497 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.01 17.61 0.18 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.597 -0.728 . . . . 0.0 113.243 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.912 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.2 OUTLIER -58.61 158.47 7.76 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.964 0.412 . . . . 0.0 111.441 -179.393 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -128.49 152.32 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.052 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.715 HG22 ' CD1' ' A' ' 164' ' ' PHE . 46.1 t -111.74 147.72 15.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.543 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 32.0 m -120.77 144.91 48.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.804 0.335 . . . . 0.0 110.946 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.886 HD11 ' HB3' ' A' ' 185' ' ' ALA . 1.2 pp -138.04 175.03 9.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.828 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 146' ' ' VAL . 24.3 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.749 HG12 ' HB3' ' A' ' 97' ' ' ALA . 22.0 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.885 0.374 . . . . 0.0 111.495 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 163' ' ' HIS . 2.2 m-70 -118.93 159.14 24.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.535 0.683 . . . . 0.0 109.919 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.998 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 15.9 m-30 -111.12 130.6 55.57 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.526 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PHE . . . . . 0.614 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 39.4 m-85 -108.48 140.69 41.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.397 0.618 . . . . 0.0 110.545 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.33 -27.64 0.7 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.76 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.581 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 68.2 m -164.95 171.48 13.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.225 0.536 . . . . 0.0 111.746 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 73.0 t -69.23 -32.84 3.52 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.298 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.22 -37.76 3.16 Favored 'Trans proline' 0 CA--C 1.504 -0.983 0 C-N-CA 122.739 2.292 . . . . 0.0 110.389 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.71 -40.17 49.6 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.146 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.9 -45.49 93.49 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.2 mt-10 -78.96 -27.37 43.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.288 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 169' ' ' PRO . 13.8 t70 -70.75 -55.78 7.86 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.457 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' TRP . . . . . 0.918 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 39.2 t-105 -64.64 -28.58 69.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.616 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.85 -41.58 97.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.311 178.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.56 -42.23 55.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.228 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.6 22.75 7.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.294 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' HIS . . . . . 0.799 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -142.66 31.73 1.46 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.889 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.289 179.882 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.799 HD13 ' O ' ' A' ' 178' ' ' HIS . 1.4 tt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.811 0.339 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.886 ' HB3' HD11 ' A' ' 145' ' ' LEU . . . -142.4 150.08 40.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.221 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.671 HD11 ' HB2' ' A' ' 175' ' ' ALA . 17.2 mm -103.14 161.71 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.961 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.484 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -158.56 162.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.099 0.476 . . . . 0.0 111.833 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.412 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -90.15 128.09 36.26 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.896 178.656 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.912 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.2 m -46.78 -20.14 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.915 0.388 . . . . 0.0 110.758 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' HIS . . . . . 0.412 ' N ' ' C ' ' A' ' 188' ' ' SER . 7.3 m-70 -71.5 -41.68 68.97 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.126 0.488 . . . . 0.0 109.709 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.474 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.7 OUTLIER -82.12 -25.66 34.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.412 179.097 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.83 -24.86 62.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.043 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' PHE . . . . . 0.915 ' CE2' HG13 ' A' ' 128' ' ' VAL . 5.0 t80 -81.15 -24.98 37.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.8 -29.82 33.98 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 191' ' ' GLU . 9.6 mp -82.4 -28.27 31.52 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -28.36 31.4 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.402 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 9.1 tt0 -80.55 -22.99 40.29 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.897 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -73.46 -22.89 60.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.102 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.03 -36.95 51.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.959 0.409 . . . . 0.0 111.246 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -73.07 -24.81 60.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.108 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.794 0.33 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -139.59 173.69 11.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.2 mt -151.74 111.44 4.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.949 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.464 ' O ' HD23 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -98.43 35.69 1.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t 59.81 64.25 2.91 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.71 -21.99 50.4 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.519 2.146 . . . . 0.0 112.292 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.688 ' CD2' HD21 ' A' ' 42' ' ' LEU . 2.6 mt -52.0 -57.3 9.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.244 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.55 -27.09 62.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -61.0 -53.27 59.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.653 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.9 -25.07 62.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.298 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.819 HD11 ' CA ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -67.0 -47.65 70.82 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.824 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.39 -25.85 17.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -67.74 -22.26 65.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.212 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.6 47.99 88.44 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.039 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.14 153.1 81.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.768 0.318 . . . . 0.0 110.928 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.01 109.08 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.596 2.197 . . . . 0.0 111.987 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.686 HG23 HG22 ' A' ' 41' ' ' THR . 11.0 p -115.56 110.17 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.334 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 57.5 p -85.14 177.6 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.677 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.09 -37.17 72.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.192 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -26.46 67.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.814 0.34 . . . . 0.0 110.136 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.686 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.4 -42.65 14.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.688 HD21 ' CD2' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -63.11 -36.38 83.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.2 -43.0 62.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.492 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.01 -30.61 74.18 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.734 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.586 HD12 HG23 ' A' ' 41' ' ' THR . 6.7 mt -79.16 -41.58 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.055 0.455 . . . . 0.0 110.297 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.443 HD12 HG22 ' A' ' 45' ' ' ILE . 6.5 mp -77.17 -9.66 58.91 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.336 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 t70 59.88 21.95 10.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.408 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 6.5 m95 -109.95 158.31 35.36 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.162 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.68 142.75 71.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.533 2.155 . . . . 0.0 112.02 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.64 -16.82 1.04 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -78.95 -34.34 44.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.062 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -67.47 -41.58 84.39 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.0 t -63.36 -46.99 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.482 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.91 -51.35 61.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.383 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.96 -37.65 20.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.719 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 52' ' ' ARG . 23.2 t -63.6 -53.01 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.793 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 58' ' ' GLU . 3.9 pp -73.52 -16.92 61.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.968 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.598 ' N ' HD12 ' A' ' 57' ' ' LEU . 59.2 tt0 -58.12 -19.58 33.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.049 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.85 12.57 12.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.825 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -123.06 76.5 1.38 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.771 0.796 . . . . 0.0 110.48 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 p -87.43 -26.95 23.02 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.762 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.25 -21.29 63.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.76 141.2 53.6 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.431 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.61 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -84.68 126.96 33.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 111.642 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.408 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 14.8 m-85 -100.36 173.14 6.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.163 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -153.11 143.3 22.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 111.504 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 tptp 66.06 -104.06 0.09 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.82 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -92.73 -13.05 29.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.715 0.293 . . . . 0.0 111.782 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 128.64 31.98 0.63 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.14 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -87.14 170.56 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.82 0.343 . . . . 0.0 110.166 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.67 HD13 HD12 ' A' ' 42' ' ' LEU . 3.7 mp -79.7 109.43 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.159 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.866 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -68.3 -33.66 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.107 0.479 . . . . 0.0 111.002 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.819 ' CA ' HD11 ' A' ' 31' ' ' LEU . . . 100.83 -130.47 10.24 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.63 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 102' ' ' ILE . 1.1 m-85 -103.44 -170.61 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.847 0.356 . . . . 0.0 110.954 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.01 -29.72 0.15 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.51 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 76' ' ' LEU . 3.1 mm? 65.16 -85.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 111.032 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -129.43 159.62 35.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.6 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.8 mt -77.91 51.13 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.266 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 4.7 ttt-85 44.47 85.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.635 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.07 23.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.469 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.1 p -119.17 -171.07 2.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.114 0.483 . . . . 0.0 111.599 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 p -104.08 -29.14 11.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.301 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 95' ' ' TRP . 10.8 m-85 -79.27 111.83 15.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.628 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.57 140.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.059 0.457 . . . . 0.0 111.098 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.826 ' CD1' HG22 ' A' ' 113' ' ' VAL . 43.8 t80 -129.95 106.38 8.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.588 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -100.17 130.54 46.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.921 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.503 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -140.03 124.62 19.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.16 -70.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.283 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -166.94 34.39 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.251 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -137.71 111.94 8.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.906 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.413 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -78.42 121.56 24.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.837 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 92' ' ' LEU . 3.8 mm? -114.43 164.8 13.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.969 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 79' ' ' ARG . 24.8 m-85 -130.78 165.09 23.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.112 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.632 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -151.79 170.17 20.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.106 0.479 . . . . 0.0 111.848 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.405 ' O ' ' CE1' ' A' ' 83' ' ' TYR . 5.3 m95 -98.81 -18.67 17.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.684 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 28.1 m -147.61 162.55 38.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.924 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -52.03 -22.62 4.2 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 tp -85.79 -51.53 6.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.656 0.265 . . . . 0.0 111.305 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.617 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -45.16 -28.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.632 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -60.41 -39.1 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 110.549 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.44 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.3 pt? -121.87 174.9 6.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.059 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 74' ' ' TYR . 19.2 mt -151.31 -46.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.044 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -156.92 79.02 3.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.742 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.517 ' HA ' HG12 ' A' ' 107' ' ' ILE . 20.3 Cg_endo -60.78 -40.13 56.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.703 2.269 . . . . 0.0 112.41 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.24 -25.94 67.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.547 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.3 tp -79.9 -26.47 40.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 104' ' ' PRO . 4.5 mm -64.5 -58.88 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.117 0.961 . . . . 0.0 111.013 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.54 22.14 13.22 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.637 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.07 -177.03 5.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.925 0.393 . . . . 0.0 110.344 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.54 154.11 20.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.227 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.779 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -136.85 110.06 7.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.639 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -80.38 119.91 23.71 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.767 0.794 . . . . 0.0 111.277 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.826 HG22 ' CD1' ' A' ' 85' ' ' PHE . 47.2 t -112.05 129.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.947 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 m -122.87 137.56 54.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.114 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.546 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.6 OUTLIER -141.4 172.82 12.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.317 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -134.54 133.88 40.79 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.407 ' HB3' ' H ' ' A' ' 121' ' ' GLY . 30.5 t -62.29 130.38 45.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.047 0.451 . . . . 0.0 112.037 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.95 -3.59 23.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.974 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.885 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.54 -49.85 2.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 111.545 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.686 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -91.77 -24.62 19.36 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.281 -179.522 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 117' ' ' CYS . . . 76.28 5.55 81.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.195 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.686 ' H ' HG22 ' A' ' 120' ' ' THR . . . -57.93 148.92 57.51 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-O 120.528 0.204 . . . . 0.0 110.636 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 1.0 OUTLIER -82.31 104.1 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.686 2.258 . . . . 0.0 110.806 179.327 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 115' ' ' SER . 30.5 m -100.16 144.91 11.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.4 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.0 p -151.64 141.49 21.97 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.415 0.626 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -138.55 151.92 47.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.83 178.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.857 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 53.8 m -106.52 113.49 27.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.871 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.69 HG13 ' CE2' ' A' ' 193' ' ' PHE . 47.9 t -96.31 111.79 27.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.902 0.382 . . . . 0.0 111.474 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.25 168.53 8.05 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.08 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.75 -14.55 45.2 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.49 2.126 . . . . 0.0 113.015 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -118.84 -26.91 5.93 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 179.6 -163.29 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.16 0.505 . . . . 0.0 110.017 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -96.61 160.47 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.879 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.4 mm-40 -148.21 20.75 1.09 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.468 0.651 . . . . 0.0 112.194 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.857 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.94 86.69 0.08 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.408 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.577 HG13 ' SD ' ' A' ' 141' ' ' MET . 39.2 t -103.54 115.4 45.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.193 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -146.27 122.28 5.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.74 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.87 157.0 99.14 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 123.523 -1.449 . . . . 0.0 112.283 0.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.42 79.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 0.0 110.553 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.58 16.61 0.15 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.407 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.868 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -60.13 156.49 15.01 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.065 0.459 . . . . 0.0 111.313 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -125.43 151.87 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.734 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.739 HG13 ' CE1' ' A' ' 164' ' ' PHE . 18.4 t -113.0 152.22 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.793 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 1.6 p -120.72 140.98 50.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.938 0.399 . . . . 0.0 110.945 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.664 HD12 HG22 ' A' ' 162' ' ' VAL . 5.7 tp -135.84 175.13 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.871 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 147' ' ' LEU . 22.1 t -125.06 158.88 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.083 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.67 HD12 ' HA3' ' A' ' 183' ' ' GLY . 37.1 mt -89.23 149.45 42.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.964 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 129.32 17.28 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.637 2.225 . . . . 0.0 112.256 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -114.01 147.28 38.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.826 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.96 35.47 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.834 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.31 39.12 0.73 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -123.08 162.48 22.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 36.7 p30 -59.37 -176.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.1 m -107.18 125.13 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.235 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.29 -50.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.681 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -163.4 -46.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.816 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.3 m 57.24 45.21 20.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.001 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 61.42 66.59 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.825 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.75 -26.38 45.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.071 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 51.2 m -143.5 -75.32 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.442 ' HB3' HG21 ' A' ' 146' ' ' VAL . 4.8 t-160 55.67 38.18 29.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.736 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.664 HG22 HD12 ' A' ' 145' ' ' LEU . 22.4 t -100.5 110.88 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.499 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -117.1 169.05 9.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.602 0.715 . . . . 0.0 109.801 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.739 ' CE1' HG13 ' A' ' 143' ' ' VAL . 2.5 m-85 -119.38 152.9 36.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.127 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.619 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 49.1 m-85 -129.35 133.67 47.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.845 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -41.48 -27.51 0.09 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 10.8 p -168.84 174.36 6.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.015 0.436 . . . . 0.0 111.511 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.6 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 85.6 t -68.6 -33.53 4.6 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.673 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.683 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.6 Cg_exo -72.51 -38.17 3.61 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.718 2.279 . . . . 0.0 110.371 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.57 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.54 -39.47 52.75 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.44 -46.02 90.42 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.7 mt-10 -78.78 -28.12 44.61 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.323 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 169' ' ' PRO . 12.3 t70 -71.33 -55.81 7.26 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.384 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.885 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 58.3 t-105 -64.04 -28.48 69.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.739 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -62.99 -42.22 99.79 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.166 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 71.1 m -51.37 -41.74 60.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.399 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 21.04 9.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.421 0.629 . . . . 0.0 111.298 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -128.4 28.74 5.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.864 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -91.45 171.07 9.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.709 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 97.12 -27.52 18.04 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.424 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.529 HD12 HD22 ' A' ' 184' ' ' LEU . 14.3 mt -63.76 -176.18 0.17 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.765 0.317 . . . . 0.0 110.86 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.74 66.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.777 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.67 ' HA3' HD12 ' A' ' 147' ' ' LEU . . . 91.16 -86.28 1.31 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.431 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.529 HD22 HD12 ' A' ' 181' ' ' LEU . 6.0 tp 62.65 122.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.29 150.08 42.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.037 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.571 ' CG2' ' HB1' ' A' ' 171' ' ' ALA . 10.6 mm -100.14 159.04 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.035 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.444 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -162.02 162.56 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.289 0.566 . . . . 0.0 112.076 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.415 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -88.53 129.52 35.45 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.669 178.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.868 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.2 m -46.44 -20.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.832 0.349 . . . . 0.0 110.717 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.415 ' N ' ' C ' ' A' ' 188' ' ' SER . 1.8 t-160 -73.82 -42.07 61.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.784 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -82.25 -21.2 36.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.25 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.4 -24.93 63.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.813 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.69 ' CE2' HG13 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -81.11 -24.91 37.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.72 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.81 -31.26 29.91 Favored Glycine 0 CA--C 1.509 -0.317 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.7 tp -82.13 -29.25 31.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -83.12 -27.43 40.59 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -82.28 -21.93 35.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.938 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -81.03 -26.21 36.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -52.68 -30.52 32.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.115 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.67 -54.46 27.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -58.46 -31.81 68.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -72.47 -40.43 66.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 mt -79.54 -30.24 41.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.012 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 204' ' ' LEU . 1.4 tt -56.82 -30.83 64.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.072 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -66.02 121.34 14.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.446 HG23 ' N ' ' A' ' 207' ' ' MET . 9.9 t -59.73 -46.6 88.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' MET . . . . . 0.446 ' N ' HG23 ' A' ' 206' ' ' THR . 0.2 OUTLIER -160.54 156.83 26.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.57 165.23 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.79 87.24 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -93.04 116.83 29.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.436 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -176.47 -62.91 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.029 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.0 Cg_endo . . . . . 0 C--O 1.25 1.121 0 C-N-CA 122.34 2.027 . . . . 0.0 112.353 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.87 0.367 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -174.74 149.89 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.517 HD22 HD11 ' A' ' 106' ' ' LEU . 13.7 mt -59.92 -29.88 68.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' C ' HG22 ' A' ' 25' ' ' VAL . 0.5 OUTLIER 62.19 -166.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 ' C ' ' A' ' 24' ' ' LEU . 25.7 m 42.51 53.88 8.92 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.695 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.2 -16.97 45.08 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.695 2.263 . . . . 0.0 112.456 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.589 HD23 HG21 ' A' ' 71' ' ' ILE . 2.0 tm? -54.25 -57.44 11.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.949 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.497 ' N ' HD13 ' A' ' 27' ' ' LEU . 9.2 tp -63.7 -27.05 68.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.982 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -68.43 -53.33 24.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.719 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.889 ' HB3' HG21 ' A' ' 37' ' ' VAL . 2.7 mm-40 -72.61 -29.72 63.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.318 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.549 HD12 ' HA3' ' A' ' 73' ' ' GLY . 9.2 tt -67.25 -45.71 75.9 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.56 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.08 -23.06 18.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -22.75 62.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.005 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.3 39.72 98.09 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.26 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -133.38 166.09 31.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.595 0.236 . . . . 0.0 110.673 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.64 112.65 2.92 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.517 2.145 . . . . 0.0 112.201 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.889 HG21 ' HB3' ' A' ' 30' ' ' GLU . 33.4 t -112.22 109.92 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.331 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -90.46 -168.4 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.835 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -78.07 -38.44 44.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.513 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -25.31 68.06 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.45 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.722 ' CG2' HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.1 -43.56 12.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.391 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.422 HD13 HD13 ' A' ' 71' ' ' ILE . 1.5 tp -63.01 -35.46 80.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.664 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -74.24 -42.94 58.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.496 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.13 -30.96 74.11 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.579 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.603 HD12 HG23 ' A' ' 41' ' ' THR . 7.3 mt -78.7 -44.44 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 120.995 0.426 . . . . 0.0 110.584 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.577 HD12 HG22 ' A' ' 45' ' ' ILE . 7.3 mp -76.81 -9.8 58.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.421 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.6 t70 58.21 22.88 9.65 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -97.81 139.62 21.43 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.461 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.508 ' O ' HG23 ' A' ' 53' ' ' VAL . 44.4 Cg_exo -56.07 137.37 79.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.445 2.097 . . . . 0.0 111.797 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.85 -22.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -78.33 -36.12 46.73 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 110.951 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.2 mtt-85 -67.07 -40.41 87.02 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -63.01 -47.98 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.487 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.04 -53.69 46.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.117 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.39 -48.28 77.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.836 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 52' ' ' ARG . 41.1 t -64.31 -31.95 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.664 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.14 -31.4 71.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.581 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 61' ' ' THR . 5.5 tt0 -58.17 -21.83 48.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -96.13 -19.57 19.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.002 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.558 ' HB1' ' HG1' ' A' ' 63' ' ' THR . . . -99.75 32.07 3.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.466 0.651 . . . . 0.0 110.88 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 58' ' ' GLU . 25.2 p -69.43 -13.04 62.14 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.173 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.7 p -90.91 -23.11 20.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 111.266 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.558 ' HG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -56.49 141.23 43.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -78.77 126.96 31.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.397 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 66.8 m-85 -102.14 173.25 6.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.505 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD2' HD13 ' A' ' 72' ' ' ILE . 14.0 t0 -152.77 147.09 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.948 0.404 . . . . 0.0 111.441 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.41 -104.01 0.09 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.745 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.65 -11.1 46.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.726 0.298 . . . . 0.0 111.726 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.04 27.69 1.82 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.076 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -86.64 168.47 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.589 HG21 HD23 ' A' ' 27' ' ' LEU . 2.5 mp -79.64 120.41 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.379 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.524 HD13 ' OD2' ' A' ' 66' ' ' ASP . 2.3 tt -108.2 -28.0 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.549 ' HA3' HD12 ' A' ' 31' ' ' LEU . . . 85.17 -156.05 30.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.617 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.22 90.83 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.959 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.95 -44.63 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.412 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.556 HD21 HD11 ' A' ' 92' ' ' LEU . 3.3 mm? -80.75 150.51 29.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 0.0 110.748 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.519 HG21 HG23 ' A' ' 81' ' ' THR . 1.4 t -100.32 152.6 20.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.88 -45.95 76.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -103.47 147.72 26.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.946 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.424 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 3.1 tt0 -59.43 132.21 53.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.519 HG23 HG21 ' A' ' 77' ' ' THR . 35.2 p -110.09 -173.6 2.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.6 p -93.62 -35.74 12.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.928 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.424 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 4.9 m-85 -79.15 109.72 13.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.385 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.55 137.51 34.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.139 0.495 . . . . 0.0 111.377 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.758 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 21.7 t80 -132.58 105.77 7.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.103 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -102.52 135.26 44.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.387 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.48 HG23 ' CE1' ' A' ' 85' ' ' PHE . 2.8 pt -140.14 126.54 22.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t0 61.89 -72.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 87' ' ' ILE . 13.4 t0 -158.05 37.7 0.25 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -140.34 148.74 41.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.611 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.88 86.19 2.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.094 0.473 . . . . 0.0 110.571 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.556 HD11 HD21 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -71.6 164.69 25.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.091 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.424 ' CZ ' ' HG3' ' A' ' 80' ' ' GLU . 9.7 m-85 -134.31 165.16 25.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.113 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.625 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -151.16 167.24 28.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.152 0.501 . . . . 0.0 111.849 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -101.09 -10.54 20.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.751 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 11.9 m -153.31 160.0 42.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.854 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.842 ' HB1' ' CE2' ' A' ' 164' ' ' PHE . . . -51.81 -22.46 3.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -85.93 -51.34 6.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.674 0.273 . . . . 0.0 111.172 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.625 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 1.9 m-20 -44.38 -27.66 0.46 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -60.28 -39.2 86.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.892 0.377 . . . . 0.0 110.544 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.857 HD21 HG21 ' A' ' 128' ' ' VAL . 5.3 mt -93.45 -176.1 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.032 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 103' ' ' PHE . 7.5 tp -174.67 -40.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.84 ' O ' HG22 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -172.02 65.48 0.39 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.797 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.417 ' HG3' HD22 ' A' ' 101' ' ' LEU . 33.6 Cg_exo -59.85 -42.04 48.94 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.73 2.287 . . . . 0.0 112.351 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.07 -23.91 43.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.332 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.517 HD11 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.11 -38.33 19.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.481 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -57.19 -45.82 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 111.394 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.61 23.37 16.19 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.568 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.41 173.61 13.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.036 0.446 . . . . 0.0 110.954 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m -81.61 156.51 25.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.901 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.758 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -136.76 109.96 7.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.847 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -81.28 120.07 24.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.717 0.77 . . . . 0.0 111.232 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.3 t -111.07 127.29 68.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.626 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.3 m -122.36 137.6 54.8 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.317 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.595 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.0 OUTLIER -141.5 172.85 12.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.265 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -134.32 133.23 40.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 22.6 t -62.77 131.84 50.23 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.248 0.547 . . . . 0.0 112.222 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.17 -3.59 20.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.988 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.866 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -123.27 -51.07 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.631 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -87.68 -24.57 23.85 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.208 -179.572 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.44 5.45 72.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.114 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.715 ' H ' HG22 ' A' ' 120' ' ' THR . . . -59.94 152.27 60.78 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-O 120.591 0.234 . . . . 0.0 110.515 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -84.71 105.03 0.97 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.683 2.255 . . . . 0.0 110.947 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.595 HG22 ' C ' ' A' ' 115' ' ' SER . 35.3 m -99.36 144.46 11.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.364 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.427 ' O ' ' HE1' ' A' ' 141' ' ' MET . 82.4 p -151.64 141.68 22.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.424 0.631 . . . . 0.0 110.936 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -138.64 152.09 47.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.724 178.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.815 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 20.1 m -106.73 115.23 29.83 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.857 HG21 HD21 ' A' ' 101' ' ' LEU . 42.4 t -96.18 111.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.843 0.354 . . . . 0.0 111.211 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.97 175.79 1.9 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.32 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.77 -15.5 33.33 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.629 2.219 . . . . 0.0 112.978 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 18.0 t -118.96 -25.7 6.19 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 131' ' ' SER . 10.7 pt-20 178.56 -162.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.158 0.504 . . . . 0.0 110.036 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -93.44 156.49 3.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.94 178.572 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.72 18.59 2.0 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.469 0.652 . . . . 0.0 112.279 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.815 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.57 86.45 0.09 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.421 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.536 HG13 ' SD ' ' A' ' 141' ' ' MET . 39.7 t -102.29 115.82 44.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.063 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -146.3 122.25 5.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.748 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.11 160.17 94.37 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.495 -1.461 . . . . 0.0 112.362 -0.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.64 78.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.673 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.0 16.92 0.16 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.33 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.921 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -58.67 155.03 13.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 111.619 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -124.88 151.9 44.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.977 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.799 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -112.93 149.32 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.666 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 162' ' ' VAL . 9.8 m -120.54 141.39 50.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.544 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.415 ' CD2' HG22 ' A' ' 187' ' ' VAL . 0.7 OUTLIER -146.79 176.64 9.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.031 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.75 131.19 72.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.811 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 185' ' ' ALA . 1.5 mp -70.46 -63.29 1.74 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.114 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 73.2 Cg_endo -75.75 -168.23 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.434 2.09 . . . . 0.0 112.379 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -174.27 115.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -149.19 30.87 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -174.91 36.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.036 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.37 74.73 1.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.087 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -156.74 31.7 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.9 m -73.76 -30.24 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -160.32 -74.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.83 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -140.81 39.4 1.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 m -99.32 111.41 23.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.08 -68.38 0.79 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 18.1 m -81.09 -45.99 15.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 5.4 t 80.03 -50.79 0.37 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.31 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -109.06 48.05 0.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.944 0.402 . . . . 0.0 111.112 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 144' ' ' SER . 3.2 p -106.34 110.46 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.451 . . . . 0.0 110.948 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.4 169.33 14.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.454 0.645 . . . . 0.0 110.379 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.842 ' CE2' ' HB1' ' A' ' 97' ' ' ALA . 14.0 m-85 -107.54 129.66 54.95 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.425 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.568 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 43.7 m-85 -108.78 139.73 43.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.347 0.594 . . . . 0.0 110.589 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -47.65 -26.64 1.58 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.797 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.591 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 49.0 m -164.43 168.99 17.87 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.836 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 82.1 t -68.47 -34.13 5.35 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.019 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.1 Cg_exo -72.5 -37.22 4.37 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.629 2.22 . . . . 0.0 110.27 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.44 -40.39 50.75 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.731 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.81 -46.43 89.54 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 3.0 mm-40 -78.98 -27.87 43.47 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.462 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.5 t70 -69.7 -55.85 8.84 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.165 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.866 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 71.5 t-105 -65.73 -28.3 68.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.795 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.96 -39.95 95.31 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.054 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.96 -43.66 63.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.249 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.51 22.43 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.289 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.697 ' CE1' HD11 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -145.79 29.89 1.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.911 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -108.41 -16.92 14.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.167 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.32 -21.25 25.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.697 HD11 ' CE1' ' A' ' 178' ' ' HIS . 4.1 mt -57.07 -176.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.831 0.348 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -101.29 36.73 1.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.976 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.41 ' HA3' ' CG ' ' A' ' 148' ' ' PRO . . . 149.33 117.62 0.89 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.614 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 178' ' ' HIS . 0.8 OUTLIER -178.7 127.22 0.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.379 . . . . 0.0 110.992 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -141.57 149.09 40.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.815 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 175' ' ' ALA . 16.3 mm -102.13 160.48 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.08 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.481 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.05 164.17 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.257 0.551 . . . . 0.0 112.067 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.413 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -89.61 127.99 35.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.744 178.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.921 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.0 m -46.63 -20.5 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.824 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.413 ' N ' ' C ' ' A' ' 188' ' ' SER . 2.4 m-70 -72.76 -42.88 63.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.211 0.529 . . . . 0.0 109.746 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.28 -21.92 35.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.153 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.11 61.88 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.832 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.825 ' CE2' HG13 ' A' ' 128' ' ' VAL . 3.3 t80 -81.06 -24.95 37.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.688 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.89 -29.91 33.42 Favored Glycine 0 CA--C 1.51 -0.277 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -28.49 32.32 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.81 -27.97 33.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.22 -22.02 36.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.99 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.06 -23.1 55.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.213 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -51.92 -37.17 51.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -81.08 -28.31 35.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.832 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -58.13 -28.35 64.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -57.88 -48.52 79.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.976 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.36 -39.4 87.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.75 -43.87 85.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 59.79 -176.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.919 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 p -71.37 80.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 2.8 ttm -172.14 126.64 0.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.17 -68.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.4 t -158.15 130.39 7.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.37 35.64 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.986 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.796 HG22 ' HD3' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -70.96 -34.63 3.62 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.795 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.796 ' HD3' HG22 ' A' ' 211' ' ' THR . 63.5 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 121.972 1.781 . . . . 0.0 112.498 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.523 ' C ' HD12 ' A' ' 23' ' ' LEU . 6.1 t0 61.89 152.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 22' ' ' ASP . 4.8 mp -148.97 160.86 42.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.7 mt -146.49 -75.99 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.58 77.61 2.43 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.078 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.664 ' CG ' HD11 ' A' ' 46' ' ' LEU . 57.7 Cg_endo -71.48 -24.77 22.03 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.518 2.145 . . . . 0.0 112.502 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.5 mt -54.89 -57.55 11.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.374 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.22 -27.36 38.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -53.23 15.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.966 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.92 -26.12 66.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.49 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.596 HD11 ' CG2' ' A' ' 71' ' ' ILE . 9.5 mt -73.68 -30.3 62.81 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.746 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.34 -28.77 30.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.199 0.524 . . . . 0.0 110.909 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -64.23 -19.46 65.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.208 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.0 48.49 83.05 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.038 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.42 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -129.78 164.92 36.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.658 0.266 . . . . 0.0 110.71 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.52 111.41 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.482 2.121 . . . . 0.0 112.2 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 41' ' ' THR . 24.5 t -120.32 109.98 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.358 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 p -91.51 -172.72 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.699 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -74.61 -37.85 62.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.192 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -28.25 68.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.973 0.416 . . . . 0.0 110.246 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.724 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.5 -42.36 15.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 71' ' ' ILE . 0.6 OUTLIER -62.53 -36.74 83.54 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.62 -42.95 63.91 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.589 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -31.98 77.09 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.613 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.616 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -78.66 -43.36 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 120.936 0.398 . . . . 0.0 110.478 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.664 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.5 mp -78.52 -7.41 57.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.485 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 54.91 23.64 5.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 18.0 m0 -101.02 152.03 37.77 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.285 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 53' ' ' VAL . 35.5 Cg_endo -65.18 137.05 50.33 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.433 2.089 . . . . 0.0 111.92 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.22 -21.29 0.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.15 -36.69 47.4 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.959 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.71 -40.52 88.46 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.466 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.726 ' O ' HD23 ' A' ' 57' ' ' LEU . 2.1 t -62.84 -47.97 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.423 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.7 -53.7 43.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.239 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.82 73.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.849 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 52' ' ' ARG . 36.7 t -64.36 -34.63 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.744 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 53' ' ' VAL . 3.8 mm? -61.88 -32.63 73.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 61' ' ' THR . 5.7 tt0 -57.9 -22.49 48.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -94.26 -19.85 20.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.997 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.77 32.22 2.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.435 0.636 . . . . 0.0 111.041 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 58' ' ' GLU . 38.8 p -62.16 -19.13 62.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.888 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 m -90.09 -21.99 22.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.37 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.61 141.23 55.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.384 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.512 ' O ' HG22 ' A' ' 72' ' ' ILE . 4.0 tt0 -78.86 131.06 36.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 111.634 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.452 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.7 m-85 -105.26 173.18 6.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.278 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.54 146.68 26.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 111.43 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.5 -103.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.77 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -89.88 -11.02 43.11 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.63 29.37 1.43 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.975 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -87.55 172.14 9.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.835 0.35 . . . . 0.0 110.143 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 42' ' ' LEU . 2.9 mp -79.58 118.42 27.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.272 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.865 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -97.96 -33.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.004 0.431 . . . . 0.0 110.958 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.88 -179.19 19.12 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.512 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -147.86 -173.87 4.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 110.891 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.557 ' C ' HD12 ' A' ' 76' ' ' LEU . . . 99.74 27.85 7.74 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.567 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.557 HD12 ' C ' ' A' ' 75' ' ' GLY . 5.6 mp -145.43 151.33 38.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.747 0.308 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.452 HG21 ' CD1' ' A' ' 95' ' ' TRP . 30.6 p -104.25 159.08 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.811 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.7 mt -91.73 49.21 1.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -178.29 137.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.08 121.32 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.7 p -109.24 -174.89 2.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.083 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -93.0 -34.35 13.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.974 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.416 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 7.7 m-85 -83.76 112.41 20.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.316 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.469 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.5 t -107.84 144.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.985 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.919 ' CD1' HG22 ' A' ' 113' ' ' VAL . 38.4 t80 -133.93 105.36 6.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.144 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -97.47 131.9 43.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.052 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.05 124.29 18.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 -71.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.537 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -161.22 35.44 0.14 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.601 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -137.62 142.28 41.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.295 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.94 86.28 2.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 110.74 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -71.62 164.7 25.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.781 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -134.91 164.18 28.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.161 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.615 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -151.02 167.03 28.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.014 0.435 . . . . 0.0 111.881 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.452 ' CD1' HG21 ' A' ' 77' ' ' THR . 8.4 m0 -95.09 -18.92 20.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.62 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.449 ' HB3' HG13 ' A' ' 162' ' ' VAL . 1.7 m -150.11 166.61 29.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.154 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.594 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -53.76 -21.81 8.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.845 HD13 HG11 ' A' ' 162' ' ' VAL . 10.8 mp -84.67 -51.59 6.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.561 0.22 . . . . 0.0 111.536 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.599 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -47.96 -28.16 2.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -60.69 -39.32 88.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 110.58 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.042 HD21 HG11 ' A' ' 128' ' ' VAL . 1.5 mt -86.35 168.5 13.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.225 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 101' ' ' LEU . 6.8 pt -160.66 -43.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.031 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.808 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.0 OUTLIER 178.16 78.34 0.14 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.453 ' CB ' HG12 ' A' ' 128' ' ' VAL . 52.2 Cg_endo -69.12 -38.8 8.65 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.623 2.216 . . . . 0.0 112.474 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.77 -23.94 45.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.242 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -83.94 -40.9 17.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.259 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.808 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.2 tp -57.37 -46.48 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.239 0.542 . . . . 0.0 111.473 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.9 24.75 12.49 Favored Glycine 0 C--N 1.319 -0.392 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.565 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.43 173.79 14.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 0.0 110.965 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -81.39 155.67 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.845 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.1 110.0 7.64 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.3 mtm180 -81.23 119.87 24.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.816 0.817 . . . . 0.0 111.242 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.919 HG22 ' CD1' ' A' ' 85' ' ' PHE . 48.9 t -111.88 129.89 66.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.162 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.469 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 75.9 p -123.98 137.74 54.56 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.249 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.578 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.53 172.89 12.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.343 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -134.41 133.3 40.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.23 134.65 55.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.251 0.548 . . . . 0.0 112.337 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.68 -3.55 22.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.284 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.882 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -123.26 -51.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.958 0.409 . . . . 0.0 111.476 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.44 HG23 HG21 ' A' ' 170' ' ' THR . 1.4 p -84.99 -29.44 25.03 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.002 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.02 4.97 79.27 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.219 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . . . -59.11 150.77 60.48 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 1.1 Cg_endo -82.54 104.11 1.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.561 2.174 . . . . 0.0 111.093 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.578 HG22 ' C ' ' A' ' 115' ' ' SER . 35.9 m -97.71 144.28 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.985 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.0 p -150.6 142.35 23.72 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.439 0.637 . . . . 0.0 110.856 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -139.61 151.64 46.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.815 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.843 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 52.4 m -107.88 113.91 27.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 1.042 HG11 HD21 ' A' ' 101' ' ' LEU . 46.2 t -96.0 111.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.087 0.47 . . . . 0.0 111.403 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.502 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -106.79 177.83 1.24 Allowed Pre-proline 0 N--CA 1.453 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.638 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 56.6 Cg_endo -72.55 -20.1 23.91 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 121.961 1.774 . . . . 0.0 112.87 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 26.8 t -109.96 -28.06 8.92 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 131' ' ' SER . 11.8 pt-20 177.63 -162.73 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.11 0.481 . . . . 0.0 110.08 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.69 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -95.72 143.96 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.8 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -129.41 21.82 5.61 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.399 0.619 . . . . 0.0 112.295 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.843 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.66 87.65 0.1 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.225 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.577 HG13 ' SD ' ' A' ' 141' ' ' MET . 41.6 t -104.55 115.59 46.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.332 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -146.37 124.24 6.16 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.652 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.79 157.08 95.24 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.207 0.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.85 79.04 0.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.123 0.487 . . . . 0.0 110.611 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 143.15 19.22 0.23 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.184 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.745 ' HG3' HG21 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -57.73 156.78 8.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.939 0.4 . . . . 0.0 111.577 -179.346 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -129.5 152.21 49.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.123 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.669 HG13 ' CD1' ' A' ' 164' ' ' PHE . 21.1 t -115.35 151.03 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.825 ' O ' HG23 ' A' ' 162' ' ' VAL . 51.6 p -116.81 141.43 48.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.712 0.292 . . . . 0.0 110.405 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 184' ' ' LEU . 1.6 mp -138.16 176.09 9.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.695 HG22 ' HB3' ' A' ' 159' ' ' CYS . 27.0 m -124.99 120.16 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.965 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.421 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . 6.5 mp -57.23 -61.9 6.26 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.012 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 68.9 Cg_endo -74.69 -168.18 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.465 2.11 . . . . 0.0 112.267 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.53 115.24 2.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -141.27 146.35 36.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 60.14 31.23 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.59 77.96 1.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -131.69 82.41 2.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.501 HG12 ' OG ' ' A' ' 157' ' ' SER . 10.7 p -127.82 -44.97 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.035 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.481 ' N ' HG13 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -173.91 -53.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -165.65 34.15 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.501 ' OG ' HG12 ' A' ' 154' ' ' VAL . 2.3 p -71.76 123.69 23.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -83.54 -73.55 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.695 ' HB3' HG22 ' A' ' 146' ' ' VAL . 59.1 m -77.42 -46.0 24.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.5 t 76.48 0.11 3.14 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.589 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -158.86 63.05 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.956 0.408 . . . . 0.0 110.944 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.845 HG11 HD13 ' A' ' 98' ' ' LEU . 8.9 p -114.74 120.88 65.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.54 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 3.5 m-70 -125.65 169.26 12.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.48 0.657 . . . . 0.0 109.973 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.669 ' CD1' HG13 ' A' ' 143' ' ' VAL . 2.7 m-85 -113.01 129.72 56.4 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.728 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.613 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 42.9 m-85 -108.6 140.76 41.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.46 0.647 . . . . 0.0 110.722 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.28 -26.17 1.87 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.978 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.538 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 10.8 t -163.99 169.55 17.84 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.086 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 84.6 t -68.78 -35.11 6.04 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.403 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.5 Cg_exo -72.19 -37.28 4.75 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.83 2.354 . . . . 0.0 110.192 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.571 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -75.95 -41.22 52.22 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.538 178.054 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.759 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.76 -45.57 93.35 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.0 mt-10 -78.78 -27.96 44.64 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.21 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.3 t70 -70.82 -55.97 7.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.604 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.882 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 64.2 t-105 -64.83 -28.83 69.83 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -61.22 -40.98 96.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.196 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -46.13 65.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.246 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -98.02 25.6 5.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.068 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.772 ' NE2' HD11 ' A' ' 181' ' ' LEU . 1.9 t-160 -153.03 33.62 0.48 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.0 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -99.75 -16.04 18.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.13 -19.93 33.27 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.567 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.772 HD11 ' NE2' ' A' ' 178' ' ' HIS . 16.0 mt -66.69 71.45 0.08 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.831 0.348 . . . . 0.0 111.202 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 54.34 28.31 9.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 102.92 -67.23 0.34 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.518 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 145' ' ' LEU . 6.7 tp 62.82 147.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.831 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.55 149.0 40.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.999 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 175' ' ' ALA . 19.2 mm -102.9 161.73 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.503 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -157.57 156.69 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 112.051 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.8 OUTLIER -82.64 122.11 27.7 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.142 178.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.745 HG21 ' HG3' ' A' ' 141' ' ' MET . 0.9 OUTLIER -41.29 -29.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.549 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -64.47 -46.13 84.36 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -82.2 -20.8 37.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.841 178.052 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.669 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -72.91 -25.82 61.19 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -81.65 -24.91 36.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.557 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.75 -28.3 39.02 Favored Glycine 0 CA--C 1.509 -0.326 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 21.1 tp -82.06 -28.38 32.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.06 -28.85 29.93 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.405 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -76.19 -21.96 55.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.964 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.01 -22.86 39.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.15 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -51.85 -37.4 51.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.15 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.98 -55.19 38.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -27.08 68.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -55.07 -35.62 64.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.138 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.55 -50.18 10.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.3 tp -59.86 -50.81 72.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -139.26 -174.62 3.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.37 166.83 19.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.957 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -65.29 79.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.31 96.0 6.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.0 m -74.77 172.78 11.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -131.58 -178.97 5.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.831 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.435 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -176.33 -63.0 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.973 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.6 Cg_endo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.391 2.06 . . . . 0.0 112.342 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.842 0.353 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -140.75 78.68 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tt -177.02 -40.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mt -76.37 -179.36 5.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.515 HG21 HD12 ' A' ' 28' ' ' LEU . 6.2 m -100.21 96.46 5.08 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.577 ' CG ' HD11 ' A' ' 46' ' ' LEU . 39.6 Cg_endo -67.06 -29.18 40.53 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.411 2.074 . . . . 0.0 112.312 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.53 -57.36 12.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.041 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.515 HD12 HG21 ' A' ' 25' ' ' VAL . 12.0 mt -57.3 -27.05 61.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.397 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -65.72 -53.24 43.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.087 0.47 . . . . 0.0 109.887 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -77.12 -28.31 54.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.533 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.6 HD21 ' HD2' ' A' ' 74' ' ' TYR . 1.7 tm? -70.77 -52.13 22.66 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.84 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.98 -25.67 22.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.043 0.449 . . . . 0.0 110.981 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -68.71 -21.8 64.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.224 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.27 46.81 93.59 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.026 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -130.0 158.6 73.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 0.0 110.815 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.96 110.76 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.499 2.132 . . . . 0.0 112.065 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.654 HG23 ' CG2' ' A' ' 41' ' ' THR . 11.6 p -118.98 111.0 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.36 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 p -75.85 -178.7 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.967 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -77.94 -35.86 49.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.253 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -24.88 66.68 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.195 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.654 ' CG2' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.13 -42.84 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.326 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 46' ' ' LEU . 10.3 tp -63.63 -36.25 83.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 176.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -74.17 -42.48 59.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.492 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.8 -29.02 72.65 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.546 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 41' ' ' THR . 7.1 mt -79.06 -41.45 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 121.17 0.51 . . . . 0.0 110.074 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 26' ' ' PRO . 6.9 mp -77.15 -9.92 59.07 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.354 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 t70 61.46 21.35 11.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -110.08 158.32 35.42 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.23 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.63 143.27 56.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.611 2.208 . . . . 0.0 111.917 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.3 -16.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -32.0 41.52 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.967 0.413 . . . . 0.0 111.146 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -68.98 -41.66 77.61 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.643 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.0 t -63.95 -46.44 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.56 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.71 -50.07 69.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.575 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.13 -35.78 27.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 52' ' ' ARG . 28.5 t -68.75 -31.05 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.081 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 53' ' ' VAL . 4.9 mp -81.08 -17.21 50.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.319 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -58.52 -19.24 35.8 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.256 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.66 17.91 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.705 0.288 . . . . 0.0 111.173 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . . . -113.12 71.11 0.73 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.803 0.811 . . . . 0.0 110.635 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.1 p -63.88 -15.27 58.59 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.415 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.1 t -95.19 34.68 1.37 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.5 HG21 HD23 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -95.91 110.93 23.04 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.419 ' HB3' ' CA ' ' A' ' 73' ' ' GLY . 2.2 tt0 -82.3 126.51 32.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.1 0.476 . . . . 0.0 111.997 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 69' ' ' GLY . 5.8 m-85 -110.83 160.3 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.14 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.13 143.9 25.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 0.0 111.498 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.1 -100.44 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.854 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -93.82 -10.46 34.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.411 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 125.07 33.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.939 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -93.99 154.24 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 37' ' ' VAL . 4.3 mt -79.79 125.19 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.979 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -168.43 -36.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.706 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.419 ' CA ' ' HB3' ' A' ' 64' ' ' GLU . . . -60.93 137.99 48.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.264 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.6 ' HD2' HD21 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -175.99 -164.76 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 0.0 110.888 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.42 24.27 1.79 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.764 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.771 HD13 ' O ' ' A' ' 93' ' ' TYR . 0.2 OUTLIER 61.7 -82.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.844 0.354 . . . . 0.0 111.202 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.465 HG21 HG23 ' A' ' 81' ' ' THR . 12.9 t -102.38 159.09 15.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.938 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.503 ' C ' HD23 ' A' ' 78' ' ' LEU . 9.9 tt -82.21 -40.9 21.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 77' ' ' THR . 4.1 mtt180 -96.8 153.63 17.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 110.979 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -66.25 126.66 29.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.465 HG23 HG21 ' A' ' 77' ' ' THR . 35.5 p -110.59 -172.47 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.109 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.27 -32.87 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.38 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -79.34 110.75 14.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.751 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.829 HG22 ' CE1' ' A' ' 93' ' ' TYR . 25.1 t -104.73 135.0 44.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.964 0.412 . . . . 0.0 111.045 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.936 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 55.1 t80 -127.55 106.6 9.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.579 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -101.5 132.59 47.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.329 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.5 pt -140.03 123.1 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 111.825 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.6 t70 60.97 -69.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.381 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 87' ' ' ILE . 1.8 t70 -166.24 35.33 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.348 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -136.45 111.96 9.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.013 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -77.91 120.63 23.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.639 HD12 ' CD2' ' A' ' 85' ' ' PHE . 23.2 mt -117.15 165.08 13.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.829 ' CE1' HG22 ' A' ' 84' ' ' VAL . 6.0 m-85 -133.44 165.16 25.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.362 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.679 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -150.85 173.01 14.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.118 0.485 . . . . 0.0 111.95 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -108.29 -5.67 16.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.832 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.6 p -160.09 163.08 34.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.13 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.625 ' HB1' ' CZ ' ' A' ' 164' ' ' PHE . . . -51.7 -23.1 4.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -88.76 -51.59 5.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.715 0.293 . . . . 0.0 111.349 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.679 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 1.9 m-20 -39.7 -28.81 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -59.72 -35.42 74.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.64 0.257 . . . . 0.0 110.812 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.936 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 14.8 tp -156.93 160.22 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.553 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 mt -113.52 -31.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.07 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 200' ' ' ASN . 4.1 m-85 -161.81 99.27 1.2 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.964 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.543 ' CB ' HG12 ' A' ' 128' ' ' VAL . 59.7 Cg_endo -71.77 -26.35 19.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.578 2.185 . . . . 0.0 112.335 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.36 -23.5 43.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.338 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 tp -81.7 -40.5 22.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.573 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.7 tp -54.39 -48.34 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.171 0.51 . . . . 0.0 111.595 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.22 20.71 22.32 Favored Glycine 0 C--N 1.319 -0.41 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.799 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 173.04 14.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.949 0.404 . . . . 0.0 111.023 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -78.28 152.79 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.644 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.819 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -137.15 109.88 7.56 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -83.71 120.57 26.17 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.79 0.805 . . . . 0.0 111.056 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.451 HG22 ' HD1' ' A' ' 85' ' ' PHE . 93.6 t -111.82 130.59 65.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.014 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 m -122.45 136.24 54.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.101 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.548 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -141.99 173.17 11.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.684 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 71.6 m80 -134.56 136.64 43.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 165' ' ' PHE . 28.5 t -64.76 134.44 54.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.179 0.514 . . . . 0.0 112.175 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.32 -5.76 34.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.819 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.895 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -126.89 -50.91 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.471 ' CG2' ' HB2' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -74.41 -33.6 63.05 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.217 0.532 . . . . 0.0 110.026 -179.104 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.17 34.92 57.67 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.373 -0.918 . . . . 0.0 110.818 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.471 ' HB2' ' CG2' ' A' ' 120' ' ' THR . . . -100.34 160.32 27.34 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.178 -0.511 . . . . 0.0 109.994 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -87.78 108.02 0.62 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.731 2.287 . . . . 0.0 111.257 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.548 HG22 ' C ' ' A' ' 115' ' ' SER . 35.9 m -104.41 144.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.157 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 85.4 p -147.22 142.79 27.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.51 0.671 . . . . 0.0 110.631 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -136.63 152.38 50.37 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.56 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.873 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.1 m -112.26 113.98 26.51 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 23.8 t -96.3 111.91 27.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.84 0.353 . . . . 0.0 111.586 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.47 167.21 9.88 Favored Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.211 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.79 -16.54 55.84 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.521 2.147 . . . . 0.0 113.051 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 27.2 t -116.72 -25.6 7.28 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 131' ' ' SER . 12.5 pt-20 178.94 -162.41 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.123 0.487 . . . . 0.0 109.854 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -96.05 160.14 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.878 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -147.01 18.64 1.25 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.422 0.629 . . . . 0.0 112.409 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.873 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.95 86.56 0.08 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.643 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.464 HG13 ' SD ' ' A' ' 141' ' ' MET . 41.0 t -105.07 120.79 56.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.848 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -145.23 126.16 7.49 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.985 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.22 165.53 84.12 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.475 -1.469 . . . . 0.0 112.271 -0.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.77 78.01 0.86 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.148 0.499 . . . . 0.0 110.656 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.7 19.32 0.18 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.171 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.682 ' CG ' HG11 ' A' ' 189' ' ' VAL . 10.4 ptm -61.03 160.91 9.16 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.949 0.404 . . . . 0.0 111.396 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -126.89 152.19 47.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.381 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.722 HG13 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -113.76 147.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.863 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.747 ' O ' HG13 ' A' ' 162' ' ' VAL . 56.3 p -117.29 137.52 52.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.697 0.284 . . . . 0.0 110.659 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 146' ' ' VAL . 0.3 OUTLIER -144.11 176.18 9.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 146' ' ' VAL . 8.5 p -125.18 106.78 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.801 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -57.99 -52.25 75.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 147' ' ' LEU . 44.9 Cg_exo -56.27 160.98 9.81 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.545 2.163 . . . . 0.0 112.299 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 62.54 146.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.958 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -108.05 -24.53 11.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.016 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -112.48 -22.6 10.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.309 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 57.22 55.84 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.091 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.528 ' O ' HG13 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -127.59 115.91 19.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 153' ' ' ASP . 5.8 m -159.01 -48.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.419 ' N ' HG23 ' A' ' 154' ' ' VAL . 5.6 tpp180 -176.44 -66.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -68.66 -48.96 62.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.6 m -104.48 133.91 48.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -125.6 -51.48 1.6 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.99 -46.04 15.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.043 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.509 ' HB3' HG23 ' A' ' 162' ' ' VAL . 0.5 OUTLIER 179.33 -36.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.165 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 20.4 t60 70.96 60.66 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.691 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 144' ' ' SER . 21.9 t -112.15 124.62 69.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.233 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.473 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 8.8 m-70 -120.5 165.96 14.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.58 0.705 . . . . 0.0 110.152 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.722 ' CE1' HG13 ' A' ' 143' ' ' VAL . 40.9 m-85 -115.52 140.67 48.94 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.536 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.591 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 57.0 m-85 -117.6 137.94 52.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.228 0.537 . . . . 0.0 110.287 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.38 -26.13 0.5 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.656 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 30.8 p -167.52 170.65 11.05 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.73 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.603 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 90.5 t -68.03 -34.37 6.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.32 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.707 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.8 Cg_exo -72.33 -37.41 4.46 Favored 'Trans proline' 0 CA--C 1.503 -1.06 0 C-N-CA 122.58 2.187 . . . . 0.0 110.321 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.584 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.34 -40.45 51.24 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.733 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.84 -46.38 89.73 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.561 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 2.3 mm-40 -79.09 -27.43 42.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.425 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 169' ' ' PRO . 17.6 t70 -69.8 -55.77 8.93 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.168 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.895 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 54.7 t-105 -65.87 -28.76 69.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.652 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.733 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.47 -39.05 93.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.213 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.5 t -51.98 -45.32 64.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.386 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 22.33 7.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.345 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.83 ' ND1' HD11 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -160.75 37.77 0.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.903 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.03 -10.96 16.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.326 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.44 24.57 24.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.559 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.83 HD11 ' ND1' ' A' ' 178' ' ' HIS . 47.5 mt -85.85 56.07 3.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.797 0.332 . . . . 0.0 110.764 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 60.31 28.59 18.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.656 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.4 ' HA3' ' HG2' ' A' ' 148' ' ' PRO . . . 131.51 -105.64 0.63 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.371 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.502 ' CD1' HD12 ' A' ' 181' ' ' LEU . 5.4 tt 63.4 130.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 110.998 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.33 150.1 40.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 111.015 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.3 mm -102.42 159.99 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.923 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.454 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.09 162.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.175 0.512 . . . . 0.0 111.782 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.9 OUTLIER -88.77 125.68 34.99 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.792 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.706 HG21 HD23 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -46.98 -20.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.596 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -69.27 -43.16 74.44 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -82.53 -24.49 34.04 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.249 178.473 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -71.91 -25.28 61.84 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.534 ' CE2' HG23 ' A' ' 133' ' ' ILE . 2.8 t80 -81.76 -31.38 31.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.145 0.498 . . . . 0.0 110.511 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.16 -30.45 31.06 Favored Glycine 0 CA--C 1.51 -0.253 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.359 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.01 -28.26 35.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.92 -29.07 29.75 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.62 -22.82 34.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.377 -0.411 . . . . 0.0 110.962 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -78.9 -22.8 45.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.23 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.76 -28.71 16.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.201 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . 63.6 t-20 -81.1 -41.6 22.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.44 -49.16 78.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -72.93 -30.52 63.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 mt -66.45 -19.94 65.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.81 -51.92 8.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.862 0.363 . . . . 0.0 110.944 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.682 ' O ' HG23 ' A' ' 206' ' ' THR . 2.4 pt20 -60.16 159.69 9.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 205' ' ' GLN . 0.9 OUTLIER -167.21 88.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.799 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 25.0 ttm -56.8 -57.11 13.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.049 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.02 94.51 5.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.9 p -140.1 134.38 31.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 60.26 31.78 20.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.439 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -67.58 -62.78 3.13 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.041 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.5 Cg_endo . . . . . 0 C--O 1.248 1.018 0 C-N-CA 122.397 2.064 . . . . 0.0 112.372 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.786 0.327 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -130.53 87.81 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.993 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mt -106.94 -32.27 7.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.13 177.48 4.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.715 HG11 HD12 ' A' ' 28' ' ' LEU . 6.4 t -104.12 90.59 3.17 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.071 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.532 ' HG3' HD11 ' A' ' 46' ' ' LEU . 43.4 Cg_endo -68.18 -43.62 4.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.565 2.176 . . . . 0.0 112.659 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.596 HD12 ' HG ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -51.95 -57.03 10.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.715 HD12 HG11 ' A' ' 25' ' ' VAL . 15.7 mt -63.25 -26.83 68.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.011 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 -60.34 -53.1 61.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.933 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.745 ' HB3' HG21 ' A' ' 37' ' ' VAL . 24.8 mm-40 -75.32 -22.05 57.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.582 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.758 HD11 ' HA3' ' A' ' 73' ' ' GLY . 1.7 tp -75.15 -52.15 11.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.254 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.0 -36.3 62.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.966 0.412 . . . . 0.0 112.003 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 30' ' ' GLU . 6.5 ptmt -68.23 -19.52 64.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.155 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.32 56.88 13.14 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.228 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.9 165.76 25.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.653 0.263 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.57 114.41 3.93 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.546 2.164 . . . . 0.0 112.24 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.745 HG21 ' HB3' ' A' ' 30' ' ' GLU . 25.0 t -126.91 110.45 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.428 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 82.1 p -89.97 -169.84 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -78.04 -37.88 45.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.361 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -29.13 69.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.907 0.384 . . . . 0.0 110.174 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.708 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -83.41 -42.76 16.62 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.393 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.653 ' CD1' HD13 ' A' ' 71' ' ' ILE . 10.2 mt -62.15 -36.76 82.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -71.28 -43.02 67.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.788 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.83 -31.84 70.16 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.86 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.617 HD12 HG23 ' A' ' 41' ' ' THR . 6.7 mt -77.42 -45.44 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 120.885 0.374 . . . . 0.0 110.722 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 42' ' ' LEU . 2.0 mm? -76.81 -8.51 57.46 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.567 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 t0 60.5 24.27 13.9 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.425 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 5.3 m95 -111.37 139.8 22.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.181 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.85 144.48 20.79 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.556 2.17 . . . . 0.0 112.252 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.46 -16.69 2.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -77.2 -34.88 56.11 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.427 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.603 ' O ' HG23 ' A' ' 56' ' ' VAL . 9.7 mtt85 -67.71 -41.33 83.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.636 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -63.82 -47.99 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.389 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.4 -52.53 59.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.299 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.98 -34.99 10.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.891 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 52' ' ' ARG . 36.1 t -63.97 -32.29 56.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.015 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 3.6 mm? -66.63 -34.65 78.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.758 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 61' ' ' THR . 4.4 tt0 -56.03 -34.08 65.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.549 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -96.19 -18.36 20.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.737 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . . . -96.6 35.96 1.44 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.438 0.637 . . . . 0.0 111.098 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 58' ' ' GLU . 72.6 p -58.75 -18.16 29.26 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.269 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 m -112.77 38.12 2.89 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.785 0.326 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 60' ' ' ALA . 0.9 OUTLIER -101.24 141.58 33.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.102 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.503 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -78.62 126.79 31.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.092 0.472 . . . . 0.0 111.257 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CZ ' HG22 ' A' ' 63' ' ' THR . 61.1 m-85 -117.2 173.15 6.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.369 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.595 ' OD1' HD13 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -151.64 146.75 26.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.027 0.441 . . . . 0.0 111.333 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.9 tttm 66.7 -103.33 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.813 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -87.92 -11.46 47.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.21 26.96 2.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.128 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -81.49 169.43 17.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.953 0.406 . . . . 0.0 109.914 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.653 HD13 ' CD1' ' A' ' 42' ' ' LEU . 3.9 mp -79.69 120.13 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.652 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.595 HD13 ' OD1' ' A' ' 66' ' ' ASP . 2.4 tt -107.26 -27.29 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.758 ' HA3' HD11 ' A' ' 31' ' ' LEU . . . 47.17 -150.01 2.38 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.982 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.644 ' H ' HD21 ' A' ' 31' ' ' LEU . 0.3 OUTLIER 62.39 113.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.779 0.323 . . . . 0.0 111.041 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.66 65.12 0.83 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.479 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.44 145.28 27.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 110.933 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.1 p -109.88 159.1 17.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -92.2 42.74 1.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -155.06 123.61 6.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' THR . 14.8 pm0 -57.46 -19.76 26.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.43 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 80' ' ' GLU . 54.4 p 36.88 -165.83 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -110.0 -26.26 9.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 28.1 m-85 -87.83 117.37 26.62 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.596 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.424 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.7 t -110.1 145.08 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.024 0.44 . . . . 0.0 111.521 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.797 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 17.4 t80 -134.13 107.46 7.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.016 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -102.51 133.03 48.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 0.0 111.843 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.486 HG23 ' CE1' ' A' ' 85' ' ' PHE . 3.8 pt -140.1 124.37 18.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.255 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.5 t70 63.12 -68.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.216 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.3 t0 -166.92 36.15 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.413 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -135.76 114.72 12.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.938 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.443 ' CD ' ' H ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -83.1 85.77 7.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.233 0.539 . . . . 0.0 110.885 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -74.13 165.05 25.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.08 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -134.88 165.28 25.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.365 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.683 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -151.56 169.75 21.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 0.0 111.919 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 17.8 m0 -88.24 -25.22 22.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.828 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.903 ' HB2' HG13 ' A' ' 162' ' ' VAL . 3.9 p -147.57 173.0 13.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.388 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.527 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -56.6 -20.87 23.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.826 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.821 HD12 HG11 ' A' ' 162' ' ' VAL . 14.2 mt -87.31 -51.66 5.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.59 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 5.3 m-20 -50.12 -24.65 2.87 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.683 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.7 -39.48 88.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.719 0.295 . . . . 0.0 110.651 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.532 HD12 ' C ' ' A' ' 101' ' ' LEU . 4.2 pp -112.08 178.42 4.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 111.106 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 101' ' ' LEU . 4.3 tt -157.93 -45.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.11 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.651 ' O ' HG22 ' A' ' 107' ' ' ILE . 8.0 m-85 -164.4 90.89 1.04 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.07 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.666 ' HB3' HG12 ' A' ' 128' ' ' VAL . 60.1 Cg_endo -72.86 -33.69 7.59 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.522 2.148 . . . . 0.0 112.456 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.411 ' HA ' ' CB ' ' A' ' 130' ' ' PRO . . . -78.05 -23.92 47.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.391 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.401 ' CB ' ' HB3' ' A' ' 103' ' ' PHE . 1.9 tp -84.84 -42.73 14.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.223 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -54.7 -48.6 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.175 0.512 . . . . 0.0 111.419 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.74 21.6 15.94 Favored Glycine 0 C--N 1.319 -0.408 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.921 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.77 177.36 10.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.053 0.454 . . . . 0.0 111.109 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -83.52 153.74 24.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.926 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.797 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -137.09 109.87 7.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -82.75 121.05 26.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.778 0.799 . . . . 0.0 111.034 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.455 HG22 ' HD2' ' A' ' 85' ' ' PHE . 99.0 t -113.18 132.61 61.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.811 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.424 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 60.5 p -120.77 139.09 53.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.066 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.553 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.3 m -140.73 172.9 12.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.26 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -133.61 130.56 38.5 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.8 m -57.33 123.26 14.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.044 0.45 . . . . 0.0 111.803 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.34 -9.3 39.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.695 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.693 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.54 -50.59 1.98 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.558 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -75.74 -21.21 57.69 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.965 0.412 . . . . 0.0 110.848 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.45 33.96 86.61 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.118 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.558 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -102.41 167.8 9.86 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.43 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.409 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 37.7 Cg_endo -93.22 110.05 0.2 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.954 2.436 . . . . 0.0 111.28 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.553 HG22 ' C ' ' A' ' 115' ' ' SER . 35.0 m -108.5 148.32 12.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.547 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.861 ' C ' HD13 ' A' ' 126' ' ' LEU . 79.4 p -149.21 141.44 24.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.406 0.622 . . . . 0.0 110.795 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.861 HD13 ' C ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -132.6 153.78 50.69 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.53 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.811 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.2 m -110.99 114.46 27.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.828 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.765 HG13 ' CE2' ' A' ' 193' ' ' PHE . 38.4 t -96.47 111.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.412 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -106.65 168.9 7.44 Favored Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.958 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.2 Cg_endo -66.09 -19.27 57.33 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.229 1.953 . . . . 0.0 112.891 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 34.6 p -112.89 -26.12 8.69 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 131' ' ' SER . 11.1 pt-20 178.09 -162.23 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.131 0.491 . . . . 0.0 110.099 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.695 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.35 158.76 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.752 178.408 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -146.19 20.43 1.4 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.387 0.613 . . . . 0.0 112.299 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.811 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.67 86.47 0.09 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.646 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.631 HG13 ' SD ' ' A' ' 141' ' ' MET . 58.4 t -102.87 113.51 39.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.375 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.447 ' O ' ' HE1' ' A' ' 141' ' ' MET . 4.2 tm-20 -146.26 121.94 5.61 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.498 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.608 ' HD2' ' HE3' ' A' ' 141' ' ' MET . 55.6 Cg_endo -69.28 157.6 90.53 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.459 -1.475 . . . . 0.0 112.737 -0.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.02 80.33 1.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.54 16.64 0.15 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.351 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.811 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -61.16 159.24 12.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.033 0.444 . . . . 0.0 111.571 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -129.03 152.1 48.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.515 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.697 HG13 ' CD1' ' A' ' 164' ' ' PHE . 4.6 t -115.31 152.97 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.88 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 162' ' ' VAL . 23.5 m -120.0 141.08 50.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.582 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.534 HD13 HG21 ' A' ' 187' ' ' VAL . 5.2 mp -142.23 176.27 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.985 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 1.012 HG22 HD12 ' A' ' 184' ' ' LEU . 36.4 t -125.21 144.11 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.811 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.673 HD23 ' HA2' ' A' ' 183' ' ' GLY . 2.1 pp -59.25 160.88 11.07 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.893 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.45 -62.11 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.703 2.269 . . . . 0.0 112.621 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.665 ' N ' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER 64.92 -172.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.835 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -139.39 55.37 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -179.99 -35.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.974 0.416 . . . . 0.0 111.219 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -106.77 135.71 47.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -60.63 171.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.933 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.1 p -110.74 -30.27 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.052 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 -40.08 6.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.983 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.444 ' NE2' ' OD1' ' A' ' 99' ' ' ASP . 7.9 mp0 -140.39 78.06 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.997 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.445 ' HB2' ' CD2' ' A' ' 161' ' ' HIS . 9.1 t -60.84 -80.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -134.9 -76.18 0.46 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 5.0 m -81.04 -45.96 15.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.895 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 161' ' ' HIS . 1.8 t -162.82 -62.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.651 ' CE1' HG21 ' A' ' 146' ' ' VAL . 0.3 OUTLIER 80.79 -50.49 0.31 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.32 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.903 HG13 ' HB2' ' A' ' 96' ' ' CYS . 2.6 p -107.13 115.81 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.068 0.461 . . . . 0.0 111.155 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.41 ' CE1' ' OH ' ' A' ' 83' ' ' TYR . 3.6 m-70 -126.96 169.38 13.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.555 0.693 . . . . 0.0 110.05 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.697 ' CD1' HG13 ' A' ' 143' ' ' VAL . 1.9 m-85 -108.61 150.69 27.16 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.796 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 37.9 m-85 -132.96 136.26 45.99 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.361 0.601 . . . . 0.0 110.564 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.641 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -39.19 -28.67 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.142 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.498 ' HB3' ' HD2' ' A' ' 169' ' ' PRO . 30.5 t -171.7 176.78 3.58 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.796 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 85.3 t -69.05 -34.3 4.92 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.552 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.7 Cg_exo -72.55 -38.38 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.813 2.342 . . . . 0.0 110.396 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.595 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.52 -39.84 51.77 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.546 177.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.706 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.33 -45.37 94.69 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.6 mt-10 -79.19 -27.56 42.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.179 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 169' ' ' PRO . 8.8 t70 -70.24 -55.86 8.21 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.421 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.693 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 57.4 t90 -65.17 -28.05 69.13 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.8 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -66.73 -37.04 83.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.323 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 t -53.09 -46.51 68.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.404 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -95.16 22.79 6.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.211 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.501 ' CD2' ' CZ2' ' A' ' 174' ' ' TRP . 79.5 m80 -152.8 45.43 0.69 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.952 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -179.38 3.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.739 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 58.02 29.41 62.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.486 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.434 HD12 HD22 ' A' ' 184' ' ' LEU . 4.0 mt -97.05 61.76 1.79 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.931 0.396 . . . . 0.0 110.901 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 55.75 26.5 9.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.929 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.86 ' O ' HG13 ' A' ' 146' ' ' VAL . . . 114.73 128.39 4.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.438 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 1.012 HD12 HG22 ' A' ' 146' ' ' VAL . 1.1 tp -176.92 129.49 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.11 41.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.021 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 175' ' ' ALA . 10.0 mm -99.78 159.45 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.864 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -161.12 162.03 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.361 0.6 . . . . 0.0 111.967 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -90.8 129.64 36.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.778 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.811 HG11 ' HG3' ' A' ' 141' ' ' MET . 1.5 m -46.98 -19.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.75 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 8.7 m80 -71.76 -41.84 67.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.798 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.21 -24.22 34.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.364 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.9 61.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.175 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.765 ' CE2' HG13 ' A' ' 128' ' ' VAL . 5.4 t80 -81.3 -25.57 36.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.682 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.76 -30.25 32.92 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 -28.22 32.48 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.14 -28.32 31.2 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.414 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -82.28 -23.99 34.95 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.883 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.08 -23.04 57.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.146 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -51.89 -33.08 35.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.144 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -80.99 -25.08 37.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -57.28 -48.45 78.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.948 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -80.07 -31.27 39.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.754 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.625 ' O ' HD13 ' A' ' 203' ' ' LEU . 0.3 OUTLIER -71.42 -24.68 62.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.078 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.04 -51.79 8.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.956 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -161.18 80.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.7 t -82.92 -37.25 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 10.0 mtp -153.22 137.7 16.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.25 146.58 30.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.96 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.7 t 60.66 178.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -89.17 -170.44 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.972 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.437 ' HB ' ' HD3' ' A' ' 212' ' ' PRO . 0.9 OUTLIER 178.4 -55.2 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.848 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.437 ' HD3' ' HB ' ' A' ' 211' ' ' THR . 74.1 Cg_exo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.516 2.144 . . . . 0.0 112.436 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.99 100.36 9.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.826 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -176.07 -171.31 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.936 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 tp 63.13 162.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.623 HG21 HD22 ' A' ' 106' ' ' LEU . 17.0 m 41.95 61.12 8.66 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.823 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.607 ' HG2' HD11 ' A' ' 46' ' ' LEU . 52.9 Cg_exo -52.49 -26.23 27.86 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.482 2.122 . . . . 0.0 112.219 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.639 HD22 ' HA2' ' A' ' 73' ' ' GLY . 1.0 OUTLIER -52.13 -57.37 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.352 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 mt -80.17 -27.28 39.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.55 -53.22 51.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.548 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.584 ' HG2' HD13 ' A' ' 45' ' ' ILE . 3.0 mp0 -66.03 -23.28 66.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.291 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.609 HD21 ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -69.52 -38.38 77.53 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.07 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.08 -25.63 13.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.001 0.429 . . . . 0.0 111.174 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.01 -20.87 65.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.073 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.56 42.46 95.61 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.267 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -133.36 165.85 33.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.704 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.55 114.28 3.78 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.502 2.135 . . . . 0.0 112.016 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.696 HG12 ' HG ' ' A' ' 42' ' ' LEU . 20.8 t -115.57 110.19 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.421 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.7 p -88.03 -171.65 3.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.746 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -77.99 -36.64 48.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.313 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -29.42 69.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.276 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.651 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -83.52 -42.65 16.61 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.696 ' HG ' HG12 ' A' ' 37' ' ' VAL . 12.6 mt -62.53 -36.56 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.975 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.87 -43.01 63.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.646 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.28 -31.65 77.76 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.477 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.634 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -79.54 -38.52 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 121.061 0.458 . . . . 0.0 110.231 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.607 HD11 ' HG2' ' A' ' 26' ' ' PRO . 6.4 mp -78.13 -10.01 59.43 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.178 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 59.38 22.54 10.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.439 ' CD1' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -102.77 137.06 19.21 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.189 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.731 ' O ' HG23 ' A' ' 53' ' ' VAL . 10.1 Cg_endo -53.04 142.81 52.8 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.697 2.265 . . . . 0.0 112.207 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.8 -20.64 2.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.55 -39.95 36.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.121 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.896 ' O ' HG23 ' A' ' 56' ' ' VAL . 13.0 mmt180 -67.93 -38.28 82.7 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.975 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.5 t -65.73 -48.1 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.89 -54.37 30.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.177 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.14 64.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.898 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 52' ' ' ARG . 35.9 t -65.06 -31.73 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.747 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.21 -35.12 79.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.59 ' O ' HG23 ' A' ' 61' ' ' THR . 1.8 mp0 -57.49 -22.82 46.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.851 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -96.42 -20.68 18.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.38 31.89 2.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.55 0.69 . . . . 0.0 110.916 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 58' ' ' GLU . 21.1 p -71.61 -27.65 63.26 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.8 m -75.86 -25.51 56.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.35 141.25 56.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.042 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.6 ' CG ' HG21 ' A' ' 72' ' ' ILE . 14.5 pt-20 -78.92 133.77 36.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.046 0.45 . . . . 0.0 111.274 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.426 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 55.2 m-85 -105.19 173.42 6.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.48 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -149.82 145.97 26.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.969 0.414 . . . . 0.0 111.499 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 tttp 65.6 -105.03 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.634 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -86.91 -11.51 50.46 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.713 0.292 . . . . 0.0 111.561 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 122.67 25.87 1.86 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.228 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -78.02 158.79 29.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 110.006 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.669 HD13 ' CD1' ' A' ' 42' ' ' LEU . 1.9 mp -79.74 126.32 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.574 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.819 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -72.16 -28.97 30.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.027 0.442 . . . . 0.0 111.021 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.639 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 86.62 -106.62 3.13 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.677 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.453 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -53.91 161.77 1.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.877 0.37 . . . . 0.0 111.156 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.5 125.58 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.654 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tp -124.63 149.51 47.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.33 . . . . 0.0 110.76 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -113.72 140.86 47.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.579 ' H ' HD12 ' A' ' 78' ' ' LEU . 5.1 mp -59.75 -23.87 63.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -92.97 123.61 36.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 111.096 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.2 pt-20 -60.64 -16.76 42.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.461 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.756 HG21 ' HA ' ' A' ' 95' ' ' TRP . 0.5 OUTLIER 37.46 -167.97 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.08 -24.88 12.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.113 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -80.78 114.85 19.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.55 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.82 136.14 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.015 0.436 . . . . 0.0 111.423 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.819 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 56.5 t80 -128.16 104.6 7.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.177 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -98.6 131.12 45.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.396 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -140.06 122.95 17.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.07 -72.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 87' ' ' ILE . 18.3 t0 -159.26 37.11 0.2 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -139.8 145.95 38.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.56 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.96 86.49 2.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.871 0.367 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.418 ' HG ' ' CD2' ' A' ' 74' ' ' TYR . 4.3 mm? -71.27 164.79 25.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.589 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.41 ' CD2' ' HA ' ' A' ' 80' ' ' GLU . 5.1 m-85 -131.12 160.08 35.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.356 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.549 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -146.55 161.44 40.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.737 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.756 ' HA ' HG21 ' A' ' 81' ' ' THR . 7.7 m0 -90.61 -24.7 20.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.409 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.436 ' HB3' ' CG1' ' A' ' 162' ' ' VAL . 5.6 m -146.97 172.37 13.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.974 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.716 ' HB1' ' CE2' ' A' ' 164' ' ' PHE . . . -53.77 -21.53 7.51 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.432 ' HB2' HG11 ' A' ' 162' ' ' VAL . 2.1 tp -86.8 -51.53 6.03 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.549 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -45.57 -25.39 0.45 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -60.31 -36.73 78.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.688 0.28 . . . . 0.0 110.87 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.866 HD12 ' CG ' ' A' ' 104' ' ' PRO . 1.9 pt? -137.5 166.18 24.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.004 0.431 . . . . 0.0 111.386 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.405 HG22 ' CZ ' ' A' ' 103' ' ' PHE . 4.1 mp -143.62 -46.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.405 ' CZ ' HG22 ' A' ' 102' ' ' ILE . 38.5 m-85 -141.1 65.83 23.45 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.664 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.866 ' CG ' HD12 ' A' ' 101' ' ' LEU . 34.3 Cg_exo -57.83 -30.61 89.99 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.742 2.295 . . . . 0.0 112.531 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.36 -23.61 43.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.455 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.623 HD22 HG21 ' A' ' 25' ' ' VAL . 1.1 tt -85.94 -34.04 20.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.143 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 tp -54.51 -47.61 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.174 0.511 . . . . 0.0 111.687 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.91 20.85 25.0 Favored Glycine 0 C--N 1.32 -0.351 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.733 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 173.42 14.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 111.011 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -78.87 151.8 31.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.819 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.14 109.75 7.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 112.001 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -82.35 119.64 24.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.818 0.818 . . . . 0.0 111.198 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.768 HG22 ' CD1' ' A' ' 85' ' ' PHE . 39.6 t -111.61 130.47 65.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.137 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.0 m -122.29 137.04 54.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.093 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.548 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.62 172.8 12.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.209 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.44 ' CD2' ' HA ' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -136.68 135.06 37.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.505 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 26.4 t -61.77 132.14 52.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.227 0.537 . . . . 0.0 112.147 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.48 -3.84 23.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.935 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.915 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.58 -50.6 1.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.616 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -88.98 -24.23 22.45 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.247 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.36 5.03 76.05 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.179 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.689 ' H ' HG22 ' A' ' 120' ' ' THR . . . -57.74 151.17 43.54 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.504 0.193 . . . . 0.0 110.579 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.44 ' HA ' ' CD2' ' A' ' 116' ' ' HIS . 2.5 Cg_endo -84.54 105.8 1.06 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.736 2.29 . . . . 0.0 110.898 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.65 HG12 ' CD ' ' A' ' 138' ' ' PRO . 35.2 m -103.29 145.49 12.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.419 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.906 ' O ' HD13 ' A' ' 126' ' ' LEU . 72.8 p -151.49 141.62 22.22 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.443 0.64 . . . . 0.0 110.699 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.906 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -134.82 152.92 52.14 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.306 178.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.882 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 82.7 m -111.34 113.31 25.69 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.541 HG22 ' HZ ' ' A' ' 193' ' ' PHE . 19.7 t -95.86 111.73 26.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.631 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.14 175.63 2.07 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.401 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.78 -15.62 37.11 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.695 2.263 . . . . 0.0 112.971 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 50.1 m -120.11 -26.03 5.61 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 131' ' ' SER . 14.6 pt-20 179.74 -162.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.169 0.509 . . . . 0.0 110.186 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.777 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -96.62 161.36 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.992 178.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -149.31 19.25 0.95 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.298 0.57 . . . . 0.0 112.253 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.882 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.09 86.23 0.08 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.593 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.557 HG13 HD12 ' A' ' 126' ' ' LEU . 24.4 t -105.02 118.35 52.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.138 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -146.21 117.12 4.82 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.65 ' CD ' HG12 ' A' ' 124' ' ' VAL . 13.9 Cg_exo -69.47 146.99 83.12 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.643 -1.399 . . . . 0.0 112.28 0.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.18 -33.83 54.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.642 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.93 28.98 12.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.957 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.759 ' HE1' HD21 ' A' ' 126' ' ' LEU . 1.9 ppp? -64.9 156.55 30.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.126 0.489 . . . . 0.0 111.529 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -128.72 152.32 48.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.616 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.844 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -112.49 150.67 14.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.965 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 162' ' ' VAL . 23.0 p -119.86 140.37 50.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.757 0.313 . . . . 0.0 111.026 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.4 mt -139.02 176.28 8.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.873 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 158' ' ' PHE . 18.5 m -125.04 154.39 33.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.051 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' A' ' 149' ' ' GLN . 0.1 OUTLIER 62.47 96.19 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.839 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.32 -19.36 43.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.489 2.126 . . . . 0.0 112.581 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.687 ' HB2' HD12 ' A' ' 147' ' ' LEU . 7.5 mm-40 -53.95 137.86 38.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.834 0.349 . . . . 0.0 111.061 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.34 -25.15 68.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -110.48 -29.15 8.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.434 ' HB1' ' HG ' ' A' ' 147' ' ' LEU . . . 51.74 29.61 5.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.309 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 59.83 -175.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.849 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 154' ' ' VAL . 9.5 p -109.45 70.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.98 0.419 . . . . 0.0 111.228 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -153.43 24.3 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.122 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 54.37 88.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.095 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.65 68.41 1.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.049 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' ' 146' ' ' VAL . 4.8 p90 -162.15 -55.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.743 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 43.6 t -81.31 -15.85 54.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 42.2 t -49.55 -34.59 17.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.396 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -151.91 65.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.779 0.323 . . . . 0.0 111.357 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 144' ' ' SER . 8.0 p -108.15 114.56 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.13 0.491 . . . . 0.0 110.865 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.447 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 2.5 m-70 -126.81 169.24 13.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.609 0.719 . . . . 0.0 110.076 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.844 ' CE1' HG22 ' A' ' 143' ' ' VAL . 11.9 m-85 -106.11 151.71 24.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.62 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 49.2 m-85 -131.13 136.3 48.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.495 0.664 . . . . 0.0 110.502 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -43.42 -26.42 0.2 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.67 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.526 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 22.3 p -169.24 172.76 7.1 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.941 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 81.5 t -69.01 -34.04 4.7 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.389 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.76 -37.35 3.91 Favored 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 122.669 2.246 . . . . 0.0 110.24 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.587 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.6 -40.42 49.54 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.578 178.077 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.73 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.0 -45.59 92.96 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.6 mt-10 -78.92 -27.56 43.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.119 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 25.3 t70 -70.77 -55.94 7.47 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.451 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.915 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.6 t-105 -65.03 -28.28 69.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.632 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.59 -40.7 97.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.221 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.2 p -51.85 -43.56 63.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.354 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.82 21.01 7.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.358 0.599 . . . . 0.0 111.353 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.468 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -125.94 27.39 6.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.811 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -97.91 -178.75 4.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.757 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.6 -28.38 13.66 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.465 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.94 -174.94 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.94 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -97.94 33.41 2.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.849 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 145.76 126.51 1.82 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.525 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 178' ' ' HIS . 2.9 tt -176.66 116.76 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 110.927 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.65 149.76 41.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.659 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.9 mm -99.78 159.59 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.954 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -160.09 147.81 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.815 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.5 OUTLIER -77.41 124.49 27.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.467 177.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.635 HG11 ' HG3' ' A' ' 141' ' ' MET . 1.0 OUTLIER -46.93 -20.67 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.644 179.316 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.37 -39.63 77.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.7 mt-10 -82.46 -28.38 31.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.036 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.436 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -63.69 -24.69 67.88 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.116 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.777 ' CZ ' HG23 ' A' ' 133' ' ' ILE . 0.6 OUTLIER -81.15 -24.72 37.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.032 0.444 . . . . 0.0 110.818 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.56 -30.3 33.45 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.17 -28.47 32.07 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -27.87 32.77 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.601 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -82.17 -25.85 33.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 110.951 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.418 ' HB3' ' CE1' ' A' ' 202' ' ' HIS . 4.0 mt-10 -73.88 -23.32 59.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.089 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -55.84 -43.3 76.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.128 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.43 ' OD1' HD23 ' A' ' 204' ' ' LEU . 35.6 t30 -81.01 -50.07 10.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.113 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -56.52 -28.85 61.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.253 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' HIS . . . . . 0.418 ' CE1' ' HB3' ' A' ' 198' ' ' GLU . 2.9 m80 -66.33 -48.49 70.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 203' ' ' LEU . 3.3 mm? -82.16 -42.74 18.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.005 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.43 HD23 ' OD1' ' A' ' 200' ' ' ASN . 4.2 mm? -74.56 -51.9 13.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 60.29 -169.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.0 t -60.4 147.52 40.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.961 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 3.5 ptp -113.16 -175.4 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.2 m -125.88 175.69 7.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.4 m -111.56 -33.99 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 61.16 112.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.432 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -65.64 -62.71 4.1 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.987 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.2 Cg_endo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.379 2.053 . . . . 0.0 112.262 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.774 0.321 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 60.45 165.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.978 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mp -96.43 104.24 16.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -113.72 77.99 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 25' ' ' VAL . 11.2 p -171.18 54.18 0.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.078 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.626 ' HG3' HD11 ' A' ' 46' ' ' LEU . 57.0 Cg_endo -71.02 -21.81 27.13 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.595 2.197 . . . . 0.0 112.484 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.711 ' HG ' HG21 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -56.46 -57.44 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 111.363 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -80.12 -27.43 39.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.227 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.426 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -71.54 -53.22 14.53 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.888 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.88 -24.52 66.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.506 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.795 HD22 ' HA3' ' A' ' 73' ' ' GLY . 16.4 tp -69.45 -28.93 66.53 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.73 -22.56 9.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.351 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -69.11 -21.7 64.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.192 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.95 39.51 94.94 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.399 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -133.25 166.04 32.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.572 0.225 . . . . 0.0 110.833 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.64 114.12 3.58 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.468 2.112 . . . . 0.0 111.952 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.782 HG23 HG22 ' A' ' 41' ' ' THR . 11.1 p -111.59 109.87 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.438 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.3 p -85.99 -170.47 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.723 ' NH1' HD11 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -78.04 -37.52 46.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.465 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -27.91 68.66 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.199 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.782 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.53 -42.34 15.61 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.324 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -62.74 -36.6 83.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 176.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.04 -42.74 62.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.604 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.74 -30.19 72.7 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.643 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.556 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.03 -43.51 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.055 0.455 . . . . 0.0 110.397 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.626 HD11 ' HG3' ' A' ' 26' ' ' PRO . 7.2 mp -76.75 -9.83 58.95 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.506 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.5 t70 60.63 21.77 11.64 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.442 ' CD1' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -104.47 137.79 19.33 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.068 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.442 ' HD2' ' CD1' ' A' ' 48' ' ' TRP . 10.7 Cg_endo -53.66 140.01 66.56 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.597 2.198 . . . . 0.0 112.012 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.19 -17.89 1.28 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.6 -32.61 47.66 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.258 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.791 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.17 -39.87 86.53 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.05 -48.14 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.586 177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.87 57.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.389 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.2 -42.77 66.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.891 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 52' ' ' ARG . 26.9 t -67.76 -31.17 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.539 ' C ' HD23 ' A' ' 57' ' ' LEU . 9.2 tt -63.95 -35.37 80.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.758 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.25 -45.12 88.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.755 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -88.05 -7.88 56.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.62 74.98 1.04 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.765 0.793 . . . . 0.0 110.133 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -106.66 -16.09 14.6 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.42 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -73.87 -28.13 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.17 141.33 50.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.448 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.822 ' O ' HG22 ' A' ' 72' ' ' ILE . 23.9 mt-10 -78.79 126.94 31.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.313 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -103.37 171.78 7.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.463 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 70' ' ' ASN . 1.6 t70 -92.16 -172.76 3.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.479 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -67.55 -35.42 79.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -91.73 12.24 21.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.648 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.28 17.33 74.23 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.156 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 66' ' ' ASP . 24.3 m120 -91.49 165.62 13.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.983 0.392 . . . . 0.0 110.04 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.776 HD13 HD13 ' A' ' 42' ' ' LEU . 3.2 mp -79.84 127.8 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.546 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.822 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.4 tt -85.32 -24.95 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.022 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.795 ' HA3' HD22 ' A' ' 31' ' ' LEU . . . 66.36 11.95 57.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.035 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.786 ' H ' HG23 ' A' ' 72' ' ' ILE . 86.8 m-85 51.45 -176.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.793 0.33 . . . . 0.0 111.092 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.36 -87.3 0.43 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.578 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.54 138.07 46.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 110.895 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.572 HG21 ' CD1' ' A' ' 95' ' ' TRP . 81.7 p -97.82 159.05 15.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.5 -41.41 85.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.979 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.9 mtt-85 -110.31 150.29 28.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 4.5 tt0 -57.05 132.34 52.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.925 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.8 p -108.44 -173.67 2.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.046 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 70.2 m -94.94 -38.54 10.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.016 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.431 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 32.6 m-85 -79.52 111.09 15.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.507 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.62 138.13 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.762 ' HD1' HG22 ' A' ' 113' ' ' VAL . 69.4 t80 -123.51 106.73 10.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.544 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -98.06 125.77 43.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.279 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -139.59 122.91 18.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.853 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 t70 59.4 -72.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.159 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 87' ' ' ILE . 35.1 t0 -165.74 34.15 0.05 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.313 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.3 mmp_? -136.64 111.82 9.06 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.751 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -77.87 120.63 23.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.909 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.95 164.78 11.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 111.022 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.435 ' CZ ' ' HG3' ' A' ' 80' ' ' GLU . 28.4 m-85 -131.49 155.39 47.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.355 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.768 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -150.39 168.41 24.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.973 0.416 . . . . 0.0 111.614 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.572 ' CD1' HG21 ' A' ' 77' ' ' THR . 6.3 m95 -100.21 -6.97 25.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.189 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.431 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.5 OUTLIER 178.03 -179.28 0.27 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.827 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 164' ' ' PHE . . . -55.09 164.36 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.729 0.3 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 tt 70.21 -52.92 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.103 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.768 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 8.8 t0 -47.3 -29.27 2.38 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.834 0.349 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.481 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 2.7 p -60.02 -39.44 85.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.717 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER 169.92 153.45 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.554 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.755 ' O ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -143.33 48.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.867 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.705 ' O ' HG22 ' A' ' 107' ' ' ILE . 16.9 m-85 -166.27 59.27 0.54 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.992 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.583 ' HB3' HG12 ' A' ' 128' ' ' VAL . 61.2 Cg_endo -73.14 -37.67 3.28 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.596 2.197 . . . . 0.0 112.253 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.08 -23.8 43.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.218 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -82.72 -41.06 19.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.26 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.3 tp -57.68 -46.6 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.177 0.513 . . . . 0.0 111.422 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.88 24.29 15.68 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.636 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -152.55 173.53 15.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.003 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -80.09 153.42 28.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.772 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.752 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -137.06 109.78 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -83.19 120.26 25.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.781 0.8 . . . . 0.0 111.23 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.762 HG22 ' HD1' ' A' ' 85' ' ' PHE . 94.6 t -112.79 130.68 66.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.013 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 m -122.78 136.91 55.02 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.202 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.598 ' HB3' HG23 ' A' ' 124' ' ' VAL . 2.0 t -141.81 173.0 11.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.36 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.455 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -133.53 137.23 45.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.208 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 34.0 t -66.65 134.0 51.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.086 0.47 . . . . 0.0 112.234 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -72.52 -3.98 27.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.102 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.888 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.59 -51.34 2.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.928 0.395 . . . . 0.0 111.529 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.37 -24.18 22.01 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.356 -179.448 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.15 6.09 73.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.114 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.716 ' H ' HG22 ' A' ' 120' ' ' THR . . . -59.39 150.69 63.37 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.552 0.215 . . . . 0.0 110.501 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.0 104.39 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.652 2.235 . . . . 0.0 110.77 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.598 HG23 ' HB3' ' A' ' 115' ' ' SER . 35.0 m -99.22 144.35 12.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.299 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.9 p -150.48 141.95 23.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.448 0.642 . . . . 0.0 110.639 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.675 HD21 HG11 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -138.26 151.28 47.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.026 179.072 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.871 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 39.2 m -107.1 113.76 27.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.732 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.583 HG12 ' HB3' ' A' ' 104' ' ' PRO . 36.2 t -96.15 111.72 26.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.382 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.23 167.68 9.09 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.793 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.62 -19.16 60.15 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.084 1.856 . . . . 0.0 112.884 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 4.4 m -112.79 -26.73 8.43 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 131' ' ' SER . 2.9 pt-20 178.37 -162.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.15 0.5 . . . . 0.0 110.159 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -96.23 157.75 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.014 178.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -144.85 19.05 1.64 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.367 0.603 . . . . 0.0 112.241 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.871 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.9 86.56 0.08 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.326 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.574 HG13 ' SD ' ' A' ' 141' ' ' MET . 23.8 t -104.99 115.92 47.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.431 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.35 124.32 6.2 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.575 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.65 154.79 95.81 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.874 -1.302 . . . . 0.0 112.247 0.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.42 79.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.106 0.479 . . . . 0.0 110.434 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 141.82 20.46 0.27 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.017 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.574 ' SD ' HG13 ' A' ' 136' ' ' VAL . 0.4 OUTLIER -61.06 160.32 10.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.035 0.445 . . . . 0.0 111.298 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -129.24 152.29 48.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.091 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.641 HG13 ' CD1' ' A' ' 164' ' ' PHE . 40.5 t -113.98 150.67 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.624 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.745 ' O ' HG13 ' A' ' 162' ' ' VAL . 2.8 p -117.81 138.77 51.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.865 0.364 . . . . 0.0 110.912 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.868 HD21 HG21 ' A' ' 187' ' ' VAL . 1.3 pp -149.93 176.63 10.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.599 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.597 ' O ' HG13 ' A' ' 146' ' ' VAL . 8.9 p -108.09 104.18 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 0.0 110.88 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.605 HD23 ' HB3' ' A' ' 185' ' ' ALA . 0.4 OUTLIER -72.71 -62.39 1.38 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.246 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.835 ' CG ' HD22 ' A' ' 184' ' ' LEU . 38.2 Cg_endo -66.56 83.65 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.514 2.143 . . . . 0.0 112.468 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -175.0 122.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.683 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -140.39 116.89 10.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 59.7 40.51 19.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.551 ' HB3' ' OG ' ' A' ' 157' ' ' SER . . . -97.84 30.33 3.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.058 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.526 ' O ' HG13 ' A' ' 154' ' ' VAL . 1.5 t70 -177.5 -56.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 153' ' ' ASP . 6.1 m -158.95 -47.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.068 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.421 ' N ' HG23 ' A' ' 154' ' ' VAL . 4.6 mtt-85 -152.78 -74.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -80.28 -34.52 36.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.551 ' OG ' ' HB3' ' A' ' 152' ' ' ALA . 23.0 t 63.15 124.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.052 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.438 ' HB2' HG11 ' A' ' 146' ' ' VAL . 3.0 m-85 59.24 31.16 20.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.905 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 29.4 p -72.65 -28.21 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.929 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.8 m -86.69 -19.75 28.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.169 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -87.44 53.84 2.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 144' ' ' SER . 25.2 t -111.7 127.49 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.047 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -113.99 164.81 13.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.717 0.77 . . . . 0.0 110.469 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.641 ' CD1' HG13 ' A' ' 143' ' ' VAL . 3.3 m-85 -122.3 129.83 52.56 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.559 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 44.8 m-85 -108.54 140.95 41.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.45 0.643 . . . . 0.0 110.771 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.38 -25.66 1.71 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.78 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.599 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 32.1 m -162.36 165.84 25.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.663 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.625 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 74.9 t -67.66 -33.91 5.94 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.955 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.63 -36.92 4.44 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.669 2.246 . . . . 0.0 110.262 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.65 -40.37 49.33 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.468 177.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.72 -45.79 92.44 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.547 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 3.1 mm-40 -78.88 -27.06 43.97 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.351 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 169' ' ' PRO . 25.9 t0 -70.62 -55.91 7.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.888 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 31.8 t-105 -65.23 -28.97 69.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.635 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.43 -39.93 95.8 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.346 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.8 m -52.22 -44.54 64.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.327 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.408 ' O ' ' CD2' ' A' ' 178' ' ' HIS . 0.0 OUTLIER -96.15 22.33 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.259 0.552 . . . . 0.0 111.235 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.436 ' NE2' ' CE2' ' A' ' 174' ' ' TRP . 15.8 m-70 -145.46 40.75 1.22 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.084 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -81.53 136.69 35.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.575 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 97.19 -25.5 26.76 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.174 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.409 HD12 ' CA ' ' A' ' 178' ' ' HIS . 3.2 mt -66.76 -175.49 0.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.728 0.299 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.86 -25.37 11.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.051 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -103.76 52.51 0.76 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.182 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.835 HD22 ' CG ' ' A' ' 148' ' ' PRO . 0.2 OUTLIER -56.06 -26.96 51.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.639 0.257 . . . . 0.0 111.14 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.605 ' HB3' HD23 ' A' ' 147' ' ' LEU . . . -135.04 143.65 46.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.949 0.404 . . . . 0.0 111.225 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 175' ' ' ALA . 15.9 mm -103.52 161.56 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.94 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.868 HG21 HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -161.99 164.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.363 0.601 . . . . 0.0 112.012 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.424 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -92.97 133.83 35.73 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.49 178.209 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.675 HG11 HD21 ' A' ' 126' ' ' LEU . 18.3 m -47.43 -18.68 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 120.879 0.371 . . . . 0.0 110.838 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.424 ' N ' ' C ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -73.83 -43.08 59.85 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.037 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -20.98 36.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.327 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.38 -25.2 59.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.087 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -81.42 -24.82 36.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.762 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.85 -30.63 31.52 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.4 mt -82.05 -27.62 32.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.05 -25.84 39.28 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -82.19 -22.95 35.74 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.56 -0.32 . . . . 0.0 111.116 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -79.67 -24.8 41.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.141 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -53.88 -30.47 45.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 111.189 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.576 ' O ' HD23 ' A' ' 204' ' ' LEU . 2.2 m-80 -55.63 -54.98 37.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.061 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -54.65 -43.08 72.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.157 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -36.22 82.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.737 ' O ' HD13 ' A' ' 203' ' ' LEU . 0.6 OUTLIER -82.06 -27.61 32.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.037 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 200' ' ' ASN . 4.2 mm? -80.97 -42.13 21.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -58.96 146.41 38.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.917 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.5 t -131.81 -51.81 0.98 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.08 37.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.8 m -95.92 133.4 40.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.998 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.87 -74.81 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.957 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 60.3 106.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.797 HG22 ' HD3' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -78.79 -34.52 0.99 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.881 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.797 ' HD3' HG22 ' A' ' 211' ' ' THR . 63.7 Cg_exo . . . . . 0 C--O 1.248 1.015 0 C-N-CA 121.971 1.78 . . . . 0.0 112.419 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.13 175.36 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.924 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.659 ' C ' HD13 ' A' ' 24' ' ' LEU . 6.6 mt -137.98 -178.72 5.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.676 ' N ' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -156.43 30.92 0.33 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.416 HG13 HD23 ' A' ' 24' ' ' LEU . 3.6 m -152.84 70.16 7.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.033 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.833 ' CG ' HD11 ' A' ' 46' ' ' LEU . 58.6 Cg_endo -71.78 -26.38 19.25 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.517 2.145 . . . . 0.0 112.435 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -54.16 -57.49 10.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.042 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 31' ' ' LEU . 9.2 mt -63.19 -26.91 69.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -68.68 -53.25 23.45 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.118 0.485 . . . . 0.0 109.907 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.769 ' HB3' HG21 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -72.67 -30.76 64.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.297 178.52 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.783 HD11 ' CA ' ' A' ' 73' ' ' GLY . 9.8 tt -70.81 -49.76 42.9 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.825 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.8 -27.64 30.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 0.0 110.973 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -21.1 65.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.136 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 45.9 94.97 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.068 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.656 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -130.86 152.6 80.87 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.622 0.248 . . . . 0.0 110.834 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.89 89.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.643 2.229 . . . . 0.0 112.346 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.769 HG21 ' HB3' ' A' ' 30' ' ' GLU . 39.2 t -97.61 110.7 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 p -85.34 -172.98 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.007 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.673 ' HE ' HG23 ' A' ' 40' ' ' THR . 0.2 OUTLIER -78.07 -35.51 49.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.339 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.673 HG23 ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -65.74 -27.19 68.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.954 0.407 . . . . 0.0 110.331 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.657 ' CG2' HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.19 -42.68 14.49 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.342 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 tp -63.05 -35.91 81.82 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.604 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.31 -43.0 61.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.59 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.12 -31.49 74.97 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.7 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.604 HD12 HG23 ' A' ' 41' ' ' THR . 6.7 mt -78.81 -44.38 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-O 120.873 0.368 . . . . 0.0 110.535 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.833 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.2 mp -76.57 -9.66 58.82 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.434 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t0 59.3 22.15 10.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.438 ' HE3' HD23 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -105.01 144.82 29.51 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.274 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.3 140.0 81.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.457 2.104 . . . . 0.0 112.033 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.15 -18.39 1.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -78.36 -32.38 48.96 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.203 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -67.14 -40.95 86.84 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -61.98 -48.54 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.646 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.68 -53.18 55.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.232 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.62 -46.93 77.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.837 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 52' ' ' ARG . 37.0 t -66.4 -31.84 55.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.714 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 mt -62.1 -32.2 72.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.613 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -56.78 -24.48 50.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.741 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -96.22 -17.88 20.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.49 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -101.72 32.77 3.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.478 0.656 . . . . 0.0 110.816 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 58' ' ' GLU . 27.2 p -67.52 -13.71 62.29 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.212 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 p -88.44 -22.65 23.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.778 0.323 . . . . 0.0 111.368 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.49 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -57.54 141.32 48.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.027 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' O ' HG22 ' A' ' 72' ' ' ILE . 3.4 mt-10 -79.1 127.0 31.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.05 0.452 . . . . 0.0 111.414 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.447 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.8 m-85 -101.74 173.13 6.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.263 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -151.46 146.95 26.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.941 0.4 . . . . 0.0 111.492 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm 66.68 -102.54 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.865 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -91.85 -10.05 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 120.95 30.42 1.35 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.028 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.01 170.65 10.93 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 37' ' ' VAL . 3.1 mp -79.84 114.28 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.239 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.6 tt -109.82 -28.93 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.246 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.783 ' CA ' HD11 ' A' ' 31' ' ' LEU . . . 95.43 -179.16 35.93 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.471 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -149.63 67.17 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.536 ' C ' HD12 ' A' ' 76' ' ' LEU . . . -113.67 25.82 10.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.555 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.536 HD12 ' C ' ' A' ' 75' ' ' GLY . 4.8 mp -149.17 156.16 41.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.833 0.349 . . . . 0.0 110.955 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.721 HG21 HG23 ' A' ' 81' ' ' THR . 1.3 t -101.19 159.04 15.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.35 -43.79 85.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.992 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -103.59 147.46 27.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.966 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.8 128.59 37.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.721 HG23 HG21 ' A' ' 77' ' ' THR . 32.1 p -106.9 -174.46 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.4 -34.45 12.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 52.2 m-85 -81.15 110.48 16.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.606 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.57 137.25 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.844 ' CE2' HD23 ' A' ' 101' ' ' LEU . 36.4 t80 -126.82 105.6 8.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.567 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -98.58 126.55 44.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.685 0.279 . . . . 0.0 110.984 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.546 HG21 ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.07 127.19 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 59.18 -77.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.296 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' ILE . 19.4 t0 -160.11 35.34 0.17 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.483 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -138.42 114.05 9.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.503 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -77.82 86.4 4.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 110.894 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -71.73 164.84 25.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.704 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -136.76 162.89 31.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.327 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -149.59 167.22 26.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.011 0.434 . . . . 0.0 112.068 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -98.88 -8.96 24.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.126 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.432 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -161.15 172.77 16.16 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.983 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.673 ' HB1' ' CE2' ' A' ' 164' ' ' PHE . . . -55.35 -24.2 28.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.273 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.904 HD22 ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -94.62 -38.03 11.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.175 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.904 ' N ' HD22 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -53.84 -22.0 8.8 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.708 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -60.12 -35.07 74.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.739 0.304 . . . . 0.0 110.482 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.844 HD23 ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -169.66 147.12 3.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.988 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.699 ' H ' HD13 ' A' ' 101' ' ' LEU . 2.8 tt -107.29 -43.09 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.45 ' N ' HG23 ' A' ' 102' ' ' ILE . 22.6 m-85 -129.57 72.47 81.95 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.05 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.593 ' N ' HD12 ' A' ' 101' ' ' LEU . 26.8 Cg_exo -62.47 -21.06 72.29 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.642 2.228 . . . . 0.0 112.426 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.63 -23.3 42.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.894 0.378 . . . . 0.0 111.407 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.5 tp -86.02 -24.42 26.43 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.3 tp -57.99 -47.99 85.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.133 0.492 . . . . 0.0 111.679 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.73 19.29 27.49 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.785 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.17 175.49 12.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 111.001 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -78.79 150.15 32.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.799 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.793 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.15 110.03 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -81.26 120.19 24.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.852 0.834 . . . . 0.0 111.114 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.807 HG22 ' CD1' ' A' ' 85' ' ' PHE . 33.4 t -111.53 131.01 64.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.024 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.3 m -119.57 137.57 53.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.947 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.529 ' HB2' HG23 ' A' ' 124' ' ' VAL . 1.0 OUTLIER -140.74 172.6 12.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.442 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -135.45 131.76 36.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.681 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.0 m -57.12 123.6 15.84 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.863 0.363 . . . . 0.0 111.963 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -68.06 -9.01 42.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.615 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.681 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.49 -50.6 1.98 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.545 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -76.8 -20.36 56.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 110.935 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.49 33.28 84.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.168 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.545 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -101.4 168.67 8.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.426 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.422 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 41.6 Cg_endo -94.55 111.13 0.16 Allowed 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 123.043 2.495 . . . . 0.0 111.529 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.752 HG12 ' CD ' ' A' ' 138' ' ' PRO . 34.5 m -110.57 149.32 13.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.569 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.859 ' O ' HD13 ' A' ' 126' ' ' LEU . 76.0 p -149.36 141.82 24.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.337 0.589 . . . . 0.0 110.731 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.859 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -133.37 152.42 51.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.131 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.867 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 60.6 m -112.02 113.06 25.14 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.552 HG22 ' HZ ' ' A' ' 193' ' ' PHE . 23.3 t -96.31 111.88 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.626 -0.429 . . . . 0.0 111.351 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.3 p -106.47 175.88 1.89 Allowed Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.212 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.11 -13.4 33.74 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.562 2.174 . . . . 0.0 113.192 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.1 t -120.31 -27.7 5.18 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.73 -162.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.023 0.439 . . . . 0.0 110.201 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.725 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -96.67 155.08 3.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.863 178.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -142.87 19.39 1.98 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.347 0.594 . . . . 0.0 112.589 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.867 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.15 86.18 0.08 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.686 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.517 HG13 HD12 ' A' ' 126' ' ' LEU . 24.5 t -104.83 122.07 57.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.106 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -146.13 124.19 6.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.869 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.752 ' CD ' HG12 ' A' ' 124' ' ' VAL . 60.1 Cg_endo -72.3 158.65 96.9 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.226 0.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.31 78.43 0.54 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.224 0.535 . . . . 0.0 110.645 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.41 18.14 0.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.195 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.661 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.5 OUTLIER -60.78 161.14 8.37 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.047 0.423 . . . . 0.0 111.225 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -132.21 152.09 51.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.776 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.929 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -110.15 150.49 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.372 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.3 m -123.51 147.45 47.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.92 0.391 . . . . 0.0 111.203 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 146' ' ' VAL . 2.6 tt -129.28 157.81 40.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.515 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.914 HG12 ' HD3' ' A' ' 148' ' ' PRO . 20.0 t -125.56 142.12 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.904 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.32 68.69 26.77 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.993 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.914 ' HD3' HG12 ' A' ' 146' ' ' VAL . 90.8 Cg_endo -87.82 146.25 6.79 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.922 2.415 . . . . 0.0 112.466 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 59.28 20.84 9.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.462 0.649 . . . . 0.0 111.457 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 63.19 86.46 0.12 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.779 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 63.48 106.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.84 93.45 4.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.075 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.87 -68.36 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.841 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 154' ' ' VAL . 10.8 p -143.31 123.22 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.28 -68.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -157.52 33.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 53.7 m -145.16 81.89 1.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -139.6 28.93 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.107 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 17.0 p -77.29 -42.74 35.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.387 . . . . 0.0 110.674 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 161' ' ' HIS . 1.8 m -163.19 -78.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.455 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.666 ' O ' HG23 ' A' ' 146' ' ' VAL . 0.8 OUTLIER 83.69 -51.58 0.14 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.725 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.59 110.95 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -124.67 169.25 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.574 0.702 . . . . 0.0 109.756 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.929 ' CE1' HG22 ' A' ' 143' ' ' VAL . 6.2 m-85 -110.63 152.53 26.37 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.982 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 118' ' ' ALA . 18.1 m-85 -134.62 137.06 43.36 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.42 0.629 . . . . 0.0 110.31 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.635 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -37.93 -30.67 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.739 -1.118 . . . . 0.0 113.109 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.52 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 18.7 m -172.6 -179.97 2.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.157 0.503 . . . . 0.0 111.65 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 84.2 t -69.69 -33.49 3.75 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.563 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.1 Cg_exo -72.94 -39.05 2.5 Favored 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 122.604 2.203 . . . . 0.0 110.5 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.601 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.48 -39.69 52.45 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.122 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.61 -45.81 92.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.3 mt-10 -78.99 -27.39 43.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.316 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.6 t70 -70.51 -55.86 7.93 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.355 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.681 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.7 t-105 -64.91 -28.31 69.44 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.786 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -66.83 -38.68 86.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.264 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.8 t -51.45 -42.53 61.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.454 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -94.25 20.48 8.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.363 0.602 . . . . 0.0 111.458 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.55 ' O ' HD22 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -129.62 29.46 5.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.759 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -91.51 -166.62 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.48 -32.98 5.98 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.385 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.7 mt -59.17 -175.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.738 0.304 . . . . 0.0 110.793 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 148' ' ' PRO . 4.1 mt-10 -97.99 33.52 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.833 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 163.15 -105.43 0.25 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.419 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.55 HD22 ' O ' ' A' ' 178' ' ' HIS . 5.1 tp 62.15 118.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.363 . . . . 0.0 110.761 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.83 150.14 39.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 111.518 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.571 HD11 ' HB2' ' A' ' 175' ' ' ALA . 11.9 mm -99.84 160.32 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.611 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.694 HG23 ' HB ' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -157.49 157.72 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.367 0.603 . . . . 0.0 112.198 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.9 OUTLIER -88.41 125.47 34.74 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.542 178.325 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.661 HG11 ' HG3' ' A' ' 141' ' ' MET . 0.3 OUTLIER -45.9 -21.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.556 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.407 ' N ' ' C ' ' A' ' 188' ' ' SER . 47.7 m170 -67.58 -40.1 84.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.2 mt-10 -82.32 -27.7 32.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.094 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -61.8 -24.71 67.03 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.725 ' CZ ' HG23 ' A' ' 133' ' ' ILE . 0.6 OUTLIER -79.31 -24.76 42.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.625 179.299 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.94 -29.71 33.8 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.27 -28.55 31.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.97 -27.92 32.82 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -82.19 -25.48 34.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.816 0.341 . . . . 0.0 110.839 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -81.05 -22.97 38.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.193 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.82 -39.64 59.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.217 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -76.15 -49.35 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -56.27 -39.45 72.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' HIS . . . . . 0.652 ' O ' HG23 ' A' ' 206' ' ' THR . 0.0 OUTLIER -80.0 -44.79 19.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.951 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 16.7 tp -59.04 -23.13 61.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.165 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.0 tp -81.0 -52.14 7.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -100.66 88.98 3.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 202' ' ' HIS . 0.8 OUTLIER -146.02 -47.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.88 177.05 8.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 54.8 m 60.67 108.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.5 m -75.68 84.75 2.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 110.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.938 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.789 HG22 ' HD3' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -70.99 -34.56 3.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.753 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.789 ' HD3' HG22 ' A' ' 211' ' ' THR . 60.5 Cg_exo . . . . . 0 C--O 1.249 1.062 0 C-N-CA 121.973 1.782 . . . . 0.0 112.475 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.718 0.294 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -148.37 81.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.491 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -130.76 -179.18 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.749 HD13 ' HG ' ' A' ' 106' ' ' LEU . 9.2 mt -137.85 174.24 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.805 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.546 ' O ' HG23 ' A' ' 25' ' ' VAL . 23.4 m -57.86 109.33 1.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.219 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.715 ' HB2' HD11 ' A' ' 46' ' ' LEU . 48.9 Cg_exo -55.84 -21.07 31.41 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.45 2.1 . . . . 0.0 112.484 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.608 HD11 HG21 ' A' ' 71' ' ' ILE . 8.6 tp -53.39 -57.48 10.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.995 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.776 HD11 HG21 ' A' ' 102' ' ' ILE . 1.3 tt -59.26 -26.78 65.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.183 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.29 -53.35 37.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.032 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -28.8 56.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.398 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 28' ' ' LEU . 8.1 tt -70.57 -52.05 24.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.733 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HB2' HD23 ' A' ' 28' ' ' LEU . . . -53.54 -26.4 21.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.142 0.496 . . . . 0.0 111.058 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -68.21 -21.63 64.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.172 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.04 45.72 95.44 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.067 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -133.07 150.16 74.76 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.678 0.275 . . . . 0.0 110.767 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.85 106.08 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.63 2.22 . . . . 0.0 112.342 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.715 HG23 HG22 ' A' ' 41' ' ' THR . 10.7 p -113.51 109.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.176 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 p -85.85 -172.2 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 43' ' ' ALA . 6.2 ptt180 -78.03 -35.32 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.227 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -26.52 67.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.845 0.355 . . . . 0.0 110.206 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.715 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.59 -42.45 14.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.341 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.434 ' HA ' HD12 ' A' ' 42' ' ' LEU . 10.0 tp -63.2 -36.0 82.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.639 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.45 -42.94 61.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.543 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.29 -30.94 73.73 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.694 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.592 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -78.68 -44.59 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 121.0 0.429 . . . . 0.0 110.498 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 26' ' ' PRO . 7.2 mp -76.26 -10.08 59.13 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.405 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.03 21.76 10.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.441 ' CH2' ' CZ ' ' A' ' 52' ' ' ARG . 10.6 m95 -107.57 136.77 19.59 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.265 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.2 142.41 16.44 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.5 2.133 . . . . 0.0 112.286 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.77 -16.86 1.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.88 -34.46 51.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.325 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.753 ' O ' HG23 ' A' ' 56' ' ' VAL . 7.5 tpt180 -67.01 -40.64 87.34 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.62 -48.11 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.613 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 57' ' ' LEU . . . -53.43 -53.38 52.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.354 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.94 -45.1 71.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.877 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 52' ' ' ARG . 32.5 t -71.48 -30.23 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.723 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 54' ' ' ALA . 13.0 mt -68.06 -39.81 82.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.738 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.68 -45.04 86.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.66 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -66.9 -14.97 63.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.027 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.584 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -112.14 70.43 0.71 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.67 0.748 . . . . 0.0 110.759 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.7 p -83.95 -3.87 58.29 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.247 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.0 p -96.41 -20.0 18.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.713 0.292 . . . . 0.0 111.333 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.584 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -52.77 141.23 21.82 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.033 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.73 126.69 31.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.154 0.502 . . . . 0.0 111.65 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.428 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 5.0 m-85 -102.92 163.06 12.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.287 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -148.3 133.79 18.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 111.711 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 tptt 70.28 -94.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.177 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.23 -15.06 20.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 127.95 34.48 0.55 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.124 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -92.67 159.6 15.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.368 . . . . 0.0 110.193 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.608 HG21 HD11 ' A' ' 27' ' ' LEU . 2.6 mp -79.85 114.45 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.235 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 73' ' ' GLY . 2.5 tt -178.08 -44.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.038 0.447 . . . . 0.0 111.446 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.477 ' N ' HG23 ' A' ' 72' ' ' ILE . . . 66.53 -91.64 0.17 Allowed Glycine 0 C--N 1.32 -0.306 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.456 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.415 ' CZ ' HD21 ' A' ' 78' ' ' LEU . 8.0 p90 -166.89 -178.49 4.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 0.0 110.894 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.34 76.96 0.13 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.616 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 92' ' ' LEU . 8.5 mt 58.71 -86.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.783 0.325 . . . . 0.0 111.082 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.468 HG21 ' HD1' ' A' ' 95' ' ' TRP . 20.1 p -98.96 159.07 15.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.415 HD21 ' CZ ' ' A' ' 74' ' ' TYR . 1.9 mt -78.4 -50.12 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.07 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -97.02 156.71 16.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.993 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -67.46 129.59 40.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.6 p -111.76 -174.48 2.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.532 ' HG ' ' CE1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -91.82 -29.67 16.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.147 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.415 ' OH ' ' CD2' ' A' ' 163' ' ' HIS . 26.4 m-85 -82.09 111.53 18.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.603 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 t -105.91 139.51 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.019 0.437 . . . . 0.0 111.156 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.941 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 68.9 t80 -129.42 106.63 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.649 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -102.0 128.89 48.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.3 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.6 pt -138.52 124.64 24.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.583 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.82 -68.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.24 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 87' ' ' ILE . 1.3 p30 -169.33 35.21 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.253 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -137.06 113.18 9.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.1 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.409 ' CD ' ' O ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -81.0 124.69 29.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 76' ' ' LEU . 1.7 mm? -118.63 165.07 14.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.102 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.72 ' O ' HD13 ' A' ' 76' ' ' LEU . 1.5 m-85 -129.22 165.21 21.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.206 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.65 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -151.63 169.58 21.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.12 0.486 . . . . 0.0 111.984 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.468 ' HD1' HG21 ' A' ' 77' ' ' THR . 7.2 m0 -99.3 -11.83 20.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.061 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 162' ' ' VAL . 0.9 OUTLIER -154.44 162.09 41.34 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.978 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.79 -22.28 3.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.769 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.86 -51.5 5.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.693 0.282 . . . . 0.0 111.288 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.65 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -41.55 -26.39 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.529 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -59.7 -32.34 70.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.309 . . . . 0.0 110.764 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.941 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 12.3 tp -148.76 167.35 25.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.36 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.776 HG21 HD11 ' A' ' 28' ' ' LEU . 1.1 tp -118.61 -41.19 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.958 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.431 ' N ' HG23 ' A' ' 102' ' ' ILE . 1.2 t80 -162.89 102.77 1.03 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.778 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.759 ' HG3' HD23 ' A' ' 101' ' ' LEU . 15.6 Cg_exo -68.16 -25.78 36.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.75 2.3 . . . . 0.0 112.556 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.64 48.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.524 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.749 ' HG ' HD13 ' A' ' 24' ' ' LEU . 8.6 tt -83.05 -42.17 17.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.615 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 tp -53.85 -48.73 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.192 0.52 . . . . 0.0 111.631 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.52 21.53 24.04 Favored Glycine 0 C--N 1.319 -0.396 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.764 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.32 173.52 14.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.955 0.407 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -78.33 151.54 32.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.868 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.822 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -136.67 109.72 7.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.3 mtt-85 -82.28 119.76 24.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.761 0.791 . . . . 0.0 111.08 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.2 t -110.07 127.46 66.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.513 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.6 m -116.41 137.23 52.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.248 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.664 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.5 m -140.97 172.91 12.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.379 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.532 ' CE1' ' HG ' ' A' ' 82' ' ' SER . 2.6 p80 -133.58 130.23 38.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.3 m -56.76 122.53 12.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.943 0.402 . . . . 0.0 111.841 -178.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.17 -9.72 42.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.615 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.72 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.81 -51.14 2.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.963 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.552 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -75.5 -21.8 57.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.836 0.351 . . . . 0.0 110.728 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.12 34.06 87.83 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.948 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -103.09 166.26 12.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.516 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -91.6 111.23 0.31 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.996 2.464 . . . . 0.0 111.196 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.796 HG12 ' HD2' ' A' ' 138' ' ' PRO . 22.0 m -107.7 146.42 13.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.485 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.722 ' C ' HD23 ' A' ' 126' ' ' LEU . 93.2 p -144.91 142.59 29.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.394 0.616 . . . . 0.0 110.216 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 125' ' ' SER . 0.1 OUTLIER -132.91 154.13 50.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.539 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.839 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 22.4 m -110.79 112.38 24.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.376 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.723 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 2.8 t -96.87 111.99 28.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.913 0.387 . . . . 0.0 111.423 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 m -108.31 160.73 25.96 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.167 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.23 -16.44 40.5 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.516 2.144 . . . . 0.0 112.968 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 78.1 p -114.35 -27.31 7.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 131' ' ' SER . 0.4 OUTLIER 178.95 -162.83 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.165 0.507 . . . . 0.0 110.061 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.632 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -94.8 166.24 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.657 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -155.17 19.39 0.43 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.839 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.14 85.79 0.07 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.973 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.56 HG13 ' SD ' ' A' ' 141' ' ' MET . 51.5 t -100.37 114.87 40.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.522 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -146.37 125.24 6.47 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.235 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.796 ' HD2' HG12 ' A' ' 124' ' ' VAL . 71.6 Cg_endo -76.99 155.68 97.46 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 123.515 -1.452 . . . . 0.0 111.847 -0.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.7 161.32 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 67.41 11.68 59.87 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.132 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.658 ' SD ' HD22 ' A' ' 126' ' ' LEU . 12.6 ptp -61.55 156.59 19.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.151 0.501 . . . . 0.0 111.844 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.03 152.38 49.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.183 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.685 HG13 ' CD1' ' A' ' 164' ' ' PHE . 11.4 t -113.25 151.64 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.688 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.477 ' C ' HD12 ' A' ' 145' ' ' LEU . 14.8 p -120.62 139.51 52.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.795 0.331 . . . . 0.0 110.769 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 144' ' ' SER . 5.3 mp -139.06 176.34 8.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.832 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.671 HG21 ' HB3' ' A' ' 158' ' ' PHE . 21.8 t -112.89 151.23 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.938 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 tp -56.98 109.01 1.42 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.013 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.4 135.84 29.9 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.526 2.151 . . . . 0.0 112.315 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -147.59 145.8 29.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -97.27 23.13 7.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.074 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -113.7 -19.72 11.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.373 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.26 -69.18 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.033 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -157.96 -176.54 5.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.93 31.05 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.3 mtp180 -119.03 -59.21 1.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.819 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -176.65 -52.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.9 m 61.83 116.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.053 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.671 ' HB3' HG21 ' A' ' 146' ' ' VAL . 75.6 m-85 61.99 35.27 16.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.007 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -33.52 33.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.774 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 45.4 t -84.43 -0.46 52.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.437 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.579 ' CE1' HD13 ' A' ' 181' ' ' LEU . 8.2 t-80 -94.93 26.87 3.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.687 0.28 . . . . 0.0 111.304 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 96' ' ' CYS . 15.1 t -105.08 113.96 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 110.801 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.415 ' CD2' ' OH ' ' A' ' 83' ' ' TYR . 24.7 m80 -128.34 169.39 14.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.676 0.75 . . . . 0.0 110.387 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.685 ' CD1' HG13 ' A' ' 143' ' ' VAL . 3.2 m-85 -110.48 151.54 27.42 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.678 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 118' ' ' ALA . 17.8 m-85 -129.15 137.36 51.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.559 0.695 . . . . 0.0 110.358 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.689 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -42.7 -28.26 0.22 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.125 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.738 ' HB3' ' HD2' ' A' ' 169' ' ' PRO . 1.0 OUTLIER -166.72 171.62 11.33 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.754 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.587 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 92.6 t -68.96 -36.44 7.65 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.341 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' ' 167' ' ' SER . 11.4 Cg_exo -71.37 -37.14 6.02 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.749 2.299 . . . . 0.0 110.063 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.15 -40.22 53.11 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.757 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.04 -45.96 91.27 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.544 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 1.4 mm-40 -78.99 -27.66 43.38 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.452 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 169' ' ' PRO . 13.5 t0 -70.43 -55.61 8.61 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.72 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 30.4 t-105 -65.28 -28.98 69.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.712 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.44 -39.97 94.85 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.394 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.41 -43.7 62.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.396 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -96.02 22.77 7.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.113 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.456 ' O ' HD22 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -132.82 29.16 4.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.928 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -90.66 145.63 24.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 121.36 -26.11 6.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.454 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.579 HD13 ' CE1' ' A' ' 161' ' ' HIS . 5.0 mt -69.21 68.51 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.937 0.399 . . . . 0.0 111.052 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' HG3' ' CE2' ' A' ' 158' ' ' PHE . 0.1 OUTLIER 56.99 30.78 18.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 106.32 -70.47 0.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.551 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.456 HD22 ' O ' ' A' ' 178' ' ' HIS . 7.9 tp 63.68 131.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.872 0.367 . . . . 0.0 110.917 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.43 149.91 41.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.118 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.616 HD11 ' HB2' ' A' ' 175' ' ' ALA . 15.4 mm -102.11 160.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.955 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.48 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.95 163.16 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.221 0.534 . . . . 0.0 111.89 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -86.31 127.97 34.86 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.774 178.463 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.478 HG12 ' CG2' ' A' ' 143' ' ' VAL . 0.9 OUTLIER -45.16 -22.27 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.685 179.344 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.408 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.8 t-160 -71.9 -43.3 65.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.185 0.517 . . . . 0.0 109.785 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.3 OUTLIER -82.15 -21.0 36.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.353 179.036 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.45 -25.31 64.04 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.776 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.574 ' CE2' HG23 ' A' ' 133' ' ' ILE . 2.4 m-85 -81.35 -24.89 36.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.111 0.481 . . . . 0.0 110.664 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.99 -31.01 29.98 Favored Glycine 0 CA--C 1.51 -0.273 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.314 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.9 tp -81.06 -29.66 34.96 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -81.23 -26.15 52.98 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -82.18 -21.76 36.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.963 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.99 -23.01 41.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.247 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -51.76 -37.46 51.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.063 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.98 -40.82 23.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -30.88 65.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.035 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.19 -36.67 84.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.923 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -49.32 78.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.83 -30.73 65.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.984 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -75.01 -31.55 61.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.2 m -94.67 121.26 36.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.972 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.34 116.32 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 12.2 p 59.27 108.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.9 p -97.06 77.9 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? 61.92 116.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.999 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.778 HG22 ' HD3' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -71.22 -34.39 3.32 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.744 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.778 ' HD3' HG22 ' A' ' 211' ' ' THR . 66.0 Cg_exo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 121.96 1.774 . . . . 0.0 112.475 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.891 0.376 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.679 ' C ' HD13 ' A' ' 23' ' ' LEU . 4.1 p30 -60.35 -179.72 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.982 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.754 HD23 HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -157.5 -179.93 8.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.957 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.754 HD13 HD23 ' A' ' 23' ' ' LEU . 5.4 mp 61.01 160.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.896 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 25' ' ' VAL . 5.3 m -130.41 90.58 40.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.02 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 29' ' ' ARG . 76.3 Cg_exo -50.55 -40.43 54.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.676 2.25 . . . . 0.0 112.422 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.731 HD11 HD21 ' A' ' 46' ' ' LEU . 6.0 mp -52.79 -57.18 11.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.308 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.485 ' O ' HD23 ' A' ' 28' ' ' LEU . 5.0 tt -79.3 -27.16 42.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.051 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.41 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 3.3 ttt180 -67.52 -53.36 29.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.08 -26.5 66.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 tp -71.8 -36.77 70.39 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.802 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.26 -29.33 32.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.229 0.538 . . . . 0.0 110.836 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -19.31 65.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.142 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.18 51.75 50.15 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.061 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.6 mtp85 -127.47 165.91 26.57 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.743 0.306 . . . . 0.0 110.741 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.19 111.55 2.05 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.399 2.066 . . . . 0.0 112.097 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.872 HG23 HG22 ' A' ' 41' ' ' THR . 8.1 p -125.85 109.76 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.272 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t -94.99 -170.06 2.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.965 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' ALA . 20.0 ptt-85 -72.55 -38.69 67.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.608 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -31.0 71.73 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.244 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.872 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -83.1 -41.91 18.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.389 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.426 HD22 HD12 ' A' ' 71' ' ' ILE . 9.3 tp -62.18 -36.69 82.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.41 -43.19 64.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.646 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.57 -31.68 76.96 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.587 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.617 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -78.95 -44.07 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.106 0.479 . . . . 0.0 110.423 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.731 HD21 HD11 ' A' ' 27' ' ' LEU . 6.9 mp -76.75 -9.38 58.63 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.518 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.2 t70 60.08 21.84 11.04 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.416 ' CG ' ' HD2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -100.27 155.86 35.92 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.223 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 48' ' ' TRP . 57.8 Cg_endo -71.58 139.96 35.18 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.551 2.167 . . . . 0.0 112.132 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.14 -19.2 1.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -77.84 -35.49 51.1 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 111.279 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.846 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.7 -40.34 88.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.56 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.39 -48.47 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.54 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.1 -53.93 43.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.259 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.67 75.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 52' ' ' ARG . 27.3 t -68.6 -31.01 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.711 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.412 HD23 HG12 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -66.35 -35.62 80.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.679 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.43 -44.95 85.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.701 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -76.75 -9.78 58.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.038 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.4 73.62 0.89 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.723 0.773 . . . . 0.0 110.397 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.5 p -96.99 -24.33 15.86 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.138 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -70.26 -25.46 63.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.216 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.48 141.16 31.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.242 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.602 ' O ' HG22 ' A' ' 72' ' ' ILE . 3.4 mt-10 -78.92 126.9 31.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.063 0.459 . . . . 0.0 111.376 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.421 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 64.1 m-85 -104.29 170.85 7.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.323 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -156.12 145.43 20.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.031 0.443 . . . . 0.0 111.344 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp 66.74 -103.78 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.8 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -92.3 -13.57 30.13 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 125.92 30.76 0.85 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.154 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -87.34 163.44 16.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.816 HG12 HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -79.79 118.28 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.187 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.796 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -93.72 -26.01 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.208 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.68 -170.79 13.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.5 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -162.9 171.17 17.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.919 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.3 -59.04 1.38 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.03 HD13 HD11 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -85.43 166.48 16.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.777 0.322 . . . . 0.0 110.736 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.75 HG21 ' HE1' ' A' ' 95' ' ' TRP . 18.0 p -126.43 159.61 32.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.2 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -48.18 -86.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.583 0.23 . . . . 0.0 110.804 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.458 ' HG3' ' CD1' ' A' ' 93' ' ' TYR . 4.6 mtp180 -173.71 98.96 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.78 23.54 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.614 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.7 p -120.08 -173.66 2.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.13 0.491 . . . . 0.0 111.648 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 p -101.07 -25.82 13.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.209 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 97' ' ' ALA . 30.0 m-85 -87.49 116.33 25.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 110.613 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.16 144.89 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.066 0.46 . . . . 0.0 111.439 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.834 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 67.9 t80 -131.66 105.85 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.516 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -97.25 129.89 44.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.655 0.264 . . . . 0.0 111.269 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -140.07 125.61 20.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.69 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 87' ' ' ILE . 17.0 t0 -154.35 37.46 0.43 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.664 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -141.48 145.85 35.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.297 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.04 86.59 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.904 0.383 . . . . 0.0 110.867 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.03 HD11 HD13 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -71.1 164.55 25.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CD1' ' HG3' ' A' ' 79' ' ' ARG . 2.1 m-85 -135.36 161.68 34.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.548 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.772 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -148.1 163.72 36.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.057 0.456 . . . . 0.0 111.592 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.75 ' HE1' HG21 ' A' ' 77' ' ' THR . 21.7 m0 -84.24 -20.25 32.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.509 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.441 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -158.59 -177.38 6.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.091 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.604 ' O ' HD21 ' A' ' 101' ' ' LEU . . . -61.38 -16.45 46.58 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.57 HD12 HG21 ' A' ' 162' ' ' VAL . 1.5 tt -86.62 -51.64 6.02 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.856 ' HA ' HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -57.08 -21.24 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -178.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -66.1 -39.58 90.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.592 0.234 . . . . 0.0 111.491 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.604 HD21 ' O ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -92.1 -83.92 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.856 HD11 ' HA ' ' A' ' 99' ' ' ASP . 25.5 mm 78.25 -59.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.654 0.264 . . . . 0.0 111.113 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -151.25 65.95 6.89 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 111.056 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.513 ' CB ' HG11 ' A' ' 128' ' ' VAL . 12.3 Cg_exo -71.3 -28.72 18.0 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.969 2.446 . . . . 0.0 112.551 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.6 -23.48 42.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.94 0.4 . . . . 0.0 111.584 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 106' ' ' LEU . 0.9 OUTLIER -81.93 -31.29 31.4 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.476 ' O ' HD12 ' A' ' 107' ' ' ILE . 1.0 OUTLIER -56.64 -46.36 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.998 0.428 . . . . 0.0 111.662 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.16 19.36 21.56 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.828 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 177.23 10.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 110.865 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -75.1 150.87 38.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.665 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.834 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.09 109.82 7.55 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -84.25 120.99 26.87 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.779 0.8 . . . . 0.0 110.915 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.789 HG22 ' CD1' ' A' ' 85' ' ' PHE . 46.8 t -112.51 130.94 65.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.005 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.7 m -122.22 137.61 54.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.133 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.522 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -141.21 172.86 12.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.031 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 121' ' ' GLY . 0.1 OUTLIER -132.1 131.37 42.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.626 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 34.0 m -58.15 125.85 24.98 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.03 0.443 . . . . 0.0 112.165 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -68.75 -8.03 39.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.049 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.622 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -119.0 -51.62 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 0.0 111.189 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.612 HG21 ' HB3' ' A' ' 166' ' ' ALA . 0.9 OUTLIER -82.66 -23.9 34.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.465 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 117' ' ' CYS . . . 69.82 6.81 57.31 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.923 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.8 160.08 71.08 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 120.609 0.243 . . . . 0.0 110.671 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -86.55 106.79 0.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.92 2.413 . . . . 0.0 111.033 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.527 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 26.9 m -103.78 146.59 11.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.822 ' C ' HD13 ' A' ' 126' ' ' LEU . 62.1 p -152.42 142.17 21.95 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.333 0.587 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.822 HD13 ' C ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -131.96 153.22 50.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.447 178.507 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.842 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 24.0 m -110.02 113.01 25.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.513 HG11 ' CB ' ' A' ' 104' ' ' PRO . 51.5 t -96.53 114.12 32.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.088 0.471 . . . . 0.0 111.955 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.41 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.8 OUTLIER -107.32 169.03 7.16 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.734 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 35.5 Cg_endo -65.86 -19.32 58.67 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.197 1.931 . . . . 0.0 112.885 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -110.68 -27.54 8.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.437 ' HA ' ' CE1' ' A' ' 193' ' ' PHE . 3.7 pt-20 178.85 -164.68 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.069 0.462 . . . . 0.0 110.007 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.742 HG23 ' CE2' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -94.73 152.12 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.708 178.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.31 21.89 2.77 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.308 0.575 . . . . 0.0 112.445 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.842 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.77 87.4 0.09 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.814 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.498 HG13 ' SD ' ' A' ' 141' ' ' MET . 60.9 t -103.72 115.05 44.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.347 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.405 ' O ' ' CE ' ' A' ' 141' ' ' MET . 19.3 tt0 -143.13 123.76 8.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.486 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.499 ' HD2' ' HE3' ' A' ' 141' ' ' MET . 57.8 Cg_endo -70.95 162.25 87.84 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 123.502 -1.457 . . . . 0.0 112.544 -0.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.19 79.91 1.79 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.16 18.5 0.2 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.268 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.733 ' CG ' HG11 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -63.57 164.22 9.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.06 0.457 . . . . 0.0 111.708 -179.436 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -129.13 152.09 49.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.69 HG13 ' CD1' ' A' ' 164' ' ' PHE . 3.3 t -115.8 152.05 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.701 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.2 m -120.84 143.1 49.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.958 0.408 . . . . 0.0 111.242 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.54 HD13 HG22 ' A' ' 162' ' ' VAL . 1.6 mm? -123.39 159.53 28.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.604 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 161' ' ' HIS . 41.3 t -125.45 131.52 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.103 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.465 HD22 ' HG3' ' A' ' 149' ' ' GLN . 1.3 tt 57.68 87.57 0.14 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.016 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.58 75.02 1.6 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.539 2.16 . . . . 0.0 112.318 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.465 ' HG3' HD22 ' A' ' 147' ' ' LEU . 4.6 mm-40 -104.21 167.09 9.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -109.0 -21.67 12.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.74 -82.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.58 -169.27 0.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.115 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 61.28 31.6 19.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.976 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.2 m -84.75 -32.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.18 -41.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.09 67.9 0.49 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -175.43 1.04 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.408 ' CD2' HD12 ' A' ' 147' ' ' LEU . 43.1 m-85 -113.45 29.8 7.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.006 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.88 -15.97 60.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 97.4 m -92.4 0.63 57.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.302 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.428 ' O ' HG23 ' A' ' 146' ' ' VAL . 10.0 m-70 -102.22 48.18 0.88 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 110.818 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.57 HG21 HD12 ' A' ' 98' ' ' LEU . 22.0 t -101.14 113.6 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.265 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -116.69 169.15 9.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.692 . . . . 0.0 110.336 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.69 ' CD1' HG13 ' A' ' 143' ' ' VAL . 4.7 m-85 -118.64 153.52 34.17 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.076 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.612 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 59.2 m-85 -132.59 136.14 46.35 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.038 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.612 ' HB3' HG21 ' A' ' 120' ' ' THR . . . -41.87 -27.68 0.13 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.091 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.564 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 74.0 m -165.5 173.67 10.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.194 0.521 . . . . 0.0 111.936 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.8 t -70.0 -33.75 3.75 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.346 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.19 -37.32 3.47 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.688 2.259 . . . . 0.0 110.289 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.602 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.91 -40.27 47.91 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.483 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.726 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.2 -44.88 96.57 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.0 mt-10 -78.97 -27.22 43.46 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.232 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.69 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.2 t70 -71.04 -55.94 7.2 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.429 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.622 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.3 t-105 -64.59 -28.0 69.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.726 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -65.01 -40.37 94.8 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.359 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.25 -43.26 61.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.382 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -95.77 21.86 7.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.374 0.607 . . . . 0.0 111.194 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.461 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -127.71 27.42 5.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.78 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -98.91 178.06 5.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.77 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.93 -27.35 18.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.448 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.573 HD12 ' CD1' ' A' ' 184' ' ' LEU . 8.2 mt -64.84 -176.79 0.29 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.804 0.335 . . . . 0.0 110.948 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.72 58.32 4.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 100.57 143.44 14.18 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.517 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.573 ' CD1' HD12 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -179.05 125.27 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.871 0.367 . . . . 0.0 110.764 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.89 150.09 41.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.077 0.465 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.645 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.9 mm -100.91 160.41 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.832 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.463 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -160.54 159.16 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.809 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.5 OUTLIER -86.03 124.96 33.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.908 178.571 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.733 HG11 ' CG ' ' A' ' 141' ' ' MET . 0.7 OUTLIER -47.83 -20.59 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.608 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -69.35 -41.41 76.63 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.6 mt-10 -82.6 -26.46 32.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.058 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -68.75 -25.02 64.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.742 ' CE2' HG23 ' A' ' 133' ' ' ILE . 7.9 t80 -81.61 -26.17 35.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.689 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.93 -30.06 32.84 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.1 mt -82.11 -27.35 32.88 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.11 -26.75 35.88 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.444 ' CG ' ' CE1' ' A' ' 193' ' ' PHE . 46.6 mm-40 -81.91 -24.86 35.4 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.041 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 -22.96 61.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -51.97 -42.4 62.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.272 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -81.18 -29.57 34.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.005 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.66 -27.71 29.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.233 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -57.98 -29.73 65.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.958 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.5 tp -81.95 -30.01 31.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.653 HD13 ' O ' ' A' ' 204' ' ' LEU . 0.3 OUTLIER -60.28 -37.45 80.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 61.22 170.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.6 t -157.43 173.82 16.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.912 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 17.9 mtt 60.24 80.71 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 74.5 p -115.12 147.76 39.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.3 t -98.66 33.72 2.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 31.54 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.436 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -67.74 -62.8 3.05 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.983 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.2 Cg_endo . . . . . 0 C--O 1.25 1.107 0 C-N-CA 122.418 2.079 . . . . 0.0 112.367 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.509 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.825 0.345 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 65.34 -77.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tp -143.92 -47.64 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.868 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tp -115.62 157.34 24.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.574 ' O ' HG23 ' A' ' 25' ' ' VAL . 19.1 m -133.19 81.54 56.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.71 -46.19 35.22 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.589 2.193 . . . . 0.0 112.355 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -51.95 -57.24 10.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 27' ' ' LEU . 2.1 mt -72.7 -27.11 61.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.814 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.52 -53.22 55.29 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.598 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -69.91 -26.51 64.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.163 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.58 HD11 ' CA ' ' A' ' 73' ' ' GLY . 6.0 tp -70.68 -44.2 67.49 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.686 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.22 -28.54 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.138 0.494 . . . . 0.0 110.89 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -64.77 -20.44 66.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.181 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.37 54.05 25.57 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.296 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -133.04 165.36 37.33 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.298 . . . . 0.0 110.719 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.38 113.5 3.33 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.464 2.109 . . . . 0.0 112.088 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.717 HG13 HG22 ' A' ' 41' ' ' THR . 31.7 t -117.98 109.88 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.458 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.2 p -87.97 179.63 6.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.836 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -70.13 -37.46 75.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.306 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -30.11 70.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 110.074 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.717 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -82.92 -41.96 18.25 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.319 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.738 ' CD1' HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -62.49 -37.02 84.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.643 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.63 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -71.64 -43.29 66.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.626 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.68 -31.03 72.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.807 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.585 HD12 HG23 ' A' ' 41' ' ' THR . 6.8 mt -78.59 -43.98 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-O 120.997 0.427 . . . . 0.0 110.519 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.539 HD12 HG22 ' A' ' 45' ' ' ILE . 7.2 mp -76.06 -10.18 59.21 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.387 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 61.0 21.41 11.75 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.412 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 29.6 m95 -107.26 138.78 19.98 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.018 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.34 140.54 34.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.74 2.294 . . . . 0.0 112.053 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.33 -16.88 0.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -78.86 -31.86 45.78 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.292 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.76 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -68.61 -40.86 80.21 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.63 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.64 -47.62 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.635 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.83 -52.35 57.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.352 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.22 -43.09 67.0 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.786 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 52' ' ' ARG . 21.8 t -69.7 -33.58 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.756 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.2 mt -61.75 -35.88 79.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.657 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.685 ' O ' HG23 ' A' ' 61' ' ' THR . 5.6 tt0 -57.55 -26.33 61.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.717 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -90.49 -16.46 28.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.028 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' A' ' 63' ' ' THR . . . -98.61 33.58 2.24 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.398 0.618 . . . . 0.0 111.006 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 58' ' ' GLU . 65.6 p -58.93 -20.88 56.02 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.009 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 p -88.76 -22.94 23.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.352 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.404 ' HB ' ' HB1' ' A' ' 60' ' ' ALA . 0.8 OUTLIER -59.41 141.21 55.15 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.327 179.52 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.842 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -85.37 132.16 34.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 111.685 -179.276 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.43 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 76.9 m-85 -105.73 173.23 6.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -150.37 146.8 26.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.047 0.451 . . . . 0.0 111.535 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 tptt 66.28 -102.64 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.853 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -90.36 -10.46 43.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 119.94 29.56 1.65 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.951 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -86.01 171.31 11.51 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.738 HD13 ' CD1' ' A' ' 42' ' ' LEU . 4.1 mp -79.76 116.8 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.316 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.7 tt -86.49 -25.54 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.252 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.58 ' CA ' HD11 ' A' ' 31' ' ' LEU . . . 98.64 152.22 27.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.441 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -108.65 159.39 16.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.85 -50.56 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.774 HD22 ' CD1' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -93.56 156.1 16.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.836 0.35 . . . . 0.0 110.926 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 79' ' ' ARG . 4.8 t -111.01 159.0 18.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.27 -25.82 64.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.745 ' O ' HG23 ' A' ' 77' ' ' THR . 1.0 OUTLIER -102.86 146.99 27.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.005 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -63.56 129.63 40.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.533 HG23 HG21 ' A' ' 77' ' ' THR . 27.9 p -106.36 -176.47 3.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.011 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.1 m -89.57 -31.83 17.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.439 ' CE2' ' N ' ' A' ' 97' ' ' ALA . 5.3 m-85 -89.53 117.67 28.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.446 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.8 t -108.75 139.12 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.078 0.466 . . . . 0.0 111.114 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.876 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 30.3 t80 -123.1 106.92 11.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.887 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.2 124.08 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.741 0.305 . . . . 0.0 111.144 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.623 HG21 ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.15 126.29 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.62 -77.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.317 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.0 t70 -156.11 37.0 0.34 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.633 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -141.45 147.44 37.91 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.578 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.2 86.41 2.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 0.0 110.752 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.774 ' CD1' HD22 ' A' ' 76' ' ' LEU . 3.9 mm? -71.46 164.49 25.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.628 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -131.88 158.9 40.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.749 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.509 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -143.52 163.03 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.281 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -88.33 -5.64 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.137 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.43 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.0 OUTLIER 176.06 -175.2 0.11 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.006 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.453 ' CB ' ' CD1' ' A' ' 164' ' ' PHE . . . -61.3 149.42 38.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.76 0.315 . . . . 0.0 110.761 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 97' ' ' ALA . 20.0 mt 82.62 -52.32 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.509 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -48.05 -25.09 1.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.937 0.399 . . . . 0.0 111.166 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.493 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 3.1 p -60.15 -39.32 85.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.759 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.876 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 22.9 tp -131.4 165.17 24.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.228 0.537 . . . . 0.0 111.842 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.753 HD12 ' CE2' ' A' ' 103' ' ' PHE . 3.3 pt -121.92 -37.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.885 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.753 ' CE2' HD12 ' A' ' 102' ' ' ILE . 2.4 p90 -165.61 103.29 0.74 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.631 ' HB3' HG12 ' A' ' 128' ' ' VAL . 74.0 Cg_endo -75.15 -27.58 9.65 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.745 2.297 . . . . 0.0 112.897 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.17 -23.65 54.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.703 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.71 -40.99 16.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.58 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 tp -56.0 -49.22 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.183 0.516 . . . . 0.0 111.531 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.04 24.02 18.34 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.768 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -152.41 173.24 15.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 111.037 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.411 HG23 ' OG ' ' A' ' 129' ' ' SER . 0.9 OUTLIER -80.79 151.8 28.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.862 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.832 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.4 110.16 7.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -81.44 120.23 24.73 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.719 0.771 . . . . 0.0 111.448 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.745 HG22 ' HD1' ' A' ' 85' ' ' PHE . 58.6 t -112.55 129.63 67.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.79 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 m -122.49 137.15 54.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.393 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.554 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -141.76 173.1 11.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.179 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -134.85 135.44 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 36.2 t -64.35 133.83 53.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.532 . . . . 0.0 112.132 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -71.43 -4.05 24.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.214 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.897 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -123.37 -51.04 1.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 111.673 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.732 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -87.38 -25.1 24.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.016 -179.599 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.21 5.58 72.01 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.094 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.732 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.7 147.19 72.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.618 0.247 . . . . 0.0 110.513 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.35 104.7 1.66 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.56 2.174 . . . . 0.0 110.422 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.554 HG22 ' C ' ' A' ' 115' ' ' SER . 35.3 m -101.4 145.65 11.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.397 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.89 ' O ' HD13 ' A' ' 126' ' ' LEU . 71.1 p -152.53 142.07 21.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.484 0.659 . . . . 0.0 110.929 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.986 HD11 ' CE ' ' A' ' 141' ' ' MET . 0.1 OUTLIER -134.88 153.12 52.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.464 178.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.873 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.2 m -109.36 113.09 25.61 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' A' ' 104' ' ' PRO . 29.2 t -96.1 111.86 27.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.118 0.485 . . . . 0.0 111.819 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.411 ' OG ' HG23 ' A' ' 110' ' ' THR . 0.4 OUTLIER -106.59 175.51 2.03 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.975 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.43 -6.25 18.76 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.548 2.166 . . . . 0.0 113.286 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m -122.77 -31.31 3.71 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 193' ' ' PHE . 14.5 pt-20 -179.7 -162.3 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 110.005 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -91.78 144.3 9.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.563 178.234 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -133.6 18.2 3.93 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.392 0.615 . . . . 0.0 112.412 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.873 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.03 86.34 0.08 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.523 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.668 HG13 HD12 ' A' ' 126' ' ' LEU . 37.2 t -105.65 120.62 56.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.898 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -146.21 122.14 5.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.08 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.458 ' HD2' HG12 ' A' ' 124' ' ' VAL . 53.2 Cg_endo -68.23 167.73 63.35 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.626 -1.406 . . . . 0.0 112.951 -0.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.7 83.7 7.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.97 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 140.87 21.08 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.046 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.986 ' CE ' HD11 ' A' ' 126' ' ' LEU . 9.1 mtp -60.98 164.72 4.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.144 0.497 . . . . 0.0 111.968 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -131.92 151.87 51.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.82 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.702 HG13 ' CD1' ' A' ' 164' ' ' PHE . 7.6 t -112.77 148.98 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.417 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 162' ' ' VAL . 64.4 m -118.29 143.53 46.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.77 0.319 . . . . 0.0 110.854 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 162' ' ' VAL . 0.6 OUTLIER -99.9 147.23 25.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.954 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 146' ' ' VAL . 9.0 p -125.12 107.92 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.971 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.607 HD11 ' CB ' ' A' ' 182' ' ' GLU . 1.4 mm? 62.49 84.96 0.18 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.31 158.38 57.75 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.57 2.18 . . . . 0.0 112.246 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -146.28 138.74 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -100.68 -21.08 15.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -156.61 77.66 0.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.102 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -171.89 146.27 2.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.058 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -176.11 37.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.2 p -109.17 -36.27 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -169.16 -42.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.954 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -59.27 -31.81 69.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.978 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.0 t -68.02 118.78 11.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.007 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -123.89 28.9 6.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.976 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 29.7 p -81.01 -23.85 38.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.075 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 37.3 t -65.44 -22.48 66.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.251 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -112.78 54.54 0.72 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.813 0.34 . . . . 0.0 111.037 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 144' ' ' SER . 0.7 OUTLIER -83.01 174.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.38 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -113.68 159.45 19.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.679 0.752 . . . . 0.0 110.177 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.702 ' CD1' HG13 ' A' ' 143' ' ' VAL . 2.3 m-85 -116.9 129.74 56.26 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.837 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 29.8 m-85 -108.53 142.39 39.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.449 0.642 . . . . 0.0 110.796 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.19 -26.15 2.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.888 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.608 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 50.7 m -163.3 167.68 21.54 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.862 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 75.1 t -67.92 -33.64 5.35 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.07 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.704 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.4 Cg_exo -73.01 -37.49 3.49 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.667 2.244 . . . . 0.0 110.336 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.586 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.16 -40.59 52.19 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.006 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.716 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.8 -45.94 91.67 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.9 mt-10 -78.81 -27.39 44.4 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.313 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 169' ' ' PRO . 9.5 t70 -70.65 -55.86 7.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.383 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.897 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.9 t-105 -64.91 -28.62 69.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.765 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.9 -40.72 95.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.317 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 40.7 t -50.85 -42.55 58.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.369 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.1 20.87 8.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.308 0.575 . . . . 0.0 111.271 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.5 25.01 7.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.788 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -95.12 -176.04 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.83 -29.85 9.29 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.424 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.535 HD13 ' CD1' ' A' ' 184' ' ' LEU . 1.2 mt -64.5 -175.14 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.86 0.362 . . . . 0.0 110.852 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.607 ' CB ' HD11 ' A' ' 147' ' ' LEU . 1.7 mt-10 -60.02 -20.51 58.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.259 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 147.92 135.0 2.55 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.585 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.535 ' CD1' HD13 ' A' ' 181' ' ' LEU . 1.3 mp -147.59 146.8 29.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.17 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.684 HD11 ' HB2' ' A' ' 175' ' ' ALA . 14.5 mm -102.32 162.01 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.937 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.487 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.69 166.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.265 0.555 . . . . 0.0 111.794 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -89.59 128.13 35.99 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.014 178.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.445 HG12 ' CG2' ' A' ' 143' ' ' VAL . 1.4 m -45.88 -21.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.621 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.402 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.8 t60 -71.47 -42.72 67.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.215 0.531 . . . . 0.0 109.98 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -82.28 -21.58 36.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -73.86 -25.23 59.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.092 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 132' ' ' GLU . 72.7 t80 -81.6 -24.77 36.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.585 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.84 -29.11 35.86 Favored Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.3 mp -82.06 -28.4 32.44 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.32 -28.84 29.26 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.543 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 1.3 tm0? -82.24 -25.26 34.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.575 -0.312 . . . . 0.0 111.28 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -76.86 -22.79 52.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.124 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -51.82 -33.63 36.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.963 0.411 . . . . 0.0 111.082 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -81.06 -53.78 6.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -55.03 -29.39 57.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -59.05 -30.57 68.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.911 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 206' ' ' THR . 8.4 mp -66.55 -40.93 89.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.02 -35.86 75.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.836 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -98.27 36.53 1.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 203' ' ' LEU . 1.1 p -61.4 150.35 35.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.913 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 6.6 ptp -141.28 120.69 13.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.31 135.82 40.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.6 m -137.72 -70.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.91 34.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 212' ' ' PRO . 1.1 m -176.43 -63.02 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.031 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.429 ' N ' HG22 ' A' ' 211' ' ' THR . 19.6 Cg_endo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.397 2.065 . . . . 0.0 112.37 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.783 0.325 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -109.4 -61.91 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 mt -103.36 113.78 27.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.36 -41.33 85.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.4 m 41.17 83.37 0.21 Allowed Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.717 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.759 ' CG ' HD11 ' A' ' 46' ' ' LEU . 43.9 Cg_endo -67.91 -17.02 46.57 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.583 2.189 . . . . 0.0 112.552 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 71' ' ' ILE . 6.0 tp -52.76 -57.41 10.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.368 . . . . 0.0 111.01 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 31' ' ' LEU . 4.4 mm? -70.09 -27.05 64.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.76 -53.22 60.53 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.611 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.34 -23.7 61.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.272 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 28' ' ' LEU . 9.0 tt -63.13 -49.03 75.99 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.479 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.0 18.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.34 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -24.33 61.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.126 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.64 39.58 96.76 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.34 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -133.32 150.06 74.2 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.696 0.284 . . . . 0.0 110.755 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.67 107.07 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.559 2.172 . . . . 0.0 111.978 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.726 HG23 HG22 ' A' ' 41' ' ' THR . 14.0 p -99.23 112.1 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.519 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 p -93.32 175.62 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.422 ' O ' ' N ' ' A' ' 43' ' ' ALA . 2.1 mpp_? -65.26 -40.33 93.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.302 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -25.09 67.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.869 0.366 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.726 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.11 -43.3 13.17 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.352 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -62.79 -36.28 82.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.629 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.691 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.2 -43.0 62.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.595 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.79 -30.7 72.58 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.697 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.588 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -78.42 -44.75 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 120.999 0.428 . . . . 0.0 110.563 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.759 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.2 mp -75.65 -9.85 58.93 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.491 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t70 59.72 21.92 10.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.446 ' CZ2' ' NH1' ' A' ' 52' ' ' ARG . 1.8 m0 -109.27 146.02 33.03 Favored Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.217 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.13 143.18 52.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.557 2.171 . . . . 0.0 112.063 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.19 -16.9 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.65 -33.61 47.04 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.236 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.632 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.95 -41.2 82.83 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.851 HG13 HD23 ' A' ' 42' ' ' LEU . 2.1 t -63.29 -47.65 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.544 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.579 ' HA ' HD13 ' A' ' 57' ' ' LEU . . . -53.49 -52.32 59.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.269 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.67 -36.65 25.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.019 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 52' ' ' ARG . 28.9 t -59.4 -35.81 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.035 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.579 HD13 ' HA ' ' A' ' 54' ' ' ALA . 3.7 mp -60.93 -32.43 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.873 0.368 . . . . 0.0 110.723 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.423 ' O ' HG23 ' A' ' 61' ' ' THR . 1.9 tp10 -58.65 -34.8 71.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.467 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -100.19 -20.42 15.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.87 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.494 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -102.59 33.44 3.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.476 0.655 . . . . 0.0 110.742 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 58' ' ' GLU . 32.1 p -66.99 -13.87 62.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.343 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 p -88.02 -23.57 23.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.325 . . . . 0.0 111.359 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.494 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -58.22 141.47 50.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.016 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.68 126.99 31.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 111.326 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -102.1 173.13 6.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.465 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.409 ' HB2' ' ND2' ' A' ' 70' ' ' ASN . 6.6 t0 -97.18 -172.88 2.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -34.5 76.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.955 0.407 . . . . 0.0 111.128 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.28 1.7 55.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.343 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.05 14.45 60.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.267 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 66' ' ' ASP . 1.1 p-10 -86.79 146.82 26.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.491 0.645 . . . . 0.0 109.881 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.579 ' O ' HG22 ' A' ' 72' ' ' ILE . 1.7 mp -79.76 143.28 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.905 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 71' ' ' ILE . 0.4 OUTLIER 90.5 -23.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.692 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.91 -91.73 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.613 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -131.9 -45.78 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.63 -160.49 9.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 mt -110.68 -33.37 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.983 0.42 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.615 HG22 ' CD1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -111.01 159.53 17.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.72 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.72 24.96 1.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.619 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 51.56 96.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.808 0.337 . . . . 0.0 111.505 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -156.21 -84.76 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.483 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.37 163.7 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.844 0.354 . . . . 0.0 111.592 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 84' ' ' VAL . 65.3 m -82.18 -5.88 58.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.97 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -66.21 96.77 0.35 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 110.293 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 82' ' ' SER . 17.8 t -109.69 144.71 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.369 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.966 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 33.5 t80 -131.16 107.57 9.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.086 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -102.72 132.46 48.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.517 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' ASP . 2.3 pt -138.74 123.0 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.396 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.12 -67.5 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.134 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.6 m-20 -168.54 34.82 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.304 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -135.57 112.49 10.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.968 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.628 ' C ' HD22 ' A' ' 92' ' ' LEU . 9.3 mpt_? -82.11 124.63 30.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.971 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.628 HD22 ' C ' ' A' ' 91' ' ' ARG . 2.8 mm? -115.57 165.1 13.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -129.75 165.21 22.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.994 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.787 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -153.48 170.97 19.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.939 0.4 . . . . 0.0 111.705 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.615 ' CD1' HG22 ' A' ' 77' ' ' THR . 49.6 m0 -95.25 -17.95 21.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.679 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 160' ' ' CYS . 98.9 m -152.54 166.48 31.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.255 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.548 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -54.21 -21.08 8.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.515 HD22 ' SG ' ' A' ' 160' ' ' CYS . 8.4 tt -86.93 -51.73 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.787 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 41.4 t0 -50.1 -23.23 2.0 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -60.11 -32.67 71.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.676 0.274 . . . . 0.0 110.688 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.966 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 50.9 tp -140.84 162.22 35.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 111.296 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.795 HD12 ' HB2' ' A' ' 103' ' ' PHE . 2.7 pp -125.24 -39.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.28 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.795 ' HB2' HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -163.19 103.22 1.0 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.099 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.563 ' CB ' HG12 ' A' ' 128' ' ' VAL . 74.4 Cg_endo -74.91 -31.76 6.1 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.575 2.184 . . . . 0.0 112.609 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.08 -23.83 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.456 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -82.43 -40.89 20.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.36 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 tp -56.1 -47.15 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.154 0.502 . . . . 0.0 111.556 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.04 21.41 20.72 Favored Glycine 0 C--N 1.32 -0.338 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.836 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 174.68 13.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.01 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -79.46 151.77 30.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.671 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.824 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -137.02 109.95 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 65.0 mtm-85 -82.22 121.63 26.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.745 0.783 . . . . 0.0 110.975 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.4 t -113.6 130.76 67.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.961 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.8 m -121.18 137.48 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.735 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.58 ' HB3' HG23 ' A' ' 124' ' ' VAL . 3.1 t -141.06 173.01 11.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.347 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -131.14 130.74 43.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 23.3 m -56.68 123.97 16.75 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.95 0.405 . . . . 0.0 111.811 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.855 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . . . -67.8 -9.44 44.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.617 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.736 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.14 -50.64 2.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.559 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -77.12 -21.05 54.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.815 0.34 . . . . 0.0 110.895 -178.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.87 33.58 85.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.157 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.559 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -102.0 169.12 8.02 Favored Pre-proline 0 N--CA 1.453 -0.324 0 CA-C-N 115.459 -0.37 . . . . 0.0 110.372 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.426 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 51.1 Cg_endo -92.98 108.23 0.19 Allowed 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.92 2.413 . . . . 0.0 111.454 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.58 HG23 ' HB3' ' A' ' 115' ' ' SER . 35.7 m -105.43 146.26 12.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.45 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.8 p -148.99 142.49 25.32 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.397 0.618 . . . . 0.0 110.695 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -139.08 151.85 47.06 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.852 178.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.795 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 40.3 m -107.64 114.09 27.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.053 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.563 HG12 ' CB ' ' A' ' 104' ' ' PRO . 10.7 t -96.56 111.83 27.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.853 0.358 . . . . 0.0 111.412 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -106.69 172.18 4.09 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.009 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -68.83 -14.64 39.34 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.42 2.08 . . . . 0.0 112.995 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 1.1 t -117.86 -26.46 6.48 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 131' ' ' SER . 21.1 pt-20 178.65 -162.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.124 0.488 . . . . 0.0 110.01 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.69 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.88 159.2 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.849 178.562 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -145.67 19.34 1.49 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.402 0.62 . . . . 0.0 112.274 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.795 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.91 86.45 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.493 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.569 HG13 ' SD ' ' A' ' 141' ' ' MET . 45.2 t -102.42 116.06 45.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -146.36 121.49 5.47 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.721 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.5 155.35 98.95 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.542 -1.441 . . . . 0.0 112.243 -0.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.29 78.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 147.76 15.84 0.13 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.503 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.885 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -60.69 157.88 13.79 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.187 0.494 . . . . 0.0 111.227 -179.508 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -128.63 151.98 48.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.917 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.7 HG13 ' CD1' ' A' ' 164' ' ' PHE . 4.6 t -113.83 150.41 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.307 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.783 ' O ' HG13 ' A' ' 162' ' ' VAL . 0.1 OUTLIER -120.04 146.29 46.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.906 0.384 . . . . 0.0 111.078 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.687 HD22 ' C ' ' A' ' 144' ' ' SER . 3.8 mm? -122.08 158.12 29.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.651 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.741 ' HA ' HD22 ' A' ' 184' ' ' LEU . 34.6 m -125.24 143.71 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.269 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.571 HD23 ' HG2' ' A' ' 182' ' ' GLU . 2.7 tp -91.64 -52.59 0.28 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.89 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.442 ' HD3' ' CB ' ' A' ' 147' ' ' LEU . 17.2 Cg_exo -66.73 -158.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.601 2.201 . . . . 0.0 112.127 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -118.3 -179.39 3.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.749 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -171.18 110.93 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 58.01 83.76 0.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.405 ' CB ' ' CB ' ' A' ' 157' ' ' SER . . . -159.63 176.16 12.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.199 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -113.15 -34.7 5.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.486 HG22 ' N ' ' A' ' 155' ' ' ARG . 12.0 p -67.06 159.05 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.038 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.486 ' N ' HG22 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -60.18 -50.79 72.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.232 -179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -121.95 69.0 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.05 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.469 ' N ' HG13 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -69.04 151.54 46.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -177.28 53.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.2 m -61.3 -46.27 91.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.658 ' O ' HG23 ' A' ' 162' ' ' VAL . 75.8 m -152.42 -75.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.775 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.523 ' HB3' HG21 ' A' ' 146' ' ' VAL . 50.1 m80 48.86 38.05 11.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.783 HG13 ' O ' ' A' ' 144' ' ' SER . 24.2 t -115.88 127.61 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.595 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -115.37 169.14 9.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.611 0.719 . . . . 0.0 109.677 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.7 ' CD1' HG13 ' A' ' 143' ' ' VAL . 3.2 m-85 -117.23 153.51 32.75 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.293 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.855 ' CE1' ' HB3' ' A' ' 118' ' ' ALA . 42.3 m-85 -133.16 137.32 46.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.166 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.635 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -38.9 -29.05 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.869 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.492 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 5.0 p -172.02 178.55 2.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.04 0.448 . . . . 0.0 111.54 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.606 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 77.8 t -69.13 -33.14 3.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.583 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.669 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.3 Cg_exo -72.98 -39.31 2.34 Favored 'Trans proline' 0 CA--C 1.505 -0.936 0 C-N-CA 122.731 2.288 . . . . 0.0 110.586 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.569 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.34 -39.44 53.92 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.728 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.86 -46.04 91.16 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.466 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.3 mt-10 -78.81 -27.66 44.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.225 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 169' ' ' PRO . 22.7 t0 -71.04 -55.74 7.63 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.43 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.736 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 8.1 t-105 -64.79 -28.49 69.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.702 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.96 -40.33 94.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.249 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.55 -42.79 55.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.402 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.407 ' O ' ' CD2' ' A' ' 178' ' ' HIS . 0.2 OUTLIER -97.1 23.7 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.338 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.46 ' O ' HD12 ' A' ' 184' ' ' LEU . 11.1 m170 -152.87 45.12 0.68 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.926 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -112.04 -12.57 13.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.68 -23.65 22.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.441 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.465 HD12 HD11 ' A' ' 184' ' ' LEU . 7.9 mt -71.51 65.82 0.47 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.571 ' HG2' HD23 ' A' ' 147' ' ' LEU . 5.9 tt0 58.71 26.45 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.972 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.16 81.5 0.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.588 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 146' ' ' VAL . 29.6 mt -66.87 173.38 3.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.734 0.302 . . . . 0.0 110.698 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.14 142.64 46.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.141 0.496 . . . . 0.0 111.3 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.685 HD11 ' HB2' ' A' ' 175' ' ' ALA . 16.0 mm -101.69 160.85 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.758 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.461 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -158.71 157.47 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.233 0.54 . . . . 0.0 112.013 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.5 OUTLIER -86.02 127.98 34.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.767 178.461 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.885 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.1 m -46.43 -20.93 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.874 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.4 ' N ' ' C ' ' A' ' 188' ' ' SER . 1.8 t-80 -73.67 -43.3 59.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.208 0.527 . . . . 0.0 109.761 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.38 -20.86 36.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.378 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.2 -25.36 61.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.972 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.45 ' CZ ' HG22 ' A' ' 128' ' ' VAL . 3.5 m-85 -81.81 -30.96 31.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.252 0.548 . . . . 0.0 110.37 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.07 -33.48 23.52 Favored Glycine 0 CA--C 1.509 -0.31 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.336 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.413 ' O ' HD23 ' A' ' 195' ' ' LEU . 4.2 tt -76.65 -29.65 56.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.58 -26.88 37.26 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -82.71 -22.69 34.4 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.445 -0.377 . . . . 0.0 110.87 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.38 -22.95 43.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.424 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.7 ' O ' HD23 ' A' ' 203' ' ' LEU . 2.2 m-85 -51.95 -26.87 11.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 111.168 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -81.18 -54.31 5.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -66.09 -44.91 83.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.155 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -54.14 -30.1 47.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 199' ' ' PHE . 0.6 OUTLIER -59.99 -29.49 68.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.952 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.6 tp -69.62 -32.01 70.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.986 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 61.71 165.91 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.88 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.1 p -141.43 -177.96 5.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -169.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 6.3 t -123.7 -43.49 2.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.868 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 62.1 p -59.62 -175.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.994 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 60.88 87.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.779 HG22 ' HD3' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -78.58 -34.47 1.02 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.76 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.779 ' HD3' HG22 ' A' ' 211' ' ' THR . 65.2 Cg_exo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.015 1.81 . . . . 0.0 112.421 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -146.05 -178.84 6.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.72 -169.0 2.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -156.13 150.28 25.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 28' ' ' LEU . 19.0 m -63.13 143.09 97.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.022 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.544 ' CG ' HD11 ' A' ' 46' ' ' LEU . 66.2 Cg_endo -74.04 -35.68 4.0 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.452 2.101 . . . . 0.0 112.384 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 mt -53.9 -57.47 10.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.194 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.463 HD23 ' HB2' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -55.44 -26.87 44.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.259 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -63.72 -53.21 54.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.152 0.501 . . . . 0.0 109.982 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -78.88 -27.47 44.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.627 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.553 HD11 ' H ' ' A' ' 74' ' ' TYR . 3.4 tt -69.78 -52.42 25.37 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.794 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HB2' HD23 ' A' ' 28' ' ' LEU . . . -58.63 -25.93 63.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 110.822 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -70.0 -23.3 63.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.047 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.63 48.8 82.3 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.147 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -133.09 150.17 74.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.715 0.293 . . . . 0.0 110.855 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.64 106.36 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.536 2.157 . . . . 0.0 112.397 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.647 HG23 ' CG2' ' A' ' 41' ' ' THR . 11.2 p -112.32 109.9 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.221 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 p -84.15 -175.01 5.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.962 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 43' ' ' ALA . 9.3 mtp180 -76.93 -35.97 56.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.471 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -25.83 67.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.894 0.378 . . . . 0.0 110.348 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.647 ' CG2' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.05 -42.74 13.69 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.402 ' O ' HD13 ' A' ' 46' ' ' LEU . 5.2 tp -63.43 -35.92 82.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.559 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -74.06 -42.57 60.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.425 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.95 -30.98 74.54 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.567 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.59 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.09 -43.0 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.04 0.448 . . . . 0.0 110.432 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.544 HD11 ' CG ' ' A' ' 26' ' ' PRO . 6.9 mp -78.16 -7.75 57.45 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.509 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.66 23.41 6.15 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.63 145.4 31.22 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.264 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.07 139.61 70.95 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.415 2.077 . . . . 0.0 111.961 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.79 -17.46 0.94 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -78.56 -32.49 47.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.285 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.603 ' O ' HG23 ' A' ' 56' ' ' VAL . 4.1 mmt85 -67.66 -41.27 84.02 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.559 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.0 t -63.0 -48.07 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.516 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.01 -51.79 62.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.469 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.64 -37.47 18.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 52' ' ' ARG . 41.6 t -60.21 -33.06 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.754 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.6 mm? -81.06 -26.51 36.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.057 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -56.63 -22.7 36.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.197 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -1.67 11.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.231 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.77 72.19 0.78 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.819 0.819 . . . . 0.0 110.618 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.3 p -77.79 -3.96 44.02 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.376 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.2 m -113.14 39.92 2.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.061 0.458 . . . . 0.0 110.706 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.44 141.43 29.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.081 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.79 126.58 30.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.067 0.46 . . . . 0.0 111.237 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.413 ' OH ' HD12 ' A' ' 57' ' ' LEU . 31.8 m-85 -119.51 160.83 21.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.402 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.458 ' OD1' HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -154.52 145.6 22.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 111.289 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 tptt 66.06 -102.71 0.08 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.68 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.86 -14.04 32.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.728 0.299 . . . . 0.0 111.767 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 122.79 30.08 1.18 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.145 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -87.39 170.01 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.069 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.44 HD12 ' O ' ' A' ' 37' ' ' VAL . 2.0 mt -79.7 117.37 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.355 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.458 HD13 ' OD1' ' A' ' 66' ' ' ASP . 2.1 tt -89.88 -27.33 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.109 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 105.54 139.06 9.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.571 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.553 ' H ' HD11 ' A' ' 31' ' ' LEU . 1.5 t80 -100.99 177.0 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.353 . . . . 0.0 110.857 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.97 -43.75 2.12 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.414 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.887 HD23 HD21 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -79.93 155.4 27.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.777 0.322 . . . . 0.0 110.829 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.8 p -132.42 159.06 40.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt -85.24 5.72 29.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.476 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.44 113.26 24.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -55.77 -23.15 27.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.332 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER 35.66 -166.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 m -104.82 -25.92 12.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.561 ' OH ' ' CE1' ' A' ' 163' ' ' HIS . 4.8 m-85 -85.5 117.19 24.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.454 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.441 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.6 t -109.09 142.54 21.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.001 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.838 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 54.5 t80 -130.05 106.95 8.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.62 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -99.53 126.51 45.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.167 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -135.47 122.73 35.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.847 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t0 61.02 -69.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.319 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 87' ' ' ILE . 7.5 t70 -167.48 35.29 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.196 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.0 mmt-85 -137.6 113.24 9.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.986 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.55 121.9 25.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.501 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.887 HD21 HD23 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -114.93 164.69 13.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.323 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -129.03 165.0 22.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.038 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.679 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -152.65 169.03 23.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.987 0.422 . . . . 0.0 112.105 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.446 ' HA ' HG21 ' A' ' 81' ' ' THR . 18.3 m95 -95.03 -19.59 20.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.783 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.48 166.64 30.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.091 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -51.93 -23.28 4.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tp -86.38 -51.65 6.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.745 0.307 . . . . 0.0 111.434 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.622 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -45.03 -28.28 0.67 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.972 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.679 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -60.46 -39.56 88.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 0.0 110.725 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 102' ' ' ILE . 4.2 pp -111.08 -173.45 2.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 0.0 111.232 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 101' ' ' LEU . 7.5 tp -165.22 -42.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.052 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.562 ' O ' HG22 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -162.98 76.15 1.91 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.023 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.422 ' CB ' HG12 ' A' ' 128' ' ' VAL . 25.7 Cg_exo -62.96 -34.78 69.87 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.632 2.221 . . . . 0.0 112.374 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.18 -23.66 43.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.472 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -84.15 -39.23 19.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.409 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -58.05 -45.97 88.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.098 0.475 . . . . 0.0 111.371 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.94 24.03 16.23 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.474 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.26 173.73 14.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 111.038 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -80.65 155.3 26.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.838 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.11 109.83 7.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -81.9 119.8 24.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.771 0.796 . . . . 0.0 111.178 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.793 HG22 ' HD1' ' A' ' 85' ' ' PHE . 96.6 t -112.69 130.22 66.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.061 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.441 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 59.6 p -121.97 137.78 54.67 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.208 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.624 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.1 m -141.37 173.01 11.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.319 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -135.21 134.72 40.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.403 ' O ' ' HA2' ' A' ' 121' ' ' GLY . 35.5 t -62.09 128.84 38.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.142 0.496 . . . . 0.0 111.89 -178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.569 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . . . -69.65 -5.52 25.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.84 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.909 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.47 -50.11 2.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.845 0.355 . . . . 0.0 111.682 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.674 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.51 -24.4 21.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.058 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 117' ' ' CYS . . . 74.94 6.78 79.94 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.135 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.674 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.19 147.82 64.8 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.643 0.259 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.32 105.73 1.48 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.676 2.251 . . . . 0.0 110.448 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.729 HG12 ' HD2' ' A' ' 138' ' ' PRO . 27.7 m -103.32 145.7 12.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.945 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.955 ' O ' HD13 ' A' ' 126' ' ' LEU . 77.3 p -153.29 141.3 20.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.237 0.541 . . . . 0.0 110.421 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 1.008 HD21 ' HE1' ' A' ' 141' ' ' MET . 0.2 OUTLIER -136.72 153.6 50.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.258 178.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.772 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 89.5 m -105.75 112.57 25.69 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.654 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 62.1 t -96.21 111.95 27.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.935 0.398 . . . . 0.0 111.46 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.453 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -106.14 171.0 5.18 Favored Pre-proline 0 N--CA 1.453 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.853 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 37.7 Cg_endo -67.16 -19.22 51.1 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.028 1.819 . . . . 0.0 112.965 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 8.5 m -109.25 -29.41 8.5 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 131' ' ' SER . 10.5 pt-20 178.63 -161.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.198 0.523 . . . . 0.0 110.101 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -94.26 163.6 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.602 178.424 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -153.07 21.07 0.58 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.295 0.569 . . . . 0.0 112.448 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.772 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.95 86.32 0.08 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.445 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 139' ' ' ALA . 39.5 t -101.59 107.69 22.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.451 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -146.82 119.77 4.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.812 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.729 ' HD2' HG12 ' A' ' 124' ' ' VAL . 73.1 Cg_endo -76.63 145.95 83.04 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.582 -1.424 . . . . 0.0 112.222 0.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 136' ' ' VAL . . . -61.94 165.47 5.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.746 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 66.89 13.18 61.15 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.312 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' MET . . . . . 1.008 ' HE1' HD21 ' A' ' 126' ' ' LEU . 0.5 OUTLIER -61.43 158.3 15.03 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.983 0.42 . . . . 0.0 111.613 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.582 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.05 152.35 49.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.241 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.878 ' CG2' HG12 ' A' ' 189' ' ' VAL . 21.3 t -111.92 151.24 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.575 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.772 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.3 p -120.18 140.76 50.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.79 0.328 . . . . 0.0 110.804 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.96 154.71 39.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.914 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 161' ' ' HIS . 38.3 t -125.61 159.38 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.925 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 182' ' ' GLU . 15.4 mt -92.39 148.71 37.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.701 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.58 149.37 79.57 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.512 2.142 . . . . 0.0 112.323 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -108.91 -171.93 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.832 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.16 -20.63 12.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -108.03 51.75 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -168.84 -173.14 1.76 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 60.81 36.47 19.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.4 m -109.98 -38.75 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.067 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.3 mtp180 -130.96 -60.41 0.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -176.07 83.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.89 126.76 0.22 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.402 ' HA ' ' CE1' ' A' ' 161' ' ' HIS . 1.3 t80 60.52 40.44 16.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.8 t -59.83 -31.09 69.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.3 t -165.39 -43.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.534 ' O ' HG23 ' A' ' 146' ' ' VAL . 0.5 OUTLIER 62.34 67.62 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.844 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 144' ' ' SER . 30.5 t -110.94 123.39 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.561 ' CE1' ' OH ' ' A' ' 83' ' ' TYR . 0.1 OUTLIER -117.03 169.23 9.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.602 0.715 . . . . 0.0 110.182 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.666 ' CE1' HG13 ' A' ' 143' ' ' VAL . 1.8 m-85 -120.48 132.26 55.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.915 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.625 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 54.5 m-85 -108.65 136.15 48.72 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.144 0.497 . . . . 0.0 110.001 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -46.89 -25.79 0.85 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.594 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 40.1 m -163.09 167.49 22.22 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.825 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 77.4 t -68.1 -34.43 6.09 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.97 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.0 Cg_exo -72.69 -36.8 4.48 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 122.753 2.302 . . . . 0.0 110.001 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.593 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.75 -40.27 48.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.465 178.007 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.7 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.45 -45.24 95.1 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.1 mt-10 -78.93 -27.94 43.77 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.249 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 169' ' ' PRO . 28.3 t70 -70.19 -55.89 8.19 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.457 0.646 . . . . 0.0 109.475 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.909 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 29.8 t-105 -64.88 -27.74 69.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.83 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -65.54 -40.27 92.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.265 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -42.29 63.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.471 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -95.11 20.46 9.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.271 0.558 . . . . 0.0 111.435 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.494 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -127.84 29.25 5.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.721 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -96.81 -173.06 2.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.802 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.99 -31.24 7.49 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.443 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.549 ' CD1' HD12 ' A' ' 184' ' ' LEU . 4.8 mt -62.67 -174.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.712 0.292 . . . . 0.0 110.854 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.787 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.6 mm-40 -97.62 34.15 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 165.01 -117.58 0.76 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.614 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.549 HD12 ' CD1' ' A' ' 181' ' ' LEU . 1.2 tt 62.5 114.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.423 ' N ' HD23 ' A' ' 184' ' ' LEU . . . -142.24 149.9 40.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 175' ' ' ALA . 10.6 mm -100.29 158.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.937 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -162.46 161.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.219 0.533 . . . . 0.0 112.016 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -88.08 127.97 35.41 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.652 178.529 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.955 HG11 ' SD ' ' A' ' 141' ' ' MET . 2.1 m -48.01 -19.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.405 ' N ' ' C ' ' A' ' 188' ' ' SER . 23.6 m-70 -73.02 -44.39 60.96 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -22.3 35.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.524 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -74.89 -25.18 58.76 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.282 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -81.51 -24.86 36.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.942 0.401 . . . . 0.0 110.666 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.86 -29.81 33.81 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -82.3 -28.3 31.8 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.435 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.04 -28.17 31.89 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -82.15 -21.88 36.37 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.44 -0.38 . . . . 0.0 110.995 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -81.12 -22.84 38.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.126 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.451 ' CD2' ' CD1' ' A' ' 203' ' ' LEU . 0.5 OUTLIER -52.65 -28.32 20.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.129 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -52.39 -55.08 24.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -58.03 -30.76 66.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.031 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -55.92 5.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.978 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.451 ' CD1' ' CD2' ' A' ' 199' ' ' PHE . 9.9 mt -64.88 -35.21 80.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.973 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.69 -49.67 44.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -71.24 79.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.5 m -84.65 101.65 12.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.905 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 7.5 tpp -63.3 147.52 50.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 59.2 p -142.13 144.79 33.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.6 t -130.93 35.15 3.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.7 157.63 31.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.441 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -59.53 -62.93 4.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.978 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.6 Cg_endo . . . . . 0 C--O 1.249 1.043 0 C-N-CA 122.363 2.042 . . . . 0.0 112.362 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.857 0.36 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 61.01 112.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp 60.26 158.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.003 HD13 HD23 ' A' ' 106' ' ' LEU . 15.2 mt -100.68 155.02 18.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.39 107.41 0.87 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.172 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.747 ' HB2' HD11 ' A' ' 46' ' ' LEU . 37.1 Cg_exo -60.99 -19.83 64.74 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.49 2.127 . . . . 0.0 112.403 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.5 tt -55.27 -57.62 11.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.447 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -80.27 -27.36 38.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.334 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 8.7 ttt-85 -70.86 -53.31 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.941 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -66.5 -25.52 66.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.499 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.755 HD11 ' C ' ' A' ' 72' ' ' ILE . 4.4 tp -72.02 -30.56 65.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.714 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.38 -27.87 26.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.146 0.498 . . . . 0.0 110.944 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -64.76 -19.96 66.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.245 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.64 47.52 89.98 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.134 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.766 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -131.06 143.93 51.46 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.601 0.239 . . . . 0.0 110.676 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -51.46 91.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.458 2.106 . . . . 0.0 112.306 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 35' ' ' ARG . 23.1 t -93.17 112.08 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.281 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.9 p -86.73 -176.57 5.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.688 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -75.71 -36.73 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.248 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -27.3 67.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.206 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.64 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.94 -42.52 14.88 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.367 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.752 ' CD1' HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -62.73 -36.7 83.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.62 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.43 -43.02 64.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.625 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.23 -31.72 75.01 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.591 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.606 HG22 HD12 ' A' ' 46' ' ' LEU . 7.1 mt -78.02 -46.15 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 120.968 0.413 . . . . 0.0 110.409 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 26' ' ' PRO . 7.9 mp -75.58 -9.51 58.64 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.543 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 60.31 21.65 11.14 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -102.0 160.43 26.45 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.25 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.16 138.99 34.54 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.608 2.205 . . . . 0.0 111.925 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.54 -20.27 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -32.25 47.35 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.045 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -67.39 -40.66 85.69 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.0 t -62.98 -47.85 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.518 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.26 -52.46 58.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.164 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.98 79.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.154 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -66.62 -26.81 38.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.922 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.443 HD23 HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -72.06 -31.77 66.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.632 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.735 ' O ' HG23 ' A' ' 61' ' ' THR . 7.6 mt-10 -56.17 -23.18 33.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -88.54 -16.36 32.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 63' ' ' THR . . . -96.96 33.35 1.92 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.381 0.61 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.735 HG23 ' O ' ' A' ' 58' ' ' GLU . 80.6 p -59.01 -20.76 56.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.01 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.6 m -90.21 -21.43 22.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.366 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HB1' ' A' ' 60' ' ' ALA . 0.8 OUTLIER -60.75 141.24 57.13 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.354 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.627 ' O ' HG22 ' A' ' 72' ' ' ILE . 2.1 mt-10 -79.0 131.09 36.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 0.0 111.62 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.6 m-85 -104.06 173.06 6.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.169 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -152.73 146.52 25.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 111.541 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tptt 65.95 -103.54 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.799 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.95 -12.29 33.81 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 124.6 31.15 0.91 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.006 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -85.75 168.05 14.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.179 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.752 HD13 ' CD1' ' A' ' 42' ' ' LEU . 3.6 mp -79.91 115.76 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.469 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.755 ' C ' HD11 ' A' ' 31' ' ' LEU . 2.3 tt -110.1 -26.02 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.164 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.656 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 88.99 -133.64 11.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.572 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -176.34 93.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.869 0.366 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.07 22.06 1.76 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.585 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.3 mt -147.09 144.04 28.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.716 0.293 . . . . 0.0 110.952 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.8 p -102.8 159.01 15.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.867 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.63 -48.03 82.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -110.65 155.43 22.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.02 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -57.21 129.44 41.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -109.23 -172.68 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.985 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 m -94.34 -41.33 9.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -78.58 108.52 12.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.644 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.86 140.97 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.898 ' CZ ' HD22 ' A' ' 101' ' ' LEU . 28.3 t80 -131.03 108.01 9.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.632 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -101.75 136.71 41.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -138.78 122.98 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.76 -68.94 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.466 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 87' ' ' ILE . 11.0 t0 -164.94 35.05 0.06 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.447 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -137.83 111.67 8.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.793 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -77.91 120.11 22.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.785 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.631 HD12 ' HD2' ' A' ' 85' ' ' PHE . 10.4 mt -109.86 164.86 12.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -133.27 165.05 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.131 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -153.23 169.95 21.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.057 0.456 . . . . 0.0 111.815 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -106.44 -7.42 17.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.876 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.888 ' HB3' HG23 ' A' ' 162' ' ' VAL . 76.6 m -152.74 159.94 43.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.331 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.719 ' HB2' ' O ' ' A' ' 162' ' ' VAL . . . -51.5 -25.37 6.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.527 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.417 HD21 HG12 ' A' ' 102' ' ' ILE . 3.6 tt -87.86 -50.27 6.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.12 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.617 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -43.25 -22.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.529 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -59.0 -32.38 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.898 HD22 ' CZ ' ' A' ' 85' ' ' PHE . 2.2 tp 178.65 149.19 0.22 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 111.218 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.417 HG12 HD21 ' A' ' 98' ' ' LEU . 5.1 mt -128.45 128.42 68.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.701 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.64 ' HB3' HD12 ' A' ' 106' ' ' LEU . 13.1 m-85 66.84 66.91 0.66 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.864 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.474 ' O ' HG12 ' A' ' 107' ' ' ILE . 24.2 Cg_exo -63.65 -20.92 69.98 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.842 2.361 . . . . 0.0 112.404 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.75 -23.67 59.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.916 0.388 . . . . 0.0 111.278 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.003 HD23 HD13 ' A' ' 24' ' ' LEU . 7.7 mt -78.6 -29.75 46.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.24 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 104' ' ' PRO . 3.7 mm -53.17 -61.08 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.006 0.908 . . . . 0.0 111.051 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.89 18.61 26.77 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.294 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.37 -179.95 7.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.714 0.292 . . . . 0.0 110.597 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.54 149.0 26.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.729 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.09 110.34 7.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -79.56 119.08 22.03 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.849 0.833 . . . . 0.0 111.223 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.773 HG22 ' CD1' ' A' ' 85' ' ' PHE . 12.2 t -110.49 131.53 61.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.983 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 m -122.61 137.33 54.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.246 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.547 ' OG ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -140.94 172.77 12.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.062 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -131.84 130.83 42.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.829 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 29.5 m -56.02 123.84 15.72 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.029 0.443 . . . . 0.0 111.979 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.39 -6.95 33.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.788 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.625 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -119.47 -50.6 2.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.696 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.16 -13.75 37.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.996 -179.172 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 117' ' ' CYS . . . 64.23 10.34 40.81 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.746 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.554 ' H ' HG22 ' A' ' 120' ' ' THR . . . -71.2 168.99 16.78 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.808 0.337 . . . . 0.0 110.647 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.461 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 53.8 Cg_endo -93.69 108.71 0.17 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.073 2.515 . . . . 0.0 111.629 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.547 HG23 ' OG ' ' A' ' 115' ' ' SER . 34.3 m -106.53 146.84 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.341 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.2 p -151.66 142.8 23.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.375 0.607 . . . . 0.0 110.771 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -134.43 151.74 51.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.484 178.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.888 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 30.2 m -107.62 113.59 26.99 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.485 HG23 ' CG2' ' A' ' 113' ' ' VAL . 36.2 t -96.51 111.69 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.968 0.413 . . . . 0.0 111.489 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -105.76 169.8 6.58 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.15 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.58 -14.52 44.33 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.456 2.104 . . . . 0.0 112.982 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 p -118.19 -27.01 6.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.52 -163.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.112 0.482 . . . . 0.0 109.999 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -95.3 162.29 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.717 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -151.41 19.98 0.74 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.888 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.04 86.14 0.08 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.791 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.15 122.74 53.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.707 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -146.12 119.3 5.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.98 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.425 ' HD2' HG12 ' A' ' 124' ' ' VAL . 70.8 Cg_endo -74.71 162.3 92.97 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 123.435 -1.485 . . . . 0.0 112.274 0.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.82 78.24 1.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.151 0.5 . . . . 0.0 110.737 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 147.4 15.91 0.13 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.576 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 126' ' ' LEU . 10.2 ptp -62.51 160.82 12.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.079 0.439 . . . . 0.0 111.534 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.65 152.06 50.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.942 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.773 HG11 ' HB2' ' A' ' 161' ' ' HIS . 2.5 t -117.44 154.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.443 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 55.6 p -121.16 146.8 46.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.842 0.353 . . . . 0.0 110.921 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.856 HD21 ' HB3' ' A' ' 185' ' ' ALA . 4.0 pp -113.47 158.4 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.993 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 146' ' ' VAL . 11.1 p -125.18 112.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.416 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . 1.8 mt -77.01 -61.96 0.64 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.246 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 47.4 Cg_endo -69.98 -50.47 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.475 2.117 . . . . 0.0 112.479 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.491 ' HA ' HG21 ' A' ' 146' ' ' VAL . 5.3 tt0 62.94 145.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.866 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -109.05 -21.5 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.73 31.68 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.093 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.473 ' HB2' ' NE2' ' A' ' 149' ' ' GLN . . . -118.62 98.14 6.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.045 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -99.41 35.5 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.413 HG23 ' N ' ' A' ' 155' ' ' ARG . 15.5 m -118.67 -44.37 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.413 ' N ' HG23 ' A' ' 154' ' ' VAL . 9.6 ttt180 -173.08 -68.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.979 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -154.79 -45.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.992 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 m 61.8 158.64 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.963 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -170.18 79.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.873 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 8.9 m -56.59 -26.91 56.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 145' ' ' LEU . 4.6 t 76.43 0.09 3.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.585 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.773 ' HB2' HG11 ' A' ' 143' ' ' VAL . 8.3 p80 178.04 84.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.549 0.214 . . . . 0.0 110.732 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.888 HG23 ' HB3' ' A' ' 96' ' ' CYS . 7.2 p -101.27 -44.89 11.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.467 ' N ' HG13 ' A' ' 162' ' ' VAL . 16.0 m-70 -107.19 148.5 28.8 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.65 0.738 . . . . 0.0 109.979 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.757 ' CE2' HG22 ' A' ' 143' ' ' VAL . 40.4 m-85 -109.9 150.67 28.11 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.238 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 49.7 m-85 -131.83 136.09 47.21 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.557 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.568 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -39.75 -28.32 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.243 -0.889 . . . . 0.0 113.141 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.499 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 11.4 p -170.59 176.45 4.31 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.655 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.61 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 79.6 t -69.4 -34.27 4.61 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.369 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.88 -37.55 3.62 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.763 2.309 . . . . 0.0 110.313 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.592 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -77.21 -39.78 47.42 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.471 178.045 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.701 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.37 -44.56 96.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 177.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.6 mt-10 -79.07 -27.95 43.08 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.099 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.3 t70 -69.92 -56.03 8.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.466 0.651 . . . . 0.0 109.395 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.625 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 35.6 t-105 -64.87 -27.88 69.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.817 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -66.54 -38.51 87.3 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.218 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -44.32 63.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.302 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -94.95 22.47 6.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.031 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.33 30.57 0.68 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.69 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -108.6 -176.09 2.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 59.32 25.67 60.65 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.492 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 36.7 mt -96.57 44.18 1.07 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 110.827 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 63.07 30.87 16.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 110.724 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 143.05 -127.38 3.1 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.378 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.5 tt 62.87 123.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.856 ' HB3' HD21 ' A' ' 145' ' ' LEU . . . -143.24 150.32 39.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.002 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.541 HD11 ' HB2' ' A' ' 175' ' ' ALA . 11.7 mm -99.66 160.82 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.938 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.476 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -165.61 162.9 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.474 0.654 . . . . 0.0 112.197 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.9 OUTLIER -89.16 130.26 35.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.905 178.456 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.538 HG12 ' CG2' ' A' ' 143' ' ' VAL . 1.2 m -46.49 -20.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 2.1 m-70 -72.65 -43.36 63.29 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.761 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -21.02 36.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.347 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.75 -25.21 58.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 128' ' ' VAL . 9.7 t80 -81.42 -24.86 36.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.703 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.66 -29.98 34.02 Favored Glycine 0 CA--C 1.509 -0.3 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.8 mt -81.59 -27.85 34.06 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.01 -26.52 37.01 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -81.99 -22.02 36.8 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.517 -0.342 . . . . 0.0 111.026 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -74.11 -24.37 59.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -54.06 -39.53 66.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.107 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.17 -24.95 37.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -54.93 -42.91 72.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.039 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -80.01 -30.83 39.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.98 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 7.0 tp -78.29 -19.99 52.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.278 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.492 HD13 ' O ' ' A' ' 204' ' ' LEU . 0.5 OUTLIER -81.05 -52.01 7.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.818 0.342 . . . . 0.0 110.92 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -74.16 -177.03 2.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.4 t -71.07 160.7 32.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -110.57 -177.05 3.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.1 158.5 11.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.5 m -105.73 105.38 15.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.44 -81.18 0.23 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.441 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -59.98 -62.75 5.27 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.98 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.5 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.425 2.084 . . . . 0.0 112.307 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.843 0.354 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -112.28 -43.09 3.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mt -109.95 -31.43 7.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -152.12 167.79 27.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.648 HG22 ' HB2' ' A' ' 27' ' ' LEU . 9.7 p -108.71 99.71 35.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.932 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.564 ' HB2' HD11 ' A' ' 46' ' ' LEU . 52.3 Cg_exo -55.15 -20.0 22.69 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.693 2.262 . . . . 0.0 112.851 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.648 ' HB2' HG22 ' A' ' 25' ' ' VAL . 4.8 mp -52.01 -57.4 9.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.747 0.308 . . . . 0.0 111.227 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.623 HD23 ' CG1' ' A' ' 25' ' ' VAL . 3.9 pp -66.42 -26.98 67.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.138 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.451 ' N ' HD12 ' A' ' 28' ' ' LEU . 41.2 mtp85 -68.84 -53.32 22.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.846 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -72.86 -30.32 63.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.318 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 72' ' ' ILE . 5.7 tp -72.57 -43.16 63.79 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.837 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.11 -26.74 17.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.074 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -66.62 -20.62 66.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.188 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.91 47.41 89.07 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.136 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -133.07 148.58 69.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.622 0.249 . . . . 0.0 110.814 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.01 105.46 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.556 2.171 . . . . 0.0 112.31 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.739 HG23 HG22 ' A' ' 41' ' ' THR . 11.1 p -107.23 110.0 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.36 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 94.1 p -86.83 -179.54 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.744 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.4 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -71.96 -36.36 69.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.246 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -27.39 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 0.0 110.117 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.739 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.33 -41.61 15.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.488 HD22 ' CD1' ' A' ' 71' ' ' ILE . 7.8 tp -63.53 -36.51 84.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 176.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.21 -42.6 62.46 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.463 177.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.26 -31.09 73.98 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.617 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.574 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -78.78 -44.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-O 120.998 0.428 . . . . 0.0 110.518 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.567 HD12 HG22 ' A' ' 45' ' ' ILE . 7.4 mp -76.72 -9.75 58.89 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.412 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 59.36 22.24 10.62 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.442 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 7.8 m0 -104.99 144.75 29.37 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.337 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.7 138.23 80.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.455 2.103 . . . . 0.0 112.012 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.95 -18.94 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.7 -32.03 46.77 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.106 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.779 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -67.21 -40.53 86.44 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.581 ' O ' HD23 ' A' ' 57' ' ' LEU . 2.1 t -62.26 -48.23 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.667 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.64 -52.74 58.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.516 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.64 -45.73 73.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 52' ' ' ARG . 30.1 t -68.83 -29.3 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.728 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.837 HD12 ' OH ' ' A' ' 65' ' ' TYR . 2.2 mm? -72.17 -38.52 69.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.95 -45.16 87.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -64.5 -17.18 63.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.36 67.59 0.7 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.748 0.785 . . . . 0.0 110.847 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 p -72.41 -8.64 56.09 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.335 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.0 m -114.51 40.81 2.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.179 0.514 . . . . 0.0 110.781 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.66 141.4 33.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.164 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.456 ' CG ' ' CZ ' ' A' ' 74' ' ' TYR . 1.9 mm-40 -78.77 126.74 31.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.033 0.444 . . . . 0.0 111.16 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.837 ' OH ' HD12 ' A' ' 57' ' ' LEU . 43.9 m-85 -115.16 165.6 12.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.349 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -154.22 144.3 21.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 111.286 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 tptt 66.42 -103.2 0.08 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.733 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -91.55 -13.47 32.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.751 0.31 . . . . 0.0 111.818 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 124.36 30.65 0.98 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.134 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -86.55 168.79 13.36 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.488 ' CD1' HD22 ' A' ' 42' ' ' LEU . 2.1 mp -79.8 121.53 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.413 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.817 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -104.21 -29.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.005 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.76 171.64 18.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.64 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.456 ' CZ ' ' CG ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -151.65 -174.02 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 110.802 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.79 -48.28 3.26 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.575 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.604 HD11 HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -57.6 174.26 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.682 0.277 . . . . 0.0 110.953 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.464 HG21 ' C ' ' A' ' 94' ' ' ALA . 15.8 p -113.39 159.55 19.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.709 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.31 48.99 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.622 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 43.47 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.985 0.421 . . . . 0.0 112.067 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -156.99 -88.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.475 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -38.63 157.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.958 0.408 . . . . 0.0 111.996 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.437 ' O ' HG23 ' A' ' 84' ' ' VAL . 15.0 t -75.07 -10.64 59.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.89 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 97' ' ' ALA . 23.2 m-85 -70.87 101.2 2.09 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG13 ' CE1' ' A' ' 93' ' ' TYR . 9.2 t -110.23 143.61 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.398 . . . . 0.0 111.186 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.862 ' CD1' HG22 ' A' ' 113' ' ' VAL . 32.5 t80 -134.33 109.25 8.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.352 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.84 125.22 39.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.995 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.477 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -136.31 122.99 31.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.87 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.5 -76.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.063 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.9 p-10 -159.15 36.7 0.21 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.461 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -140.94 115.66 9.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.636 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -77.76 85.89 4.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.86 0.362 . . . . 0.0 110.989 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 76' ' ' LEU . 51.5 mt -71.97 165.0 25.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.84 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.558 ' CE1' HG13 ' A' ' 84' ' ' VAL . 50.6 m-85 -138.45 165.15 27.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.312 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 100' ' ' THR . . . -144.14 162.04 37.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.866 0.365 . . . . 0.0 111.861 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -85.31 -27.43 25.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.402 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.438 ' HB2' ' HB ' ' A' ' 162' ' ' VAL . 0.5 OUTLIER -129.89 159.04 37.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.754 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.674 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -61.98 -11.87 15.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.83 HD12 HG11 ' A' ' 162' ' ' VAL . 9.0 mt -103.64 -20.76 13.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.49 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 14.7 t70 -82.5 -3.6 56.13 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.706 ' HA ' ' HB2' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.54 -39.1 86.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 0.0 110.341 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.648 ' H ' HD13 ' A' ' 101' ' ' LEU . 0.0 OUTLIER -98.33 173.77 6.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.719 HD12 ' N ' ' A' ' 103' ' ' PHE . 2.5 pp -154.92 -45.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.133 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.719 ' N ' HD12 ' A' ' 102' ' ' ILE . 11.3 m-85 -163.06 79.12 1.72 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.016 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.466 ' CB ' HG12 ' A' ' 128' ' ' VAL . 59.3 Cg_endo -71.92 -32.84 10.71 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.591 2.194 . . . . 0.0 112.294 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.15 -23.78 43.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.263 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.403 HD21 HD11 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -84.89 -40.08 17.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.38 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.1 tp -57.94 -45.34 87.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.263 0.554 . . . . 0.0 111.372 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.19 24.26 15.09 Favored Glycine 0 C--N 1.319 -0.385 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.484 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -151.42 173.62 14.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.065 0.459 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -83.84 157.18 22.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.971 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.575 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.07 110.06 7.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.2 mtt-85 -80.91 119.03 22.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.732 0.777 . . . . 0.0 111.178 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.862 HG22 ' CD1' ' A' ' 85' ' ' PHE . 13.4 t -108.27 129.54 62.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.847 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.415 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 1.5 p -124.49 137.62 54.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.318 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.591 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.1 172.96 11.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.986 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -130.13 130.94 45.42 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.571 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.1 m -57.76 123.06 14.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.873 0.368 . . . . 0.0 111.927 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.78 -8.28 34.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.783 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.703 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.43 -50.54 1.99 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.563 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -77.9 -21.15 51.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 111.198 -178.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 63.31 33.28 86.83 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.01 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.563 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -102.93 169.69 7.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.432 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.444 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 58.6 Cg_endo -93.86 107.49 0.16 Allowed 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.922 2.415 . . . . 0.0 111.681 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.591 HG22 ' C ' ' A' ' 115' ' ' SER . 33.8 m -102.54 146.26 10.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.235 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.897 ' O ' HD13 ' A' ' 126' ' ' LEU . 67.0 p -151.87 141.49 21.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.457 0.646 . . . . 0.0 111.196 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.897 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -134.18 153.14 52.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.001 178.48 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.906 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 23.6 m -110.05 114.95 28.89 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.469 HG23 ' CG2' ' A' ' 113' ' ' VAL . 47.8 t -96.2 111.52 26.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.999 0.428 . . . . 0.0 110.869 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -108.29 176.51 1.57 Allowed Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.461 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 129' ' ' SER . 13.3 Cg_exo -70.33 -12.69 32.25 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.727 2.285 . . . . 0.0 113.112 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 0.8 OUTLIER -121.91 -27.91 4.54 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.076 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 131' ' ' SER . 13.4 pt-20 179.63 -161.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.13 0.49 . . . . 0.0 110.374 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -91.38 156.39 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.758 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -146.31 17.16 1.35 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.906 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.99 85.04 0.07 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.882 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.472 HG13 HD12 ' A' ' 126' ' ' LEU . 23.1 t -98.88 123.16 51.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.834 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.17 117.09 4.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.018 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.12 161.85 93.56 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.423 -1.491 . . . . 0.0 112.087 -0.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.01 78.0 1.69 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.117 0.484 . . . . 0.0 110.674 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.86 18.76 0.18 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.388 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.836 ' SD ' HD11 ' A' ' 126' ' ' LEU . 6.7 ptm -64.38 161.45 16.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.969 0.385 . . . . 0.0 111.2 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -125.55 152.36 45.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.07 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.516 HG22 ' CE1' ' A' ' 164' ' ' PHE . 61.2 t -114.09 148.9 16.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.775 ' O ' HG13 ' A' ' 162' ' ' VAL . 50.3 m -120.19 140.87 50.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.769 0.319 . . . . 0.0 110.372 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.516 HD11 ' CD1' ' A' ' 147' ' ' LEU . 2.0 pt? -144.01 176.11 9.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.071 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.44 93.79 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.967 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.516 ' CD1' HD11 ' A' ' 145' ' ' LEU . 0.9 OUTLIER -72.11 -60.86 2.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.911 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 74.4 Cg_endo -75.16 148.56 34.86 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.608 2.205 . . . . 0.0 112.367 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -152.96 121.06 6.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.96 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -112.92 -23.35 10.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.166 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.68 106.17 5.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.021 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.501 ' O ' HG22 ' A' ' 154' ' ' VAL . . . -178.35 -36.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.349 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -56.05 100.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.176 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 152' ' ' ALA . 35.0 m -156.39 -44.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.003 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.474 ' N ' HG23 ' A' ' 154' ' ' VAL . 3.2 tpt85 -144.32 -47.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.682 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -124.64 -62.66 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.715 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 p 56.9 33.31 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.178 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -176.53 37.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.977 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.5 p -63.72 -46.15 86.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.812 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.561 ' O ' HG23 ' A' ' 162' ' ' VAL . 0.6 OUTLIER -176.29 -88.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.029 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 60.52 17.52 7.42 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.444 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.83 HG11 HD12 ' A' ' 98' ' ' LEU . 26.0 t -113.21 121.84 66.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.882 0.372 . . . . 0.0 111.235 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 163' ' ' HIS . 3.2 m-70 -128.14 169.25 14.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.314 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.674 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 10.5 m-30 -110.73 152.95 25.97 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.812 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.595 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 27.1 m-85 -132.54 138.13 47.38 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.582 0.706 . . . . 0.0 110.238 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.571 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -42.66 -28.84 0.26 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.141 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.552 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 71.4 m -166.96 174.7 8.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.121 0.486 . . . . 0.0 111.685 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.601 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.4 t -69.53 -33.84 4.15 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.199 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.4 Cg_exo -73.33 -37.92 2.97 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.81 2.34 . . . . 0.0 110.361 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.577 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.6 -39.63 51.93 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.53 177.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.734 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.06 -45.63 92.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.2 mt-10 -78.9 -27.68 43.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.34 178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.688 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.5 t70 -71.11 -56.0 7.04 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.301 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.703 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 36.0 t-105 -64.45 -28.91 69.99 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.675 178.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.02 -39.76 94.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.145 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -43.88 63.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.372 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.75 21.92 7.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.177 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.79 23.89 5.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.881 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -81.9 -176.13 5.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.716 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.94 -32.67 6.38 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.363 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.2 mt -71.74 61.66 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.902 0.382 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.4 16.73 6.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.456 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 113.07 -63.29 0.29 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.962 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.554 HD23 ' N ' ' A' ' 185' ' ' ALA . 8.1 tt 65.27 151.62 0.05 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.584 0.192 . . . . 0.0 110.513 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.554 ' N ' HD23 ' A' ' 184' ' ' LEU . . . -144.98 150.13 36.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.153 0.502 . . . . 0.0 111.815 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.0 mm -103.95 162.04 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.506 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.462 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -157.35 162.31 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.578 0.704 . . . . 0.0 112.313 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -94.97 133.34 38.83 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.375 178.079 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.464 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 2.8 m -47.35 -18.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.879 0.371 . . . . 0.0 110.817 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 11.6 m170 -73.67 -44.87 55.54 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.18 0.514 . . . . 0.0 109.69 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.576 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.7 OUTLIER -82.41 -20.91 36.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.478 179.152 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.51 -24.79 62.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.97 -24.73 37.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.74 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.71 -31.28 30.19 Favored Glycine 0 CA--C 1.509 -0.338 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 191' ' ' GLU . 8.3 mp -80.8 -28.42 36.3 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.92 -24.31 45.67 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.614 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -82.13 -22.01 36.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.805 0.336 . . . . 0.0 111.092 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.21 -23.15 43.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.186 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -54.24 -38.72 66.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 111.105 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASN . . . . . 0.465 ' HA ' HD12 ' A' ' 203' ' ' LEU . 1.0 OUTLIER -80.73 -54.73 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.926 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -57.87 -31.28 66.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.996 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -76.09 -31.48 58.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 200' ' ' ASN . 10.1 mt -60.27 -48.5 81.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.4 mt -60.77 -37.44 81.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.948 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -74.55 169.36 17.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.0 t -155.16 35.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 6.5 mtm -131.64 103.4 6.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.7 -46.83 51.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.27 137.37 48.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -170.61 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.43 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -176.37 -62.95 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.008 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.4 Cg_endo . . . . . 0 C--O 1.249 1.06 0 C-N-CA 122.372 2.048 . . . . 0.0 112.342 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.82 0.343 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.6 t0 60.42 104.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.864 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 60.9 112.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tp -166.45 82.89 0.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 m -59.81 148.85 74.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.062 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.416 ' CG ' HD11 ' A' ' 46' ' ' LEU . 58.4 Cg_endo -71.57 -37.28 5.61 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.551 2.168 . . . . 0.0 112.317 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.73 -57.14 11.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.568 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -60.23 -26.82 66.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.427 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -53.42 23.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.027 0.441 . . . . 0.0 110.274 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.37 -30.1 57.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.419 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.487 HD23 HD22 ' A' ' 28' ' ' LEU . 49.1 tp -70.36 -49.94 44.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.71 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB2' HD13 ' A' ' 28' ' ' LEU . . . -53.48 -25.31 15.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.997 0.427 . . . . 0.0 111.133 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -22.39 64.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.137 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.21 48.14 77.83 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.297 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -133.18 155.11 81.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.659 0.266 . . . . 0.0 110.854 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.9 108.99 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.518 2.145 . . . . 0.0 111.973 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.768 HG13 HG12 ' A' ' 71' ' ' ILE . 9.6 p -113.58 109.84 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 120.954 0.407 . . . . 0.0 111.394 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 p -87.62 -169.79 2.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.8 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 43' ' ' ALA . 15.8 ttm180 -78.07 -36.84 47.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.406 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -26.96 68.04 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.363 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.76 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.56 -42.15 14.65 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.413 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.29 -36.29 83.17 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.83 -42.7 60.49 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.494 177.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.81 -30.84 74.75 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.612 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.582 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.14 -42.48 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 120.949 0.404 . . . . 0.0 110.468 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.546 HD12 HG22 ' A' ' 45' ' ' ILE . 7.1 mp -78.94 -7.43 58.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.505 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 55.37 23.5 5.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.421 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -98.89 153.12 37.98 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.272 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.433 ' O ' HG23 ' A' ' 53' ' ' VAL . 49.4 Cg_endo -69.02 137.1 36.75 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.592 2.195 . . . . 0.0 111.923 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.91 -22.18 0.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -78.57 -35.47 45.86 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.876 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.85 ' O ' HG23 ' A' ' 56' ' ' VAL . 32.2 mmt-85 -66.84 -40.84 88.08 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.11 -48.2 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.544 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.15 -53.47 50.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.383 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.7 -49.82 75.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.898 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 52' ' ' ARG . 39.7 t -63.57 -30.66 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.642 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.493 HD11 ' OH ' ' A' ' 65' ' ' TYR . 1.8 tp -62.16 -32.13 72.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.675 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.607 ' O ' HG23 ' A' ' 61' ' ' THR . 3.3 tt0 -57.82 -22.26 46.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -95.93 -18.3 20.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.149 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.448 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -100.95 32.57 3.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.448 0.642 . . . . 0.0 110.85 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 58' ' ' GLU . 26.9 p -67.48 -27.99 67.47 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.956 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.4 t -75.93 -25.56 56.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.254 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.448 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -56.56 141.4 43.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.073 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.711 ' O ' HG22 ' A' ' 72' ' ' ILE . 31.5 mt-10 -78.43 126.87 31.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.493 ' OH ' HD11 ' A' ' 57' ' ' LEU . 39.8 m-85 -102.49 173.08 6.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.583 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.17 -172.77 2.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.564 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.25 -36.99 85.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.516 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -88.46 10.8 18.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.739 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.76 13.11 82.78 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.262 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -89.03 161.77 16.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.233 0.517 . . . . 0.0 109.827 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.768 HG12 HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -79.76 124.83 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.401 -179.15 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.84 HD11 HD11 ' A' ' 76' ' ' LEU . 2.2 tt -92.73 -21.12 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.204 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.14 116.07 0.56 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.602 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.413 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 44.9 p90 -60.31 111.87 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 0.0 110.889 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.29 -66.16 0.17 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.84 HD11 HD11 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -63.31 141.43 58.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.356 . . . . 0.0 110.857 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.5 p -123.57 159.55 28.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.39 -25.02 0.58 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.664 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.433 ' HD2' ' CD1' ' A' ' 93' ' ' TYR . 18.9 mtm180 79.9 92.03 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.889 0.376 . . . . 0.0 110.922 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.87 25.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.021 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 p -122.24 -138.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.959 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 p -129.65 -31.12 2.02 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.588 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 96' ' ' CYS . 12.4 m-85 -72.1 104.19 3.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.534 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.54 141.09 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.347 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.818 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 20.4 t80 -133.78 107.44 7.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.145 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -102.33 134.67 45.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.446 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.479 HG23 ' CE1' ' A' ' 85' ' ' PHE . 2.6 pt -140.06 123.91 18.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.724 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 t0 63.32 -66.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.43 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 87' ' ' ILE . 16.0 m-20 -168.0 35.28 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.499 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -135.61 113.23 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.895 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -80.21 86.17 5.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.083 0.468 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.404 ' CB ' ' O ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -73.65 164.63 26.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.114 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.433 ' CD1' ' HD2' ' A' ' 79' ' ' ARG . 7.9 m-85 -135.49 165.2 26.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.228 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -153.37 173.44 15.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.073 0.463 . . . . 0.0 111.946 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.411 ' O ' ' CE2' ' A' ' 83' ' ' TYR . 12.0 m0 -97.02 -17.58 19.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.008 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.43 ' HA ' ' CE2' ' A' ' 83' ' ' TYR . 1.2 m -153.96 165.91 34.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.155 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -52.46 -22.8 5.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.666 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.2 mt -85.22 -51.67 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.593 0.235 . . . . 0.0 111.292 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.593 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -49.4 -27.4 4.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.704 0.287 . . . . 0.0 111.542 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.627 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.48 -29.81 69.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.454 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.529 ' N ' HD23 ' A' ' 101' ' ' LEU . 1.8 pt? -154.65 126.3 7.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.773 HD13 ' O ' ' A' ' 102' ' ' ILE . 0.0 OUTLIER -96.22 -36.68 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 106' ' ' LEU . 1.6 m-85 -124.76 78.0 64.61 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.724 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.812 ' O ' HG22 ' A' ' 107' ' ' ILE . 36.1 Cg_exo -61.2 -51.42 4.5 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.631 2.221 . . . . 0.0 112.327 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.85 -23.41 41.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.567 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -90.35 -15.84 30.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 104' ' ' PRO . 2.9 tp -47.84 -53.31 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 111.993 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.443 ' H ' HG23 ' A' ' 107' ' ' ILE . . . 102.3 0.73 50.7 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.966 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.95 177.88 10.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 110.399 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.35 143.94 44.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.818 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -137.18 109.88 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -81.33 120.05 24.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.75 0.786 . . . . 0.0 111.467 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.17 130.9 65.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.827 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.4 m -126.02 137.97 53.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.326 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.594 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.6 OUTLIER -141.34 172.91 12.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.075 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -133.97 135.67 43.64 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.2 t -64.59 131.97 48.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.29 -3.4 23.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.936 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.897 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.91 -50.5 2.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.87 0.367 . . . . 0.0 111.543 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.688 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -90.32 -23.62 21.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.457 -179.346 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.56 6.18 75.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.251 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.688 ' H ' HG22 ' A' ' 120' ' ' THR . . . -60.03 155.55 43.2 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-O 120.604 0.24 . . . . 0.0 110.457 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -87.97 104.27 0.51 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.719 2.279 . . . . 0.0 111.383 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.594 HG22 ' C ' ' A' ' 115' ' ' SER . 33.9 m -98.1 145.14 10.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.1 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.3 p -155.59 142.69 19.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.581 0.705 . . . . 0.0 111.26 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.585 HD21 ' SD ' ' A' ' 141' ' ' MET . 0.5 OUTLIER -135.16 153.32 52.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.685 178.349 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.874 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 32.2 m -108.26 113.84 27.25 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.723 HG13 ' CZ ' ' A' ' 193' ' ' PHE . 41.1 t -95.9 111.51 26.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.026 0.441 . . . . 0.0 111.696 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.409 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.8 OUTLIER -105.86 169.01 7.45 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.744 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 33.3 Cg_endo -65.42 -18.82 60.87 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.14 1.893 . . . . 0.0 112.844 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 70.8 m -112.59 -28.2 7.92 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 131' ' ' SER . 22.1 pt-20 179.54 -163.3 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.237 0.541 . . . . 0.0 110.139 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -95.2 158.66 2.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.753 178.605 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -147.23 19.33 1.22 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.874 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.23 86.19 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.632 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.3 t -105.03 117.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.024 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.44 117.38 4.77 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.087 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.436 ' CD ' HG12 ' A' ' 124' ' ' VAL . 16.7 Cg_exo -67.57 145.91 75.38 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.73 -1.363 . . . . 0.0 112.443 0.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.35 -33.19 52.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.867 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -101.43 30.14 11.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.245 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.873 ' SD ' HG11 ' A' ' 189' ' ' VAL . 5.4 ptp -65.22 157.22 29.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 0.0 111.889 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.8 152.44 50.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.318 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.747 ' CG2' HG12 ' A' ' 189' ' ' VAL . 11.4 t -113.41 153.08 15.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.776 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.404 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 4.4 m -121.7 143.04 49.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.741 0.305 . . . . 0.0 110.608 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.508 HD13 HG21 ' A' ' 187' ' ' VAL . 5.3 mp -145.3 176.08 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.109 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 161' ' ' HIS . 35.4 t -125.35 132.49 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.837 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.413 ' CB ' ' HD3' ' A' ' 148' ' ' PRO . 2.5 mp -78.28 -61.66 0.55 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.932 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 147' ' ' LEU . 78.1 Cg_endo -77.04 -168.07 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.595 2.197 . . . . 0.0 112.416 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -174.6 114.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.935 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.52 -21.25 10.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.286 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -128.82 79.44 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.363 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -179.02 59.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.998 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -177.25 -40.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.97 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 155' ' ' ARG . 28.6 m -61.6 -45.23 99.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.156 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.489 ' N ' HG23 ' A' ' 154' ' ' VAL . 75.6 mtm-85 -135.64 31.06 3.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.949 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 60.46 44.71 11.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.0 m -70.42 138.44 51.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -177.76 62.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -57.73 -41.2 81.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.721 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -177.95 -87.4 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.743 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.41 ' HB3' HG21 ' A' ' 146' ' ' VAL . 9.6 m170 75.93 -47.83 0.58 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.9 t -95.09 103.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.908 0.385 . . . . 0.0 111.52 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.03 169.31 12.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.738 0.78 . . . . 0.0 109.765 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.708 ' CD1' HG13 ' A' ' 143' ' ' VAL . 2.0 m-85 -113.0 152.35 29.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.912 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 60.6 m-85 -131.44 136.83 48.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.766 0.793 . . . . 0.0 110.578 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 122' ' ' ALA . . . -47.88 -25.17 1.22 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.797 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.596 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 44.7 m -164.73 167.62 18.79 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.643 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.62 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.3 t -68.12 -34.45 6.08 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.896 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.3 Cg_exo -72.45 -37.03 4.6 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.768 2.312 . . . . 0.0 110.103 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.583 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.19 -40.57 52.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.731 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.52 -46.15 91.21 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 1.7 mm-40 -78.97 -27.22 43.48 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.331 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.709 ' N ' ' O ' ' A' ' 169' ' ' PRO . 26.5 t70 -70.06 -55.76 8.66 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.192 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.897 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 51.4 t-105 -65.99 -28.29 68.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.723 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.24 -39.45 93.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.13 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.0 t -53.71 -42.25 67.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.428 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 18.46 9.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.382 0.61 . . . . 0.0 111.38 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.438 ' CD2' ' CD1' ' A' ' 174' ' ' TRP . 0.1 OUTLIER -120.31 24.15 10.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.727 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -93.38 -176.71 4.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.768 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.52 -32.22 6.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.355 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.5 mt -63.56 -174.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.323 . . . . 0.0 110.723 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.36 -27.14 67.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.849 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 170.09 159.94 17.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.497 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 185' ' ' ALA . 1.9 tt -179.03 137.68 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.757 0.313 . . . . 0.0 110.751 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.589 ' N ' HD23 ' A' ' 184' ' ' LEU . . . -142.55 150.17 40.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.11 0.481 . . . . 0.0 111.369 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 175' ' ' ALA . 15.5 mm -101.56 161.31 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.747 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.716 HG12 ' CD ' ' A' ' 191' ' ' GLU . 0.0 OUTLIER -159.89 159.79 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.277 0.56 . . . . 0.0 112.15 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 190' ' ' HIS . 42.2 p -89.83 128.59 36.19 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.669 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.873 HG11 ' SD ' ' A' ' 141' ' ' MET . 2.4 m -47.72 -19.15 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.993 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.407 ' N ' ' C ' ' A' ' 188' ' ' SER . 59.5 t-80 -72.82 -42.03 64.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.155 0.502 . . . . 0.0 109.821 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.716 ' CD ' HG12 ' A' ' 187' ' ' VAL . 1.1 pt-20 -82.16 -26.18 33.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.177 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.22 -24.91 66.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.927 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.723 ' CZ ' HG13 ' A' ' 128' ' ' VAL . 1.3 t80 -81.34 -25.58 36.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.68 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.04 -31.76 27.96 Favored Glycine 0 CA--C 1.509 -0.3 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.1 tp -80.83 -28.55 36.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -82.84 -24.77 52.04 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.2 -22.28 36.04 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.969 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -77.74 -22.77 49.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.255 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.13 -39.5 60.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.868 0.366 . . . . 0.0 111.092 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -81.09 -44.34 18.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -35.16 71.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.072 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -30.28 68.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.61 -46.77 89.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.56 ' HB3' HG22 ' A' ' 206' ' ' THR . 4.6 mm? -65.59 -52.09 54.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 59.09 31.51 21.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.56 HG22 ' HB3' ' A' ' 204' ' ' LEU . 7.2 t -100.72 116.51 32.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -157.09 36.35 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.947 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.4 m -160.35 174.05 14.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.0 p -161.48 -68.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.962 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -70.96 -177.83 1.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.417 ' HB ' ' HD3' ' A' ' 212' ' ' PRO . 0.9 OUTLIER 178.8 -55.11 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.417 ' HD3' ' HB ' ' A' ' 211' ' ' THR . 78.0 Cg_exo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.43 2.087 . . . . 0.0 112.447 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.891 0.377 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -168.44 157.36 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 mt -95.13 125.79 40.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.799 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.526 ' O ' HG13 ' A' ' 25' ' ' VAL . 1.8 tt -85.0 -56.7 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 24' ' ' LEU . 6.1 m -158.82 80.68 2.8 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.155 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.467 ' HA ' ' HB2' ' A' ' 29' ' ' ARG . 53.6 Cg_exo -52.02 -24.55 19.83 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.593 2.195 . . . . 0.0 112.407 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.083 HD12 HD12 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.93 -57.23 12.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.328 -179.432 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.083 HD12 HD12 ' A' ' 27' ' ' LEU . 1.1 mp -72.49 -27.36 62.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.251 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.467 ' HB2' ' HA ' ' A' ' 26' ' ' PRO . 5.3 mmt85 -64.42 -53.28 50.85 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.138 0.494 . . . . 0.0 109.824 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -70.91 -25.01 62.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.409 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.697 HD11 ' HA3' ' A' ' 73' ' ' GLY . 4.5 tp -67.6 -40.27 84.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.947 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.23 -25.2 13.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.573 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' NZ ' HG22 ' A' ' 37' ' ' VAL . 1.3 ptpt -70.36 -20.19 62.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.173 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.13 47.69 86.18 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.354 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -133.21 158.3 76.09 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.725 0.297 . . . . 0.0 110.74 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.7 91.63 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.566 2.177 . . . . 0.0 112.262 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.614 ' O ' HD12 ' A' ' 71' ' ' ILE . 21.9 t -92.96 114.92 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.353 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.4 p -77.44 -179.62 5.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.847 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -78.2 -32.55 50.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.631 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -68.34 -30.77 69.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.681 0.277 . . . . 0.0 110.642 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.31 -38.51 20.32 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.31 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.805 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.3 tp -63.16 -41.71 99.29 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.977 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -69.74 -42.96 73.26 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.774 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 40' ' ' THR . . . -67.47 -25.84 73.71 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.254 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.795 HG22 HD23 ' A' ' 46' ' ' LEU . 7.1 mt -76.54 -40.18 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.245 -0.478 . . . . 0.0 110.457 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.805 ' HG ' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -80.22 -6.5 57.93 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.568 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 62.95 30.15 16.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -116.99 149.64 44.52 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.624 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.16 143.72 99.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.626 2.218 . . . . 0.0 112.006 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.48 -16.45 2.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.95 -31.58 45.11 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.586 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.82 ' O ' HG23 ' A' ' 56' ' ' VAL . 13.5 mtp180 -70.18 -40.0 74.92 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.977 HG21 ' HB2' ' A' ' 43' ' ' ALA . 1.8 t -65.63 -46.36 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.36 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.38 -51.7 57.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.112 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.72 -43.24 80.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.7 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 52' ' ' ARG . 27.7 t -70.59 -32.45 49.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.577 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.562 HD22 ' OH ' ' A' ' 65' ' ' TYR . 15.9 mt -61.39 -32.52 72.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.499 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.606 ' O ' HG23 ' A' ' 61' ' ' THR . 3.0 tt0 -57.63 -24.35 56.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.701 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -96.18 -14.43 22.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.482 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -104.11 32.86 3.73 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.466 0.65 . . . . 0.0 110.598 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 58' ' ' GLU . 27.0 p -66.89 -14.39 62.7 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.233 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 t -86.78 -23.9 25.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 111.346 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.482 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -55.81 141.23 39.48 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.047 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.543 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -78.99 126.79 31.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.038 0.447 . . . . 0.0 111.474 -179.397 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.562 ' OH ' HD22 ' A' ' 57' ' ' LEU . 13.1 m-85 -100.64 168.81 9.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.267 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -153.87 143.61 21.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.549 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.7 tttp 66.9 -102.64 0.07 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.824 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.32 -13.04 28.64 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.74 31.86 0.79 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.051 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.67 169.03 11.65 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 37' ' ' VAL . 4.0 mp -79.8 114.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.27 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.782 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -103.28 -27.46 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.112 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.697 ' HA3' HD11 ' A' ' 31' ' ' LEU . . . 90.17 162.32 38.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.516 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.404 ' O ' ' CG ' ' A' ' 74' ' ' TYR . 11.9 t80 -111.23 31.44 6.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.808 0.337 . . . . 0.0 110.909 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.11 -62.44 1.43 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.556 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -78.73 147.94 33.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.3 p -107.66 159.05 16.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.35 -30.8 60.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -102.8 147.57 26.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -64.52 122.27 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.9 p -106.91 -174.72 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.2 p -92.65 -37.29 12.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 45.6 m-85 -87.24 113.97 23.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.08 142.73 20.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.984 ' CE2' HD13 ' A' ' 101' ' ' LEU . 59.8 t80 -124.72 105.19 9.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.346 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -98.62 126.23 44.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.323 . . . . 0.0 111.42 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.621 HD11 ' HB2' ' A' ' 90' ' ' ARG . 6.9 pt -118.76 177.89 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.396 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 87' ' ' ILE . 8.6 t0 -14.52 -53.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 87' ' ' ILE . 21.7 p30 -165.74 35.48 0.05 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.033 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.621 ' HB2' HD11 ' A' ' 87' ' ' ILE . 12.1 mmt180 -142.03 113.07 7.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.72 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.64 119.39 21.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.791 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.3 164.88 12.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.268 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -133.95 165.14 25.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.099 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.63 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -153.45 171.39 18.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.115 0.483 . . . . 0.0 111.855 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -94.37 -20.27 19.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.007 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.407 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 2.3 m -157.51 179.81 8.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.668 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB2' ' HD2' ' A' ' 164' ' ' PHE . . . -56.52 -21.89 29.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tp -89.18 -51.92 5.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.63 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 4.8 m-20 -46.95 -26.54 1.03 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -60.36 -36.26 77.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.666 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.984 HD13 ' CE2' ' A' ' 85' ' ' PHE . 3.3 tp -176.78 152.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.5 pt -122.82 -39.24 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.519 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -119.7 81.7 25.56 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.168 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.633 ' HA ' HD21 ' A' ' 101' ' ' LEU . 7.3 Cg_exo -72.58 -29.0 13.69 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.797 2.331 . . . . 0.0 112.215 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.09 -23.76 59.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.249 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -78.74 -29.91 45.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.906 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 104' ' ' PRO . 3.9 mm -54.16 -60.55 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.082 0.944 . . . . 0.0 110.988 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.29 25.21 Favored Glycine 0 C--N 1.316 -0.545 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.301 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.16 -177.27 5.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.357 . . . . 0.0 110.462 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.09 148.5 27.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.795 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.24 110.01 7.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -80.8 121.05 25.46 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.714 0.768 . . . . 0.0 110.86 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.822 HG22 ' CD1' ' A' ' 85' ' ' PHE . 90.5 t -113.8 131.78 64.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.934 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.6 p -119.42 138.25 53.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.712 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.535 ' OG ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -140.67 172.8 12.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.42 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -135.15 131.32 36.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.54 178.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.662 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.3 m -57.41 124.45 18.98 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.918 0.389 . . . . 0.0 111.902 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.538 ' HB2' ' HD2' ' A' ' 163' ' ' HIS . . . -68.12 -9.49 46.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.628 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.701 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.67 -51.2 2.05 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.557 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -76.24 -20.83 57.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.917 0.389 . . . . 0.0 110.767 -179.024 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.3 33.69 85.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.108 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.557 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -100.91 168.01 9.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.437 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 46.3 Cg_endo -93.89 110.27 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 123.024 2.483 . . . . 0.0 111.313 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.535 HG23 ' OG ' ' A' ' 115' ' ' SER . 35.3 m -109.51 148.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.492 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 86.0 p -147.62 142.43 26.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.509 0.671 . . . . 0.0 110.567 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -135.19 152.13 51.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.743 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.801 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 42.8 m -111.25 112.31 24.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 104' ' ' PRO . 32.6 t -96.93 114.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.008 0.432 . . . . 0.0 112.137 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.42 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -105.72 170.19 6.15 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.702 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.9 Cg_endo -66.64 -19.51 53.9 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.158 1.905 . . . . 0.0 113.001 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 6.9 t -108.87 -27.41 9.73 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 131' ' ' SER . 14.9 pt-20 178.05 -162.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.64 162.84 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.472 178.248 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -150.09 21.28 0.87 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.434 0.635 . . . . 0.0 112.326 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.801 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.95 87.4 0.09 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.44 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 t -104.1 119.88 53.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.156 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.18 122.9 5.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.796 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.506 ' CD ' HG12 ' A' ' 124' ' ' VAL . 61.9 Cg_endo -73.24 159.63 97.03 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.382 -1.507 . . . . 0.0 112.322 0.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.92 79.37 0.64 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.134 0.492 . . . . 0.0 110.658 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.26 18.02 0.17 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.282 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.593 ' CG ' HG11 ' A' ' 189' ' ' VAL . 9.8 ptm -60.98 157.82 14.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.019 0.438 . . . . 0.0 111.395 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.492 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -127.13 152.01 47.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.326 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.939 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -117.93 152.34 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.991 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.423 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 53.1 p -117.47 143.74 45.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.766 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 146' ' ' VAL . 0.2 OUTLIER -136.54 176.05 9.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.819 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.722 HG12 ' CD1' ' A' ' 184' ' ' LEU . 29.9 m -120.42 159.72 21.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.9 mt -89.36 149.32 42.48 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.08 -45.92 35.85 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.588 2.192 . . . . 0.0 112.338 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLN . . . . . 0.749 ' OE1' ' HB3' ' A' ' 151' ' ' ALA . 0.7 OUTLIER 61.15 158.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -92.82 -21.4 19.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.179 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.749 ' HB3' ' OE1' ' A' ' 149' ' ' GLN . . . -87.14 -20.13 27.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.366 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.87 167.67 20.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.536 ' O ' HG13 ' A' ' 154' ' ' VAL . 1.6 t70 -130.82 -67.93 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 153' ' ' ASP . 5.5 m -159.21 -45.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -81.57 -30.59 32.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -100.97 58.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' A' ' 158' ' ' PHE . 13.3 t -154.5 -81.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.432 ' CG ' ' O ' ' A' ' 157' ' ' SER . 42.4 p90 43.53 36.46 1.18 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.364 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 17.2 m -73.8 -46.05 47.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.78 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.658 ' SG ' HD13 ' A' ' 181' ' ' LEU . 1.5 m -115.3 -37.12 4.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.405 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 1.3 t60 63.58 28.29 15.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.053 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 145' ' ' LEU . 75.8 t 57.82 110.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.047 0.451 . . . . 0.0 111.611 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.538 ' HD2' ' HB2' ' A' ' 118' ' ' ALA . 1.6 m80 -118.91 169.35 9.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.558 0.694 . . . . 0.0 109.773 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.939 ' CE1' HG22 ' A' ' 143' ' ' VAL . 0.4 OUTLIER -111.05 151.14 28.38 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.036 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 45.6 m-85 -135.83 134.6 39.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.251 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.662 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -38.93 -29.68 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.146 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 35.2 m -170.49 178.0 3.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.062 0.458 . . . . 0.0 111.575 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.61 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 90.5 t -69.57 -33.77 4.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.491 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.5 Cg_exo -72.64 -38.78 3.0 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.563 2.175 . . . . 0.0 110.41 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.556 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.23 -39.65 54.05 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.035 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.751 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.88 -46.81 87.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 2.3 mm-40 -78.99 -26.98 43.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.5 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 169' ' ' PRO . 4.8 t70 -70.89 -55.72 7.82 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.701 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 32.3 t-105 -65.03 -29.75 70.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.787 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.33 -39.6 95.0 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.242 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -44.43 62.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.338 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.16 23.87 6.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.172 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.798 ' CE1' HD11 ' A' ' 181' ' ' LEU . 4.0 t60 -136.41 33.38 2.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.037 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -95.32 143.79 26.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.675 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 125.54 -24.45 5.83 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.573 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.798 HD11 ' CE1' ' A' ' 178' ' ' HIS . 3.6 mt -68.24 69.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 55.88 28.64 12.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 75.6 72.54 1.05 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.515 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.722 ' CD1' HG12 ' A' ' 146' ' ' VAL . 7.9 tp -75.0 152.66 38.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.771 0.32 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -140.28 148.89 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.022 0.439 . . . . 0.0 111.121 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.662 HD11 ' HB2' ' A' ' 175' ' ' ALA . 17.1 mm -100.71 160.53 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.987 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.473 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -162.79 150.66 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.144 0.497 . . . . 0.0 111.969 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -78.98 126.07 30.2 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.635 178.082 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.612 ' HA ' ' HB3' ' A' ' 192' ' ' ALA . 0.2 OUTLIER -46.54 -20.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.885 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -72.24 -45.1 61.63 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.0 OUTLIER -82.73 -22.41 34.44 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.141 178.175 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -67.83 -25.61 65.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.729 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 197' ' ' GLN . 0.2 OUTLIER -81.75 -24.94 35.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.627 179.147 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.08 -31.52 28.43 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -29.73 31.53 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -82.27 -28.46 40.38 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.409 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 37.5 tt0 -82.47 -22.57 35.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.866 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -81.09 -25.23 37.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.85 -29.76 20.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 0.0 111.291 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -80.43 -55.13 5.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.902 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -63.24 -30.57 71.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -80.02 -45.07 19.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.005 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.82 -41.18 86.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.956 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -44.87 83.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -87.38 144.05 26.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.13 -39.97 6.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -113.58 159.96 19.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.5 m -93.2 111.38 23.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.936 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.0 t -151.82 -66.0 0.18 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.47 167.51 22.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.436 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -176.4 -63.09 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.993 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.5 Cg_endo . . . . . 0 C--O 1.247 0.943 0 C-N-CA 122.348 2.032 . . . . 0.0 112.34 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.81 0.338 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -65.89 165.62 12.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.0 tp -99.03 98.95 9.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.568 HD21 HH11 ' A' ' 29' ' ' ARG . 0.7 OUTLIER -142.64 150.21 39.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.76 HG11 HD23 ' A' ' 28' ' ' LEU . 21.5 t -110.3 86.8 5.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.136 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.796 ' CG ' HD11 ' A' ' 46' ' ' LEU . 43.0 Cg_endo -67.83 -27.12 37.74 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.525 2.15 . . . . 0.0 112.371 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.709 ' HG ' HD21 ' A' ' 42' ' ' LEU . 5.2 mp -52.66 -57.44 10.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.232 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.76 HD23 HG11 ' A' ' 25' ' ' VAL . 3.9 pp -80.07 -27.3 39.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.066 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.568 HH11 HD21 ' A' ' 24' ' ' LEU . 10.6 ttt85 -64.83 -53.29 49.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -65.78 -23.78 66.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.287 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.677 HD11 ' O ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -68.04 -37.59 81.53 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.773 179.727 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.19 -26.41 17.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 111.03 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -20.97 66.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.226 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.63 48.3 82.63 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.153 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -133.06 157.26 78.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.724 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.3 91.02 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.516 2.144 . . . . 0.0 112.121 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.644 HG13 HG22 ' A' ' 41' ' ' THR . 21.5 t -93.01 113.5 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.38 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.8 p -87.0 -174.16 4.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.718 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -77.93 -36.23 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.321 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -28.72 69.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.907 0.384 . . . . 0.0 110.09 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.644 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.46 -41.82 16.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.345 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.709 HD21 ' HG ' ' A' ' 27' ' ' LEU . 2.2 tp -62.63 -36.5 83.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.92 -43.27 62.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.589 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -30.89 74.95 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.689 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.588 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.09 -42.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.067 0.461 . . . . 0.0 110.376 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.796 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.1 mp -76.44 -9.66 58.82 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.41 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.1 t0 60.34 21.64 11.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.43 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 5.3 m95 -107.48 158.1 34.07 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.171 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.02 144.09 62.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.607 2.205 . . . . 0.0 112.114 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.0 -16.92 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -78.64 -35.04 46.01 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.208 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.828 ' O ' HG23 ' A' ' 56' ' ' VAL . 3.6 ttt-85 -67.6 -41.1 84.59 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.645 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -63.03 -47.73 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.483 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.26 -53.11 55.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.206 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.77 -46.92 77.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.794 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 52' ' ' ARG . 30.9 t -67.65 -32.03 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.724 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -64.22 -33.26 75.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.657 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 61' ' ' THR . 6.0 tp10 -58.16 -22.06 49.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.88 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -90.85 -17.47 26.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.06 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HB1' ' HB ' ' A' ' 63' ' ' THR . . . -97.18 33.09 2.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.367 0.603 . . . . 0.0 111.121 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.694 HG23 ' O ' ' A' ' 58' ' ' GLU . 73.1 p -60.1 -20.63 59.15 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.912 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.56 -22.6 21.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.411 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB1' ' A' ' 60' ' ' ALA . 0.8 OUTLIER -58.46 141.06 52.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.523 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -78.85 126.9 31.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 0.0 111.604 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.433 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 62.5 m-85 -103.43 173.17 6.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.192 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.824 ' HB2' HG21 ' A' ' 72' ' ' ILE . 22.5 t70 -153.53 147.87 25.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.416 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.7 tttp 66.28 -102.01 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.782 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.23 -13.05 33.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.97 30.76 1.18 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.92 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -85.92 164.83 17.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.957 0.408 . . . . 0.0 110.189 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -79.96 109.61 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.336 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.824 HG21 ' HB2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -123.51 -26.88 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.642 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.84 174.36 24.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.578 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 28' ' ' LEU . 46.7 t80 -173.88 -51.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.814 ' O ' HD12 ' A' ' 92' ' ' LEU . . . -147.05 46.83 0.71 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.553 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.617 HD12 HD13 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -128.15 150.96 49.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.764 0.316 . . . . 0.0 110.96 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.571 ' N ' HD23 ' A' ' 76' ' ' LEU . 67.5 p -99.75 159.08 15.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.812 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.73 -32.66 25.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -96.53 144.23 26.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.1 122.09 17.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.3 p -107.36 -177.05 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 53.1 m -93.08 -30.47 15.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.904 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.544 ' HE2' ' HB2' ' A' ' 97' ' ' ALA . 20.6 m-85 -86.68 117.35 25.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.362 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.458 HG22 ' HE1' ' A' ' 93' ' ' TYR . 21.2 t -110.01 142.31 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.488 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.83 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 46.2 t80 -125.58 105.21 8.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.717 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.14 121.01 34.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.173 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.608 HD11 HD23 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -139.03 122.93 19.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.617 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 58.3 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.327 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.0 t70 -159.38 35.83 0.2 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.432 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -139.79 113.88 8.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.641 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -77.78 86.32 4.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.979 0.418 . . . . 0.0 111.02 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 75' ' ' GLY . 3.4 mm? -71.77 164.64 25.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.439 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.458 ' HE1' HG22 ' A' ' 84' ' ' VAL . 40.5 m-85 -137.46 162.2 34.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.821 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 100' ' ' THR . . . -145.03 164.09 32.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.119 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -81.31 -33.37 32.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.45 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 59.7 m -152.92 -177.8 6.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.056 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.874 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -61.84 148.86 41.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.706 0.289 . . . . 0.0 110.917 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.48 ' CB ' ' O ' ' A' ' 97' ' ' ALA . 1.7 tt 88.11 -51.48 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.666 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -54.58 -21.61 10.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.208 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 1.3 p -60.45 -39.51 87.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.381 . . . . 0.0 110.544 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.627 ' O ' HG23 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -110.34 -172.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.174 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.8 HD12 ' CE2' ' A' ' 103' ' ' PHE . 3.3 pt -161.76 -43.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.975 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 102' ' ' ILE . 2.2 p90 -163.0 93.64 1.16 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.762 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.672 ' HB3' HG12 ' A' ' 128' ' ' VAL . 74.1 Cg_endo -74.45 -35.07 4.0 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.7 2.266 . . . . 0.0 112.368 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.69 -23.99 53.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.8 tp -84.89 -42.41 15.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.338 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.3 tp -57.18 -46.95 84.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.295 0.569 . . . . 0.0 111.417 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.52 23.64 18.31 Favored Glycine 0 C--N 1.318 -0.423 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.699 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 173.46 15.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.893 0.378 . . . . 0.0 111.077 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -80.81 152.91 28.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.897 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.83 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.16 109.77 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -83.03 120.64 26.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.78 0.8 . . . . 0.0 111.158 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.75 HG22 ' HD1' ' A' ' 85' ' ' PHE . 60.3 t -112.44 129.44 67.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.963 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.7 m -119.72 137.93 53.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.029 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.695 ' HB2' HG23 ' A' ' 124' ' ' VAL . 3.1 m -141.25 172.8 12.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.478 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 3.8 p80 -137.82 132.67 32.98 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 23.0 t -61.15 130.8 48.09 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.152 0.501 . . . . 0.0 112.16 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.91 -3.14 20.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.756 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.823 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.14 -50.46 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 0.0 111.601 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -90.14 -24.67 21.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.29 -179.465 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.09 81.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.108 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.689 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.29 158.68 13.48 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 120.581 0.229 . . . . 0.0 110.483 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -91.49 106.16 0.26 Allowed 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.757 2.305 . . . . 0.0 111.246 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.7 HG12 ' CD ' ' A' ' 138' ' ' PRO . 32.2 m -103.92 145.66 12.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.277 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.926 ' O ' HD13 ' A' ' 126' ' ' LEU . 64.3 p -151.47 141.47 22.09 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.386 0.612 . . . . 0.0 110.79 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.926 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -135.22 153.07 52.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.434 178.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.864 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 54.7 m -110.57 113.52 26.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.814 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.672 HG12 ' HB3' ' A' ' 104' ' ' PRO . 24.2 t -96.04 111.63 26.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.482 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.79 171.17 4.94 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.282 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.34 -14.93 46.32 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.503 2.135 . . . . 0.0 113.087 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.9 p -119.88 -27.23 5.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -179.97 -163.57 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.166 0.508 . . . . 0.0 110.17 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -95.88 158.94 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.97 178.784 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -147.34 18.75 1.21 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.404 0.621 . . . . 0.0 112.555 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.864 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.32 85.83 0.07 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.466 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.815 HG13 HD12 ' A' ' 126' ' ' LEU . 21.3 t -106.46 118.13 53.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.334 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -146.45 116.28 4.64 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.691 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.7 ' CD ' HG12 ' A' ' 124' ' ' VAL . 15.4 Cg_exo -68.55 145.25 76.15 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.726 -1.364 . . . . 0.0 112.32 0.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.25 -29.31 22.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.698 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.55 33.7 6.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.776 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.781 ' SD ' HD11 ' A' ' 126' ' ' LEU . 1.1 ptm -66.26 159.74 25.9 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.068 0.434 . . . . 0.0 111.13 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -131.58 152.74 50.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.063 0.459 . . . . 0.0 111.604 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.677 ' CG2' HG12 ' A' ' 189' ' ' VAL . 44.4 t -111.12 146.16 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.314 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.468 ' O ' ' HB ' ' A' ' 162' ' ' VAL . 47.4 m -114.8 141.26 48.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.689 0.281 . . . . 0.0 110.653 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.612 ' HA ' HG12 ' A' ' 162' ' ' VAL . 6.8 mt -103.18 149.07 25.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.081 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.866 HG22 ' HD3' ' A' ' 148' ' ' PRO . 11.6 p -125.11 137.55 57.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.011 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.762 ' HB2' HD13 ' A' ' 184' ' ' LEU . 2.1 mm? -134.9 73.53 66.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.921 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.866 ' HD3' HG22 ' A' ' 146' ' ' VAL . 70.7 Cg_endo -74.91 -39.84 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.513 2.142 . . . . 0.0 112.37 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -176.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.95 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -101.71 -20.58 14.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.092 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -179.91 -35.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.222 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.75 -174.11 0.11 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.14 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.528 ' O ' HG13 ' A' ' 154' ' ' VAL . 3.9 t70 -141.97 -62.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.945 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 153' ' ' ASP . 6.6 m -158.77 -44.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -57.76 -30.86 65.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.986 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -125.63 61.29 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.03 0.443 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.2 p -171.73 94.81 0.16 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -161.84 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 60.7 m -81.07 -46.01 15.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.905 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 28.9 m 74.18 -1.0 3.19 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.857 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 3.3 m80 51.44 43.22 29.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 111.015 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 145' ' ' LEU . 3.5 m -62.04 169.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.872 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -116.03 166.81 11.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.525 0.679 . . . . 0.0 109.762 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.874 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.3 m-30 -117.84 129.67 55.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.768 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.509 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 19.4 m-85 -108.68 142.58 38.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.401 0.619 . . . . 0.0 110.608 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -46.08 -26.72 0.79 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.825 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.556 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 25.7 p -169.94 170.8 7.47 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.82 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 72.0 t -67.76 -33.41 5.23 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.32 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.2 Cg_exo -72.7 -37.89 3.6 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.724 2.283 . . . . 0.0 110.292 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.08 -40.39 53.23 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.97 -45.97 91.31 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.6 mt-10 -78.96 -27.63 43.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.244 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 169' ' ' PRO . 9.4 t70 -70.79 -55.94 7.44 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.59 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.823 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 77.2 t-105 -65.15 -27.84 69.0 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.685 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -62.4 -38.99 91.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.215 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.3 t -54.68 -47.78 73.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.442 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -95.48 21.6 7.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.258 0.551 . . . . 0.0 111.034 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.697 ' HA ' HD12 ' A' ' 181' ' ' LEU . 78.8 t60 -132.77 29.75 4.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.951 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -87.49 132.72 33.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.604 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.02 -25.72 22.47 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.864 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 178' ' ' HIS . 5.3 mt -83.67 -162.82 0.68 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.595 0.236 . . . . 0.0 110.666 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.518 ' HG3' HG21 ' A' ' 146' ' ' VAL . 5.3 tt0 -59.77 82.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.93 0.395 . . . . 0.0 110.845 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.449 ' N ' HG23 ' A' ' 146' ' ' VAL . . . 175.86 -167.88 39.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.093 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 147' ' ' LEU . 4.3 tp -176.48 -58.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 111.406 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -143.64 150.51 38.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.109 0.481 . . . . 0.0 111.539 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.5 mm -100.7 161.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.638 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.471 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -164.48 165.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.398 0.618 . . . . 0.0 112.11 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.5 OUTLIER -93.79 132.79 37.84 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.539 178.442 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.763 HG11 ' SD ' ' A' ' 141' ' ' MET . 3.6 m -48.27 -17.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.878 0.37 . . . . 0.0 110.927 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 0.6 OUTLIER -73.33 -44.51 58.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.134 0.492 . . . . 0.0 109.753 179.075 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.38 -21.61 35.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.53 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -76.49 -25.37 54.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.278 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.42 ' CE2' ' HG3' ' A' ' 197' ' ' GLN . 85.8 t80 -81.7 -25.89 35.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 110.722 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.79 -30.25 32.81 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -81.59 -27.74 34.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.482 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -27.33 34.29 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.42 ' HG3' ' CE2' ' A' ' 193' ' ' PHE . 1.5 mm100 -82.33 -23.21 35.22 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.495 -0.352 . . . . 0.0 111.023 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -79.28 -23.08 43.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.229 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -52.2 -32.01 34.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -81.14 -55.03 5.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -58.98 -45.9 89.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -58.94 -31.09 68.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.14 -48.52 17.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.2 mt -61.24 -51.99 66.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -60.55 146.78 43.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.6 m -143.7 117.42 9.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 15.4 mtp -81.43 -38.75 25.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.6 p -72.8 142.24 48.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 14.5 p -93.83 121.46 35.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.926 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.6 110.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.432 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -176.3 -63.0 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.5 Cg_endo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.444 2.096 . . . . 0.0 112.294 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.826 0.346 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.34 34.45 3.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mp 63.71 -79.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.998 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 24' ' ' LEU . 3.9 pp -130.88 133.2 45.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.89 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 25' ' ' VAL . 10.8 p -68.36 120.99 78.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.022 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.604 ' CG ' HD11 ' A' ' 46' ' ' LEU . 58.7 Cg_endo -71.51 -28.65 17.42 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.403 2.069 . . . . 0.0 112.359 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 27' ' ' LEU . 5.8 mp -52.27 -57.18 10.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.632 HD13 HD13 ' A' ' 31' ' ' LEU . 4.0 mm? -75.56 -27.14 58.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.921 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -53.45 57.38 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.629 ' OE2' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -71.12 -24.3 62.26 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.126 178.165 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.632 HD13 HD13 ' A' ' 28' ' ' LEU . 8.8 tt -66.2 -48.24 71.26 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.759 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.49 -26.09 19.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.61 -22.11 65.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.27 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 47.03 92.97 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.147 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -127.42 163.95 39.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.694 0.283 . . . . 0.0 110.86 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.34 111.61 2.1 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.553 2.169 . . . . 0.0 112.107 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.692 HG13 HG22 ' A' ' 41' ' ' THR . 22.6 t -116.35 111.04 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.398 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 p -91.39 179.62 5.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.688 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -69.22 -40.99 77.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.213 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -24.64 66.83 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.279 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.692 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.96 -44.16 12.59 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.383 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.73 HD12 HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -62.8 -36.29 82.67 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.664 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.95 -42.83 63.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.57 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.51 -31.56 73.98 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.652 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.604 HD12 HG23 ' A' ' 41' ' ' THR . 7.3 mt -78.32 -46.08 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 120.965 0.412 . . . . 0.0 110.528 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.604 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.7 mp -75.73 -9.61 58.73 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.614 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 59.91 21.78 10.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.456 ' CE3' HD23 ' A' ' 46' ' ' LEU . 16.4 m0 -103.68 160.06 27.32 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.175 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.93 138.79 41.42 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.595 2.197 . . . . 0.0 111.91 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.03 -20.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.55 -32.28 47.78 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.059 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.615 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.48 -40.98 85.27 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.578 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.69 -48.02 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.616 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.75 -52.05 61.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.488 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.22 -38.79 27.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 52' ' ' ARG . 39.1 t -58.38 -30.06 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.782 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 57' ' ' LEU . 7.2 mp -81.0 -23.62 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.873 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.9 -23.49 31.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.091 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -126.64 5.83 6.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.229 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -123.17 76.94 1.42 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.722 0.772 . . . . 0.0 110.441 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.9 p -99.3 -22.44 15.59 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.118 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 p -70.5 -26.08 63.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.192 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.46 141.38 42.7 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' O ' HG22 ' A' ' 72' ' ' ILE . 1.7 tt0 -78.85 126.77 31.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 111.354 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -104.03 171.7 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.491 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 70' ' ' ASN . 1.9 t0 -92.45 -172.85 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.376 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -37.71 86.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.58 9.52 29.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.718 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.76 18.76 62.93 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.065 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 66' ' ' ASP . 56.8 m-20 -92.03 167.34 12.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.076 0.438 . . . . 0.0 110.091 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.73 HD13 HD12 ' A' ' 42' ' ' LEU . 4.1 mp -79.82 119.18 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.329 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.7 tt -102.49 -27.26 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.028 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.403 ' CA ' HD11 ' A' ' 31' ' ' LEU . . . 64.54 -174.03 15.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.605 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CZ ' ' HG3' ' A' ' 90' ' ' ARG . 87.3 m-85 61.0 155.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.881 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.06 -98.5 0.13 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.632 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.591 HD13 ' CD2' ' A' ' 92' ' ' LEU . 4.6 mp 60.71 -87.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.701 0.286 . . . . 0.0 110.68 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.476 HG21 ' HD1' ' A' ' 95' ' ' TRP . 12.3 p -126.06 159.33 33.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.501 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.504 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.9 OUTLIER -83.97 52.44 2.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 0.0 111.096 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.428 ' HA ' ' CD1' ' A' ' 93' ' ' TYR . 27.4 mtm-85 49.38 95.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.088 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.1 tp10 -169.15 -144.09 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.635 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.884 HG21 ' HA ' ' A' ' 95' ' ' TRP . 0.7 OUTLIER 41.19 -173.36 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 178.413 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 p -107.34 -19.65 13.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.364 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -76.87 111.25 12.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.688 0.28 . . . . 0.0 110.485 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.0 137.65 41.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 111.388 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.851 ' CD1' HG22 ' A' ' 113' ' ' VAL . 34.6 t80 -126.79 105.07 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.162 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -96.82 124.83 40.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.14 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.548 HG21 ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.15 128.72 26.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.998 0.428 . . . . 0.0 112.109 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 61.13 -77.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.318 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 87' ' ' ILE . 7.6 t70 -156.3 37.39 0.33 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.65 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.437 ' HG3' ' CZ ' ' A' ' 74' ' ' TYR . 4.2 mmm180 -141.78 149.65 40.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.781 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 86.22 2.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.013 0.435 . . . . 0.0 110.673 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.591 ' CD2' HD13 ' A' ' 76' ' ' LEU . 8.5 mp -71.39 164.64 25.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.975 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 79' ' ' ARG . 88.9 m-85 -133.48 165.18 25.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.973 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -150.91 166.24 31.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.001 0.429 . . . . 0.0 111.962 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.884 ' HA ' HG21 ' A' ' 81' ' ' THR . 12.0 m0 -90.75 -23.17 20.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.403 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 65.2 m -153.81 174.83 14.05 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.941 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB1' ' CZ ' ' A' ' 164' ' ' PHE . . . -53.83 -21.49 7.65 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -51.78 6.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.622 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -49.36 -25.65 2.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.696 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -60.07 -28.97 68.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.952 0.406 . . . . 0.0 110.5 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 102' ' ' ILE . 5.1 tp 70.48 155.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.069 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.719 ' HB ' HG11 ' A' ' 128' ' ' VAL . 2.1 pt -158.84 77.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.789 ' O ' HG22 ' A' ' 107' ' ' ILE . 14.8 p90 -121.2 54.13 4.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.947 ' HG3' HG12 ' A' ' 128' ' ' VAL . 28.8 Cg_endo -62.7 -37.61 55.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.696 2.264 . . . . 0.0 112.235 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 130' ' ' PRO . . . -64.03 -30.33 71.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.581 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.89 -47.69 13.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -67.73 -41.09 84.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 111.285 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.82 28.47 8.29 Favored Glycine 0 C--N 1.319 -0.38 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.171 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.14 177.39 10.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.051 0.453 . . . . 0.0 110.895 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 m -87.28 160.28 18.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.993 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.663 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -136.55 109.84 7.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.869 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -82.96 119.43 24.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.818 0.818 . . . . 0.0 111.185 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.851 HG22 ' CD1' ' A' ' 85' ' ' PHE . 42.0 t -109.98 128.92 65.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.878 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.1 m -121.75 136.72 54.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.961 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.625 ' HB2' HG23 ' A' ' 124' ' ' VAL . 3.4 m -141.5 172.98 11.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -131.06 130.93 43.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 30.9 m -56.29 125.6 22.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.95 0.405 . . . . 0.0 112.041 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.21 -7.0 38.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.62 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -119.39 -50.56 2.33 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.35 -13.96 36.7 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.898 -179.166 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 63.8 11.24 42.46 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.674 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.547 ' H ' HG22 ' A' ' 120' ' ' THR . . . -71.83 164.38 58.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.697 0.284 . . . . 0.0 110.691 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.49 107.98 0.42 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 123.037 2.491 . . . . 0.0 111.328 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' A' ' 115' ' ' SER . 33.5 m -104.95 146.27 12.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.421 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.891 ' O ' HD13 ' A' ' 126' ' ' LEU . 60.6 p -151.45 141.69 22.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.384 0.611 . . . . 0.0 110.883 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -134.3 152.58 51.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.137 178.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.843 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 20.8 m -111.55 114.3 27.28 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.947 HG12 ' HG3' ' A' ' 104' ' ' PRO . 39.7 t -96.09 111.79 27.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.016 0.436 . . . . 0.0 111.243 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.491 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -105.68 172.9 3.59 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.215 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 41.2 Cg_endo -67.57 -19.82 47.95 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.271 1.981 . . . . 0.0 113.097 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 0.4 OUTLIER -112.57 -26.7 8.53 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.117 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 131' ' ' SER . 19.9 pt-20 178.62 -161.02 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.19 0.519 . . . . 0.0 110.108 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -91.79 160.5 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.565 178.532 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -150.18 17.87 0.85 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.843 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.07 85.12 0.07 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.102 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.407 HG13 HD12 ' A' ' 126' ' ' LEU . 32.9 t -99.6 122.86 51.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.637 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -146.06 118.8 5.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.95 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.413 ' HD2' HG12 ' A' ' 124' ' ' VAL . 60.0 Cg_endo -72.42 159.65 95.8 Favored 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 123.396 -1.502 . . . . 0.0 112.094 -0.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.26 78.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.103 0.478 . . . . 0.0 110.673 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.13 18.47 0.17 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.692 -0.765 . . . . 0.0 113.288 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.873 ' SD ' HD11 ' A' ' 126' ' ' LEU . 6.5 ptm -67.4 164.43 18.67 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.968 0.384 . . . . 0.0 111.303 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -125.0 152.16 44.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.172 0.511 . . . . 0.0 111.049 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.738 HG13 ' CD1' ' A' ' 164' ' ' PHE . 2.5 t -113.08 150.42 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 20.3 p -118.29 140.19 50.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.851 0.358 . . . . 0.0 110.835 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.404 HD21 HG21 ' A' ' 187' ' ' VAL . 0.8 OUTLIER -149.23 176.52 10.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.723 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 146' ' ' VAL . 11.8 p -117.08 112.77 40.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.901 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' A' ' 185' ' ' ALA . 2.7 mt -58.14 -61.76 6.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.867 ' CG ' HD21 ' A' ' 184' ' ' LEU . 56.1 Cg_endo -70.4 145.86 54.64 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.515 2.144 . . . . 0.0 112.339 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -145.34 115.09 7.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.44 -21.26 15.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.205 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.06 74.52 1.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.032 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -153.55 -68.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.035 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.4 t70 68.58 -68.37 0.18 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 155' ' ' ARG . 6.3 m -142.54 -47.12 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.158 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.421 ' N ' HG23 ' A' ' 154' ' ' VAL . 3.7 ttp85 -160.67 52.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.868 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -94.3 -34.74 12.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.1 t -73.63 -174.42 1.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.931 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -140.94 -50.32 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.95 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -46.21 15.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' CYS . . . . . 0.531 ' HB3' HG23 ' A' ' 162' ' ' VAL . 6.0 t 78.36 -3.25 2.32 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.589 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 182' ' ' GLU . 4.1 m-70 48.44 42.61 18.73 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.884 0.373 . . . . 0.0 111.287 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 160' ' ' CYS . 12.4 t -104.97 110.62 31.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.583 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -120.84 169.44 10.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.565 0.698 . . . . 0.0 109.777 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.738 ' CD1' HG13 ' A' ' 143' ' ' VAL . 49.8 m-85 -115.08 152.67 32.11 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.382 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 37.9 m-85 -134.09 137.84 44.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.181 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.626 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -43.85 -27.92 0.39 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.255 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.569 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 67.8 m -165.98 172.3 11.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.118 0.485 . . . . 0.0 111.577 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 76.2 t -69.38 -34.16 4.53 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.02 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.3 -37.41 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.645 2.23 . . . . 0.0 110.136 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.59 -40.02 50.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.085 -0.962 . . . . 0.0 108.415 177.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.724 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.29 -45.75 93.16 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.8 mt-10 -78.79 -27.47 44.48 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.291 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 169' ' ' PRO . 28.8 t70 -71.05 -55.92 7.23 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.517 0.675 . . . . 0.0 109.308 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.62 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 32.9 t-105 -64.59 -28.66 69.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.806 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -65.39 -38.55 90.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.349 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.2 t -52.07 -46.42 65.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.469 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -97.55 24.36 6.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.017 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.723 ' HA ' HD12 ' A' ' 181' ' ' LEU . 3.9 t60 -156.68 45.81 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.091 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -88.56 125.39 34.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.691 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 91.32 -19.99 43.54 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.261 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.723 HD12 ' HA ' ' A' ' 178' ' ' HIS . 2.8 mt -86.86 87.11 7.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.733 0.301 . . . . 0.0 111.104 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.419 ' HA ' ' CD2' ' A' ' 161' ' ' HIS . 18.8 mt-10 57.62 69.36 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.945 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 110.51 91.83 2.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.367 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.867 HD21 ' CG ' ' A' ' 148' ' ' PRO . 3.7 pp -94.67 -3.93 48.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.442 ' HB2' HD12 ' A' ' 147' ' ' LEU . . . -131.34 141.19 49.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.101 0.477 . . . . 0.0 111.353 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 175' ' ' ALA . 18.3 mm -104.44 160.95 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.019 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -160.62 162.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.373 0.606 . . . . 0.0 111.775 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 190' ' ' HIS . 1.7 m -92.13 133.99 35.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.475 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.536 HG11 ' HG3' ' A' ' 141' ' ' MET . 1.7 m -45.87 -20.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.882 0.373 . . . . 0.0 110.654 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.425 ' N ' ' C ' ' A' ' 188' ' ' SER . 93.9 m-70 -70.77 -45.2 65.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.818 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.631 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.4 OUTLIER -82.42 -20.89 36.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.656 179.254 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -76.69 -25.36 53.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.228 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -81.41 -24.85 36.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.687 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.84 -29.26 35.44 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.631 HD13 ' O ' ' A' ' 191' ' ' GLU . 6.7 mp -82.33 -28.45 31.62 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.05 -28.33 31.43 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -80.84 -21.95 40.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.996 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -75.75 -22.94 56.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.103 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -52.09 -37.87 55.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.932 0.396 . . . . 0.0 111.168 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -69.64 -24.85 63.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.132 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -46.67 85.24 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -80.02 -35.21 37.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.6 tp -61.29 -31.19 71.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.4 tp -59.39 -39.22 82.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 60.08 108.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.923 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 73.3 p -141.54 79.07 1.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 3.5 tpt -99.22 -58.65 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.0 p -159.17 -174.04 4.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.8 m 60.56 105.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.76 31.49 4.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.95 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.441 ' HB ' ' HD3' ' A' ' 212' ' ' PRO . 0.9 OUTLIER 178.55 -54.94 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.441 ' HD3' ' HB ' ' A' ' 211' ' ' THR . 78.1 Cg_exo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.471 2.114 . . . . 0.0 112.368 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.81 0.338 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -87.56 110.27 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.691 ' C ' HD22 ' A' ' 24' ' ' LEU . 7.3 mt -132.1 127.85 36.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.691 HD22 ' C ' ' A' ' 23' ' ' LEU . 3.4 mm? -120.47 77.43 1.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.953 HG21 HD12 ' A' ' 28' ' ' LEU . 7.3 p 42.92 59.98 10.69 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.583 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HB2' HD11 ' A' ' 46' ' ' LEU . 48.9 Cg_exo -55.78 -30.05 74.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.558 2.172 . . . . 0.0 112.54 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.706 HD12 ' HG ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -52.94 -57.5 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.068 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.953 HD12 HG21 ' A' ' 25' ' ' VAL . 82.3 mt -60.87 -27.05 67.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -60.04 -53.18 60.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 0.0 109.673 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -76.75 -25.09 53.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.39 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.703 HD11 ' O ' ' A' ' 73' ' ' GLY . 5.7 tp -67.28 -52.15 44.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.21 -23.68 15.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.254 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -70.84 -23.58 62.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.186 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.1 49.15 77.81 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.174 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -132.98 166.02 32.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.48 115.16 3.92 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.515 2.144 . . . . 0.0 111.927 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.685 HG23 ' CG2' ' A' ' 41' ' ' THR . 9.3 p -124.21 109.87 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.487 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.9 p -79.15 -176.19 5.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -78.04 -33.44 51.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.315 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -28.11 68.25 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.132 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.685 ' CG2' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.59 -41.42 16.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.228 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -63.35 -36.81 84.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.613 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.36 -42.94 61.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.409 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.88 -29.64 73.78 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.463 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -78.86 -42.21 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 121.2 0.524 . . . . 0.0 109.903 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 26' ' ' PRO . 6.5 mp -76.82 -9.82 58.94 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.445 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 t70 61.77 21.29 12.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.421 ' CD1' ' HD2' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -101.6 152.47 38.06 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.132 -179.535 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.72 139.02 35.98 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.503 2.135 . . . . 0.0 112.027 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.62 -19.22 0.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.25 -31.2 49.06 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.237 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.62 -40.36 84.69 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.518 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -61.73 -48.07 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.735 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.16 -52.61 58.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.461 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.47 -43.51 68.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.923 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 52' ' ' ARG . 27.6 t -75.12 -29.3 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.856 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.643 HD21 ' OH ' ' A' ' 65' ' ' TYR . 6.5 tp -68.78 -38.86 80.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.816 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.75 -45.11 86.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.616 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -74.22 -8.23 55.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.111 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.04 70.98 0.73 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.766 0.793 . . . . 0.0 110.531 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.9 p -76.51 -6.36 51.51 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.424 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.51 37.9 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 0.0 110.852 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.8 141.2 28.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.181 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -78.88 126.63 30.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 111.28 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.643 ' OH ' HD21 ' A' ' 57' ' ' LEU . 27.0 m-85 -124.4 154.01 41.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.343 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.625 ' HB2' HG21 ' A' ' 72' ' ' ILE . 26.8 t70 -153.14 146.11 24.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.233 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 tttm 66.04 -101.68 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.672 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -89.96 -14.4 34.15 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.11 29.23 1.68 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.989 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -87.41 172.65 9.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.1 mt -79.59 105.84 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.845 0.355 . . . . 0.0 110.999 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.625 HG21 ' HB2' ' A' ' 66' ' ' ASP . 2.7 tt -103.78 -19.99 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.555 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.703 ' O ' HD11 ' A' ' 31' ' ' LEU . . . -44.39 95.62 0.01 OUTLIER Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.919 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -83.16 -79.38 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 0.0 110.94 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.682 ' HA2' HD11 ' A' ' 92' ' ' LEU . . . -97.52 -148.42 23.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.492 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.9 -41.29 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.061 0.457 . . . . 0.0 110.911 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.583 HG23 ' HB2' ' A' ' 93' ' ' TYR . 1.4 t -144.08 159.39 42.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.566 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 78' ' ' LEU . 5.1 mp -83.12 52.76 2.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 111.053 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HG2' ' CZ ' ' A' ' 93' ' ' TYR . 7.3 tmm_? 57.84 113.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -177.71 -28.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.497 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.433 HG21 ' HA ' ' A' ' 95' ' ' TRP . 4.8 p -89.41 -178.23 5.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.945 0.402 . . . . 0.0 111.332 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.75 -26.98 14.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.345 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 81.7 m-85 -76.56 110.79 11.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.628 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.4 HG22 ' CE1' ' A' ' 93' ' ' TYR . 25.0 t -108.26 139.12 31.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.169 0.509 . . . . 0.0 111.573 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.781 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 14.5 t80 -136.38 108.19 7.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.847 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -103.7 137.12 42.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.806 0.336 . . . . 0.0 111.552 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.542 HG23 ' CE1' ' A' ' 85' ' ' PHE . 2.2 pt -140.03 123.35 17.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.572 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 t0 63.65 -66.68 0.1 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.189 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.5 t70 -168.0 35.2 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.401 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -134.07 113.48 12.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.927 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.21 86.2 5.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 111.0 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.682 HD11 ' HA2' ' A' ' 75' ' ' GLY . 0.2 OUTLIER -76.0 164.92 25.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.016 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.583 ' HB2' HG23 ' A' ' 77' ' ' THR . 61.0 m-85 -136.2 165.45 25.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.263 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.615 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -150.73 169.98 20.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.922 0.391 . . . . 0.0 111.879 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.433 ' HA ' HG21 ' A' ' 81' ' ' THR . 15.0 m0 -92.93 -23.5 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.931 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.427 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 50.9 m -147.44 167.08 25.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.283 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.998 ' HB1' ' CZ ' ' A' ' 164' ' ' PHE . . . -51.97 -22.44 3.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.011 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.457 ' HA ' HD21 ' A' ' 101' ' ' LEU . 2.4 tp -86.26 -51.55 6.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.615 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 2.7 m-20 -48.14 -25.94 1.68 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.26 -39.1 85.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.515 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -99.18 166.56 11.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 101' ' ' LEU . 12.7 pt -158.03 -43.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.838 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.5 m-85 -162.58 64.46 1.55 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 103' ' ' PHE . 37.8 Cg_exo -60.22 -43.04 37.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.747 2.298 . . . . 0.0 112.416 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.19 -23.76 43.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.376 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -84.09 -38.74 20.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.509 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.838 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.4 tp -57.16 -45.7 84.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.146 0.498 . . . . 0.0 111.309 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.56 25.31 10.09 Favored Glycine 0 C--N 1.319 -0.372 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.508 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.65 174.15 14.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 110.939 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.0 m -81.08 158.14 25.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.756 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -136.77 109.67 7.63 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -81.61 119.78 24.23 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.765 0.793 . . . . 0.0 111.015 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.409 HG22 ' HD2' ' A' ' 85' ' ' PHE . 57.6 t -112.17 129.86 66.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.084 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.4 m -124.21 137.35 54.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.045 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.594 ' HB2' HG23 ' A' ' 124' ' ' VAL . 1.4 m -141.6 173.09 11.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.377 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -134.09 133.24 40.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.6 t -62.44 133.37 54.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.216 0.532 . . . . 0.0 112.213 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.98 -3.81 24.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.891 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.918 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.68 -50.94 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.786 0.327 . . . . 0.0 111.662 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.45 -24.13 21.94 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.306 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.76 5.15 73.44 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.144 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.705 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.07 149.41 56.46 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-O 120.544 0.212 . . . . 0.0 110.631 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 1.0 OUTLIER -82.31 103.85 1.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.667 2.244 . . . . 0.0 110.807 179.324 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 115' ' ' SER . 35.8 m -99.14 144.72 11.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.311 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.419 ' O ' ' HE1' ' A' ' 141' ' ' MET . 81.5 p -151.87 141.72 21.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.431 0.634 . . . . 0.0 110.836 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -138.82 151.39 46.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.875 178.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.802 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.2 m -105.94 115.21 29.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.639 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.915 HG13 ' CE2' ' A' ' 193' ' ' PHE . 38.8 t -96.11 111.73 26.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.853 0.359 . . . . 0.0 111.505 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.422 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -107.22 169.5 6.67 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.938 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.4 Cg_endo -66.23 -19.25 56.52 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.198 1.932 . . . . 0.0 112.816 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 19.6 p -112.66 -26.97 8.37 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 131' ' ' SER . 0.4 OUTLIER 178.39 -162.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.133 0.492 . . . . 0.0 110.043 -179.363 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -93.68 158.46 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.922 178.578 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -144.66 19.49 1.67 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.448 0.642 . . . . 0.0 112.154 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.802 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.83 86.81 0.08 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.238 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.544 HG13 ' SD ' ' A' ' 141' ' ' MET . 36.3 t -103.25 113.64 40.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.334 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -146.5 122.72 5.67 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.48 155.83 95.05 Favored 'Cis proline' 0 C--N 1.348 0.517 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.26 0.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.39 79.46 0.38 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.178 0.514 . . . . 0.0 110.497 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.01 17.61 0.18 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.597 -0.728 . . . . 0.0 113.243 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.912 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.2 OUTLIER -58.61 158.47 7.76 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.964 0.412 . . . . 0.0 111.441 -179.393 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -128.49 152.32 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.052 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.715 HG22 ' CD1' ' A' ' 164' ' ' PHE . 46.1 t -111.74 147.72 15.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.543 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 32.0 m -120.77 144.91 48.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.804 0.335 . . . . 0.0 110.946 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.886 HD11 ' HB3' ' A' ' 185' ' ' ALA . 1.2 pp -138.04 175.03 9.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.828 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 146' ' ' VAL . 24.3 m -125.04 120.14 57.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 33.0 mt 60.05 87.84 0.13 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.79 63.75 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.54 2.16 . . . . 0.0 112.307 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -63.54 131.71 48.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -112.33 33.99 4.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.84 30.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.513 ' O ' HG22 ' A' ' 154' ' ' VAL . . . -169.78 -73.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.209 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.535 ' O ' HG13 ' A' ' 154' ' ' VAL . 5.5 t0 58.28 29.96 18.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 153' ' ' ASP . 5.9 m -159.08 174.69 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.111 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 59.9 64.9 1.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 58.86 31.46 21.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.1 t -60.16 -81.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -133.7 8.81 3.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.394 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.423 ' HA ' ' CG2' ' A' ' 162' ' ' VAL . 52.9 t -81.13 -15.83 54.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.649 0.262 . . . . 0.0 111.485 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 94.2 m -79.76 -0.74 35.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -154.76 54.76 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.743 0.306 . . . . 0.0 111.505 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.749 HG12 ' HB3' ' A' ' 97' ' ' ALA . 22.0 t -104.26 109.76 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.495 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 163' ' ' HIS . 2.2 m-70 -118.93 159.14 24.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.535 0.683 . . . . 0.0 109.919 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.998 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 15.9 m-30 -111.12 130.6 55.57 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.526 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PHE . . . . . 0.614 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 39.4 m-85 -108.48 140.69 41.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.397 0.618 . . . . 0.0 110.545 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.33 -27.64 0.7 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.76 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.581 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 68.2 m -164.95 171.48 13.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.225 0.536 . . . . 0.0 111.746 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 73.0 t -69.23 -32.84 3.52 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.298 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.22 -37.76 3.16 Favored 'Trans proline' 0 CA--C 1.504 -0.983 0 C-N-CA 122.739 2.292 . . . . 0.0 110.389 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.71 -40.17 49.6 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.146 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.9 -45.49 93.49 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.2 mt-10 -78.96 -27.37 43.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.288 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 169' ' ' PRO . 13.8 t70 -70.75 -55.78 7.86 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.457 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' TRP . . . . . 0.918 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 39.2 t-105 -64.64 -28.58 69.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.616 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.85 -41.58 97.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.311 178.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.56 -42.23 55.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.228 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.6 22.75 7.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.294 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' HIS . . . . . 0.799 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -142.66 31.73 1.46 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.889 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -107.89 -15.41 14.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.289 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.55 -22.49 24.65 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.472 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.544 HD12 HD12 ' A' ' 184' ' ' LEU . 18.2 mt -59.56 -176.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.924 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -87.39 54.73 3.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 110.15 139.89 8.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.536 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.799 HD13 ' O ' ' A' ' 178' ' ' HIS . 1.4 tt -177.19 133.57 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.762 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.886 ' HB3' HD11 ' A' ' 145' ' ' LEU . . . -142.4 150.08 40.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.221 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.671 HD11 ' HB2' ' A' ' 175' ' ' ALA . 17.2 mm -103.14 161.71 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.961 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.484 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -158.56 162.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.099 0.476 . . . . 0.0 111.833 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.412 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -90.15 128.09 36.26 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.896 178.656 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.912 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.2 m -46.78 -20.14 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.915 0.388 . . . . 0.0 110.758 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.412 ' N ' ' C ' ' A' ' 188' ' ' SER . 7.3 m-70 -71.5 -41.68 68.97 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.126 0.488 . . . . 0.0 109.709 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.474 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.7 OUTLIER -82.12 -25.66 34.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.412 179.097 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.83 -24.86 62.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.043 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PHE . . . . . 0.915 ' CE2' HG13 ' A' ' 128' ' ' VAL . 5.0 t80 -81.15 -24.98 37.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.8 -29.82 33.98 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 191' ' ' GLU . 9.6 mp -82.4 -28.27 31.52 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -28.36 31.4 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.402 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 9.1 tt0 -80.55 -22.99 40.29 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.897 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -73.46 -22.89 60.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.102 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.03 -36.95 51.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.959 0.409 . . . . 0.0 111.246 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -73.07 -24.81 60.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.108 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -49.71 -29.71 7.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -80.01 -31.64 39.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.941 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.5 mt -82.09 -22.17 36.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.07 -28.17 66.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.002 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 60.84 99.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.948 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 28.9 m -155.89 79.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 5.3 mtm -59.86 -59.09 5.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.829 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 18.4 m -128.57 162.56 26.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 60.7 p -100.96 141.78 33.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -78.02 -171.0 2.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.984 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.433 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -176.36 -63.01 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.007 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.8 Cg_endo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.442 2.095 . . . . 0.0 112.268 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.828 0.347 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.71 -21.99 50.4 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.519 2.146 . . . . 0.0 112.292 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.688 ' CD2' HD21 ' A' ' 42' ' ' LEU . 2.6 mt -52.0 -57.3 9.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.244 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.55 -27.09 62.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -61.0 -53.27 59.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.653 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.9 -25.07 62.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.298 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.464 ' HA ' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -67.0 -47.65 70.82 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.824 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.39 -25.85 17.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -67.74 -22.26 65.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.212 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.6 47.99 88.44 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.039 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.14 153.1 81.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.768 0.318 . . . . 0.0 110.928 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.01 109.08 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.596 2.197 . . . . 0.0 111.987 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.686 HG23 HG22 ' A' ' 41' ' ' THR . 11.0 p -115.56 110.17 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.334 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 57.5 p -85.14 177.6 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.677 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.09 -37.17 72.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.192 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -26.46 67.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.814 0.34 . . . . 0.0 110.136 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.686 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.4 -42.65 14.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.688 HD21 ' CD2' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -63.11 -36.38 83.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.2 -43.0 62.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.492 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.01 -30.61 74.18 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.734 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.586 HD12 HG23 ' A' ' 41' ' ' THR . 6.7 mt -79.16 -41.58 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.055 0.455 . . . . 0.0 110.297 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.443 HD12 HG22 ' A' ' 45' ' ' ILE . 6.5 mp -77.17 -9.66 58.91 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.336 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 t70 59.88 21.95 10.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.408 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 6.5 m95 -109.95 158.31 35.36 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.162 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.68 142.75 71.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.533 2.155 . . . . 0.0 112.02 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.64 -16.82 1.04 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -78.95 -34.34 44.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.062 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -67.47 -41.58 84.39 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.0 t -63.36 -46.99 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.482 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.91 -51.35 61.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.383 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.96 -37.65 20.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.719 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 52' ' ' ARG . 23.2 t -63.6 -53.01 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.793 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 58' ' ' GLU . 3.9 pp -73.52 -16.92 61.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.968 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.598 ' N ' HD12 ' A' ' 57' ' ' LEU . 59.2 tt0 -58.12 -19.58 33.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.049 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.85 12.57 12.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.825 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -123.06 76.5 1.38 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.771 0.796 . . . . 0.0 110.48 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 p -87.43 -26.95 23.02 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.762 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.25 -21.29 63.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.76 141.2 53.6 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.431 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.61 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -84.68 126.96 33.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 111.642 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.408 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 14.8 m-85 -100.36 173.14 6.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.163 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -153.11 143.3 22.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 111.504 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 tptp 66.06 -104.06 0.09 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.82 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -92.73 -13.05 29.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.715 0.293 . . . . 0.0 111.782 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 128.64 31.98 0.63 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.14 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -87.14 170.56 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.82 0.343 . . . . 0.0 110.166 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.67 HD13 HD12 ' A' ' 42' ' ' LEU . 3.7 mp -79.7 109.43 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.159 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.866 ' O ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 121.107 0.479 . . . . 0.0 111.002 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 76' ' ' LEU . 3.1 mm? . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.864 0.364 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -129.43 159.62 35.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.6 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.8 mt -77.91 51.13 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.266 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 4.7 ttt-85 44.47 85.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.635 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.07 23.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.469 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.1 p -119.17 -171.07 2.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.114 0.483 . . . . 0.0 111.599 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 p -104.08 -29.14 11.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.301 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 95' ' ' TRP . 10.8 m-85 -79.27 111.83 15.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.628 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.57 140.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.059 0.457 . . . . 0.0 111.098 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.826 ' CD1' HG22 ' A' ' 113' ' ' VAL . 43.8 t80 -129.95 106.38 8.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.588 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -100.17 130.54 46.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.921 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.503 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -140.03 124.62 19.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.16 -70.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.283 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -166.94 34.39 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.251 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -137.71 111.94 8.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.906 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.413 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -78.42 121.56 24.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.837 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 92' ' ' LEU . 3.8 mm? -114.43 164.8 13.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.969 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 79' ' ' ARG . 24.8 m-85 -130.78 165.09 23.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.112 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.632 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -151.79 170.17 20.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.106 0.479 . . . . 0.0 111.848 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.405 ' O ' ' CE1' ' A' ' 83' ' ' TYR . 5.3 m95 -98.81 -18.67 17.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.684 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 28.1 m -147.61 162.55 38.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.924 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -52.03 -22.62 4.2 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 tp -85.79 -51.53 6.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.656 0.265 . . . . 0.0 111.305 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.617 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -45.16 -28.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.632 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -60.41 -39.1 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 110.549 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.44 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.3 pt? -121.87 174.9 6.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.059 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.2 mt -151.31 -46.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.044 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -156.92 79.02 3.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.742 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.517 ' HA ' HG12 ' A' ' 107' ' ' ILE . 20.3 Cg_endo -60.78 -40.13 56.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.703 2.269 . . . . 0.0 112.41 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.24 -25.94 67.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.547 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.3 tp -79.9 -26.47 40.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 104' ' ' PRO . 4.5 mm -64.5 -58.88 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.117 0.961 . . . . 0.0 111.013 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.54 22.14 13.22 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.637 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.07 -177.03 5.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.925 0.393 . . . . 0.0 110.344 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.54 154.11 20.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.227 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.779 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -136.85 110.06 7.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.639 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -80.38 119.91 23.71 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.767 0.794 . . . . 0.0 111.277 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.826 HG22 ' CD1' ' A' ' 85' ' ' PHE . 47.2 t -112.05 129.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.947 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 m -122.87 137.56 54.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.114 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.546 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.6 OUTLIER -141.4 172.82 12.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.317 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -134.54 133.88 40.79 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.407 ' HB3' ' H ' ' A' ' 121' ' ' GLY . 30.5 t -62.29 130.38 45.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.047 0.451 . . . . 0.0 112.037 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.95 -3.59 23.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.974 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.885 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.54 -49.85 2.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 111.545 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.686 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -91.77 -24.62 19.36 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.281 -179.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 117' ' ' CYS . . . 76.28 5.55 81.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.195 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.686 ' H ' HG22 ' A' ' 120' ' ' THR . . . -57.93 148.92 57.51 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-O 120.528 0.204 . . . . 0.0 110.636 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 1.0 OUTLIER -82.31 104.1 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.686 2.258 . . . . 0.0 110.806 179.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 115' ' ' SER . 30.5 m -100.16 144.91 11.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.4 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.0 p -151.64 141.49 21.97 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.415 0.626 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -138.55 151.92 47.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.83 178.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.857 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 53.8 m -106.52 113.49 27.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.871 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.69 HG13 ' CE2' ' A' ' 193' ' ' PHE . 47.9 t -96.31 111.79 27.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.902 0.382 . . . . 0.0 111.474 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.25 168.53 8.05 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.08 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.75 -14.55 45.2 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.49 2.126 . . . . 0.0 113.015 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -118.84 -26.91 5.93 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 179.6 -163.29 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.16 0.505 . . . . 0.0 110.017 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -96.61 160.47 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.879 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -148.21 20.75 1.09 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.468 0.651 . . . . 0.0 112.194 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.857 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.94 86.69 0.08 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.408 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.577 HG13 ' SD ' ' A' ' 141' ' ' MET . 39.2 t -103.54 115.4 45.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.193 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -146.27 122.28 5.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.74 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.87 157.0 99.14 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 123.523 -1.449 . . . . 0.0 112.283 0.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.42 79.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 0.0 110.553 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.58 16.61 0.15 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.407 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.868 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -60.13 156.49 15.01 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.065 0.459 . . . . 0.0 111.313 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -125.43 151.87 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.734 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.739 HG13 ' CE1' ' A' ' 164' ' ' PHE . 18.4 t -113.0 152.22 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.793 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 1.6 p -120.72 140.98 50.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.938 0.399 . . . . 0.0 110.945 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.664 HD12 HG22 ' A' ' 162' ' ' VAL . 5.7 tp -135.84 175.13 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.871 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.083 179.81 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.664 HG22 HD12 ' A' ' 145' ' ' LEU . 22.4 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.84 0.353 . . . . 0.0 111.499 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -117.1 169.05 9.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.602 0.715 . . . . 0.0 109.801 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.739 ' CE1' HG13 ' A' ' 143' ' ' VAL . 2.5 m-85 -119.38 152.9 36.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.127 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.619 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 49.1 m-85 -129.35 133.67 47.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.845 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -41.48 -27.51 0.09 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 10.8 p -168.84 174.36 6.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.015 0.436 . . . . 0.0 111.511 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.6 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 85.6 t -68.6 -33.53 4.6 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.673 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.683 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.6 Cg_exo -72.51 -38.17 3.61 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.718 2.279 . . . . 0.0 110.371 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.57 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.54 -39.47 52.75 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.44 -46.02 90.42 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.7 mt-10 -78.78 -28.12 44.61 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.323 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 169' ' ' PRO . 12.3 t70 -71.33 -55.81 7.26 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.384 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.885 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 58.3 t-105 -64.04 -28.48 69.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.739 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -62.99 -42.22 99.79 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.166 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 71.1 m -51.37 -41.74 60.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.399 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 21.04 9.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.421 0.629 . . . . 0.0 111.298 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.521 ' HD2' HD21 ' A' ' 184' ' ' LEU . 2.8 t60 -128.4 28.74 5.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.864 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.709 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.521 HD21 ' HD2' ' A' ' 178' ' ' HIS . 6.0 tp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.817 0.341 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.29 150.08 42.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.037 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.571 ' CG2' ' HB1' ' A' ' 171' ' ' ALA . 10.6 mm -100.14 159.04 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.035 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.444 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -162.02 162.56 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.289 0.566 . . . . 0.0 112.076 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.415 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -88.53 129.52 35.45 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.669 178.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.868 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.2 m -46.44 -20.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.832 0.349 . . . . 0.0 110.717 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.415 ' N ' ' C ' ' A' ' 188' ' ' SER . 1.8 t-160 -73.82 -42.07 61.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.784 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -82.25 -21.2 36.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.25 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.4 -24.93 63.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.813 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.69 ' CE2' HG13 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -81.11 -24.91 37.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.72 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.81 -31.26 29.91 Favored Glycine 0 CA--C 1.509 -0.317 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.7 tp -82.13 -29.25 31.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -83.12 -27.43 40.59 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -82.28 -21.93 35.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.938 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -81.03 -26.21 36.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -52.68 -30.52 32.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.115 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.67 -54.46 27.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.016 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.7 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.857 0.361 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.2 -16.97 45.08 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.695 2.263 . . . . 0.0 112.456 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.589 HD23 HG21 ' A' ' 71' ' ' ILE . 2.0 tm? -54.25 -57.44 11.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.949 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.497 ' N ' HD13 ' A' ' 27' ' ' LEU . 9.2 tp -63.7 -27.05 68.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.982 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -68.43 -53.33 24.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.719 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.889 ' HB3' HG21 ' A' ' 37' ' ' VAL . 2.7 mm-40 -72.61 -29.72 63.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.318 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.548 ' C ' HD23 ' A' ' 31' ' ' LEU . 9.2 tt -67.25 -45.71 75.9 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.56 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.08 -23.06 18.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -22.75 62.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.005 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.3 39.72 98.09 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.26 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -133.38 166.09 31.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.595 0.236 . . . . 0.0 110.673 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.64 112.65 2.92 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.517 2.145 . . . . 0.0 112.201 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.889 HG21 ' HB3' ' A' ' 30' ' ' GLU . 33.4 t -112.22 109.92 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.331 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -90.46 -168.4 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.835 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -78.07 -38.44 44.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.513 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -25.31 68.06 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.45 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.722 ' CG2' HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.1 -43.56 12.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.422 HD13 HD13 ' A' ' 71' ' ' ILE . 1.5 tp -63.01 -35.46 80.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.664 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -74.24 -42.94 58.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.496 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.13 -30.96 74.11 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.579 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.603 HD12 HG23 ' A' ' 41' ' ' THR . 7.3 mt -78.7 -44.44 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 120.995 0.426 . . . . 0.0 110.584 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.577 HD12 HG22 ' A' ' 45' ' ' ILE . 7.3 mp -76.81 -9.8 58.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.421 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.6 t70 58.21 22.88 9.65 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -97.81 139.62 21.43 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.461 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.508 ' O ' HG23 ' A' ' 53' ' ' VAL . 44.4 Cg_exo -56.07 137.37 79.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.445 2.097 . . . . 0.0 111.797 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.85 -22.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -78.33 -36.12 46.73 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 110.951 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.2 mtt-85 -67.07 -40.41 87.02 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -63.01 -47.98 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.487 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.04 -53.69 46.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.117 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.39 -48.28 77.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.836 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 52' ' ' ARG . 41.1 t -64.31 -31.95 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.664 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.14 -31.4 71.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.581 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 61' ' ' THR . 5.5 tt0 -58.17 -21.83 48.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -96.13 -19.57 19.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.002 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.558 ' HB1' ' HG1' ' A' ' 63' ' ' THR . . . -99.75 32.07 3.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.466 0.651 . . . . 0.0 110.88 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 58' ' ' GLU . 25.2 p -69.43 -13.04 62.14 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.173 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.7 p -90.91 -23.11 20.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 111.266 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.558 ' HG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -56.49 141.23 43.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -78.77 126.96 31.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.397 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 66.8 m-85 -102.14 173.25 6.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.505 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD2' HD13 ' A' ' 72' ' ' ILE . 14.0 t0 -152.77 147.09 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.948 0.404 . . . . 0.0 111.441 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.41 -104.01 0.09 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.745 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.65 -11.1 46.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.726 0.298 . . . . 0.0 111.726 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.04 27.69 1.82 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.076 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -86.64 168.47 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.589 HG21 HD23 ' A' ' 27' ' ' LEU . 2.5 mp -79.64 120.41 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.379 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.524 HD13 ' OD2' ' A' ' 66' ' ' ASP . 2.3 tt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.556 HD21 HD11 ' A' ' 92' ' ' LEU . 3.3 mm? . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.854 0.359 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.519 HG21 HG23 ' A' ' 81' ' ' THR . 1.4 t -100.32 152.6 20.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.88 -45.95 76.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -103.47 147.72 26.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.946 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.424 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 3.1 tt0 -59.43 132.21 53.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.519 HG23 HG21 ' A' ' 77' ' ' THR . 35.2 p -110.09 -173.6 2.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.6 p -93.62 -35.74 12.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.928 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.424 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 4.9 m-85 -79.15 109.72 13.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.385 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.55 137.51 34.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.139 0.495 . . . . 0.0 111.377 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.758 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 21.7 t80 -132.58 105.77 7.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.103 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -102.52 135.26 44.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.387 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.48 HG23 ' CE1' ' A' ' 85' ' ' PHE . 2.8 pt -140.14 126.54 22.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t0 61.89 -72.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 87' ' ' ILE . 13.4 t0 -158.05 37.7 0.25 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -140.34 148.74 41.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.611 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.88 86.19 2.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.094 0.473 . . . . 0.0 110.571 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.556 HD11 HD21 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -71.6 164.69 25.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.091 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.424 ' CZ ' ' HG3' ' A' ' 80' ' ' GLU . 9.7 m-85 -134.31 165.16 25.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.113 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.625 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -151.16 167.24 28.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.152 0.501 . . . . 0.0 111.849 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -101.09 -10.54 20.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.751 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 11.9 m -153.31 160.0 42.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.854 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.842 ' HB1' ' CE2' ' A' ' 164' ' ' PHE . . . -51.81 -22.46 3.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.455 ' O ' HD13 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -85.93 -51.34 6.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.674 0.273 . . . . 0.0 111.172 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.625 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 1.9 m-20 -44.38 -27.66 0.46 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -60.28 -39.2 86.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.892 0.377 . . . . 0.0 110.544 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.857 HD21 HG21 ' A' ' 128' ' ' VAL . 5.3 mt -93.45 -176.1 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.032 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 103' ' ' PHE . 7.5 tp -174.67 -40.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.84 ' O ' HG22 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -172.02 65.48 0.39 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.797 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.417 ' HG3' HD22 ' A' ' 101' ' ' LEU . 33.6 Cg_exo -59.85 -42.04 48.94 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.73 2.287 . . . . 0.0 112.351 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.07 -23.91 43.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.332 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.439 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -85.11 -38.33 19.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.481 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -57.19 -45.82 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 111.394 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.61 23.37 16.19 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.568 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.41 173.61 13.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.036 0.446 . . . . 0.0 110.954 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m -81.61 156.51 25.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.901 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.758 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -136.76 109.96 7.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.847 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -81.28 120.07 24.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.717 0.77 . . . . 0.0 111.232 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.3 t -111.07 127.29 68.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.626 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.3 m -122.36 137.6 54.8 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.317 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.595 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.0 OUTLIER -141.5 172.85 12.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.265 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -134.32 133.23 40.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 22.6 t -62.77 131.84 50.23 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.248 0.547 . . . . 0.0 112.222 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.17 -3.59 20.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.988 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.866 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -123.27 -51.07 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.631 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -87.68 -24.57 23.85 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.208 -179.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.44 5.45 72.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.114 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.715 ' H ' HG22 ' A' ' 120' ' ' THR . . . -59.94 152.27 60.78 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-O 120.591 0.234 . . . . 0.0 110.515 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -84.71 105.03 0.97 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.683 2.255 . . . . 0.0 110.947 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.595 HG22 ' C ' ' A' ' 115' ' ' SER . 35.3 m -99.36 144.46 11.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.364 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.427 ' O ' ' HE1' ' A' ' 141' ' ' MET . 82.4 p -151.64 141.68 22.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.424 0.631 . . . . 0.0 110.936 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -138.64 152.09 47.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.724 178.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.815 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 20.1 m -106.73 115.23 29.83 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.857 HG21 HD21 ' A' ' 101' ' ' LEU . 42.4 t -96.18 111.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.843 0.354 . . . . 0.0 111.211 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.97 175.79 1.9 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.32 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.77 -15.5 33.33 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.629 2.219 . . . . 0.0 112.978 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 18.0 t -118.96 -25.7 6.19 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 131' ' ' SER . 10.7 pt-20 178.56 -162.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.158 0.504 . . . . 0.0 110.036 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -93.44 156.49 3.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.94 178.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.72 18.59 2.0 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.469 0.652 . . . . 0.0 112.279 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.815 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.57 86.45 0.09 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.421 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.536 HG13 ' SD ' ' A' ' 141' ' ' MET . 39.7 t -102.29 115.82 44.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.063 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -146.3 122.25 5.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.748 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.11 160.17 94.37 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.495 -1.461 . . . . 0.0 112.362 -0.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.64 78.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.673 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.0 16.92 0.16 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.33 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.921 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -58.67 155.03 13.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 111.619 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -124.88 151.9 44.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.977 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.799 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -112.93 149.32 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.666 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 162' ' ' VAL . 9.8 m -120.54 141.39 50.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.544 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.415 ' CD2' HG22 ' A' ' 187' ' ' VAL . 0.7 OUTLIER -146.79 176.64 9.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.031 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.811 179.64 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 144' ' ' SER . 3.2 p . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.048 0.451 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.4 169.33 14.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.454 0.645 . . . . 0.0 110.379 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.842 ' CE2' ' HB1' ' A' ' 97' ' ' ALA . 14.0 m-85 -107.54 129.66 54.95 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.425 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.568 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 43.7 m-85 -108.78 139.73 43.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.347 0.594 . . . . 0.0 110.589 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -47.65 -26.64 1.58 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.797 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.591 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 49.0 m -164.43 168.99 17.87 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.836 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 82.1 t -68.47 -34.13 5.35 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.019 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.1 Cg_exo -72.5 -37.22 4.37 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.629 2.22 . . . . 0.0 110.27 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.44 -40.39 50.75 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.731 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.81 -46.43 89.54 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 3.0 mm-40 -78.98 -27.87 43.47 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.462 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.5 t70 -69.7 -55.85 8.84 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.165 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.866 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 71.5 t-105 -65.73 -28.3 68.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.795 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.96 -39.95 95.31 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.054 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.96 -43.66 63.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.249 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.51 22.43 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.289 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.417 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -145.79 29.89 1.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.911 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.167 179.799 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 178' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.895 0.379 . . . . 0.0 110.992 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.57 149.09 40.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.815 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 175' ' ' ALA . 16.3 mm -102.13 160.48 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.08 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.481 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.05 164.17 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.257 0.551 . . . . 0.0 112.067 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.413 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -89.61 127.99 35.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.744 178.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.921 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.0 m -46.63 -20.5 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.824 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.413 ' N ' ' C ' ' A' ' 188' ' ' SER . 2.4 m-70 -72.76 -42.88 63.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.211 0.529 . . . . 0.0 109.746 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.28 -21.92 35.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.153 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.11 61.88 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.832 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.825 ' CE2' HG13 ' A' ' 128' ' ' VAL . 3.3 t80 -81.06 -24.95 37.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.688 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.89 -29.91 33.42 Favored Glycine 0 CA--C 1.51 -0.277 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -28.49 32.32 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.81 -27.97 33.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.22 -22.02 36.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.99 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.06 -23.1 55.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.213 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -51.92 -37.17 51.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -81.08 -28.31 35.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.832 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.832 0.349 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.664 ' CG ' HD11 ' A' ' 46' ' ' LEU . 57.7 Cg_endo -71.48 -24.77 22.03 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.518 2.145 . . . . 0.0 112.502 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.5 mt -54.89 -57.55 11.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.374 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.22 -27.36 38.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -53.23 15.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.966 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.92 -26.12 66.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.49 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.596 HD11 ' CG2' ' A' ' 71' ' ' ILE . 9.5 mt -73.68 -30.3 62.81 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.746 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.34 -28.77 30.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.199 0.524 . . . . 0.0 110.909 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -64.23 -19.46 65.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.208 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.0 48.49 83.05 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.038 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.42 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -129.78 164.92 36.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.658 0.266 . . . . 0.0 110.71 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.52 111.41 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.482 2.121 . . . . 0.0 112.2 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 41' ' ' THR . 24.5 t -120.32 109.98 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.358 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 p -91.51 -172.72 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.699 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -74.61 -37.85 62.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.192 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -28.25 68.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.973 0.416 . . . . 0.0 110.246 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.724 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.5 -42.36 15.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 71' ' ' ILE . 0.6 OUTLIER -62.53 -36.74 83.54 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.62 -42.95 63.91 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.589 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -31.98 77.09 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.613 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.616 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -78.66 -43.36 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 120.936 0.398 . . . . 0.0 110.478 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.664 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.5 mp -78.52 -7.41 57.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.485 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 54.91 23.64 5.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 18.0 m0 -101.02 152.03 37.77 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.285 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 53' ' ' VAL . 35.5 Cg_endo -65.18 137.05 50.33 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.433 2.089 . . . . 0.0 111.92 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.22 -21.29 0.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.15 -36.69 47.4 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.959 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.71 -40.52 88.46 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.726 ' O ' HD23 ' A' ' 57' ' ' LEU . 2.1 t -62.84 -47.97 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.423 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.7 -53.7 43.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.239 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.82 73.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.849 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 52' ' ' ARG . 36.7 t -64.36 -34.63 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.744 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 53' ' ' VAL . 3.8 mm? -61.88 -32.63 73.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 61' ' ' THR . 5.7 tt0 -57.9 -22.49 48.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -94.26 -19.85 20.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.997 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.77 32.22 2.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.435 0.636 . . . . 0.0 111.041 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 58' ' ' GLU . 38.8 p -62.16 -19.13 62.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.888 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 m -90.09 -21.99 22.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.37 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.61 141.23 55.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.384 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.512 ' O ' HG22 ' A' ' 72' ' ' ILE . 4.0 tt0 -78.86 131.06 36.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 111.634 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.452 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.7 m-85 -105.26 173.18 6.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.278 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.54 146.68 26.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 111.43 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.5 -103.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.77 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -89.88 -11.02 43.11 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.63 29.37 1.43 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.975 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -87.55 172.14 9.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.835 0.35 . . . . 0.0 110.143 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 42' ' ' LEU . 2.9 mp -79.58 118.42 27.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.272 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.865 ' O ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.004 0.431 . . . . 0.0 110.958 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--O 1.23 0.03 0 CA-C-O 120.747 0.308 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.452 HG21 ' CD1' ' A' ' 95' ' ' TRP . 30.6 p -104.25 159.08 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.811 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.7 mt -91.73 49.21 1.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -178.29 137.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.08 121.32 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.7 p -109.24 -174.89 2.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.083 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -93.0 -34.35 13.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.974 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.416 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 7.7 m-85 -83.76 112.41 20.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.316 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.469 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.5 t -107.84 144.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.985 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.919 ' CD1' HG22 ' A' ' 113' ' ' VAL . 38.4 t80 -133.93 105.36 6.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.144 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -97.47 131.9 43.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.052 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.05 124.29 18.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 -71.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.537 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -161.22 35.44 0.14 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.601 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -137.62 142.28 41.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.295 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.94 86.28 2.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 110.74 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -71.62 164.7 25.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.781 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -134.91 164.18 28.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.161 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.615 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -151.02 167.03 28.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.014 0.435 . . . . 0.0 111.881 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.452 ' CD1' HG21 ' A' ' 77' ' ' THR . 8.4 m0 -95.09 -18.92 20.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.62 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.449 ' HB3' HG13 ' A' ' 162' ' ' VAL . 1.7 m -150.11 166.61 29.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.154 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.594 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -53.76 -21.81 8.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.845 HD13 HG11 ' A' ' 162' ' ' VAL . 10.8 mp -84.67 -51.59 6.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.561 0.22 . . . . 0.0 111.536 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.599 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -47.96 -28.16 2.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -60.69 -39.32 88.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 110.58 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.042 HD21 HG11 ' A' ' 128' ' ' VAL . 1.5 mt -86.35 168.5 13.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.225 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 101' ' ' LEU . 6.8 pt -160.66 -43.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.031 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.808 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.0 OUTLIER 178.16 78.34 0.14 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.453 ' CB ' HG12 ' A' ' 128' ' ' VAL . 52.2 Cg_endo -69.12 -38.8 8.65 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.623 2.216 . . . . 0.0 112.474 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.77 -23.94 45.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.242 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -83.94 -40.9 17.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.259 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.808 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.2 tp -57.37 -46.48 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.239 0.542 . . . . 0.0 111.473 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.9 24.75 12.49 Favored Glycine 0 C--N 1.319 -0.392 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.565 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.43 173.79 14.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 0.0 110.965 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -81.39 155.67 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.845 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.1 110.0 7.64 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.3 mtm180 -81.23 119.87 24.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.816 0.817 . . . . 0.0 111.242 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.919 HG22 ' CD1' ' A' ' 85' ' ' PHE . 48.9 t -111.88 129.89 66.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.162 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.469 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 75.9 p -123.98 137.74 54.56 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.249 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.578 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.53 172.89 12.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.343 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -134.41 133.3 40.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.23 134.65 55.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.251 0.548 . . . . 0.0 112.337 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.68 -3.55 22.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.284 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.882 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -123.26 -51.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.958 0.409 . . . . 0.0 111.476 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.44 HG23 HG21 ' A' ' 170' ' ' THR . 1.4 p -84.99 -29.44 25.03 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.002 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.02 4.97 79.27 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.219 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . . . -59.11 150.77 60.48 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 1.1 Cg_endo -82.54 104.11 1.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.561 2.174 . . . . 0.0 111.093 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.578 HG22 ' C ' ' A' ' 115' ' ' SER . 35.9 m -97.71 144.28 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.985 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.0 p -150.6 142.35 23.72 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.439 0.637 . . . . 0.0 110.856 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -139.61 151.64 46.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.815 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.843 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 52.4 m -107.88 113.91 27.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 1.042 HG11 HD21 ' A' ' 101' ' ' LEU . 46.2 t -96.0 111.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.087 0.47 . . . . 0.0 111.403 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.502 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -106.79 177.83 1.24 Allowed Pre-proline 0 N--CA 1.453 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.638 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 56.6 Cg_endo -72.55 -20.1 23.91 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 121.961 1.774 . . . . 0.0 112.87 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 26.8 t -109.96 -28.06 8.92 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 131' ' ' SER . 11.8 pt-20 177.63 -162.73 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.11 0.481 . . . . 0.0 110.08 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.69 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -95.72 143.96 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.8 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -129.41 21.82 5.61 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.399 0.619 . . . . 0.0 112.295 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.843 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.66 87.65 0.1 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.225 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.577 HG13 ' SD ' ' A' ' 141' ' ' MET . 41.6 t -104.55 115.59 46.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.332 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -146.37 124.24 6.16 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.652 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.79 157.08 95.24 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.207 0.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.85 79.04 0.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.123 0.487 . . . . 0.0 110.611 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 143.15 19.22 0.23 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.184 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.745 ' HG3' HG21 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -57.73 156.78 8.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.939 0.4 . . . . 0.0 111.577 -179.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -129.5 152.21 49.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.123 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.669 HG13 ' CD1' ' A' ' 164' ' ' PHE . 21.1 t -115.35 151.03 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.825 ' O ' HG23 ' A' ' 162' ' ' VAL . 51.6 p -116.81 141.43 48.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.712 0.292 . . . . 0.0 110.405 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 184' ' ' LEU . 1.6 mp -138.16 176.09 9.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 146' ' ' VAL . 27.0 m . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.965 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.845 HG11 HD13 ' A' ' 98' ' ' LEU . 8.9 p . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 121.063 0.459 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -125.65 169.26 12.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.48 0.657 . . . . 0.0 109.973 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.669 ' CD1' HG13 ' A' ' 143' ' ' VAL . 2.7 m-85 -113.01 129.72 56.4 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.728 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.613 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 42.9 m-85 -108.6 140.76 41.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.46 0.647 . . . . 0.0 110.722 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.28 -26.17 1.87 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.978 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.538 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 10.8 t -163.99 169.55 17.84 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.086 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 84.6 t -68.78 -35.11 6.04 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.403 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.5 Cg_exo -72.19 -37.28 4.75 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.83 2.354 . . . . 0.0 110.192 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.571 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -75.95 -41.22 52.22 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.538 178.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.759 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.76 -45.57 93.35 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.0 mt-10 -78.78 -27.96 44.64 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.21 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.3 t70 -70.82 -55.97 7.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.604 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.882 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 64.2 t-105 -64.83 -28.83 69.83 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -61.22 -40.98 96.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.196 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -46.13 65.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.246 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -98.02 25.6 5.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.068 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.4 ' O ' HD22 ' A' ' 184' ' ' LEU . 1.9 t-160 -153.03 33.62 0.48 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.0 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 179.742 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 145' ' ' LEU . 6.7 tp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.735 0.302 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.55 149.0 40.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.999 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 175' ' ' ALA . 19.2 mm -102.9 161.73 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.503 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -157.57 156.69 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 112.051 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.8 OUTLIER -82.64 122.11 27.7 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.142 178.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.745 HG21 ' HG3' ' A' ' 141' ' ' MET . 0.9 OUTLIER -41.29 -29.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.549 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -64.47 -46.13 84.36 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -82.2 -20.8 37.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.841 178.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.669 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -72.91 -25.82 61.19 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -81.65 -24.91 36.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.557 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.75 -28.3 39.02 Favored Glycine 0 CA--C 1.509 -0.326 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 21.1 tp -82.06 -28.38 32.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.06 -28.85 29.93 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.405 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -76.19 -21.96 55.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.964 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.01 -22.86 39.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.15 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -51.85 -37.4 51.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.15 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.98 -55.19 38.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.515 HG21 HD12 ' A' ' 28' ' ' LEU . 6.2 m . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.641 0.257 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.577 ' CG ' HD11 ' A' ' 46' ' ' LEU . 39.6 Cg_endo -67.06 -29.18 40.53 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.411 2.074 . . . . 0.0 112.312 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.53 -57.36 12.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.041 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.515 HD12 HG21 ' A' ' 25' ' ' VAL . 12.0 mt -57.3 -27.05 61.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.397 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -65.72 -53.24 43.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.087 0.47 . . . . 0.0 109.887 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -77.12 -28.31 54.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.533 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.488 ' O ' HD13 ' A' ' 31' ' ' LEU . 1.7 tm? -70.77 -52.13 22.66 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.84 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.98 -25.67 22.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.043 0.449 . . . . 0.0 110.981 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -68.71 -21.8 64.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.224 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.27 46.81 93.59 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.026 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -130.0 158.6 73.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 0.0 110.815 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.96 110.76 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.499 2.132 . . . . 0.0 112.065 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.654 HG23 ' CG2' ' A' ' 41' ' ' THR . 11.6 p -118.98 111.0 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.36 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 p -75.85 -178.7 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.967 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -77.94 -35.86 49.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.253 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -24.88 66.68 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.195 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.654 ' CG2' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.13 -42.84 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 46' ' ' LEU . 10.3 tp -63.63 -36.25 83.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 176.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -74.17 -42.48 59.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.492 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.8 -29.02 72.65 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.546 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 41' ' ' THR . 7.1 mt -79.06 -41.45 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 121.17 0.51 . . . . 0.0 110.074 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 26' ' ' PRO . 6.9 mp -77.15 -9.92 59.07 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.354 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 t70 61.46 21.35 11.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -110.08 158.32 35.42 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.23 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.63 143.27 56.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.611 2.208 . . . . 0.0 111.917 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.3 -16.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -32.0 41.52 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.967 0.413 . . . . 0.0 111.146 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -68.98 -41.66 77.61 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.643 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.0 t -63.95 -46.44 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.56 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.71 -50.07 69.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.575 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.13 -35.78 27.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 52' ' ' ARG . 28.5 t -68.75 -31.05 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.081 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 53' ' ' VAL . 4.9 mp -81.08 -17.21 50.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.319 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -58.52 -19.24 35.8 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.256 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.66 17.91 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.705 0.288 . . . . 0.0 111.173 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . . . -113.12 71.11 0.73 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.803 0.811 . . . . 0.0 110.635 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.1 p -63.88 -15.27 58.59 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.415 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.1 t -95.19 34.68 1.37 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.5 HG21 HD23 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -95.91 110.93 23.04 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -82.3 126.51 32.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.1 0.476 . . . . 0.0 111.997 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 69' ' ' GLY . 5.8 m-85 -110.83 160.3 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.14 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.13 143.9 25.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 0.0 111.498 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.1 -100.44 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.854 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -93.82 -10.46 34.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.411 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 125.07 33.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.939 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -93.99 154.24 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 37' ' ' VAL . 4.3 mt -79.79 125.19 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.979 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.706 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.771 HD13 ' O ' ' A' ' 93' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.844 0.354 . . . . 0.0 111.202 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.465 HG21 HG23 ' A' ' 81' ' ' THR . 12.9 t -102.38 159.09 15.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.938 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.503 HD23 ' C ' ' A' ' 78' ' ' LEU . 9.9 tt -82.21 -40.9 21.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 77' ' ' THR . 4.1 mtt180 -96.8 153.63 17.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 110.979 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -66.25 126.66 29.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.465 HG23 HG21 ' A' ' 77' ' ' THR . 35.5 p -110.59 -172.47 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.109 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.27 -32.87 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.38 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.405 ' OH ' ' CD2' ' A' ' 163' ' ' HIS . 62.0 m-85 -79.34 110.75 14.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.751 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.829 HG22 ' CE1' ' A' ' 93' ' ' TYR . 25.1 t -104.73 135.0 44.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.964 0.412 . . . . 0.0 111.045 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.936 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 55.1 t80 -127.55 106.6 9.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.579 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -101.5 132.59 47.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.329 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.5 pt -140.03 123.1 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 111.825 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.6 t70 60.97 -69.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.381 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 87' ' ' ILE . 1.8 t70 -166.24 35.33 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.348 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -136.45 111.96 9.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.013 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -77.91 120.63 23.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.639 HD12 ' CD2' ' A' ' 85' ' ' PHE . 23.2 mt -117.15 165.08 13.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.829 ' CE1' HG22 ' A' ' 84' ' ' VAL . 6.0 m-85 -133.44 165.16 25.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.362 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.679 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -150.85 173.01 14.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.118 0.485 . . . . 0.0 111.95 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -108.29 -5.67 16.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.832 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.6 p -160.09 163.08 34.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.13 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.625 ' HB1' ' CZ ' ' A' ' 164' ' ' PHE . . . -51.7 -23.1 4.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -88.76 -51.59 5.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.715 0.293 . . . . 0.0 111.349 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.679 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 1.9 m-20 -39.7 -28.81 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -59.72 -35.42 74.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.64 0.257 . . . . 0.0 110.812 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.936 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 14.8 tp -156.93 160.22 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.553 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 mt -113.52 -31.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.07 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 200' ' ' ASN . 4.1 m-85 -161.81 99.27 1.2 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.964 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.543 ' CB ' HG12 ' A' ' 128' ' ' VAL . 59.7 Cg_endo -71.77 -26.35 19.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.578 2.185 . . . . 0.0 112.335 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.36 -23.5 43.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.338 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 tp -81.7 -40.5 22.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.573 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.7 tp -54.39 -48.34 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.171 0.51 . . . . 0.0 111.595 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.22 20.71 22.32 Favored Glycine 0 C--N 1.319 -0.41 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.799 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 173.04 14.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.949 0.404 . . . . 0.0 111.023 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -78.28 152.79 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.644 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.819 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -137.15 109.88 7.56 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -83.71 120.57 26.17 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.79 0.805 . . . . 0.0 111.056 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.451 HG22 ' HD1' ' A' ' 85' ' ' PHE . 93.6 t -111.82 130.59 65.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.014 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 m -122.45 136.24 54.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.101 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.548 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -141.99 173.17 11.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.684 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 71.6 m80 -134.56 136.64 43.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 165' ' ' PHE . 28.5 t -64.76 134.44 54.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.179 0.514 . . . . 0.0 112.175 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.32 -5.76 34.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.819 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.895 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -126.89 -50.91 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.471 ' CG2' ' HB2' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -74.41 -33.6 63.05 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.217 0.532 . . . . 0.0 110.026 -179.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.17 34.92 57.67 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.373 -0.918 . . . . 0.0 110.818 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.471 ' HB2' ' CG2' ' A' ' 120' ' ' THR . . . -100.34 160.32 27.34 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.178 -0.511 . . . . 0.0 109.994 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -87.78 108.02 0.62 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.731 2.287 . . . . 0.0 111.257 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.548 HG22 ' C ' ' A' ' 115' ' ' SER . 35.9 m -104.41 144.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.157 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 85.4 p -147.22 142.79 27.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.51 0.671 . . . . 0.0 110.631 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -136.63 152.38 50.37 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.56 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.873 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.1 m -112.26 113.98 26.51 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 23.8 t -96.3 111.91 27.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.84 0.353 . . . . 0.0 111.586 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.47 167.21 9.88 Favored Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.211 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.79 -16.54 55.84 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.521 2.147 . . . . 0.0 113.051 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 27.2 t -116.72 -25.6 7.28 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 131' ' ' SER . 12.5 pt-20 178.94 -162.41 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.123 0.487 . . . . 0.0 109.854 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -96.05 160.14 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.878 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -147.01 18.64 1.25 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.422 0.629 . . . . 0.0 112.409 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.873 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.95 86.56 0.08 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.643 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.464 HG13 ' SD ' ' A' ' 141' ' ' MET . 41.0 t -105.07 120.79 56.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.848 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -145.23 126.16 7.49 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.985 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.22 165.53 84.12 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.475 -1.469 . . . . 0.0 112.271 -0.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.77 78.01 0.86 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.148 0.499 . . . . 0.0 110.656 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.7 19.32 0.18 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.171 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.682 ' CG ' HG11 ' A' ' 189' ' ' VAL . 10.4 ptm -61.03 160.91 9.16 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.949 0.404 . . . . 0.0 111.396 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -126.89 152.19 47.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.381 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.722 HG13 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -113.76 147.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.863 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.747 ' O ' HG13 ' A' ' 162' ' ' VAL . 56.3 p -117.29 137.52 52.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.697 0.284 . . . . 0.0 110.659 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 146' ' ' VAL . 0.3 OUTLIER -144.11 176.18 9.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 146' ' ' VAL . 8.5 p . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.801 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 144' ' ' SER . 21.9 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.902 0.382 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.405 ' CD2' ' OH ' ' A' ' 83' ' ' TYR . 5.4 m80 -120.5 165.96 14.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.58 0.705 . . . . 0.0 110.152 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.722 ' CE1' HG13 ' A' ' 143' ' ' VAL . 40.9 m-85 -115.52 140.67 48.94 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.536 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.591 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 57.0 m-85 -117.6 137.94 52.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.228 0.537 . . . . 0.0 110.287 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.38 -26.13 0.5 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.656 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 30.8 p -167.52 170.65 11.05 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.73 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.603 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 90.5 t -68.03 -34.37 6.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.32 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.707 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.8 Cg_exo -72.33 -37.41 4.46 Favored 'Trans proline' 0 CA--C 1.503 -1.06 0 C-N-CA 122.58 2.187 . . . . 0.0 110.321 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.584 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.34 -40.45 51.24 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.733 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.84 -46.38 89.73 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.561 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 2.3 mm-40 -79.09 -27.43 42.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.425 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 169' ' ' PRO . 17.6 t70 -69.8 -55.77 8.93 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.168 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.895 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 54.7 t-105 -65.87 -28.76 69.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.652 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.733 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.47 -39.05 93.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.213 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.5 t -51.98 -45.32 64.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.386 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 22.33 7.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.345 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.75 37.77 0.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.903 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.326 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.82 0.343 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.33 150.1 40.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 111.015 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.3 mm -102.42 159.99 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.923 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.454 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.09 162.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.175 0.512 . . . . 0.0 111.782 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.9 OUTLIER -88.77 125.68 34.99 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.792 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.706 HG21 HD23 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -46.98 -20.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.596 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -69.27 -43.16 74.44 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -82.53 -24.49 34.04 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.249 178.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -71.91 -25.28 61.84 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.534 ' CE2' HG23 ' A' ' 133' ' ' ILE . 2.8 t80 -81.76 -31.38 31.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.145 0.498 . . . . 0.0 110.511 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.16 -30.45 31.06 Favored Glycine 0 CA--C 1.51 -0.253 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.359 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.01 -28.26 35.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.92 -29.07 29.75 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.62 -22.82 34.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.377 -0.411 . . . . 0.0 110.962 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -78.9 -22.8 45.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.23 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.76 -28.71 16.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.201 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . 63.6 t-20 -81.1 -41.6 22.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.715 HG11 HD12 ' A' ' 28' ' ' LEU . 6.4 t . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.637 0.256 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.532 ' HG3' HD11 ' A' ' 46' ' ' LEU . 43.4 Cg_endo -68.18 -43.62 4.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.565 2.176 . . . . 0.0 112.659 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.596 HD12 ' HG ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -51.95 -57.03 10.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.715 HD12 HG11 ' A' ' 25' ' ' VAL . 15.7 mt -63.25 -26.83 68.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.011 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 -60.34 -53.1 61.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.933 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.745 ' HB3' HG21 ' A' ' 37' ' ' VAL . 24.8 mm-40 -75.32 -22.05 57.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.582 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tp -75.15 -52.15 11.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.254 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.0 -36.3 62.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.966 0.412 . . . . 0.0 112.003 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 30' ' ' GLU . 6.5 ptmt -68.23 -19.52 64.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.155 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.32 56.88 13.14 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.228 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.9 165.76 25.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.653 0.263 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.57 114.41 3.93 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.546 2.164 . . . . 0.0 112.24 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.745 HG21 ' HB3' ' A' ' 30' ' ' GLU . 25.0 t -126.91 110.45 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.428 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 82.1 p -89.97 -169.84 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -78.04 -37.88 45.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.361 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -29.13 69.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.907 0.384 . . . . 0.0 110.174 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.708 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -83.41 -42.76 16.62 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.653 ' CD1' HD13 ' A' ' 71' ' ' ILE . 10.2 mt -62.15 -36.76 82.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -71.28 -43.02 67.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.788 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.83 -31.84 70.16 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.86 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.617 HD12 HG23 ' A' ' 41' ' ' THR . 6.7 mt -77.42 -45.44 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 120.885 0.374 . . . . 0.0 110.722 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 42' ' ' LEU . 2.0 mm? -76.81 -8.51 57.46 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.567 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 t0 60.5 24.27 13.9 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.425 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 5.3 m95 -111.37 139.8 22.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.181 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.85 144.48 20.79 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.556 2.17 . . . . 0.0 112.252 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.46 -16.69 2.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -77.2 -34.88 56.11 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.427 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.603 ' O ' HG23 ' A' ' 56' ' ' VAL . 9.7 mtt85 -67.71 -41.33 83.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.636 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -63.82 -47.99 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.389 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.4 -52.53 59.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.299 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.98 -34.99 10.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.891 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 52' ' ' ARG . 36.1 t -63.97 -32.29 56.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.015 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 3.6 mm? -66.63 -34.65 78.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.758 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 61' ' ' THR . 4.4 tt0 -56.03 -34.08 65.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.549 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -96.19 -18.36 20.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.737 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . . . -96.6 35.96 1.44 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.438 0.637 . . . . 0.0 111.098 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 58' ' ' GLU . 72.6 p -58.75 -18.16 29.26 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.269 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 m -112.77 38.12 2.89 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.785 0.326 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 60' ' ' ALA . 0.9 OUTLIER -101.24 141.58 33.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.102 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.503 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -78.62 126.79 31.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.092 0.472 . . . . 0.0 111.257 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CZ ' HG22 ' A' ' 63' ' ' THR . 61.1 m-85 -117.2 173.15 6.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.369 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.595 ' OD1' HD13 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -151.64 146.75 26.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.027 0.441 . . . . 0.0 111.333 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.9 tttm 66.7 -103.33 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.813 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -87.92 -11.46 47.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.21 26.96 2.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.128 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -81.49 169.43 17.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.953 0.406 . . . . 0.0 109.914 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.653 HD13 ' CD1' ' A' ' 42' ' ' LEU . 3.9 mp -79.69 120.13 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.652 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.595 HD13 ' OD1' ' A' ' 66' ' ' ASP . 2.4 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.796 0.332 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.1 p -109.88 159.1 17.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -92.2 42.74 1.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -155.06 123.61 6.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' THR . 14.8 pm0 -57.46 -19.76 26.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.43 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 80' ' ' GLU . 54.4 p 36.88 -165.83 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -110.0 -26.26 9.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 28.1 m-85 -87.83 117.37 26.62 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.596 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.424 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.7 t -110.1 145.08 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.024 0.44 . . . . 0.0 111.521 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.797 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 17.4 t80 -134.13 107.46 7.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.016 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -102.51 133.03 48.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 0.0 111.843 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.486 HG23 ' CE1' ' A' ' 85' ' ' PHE . 3.8 pt -140.1 124.37 18.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.255 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.5 t70 63.12 -68.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.216 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.3 t0 -166.92 36.15 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.413 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -135.76 114.72 12.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.938 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.443 ' CD ' ' H ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -83.1 85.77 7.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.233 0.539 . . . . 0.0 110.885 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -74.13 165.05 25.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.08 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -134.88 165.28 25.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.365 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.683 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -151.56 169.75 21.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 0.0 111.919 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 17.8 m0 -88.24 -25.22 22.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.828 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.903 ' HB2' HG13 ' A' ' 162' ' ' VAL . 3.9 p -147.57 173.0 13.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.388 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.527 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -56.6 -20.87 23.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.826 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.821 HD12 HG11 ' A' ' 162' ' ' VAL . 14.2 mt -87.31 -51.66 5.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.59 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 5.3 m-20 -50.12 -24.65 2.87 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.683 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.7 -39.48 88.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.719 0.295 . . . . 0.0 110.651 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 101' ' ' LEU . 4.2 pp -112.08 178.42 4.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 111.106 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 101' ' ' LEU . 4.3 tt -157.93 -45.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.11 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.651 ' O ' HG22 ' A' ' 107' ' ' ILE . 8.0 m-85 -164.4 90.89 1.04 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.07 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.666 ' HB3' HG12 ' A' ' 128' ' ' VAL . 60.1 Cg_endo -72.86 -33.69 7.59 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.522 2.148 . . . . 0.0 112.456 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.411 ' HA ' ' CB ' ' A' ' 130' ' ' PRO . . . -78.05 -23.92 47.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.391 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.401 ' CB ' ' HB3' ' A' ' 103' ' ' PHE . 1.9 tp -84.84 -42.73 14.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.223 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -54.7 -48.6 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.175 0.512 . . . . 0.0 111.419 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.74 21.6 15.94 Favored Glycine 0 C--N 1.319 -0.408 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.921 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.77 177.36 10.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.053 0.454 . . . . 0.0 111.109 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -83.52 153.74 24.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.926 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.797 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -137.09 109.87 7.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -82.75 121.05 26.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.778 0.799 . . . . 0.0 111.034 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.455 HG22 ' HD2' ' A' ' 85' ' ' PHE . 99.0 t -113.18 132.61 61.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.811 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.424 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 60.5 p -120.77 139.09 53.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.066 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.553 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.3 m -140.73 172.9 12.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.26 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -133.61 130.56 38.5 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.8 m -57.33 123.26 14.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.044 0.45 . . . . 0.0 111.803 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.34 -9.3 39.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.695 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.693 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.54 -50.59 1.98 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.558 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -75.74 -21.21 57.69 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.965 0.412 . . . . 0.0 110.848 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.45 33.96 86.61 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.118 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.558 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -102.41 167.8 9.86 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.43 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.409 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 37.7 Cg_endo -93.22 110.05 0.2 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.954 2.436 . . . . 0.0 111.28 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.553 HG22 ' C ' ' A' ' 115' ' ' SER . 35.0 m -108.5 148.32 12.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.547 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.861 ' C ' HD13 ' A' ' 126' ' ' LEU . 79.4 p -149.21 141.44 24.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.406 0.622 . . . . 0.0 110.795 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.861 HD13 ' C ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -132.6 153.78 50.69 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.53 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.811 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.2 m -110.99 114.46 27.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.828 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.765 HG13 ' CE2' ' A' ' 193' ' ' PHE . 38.4 t -96.47 111.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.412 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -106.65 168.9 7.44 Favored Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.958 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.2 Cg_endo -66.09 -19.27 57.33 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.229 1.953 . . . . 0.0 112.891 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 34.6 p -112.89 -26.12 8.69 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 131' ' ' SER . 11.1 pt-20 178.09 -162.23 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.131 0.491 . . . . 0.0 110.099 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.695 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.35 158.76 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.752 178.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -146.19 20.43 1.4 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.387 0.613 . . . . 0.0 112.299 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.811 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.67 86.47 0.09 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.646 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.631 HG13 ' SD ' ' A' ' 141' ' ' MET . 58.4 t -102.87 113.51 39.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.375 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.447 ' O ' ' HE1' ' A' ' 141' ' ' MET . 4.2 tm-20 -146.26 121.94 5.61 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.498 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.608 ' HD2' ' HE3' ' A' ' 141' ' ' MET . 55.6 Cg_endo -69.28 157.6 90.53 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.459 -1.475 . . . . 0.0 112.737 -0.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.02 80.33 1.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.54 16.64 0.15 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.351 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.811 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -61.16 159.24 12.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.033 0.444 . . . . 0.0 111.571 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -129.03 152.1 48.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.515 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.697 HG13 ' CD1' ' A' ' 164' ' ' PHE . 4.6 t -115.31 152.97 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.88 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 162' ' ' VAL . 23.5 m -120.0 141.08 50.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.582 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.534 HD13 HG21 ' A' ' 187' ' ' VAL . 5.2 mp -142.23 176.27 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.985 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 1.012 HG22 HD12 ' A' ' 184' ' ' LEU . 36.4 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.811 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.903 HG13 ' HB2' ' A' ' 96' ' ' CYS . 2.6 p . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 121.068 0.461 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.41 ' CE1' ' OH ' ' A' ' 83' ' ' TYR . 3.6 m-70 -126.96 169.38 13.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.555 0.693 . . . . 0.0 110.05 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.697 ' CD1' HG13 ' A' ' 143' ' ' VAL . 1.9 m-85 -108.61 150.69 27.16 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.796 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 37.9 m-85 -132.96 136.26 45.99 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.361 0.601 . . . . 0.0 110.564 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.641 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -39.19 -28.67 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.142 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.498 ' HB3' ' HD2' ' A' ' 169' ' ' PRO . 30.5 t -171.7 176.78 3.58 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.796 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 85.3 t -69.05 -34.3 4.92 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.552 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.7 Cg_exo -72.55 -38.38 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.813 2.342 . . . . 0.0 110.396 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.595 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.52 -39.84 51.77 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.546 177.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.706 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.33 -45.37 94.69 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.6 mt-10 -79.19 -27.56 42.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.179 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 169' ' ' PRO . 8.8 t70 -70.24 -55.86 8.21 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.421 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.693 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 57.4 t90 -65.17 -28.05 69.13 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.8 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -66.73 -37.04 83.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.323 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 t -53.09 -46.51 68.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.404 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -95.16 22.79 6.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.211 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.501 ' CD2' ' CZ2' ' A' ' 174' ' ' TRP . 79.5 m80 -152.8 45.43 0.69 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.952 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.739 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 1.012 HD12 HG22 ' A' ' 146' ' ' VAL . 1.1 tp . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.11 41.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.021 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 175' ' ' ALA . 10.0 mm -99.78 159.45 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.864 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -161.12 162.03 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.361 0.6 . . . . 0.0 111.967 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -90.8 129.64 36.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.778 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.811 HG11 ' HG3' ' A' ' 141' ' ' MET . 1.5 m -46.98 -19.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.75 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 8.7 m80 -71.76 -41.84 67.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.798 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.21 -24.22 34.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.364 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.9 61.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.175 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.765 ' CE2' HG13 ' A' ' 128' ' ' VAL . 5.4 t80 -81.3 -25.57 36.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.682 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.76 -30.25 32.92 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 -28.22 32.48 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.14 -28.32 31.2 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.414 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -82.28 -23.99 34.95 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.883 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.08 -23.04 57.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.146 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -51.89 -33.08 35.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.144 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.99 -25.08 37.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.948 179.976 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.623 HG21 HD22 ' A' ' 106' ' ' LEU . 17.0 m . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 120.852 0.358 . . . . 0.0 111.823 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.607 ' HG2' HD11 ' A' ' 46' ' ' LEU . 52.9 Cg_exo -52.49 -26.23 27.86 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.482 2.122 . . . . 0.0 112.219 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.623 HD21 ' CG2' ' A' ' 71' ' ' ILE . 1.0 OUTLIER -52.13 -57.37 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.352 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 mt -80.17 -27.28 39.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.55 -53.22 51.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.548 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.584 ' HG2' HD13 ' A' ' 45' ' ' ILE . 3.0 mp0 -66.03 -23.28 66.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.291 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.609 HD21 ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -69.52 -38.38 77.53 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.07 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.08 -25.63 13.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.001 0.429 . . . . 0.0 111.174 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.01 -20.87 65.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.073 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.56 42.46 95.61 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.267 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -133.36 165.85 33.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.704 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.55 114.28 3.78 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.502 2.135 . . . . 0.0 112.016 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.696 HG12 ' HG ' ' A' ' 42' ' ' LEU . 20.8 t -115.57 110.19 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.421 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.7 p -88.03 -171.65 3.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.746 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -77.99 -36.64 48.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.313 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -29.42 69.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.276 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.651 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -83.52 -42.65 16.61 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.696 ' HG ' HG12 ' A' ' 37' ' ' VAL . 12.6 mt -62.53 -36.56 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.975 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.87 -43.01 63.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.646 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.28 -31.65 77.76 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.477 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.634 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -79.54 -38.52 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 121.061 0.458 . . . . 0.0 110.231 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.607 HD11 ' HG2' ' A' ' 26' ' ' PRO . 6.4 mp -78.13 -10.01 59.43 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.178 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 59.38 22.54 10.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.439 ' CD1' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -102.77 137.06 19.21 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.189 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.731 ' O ' HG23 ' A' ' 53' ' ' VAL . 10.1 Cg_endo -53.04 142.81 52.8 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.697 2.265 . . . . 0.0 112.207 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.8 -20.64 2.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.55 -39.95 36.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.121 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.896 ' O ' HG23 ' A' ' 56' ' ' VAL . 13.0 mmt180 -67.93 -38.28 82.7 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.975 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.5 t -65.73 -48.1 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.89 -54.37 30.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.177 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.14 64.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.898 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 52' ' ' ARG . 35.9 t -65.06 -31.73 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.747 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.21 -35.12 79.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.59 ' O ' HG23 ' A' ' 61' ' ' THR . 1.8 mp0 -57.49 -22.82 46.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.851 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -96.42 -20.68 18.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.38 31.89 2.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.55 0.69 . . . . 0.0 110.916 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 58' ' ' GLU . 21.1 p -71.61 -27.65 63.26 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.8 m -75.86 -25.51 56.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.35 141.25 56.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.042 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.6 ' CG ' HG21 ' A' ' 72' ' ' ILE . 14.5 pt-20 -78.92 133.77 36.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.046 0.45 . . . . 0.0 111.274 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.426 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 55.2 m-85 -105.19 173.42 6.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.48 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -149.82 145.97 26.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.969 0.414 . . . . 0.0 111.499 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 tttp 65.6 -105.03 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.634 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -86.91 -11.51 50.46 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.713 0.292 . . . . 0.0 111.561 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 122.67 25.87 1.86 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.228 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -78.02 158.79 29.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 110.006 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.669 HD13 ' CD1' ' A' ' 42' ' ' LEU . 1.9 mp -79.74 126.32 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.574 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.819 ' O ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 121.027 0.442 . . . . 0.0 111.021 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.794 0.33 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -113.72 140.86 47.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.579 ' H ' HD12 ' A' ' 78' ' ' LEU . 5.1 mp -59.75 -23.87 63.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -92.97 123.61 36.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 111.096 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.2 pt-20 -60.64 -16.76 42.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.461 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.756 HG21 ' HA ' ' A' ' 95' ' ' TRP . 0.5 OUTLIER 37.46 -167.97 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.08 -24.88 12.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.113 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -80.78 114.85 19.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.55 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.82 136.14 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.015 0.436 . . . . 0.0 111.423 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.819 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 56.5 t80 -128.16 104.6 7.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.177 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -98.6 131.12 45.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.396 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -140.06 122.95 17.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.07 -72.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 87' ' ' ILE . 18.3 t0 -159.26 37.11 0.2 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -139.8 145.95 38.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.56 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.96 86.49 2.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.871 0.367 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 85' ' ' PHE . 4.3 mm? -71.27 164.79 25.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.589 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.41 ' CD2' ' HA ' ' A' ' 80' ' ' GLU . 5.1 m-85 -131.12 160.08 35.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.356 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.549 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -146.55 161.44 40.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.737 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.756 ' HA ' HG21 ' A' ' 81' ' ' THR . 7.7 m0 -90.61 -24.7 20.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.409 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.436 ' HB3' ' CG1' ' A' ' 162' ' ' VAL . 5.6 m -146.97 172.37 13.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.974 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.716 ' HB1' ' CE2' ' A' ' 164' ' ' PHE . . . -53.77 -21.53 7.51 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.432 ' HB2' HG11 ' A' ' 162' ' ' VAL . 2.1 tp -86.8 -51.53 6.03 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.549 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -45.57 -25.39 0.45 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -60.31 -36.73 78.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.688 0.28 . . . . 0.0 110.87 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.866 HD12 ' CG ' ' A' ' 104' ' ' PRO . 1.9 pt? -137.5 166.18 24.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.004 0.431 . . . . 0.0 111.386 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.405 HG22 ' CZ ' ' A' ' 103' ' ' PHE . 4.1 mp -143.62 -46.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.405 ' CZ ' HG22 ' A' ' 102' ' ' ILE . 38.5 m-85 -141.1 65.83 23.45 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.664 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.866 ' CG ' HD12 ' A' ' 101' ' ' LEU . 34.3 Cg_exo -57.83 -30.61 89.99 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.742 2.295 . . . . 0.0 112.531 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.36 -23.61 43.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.455 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.623 HD22 HG21 ' A' ' 25' ' ' VAL . 1.1 tt -85.94 -34.04 20.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.143 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 tp -54.51 -47.61 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.174 0.511 . . . . 0.0 111.687 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.91 20.85 25.0 Favored Glycine 0 C--N 1.32 -0.351 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.733 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 173.42 14.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 111.011 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -78.87 151.8 31.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.819 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.14 109.75 7.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 112.001 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -82.35 119.64 24.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.818 0.818 . . . . 0.0 111.198 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.768 HG22 ' CD1' ' A' ' 85' ' ' PHE . 39.6 t -111.61 130.47 65.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.137 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.0 m -122.29 137.04 54.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.093 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.548 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.62 172.8 12.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.209 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -136.68 135.06 37.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 26.4 t -61.77 132.14 52.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.227 0.537 . . . . 0.0 112.147 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.48 -3.84 23.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.935 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.915 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.58 -50.6 1.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.616 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -88.98 -24.23 22.45 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.247 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.36 5.03 76.05 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.179 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.689 ' H ' HG22 ' A' ' 120' ' ' THR . . . -57.74 151.17 43.54 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.504 0.193 . . . . 0.0 110.579 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 2.5 Cg_endo -84.54 105.8 1.06 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.736 2.29 . . . . 0.0 110.898 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.65 HG12 ' CD ' ' A' ' 138' ' ' PRO . 35.2 m -103.29 145.49 12.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.419 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.906 ' O ' HD13 ' A' ' 126' ' ' LEU . 72.8 p -151.49 141.62 22.22 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.443 0.64 . . . . 0.0 110.699 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.906 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -134.82 152.92 52.14 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.306 178.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.882 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 82.7 m -111.34 113.31 25.69 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.541 HG22 ' HZ ' ' A' ' 193' ' ' PHE . 19.7 t -95.86 111.73 26.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.631 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.14 175.63 2.07 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.401 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.78 -15.62 37.11 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.695 2.263 . . . . 0.0 112.971 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 50.1 m -120.11 -26.03 5.61 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 131' ' ' SER . 14.6 pt-20 179.74 -162.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.169 0.509 . . . . 0.0 110.186 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.777 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -96.62 161.36 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.992 178.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -149.31 19.25 0.95 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.298 0.57 . . . . 0.0 112.253 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.882 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.09 86.23 0.08 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.593 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.557 HG13 HD12 ' A' ' 126' ' ' LEU . 24.4 t -105.02 118.35 52.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.138 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -146.21 117.12 4.82 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.65 ' CD ' HG12 ' A' ' 124' ' ' VAL . 13.9 Cg_exo -69.47 146.99 83.12 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.643 -1.399 . . . . 0.0 112.28 0.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.18 -33.83 54.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.642 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.93 28.98 12.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.957 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.759 ' HE1' HD21 ' A' ' 126' ' ' LEU . 1.9 ppp? -64.9 156.55 30.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.126 0.489 . . . . 0.0 111.529 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -128.72 152.32 48.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.616 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.844 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -112.49 150.67 14.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.965 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 162' ' ' VAL . 23.0 p -119.86 140.37 50.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.757 0.313 . . . . 0.0 111.026 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.4 mt -139.02 176.28 8.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.873 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.051 179.741 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 144' ' ' SER . 8.0 p . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 121.13 0.491 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.447 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 2.5 m-70 -126.81 169.24 13.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.609 0.719 . . . . 0.0 110.076 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.844 ' CE1' HG22 ' A' ' 143' ' ' VAL . 11.9 m-85 -106.11 151.71 24.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.62 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 49.2 m-85 -131.13 136.3 48.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.495 0.664 . . . . 0.0 110.502 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -43.42 -26.42 0.2 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.67 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.526 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 22.3 p -169.24 172.76 7.1 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.941 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 81.5 t -69.01 -34.04 4.7 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.389 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.76 -37.35 3.91 Favored 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 122.669 2.246 . . . . 0.0 110.24 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.587 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.6 -40.42 49.54 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.578 178.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.73 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.0 -45.59 92.96 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.6 mt-10 -78.92 -27.56 43.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.119 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 25.3 t70 -70.77 -55.94 7.47 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.451 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.915 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.6 t-105 -65.03 -28.28 69.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.632 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.59 -40.7 97.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.221 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.2 p -51.85 -43.56 63.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.354 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.82 21.01 7.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.358 0.599 . . . . 0.0 111.353 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.468 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -125.94 27.39 6.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.811 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.757 -179.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 178' ' ' HIS . 2.9 tt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.735 0.302 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.65 149.76 41.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.659 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.9 mm -99.78 159.59 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.954 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -160.09 147.81 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.815 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.5 OUTLIER -77.41 124.49 27.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.467 177.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.635 HG11 ' HG3' ' A' ' 141' ' ' MET . 1.0 OUTLIER -46.93 -20.67 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.644 179.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.37 -39.63 77.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.7 mt-10 -82.46 -28.38 31.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.036 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.436 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -63.69 -24.69 67.88 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.116 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.777 ' CZ ' HG23 ' A' ' 133' ' ' ILE . 0.6 OUTLIER -81.15 -24.72 37.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.032 0.444 . . . . 0.0 110.818 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.56 -30.3 33.45 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.17 -28.47 32.07 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -27.87 32.77 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.601 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -82.17 -25.85 33.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 110.951 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -73.88 -23.32 59.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.089 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -55.84 -43.3 76.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.128 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -81.01 -50.07 10.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.113 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.253 -179.864 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 25' ' ' VAL . 11.2 p . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.84 0.352 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.626 ' HG3' HD11 ' A' ' 46' ' ' LEU . 57.0 Cg_endo -71.02 -21.81 27.13 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.595 2.197 . . . . 0.0 112.484 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.711 ' HG ' HG21 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -56.46 -57.44 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 111.363 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -80.12 -27.43 39.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.227 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.426 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -71.54 -53.22 14.53 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.888 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.88 -24.52 66.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.506 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.4 tp -69.45 -28.93 66.53 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.73 -22.56 9.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.351 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -69.11 -21.7 64.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.192 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.95 39.51 94.94 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.399 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -133.25 166.04 32.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.572 0.225 . . . . 0.0 110.833 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.64 114.12 3.58 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.468 2.112 . . . . 0.0 111.952 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.782 HG23 HG22 ' A' ' 41' ' ' THR . 11.1 p -111.59 109.87 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.438 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.3 p -85.99 -170.47 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.723 ' NH1' HD11 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -78.04 -37.52 46.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.465 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -27.91 68.66 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.199 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.782 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.53 -42.34 15.61 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -62.74 -36.6 83.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 176.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.04 -42.74 62.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.604 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.74 -30.19 72.7 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.643 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.556 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.03 -43.51 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.055 0.455 . . . . 0.0 110.397 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.626 HD11 ' HG3' ' A' ' 26' ' ' PRO . 7.2 mp -76.75 -9.83 58.95 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.506 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.5 t70 60.63 21.77 11.64 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.442 ' CD1' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -104.47 137.79 19.33 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.068 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.442 ' HD2' ' CD1' ' A' ' 48' ' ' TRP . 10.7 Cg_endo -53.66 140.01 66.56 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.597 2.198 . . . . 0.0 112.012 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.19 -17.89 1.28 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.6 -32.61 47.66 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.258 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.791 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.17 -39.87 86.53 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.05 -48.14 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.586 177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.87 57.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.389 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.2 -42.77 66.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.891 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 52' ' ' ARG . 26.9 t -67.76 -31.17 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.539 HD23 ' C ' ' A' ' 57' ' ' LEU . 9.2 tt -63.95 -35.37 80.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.758 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.25 -45.12 88.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.755 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -88.05 -7.88 56.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.62 74.98 1.04 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.765 0.793 . . . . 0.0 110.133 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -106.66 -16.09 14.6 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.42 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -73.87 -28.13 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.17 141.33 50.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.448 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.822 ' O ' HG22 ' A' ' 72' ' ' ILE . 23.9 mt-10 -78.79 126.94 31.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.313 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -103.37 171.78 7.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.463 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 70' ' ' ASN . 1.6 t70 -92.16 -172.76 3.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.479 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -67.55 -35.42 79.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -91.73 12.24 21.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.648 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.28 17.33 74.23 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.156 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 66' ' ' ASP . 24.3 m120 -91.49 165.62 13.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.983 0.392 . . . . 0.0 110.04 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.776 HD13 HD13 ' A' ' 42' ' ' LEU . 3.2 mp -79.84 127.8 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.546 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.822 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.4 tt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.022 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.742 0.306 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.572 HG21 ' CD1' ' A' ' 95' ' ' TRP . 81.7 p -97.82 159.05 15.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.5 -41.41 85.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.979 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.9 mtt-85 -110.31 150.29 28.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 4.5 tt0 -57.05 132.34 52.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.925 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.8 p -108.44 -173.67 2.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.046 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 70.2 m -94.94 -38.54 10.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.016 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.431 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 32.6 m-85 -79.52 111.09 15.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.507 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.62 138.13 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.762 ' HD1' HG22 ' A' ' 113' ' ' VAL . 69.4 t80 -123.51 106.73 10.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.544 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -98.06 125.77 43.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.279 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -139.59 122.91 18.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.853 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 t70 59.4 -72.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.159 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 87' ' ' ILE . 35.1 t0 -165.74 34.15 0.05 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.313 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.3 mmp_? -136.64 111.82 9.06 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.751 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -77.87 120.63 23.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.909 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.95 164.78 11.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 111.022 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.435 ' CZ ' ' HG3' ' A' ' 80' ' ' GLU . 28.4 m-85 -131.49 155.39 47.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.355 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.768 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -150.39 168.41 24.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.973 0.416 . . . . 0.0 111.614 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.572 ' CD1' HG21 ' A' ' 77' ' ' THR . 6.3 m95 -100.21 -6.97 25.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.189 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.431 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.5 OUTLIER 178.03 -179.28 0.27 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.827 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 164' ' ' PHE . . . -55.09 164.36 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.729 0.3 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 tt 70.21 -52.92 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.103 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.768 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 8.8 t0 -47.3 -29.27 2.38 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.834 0.349 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.481 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 2.7 p -60.02 -39.44 85.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.717 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER 169.92 153.45 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.554 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.755 ' O ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -143.33 48.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.867 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.705 ' O ' HG22 ' A' ' 107' ' ' ILE . 16.9 m-85 -166.27 59.27 0.54 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.992 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.583 ' HB3' HG12 ' A' ' 128' ' ' VAL . 61.2 Cg_endo -73.14 -37.67 3.28 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.596 2.197 . . . . 0.0 112.253 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.08 -23.8 43.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.218 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -82.72 -41.06 19.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.26 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.3 tp -57.68 -46.6 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.177 0.513 . . . . 0.0 111.422 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.88 24.29 15.68 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.636 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -152.55 173.53 15.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.003 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -80.09 153.42 28.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.772 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.752 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -137.06 109.78 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -83.19 120.26 25.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.781 0.8 . . . . 0.0 111.23 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.762 HG22 ' HD1' ' A' ' 85' ' ' PHE . 94.6 t -112.79 130.68 66.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.013 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 m -122.78 136.91 55.02 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.202 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.598 ' HB3' HG23 ' A' ' 124' ' ' VAL . 2.0 t -141.81 173.0 11.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.36 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.455 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -133.53 137.23 45.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 34.0 t -66.65 134.0 51.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.086 0.47 . . . . 0.0 112.234 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -72.52 -3.98 27.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.102 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.888 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.59 -51.34 2.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.928 0.395 . . . . 0.0 111.529 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.37 -24.18 22.01 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.356 -179.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.15 6.09 73.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.114 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.716 ' H ' HG22 ' A' ' 120' ' ' THR . . . -59.39 150.69 63.37 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.552 0.215 . . . . 0.0 110.501 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.0 104.39 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.652 2.235 . . . . 0.0 110.77 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.598 HG23 ' HB3' ' A' ' 115' ' ' SER . 35.0 m -99.22 144.35 12.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.299 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.9 p -150.48 141.95 23.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.448 0.642 . . . . 0.0 110.639 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.675 HD21 HG11 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -138.26 151.28 47.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.026 179.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.871 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 39.2 m -107.1 113.76 27.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.732 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.583 HG12 ' HB3' ' A' ' 104' ' ' PRO . 36.2 t -96.15 111.72 26.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.382 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.23 167.68 9.09 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.793 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.62 -19.16 60.15 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.084 1.856 . . . . 0.0 112.884 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 4.4 m -112.79 -26.73 8.43 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 131' ' ' SER . 2.9 pt-20 178.37 -162.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.15 0.5 . . . . 0.0 110.159 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -96.23 157.75 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.014 178.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -144.85 19.05 1.64 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.367 0.603 . . . . 0.0 112.241 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.871 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.9 86.56 0.08 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.326 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.574 HG13 ' SD ' ' A' ' 141' ' ' MET . 23.8 t -104.99 115.92 47.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.431 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.35 124.32 6.2 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.575 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.65 154.79 95.81 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.874 -1.302 . . . . 0.0 112.247 0.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.42 79.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.106 0.479 . . . . 0.0 110.434 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 141.82 20.46 0.27 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.017 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.574 ' SD ' HG13 ' A' ' 136' ' ' VAL . 0.4 OUTLIER -61.06 160.32 10.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.035 0.445 . . . . 0.0 111.298 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -129.24 152.29 48.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.091 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.641 HG13 ' CD1' ' A' ' 164' ' ' PHE . 40.5 t -113.98 150.67 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.624 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.745 ' O ' HG13 ' A' ' 162' ' ' VAL . 2.8 p -117.81 138.77 51.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.865 0.364 . . . . 0.0 110.912 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.868 HD21 HG21 ' A' ' 187' ' ' VAL . 1.3 pp -149.93 176.63 10.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.599 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 146' ' ' VAL . 8.9 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 0.0 110.88 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 144' ' ' SER . 25.2 t . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.83 0.348 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -113.99 164.81 13.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.717 0.77 . . . . 0.0 110.469 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.641 ' CD1' HG13 ' A' ' 143' ' ' VAL . 3.3 m-85 -122.3 129.83 52.56 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.559 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 44.8 m-85 -108.54 140.95 41.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.45 0.643 . . . . 0.0 110.771 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.38 -25.66 1.71 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.78 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.599 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 32.1 m -162.36 165.84 25.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.663 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.625 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 74.9 t -67.66 -33.91 5.94 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.955 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.63 -36.92 4.44 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.669 2.246 . . . . 0.0 110.262 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.65 -40.37 49.33 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.468 177.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.72 -45.79 92.44 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.547 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 3.1 mm-40 -78.88 -27.06 43.97 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.351 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 169' ' ' PRO . 25.9 t0 -70.62 -55.91 7.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.888 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 31.8 t-105 -65.23 -28.97 69.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.635 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.43 -39.93 95.8 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.346 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.8 m -52.22 -44.54 64.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.327 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.408 ' O ' ' CD2' ' A' ' 178' ' ' HIS . 0.0 OUTLIER -96.15 22.33 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.259 0.552 . . . . 0.0 111.235 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.436 ' NE2' ' CE2' ' A' ' 174' ' ' TRP . 15.8 m-70 -145.46 40.75 1.22 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.084 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.575 179.835 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.591 ' CD1' HG23 ' A' ' 146' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.639 0.257 . . . . 0.0 111.14 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.04 143.65 46.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.949 0.404 . . . . 0.0 111.225 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 175' ' ' ALA . 15.9 mm -103.52 161.56 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.94 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.868 HG21 HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -161.99 164.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.363 0.601 . . . . 0.0 112.012 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.424 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -92.97 133.83 35.73 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.49 178.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.675 HG11 HD21 ' A' ' 126' ' ' LEU . 18.3 m -47.43 -18.68 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 120.879 0.371 . . . . 0.0 110.838 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.424 ' N ' ' C ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -73.83 -43.08 59.85 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.037 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -20.98 36.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.327 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.38 -25.2 59.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.087 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -81.42 -24.82 36.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.762 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.85 -30.63 31.52 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.4 mt -82.05 -27.62 32.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.05 -25.84 39.28 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -82.19 -22.95 35.74 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.56 -0.32 . . . . 0.0 111.116 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -79.67 -24.8 41.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.141 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -53.88 -30.47 45.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 111.189 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -55.63 -54.98 37.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.061 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.157 -179.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.738 0.304 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.833 ' CG ' HD11 ' A' ' 46' ' ' LEU . 58.6 Cg_endo -71.78 -26.38 19.25 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.517 2.145 . . . . 0.0 112.435 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -54.16 -57.49 10.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.042 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 31' ' ' LEU . 9.2 mt -63.19 -26.91 69.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -68.68 -53.25 23.45 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.118 0.485 . . . . 0.0 109.907 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.769 ' HB3' HG21 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -72.67 -30.76 64.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.297 178.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 28' ' ' LEU . 9.8 tt -70.81 -49.76 42.9 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.825 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.8 -27.64 30.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 0.0 110.973 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -21.1 65.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.136 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 45.9 94.97 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.068 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.656 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -130.86 152.6 80.87 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.622 0.248 . . . . 0.0 110.834 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.89 89.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.643 2.229 . . . . 0.0 112.346 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.769 HG21 ' HB3' ' A' ' 30' ' ' GLU . 39.2 t -97.61 110.7 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 p -85.34 -172.98 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.007 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.673 ' HE ' HG23 ' A' ' 40' ' ' THR . 0.2 OUTLIER -78.07 -35.51 49.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.339 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.673 HG23 ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -65.74 -27.19 68.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.954 0.407 . . . . 0.0 110.331 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.657 ' CG2' HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.19 -42.68 14.49 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 tp -63.05 -35.91 81.82 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.604 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.31 -43.0 61.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.59 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.12 -31.49 74.97 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.7 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.604 HD12 HG23 ' A' ' 41' ' ' THR . 6.7 mt -78.81 -44.38 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-O 120.873 0.368 . . . . 0.0 110.535 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.833 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.2 mp -76.57 -9.66 58.82 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.434 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t0 59.3 22.15 10.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.438 ' HE3' HD23 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -105.01 144.82 29.51 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.274 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.3 140.0 81.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.457 2.104 . . . . 0.0 112.033 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.15 -18.39 1.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -78.36 -32.38 48.96 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.203 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -67.14 -40.95 86.84 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.604 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -61.98 -48.54 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.646 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.68 -53.18 55.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.232 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.62 -46.93 77.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.837 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 52' ' ' ARG . 37.0 t -66.4 -31.84 55.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.714 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 mt -62.1 -32.2 72.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.613 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -56.78 -24.48 50.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.741 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -96.22 -17.88 20.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.49 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -101.72 32.77 3.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.478 0.656 . . . . 0.0 110.816 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 58' ' ' GLU . 27.2 p -67.52 -13.71 62.29 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.212 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 p -88.44 -22.65 23.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.778 0.323 . . . . 0.0 111.368 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.49 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -57.54 141.32 48.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.027 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.5 ' O ' HG22 ' A' ' 72' ' ' ILE . 3.4 mt-10 -79.1 127.0 31.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.05 0.452 . . . . 0.0 111.414 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.447 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.8 m-85 -101.74 173.13 6.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.263 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -151.46 146.95 26.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.941 0.4 . . . . 0.0 111.492 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm 66.68 -102.54 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.865 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -91.85 -10.05 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 120.95 30.42 1.35 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.028 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.01 170.65 10.93 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 37' ' ' VAL . 3.1 mp -79.84 114.28 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.239 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.6 tt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.246 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.833 0.349 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.721 HG21 HG23 ' A' ' 81' ' ' THR . 1.3 t -101.19 159.04 15.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.35 -43.79 85.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.992 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -103.59 147.46 27.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.966 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.8 128.59 37.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.721 HG23 HG21 ' A' ' 77' ' ' THR . 32.1 p -106.9 -174.46 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.4 -34.45 12.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 52.2 m-85 -81.15 110.48 16.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.606 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.57 137.25 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.844 ' CE2' HD23 ' A' ' 101' ' ' LEU . 36.4 t80 -126.82 105.6 8.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.567 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -98.58 126.55 44.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.685 0.279 . . . . 0.0 110.984 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.546 HG21 ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.07 127.19 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 59.18 -77.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.296 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' ILE . 19.4 t0 -160.11 35.34 0.17 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.483 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -138.42 114.05 9.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.503 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -77.82 86.4 4.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 110.894 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -71.73 164.84 25.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.704 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -136.76 162.89 31.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.327 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -149.59 167.22 26.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.011 0.434 . . . . 0.0 112.068 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -98.88 -8.96 24.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.126 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.432 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -161.15 172.77 16.16 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.983 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.673 ' HB1' ' CE2' ' A' ' 164' ' ' PHE . . . -55.35 -24.2 28.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.273 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.904 HD22 ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -94.62 -38.03 11.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.175 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.904 ' N ' HD22 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -53.84 -22.0 8.8 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.708 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -60.12 -35.07 74.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.739 0.304 . . . . 0.0 110.482 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.844 HD23 ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -169.66 147.12 3.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.988 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.699 ' H ' HD13 ' A' ' 101' ' ' LEU . 2.8 tt -107.29 -43.09 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.45 ' N ' HG23 ' A' ' 102' ' ' ILE . 22.6 m-85 -129.57 72.47 81.95 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.05 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.593 ' N ' HD12 ' A' ' 101' ' ' LEU . 26.8 Cg_exo -62.47 -21.06 72.29 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.642 2.228 . . . . 0.0 112.426 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.63 -23.3 42.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.894 0.378 . . . . 0.0 111.407 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.5 tp -86.02 -24.42 26.43 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.3 tp -57.99 -47.99 85.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.133 0.492 . . . . 0.0 111.679 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.73 19.29 27.49 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.785 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.17 175.49 12.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 111.001 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -78.79 150.15 32.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.799 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.793 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.15 110.03 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -81.26 120.19 24.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.852 0.834 . . . . 0.0 111.114 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.807 HG22 ' CD1' ' A' ' 85' ' ' PHE . 33.4 t -111.53 131.01 64.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.024 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.3 m -119.57 137.57 53.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.947 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.529 ' HB2' HG23 ' A' ' 124' ' ' VAL . 1.0 OUTLIER -140.74 172.6 12.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.442 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -135.45 131.76 36.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.681 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.0 m -57.12 123.6 15.84 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.863 0.363 . . . . 0.0 111.963 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -68.06 -9.01 42.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.615 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.681 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.49 -50.6 1.98 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.545 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -76.8 -20.36 56.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 110.935 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.49 33.28 84.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.168 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.545 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -101.4 168.67 8.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.426 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.422 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 41.6 Cg_endo -94.55 111.13 0.16 Allowed 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 123.043 2.495 . . . . 0.0 111.529 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.752 HG12 ' CD ' ' A' ' 138' ' ' PRO . 34.5 m -110.57 149.32 13.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.569 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.859 ' O ' HD13 ' A' ' 126' ' ' LEU . 76.0 p -149.36 141.82 24.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.337 0.589 . . . . 0.0 110.731 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.859 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -133.37 152.42 51.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.131 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.867 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 60.6 m -112.02 113.06 25.14 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.552 HG22 ' HZ ' ' A' ' 193' ' ' PHE . 23.3 t -96.31 111.88 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.626 -0.429 . . . . 0.0 111.351 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.3 p -106.47 175.88 1.89 Allowed Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.212 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.11 -13.4 33.74 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.562 2.174 . . . . 0.0 113.192 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.1 t -120.31 -27.7 5.18 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.73 -162.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.023 0.439 . . . . 0.0 110.201 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.725 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -96.67 155.08 3.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.863 178.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -142.87 19.39 1.98 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.347 0.594 . . . . 0.0 112.589 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.867 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.15 86.18 0.08 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.686 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.517 HG13 HD12 ' A' ' 126' ' ' LEU . 24.5 t -104.83 122.07 57.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.106 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -146.13 124.19 6.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.869 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.752 ' CD ' HG12 ' A' ' 124' ' ' VAL . 60.1 Cg_endo -72.3 158.65 96.9 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.226 0.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.31 78.43 0.54 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.224 0.535 . . . . 0.0 110.645 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.41 18.14 0.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.195 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.661 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.5 OUTLIER -60.78 161.14 8.37 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.047 0.423 . . . . 0.0 111.225 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -132.21 152.09 51.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.776 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.929 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -110.15 150.49 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.372 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.3 m -123.51 147.45 47.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.92 0.391 . . . . 0.0 111.203 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 146' ' ' VAL . 2.6 tt -129.28 157.81 40.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.515 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.62 ' N ' HD23 ' A' ' 145' ' ' LEU . 20.0 t . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.904 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.7 t . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -124.67 169.25 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.574 0.702 . . . . 0.0 109.756 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.929 ' CE1' HG22 ' A' ' 143' ' ' VAL . 6.2 m-85 -110.63 152.53 26.37 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.982 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 118' ' ' ALA . 18.1 m-85 -134.62 137.06 43.36 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.42 0.629 . . . . 0.0 110.31 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.635 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -37.93 -30.67 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.739 -1.118 . . . . 0.0 113.109 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.52 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 18.7 m -172.6 -179.97 2.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.157 0.503 . . . . 0.0 111.65 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 84.2 t -69.69 -33.49 3.75 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.563 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.1 Cg_exo -72.94 -39.05 2.5 Favored 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 122.604 2.203 . . . . 0.0 110.5 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.601 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.48 -39.69 52.45 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.122 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.61 -45.81 92.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.3 mt-10 -78.99 -27.39 43.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.316 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.6 t70 -70.51 -55.86 7.93 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.355 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.681 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.7 t-105 -64.91 -28.31 69.44 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.786 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -66.83 -38.68 86.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.264 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.8 t -51.45 -42.53 61.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.454 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -94.25 20.48 8.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.363 0.602 . . . . 0.0 111.458 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.55 ' O ' HD22 ' A' ' 184' ' ' LEU . 1.3 m170 -129.62 29.46 5.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.759 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.55 HD22 ' O ' ' A' ' 178' ' ' HIS . 5.1 tp . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.863 0.363 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.83 150.14 39.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 111.518 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.571 HD11 ' HB2' ' A' ' 175' ' ' ALA . 11.9 mm -99.84 160.32 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.611 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.694 HG23 ' HB ' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -157.49 157.72 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.367 0.603 . . . . 0.0 112.198 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.9 OUTLIER -88.41 125.47 34.74 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.542 178.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.661 HG11 ' HG3' ' A' ' 141' ' ' MET . 0.3 OUTLIER -45.9 -21.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.556 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.407 ' N ' ' C ' ' A' ' 188' ' ' SER . 47.7 m170 -67.58 -40.1 84.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.2 mt-10 -82.32 -27.7 32.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.094 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -61.8 -24.71 67.03 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.725 ' CZ ' HG23 ' A' ' 133' ' ' ILE . 0.6 OUTLIER -79.31 -24.76 42.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.625 179.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.94 -29.71 33.8 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.27 -28.55 31.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.97 -27.92 32.82 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -82.19 -25.48 34.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.816 0.341 . . . . 0.0 110.839 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -81.05 -22.97 38.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.193 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.82 -39.64 59.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.217 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -76.15 -49.35 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 25' ' ' VAL . 23.4 m . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.584 0.231 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.715 ' HB2' HD11 ' A' ' 46' ' ' LEU . 48.9 Cg_exo -55.84 -21.07 31.41 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.45 2.1 . . . . 0.0 112.484 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.608 HD11 HG21 ' A' ' 71' ' ' ILE . 8.6 tp -53.39 -57.48 10.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.995 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.776 HD11 HG21 ' A' ' 102' ' ' ILE . 1.3 tt -59.26 -26.78 65.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.183 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.29 -53.35 37.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.032 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -28.8 56.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.398 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 28' ' ' LEU . 8.1 tt -70.57 -52.05 24.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.733 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HB2' HD23 ' A' ' 28' ' ' LEU . . . -53.54 -26.4 21.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.142 0.496 . . . . 0.0 111.058 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -68.21 -21.63 64.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.172 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.04 45.72 95.44 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.067 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -133.07 150.16 74.76 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.678 0.275 . . . . 0.0 110.767 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.85 106.08 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.63 2.22 . . . . 0.0 112.342 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.715 HG23 HG22 ' A' ' 41' ' ' THR . 10.7 p -113.51 109.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.176 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 p -85.85 -172.2 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 43' ' ' ALA . 6.2 ptt180 -78.03 -35.32 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.227 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -26.52 67.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.845 0.355 . . . . 0.0 110.206 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.715 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.59 -42.45 14.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 42' ' ' LEU . 10.0 tp -63.2 -36.0 82.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.639 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.45 -42.94 61.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.543 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.29 -30.94 73.73 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.694 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.592 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -78.68 -44.59 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 121.0 0.429 . . . . 0.0 110.498 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 26' ' ' PRO . 7.2 mp -76.26 -10.08 59.13 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.405 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.03 21.76 10.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.441 ' CH2' ' CZ ' ' A' ' 52' ' ' ARG . 10.6 m95 -107.57 136.77 19.59 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.265 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.2 142.41 16.44 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.5 2.133 . . . . 0.0 112.286 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.77 -16.86 1.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.88 -34.46 51.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.325 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.753 ' O ' HG23 ' A' ' 56' ' ' VAL . 7.5 tpt180 -67.01 -40.64 87.34 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.62 -48.11 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.613 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 57' ' ' LEU . . . -53.43 -53.38 52.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.354 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.94 -45.1 71.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.877 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 52' ' ' ARG . 32.5 t -71.48 -30.23 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.723 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 54' ' ' ALA . 13.0 mt -68.06 -39.81 82.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.738 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.68 -45.04 86.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.66 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -66.9 -14.97 63.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.027 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.584 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -112.14 70.43 0.71 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.67 0.748 . . . . 0.0 110.759 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.7 p -83.95 -3.87 58.29 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.247 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.0 p -96.41 -20.0 18.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.713 0.292 . . . . 0.0 111.333 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.584 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -52.77 141.23 21.82 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.033 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.73 126.69 31.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.154 0.502 . . . . 0.0 111.65 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.428 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 5.0 m-85 -102.92 163.06 12.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.287 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -148.3 133.79 18.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 111.711 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 tptt 70.28 -94.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.177 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.23 -15.06 20.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 127.95 34.48 0.55 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.124 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -92.67 159.6 15.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.368 . . . . 0.0 110.193 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.608 HG21 HD11 ' A' ' 27' ' ' LEU . 2.6 mp -79.85 114.45 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.235 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.5 tt . . . . . 0 C--N 1.331 -0.208 0 CA-C-O 121.038 0.447 . . . . 0.0 111.446 179.766 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 92' ' ' LEU . 8.5 mt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.783 0.325 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.468 HG21 ' HD1' ' A' ' 95' ' ' TRP . 20.1 p -98.96 159.07 15.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -78.4 -50.12 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.07 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -97.02 156.71 16.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.993 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -67.46 129.59 40.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.6 p -111.76 -174.48 2.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.532 ' HG ' ' CE1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -91.82 -29.67 16.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.147 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.09 111.53 18.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.603 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 t -105.91 139.51 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.019 0.437 . . . . 0.0 111.156 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.941 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 68.9 t80 -129.42 106.63 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.649 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -102.0 128.89 48.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.3 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.6 pt -138.52 124.64 24.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.583 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.82 -68.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.24 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 87' ' ' ILE . 1.3 p30 -169.33 35.21 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.253 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -137.06 113.18 9.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.1 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.409 ' O ' ' CD ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -81.0 124.69 29.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 76' ' ' LEU . 1.7 mm? -118.63 165.07 14.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.102 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.72 ' O ' HD13 ' A' ' 76' ' ' LEU . 1.5 m-85 -129.22 165.21 21.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.206 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.65 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -151.63 169.58 21.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.12 0.486 . . . . 0.0 111.984 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.468 ' HD1' HG21 ' A' ' 77' ' ' THR . 7.2 m0 -99.3 -11.83 20.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.061 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 162' ' ' VAL . 0.9 OUTLIER -154.44 162.09 41.34 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.978 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.79 -22.28 3.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.769 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.86 -51.5 5.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.693 0.282 . . . . 0.0 111.288 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.65 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -41.55 -26.39 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.529 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -59.7 -32.34 70.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.309 . . . . 0.0 110.764 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.941 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 12.3 tp -148.76 167.35 25.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.36 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.776 HG21 HD11 ' A' ' 28' ' ' LEU . 1.1 tp -118.61 -41.19 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.958 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.431 ' N ' HG23 ' A' ' 102' ' ' ILE . 1.2 t80 -162.89 102.77 1.03 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.778 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.759 ' HG3' HD23 ' A' ' 101' ' ' LEU . 15.6 Cg_exo -68.16 -25.78 36.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.75 2.3 . . . . 0.0 112.556 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.64 48.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.524 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 tt -83.05 -42.17 17.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.615 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 tp -53.85 -48.73 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.192 0.52 . . . . 0.0 111.631 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.52 21.53 24.04 Favored Glycine 0 C--N 1.319 -0.396 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.764 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.32 173.52 14.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.955 0.407 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -78.33 151.54 32.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.868 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.822 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -136.67 109.72 7.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.3 mtt-85 -82.28 119.76 24.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.761 0.791 . . . . 0.0 111.08 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.2 t -110.07 127.46 66.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.513 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.6 m -116.41 137.23 52.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.248 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.664 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.5 m -140.97 172.91 12.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.379 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.532 ' CE1' ' HG ' ' A' ' 82' ' ' SER . 2.6 p80 -133.58 130.23 38.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.3 m -56.76 122.53 12.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.943 0.402 . . . . 0.0 111.841 -178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.17 -9.72 42.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.615 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.72 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.81 -51.14 2.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.963 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.552 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -75.5 -21.8 57.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.836 0.351 . . . . 0.0 110.728 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.12 34.06 87.83 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.948 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -103.09 166.26 12.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.516 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -91.6 111.23 0.31 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.996 2.464 . . . . 0.0 111.196 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.796 HG12 ' HD2' ' A' ' 138' ' ' PRO . 22.0 m -107.7 146.42 13.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.485 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.722 ' C ' HD23 ' A' ' 126' ' ' LEU . 93.2 p -144.91 142.59 29.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.394 0.616 . . . . 0.0 110.216 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 125' ' ' SER . 0.1 OUTLIER -132.91 154.13 50.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.539 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.839 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 22.4 m -110.79 112.38 24.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.376 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.723 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 2.8 t -96.87 111.99 28.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.913 0.387 . . . . 0.0 111.423 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 m -108.31 160.73 25.96 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.167 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.23 -16.44 40.5 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.516 2.144 . . . . 0.0 112.968 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 78.1 p -114.35 -27.31 7.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 131' ' ' SER . 0.4 OUTLIER 178.95 -162.83 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.165 0.507 . . . . 0.0 110.061 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.632 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -94.8 166.24 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.657 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -155.17 19.39 0.43 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.839 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.14 85.79 0.07 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.973 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.56 HG13 ' SD ' ' A' ' 141' ' ' MET . 51.5 t -100.37 114.87 40.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.522 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -146.37 125.24 6.47 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.235 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.796 ' HD2' HG12 ' A' ' 124' ' ' VAL . 71.6 Cg_endo -76.99 155.68 97.46 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 123.515 -1.452 . . . . 0.0 111.847 -0.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.7 161.32 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 67.41 11.68 59.87 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.132 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.658 ' SD ' HD22 ' A' ' 126' ' ' LEU . 12.6 ptp -61.55 156.59 19.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.151 0.501 . . . . 0.0 111.844 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.03 152.38 49.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.183 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.685 HG13 ' CD1' ' A' ' 164' ' ' PHE . 11.4 t -113.25 151.64 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.688 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.477 ' C ' HD12 ' A' ' 145' ' ' LEU . 14.8 p -120.62 139.51 52.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.795 0.331 . . . . 0.0 110.769 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 144' ' ' SER . 5.3 mp -139.06 176.34 8.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.832 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.938 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 96' ' ' CYS . 15.1 t . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.958 0.409 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -128.34 169.39 14.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.676 0.75 . . . . 0.0 110.387 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.685 ' CD1' HG13 ' A' ' 143' ' ' VAL . 3.2 m-85 -110.48 151.54 27.42 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.678 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 118' ' ' ALA . 17.8 m-85 -129.15 137.36 51.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.559 0.695 . . . . 0.0 110.358 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.689 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -42.7 -28.26 0.22 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.125 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.738 ' HB3' ' HD2' ' A' ' 169' ' ' PRO . 1.0 OUTLIER -166.72 171.62 11.33 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.754 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.587 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 92.6 t -68.96 -36.44 7.65 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.341 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' ' 167' ' ' SER . 11.4 Cg_exo -71.37 -37.14 6.02 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.749 2.299 . . . . 0.0 110.063 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.15 -40.22 53.11 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.757 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.04 -45.96 91.27 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.544 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 1.4 mm-40 -78.99 -27.66 43.38 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.452 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 169' ' ' PRO . 13.5 t0 -70.43 -55.61 8.61 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.72 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 30.4 t-105 -65.28 -28.98 69.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.712 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.44 -39.97 94.85 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.394 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.41 -43.7 62.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.396 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -96.02 22.77 7.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.113 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.456 ' O ' HD22 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -132.82 29.16 4.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.928 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.879 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.456 HD22 ' O ' ' A' ' 178' ' ' HIS . 7.9 tp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.872 0.367 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.43 149.91 41.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.118 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.616 HD11 ' HB2' ' A' ' 175' ' ' ALA . 15.4 mm -102.11 160.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.955 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.48 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.95 163.16 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.221 0.534 . . . . 0.0 111.89 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -86.31 127.97 34.86 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.774 178.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.478 HG12 ' CG2' ' A' ' 143' ' ' VAL . 0.9 OUTLIER -45.16 -22.27 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.685 179.344 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.408 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.8 t-160 -71.9 -43.3 65.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.185 0.517 . . . . 0.0 109.785 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.3 OUTLIER -82.15 -21.0 36.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.353 179.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.45 -25.31 64.04 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.776 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.574 ' CE2' HG23 ' A' ' 133' ' ' ILE . 2.4 m-85 -81.35 -24.89 36.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.111 0.481 . . . . 0.0 110.664 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.99 -31.01 29.98 Favored Glycine 0 CA--C 1.51 -0.273 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.314 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.9 tp -81.06 -29.66 34.96 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -81.23 -26.15 52.98 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -82.18 -21.76 36.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.963 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.99 -23.01 41.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.247 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -51.76 -37.46 51.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.063 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.98 -40.82 23.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.035 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 25' ' ' VAL . 5.3 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.685 0.278 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 29' ' ' ARG . 76.3 Cg_exo -50.55 -40.43 54.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.676 2.25 . . . . 0.0 112.422 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.731 HD11 HD21 ' A' ' 46' ' ' LEU . 6.0 mp -52.79 -57.18 11.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.308 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 28' ' ' LEU . 5.0 tt -79.3 -27.16 42.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.051 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.41 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 3.3 ttt180 -67.52 -53.36 29.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.08 -26.5 66.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 tp -71.8 -36.77 70.39 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.802 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.26 -29.33 32.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.229 0.538 . . . . 0.0 110.836 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -19.31 65.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.142 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.18 51.75 50.15 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.061 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.6 mtp85 -127.47 165.91 26.57 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.743 0.306 . . . . 0.0 110.741 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.19 111.55 2.05 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.399 2.066 . . . . 0.0 112.097 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.872 HG23 HG22 ' A' ' 41' ' ' THR . 8.1 p -125.85 109.76 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.272 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t -94.99 -170.06 2.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.965 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' ALA . 20.0 ptt-85 -72.55 -38.69 67.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.608 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -31.0 71.73 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.244 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.872 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -83.1 -41.91 18.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.426 HD22 HD12 ' A' ' 71' ' ' ILE . 9.3 tp -62.18 -36.69 82.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.41 -43.19 64.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.646 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.57 -31.68 76.96 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.587 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.617 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -78.95 -44.07 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.106 0.479 . . . . 0.0 110.423 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.731 HD21 HD11 ' A' ' 27' ' ' LEU . 6.9 mp -76.75 -9.38 58.63 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.518 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.2 t70 60.08 21.84 11.04 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.416 ' CG ' ' HD2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -100.27 155.86 35.92 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.223 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 48' ' ' TRP . 57.8 Cg_endo -71.58 139.96 35.18 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.551 2.167 . . . . 0.0 112.132 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.14 -19.2 1.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -77.84 -35.49 51.1 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 111.279 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.846 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.7 -40.34 88.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.56 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.39 -48.47 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.54 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.1 -53.93 43.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.259 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.67 75.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 52' ' ' ARG . 27.3 t -68.6 -31.01 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.711 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.412 HD23 HG12 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -66.35 -35.62 80.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.679 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.43 -44.95 85.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.701 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -76.75 -9.78 58.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.038 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.4 73.62 0.89 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.723 0.773 . . . . 0.0 110.397 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.5 p -96.99 -24.33 15.86 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.138 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -70.26 -25.46 63.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.216 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.48 141.16 31.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.242 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.602 ' O ' HG22 ' A' ' 72' ' ' ILE . 3.4 mt-10 -78.92 126.9 31.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.063 0.459 . . . . 0.0 111.376 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.421 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 64.1 m-85 -104.29 170.85 7.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.323 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -156.12 145.43 20.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.031 0.443 . . . . 0.0 111.344 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp 66.74 -103.78 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.8 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -92.3 -13.57 30.13 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 125.92 30.76 0.85 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.154 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -87.34 163.44 16.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.816 HG12 HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -79.79 118.28 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.187 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.796 ' O ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.208 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.03 HD13 HD11 ' A' ' 92' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.777 0.322 . . . . 0.0 110.736 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.75 HG21 ' HE1' ' A' ' 95' ' ' TRP . 18.0 p -126.43 159.61 32.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.2 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -48.18 -86.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.583 0.23 . . . . 0.0 110.804 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.458 ' HG3' ' CD1' ' A' ' 93' ' ' TYR . 4.6 mtp180 -173.71 98.96 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.78 23.54 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.614 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.7 p -120.08 -173.66 2.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.13 0.491 . . . . 0.0 111.648 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 p -101.07 -25.82 13.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.209 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 97' ' ' ALA . 30.0 m-85 -87.49 116.33 25.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 110.613 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.16 144.89 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.066 0.46 . . . . 0.0 111.439 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.834 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 67.9 t80 -131.66 105.85 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.516 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -97.25 129.89 44.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.655 0.264 . . . . 0.0 111.269 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -140.07 125.61 20.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.69 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 87' ' ' ILE . 17.0 t0 -154.35 37.46 0.43 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.664 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -141.48 145.85 35.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.297 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.04 86.59 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.904 0.383 . . . . 0.0 110.867 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.03 HD11 HD13 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -71.1 164.55 25.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CD1' ' HG3' ' A' ' 79' ' ' ARG . 2.1 m-85 -135.36 161.68 34.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.548 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.772 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -148.1 163.72 36.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.057 0.456 . . . . 0.0 111.592 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.75 ' HE1' HG21 ' A' ' 77' ' ' THR . 21.7 m0 -84.24 -20.25 32.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.509 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.599 ' HG ' ' N ' ' A' ' 162' ' ' VAL . 0.8 OUTLIER -158.59 -177.38 6.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.091 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.604 ' O ' HD21 ' A' ' 101' ' ' LEU . . . -61.38 -16.45 46.58 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.57 HD12 HG21 ' A' ' 162' ' ' VAL . 1.5 tt -86.62 -51.64 6.02 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.856 ' HA ' HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -57.08 -21.24 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -178.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -66.1 -39.58 90.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.592 0.234 . . . . 0.0 111.491 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.604 HD21 ' O ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -92.1 -83.92 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.856 HD11 ' HA ' ' A' ' 99' ' ' ASP . 25.5 mm 78.25 -59.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.654 0.264 . . . . 0.0 111.113 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -151.25 65.95 6.89 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 111.056 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.513 ' CB ' HG11 ' A' ' 128' ' ' VAL . 12.3 Cg_exo -71.3 -28.72 18.0 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.969 2.446 . . . . 0.0 112.551 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.6 -23.48 42.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.94 0.4 . . . . 0.0 111.584 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -81.93 -31.29 31.4 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.476 ' O ' HD12 ' A' ' 107' ' ' ILE . 1.0 OUTLIER -56.64 -46.36 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.998 0.428 . . . . 0.0 111.662 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.16 19.36 21.56 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.828 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 177.23 10.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 110.865 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -75.1 150.87 38.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.665 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.834 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.09 109.82 7.55 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -84.25 120.99 26.87 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.779 0.8 . . . . 0.0 110.915 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.789 HG22 ' CD1' ' A' ' 85' ' ' PHE . 46.8 t -112.51 130.94 65.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.005 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.7 m -122.22 137.61 54.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.133 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.522 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -141.21 172.86 12.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.031 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 121' ' ' GLY . 0.1 OUTLIER -132.1 131.37 42.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 34.0 m -58.15 125.85 24.98 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.03 0.443 . . . . 0.0 112.165 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -68.75 -8.03 39.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.049 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.622 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -119.0 -51.62 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 0.0 111.189 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.612 HG21 ' HB3' ' A' ' 166' ' ' ALA . 0.9 OUTLIER -82.66 -23.9 34.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.465 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 117' ' ' CYS . . . 69.82 6.81 57.31 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.923 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.8 160.08 71.08 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 120.609 0.243 . . . . 0.0 110.671 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -86.55 106.79 0.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.92 2.413 . . . . 0.0 111.033 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.527 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 26.9 m -103.78 146.59 11.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.822 ' C ' HD13 ' A' ' 126' ' ' LEU . 62.1 p -152.42 142.17 21.95 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.333 0.587 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.822 HD13 ' C ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -131.96 153.22 50.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.447 178.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.842 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 24.0 m -110.02 113.01 25.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.513 HG11 ' CB ' ' A' ' 104' ' ' PRO . 51.5 t -96.53 114.12 32.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.088 0.471 . . . . 0.0 111.955 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.41 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.8 OUTLIER -107.32 169.03 7.16 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.734 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 35.5 Cg_endo -65.86 -19.32 58.67 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.197 1.931 . . . . 0.0 112.885 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -110.68 -27.54 8.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.437 ' HA ' ' CE1' ' A' ' 193' ' ' PHE . 3.7 pt-20 178.85 -164.68 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.069 0.462 . . . . 0.0 110.007 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.742 HG23 ' CE2' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -94.73 152.12 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.708 178.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.31 21.89 2.77 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.308 0.575 . . . . 0.0 112.445 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.842 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.77 87.4 0.09 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.814 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.498 HG13 ' SD ' ' A' ' 141' ' ' MET . 60.9 t -103.72 115.05 44.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.347 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.405 ' O ' ' CE ' ' A' ' 141' ' ' MET . 19.3 tt0 -143.13 123.76 8.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.486 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.499 ' HD2' ' HE3' ' A' ' 141' ' ' MET . 57.8 Cg_endo -70.95 162.25 87.84 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 123.502 -1.457 . . . . 0.0 112.544 -0.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.19 79.91 1.79 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.16 18.5 0.2 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.268 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.733 ' CG ' HG11 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -63.57 164.22 9.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.06 0.457 . . . . 0.0 111.708 -179.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -129.13 152.09 49.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.69 HG13 ' CD1' ' A' ' 164' ' ' PHE . 3.3 t -115.8 152.05 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.701 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.2 m -120.84 143.1 49.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.958 0.408 . . . . 0.0 111.242 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.54 HD13 HG22 ' A' ' 162' ' ' VAL . 1.6 mm? -123.39 159.53 28.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.604 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.103 179.836 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.599 ' N ' ' HG ' ' A' ' 96' ' ' CYS . 22.0 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.879 0.371 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -116.69 169.15 9.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.692 . . . . 0.0 110.336 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.69 ' CD1' HG13 ' A' ' 143' ' ' VAL . 4.7 m-85 -118.64 153.52 34.17 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.076 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.612 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 59.2 m-85 -132.59 136.14 46.35 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.038 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.612 ' HB3' HG21 ' A' ' 120' ' ' THR . . . -41.87 -27.68 0.13 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.091 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.564 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 74.0 m -165.5 173.67 10.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.194 0.521 . . . . 0.0 111.936 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.8 t -70.0 -33.75 3.75 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.346 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.19 -37.32 3.47 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.688 2.259 . . . . 0.0 110.289 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.602 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.91 -40.27 47.91 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.483 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.726 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.2 -44.88 96.57 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.0 mt-10 -78.97 -27.22 43.46 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.232 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.69 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.2 t70 -71.04 -55.94 7.2 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.429 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.622 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.3 t-105 -64.59 -28.0 69.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.726 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -65.01 -40.37 94.8 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.359 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.25 -43.26 61.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.382 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -95.77 21.86 7.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.374 0.607 . . . . 0.0 111.194 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.461 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -127.71 27.42 5.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.78 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.77 179.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 178' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.871 0.367 . . . . 0.0 110.764 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.89 150.09 41.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.077 0.465 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.645 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.9 mm -100.91 160.41 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.832 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.463 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -160.54 159.16 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.809 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.5 OUTLIER -86.03 124.96 33.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.908 178.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.733 HG11 ' CG ' ' A' ' 141' ' ' MET . 0.7 OUTLIER -47.83 -20.59 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.608 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -69.35 -41.41 76.63 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.6 mt-10 -82.6 -26.46 32.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.058 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -68.75 -25.02 64.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.742 ' CE2' HG23 ' A' ' 133' ' ' ILE . 7.9 t80 -81.61 -26.17 35.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.689 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.93 -30.06 32.84 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.1 mt -82.11 -27.35 32.88 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.11 -26.75 35.88 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.444 ' CG ' ' CE1' ' A' ' 193' ' ' PHE . 46.6 mm-40 -81.91 -24.86 35.4 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.041 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 -22.96 61.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -51.97 -42.4 62.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.272 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -81.18 -29.57 34.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.005 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.233 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 25' ' ' VAL . 19.1 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.784 0.326 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.71 -46.19 35.22 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.589 2.193 . . . . 0.0 112.355 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -51.95 -57.24 10.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 27' ' ' LEU . 2.1 mt -72.7 -27.11 61.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.814 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.52 -53.22 55.29 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.598 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -69.91 -26.51 64.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.163 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.0 tp -70.68 -44.2 67.49 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.686 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.22 -28.54 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.138 0.494 . . . . 0.0 110.89 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -64.77 -20.44 66.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.181 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.37 54.05 25.57 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.296 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -133.04 165.36 37.33 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.298 . . . . 0.0 110.719 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.38 113.5 3.33 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.464 2.109 . . . . 0.0 112.088 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.717 HG13 HG22 ' A' ' 41' ' ' THR . 31.7 t -117.98 109.88 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.458 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.2 p -87.97 179.63 6.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.836 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -70.13 -37.46 75.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.306 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -30.11 70.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 110.074 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.717 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -82.92 -41.96 18.25 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.738 ' CD1' HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -62.49 -37.02 84.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.63 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -71.64 -43.29 66.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.626 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.68 -31.03 72.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.807 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.585 HD12 HG23 ' A' ' 41' ' ' THR . 6.8 mt -78.59 -43.98 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-O 120.997 0.427 . . . . 0.0 110.519 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.539 HD12 HG22 ' A' ' 45' ' ' ILE . 7.2 mp -76.06 -10.18 59.21 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.387 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 61.0 21.41 11.75 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.412 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 29.6 m95 -107.26 138.78 19.98 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.018 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.34 140.54 34.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.74 2.294 . . . . 0.0 112.053 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.33 -16.88 0.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -78.86 -31.86 45.78 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.292 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.76 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -68.61 -40.86 80.21 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.63 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.64 -47.62 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.635 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.83 -52.35 57.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.352 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.22 -43.09 67.0 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.786 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 52' ' ' ARG . 21.8 t -69.7 -33.58 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.756 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.2 mt -61.75 -35.88 79.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.657 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.685 ' O ' HG23 ' A' ' 61' ' ' THR . 5.6 tt0 -57.55 -26.33 61.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.717 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -90.49 -16.46 28.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.028 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' A' ' 63' ' ' THR . . . -98.61 33.58 2.24 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.398 0.618 . . . . 0.0 111.006 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 58' ' ' GLU . 65.6 p -58.93 -20.88 56.02 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.009 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 p -88.76 -22.94 23.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.352 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.404 ' HB ' ' HB1' ' A' ' 60' ' ' ALA . 0.8 OUTLIER -59.41 141.21 55.15 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.327 179.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.842 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -85.37 132.16 34.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 111.685 -179.276 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.43 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 76.9 m-85 -105.73 173.23 6.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -150.37 146.8 26.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.047 0.451 . . . . 0.0 111.535 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 tptt 66.28 -102.64 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.853 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -90.36 -10.46 43.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 119.94 29.56 1.65 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.951 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -86.01 171.31 11.51 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.738 HD13 ' CD1' ' A' ' 42' ' ' LEU . 4.1 mp -79.76 116.8 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.316 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.7 tt . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.252 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.774 HD22 ' CD1' ' A' ' 92' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.836 0.35 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 79' ' ' ARG . 4.8 t -111.01 159.0 18.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.27 -25.82 64.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.745 ' O ' HG23 ' A' ' 77' ' ' THR . 1.0 OUTLIER -102.86 146.99 27.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.005 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -63.56 129.63 40.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.533 HG23 HG21 ' A' ' 77' ' ' THR . 27.9 p -106.36 -176.47 3.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.011 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.1 m -89.57 -31.83 17.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.439 ' CE2' ' N ' ' A' ' 97' ' ' ALA . 5.3 m-85 -89.53 117.67 28.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.446 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.8 t -108.75 139.12 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.078 0.466 . . . . 0.0 111.114 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.876 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 30.3 t80 -123.1 106.92 11.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.887 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.2 124.08 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.741 0.305 . . . . 0.0 111.144 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.623 HG21 ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.15 126.29 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.62 -77.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.317 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.0 t70 -156.11 37.0 0.34 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.633 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -141.45 147.44 37.91 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.578 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.2 86.41 2.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 0.0 110.752 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.774 ' CD1' HD22 ' A' ' 76' ' ' LEU . 3.9 mm? -71.46 164.49 25.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.628 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -131.88 158.9 40.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.749 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.509 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -143.52 163.03 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.281 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -88.33 -5.64 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.137 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.43 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.0 OUTLIER 176.06 -175.2 0.11 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.006 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.453 ' CB ' ' CD1' ' A' ' 164' ' ' PHE . . . -61.3 149.42 38.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.76 0.315 . . . . 0.0 110.761 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 97' ' ' ALA . 20.0 mt 82.62 -52.32 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.509 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -48.05 -25.09 1.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.937 0.399 . . . . 0.0 111.166 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.493 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 3.1 p -60.15 -39.32 85.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.759 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.876 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 22.9 tp -131.4 165.17 24.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.228 0.537 . . . . 0.0 111.842 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.753 HD12 ' CE2' ' A' ' 103' ' ' PHE . 3.3 pt -121.92 -37.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.885 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.753 ' CE2' HD12 ' A' ' 102' ' ' ILE . 2.4 p90 -165.61 103.29 0.74 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.631 ' HB3' HG12 ' A' ' 128' ' ' VAL . 74.0 Cg_endo -75.15 -27.58 9.65 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.745 2.297 . . . . 0.0 112.897 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.17 -23.65 54.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.703 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.71 -40.99 16.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.58 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 tp -56.0 -49.22 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.183 0.516 . . . . 0.0 111.531 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.04 24.02 18.34 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.768 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -152.41 173.24 15.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 111.037 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.411 HG23 ' OG ' ' A' ' 129' ' ' SER . 0.9 OUTLIER -80.79 151.8 28.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.862 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.832 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.4 110.16 7.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -81.44 120.23 24.73 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.719 0.771 . . . . 0.0 111.448 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.745 HG22 ' HD1' ' A' ' 85' ' ' PHE . 58.6 t -112.55 129.63 67.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.79 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 m -122.49 137.15 54.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.393 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.554 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -141.76 173.1 11.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.179 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -134.85 135.44 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 36.2 t -64.35 133.83 53.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.532 . . . . 0.0 112.132 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -71.43 -4.05 24.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.214 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.897 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -123.37 -51.04 1.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 111.673 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.732 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -87.38 -25.1 24.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.016 -179.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.21 5.58 72.01 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.094 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.732 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.7 147.19 72.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.618 0.247 . . . . 0.0 110.513 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.35 104.7 1.66 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.56 2.174 . . . . 0.0 110.422 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.554 HG22 ' C ' ' A' ' 115' ' ' SER . 35.3 m -101.4 145.65 11.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.397 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.89 ' O ' HD13 ' A' ' 126' ' ' LEU . 71.1 p -152.53 142.07 21.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.484 0.659 . . . . 0.0 110.929 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.986 HD11 ' CE ' ' A' ' 141' ' ' MET . 0.1 OUTLIER -134.88 153.12 52.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.464 178.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.873 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.2 m -109.36 113.09 25.61 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' A' ' 104' ' ' PRO . 29.2 t -96.1 111.86 27.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.118 0.485 . . . . 0.0 111.819 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.411 ' OG ' HG23 ' A' ' 110' ' ' THR . 0.4 OUTLIER -106.59 175.51 2.03 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.975 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.43 -6.25 18.76 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.548 2.166 . . . . 0.0 113.286 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m -122.77 -31.31 3.71 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 193' ' ' PHE . 14.5 pt-20 -179.7 -162.3 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 110.005 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -91.78 144.3 9.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.563 178.234 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -133.6 18.2 3.93 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.392 0.615 . . . . 0.0 112.412 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.873 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.03 86.34 0.08 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.523 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.668 HG13 HD12 ' A' ' 126' ' ' LEU . 37.2 t -105.65 120.62 56.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.898 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -146.21 122.14 5.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.08 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.458 ' HD2' HG12 ' A' ' 124' ' ' VAL . 53.2 Cg_endo -68.23 167.73 63.35 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.626 -1.406 . . . . 0.0 112.951 -0.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.7 83.7 7.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.97 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 140.87 21.08 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.046 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.986 ' CE ' HD11 ' A' ' 126' ' ' LEU . 9.1 mtp -60.98 164.72 4.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.144 0.497 . . . . 0.0 111.968 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -131.92 151.87 51.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.82 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.702 HG13 ' CD1' ' A' ' 164' ' ' PHE . 7.6 t -112.77 148.98 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.417 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 162' ' ' VAL . 64.4 m -118.29 143.53 46.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.77 0.319 . . . . 0.0 110.854 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 162' ' ' VAL . 0.6 OUTLIER -99.9 147.23 25.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.954 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 146' ' ' VAL . 9.0 p . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.971 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 144' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 111.38 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -113.68 159.45 19.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.679 0.752 . . . . 0.0 110.177 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.702 ' CD1' HG13 ' A' ' 143' ' ' VAL . 2.3 m-85 -116.9 129.74 56.26 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.837 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 29.8 m-85 -108.53 142.39 39.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.449 0.642 . . . . 0.0 110.796 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.19 -26.15 2.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.888 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.608 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 50.7 m -163.3 167.68 21.54 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.862 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 75.1 t -67.92 -33.64 5.35 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.07 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.704 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.4 Cg_exo -73.01 -37.49 3.49 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.667 2.244 . . . . 0.0 110.336 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.586 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.16 -40.59 52.19 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.716 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.8 -45.94 91.67 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.9 mt-10 -78.81 -27.39 44.4 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.313 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 169' ' ' PRO . 9.5 t70 -70.65 -55.86 7.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.383 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.897 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.9 t-105 -64.91 -28.62 69.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.765 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.9 -40.72 95.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.317 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 40.7 t -50.85 -42.55 58.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.369 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.1 20.87 8.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.308 0.575 . . . . 0.0 111.271 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.5 25.01 7.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.788 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.787 0.327 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.17 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.684 HD11 ' HB2' ' A' ' 175' ' ' ALA . 14.5 mm -102.32 162.01 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.937 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.487 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.69 166.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.265 0.555 . . . . 0.0 111.794 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -89.59 128.13 35.99 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.014 178.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.445 HG12 ' CG2' ' A' ' 143' ' ' VAL . 1.4 m -45.88 -21.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.621 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.402 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.8 t60 -71.47 -42.72 67.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.215 0.531 . . . . 0.0 109.98 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -82.28 -21.58 36.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -73.86 -25.23 59.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.092 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 132' ' ' GLU . 72.7 t80 -81.6 -24.77 36.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.585 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.84 -29.11 35.86 Favored Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.3 mp -82.06 -28.4 32.44 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.32 -28.84 29.26 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.543 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 1.3 tm0? -82.24 -25.26 34.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.575 -0.312 . . . . 0.0 111.28 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -76.86 -22.79 52.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.124 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -51.82 -33.63 36.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.963 0.411 . . . . 0.0 111.082 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -81.06 -53.78 6.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.964 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.832 0.349 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.759 ' CG ' HD11 ' A' ' 46' ' ' LEU . 43.9 Cg_endo -67.91 -17.02 46.57 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.583 2.189 . . . . 0.0 112.552 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 71' ' ' ILE . 6.0 tp -52.76 -57.41 10.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.368 . . . . 0.0 111.01 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 31' ' ' LEU . 4.4 mm? -70.09 -27.05 64.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.76 -53.22 60.53 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.611 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.34 -23.7 61.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.272 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 28' ' ' LEU . 9.0 tt -63.13 -49.03 75.99 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.479 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.0 18.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.34 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -24.33 61.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.126 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.64 39.58 96.76 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.34 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -133.32 150.06 74.2 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.696 0.284 . . . . 0.0 110.755 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.67 107.07 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.559 2.172 . . . . 0.0 111.978 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.726 HG23 HG22 ' A' ' 41' ' ' THR . 14.0 p -99.23 112.1 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.519 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 p -93.32 175.62 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.422 ' O ' ' N ' ' A' ' 43' ' ' ALA . 2.1 mpp_? -65.26 -40.33 93.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.302 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -25.09 67.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.869 0.366 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.726 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.11 -43.3 13.17 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -62.79 -36.28 82.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.691 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.2 -43.0 62.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.595 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.79 -30.7 72.58 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.697 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.588 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -78.42 -44.75 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 120.999 0.428 . . . . 0.0 110.563 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.759 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.2 mp -75.65 -9.85 58.93 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.491 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t70 59.72 21.92 10.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.446 ' CZ2' ' NH1' ' A' ' 52' ' ' ARG . 1.8 m0 -109.27 146.02 33.03 Favored Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.217 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.13 143.18 52.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.557 2.171 . . . . 0.0 112.063 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.19 -16.9 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.65 -33.61 47.04 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.236 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.632 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.95 -41.2 82.83 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.851 HG13 HD23 ' A' ' 42' ' ' LEU . 2.1 t -63.29 -47.65 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.544 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.579 ' HA ' HD13 ' A' ' 57' ' ' LEU . . . -53.49 -52.32 59.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.269 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.67 -36.65 25.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.019 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 52' ' ' ARG . 28.9 t -59.4 -35.81 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.035 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.579 HD13 ' HA ' ' A' ' 54' ' ' ALA . 3.7 mp -60.93 -32.43 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.873 0.368 . . . . 0.0 110.723 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.423 ' O ' HG23 ' A' ' 61' ' ' THR . 1.9 tp10 -58.65 -34.8 71.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.467 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -100.19 -20.42 15.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.87 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.494 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -102.59 33.44 3.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.476 0.655 . . . . 0.0 110.742 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 58' ' ' GLU . 32.1 p -66.99 -13.87 62.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.343 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 p -88.02 -23.57 23.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.325 . . . . 0.0 111.359 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.494 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -58.22 141.47 50.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.016 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.68 126.99 31.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 111.326 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -102.1 173.13 6.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.465 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.409 ' HB2' ' ND2' ' A' ' 70' ' ' ASN . 6.6 t0 -97.18 -172.88 2.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -34.5 76.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.955 0.407 . . . . 0.0 111.128 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.28 1.7 55.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.343 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.05 14.45 60.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.267 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 66' ' ' ASP . 1.1 p-10 -86.79 146.82 26.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.491 0.645 . . . . 0.0 109.881 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.579 ' O ' HG22 ' A' ' 72' ' ' ILE . 1.7 mp -79.76 143.28 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.905 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 71' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.466 0.331 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.692 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 mt . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.983 0.42 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.615 HG22 ' CD1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -111.01 159.53 17.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.72 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.72 24.96 1.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.619 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 51.56 96.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.808 0.337 . . . . 0.0 111.505 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -156.21 -84.76 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.483 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.37 163.7 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.844 0.354 . . . . 0.0 111.592 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 84' ' ' VAL . 65.3 m -82.18 -5.88 58.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.97 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -66.21 96.77 0.35 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 110.293 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 82' ' ' SER . 17.8 t -109.69 144.71 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.369 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.966 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 33.5 t80 -131.16 107.57 9.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.086 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -102.72 132.46 48.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.517 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' ASP . 2.3 pt -138.74 123.0 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.396 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.12 -67.5 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.134 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.6 m-20 -168.54 34.82 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.304 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -135.57 112.49 10.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.968 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.628 ' C ' HD22 ' A' ' 92' ' ' LEU . 9.3 mpt_? -82.11 124.63 30.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.971 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.628 HD22 ' C ' ' A' ' 91' ' ' ARG . 2.8 mm? -115.57 165.1 13.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -129.75 165.21 22.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.994 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.787 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -153.48 170.97 19.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.939 0.4 . . . . 0.0 111.705 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.615 ' CD1' HG22 ' A' ' 77' ' ' THR . 49.6 m0 -95.25 -17.95 21.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.679 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 98.9 m -152.54 166.48 31.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.255 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.548 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -54.21 -21.08 8.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.93 -51.73 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.787 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 41.4 t0 -50.1 -23.23 2.0 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -60.11 -32.67 71.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.676 0.274 . . . . 0.0 110.688 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.966 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 50.9 tp -140.84 162.22 35.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 111.296 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.795 HD12 ' HB2' ' A' ' 103' ' ' PHE . 2.7 pp -125.24 -39.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.28 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.795 ' HB2' HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -163.19 103.22 1.0 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.099 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.563 ' CB ' HG12 ' A' ' 128' ' ' VAL . 74.4 Cg_endo -74.91 -31.76 6.1 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.575 2.184 . . . . 0.0 112.609 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.08 -23.83 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.456 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -82.43 -40.89 20.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.36 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 tp -56.1 -47.15 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.154 0.502 . . . . 0.0 111.556 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.04 21.41 20.72 Favored Glycine 0 C--N 1.32 -0.338 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.836 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 174.68 13.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.01 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -79.46 151.77 30.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.671 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.824 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -137.02 109.95 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 65.0 mtm-85 -82.22 121.63 26.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.745 0.783 . . . . 0.0 110.975 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.4 t -113.6 130.76 67.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.961 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.8 m -121.18 137.48 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.735 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.58 ' HB3' HG23 ' A' ' 124' ' ' VAL . 3.1 t -141.06 173.01 11.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.347 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -131.14 130.74 43.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 23.3 m -56.68 123.97 16.75 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.95 0.405 . . . . 0.0 111.811 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.855 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . . . -67.8 -9.44 44.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.617 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.736 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.14 -50.64 2.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.559 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -77.12 -21.05 54.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.815 0.34 . . . . 0.0 110.895 -178.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.87 33.58 85.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.157 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.559 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -102.0 169.12 8.02 Favored Pre-proline 0 N--CA 1.453 -0.324 0 CA-C-N 115.459 -0.37 . . . . 0.0 110.372 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.426 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 51.1 Cg_endo -92.98 108.23 0.19 Allowed 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.92 2.413 . . . . 0.0 111.454 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.58 HG23 ' HB3' ' A' ' 115' ' ' SER . 35.7 m -105.43 146.26 12.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.45 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.8 p -148.99 142.49 25.32 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.397 0.618 . . . . 0.0 110.695 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -139.08 151.85 47.06 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.852 178.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.795 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 40.3 m -107.64 114.09 27.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.053 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.563 HG12 ' CB ' ' A' ' 104' ' ' PRO . 10.7 t -96.56 111.83 27.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.853 0.358 . . . . 0.0 111.412 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -106.69 172.18 4.09 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.009 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -68.83 -14.64 39.34 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.42 2.08 . . . . 0.0 112.995 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 1.1 t -117.86 -26.46 6.48 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 131' ' ' SER . 21.1 pt-20 178.65 -162.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.124 0.488 . . . . 0.0 110.01 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.69 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.88 159.2 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.849 178.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -145.67 19.34 1.49 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.402 0.62 . . . . 0.0 112.274 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.795 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.91 86.45 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.493 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.569 HG13 ' SD ' ' A' ' 141' ' ' MET . 45.2 t -102.42 116.06 45.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -146.36 121.49 5.47 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.721 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.5 155.35 98.95 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.542 -1.441 . . . . 0.0 112.243 -0.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.29 78.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 147.76 15.84 0.13 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.503 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.885 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -60.69 157.88 13.79 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.187 0.494 . . . . 0.0 111.227 -179.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -128.63 151.98 48.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.917 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.7 HG13 ' CD1' ' A' ' 164' ' ' PHE . 4.6 t -113.83 150.41 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.307 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.783 ' O ' HG13 ' A' ' 162' ' ' VAL . 0.1 OUTLIER -120.04 146.29 46.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.906 0.384 . . . . 0.0 111.078 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.687 HD22 ' C ' ' A' ' 144' ' ' SER . 3.8 mm? -122.08 158.12 29.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.651 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.741 ' HA ' HD22 ' A' ' 184' ' ' LEU . 34.6 m . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.269 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.783 HG13 ' O ' ' A' ' 144' ' ' SER . 24.2 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.998 0.428 . . . . 0.0 111.595 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -115.37 169.14 9.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.611 0.719 . . . . 0.0 109.677 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.7 ' CD1' HG13 ' A' ' 143' ' ' VAL . 3.2 m-85 -117.23 153.51 32.75 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.293 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.855 ' CE1' ' HB3' ' A' ' 118' ' ' ALA . 42.3 m-85 -133.16 137.32 46.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.166 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.635 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -38.9 -29.05 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.869 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.492 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 5.0 p -172.02 178.55 2.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.04 0.448 . . . . 0.0 111.54 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.606 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 77.8 t -69.13 -33.14 3.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.583 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.669 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.3 Cg_exo -72.98 -39.31 2.34 Favored 'Trans proline' 0 CA--C 1.505 -0.936 0 C-N-CA 122.731 2.288 . . . . 0.0 110.586 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.569 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.34 -39.44 53.92 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.728 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.86 -46.04 91.16 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.466 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.3 mt-10 -78.81 -27.66 44.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.225 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 169' ' ' PRO . 22.7 t0 -71.04 -55.74 7.63 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.43 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.736 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 8.1 t-105 -64.79 -28.49 69.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.702 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.96 -40.33 94.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.249 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.55 -42.79 55.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.402 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.407 ' O ' ' CD2' ' A' ' 178' ' ' HIS . 0.2 OUTLIER -97.1 23.7 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.338 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.46 ' O ' HD12 ' A' ' 184' ' ' LEU . 11.1 m170 -152.87 45.12 0.68 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.926 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.872 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 146' ' ' VAL . 29.6 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.734 0.302 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.14 142.64 46.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.141 0.496 . . . . 0.0 111.3 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.685 HD11 ' HB2' ' A' ' 175' ' ' ALA . 16.0 mm -101.69 160.85 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.758 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.461 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -158.71 157.47 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.233 0.54 . . . . 0.0 112.013 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.5 OUTLIER -86.02 127.98 34.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.767 178.461 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.885 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.1 m -46.43 -20.93 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.874 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.4 ' N ' ' C ' ' A' ' 188' ' ' SER . 1.8 t-80 -73.67 -43.3 59.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.208 0.527 . . . . 0.0 109.761 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.38 -20.86 36.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.378 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.2 -25.36 61.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.972 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.45 ' CZ ' HG22 ' A' ' 128' ' ' VAL . 3.5 m-85 -81.81 -30.96 31.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.252 0.548 . . . . 0.0 110.37 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.07 -33.48 23.52 Favored Glycine 0 CA--C 1.509 -0.31 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.336 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 195' ' ' LEU . 4.2 tt -76.65 -29.65 56.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.58 -26.88 37.26 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -82.71 -22.69 34.4 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.445 -0.377 . . . . 0.0 110.87 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.38 -22.95 43.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.424 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -51.95 -26.87 11.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 111.168 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -81.18 -54.31 5.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.155 -179.861 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 28' ' ' LEU . 19.0 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.684 0.278 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.544 ' CG ' HD11 ' A' ' 46' ' ' LEU . 66.2 Cg_endo -74.04 -35.68 4.0 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.452 2.101 . . . . 0.0 112.384 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 mt -53.9 -57.47 10.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.194 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.463 HD23 ' HB2' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -55.44 -26.87 44.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.259 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -63.72 -53.21 54.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.152 0.501 . . . . 0.0 109.982 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -78.88 -27.47 44.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.627 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 31' ' ' LEU . 3.4 tt -69.78 -52.42 25.37 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.794 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HB2' HD23 ' A' ' 28' ' ' LEU . . . -58.63 -25.93 63.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 110.822 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -70.0 -23.3 63.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.047 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.63 48.8 82.3 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.147 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -133.09 150.17 74.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.715 0.293 . . . . 0.0 110.855 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.64 106.36 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.536 2.157 . . . . 0.0 112.397 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.647 HG23 ' CG2' ' A' ' 41' ' ' THR . 11.2 p -112.32 109.9 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.221 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 p -84.15 -175.01 5.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.962 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 43' ' ' ALA . 9.3 mtp180 -76.93 -35.97 56.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.471 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -25.83 67.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.894 0.378 . . . . 0.0 110.348 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.647 ' CG2' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.05 -42.74 13.69 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.402 ' O ' HD13 ' A' ' 46' ' ' LEU . 5.2 tp -63.43 -35.92 82.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.559 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -74.06 -42.57 60.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.425 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.95 -30.98 74.54 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.567 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.59 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.09 -43.0 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.04 0.448 . . . . 0.0 110.432 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.544 HD11 ' CG ' ' A' ' 26' ' ' PRO . 6.9 mp -78.16 -7.75 57.45 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.509 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.66 23.41 6.15 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.63 145.4 31.22 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.264 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.07 139.61 70.95 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.415 2.077 . . . . 0.0 111.961 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.79 -17.46 0.94 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -78.56 -32.49 47.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.285 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.603 ' O ' HG23 ' A' ' 56' ' ' VAL . 4.1 mmt85 -67.66 -41.27 84.02 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.559 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.0 t -63.0 -48.07 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.516 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.01 -51.79 62.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.469 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.64 -37.47 18.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 52' ' ' ARG . 41.6 t -60.21 -33.06 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.754 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.6 mm? -81.06 -26.51 36.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.057 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -56.63 -22.7 36.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.197 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -1.67 11.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.231 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.77 72.19 0.78 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.819 0.819 . . . . 0.0 110.618 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.3 p -77.79 -3.96 44.02 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.376 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.2 m -113.14 39.92 2.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.061 0.458 . . . . 0.0 110.706 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.44 141.43 29.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.081 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.79 126.58 30.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.067 0.46 . . . . 0.0 111.237 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.413 ' OH ' HD12 ' A' ' 57' ' ' LEU . 31.8 m-85 -119.51 160.83 21.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.402 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.458 ' OD1' HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -154.52 145.6 22.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 111.289 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 tptt 66.06 -102.71 0.08 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.68 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.86 -14.04 32.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.728 0.299 . . . . 0.0 111.767 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 122.79 30.08 1.18 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.145 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -87.39 170.01 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.069 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.44 HD12 ' O ' ' A' ' 37' ' ' VAL . 2.0 mt -79.7 117.37 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.355 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.458 HD13 ' OD1' ' A' ' 66' ' ' ASP . 2.1 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.109 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.887 HD23 HD21 ' A' ' 92' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.777 0.322 . . . . 0.0 110.829 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.8 p -132.42 159.06 40.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt -85.24 5.72 29.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.476 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.44 113.26 24.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -55.77 -23.15 27.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.332 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER 35.66 -166.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 m -104.82 -25.92 12.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.4 ' OH ' ' CD2' ' A' ' 163' ' ' HIS . 4.8 m-85 -85.5 117.19 24.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.454 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.441 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.6 t -109.09 142.54 21.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.001 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.838 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 54.5 t80 -130.05 106.95 8.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.62 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -99.53 126.51 45.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.167 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -135.47 122.73 35.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.847 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t0 61.02 -69.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.319 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 87' ' ' ILE . 7.5 t70 -167.48 35.29 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.196 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.0 mmt-85 -137.6 113.24 9.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.986 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.55 121.9 25.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.501 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.887 HD21 HD23 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -114.93 164.69 13.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.323 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -129.03 165.0 22.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.038 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.679 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -152.65 169.03 23.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.987 0.422 . . . . 0.0 112.105 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.446 ' HA ' HG21 ' A' ' 81' ' ' THR . 18.3 m95 -95.03 -19.59 20.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.783 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.48 166.64 30.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.091 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -51.93 -23.28 4.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tp -86.38 -51.65 6.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.745 0.307 . . . . 0.0 111.434 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.622 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -45.03 -28.28 0.67 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.972 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.679 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -60.46 -39.56 88.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 0.0 110.725 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 102' ' ' ILE . 4.2 pp -111.08 -173.45 2.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 0.0 111.232 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 101' ' ' LEU . 7.5 tp -165.22 -42.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.052 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.562 ' O ' HG22 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -162.98 76.15 1.91 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.023 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.422 ' CB ' HG12 ' A' ' 128' ' ' VAL . 25.7 Cg_exo -62.96 -34.78 69.87 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.632 2.221 . . . . 0.0 112.374 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.18 -23.66 43.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.472 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -84.15 -39.23 19.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.409 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -58.05 -45.97 88.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.098 0.475 . . . . 0.0 111.371 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.94 24.03 16.23 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.474 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.26 173.73 14.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 111.038 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -80.65 155.3 26.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.838 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.11 109.83 7.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -81.9 119.8 24.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.771 0.796 . . . . 0.0 111.178 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.793 HG22 ' HD1' ' A' ' 85' ' ' PHE . 96.6 t -112.69 130.22 66.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.061 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.441 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 59.6 p -121.97 137.78 54.67 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.208 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.624 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.1 m -141.37 173.01 11.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.319 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -135.21 134.72 40.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.403 ' O ' ' HA2' ' A' ' 121' ' ' GLY . 35.5 t -62.09 128.84 38.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.142 0.496 . . . . 0.0 111.89 -178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.569 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . . . -69.65 -5.52 25.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.84 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.909 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.47 -50.11 2.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.845 0.355 . . . . 0.0 111.682 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.674 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.51 -24.4 21.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.058 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 117' ' ' CYS . . . 74.94 6.78 79.94 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.135 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.674 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.19 147.82 64.8 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.643 0.259 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.32 105.73 1.48 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.676 2.251 . . . . 0.0 110.448 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.729 HG12 ' HD2' ' A' ' 138' ' ' PRO . 27.7 m -103.32 145.7 12.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.945 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.955 ' O ' HD13 ' A' ' 126' ' ' LEU . 77.3 p -153.29 141.3 20.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.237 0.541 . . . . 0.0 110.421 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 1.008 HD21 ' HE1' ' A' ' 141' ' ' MET . 0.2 OUTLIER -136.72 153.6 50.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.258 178.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.772 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 89.5 m -105.75 112.57 25.69 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.654 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 62.1 t -96.21 111.95 27.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.935 0.398 . . . . 0.0 111.46 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.453 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -106.14 171.0 5.18 Favored Pre-proline 0 N--CA 1.453 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.853 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 37.7 Cg_endo -67.16 -19.22 51.1 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.028 1.819 . . . . 0.0 112.965 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 8.5 m -109.25 -29.41 8.5 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 131' ' ' SER . 10.5 pt-20 178.63 -161.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.198 0.523 . . . . 0.0 110.101 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -94.26 163.6 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.602 178.424 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -153.07 21.07 0.58 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.295 0.569 . . . . 0.0 112.448 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.772 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.95 86.32 0.08 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.445 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 139' ' ' ALA . 39.5 t -101.59 107.69 22.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.451 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -146.82 119.77 4.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.812 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.729 ' HD2' HG12 ' A' ' 124' ' ' VAL . 73.1 Cg_endo -76.63 145.95 83.04 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.582 -1.424 . . . . 0.0 112.222 0.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 136' ' ' VAL . . . -61.94 165.47 5.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.746 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 66.89 13.18 61.15 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.312 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 1.008 ' HE1' HD21 ' A' ' 126' ' ' LEU . 0.5 OUTLIER -61.43 158.3 15.03 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.983 0.42 . . . . 0.0 111.613 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.582 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.05 152.35 49.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.241 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.878 ' CG2' HG12 ' A' ' 189' ' ' VAL . 21.3 t -111.92 151.24 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.575 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.772 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.3 p -120.18 140.76 50.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.79 0.328 . . . . 0.0 110.804 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.96 154.71 39.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.914 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.925 179.561 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 144' ' ' SER . 30.5 t . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.835 0.35 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.4 ' CD2' ' OH ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -117.03 169.23 9.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.602 0.715 . . . . 0.0 110.182 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.666 ' CE1' HG13 ' A' ' 143' ' ' VAL . 1.8 m-85 -120.48 132.26 55.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.915 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.625 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 54.5 m-85 -108.65 136.15 48.72 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.144 0.497 . . . . 0.0 110.001 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -46.89 -25.79 0.85 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.594 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 40.1 m -163.09 167.49 22.22 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.825 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 77.4 t -68.1 -34.43 6.09 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.97 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.0 Cg_exo -72.69 -36.8 4.48 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 122.753 2.302 . . . . 0.0 110.001 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.593 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.75 -40.27 48.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.465 178.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.7 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.45 -45.24 95.1 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.1 mt-10 -78.93 -27.94 43.77 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.249 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 169' ' ' PRO . 28.3 t70 -70.19 -55.89 8.19 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.457 0.646 . . . . 0.0 109.475 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.909 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 29.8 t-105 -64.88 -27.74 69.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.83 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -65.54 -40.27 92.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.265 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -42.29 63.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.471 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -95.11 20.46 9.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.271 0.558 . . . . 0.0 111.435 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.494 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -127.84 29.25 5.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.721 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.802 179.944 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 178' ' ' HIS . 1.2 tt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.423 ' N ' HD23 ' A' ' 184' ' ' LEU . . . -142.24 149.9 40.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 175' ' ' ALA . 10.6 mm -100.29 158.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.937 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -162.46 161.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.219 0.533 . . . . 0.0 112.016 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -88.08 127.97 35.41 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.652 178.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.955 HG11 ' SD ' ' A' ' 141' ' ' MET . 2.1 m -48.01 -19.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.405 ' N ' ' C ' ' A' ' 188' ' ' SER . 23.6 m-70 -73.02 -44.39 60.96 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -22.3 35.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.524 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -74.89 -25.18 58.76 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.282 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -81.51 -24.86 36.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.942 0.401 . . . . 0.0 110.666 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.86 -29.81 33.81 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -82.3 -28.3 31.8 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.04 -28.17 31.89 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -82.15 -21.88 36.37 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.44 -0.38 . . . . 0.0 110.995 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -81.12 -22.84 38.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.126 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.65 -28.32 20.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.129 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -52.39 -55.08 24.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.031 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.618 0.247 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.747 ' HB2' HD11 ' A' ' 46' ' ' LEU . 37.1 Cg_exo -60.99 -19.83 64.74 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.49 2.127 . . . . 0.0 112.403 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.5 tt -55.27 -57.62 11.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.447 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -80.27 -27.36 38.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.334 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 8.7 ttt-85 -70.86 -53.31 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.941 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -66.5 -25.52 66.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.499 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.755 HD11 ' C ' ' A' ' 72' ' ' ILE . 4.4 tp -72.02 -30.56 65.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.714 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.38 -27.87 26.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.146 0.498 . . . . 0.0 110.944 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -64.76 -19.96 66.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.245 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.64 47.52 89.98 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.134 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.766 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -131.06 143.93 51.46 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.601 0.239 . . . . 0.0 110.676 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -51.46 91.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.458 2.106 . . . . 0.0 112.306 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 35' ' ' ARG . 23.1 t -93.17 112.08 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.281 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.9 p -86.73 -176.57 5.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.688 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -75.71 -36.73 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.248 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -27.3 67.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.206 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.64 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.94 -42.52 14.88 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.752 ' CD1' HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -62.73 -36.7 83.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.62 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.43 -43.02 64.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.625 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.23 -31.72 75.01 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.591 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.606 HG22 HD12 ' A' ' 46' ' ' LEU . 7.1 mt -78.02 -46.15 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 120.968 0.413 . . . . 0.0 110.409 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 26' ' ' PRO . 7.9 mp -75.58 -9.51 58.64 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.543 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 60.31 21.65 11.14 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -102.0 160.43 26.45 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.25 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.16 138.99 34.54 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.608 2.205 . . . . 0.0 111.925 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.54 -20.27 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -32.25 47.35 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.045 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -67.39 -40.66 85.69 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.0 t -62.98 -47.85 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.518 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.26 -52.46 58.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.164 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.98 79.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.154 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -66.62 -26.81 38.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.922 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.443 HD23 HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -72.06 -31.77 66.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.632 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.735 ' O ' HG23 ' A' ' 61' ' ' THR . 7.6 mt-10 -56.17 -23.18 33.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -88.54 -16.36 32.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 63' ' ' THR . . . -96.96 33.35 1.92 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.381 0.61 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.735 HG23 ' O ' ' A' ' 58' ' ' GLU . 80.6 p -59.01 -20.76 56.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.01 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.6 m -90.21 -21.43 22.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.366 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HB1' ' A' ' 60' ' ' ALA . 0.8 OUTLIER -60.75 141.24 57.13 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.354 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.627 ' O ' HG22 ' A' ' 72' ' ' ILE . 2.1 mt-10 -79.0 131.09 36.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 0.0 111.62 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.45 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.6 m-85 -104.06 173.06 6.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.169 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -152.73 146.52 25.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 111.541 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tptt 65.95 -103.54 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.799 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.95 -12.29 33.81 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 124.6 31.15 0.91 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.006 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -85.75 168.05 14.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.179 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.752 HD13 ' CD1' ' A' ' 42' ' ' LEU . 3.6 mp -79.91 115.76 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.469 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.755 ' C ' HD11 ' A' ' 31' ' ' LEU . 2.3 tt . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.164 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.716 0.293 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.8 p -102.8 159.01 15.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.867 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.63 -48.03 82.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -110.65 155.43 22.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.02 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -57.21 129.44 41.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -109.23 -172.68 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.985 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 m -94.34 -41.33 9.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -78.58 108.52 12.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.644 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.86 140.97 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.898 ' CZ ' HD22 ' A' ' 101' ' ' LEU . 28.3 t80 -131.03 108.01 9.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.632 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -101.75 136.71 41.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -138.78 122.98 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.76 -68.94 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.466 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 87' ' ' ILE . 11.0 t0 -164.94 35.05 0.06 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.447 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -137.83 111.67 8.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.793 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -77.91 120.11 22.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.785 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.631 HD12 ' HD2' ' A' ' 85' ' ' PHE . 10.4 mt -109.86 164.86 12.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -133.27 165.05 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.131 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -153.23 169.95 21.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.057 0.456 . . . . 0.0 111.815 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -106.44 -7.42 17.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.876 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.888 ' HB3' HG23 ' A' ' 162' ' ' VAL . 76.6 m -152.74 159.94 43.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.331 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.719 ' HB2' ' O ' ' A' ' 162' ' ' VAL . . . -51.5 -25.37 6.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.527 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.417 HD21 HG12 ' A' ' 102' ' ' ILE . 3.6 tt -87.86 -50.27 6.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.12 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.617 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -43.25 -22.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.529 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -59.0 -32.38 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.898 HD22 ' CZ ' ' A' ' 85' ' ' PHE . 2.2 tp 178.65 149.19 0.22 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 111.218 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.417 HG12 HD21 ' A' ' 98' ' ' LEU . 5.1 mt -128.45 128.42 68.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.701 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.64 ' HB3' HD12 ' A' ' 106' ' ' LEU . 13.1 m-85 66.84 66.91 0.66 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.864 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.474 ' O ' HG12 ' A' ' 107' ' ' ILE . 24.2 Cg_exo -63.65 -20.92 69.98 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.842 2.361 . . . . 0.0 112.404 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.75 -23.67 59.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.916 0.388 . . . . 0.0 111.278 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.64 HD12 ' HB3' ' A' ' 103' ' ' PHE . 7.7 mt -78.6 -29.75 46.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.24 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 104' ' ' PRO . 3.7 mm -53.17 -61.08 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.006 0.908 . . . . 0.0 111.051 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.89 18.61 26.77 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.294 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.37 -179.95 7.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.714 0.292 . . . . 0.0 110.597 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.54 149.0 26.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.729 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.09 110.34 7.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -79.56 119.08 22.03 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.849 0.833 . . . . 0.0 111.223 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.773 HG22 ' CD1' ' A' ' 85' ' ' PHE . 12.2 t -110.49 131.53 61.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.983 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 m -122.61 137.33 54.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.246 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.547 ' OG ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -140.94 172.77 12.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.062 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -131.84 130.83 42.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.829 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 29.5 m -56.02 123.84 15.72 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.029 0.443 . . . . 0.0 111.979 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.39 -6.95 33.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.788 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.625 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -119.47 -50.6 2.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.696 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.16 -13.75 37.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.996 -179.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 117' ' ' CYS . . . 64.23 10.34 40.81 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.746 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.554 ' H ' HG22 ' A' ' 120' ' ' THR . . . -71.2 168.99 16.78 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.808 0.337 . . . . 0.0 110.647 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.461 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 53.8 Cg_endo -93.69 108.71 0.17 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.073 2.515 . . . . 0.0 111.629 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.547 HG23 ' OG ' ' A' ' 115' ' ' SER . 34.3 m -106.53 146.84 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.341 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.2 p -151.66 142.8 23.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.375 0.607 . . . . 0.0 110.771 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.633 ' N ' HD12 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -134.43 151.74 51.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.484 178.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.888 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 30.2 m -107.62 113.59 26.99 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.485 HG23 ' CG2' ' A' ' 113' ' ' VAL . 36.2 t -96.51 111.69 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.968 0.413 . . . . 0.0 111.489 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -105.76 169.8 6.58 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.15 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.58 -14.52 44.33 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.456 2.104 . . . . 0.0 112.982 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 p -118.19 -27.01 6.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.52 -163.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.112 0.482 . . . . 0.0 109.999 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -95.3 162.29 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.717 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -151.41 19.98 0.74 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.888 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.04 86.14 0.08 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.791 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.15 122.74 53.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.707 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -146.12 119.3 5.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.98 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.425 ' HD2' HG12 ' A' ' 124' ' ' VAL . 70.8 Cg_endo -74.71 162.3 92.97 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 123.435 -1.485 . . . . 0.0 112.274 0.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.82 78.24 1.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.151 0.5 . . . . 0.0 110.737 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 147.4 15.91 0.13 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.576 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 126' ' ' LEU . 10.2 ptp -62.51 160.82 12.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.079 0.439 . . . . 0.0 111.534 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.65 152.06 50.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.942 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.757 HG22 ' CE2' ' A' ' 164' ' ' PHE . 2.5 t -117.44 154.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.443 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 55.6 p -121.16 146.8 46.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.842 0.353 . . . . 0.0 110.921 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.856 HD21 ' HB3' ' A' ' 185' ' ' ALA . 4.0 pp -113.47 158.4 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.993 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 146' ' ' VAL . 11.1 p . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.888 HG23 ' HB3' ' A' ' 96' ' ' CYS . 7.2 p . . . . . 0 CA--C 1.526 0.052 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.467 ' N ' HG13 ' A' ' 162' ' ' VAL . 4.7 m80 -107.19 148.5 28.8 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.65 0.738 . . . . 0.0 109.979 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.757 ' CE2' HG22 ' A' ' 143' ' ' VAL . 40.4 m-85 -109.9 150.67 28.11 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.238 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 49.7 m-85 -131.83 136.09 47.21 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.557 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.568 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -39.75 -28.32 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.243 -0.889 . . . . 0.0 113.141 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.499 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 11.4 p -170.59 176.45 4.31 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.655 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.61 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 79.6 t -69.4 -34.27 4.61 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.369 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.88 -37.55 3.62 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.763 2.309 . . . . 0.0 110.313 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.592 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -77.21 -39.78 47.42 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.471 178.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.701 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.37 -44.56 96.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 177.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.6 mt-10 -79.07 -27.95 43.08 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.099 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.3 t70 -69.92 -56.03 8.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.466 0.651 . . . . 0.0 109.395 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.625 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 35.6 t-105 -64.87 -27.88 69.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.817 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -66.54 -38.51 87.3 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.218 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -44.32 63.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.302 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -94.95 22.47 6.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.031 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.33 30.57 0.68 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.69 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.936 179.995 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.856 ' HB3' HD21 ' A' ' 145' ' ' LEU . . . -143.24 150.32 39.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.002 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.541 HD11 ' HB2' ' A' ' 175' ' ' ALA . 11.7 mm -99.66 160.82 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.938 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.476 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -165.61 162.9 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.474 0.654 . . . . 0.0 112.197 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.9 OUTLIER -89.16 130.26 35.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.905 178.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.538 HG12 ' CG2' ' A' ' 143' ' ' VAL . 1.2 m -46.49 -20.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 2.1 m-70 -72.65 -43.36 63.29 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.761 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -21.02 36.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.347 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.75 -25.21 58.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 128' ' ' VAL . 9.7 t80 -81.42 -24.86 36.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.703 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.66 -29.98 34.02 Favored Glycine 0 CA--C 1.509 -0.3 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.8 mt -81.59 -27.85 34.06 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.01 -26.52 37.01 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -81.99 -22.02 36.8 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.517 -0.342 . . . . 0.0 111.026 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -74.11 -24.37 59.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -54.06 -39.53 66.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.107 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.17 -24.95 37.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.039 -179.854 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.648 HG22 ' HB2' ' A' ' 27' ' ' LEU . 9.7 p . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 120.693 0.282 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.564 ' HB2' HD11 ' A' ' 46' ' ' LEU . 52.3 Cg_exo -55.15 -20.0 22.69 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.693 2.262 . . . . 0.0 112.851 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.648 ' HB2' HG22 ' A' ' 25' ' ' VAL . 4.8 mp -52.01 -57.4 9.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.747 0.308 . . . . 0.0 111.227 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.623 HD23 ' CG1' ' A' ' 25' ' ' VAL . 3.9 pp -66.42 -26.98 67.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.138 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.451 ' N ' HD12 ' A' ' 28' ' ' LEU . 41.2 mtp85 -68.84 -53.32 22.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.846 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -72.86 -30.32 63.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.318 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 72' ' ' ILE . 5.7 tp -72.57 -43.16 63.79 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.837 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.11 -26.74 17.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.074 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -66.62 -20.62 66.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.188 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.91 47.41 89.07 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.136 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -133.07 148.58 69.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.622 0.249 . . . . 0.0 110.814 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.01 105.46 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.556 2.171 . . . . 0.0 112.31 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.739 HG23 HG22 ' A' ' 41' ' ' THR . 11.1 p -107.23 110.0 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.36 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 94.1 p -86.83 -179.54 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.744 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.4 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -71.96 -36.36 69.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.246 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -27.39 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 0.0 110.117 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.739 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.33 -41.61 15.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.488 HD22 ' CD1' ' A' ' 71' ' ' ILE . 7.8 tp -63.53 -36.51 84.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 176.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.21 -42.6 62.46 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.463 177.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.26 -31.09 73.98 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.617 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.574 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -78.78 -44.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-O 120.998 0.428 . . . . 0.0 110.518 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.567 HD12 HG22 ' A' ' 45' ' ' ILE . 7.4 mp -76.72 -9.75 58.89 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.412 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 59.36 22.24 10.62 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.442 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 7.8 m0 -104.99 144.75 29.37 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.337 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.7 138.23 80.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.455 2.103 . . . . 0.0 112.012 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.95 -18.94 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.7 -32.03 46.77 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.106 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.779 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -67.21 -40.53 86.44 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.581 ' O ' HD23 ' A' ' 57' ' ' LEU . 2.1 t -62.26 -48.23 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.667 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.64 -52.74 58.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.516 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.64 -45.73 73.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 52' ' ' ARG . 30.1 t -68.83 -29.3 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.728 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.837 HD12 ' OH ' ' A' ' 65' ' ' TYR . 2.2 mm? -72.17 -38.52 69.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.95 -45.16 87.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -64.5 -17.18 63.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.36 67.59 0.7 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.748 0.785 . . . . 0.0 110.847 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 p -72.41 -8.64 56.09 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.335 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.0 m -114.51 40.81 2.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.179 0.514 . . . . 0.0 110.781 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.66 141.4 33.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.164 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -78.77 126.74 31.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.033 0.444 . . . . 0.0 111.16 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.837 ' OH ' HD12 ' A' ' 57' ' ' LEU . 43.9 m-85 -115.16 165.6 12.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.349 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -154.22 144.3 21.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 111.286 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 tptt 66.42 -103.2 0.08 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.733 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -91.55 -13.47 32.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.751 0.31 . . . . 0.0 111.818 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 124.36 30.65 0.98 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.134 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -86.55 168.79 13.36 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.488 ' CD1' HD22 ' A' ' 42' ' ' LEU . 2.1 mp -79.8 121.53 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.413 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.817 ' O ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.005 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.604 HD11 HD22 ' A' ' 92' ' ' LEU . 3.2 mm? . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.682 0.277 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.464 HG21 ' C ' ' A' ' 94' ' ' ALA . 15.8 p -113.39 159.55 19.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.709 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.31 48.99 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.622 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 43.47 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.985 0.421 . . . . 0.0 112.067 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -156.99 -88.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.475 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -38.63 157.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.958 0.408 . . . . 0.0 111.996 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.437 ' O ' HG23 ' A' ' 84' ' ' VAL . 15.0 t -75.07 -10.64 59.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.89 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 97' ' ' ALA . 23.2 m-85 -70.87 101.2 2.09 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG13 ' CE1' ' A' ' 93' ' ' TYR . 9.2 t -110.23 143.61 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.398 . . . . 0.0 111.186 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.862 ' CD1' HG22 ' A' ' 113' ' ' VAL . 32.5 t80 -134.33 109.25 8.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.352 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.84 125.22 39.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.995 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.477 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -136.31 122.99 31.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.87 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.5 -76.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.063 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.9 p-10 -159.15 36.7 0.21 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.461 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -140.94 115.66 9.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.636 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -77.76 85.89 4.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.86 0.362 . . . . 0.0 110.989 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 76' ' ' LEU . 51.5 mt -71.97 165.0 25.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.84 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.558 ' CE1' HG13 ' A' ' 84' ' ' VAL . 50.6 m-85 -138.45 165.15 27.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.312 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 100' ' ' THR . . . -144.14 162.04 37.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.866 0.365 . . . . 0.0 111.861 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -85.31 -27.43 25.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.402 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.438 ' HB2' ' HB ' ' A' ' 162' ' ' VAL . 0.5 OUTLIER -129.89 159.04 37.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.754 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.674 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -61.98 -11.87 15.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.83 HD12 HG11 ' A' ' 162' ' ' VAL . 9.0 mt -103.64 -20.76 13.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.49 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 14.7 t70 -82.5 -3.6 56.13 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.706 ' HA ' ' HB2' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.54 -39.1 86.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 0.0 110.341 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.648 HD13 ' H ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -98.33 173.77 6.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.719 HD12 ' N ' ' A' ' 103' ' ' PHE . 2.5 pp -154.92 -45.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.133 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.719 ' N ' HD12 ' A' ' 102' ' ' ILE . 11.3 m-85 -163.06 79.12 1.72 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.016 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.466 ' CB ' HG12 ' A' ' 128' ' ' VAL . 59.3 Cg_endo -71.92 -32.84 10.71 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.591 2.194 . . . . 0.0 112.294 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.15 -23.78 43.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.263 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.89 -40.08 17.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.38 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.1 tp -57.94 -45.34 87.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.263 0.554 . . . . 0.0 111.372 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.19 24.26 15.09 Favored Glycine 0 C--N 1.319 -0.385 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.484 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -151.42 173.62 14.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.065 0.459 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -83.84 157.18 22.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.971 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.575 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.07 110.06 7.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.2 mtt-85 -80.91 119.03 22.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.732 0.777 . . . . 0.0 111.178 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.862 HG22 ' CD1' ' A' ' 85' ' ' PHE . 13.4 t -108.27 129.54 62.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.847 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.415 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 1.5 p -124.49 137.62 54.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.318 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.591 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.1 172.96 11.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.986 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 121' ' ' GLY . 0.8 OUTLIER -130.13 130.94 45.42 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.571 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.1 m -57.76 123.06 14.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.873 0.368 . . . . 0.0 111.927 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.78 -8.28 34.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.783 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.703 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.43 -50.54 1.99 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.563 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -77.9 -21.15 51.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 111.198 -178.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.401 ' O ' ' CE1' ' A' ' 116' ' ' HIS . . . 63.31 33.28 86.83 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.01 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.563 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -102.93 169.69 7.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.432 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.444 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 58.6 Cg_endo -93.86 107.49 0.16 Allowed 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.922 2.415 . . . . 0.0 111.681 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.591 HG22 ' C ' ' A' ' 115' ' ' SER . 33.8 m -102.54 146.26 10.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.235 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.897 ' O ' HD13 ' A' ' 126' ' ' LEU . 67.0 p -151.87 141.49 21.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.457 0.646 . . . . 0.0 111.196 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.897 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -134.18 153.14 52.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.001 178.48 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.906 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 23.6 m -110.05 114.95 28.89 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 47.8 t -96.2 111.52 26.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.999 0.428 . . . . 0.0 110.869 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -108.29 176.51 1.57 Allowed Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.461 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 129' ' ' SER . 13.3 Cg_exo -70.33 -12.69 32.25 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.727 2.285 . . . . 0.0 113.112 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 0.8 OUTLIER -121.91 -27.91 4.54 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.076 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 131' ' ' SER . 13.4 pt-20 179.63 -161.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.13 0.49 . . . . 0.0 110.374 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -91.38 156.39 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.758 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -146.31 17.16 1.35 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.906 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.99 85.04 0.07 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.882 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.472 HG13 HD12 ' A' ' 126' ' ' LEU . 23.1 t -98.88 123.16 51.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.834 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.17 117.09 4.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.018 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.12 161.85 93.56 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.423 -1.491 . . . . 0.0 112.087 -0.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.01 78.0 1.69 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.117 0.484 . . . . 0.0 110.674 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.86 18.76 0.18 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.388 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.836 ' SD ' HD11 ' A' ' 126' ' ' LEU . 6.7 ptm -64.38 161.45 16.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.969 0.385 . . . . 0.0 111.2 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -125.55 152.36 45.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.07 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.516 HG22 ' CE1' ' A' ' 164' ' ' PHE . 61.2 t -114.09 148.9 16.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.775 ' O ' HG13 ' A' ' 162' ' ' VAL . 50.3 m -120.19 140.87 50.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.769 0.319 . . . . 0.0 110.372 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -144.01 176.11 9.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.071 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.967 179.686 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.83 HG11 HD12 ' A' ' 98' ' ' LEU . 26.0 t . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.882 0.372 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 163' ' ' HIS . 3.2 m-70 -128.14 169.25 14.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.314 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.674 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 10.5 m-30 -110.73 152.95 25.97 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.812 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.595 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 27.1 m-85 -132.54 138.13 47.38 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.582 0.706 . . . . 0.0 110.238 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.571 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -42.66 -28.84 0.26 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.141 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.552 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 71.4 m -166.96 174.7 8.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.121 0.486 . . . . 0.0 111.685 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.601 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.4 t -69.53 -33.84 4.15 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.199 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.4 Cg_exo -73.33 -37.92 2.97 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.81 2.34 . . . . 0.0 110.361 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.577 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.6 -39.63 51.93 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.53 177.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.734 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.06 -45.63 92.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.2 mt-10 -78.9 -27.68 43.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.34 178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.688 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.5 t70 -71.11 -56.0 7.04 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.301 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.703 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 36.0 t-105 -64.45 -28.91 69.99 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.675 178.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.02 -39.76 94.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.145 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -43.88 63.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.372 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.75 21.92 7.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.177 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.79 23.89 5.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.881 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.716 179.93 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.554 HD23 ' N ' ' A' ' 185' ' ' ALA . 8.1 tt . . . . . 0 C--O 1.231 0.099 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.554 ' N ' HD23 ' A' ' 184' ' ' LEU . . . -144.98 150.13 36.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.153 0.502 . . . . 0.0 111.815 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.0 mm -103.95 162.04 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.506 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.462 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -157.35 162.31 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.578 0.704 . . . . 0.0 112.313 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -94.97 133.34 38.83 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.375 178.079 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.464 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 2.8 m -47.35 -18.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.879 0.371 . . . . 0.0 110.817 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 11.6 m170 -73.67 -44.87 55.54 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.18 0.514 . . . . 0.0 109.69 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.576 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.7 OUTLIER -82.41 -20.91 36.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.478 179.152 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.51 -24.79 62.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.97 -24.73 37.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.74 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.71 -31.28 30.19 Favored Glycine 0 CA--C 1.509 -0.338 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 191' ' ' GLU . 8.3 mp -80.8 -28.42 36.3 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.92 -24.31 45.67 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.614 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -82.13 -22.01 36.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.805 0.336 . . . . 0.0 111.092 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.21 -23.15 43.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.186 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -54.24 -38.72 66.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 111.105 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.73 -54.73 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.996 -179.943 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.685 0.279 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.416 ' CG ' HD11 ' A' ' 46' ' ' LEU . 58.4 Cg_endo -71.57 -37.28 5.61 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.551 2.168 . . . . 0.0 112.317 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.73 -57.14 11.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.568 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -60.23 -26.82 66.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.427 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -53.42 23.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.027 0.441 . . . . 0.0 110.274 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.37 -30.1 57.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.419 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.487 HD23 HD22 ' A' ' 28' ' ' LEU . 49.1 tp -70.36 -49.94 44.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.71 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB2' HD13 ' A' ' 28' ' ' LEU . . . -53.48 -25.31 15.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.997 0.427 . . . . 0.0 111.133 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -22.39 64.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.137 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.21 48.14 77.83 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.297 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -133.18 155.11 81.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.659 0.266 . . . . 0.0 110.854 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.9 108.99 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.518 2.145 . . . . 0.0 111.973 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.768 HG13 HG12 ' A' ' 71' ' ' ILE . 9.6 p -113.58 109.84 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 120.954 0.407 . . . . 0.0 111.394 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 p -87.62 -169.79 2.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.8 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 43' ' ' ALA . 15.8 ttm180 -78.07 -36.84 47.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.406 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -26.96 68.04 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.363 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.76 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.56 -42.15 14.65 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.413 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.29 -36.29 83.17 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.83 -42.7 60.49 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.494 177.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.81 -30.84 74.75 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.612 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.582 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.14 -42.48 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 120.949 0.404 . . . . 0.0 110.468 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.546 HD12 HG22 ' A' ' 45' ' ' ILE . 7.1 mp -78.94 -7.43 58.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.505 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 55.37 23.5 5.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.421 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -98.89 153.12 37.98 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.272 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.433 ' O ' HG23 ' A' ' 53' ' ' VAL . 49.4 Cg_endo -69.02 137.1 36.75 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.592 2.195 . . . . 0.0 111.923 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.91 -22.18 0.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -78.57 -35.47 45.86 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.876 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.85 ' O ' HG23 ' A' ' 56' ' ' VAL . 32.2 mmt-85 -66.84 -40.84 88.08 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.11 -48.2 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.544 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.15 -53.47 50.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.383 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.7 -49.82 75.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.898 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 52' ' ' ARG . 39.7 t -63.57 -30.66 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.642 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.493 HD11 ' OH ' ' A' ' 65' ' ' TYR . 1.8 tp -62.16 -32.13 72.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.675 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.607 ' O ' HG23 ' A' ' 61' ' ' THR . 3.3 tt0 -57.82 -22.26 46.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -95.93 -18.3 20.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.149 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.448 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -100.95 32.57 3.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.448 0.642 . . . . 0.0 110.85 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 58' ' ' GLU . 26.9 p -67.48 -27.99 67.47 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.956 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.4 t -75.93 -25.56 56.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.254 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.448 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -56.56 141.4 43.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.073 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.711 ' O ' HG22 ' A' ' 72' ' ' ILE . 31.5 mt-10 -78.43 126.87 31.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.493 ' OH ' HD11 ' A' ' 57' ' ' LEU . 39.8 m-85 -102.49 173.08 6.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.583 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.17 -172.77 2.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.564 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.25 -36.99 85.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.516 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -88.46 10.8 18.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.739 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.76 13.11 82.78 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.262 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -89.03 161.77 16.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.233 0.517 . . . . 0.0 109.827 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.768 HG12 HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -79.76 124.83 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.401 -179.15 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.84 HD11 HD11 ' A' ' 76' ' ' LEU . 2.2 tt . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.204 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.84 HD11 HD11 ' A' ' 72' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.849 0.356 . . . . 0.0 110.857 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.5 p -123.57 159.55 28.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.39 -25.02 0.58 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.664 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.433 ' HD2' ' CD1' ' A' ' 93' ' ' TYR . 18.9 mtm180 79.9 92.03 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.889 0.376 . . . . 0.0 110.922 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.87 25.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.021 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 p -122.24 -138.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.959 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 p -129.65 -31.12 2.02 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.588 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 96' ' ' CYS . 12.4 m-85 -72.1 104.19 3.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.534 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.54 141.09 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.347 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.818 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 20.4 t80 -133.78 107.44 7.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.145 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -102.33 134.67 45.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.446 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.479 HG23 ' CE1' ' A' ' 85' ' ' PHE . 2.6 pt -140.06 123.91 18.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.724 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 t0 63.32 -66.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.43 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 87' ' ' ILE . 16.0 m-20 -168.0 35.28 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.499 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -135.61 113.23 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.895 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -80.21 86.17 5.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.083 0.468 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.404 ' CB ' ' O ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -73.65 164.63 26.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.114 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.433 ' CD1' ' HD2' ' A' ' 79' ' ' ARG . 7.9 m-85 -135.49 165.2 26.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.228 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -153.37 173.44 15.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.073 0.463 . . . . 0.0 111.946 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.411 ' O ' ' CE2' ' A' ' 83' ' ' TYR . 12.0 m0 -97.02 -17.58 19.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.008 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.43 ' HA ' ' CE2' ' A' ' 83' ' ' TYR . 1.2 m -153.96 165.91 34.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.155 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -52.46 -22.8 5.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.666 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.2 mt -85.22 -51.67 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.593 0.235 . . . . 0.0 111.292 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.593 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -49.4 -27.4 4.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.704 0.287 . . . . 0.0 111.542 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.627 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.48 -29.81 69.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.454 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.529 HD23 ' N ' ' A' ' 101' ' ' LEU . 1.8 pt? -154.65 126.3 7.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.773 ' O ' HD13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -96.22 -36.68 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 106' ' ' LEU . 1.6 m-85 -124.76 78.0 64.61 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.724 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.812 ' O ' HG22 ' A' ' 107' ' ' ILE . 36.1 Cg_exo -61.2 -51.42 4.5 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.631 2.221 . . . . 0.0 112.327 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.85 -23.41 41.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.567 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -90.35 -15.84 30.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 104' ' ' PRO . 2.9 tp -47.84 -53.31 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 111.993 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.443 ' H ' HG23 ' A' ' 107' ' ' ILE . . . 102.3 0.73 50.7 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.966 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.95 177.88 10.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 110.399 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.35 143.94 44.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.818 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -137.18 109.88 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -81.33 120.05 24.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.75 0.786 . . . . 0.0 111.467 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.17 130.9 65.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.827 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.4 m -126.02 137.97 53.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.326 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.594 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.6 OUTLIER -141.34 172.91 12.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.075 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -133.97 135.67 43.64 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.2 t -64.59 131.97 48.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.29 -3.4 23.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.936 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.897 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.91 -50.5 2.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.87 0.367 . . . . 0.0 111.543 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.688 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -90.32 -23.62 21.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.457 -179.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.56 6.18 75.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.251 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.688 ' H ' HG22 ' A' ' 120' ' ' THR . . . -60.03 155.55 43.2 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-O 120.604 0.24 . . . . 0.0 110.457 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -87.97 104.27 0.51 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.719 2.279 . . . . 0.0 111.383 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.594 HG22 ' C ' ' A' ' 115' ' ' SER . 33.9 m -98.1 145.14 10.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.1 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.3 p -155.59 142.69 19.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.581 0.705 . . . . 0.0 111.26 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.585 HD21 ' SD ' ' A' ' 141' ' ' MET . 0.5 OUTLIER -135.16 153.32 52.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.685 178.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.874 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 32.2 m -108.26 113.84 27.25 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.723 HG13 ' CZ ' ' A' ' 193' ' ' PHE . 41.1 t -95.9 111.51 26.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.026 0.441 . . . . 0.0 111.696 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.409 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.8 OUTLIER -105.86 169.01 7.45 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.744 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 33.3 Cg_endo -65.42 -18.82 60.87 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.14 1.893 . . . . 0.0 112.844 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 70.8 m -112.59 -28.2 7.92 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 131' ' ' SER . 22.1 pt-20 179.54 -163.3 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.237 0.541 . . . . 0.0 110.139 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -95.2 158.66 2.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.753 178.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -147.23 19.33 1.22 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.874 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.23 86.19 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.632 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.3 t -105.03 117.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.024 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.44 117.38 4.77 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.087 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.436 ' CD ' HG12 ' A' ' 124' ' ' VAL . 16.7 Cg_exo -67.57 145.91 75.38 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.73 -1.363 . . . . 0.0 112.443 0.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.35 -33.19 52.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.867 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -101.43 30.14 11.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.245 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.873 ' SD ' HG11 ' A' ' 189' ' ' VAL . 5.4 ptp -65.22 157.22 29.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 0.0 111.889 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.8 152.44 50.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.318 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.747 ' CG2' HG12 ' A' ' 189' ' ' VAL . 11.4 t -113.41 153.08 15.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.776 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.404 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 4.4 m -121.7 143.04 49.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.741 0.305 . . . . 0.0 110.608 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.508 HD13 HG21 ' A' ' 187' ' ' VAL . 5.3 mp -145.3 176.08 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.109 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 35.4 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.837 179.725 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.908 0.385 . . . . 0.0 111.52 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.411 ' CD2' ' OH ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -126.03 169.31 12.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.738 0.78 . . . . 0.0 109.765 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.708 ' CD1' HG13 ' A' ' 143' ' ' VAL . 2.0 m-85 -113.0 152.35 29.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.912 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 60.6 m-85 -131.44 136.83 48.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.766 0.793 . . . . 0.0 110.578 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 122' ' ' ALA . . . -47.88 -25.17 1.22 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.797 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.596 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 44.7 m -164.73 167.62 18.79 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.643 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.62 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.3 t -68.12 -34.45 6.08 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.896 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.3 Cg_exo -72.45 -37.03 4.6 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.768 2.312 . . . . 0.0 110.103 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.583 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.19 -40.57 52.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.731 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.52 -46.15 91.21 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 1.7 mm-40 -78.97 -27.22 43.48 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.331 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.709 ' N ' ' O ' ' A' ' 169' ' ' PRO . 26.5 t70 -70.06 -55.76 8.66 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.192 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.897 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 51.4 t-105 -65.99 -28.29 68.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.723 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.24 -39.45 93.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.13 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.0 t -53.71 -42.25 67.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.428 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 18.46 9.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.382 0.61 . . . . 0.0 111.38 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.438 ' CD2' ' CD1' ' A' ' 174' ' ' TRP . 0.1 OUTLIER -120.31 24.15 10.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.727 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.768 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 185' ' ' ALA . 1.9 tt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.757 0.313 . . . . 0.0 110.751 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.589 ' N ' HD23 ' A' ' 184' ' ' LEU . . . -142.55 150.17 40.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.11 0.481 . . . . 0.0 111.369 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 175' ' ' ALA . 15.5 mm -101.56 161.31 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.747 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.716 HG12 ' CD ' ' A' ' 191' ' ' GLU . 0.0 OUTLIER -159.89 159.79 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.277 0.56 . . . . 0.0 112.15 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 190' ' ' HIS . 42.2 p -89.83 128.59 36.19 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.669 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.873 HG11 ' SD ' ' A' ' 141' ' ' MET . 2.4 m -47.72 -19.15 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.993 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.407 ' N ' ' C ' ' A' ' 188' ' ' SER . 59.5 t-80 -72.82 -42.03 64.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.155 0.502 . . . . 0.0 109.821 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.716 ' CD ' HG12 ' A' ' 187' ' ' VAL . 1.1 pt-20 -82.16 -26.18 33.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.177 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.22 -24.91 66.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.927 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.723 ' CZ ' HG13 ' A' ' 128' ' ' VAL . 1.3 t80 -81.34 -25.58 36.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.68 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.04 -31.76 27.96 Favored Glycine 0 CA--C 1.509 -0.3 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.1 tp -80.83 -28.55 36.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -82.84 -24.77 52.04 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.2 -22.28 36.04 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.969 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -77.74 -22.77 49.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.255 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.13 -39.5 60.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.868 0.366 . . . . 0.0 111.092 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -81.09 -44.34 18.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.072 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 25' ' ' VAL . 6.1 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.709 0.29 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.467 ' HA ' ' HB2' ' A' ' 29' ' ' ARG . 53.6 Cg_exo -52.02 -24.55 19.83 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.593 2.195 . . . . 0.0 112.407 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.083 HD12 HD12 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.93 -57.23 12.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.328 -179.432 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.083 HD12 HD12 ' A' ' 27' ' ' LEU . 1.1 mp -72.49 -27.36 62.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.251 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.467 ' HB2' ' HA ' ' A' ' 26' ' ' PRO . 5.3 mmt85 -64.42 -53.28 50.85 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.138 0.494 . . . . 0.0 109.824 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -70.91 -25.01 62.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.409 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.6 -40.27 84.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.947 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.23 -25.2 13.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.573 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' NZ ' HG22 ' A' ' 37' ' ' VAL . 1.3 ptpt -70.36 -20.19 62.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.173 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.13 47.69 86.18 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.354 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -133.21 158.3 76.09 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.725 0.297 . . . . 0.0 110.74 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.7 91.63 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.566 2.177 . . . . 0.0 112.262 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.614 ' O ' HD12 ' A' ' 71' ' ' ILE . 21.9 t -92.96 114.92 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.353 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.4 p -77.44 -179.62 5.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.847 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -78.2 -32.55 50.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.631 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -68.34 -30.77 69.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.681 0.277 . . . . 0.0 110.642 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.31 -38.51 20.32 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.31 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.805 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.3 tp -63.16 -41.71 99.29 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.977 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -69.74 -42.96 73.26 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.774 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 40' ' ' THR . . . -67.47 -25.84 73.71 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.254 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.795 HG22 HD23 ' A' ' 46' ' ' LEU . 7.1 mt -76.54 -40.18 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.245 -0.478 . . . . 0.0 110.457 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.805 ' HG ' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -80.22 -6.5 57.93 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.568 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 62.95 30.15 16.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -116.99 149.64 44.52 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.624 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.16 143.72 99.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.626 2.218 . . . . 0.0 112.006 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.48 -16.45 2.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.95 -31.58 45.11 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.586 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.82 ' O ' HG23 ' A' ' 56' ' ' VAL . 13.5 mtp180 -70.18 -40.0 74.92 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.977 HG21 ' HB2' ' A' ' 43' ' ' ALA . 1.8 t -65.63 -46.36 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.36 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.38 -51.7 57.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.112 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.72 -43.24 80.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.7 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 52' ' ' ARG . 27.7 t -70.59 -32.45 49.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.577 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.562 HD22 ' OH ' ' A' ' 65' ' ' TYR . 15.9 mt -61.39 -32.52 72.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.499 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.606 ' O ' HG23 ' A' ' 61' ' ' THR . 3.0 tt0 -57.63 -24.35 56.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.701 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -96.18 -14.43 22.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.482 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -104.11 32.86 3.73 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.466 0.65 . . . . 0.0 110.598 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 58' ' ' GLU . 27.0 p -66.89 -14.39 62.7 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.233 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 t -86.78 -23.9 25.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 111.346 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.482 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -55.81 141.23 39.48 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.047 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.543 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -78.99 126.79 31.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.038 0.447 . . . . 0.0 111.474 -179.397 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.562 ' OH ' HD22 ' A' ' 57' ' ' LEU . 13.1 m-85 -100.64 168.81 9.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.267 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -153.87 143.61 21.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.549 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.7 tttp 66.9 -102.64 0.07 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.824 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.32 -13.04 28.64 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.74 31.86 0.79 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.051 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.67 169.03 11.65 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 37' ' ' VAL . 4.0 mp -79.8 114.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.27 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.782 ' O ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.112 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.3 p -107.66 159.05 16.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.35 -30.8 60.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -102.8 147.57 26.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -64.52 122.27 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.9 p -106.91 -174.72 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.2 p -92.65 -37.29 12.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 45.6 m-85 -87.24 113.97 23.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.08 142.73 20.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.984 ' CE2' HD13 ' A' ' 101' ' ' LEU . 59.8 t80 -124.72 105.19 9.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.346 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -98.62 126.23 44.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.323 . . . . 0.0 111.42 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.621 HD11 ' HB2' ' A' ' 90' ' ' ARG . 6.9 pt -118.76 177.89 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.396 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 87' ' ' ILE . 8.6 t0 -14.52 -53.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 87' ' ' ILE . 21.7 p30 -165.74 35.48 0.05 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.033 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.621 ' HB2' HD11 ' A' ' 87' ' ' ILE . 12.1 mmt180 -142.03 113.07 7.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.72 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.64 119.39 21.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.791 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.3 164.88 12.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.268 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -133.95 165.14 25.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.099 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.63 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -153.45 171.39 18.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.115 0.483 . . . . 0.0 111.855 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -94.37 -20.27 19.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.007 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.407 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 2.3 m -157.51 179.81 8.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.668 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB2' ' HD2' ' A' ' 164' ' ' PHE . . . -56.52 -21.89 29.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tp -89.18 -51.92 5.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.63 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 4.8 m-20 -46.95 -26.54 1.03 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -60.36 -36.26 77.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.666 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.984 HD13 ' CE2' ' A' ' 85' ' ' PHE . 3.3 tp -176.78 152.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.5 pt -122.82 -39.24 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.519 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.451 ' CZ ' ' ND2' ' A' ' 200' ' ' ASN . 9.2 m-85 -119.7 81.7 25.56 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.168 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.633 ' HA ' HD21 ' A' ' 101' ' ' LEU . 7.3 Cg_exo -72.58 -29.0 13.69 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.797 2.331 . . . . 0.0 112.215 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.09 -23.76 59.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.249 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -78.74 -29.91 45.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.906 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 104' ' ' PRO . 3.9 mm -54.16 -60.55 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.082 0.944 . . . . 0.0 110.988 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.29 25.21 Favored Glycine 0 C--N 1.316 -0.545 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.301 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.16 -177.27 5.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.357 . . . . 0.0 110.462 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.09 148.5 27.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.795 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.24 110.01 7.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -80.8 121.05 25.46 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.714 0.768 . . . . 0.0 110.86 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.822 HG22 ' CD1' ' A' ' 85' ' ' PHE . 90.5 t -113.8 131.78 64.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.934 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.6 p -119.42 138.25 53.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.712 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.535 ' OG ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -140.67 172.8 12.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.42 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -135.15 131.32 36.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.54 178.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.662 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.3 m -57.41 124.45 18.98 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.918 0.389 . . . . 0.0 111.902 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.12 -9.49 46.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.628 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.701 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.67 -51.2 2.05 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.557 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -76.24 -20.83 57.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.917 0.389 . . . . 0.0 110.767 -179.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.3 33.69 85.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.108 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.557 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -100.91 168.01 9.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.437 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.418 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 46.3 Cg_endo -93.89 110.27 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 123.024 2.483 . . . . 0.0 111.313 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.535 HG23 ' OG ' ' A' ' 115' ' ' SER . 35.3 m -109.51 148.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.492 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 86.0 p -147.62 142.43 26.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.509 0.671 . . . . 0.0 110.567 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -135.19 152.13 51.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.743 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.801 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 42.8 m -111.25 112.31 24.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 104' ' ' PRO . 32.6 t -96.93 114.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.008 0.432 . . . . 0.0 112.137 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.42 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -105.72 170.19 6.15 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.702 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.9 Cg_endo -66.64 -19.51 53.9 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.158 1.905 . . . . 0.0 113.001 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 6.9 t -108.87 -27.41 9.73 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 131' ' ' SER . 14.9 pt-20 178.05 -162.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.64 162.84 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.472 178.248 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -150.09 21.28 0.87 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.434 0.635 . . . . 0.0 112.326 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.801 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.95 87.4 0.09 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.44 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 t -104.1 119.88 53.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.156 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.18 122.9 5.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.796 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.506 ' CD ' HG12 ' A' ' 124' ' ' VAL . 61.9 Cg_endo -73.24 159.63 97.03 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.382 -1.507 . . . . 0.0 112.322 0.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.92 79.37 0.64 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.134 0.492 . . . . 0.0 110.658 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.26 18.02 0.17 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.282 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.593 ' CG ' HG11 ' A' ' 189' ' ' VAL . 9.8 ptm -60.98 157.82 14.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.019 0.438 . . . . 0.0 111.395 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.492 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -127.13 152.01 47.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.326 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.939 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -117.93 152.34 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.991 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.423 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 53.1 p -117.47 143.74 45.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.766 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 146' ' ' VAL . 0.2 OUTLIER -136.54 176.05 9.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.819 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.722 HG12 ' CD1' ' A' ' 184' ' ' LEU . 29.9 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 145' ' ' LEU . 75.8 t . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 121.047 0.451 . . . . 0.0 111.611 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -118.91 169.35 9.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.558 0.694 . . . . 0.0 109.773 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.939 ' CE1' HG22 ' A' ' 143' ' ' VAL . 0.4 OUTLIER -111.05 151.14 28.38 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.036 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 45.6 m-85 -135.83 134.6 39.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.251 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.662 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -38.93 -29.68 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.146 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 35.2 m -170.49 178.0 3.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.062 0.458 . . . . 0.0 111.575 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.61 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 90.5 t -69.57 -33.77 4.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.491 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.5 Cg_exo -72.64 -38.78 3.0 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.563 2.175 . . . . 0.0 110.41 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.556 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.23 -39.65 54.05 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.751 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.88 -46.81 87.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 2.3 mm-40 -78.99 -26.98 43.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.5 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 169' ' ' PRO . 4.8 t70 -70.89 -55.72 7.82 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.701 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 32.3 t-105 -65.03 -29.75 70.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.787 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.33 -39.6 95.0 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.242 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -44.43 62.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.338 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.16 23.87 6.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.172 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 174' ' ' TRP . 2.3 t-160 -136.41 33.38 2.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.037 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.675 179.893 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.722 ' CD1' HG12 ' A' ' 146' ' ' VAL . 7.9 tp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.771 0.32 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -140.28 148.89 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.022 0.439 . . . . 0.0 111.121 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.662 HD11 ' HB2' ' A' ' 175' ' ' ALA . 17.1 mm -100.71 160.53 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.987 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.473 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -162.79 150.66 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.144 0.497 . . . . 0.0 111.969 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -78.98 126.07 30.2 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.635 178.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.612 ' HA ' ' HB3' ' A' ' 192' ' ' ALA . 0.2 OUTLIER -46.54 -20.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.885 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -72.24 -45.1 61.63 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.0 OUTLIER -82.73 -22.41 34.44 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.141 178.175 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -67.83 -25.61 65.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.729 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 197' ' ' GLN . 0.2 OUTLIER -81.75 -24.94 35.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.627 179.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.08 -31.52 28.43 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -29.73 31.53 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -82.27 -28.46 40.38 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.409 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 37.5 tt0 -82.47 -22.57 35.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.866 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -81.09 -25.23 37.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.85 -29.76 20.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 0.0 111.291 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . 0.451 ' ND2' ' CZ ' ' A' ' 103' ' ' PHE . 6.6 m120 -80.43 -55.13 5.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 -179.879 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.76 HG11 HD23 ' A' ' 28' ' ' LEU . 21.5 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.707 0.289 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.796 ' CG ' HD11 ' A' ' 46' ' ' LEU . 43.0 Cg_endo -67.83 -27.12 37.74 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.525 2.15 . . . . 0.0 112.371 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.709 ' HG ' HD21 ' A' ' 42' ' ' LEU . 5.2 mp -52.66 -57.44 10.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.232 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.76 HD23 HG11 ' A' ' 25' ' ' VAL . 3.9 pp -80.07 -27.3 39.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.066 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.429 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 10.6 ttt85 -64.83 -53.29 49.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -65.78 -23.78 66.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.287 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.677 HD11 ' O ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -68.04 -37.59 81.53 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.773 179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.19 -26.41 17.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 111.03 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -20.97 66.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.226 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.63 48.3 82.63 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.153 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -133.06 157.26 78.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.724 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.3 91.02 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.516 2.144 . . . . 0.0 112.121 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.644 HG13 HG22 ' A' ' 41' ' ' THR . 21.5 t -93.01 113.5 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.38 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.8 p -87.0 -174.16 4.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.718 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -77.93 -36.23 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.321 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -28.72 69.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.907 0.384 . . . . 0.0 110.09 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.644 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.46 -41.82 16.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.345 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.709 HD21 ' HG ' ' A' ' 27' ' ' LEU . 2.2 tp -62.63 -36.5 83.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.92 -43.27 62.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.589 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -30.89 74.95 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.689 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.588 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.09 -42.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.067 0.461 . . . . 0.0 110.376 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.796 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.1 mp -76.44 -9.66 58.82 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.41 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.1 t0 60.34 21.64 11.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.43 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 5.3 m95 -107.48 158.1 34.07 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.171 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.02 144.09 62.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.607 2.205 . . . . 0.0 112.114 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.0 -16.92 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -78.64 -35.04 46.01 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.208 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.828 ' O ' HG23 ' A' ' 56' ' ' VAL . 3.6 ttt-85 -67.6 -41.1 84.59 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.645 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -63.03 -47.73 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.483 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.26 -53.11 55.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.206 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.77 -46.92 77.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.794 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 52' ' ' ARG . 30.9 t -67.65 -32.03 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.724 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -64.22 -33.26 75.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.657 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 61' ' ' THR . 6.0 tp10 -58.16 -22.06 49.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.88 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -90.85 -17.47 26.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.06 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HB1' ' HB ' ' A' ' 63' ' ' THR . . . -97.18 33.09 2.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.367 0.603 . . . . 0.0 111.121 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.694 HG23 ' O ' ' A' ' 58' ' ' GLU . 73.1 p -60.1 -20.63 59.15 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.912 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.56 -22.6 21.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.411 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB1' ' A' ' 60' ' ' ALA . 0.8 OUTLIER -58.46 141.06 52.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.523 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -78.85 126.9 31.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 0.0 111.604 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.433 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 62.5 m-85 -103.43 173.17 6.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.192 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.824 ' HB2' HG21 ' A' ' 72' ' ' ILE . 22.5 t70 -153.53 147.87 25.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.416 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.7 tttp 66.28 -102.01 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.782 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.23 -13.05 33.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.97 30.76 1.18 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.92 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -85.92 164.83 17.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.957 0.408 . . . . 0.0 110.189 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -79.96 109.61 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.336 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.824 HG21 ' HB2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.642 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.617 HD12 HD13 ' A' ' 92' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.764 0.316 . . . . 0.0 110.96 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.571 ' N ' HD23 ' A' ' 76' ' ' LEU . 67.5 p -99.75 159.08 15.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.812 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.73 -32.66 25.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -96.53 144.23 26.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.1 122.09 17.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.3 p -107.36 -177.05 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.451 ' CB ' ' CE1' ' A' ' 116' ' ' HIS . 53.1 m -93.08 -30.47 15.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.904 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.544 ' HE2' ' HB2' ' A' ' 97' ' ' ALA . 20.6 m-85 -86.68 117.35 25.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.362 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.458 HG22 ' HE1' ' A' ' 93' ' ' TYR . 21.2 t -110.01 142.31 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.488 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.83 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 46.2 t80 -125.58 105.21 8.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.717 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.14 121.01 34.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.173 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.608 HD11 HD23 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -139.03 122.93 19.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.617 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 58.3 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.327 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.0 t70 -159.38 35.83 0.2 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.432 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -139.79 113.88 8.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.641 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -77.78 86.32 4.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.979 0.418 . . . . 0.0 111.02 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.617 HD13 HD12 ' A' ' 76' ' ' LEU . 3.4 mm? -71.77 164.64 25.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.439 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.458 ' HE1' HG22 ' A' ' 84' ' ' VAL . 40.5 m-85 -137.46 162.2 34.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.821 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 100' ' ' THR . . . -145.03 164.09 32.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.119 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -81.31 -33.37 32.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.45 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 59.7 m -152.92 -177.8 6.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.056 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.874 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -61.84 148.86 41.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.706 0.289 . . . . 0.0 110.917 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.48 ' CB ' ' O ' ' A' ' 97' ' ' ALA . 1.7 tt 88.11 -51.48 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.666 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -54.58 -21.61 10.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.208 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 1.3 p -60.45 -39.51 87.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.381 . . . . 0.0 110.544 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.627 ' O ' HG23 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -110.34 -172.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.174 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.8 HD12 ' CE2' ' A' ' 103' ' ' PHE . 3.3 pt -161.76 -43.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.975 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 102' ' ' ILE . 2.2 p90 -163.0 93.64 1.16 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.762 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.672 ' HB3' HG12 ' A' ' 128' ' ' VAL . 74.1 Cg_endo -74.45 -35.07 4.0 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.7 2.266 . . . . 0.0 112.368 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.69 -23.99 53.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.8 tp -84.89 -42.41 15.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.338 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.3 tp -57.18 -46.95 84.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.295 0.569 . . . . 0.0 111.417 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.52 23.64 18.31 Favored Glycine 0 C--N 1.318 -0.423 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.699 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 173.46 15.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.893 0.378 . . . . 0.0 111.077 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -80.81 152.91 28.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.897 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.83 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.16 109.77 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -83.03 120.64 26.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.78 0.8 . . . . 0.0 111.158 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.75 HG22 ' HD1' ' A' ' 85' ' ' PHE . 60.3 t -112.44 129.44 67.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.963 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.7 m -119.72 137.93 53.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.029 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.695 ' HB2' HG23 ' A' ' 124' ' ' VAL . 3.1 m -141.25 172.8 12.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.478 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . 0.451 ' CE1' ' CB ' ' A' ' 82' ' ' SER . 17.6 p-80 -137.82 132.67 32.98 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 23.0 t -61.15 130.8 48.09 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.152 0.501 . . . . 0.0 112.16 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.91 -3.14 20.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.756 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.823 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.14 -50.46 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 0.0 111.601 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -90.14 -24.67 21.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.29 -179.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.09 81.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.108 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.689 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.29 158.68 13.48 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 120.581 0.229 . . . . 0.0 110.483 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -91.49 106.16 0.26 Allowed 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.757 2.305 . . . . 0.0 111.246 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.7 HG12 ' CD ' ' A' ' 138' ' ' PRO . 32.2 m -103.92 145.66 12.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.277 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.926 ' O ' HD13 ' A' ' 126' ' ' LEU . 64.3 p -151.47 141.47 22.09 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.386 0.612 . . . . 0.0 110.79 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.926 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -135.22 153.07 52.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.434 178.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.864 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 54.7 m -110.57 113.52 26.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.814 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.672 HG12 ' HB3' ' A' ' 104' ' ' PRO . 24.2 t -96.04 111.63 26.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.482 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.79 171.17 4.94 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.282 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.34 -14.93 46.32 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.503 2.135 . . . . 0.0 113.087 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.9 p -119.88 -27.23 5.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -179.97 -163.57 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.166 0.508 . . . . 0.0 110.17 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -95.88 158.94 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.97 178.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -147.34 18.75 1.21 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.404 0.621 . . . . 0.0 112.555 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.864 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.32 85.83 0.07 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.466 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.815 HG13 HD12 ' A' ' 126' ' ' LEU . 21.3 t -106.46 118.13 53.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.334 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -146.45 116.28 4.64 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.691 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.7 ' CD ' HG12 ' A' ' 124' ' ' VAL . 15.4 Cg_exo -68.55 145.25 76.15 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.726 -1.364 . . . . 0.0 112.32 0.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.25 -29.31 22.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.698 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.55 33.7 6.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.776 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.781 ' SD ' HD11 ' A' ' 126' ' ' LEU . 1.1 ptm -66.26 159.74 25.9 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.068 0.434 . . . . 0.0 111.13 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -131.58 152.74 50.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.063 0.459 . . . . 0.0 111.604 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.677 ' CG2' HG12 ' A' ' 189' ' ' VAL . 44.4 t -111.12 146.16 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.314 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.468 ' O ' ' HB ' ' A' ' 162' ' ' VAL . 47.4 m -114.8 141.26 48.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.689 0.281 . . . . 0.0 110.653 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.612 ' HA ' HG12 ' A' ' 162' ' ' VAL . 6.8 mt -103.18 149.07 25.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.081 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.011 179.812 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 145' ' ' LEU . 3.5 m . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.882 0.372 . . . . 0.0 111.872 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -116.03 166.81 11.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.525 0.679 . . . . 0.0 109.762 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.874 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.3 m-30 -117.84 129.67 55.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.768 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.509 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 19.4 m-85 -108.68 142.58 38.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.401 0.619 . . . . 0.0 110.608 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -46.08 -26.72 0.79 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.825 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.556 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 25.7 p -169.94 170.8 7.47 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.82 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 72.0 t -67.76 -33.41 5.23 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.32 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.2 Cg_exo -72.7 -37.89 3.6 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.724 2.283 . . . . 0.0 110.292 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.08 -40.39 53.23 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.97 -45.97 91.31 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.6 mt-10 -78.96 -27.63 43.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.244 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 169' ' ' PRO . 9.4 t70 -70.79 -55.94 7.44 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.59 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.823 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 77.2 t-105 -65.15 -27.84 69.0 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.685 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -62.4 -38.99 91.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.215 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.3 t -54.68 -47.78 73.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.442 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -95.48 21.6 7.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.258 0.551 . . . . 0.0 111.034 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -132.77 29.75 4.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.951 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.604 179.843 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.3 tp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.641 0.258 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -143.64 150.51 38.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.109 0.481 . . . . 0.0 111.539 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.5 mm -100.7 161.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.638 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.471 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -164.48 165.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.398 0.618 . . . . 0.0 112.11 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.5 OUTLIER -93.79 132.79 37.84 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.539 178.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.763 HG11 ' SD ' ' A' ' 141' ' ' MET . 3.6 m -48.27 -17.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.878 0.37 . . . . 0.0 110.927 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 0.6 OUTLIER -73.33 -44.51 58.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.134 0.492 . . . . 0.0 109.753 179.075 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.38 -21.61 35.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.53 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -76.49 -25.37 54.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.278 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.42 ' CE2' ' HG3' ' A' ' 197' ' ' GLN . 85.8 t80 -81.7 -25.89 35.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 110.722 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.79 -30.25 32.81 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -81.59 -27.74 34.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -27.33 34.29 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.42 ' HG3' ' CE2' ' A' ' 193' ' ' PHE . 1.5 mm100 -82.33 -23.21 35.22 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.495 -0.352 . . . . 0.0 111.023 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -79.28 -23.08 43.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.229 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -52.2 -32.01 34.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -81.14 -55.03 5.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -179.897 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 25' ' ' VAL . 10.8 p . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 120.444 0.164 . . . . 0.0 111.022 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.604 ' CG ' HD11 ' A' ' 46' ' ' LEU . 58.7 Cg_endo -71.51 -28.65 17.42 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.403 2.069 . . . . 0.0 112.359 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 27' ' ' LEU . 5.8 mp -52.27 -57.18 10.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.632 HD13 HD13 ' A' ' 31' ' ' LEU . 4.0 mm? -75.56 -27.14 58.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.921 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -53.45 57.38 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.629 ' OE2' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -71.12 -24.3 62.26 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.126 178.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.632 HD13 HD13 ' A' ' 28' ' ' LEU . 8.8 tt -66.2 -48.24 71.26 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.759 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.49 -26.09 19.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.61 -22.11 65.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.27 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 47.03 92.97 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.147 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -127.42 163.95 39.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.694 0.283 . . . . 0.0 110.86 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.34 111.61 2.1 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.553 2.169 . . . . 0.0 112.107 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.692 HG13 HG22 ' A' ' 41' ' ' THR . 22.6 t -116.35 111.04 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.398 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 p -91.39 179.62 5.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.688 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -69.22 -40.99 77.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.213 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -24.64 66.83 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.279 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.692 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.96 -44.16 12.59 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.73 HD12 HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -62.8 -36.29 82.67 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.95 -42.83 63.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.57 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.51 -31.56 73.98 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.652 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.604 HD12 HG23 ' A' ' 41' ' ' THR . 7.3 mt -78.32 -46.08 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 120.965 0.412 . . . . 0.0 110.528 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.604 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.7 mp -75.73 -9.61 58.73 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.614 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 59.91 21.78 10.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.456 ' CE3' HD23 ' A' ' 46' ' ' LEU . 16.4 m0 -103.68 160.06 27.32 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.175 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.93 138.79 41.42 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.595 2.197 . . . . 0.0 111.91 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.03 -20.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.55 -32.28 47.78 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.059 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.615 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.48 -40.98 85.27 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.578 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.69 -48.02 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.616 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.75 -52.05 61.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.488 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.22 -38.79 27.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 52' ' ' ARG . 39.1 t -58.38 -30.06 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.782 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 57' ' ' LEU . 7.2 mp -81.0 -23.62 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.873 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.9 -23.49 31.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.091 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -126.64 5.83 6.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.229 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -123.17 76.94 1.42 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.722 0.772 . . . . 0.0 110.441 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.9 p -99.3 -22.44 15.59 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.118 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 p -70.5 -26.08 63.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.192 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.46 141.38 42.7 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.5 ' O ' HG22 ' A' ' 72' ' ' ILE . 1.7 tt0 -78.85 126.77 31.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 111.354 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -104.03 171.7 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.491 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 70' ' ' ASN . 1.9 t0 -92.45 -172.85 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.376 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -37.71 86.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.58 9.52 29.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.718 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.76 18.76 62.93 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.065 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 66' ' ' ASP . 56.8 m-20 -92.03 167.34 12.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.076 0.438 . . . . 0.0 110.091 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.73 HD13 HD12 ' A' ' 42' ' ' LEU . 4.1 mp -79.82 119.18 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.329 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.7 tt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.028 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.591 HD13 ' CD2' ' A' ' 92' ' ' LEU . 4.6 mp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.701 0.286 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.476 HG21 ' HD1' ' A' ' 95' ' ' TRP . 12.3 p -126.06 159.33 33.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.501 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.504 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.9 OUTLIER -83.97 52.44 2.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 0.0 111.096 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.428 ' HA ' ' CD1' ' A' ' 93' ' ' TYR . 27.4 mtm-85 49.38 95.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.088 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.1 tp10 -169.15 -144.09 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.635 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.884 HG21 ' HA ' ' A' ' 95' ' ' TRP . 0.7 OUTLIER 41.19 -173.36 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 178.413 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 p -107.34 -19.65 13.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.364 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -76.87 111.25 12.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.688 0.28 . . . . 0.0 110.485 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.0 137.65 41.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 111.388 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.851 ' CD1' HG22 ' A' ' 113' ' ' VAL . 34.6 t80 -126.79 105.07 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.162 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -96.82 124.83 40.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.14 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.548 HG21 ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.15 128.72 26.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.998 0.428 . . . . 0.0 112.109 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 61.13 -77.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.318 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 87' ' ' ILE . 7.6 t70 -156.3 37.39 0.33 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.65 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -141.78 149.65 40.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.781 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 86.22 2.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.013 0.435 . . . . 0.0 110.673 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.591 ' CD2' HD13 ' A' ' 76' ' ' LEU . 8.5 mp -71.39 164.64 25.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.975 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 79' ' ' ARG . 88.9 m-85 -133.48 165.18 25.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.973 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -150.91 166.24 31.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.001 0.429 . . . . 0.0 111.962 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.884 ' HA ' HG21 ' A' ' 81' ' ' THR . 12.0 m0 -90.75 -23.17 20.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.403 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 65.2 m -153.81 174.83 14.05 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.941 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB1' ' CZ ' ' A' ' 164' ' ' PHE . . . -53.83 -21.49 7.65 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -51.78 6.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.622 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -49.36 -25.65 2.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.696 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -60.07 -28.97 68.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.952 0.406 . . . . 0.0 110.5 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 102' ' ' ILE . 5.1 tp 70.48 155.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.069 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.719 ' HB ' HG11 ' A' ' 128' ' ' VAL . 2.1 pt -158.84 77.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.789 ' O ' HG22 ' A' ' 107' ' ' ILE . 14.8 p90 -121.2 54.13 4.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.947 ' HG3' HG12 ' A' ' 128' ' ' VAL . 28.8 Cg_endo -62.7 -37.61 55.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.696 2.264 . . . . 0.0 112.235 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 130' ' ' PRO . . . -64.03 -30.33 71.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.581 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.89 -47.69 13.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -67.73 -41.09 84.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 111.285 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.82 28.47 8.29 Favored Glycine 0 C--N 1.319 -0.38 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.171 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.14 177.39 10.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.051 0.453 . . . . 0.0 110.895 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 m -87.28 160.28 18.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.993 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.663 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -136.55 109.84 7.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.869 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -82.96 119.43 24.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.818 0.818 . . . . 0.0 111.185 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.851 HG22 ' CD1' ' A' ' 85' ' ' PHE . 42.0 t -109.98 128.92 65.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.878 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.1 m -121.75 136.72 54.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.961 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.625 ' HB2' HG23 ' A' ' 124' ' ' VAL . 3.4 m -141.5 172.98 11.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -131.06 130.93 43.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 30.9 m -56.29 125.6 22.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.95 0.405 . . . . 0.0 112.041 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.21 -7.0 38.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.62 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -119.39 -50.56 2.33 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.35 -13.96 36.7 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.898 -179.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 63.8 11.24 42.46 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.674 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.547 ' H ' HG22 ' A' ' 120' ' ' THR . . . -71.83 164.38 58.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.697 0.284 . . . . 0.0 110.691 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.49 107.98 0.42 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 123.037 2.491 . . . . 0.0 111.328 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' A' ' 115' ' ' SER . 33.5 m -104.95 146.27 12.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.421 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.891 ' O ' HD13 ' A' ' 126' ' ' LEU . 60.6 p -151.45 141.69 22.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.384 0.611 . . . . 0.0 110.883 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -134.3 152.58 51.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.137 178.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.843 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 20.8 m -111.55 114.3 27.28 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.947 HG12 ' HG3' ' A' ' 104' ' ' PRO . 39.7 t -96.09 111.79 27.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.016 0.436 . . . . 0.0 111.243 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.491 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -105.68 172.9 3.59 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.215 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 41.2 Cg_endo -67.57 -19.82 47.95 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.271 1.981 . . . . 0.0 113.097 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 0.4 OUTLIER -112.57 -26.7 8.53 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.117 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 131' ' ' SER . 19.9 pt-20 178.62 -161.02 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.19 0.519 . . . . 0.0 110.108 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -91.79 160.5 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.565 178.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -150.18 17.87 0.85 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.843 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.07 85.12 0.07 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.102 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.407 HG13 HD12 ' A' ' 126' ' ' LEU . 32.9 t -99.6 122.86 51.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.637 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -146.06 118.8 5.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.95 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.413 ' HD2' HG12 ' A' ' 124' ' ' VAL . 60.0 Cg_endo -72.42 159.65 95.8 Favored 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 123.396 -1.502 . . . . 0.0 112.094 -0.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.26 78.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.103 0.478 . . . . 0.0 110.673 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.13 18.47 0.17 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.692 -0.765 . . . . 0.0 113.288 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.873 ' SD ' HD11 ' A' ' 126' ' ' LEU . 6.5 ptm -67.4 164.43 18.67 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.968 0.384 . . . . 0.0 111.303 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -125.0 152.16 44.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.172 0.511 . . . . 0.0 111.049 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.738 HG13 ' CD1' ' A' ' 164' ' ' PHE . 2.5 t -113.08 150.42 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 20.3 p -118.29 140.19 50.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.851 0.358 . . . . 0.0 110.835 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.404 HD21 HG21 ' A' ' 187' ' ' VAL . 0.8 OUTLIER -149.23 176.52 10.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.723 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 146' ' ' VAL . 11.8 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.901 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.46 HG12 ' HB3' ' A' ' 97' ' ' ALA . 12.4 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.881 0.372 . . . . 0.0 111.583 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -120.84 169.44 10.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.565 0.698 . . . . 0.0 109.777 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.738 ' CD1' HG13 ' A' ' 143' ' ' VAL . 49.8 m-85 -115.08 152.67 32.11 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.382 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 37.9 m-85 -134.09 137.84 44.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.181 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.626 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -43.85 -27.92 0.39 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.255 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.569 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 67.8 m -165.98 172.3 11.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.118 0.485 . . . . 0.0 111.577 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 76.2 t -69.38 -34.16 4.53 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.02 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.3 -37.41 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.645 2.23 . . . . 0.0 110.136 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.59 -40.02 50.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.085 -0.962 . . . . 0.0 108.415 177.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.724 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.29 -45.75 93.16 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.8 mt-10 -78.79 -27.47 44.48 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.291 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 169' ' ' PRO . 28.8 t70 -71.05 -55.92 7.23 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.517 0.675 . . . . 0.0 109.308 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.62 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 32.9 t-105 -64.59 -28.66 69.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.806 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -65.39 -38.55 90.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.349 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.2 t -52.07 -46.42 65.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.469 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -97.55 24.36 6.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.017 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -156.68 45.81 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.091 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.691 179.802 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 CA--C 1.528 0.127 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -131.34 141.19 49.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.101 0.477 . . . . 0.0 111.353 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 175' ' ' ALA . 18.3 mm -104.44 160.95 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.019 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -160.62 162.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.373 0.606 . . . . 0.0 111.775 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 190' ' ' HIS . 1.7 m -92.13 133.99 35.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.475 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.536 HG11 ' HG3' ' A' ' 141' ' ' MET . 1.7 m -45.87 -20.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.882 0.373 . . . . 0.0 110.654 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.425 ' N ' ' C ' ' A' ' 188' ' ' SER . 93.9 m-70 -70.77 -45.2 65.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.818 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.631 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.4 OUTLIER -82.42 -20.89 36.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.656 179.254 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -76.69 -25.36 53.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.228 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -81.41 -24.85 36.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.687 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.84 -29.26 35.44 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.631 HD13 ' O ' ' A' ' 191' ' ' GLU . 6.7 mp -82.33 -28.45 31.62 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.05 -28.33 31.43 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -80.84 -21.95 40.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.996 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -75.75 -22.94 56.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.103 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -52.09 -37.87 55.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.932 0.396 . . . . 0.0 111.168 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -69.64 -24.85 63.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.132 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.953 HG21 HD12 ' A' ' 28' ' ' LEU . 7.3 p . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 120.806 0.336 . . . . 0.0 111.583 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HB2' HD11 ' A' ' 46' ' ' LEU . 48.9 Cg_exo -55.78 -30.05 74.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.558 2.172 . . . . 0.0 112.54 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.706 HD12 ' HG ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -52.94 -57.5 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.068 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.953 HD12 HG21 ' A' ' 25' ' ' VAL . 82.3 mt -60.87 -27.05 67.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -60.04 -53.18 60.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 0.0 109.673 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -76.75 -25.09 53.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.39 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.28 -52.15 44.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.21 -23.68 15.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.254 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -70.84 -23.58 62.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.186 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.1 49.15 77.81 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.174 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -132.98 166.02 32.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.48 115.16 3.92 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.515 2.144 . . . . 0.0 111.927 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.685 HG23 ' CG2' ' A' ' 41' ' ' THR . 9.3 p -124.21 109.87 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.487 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.9 p -79.15 -176.19 5.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -78.04 -33.44 51.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.315 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -28.11 68.25 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.132 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.685 ' CG2' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.59 -41.42 16.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.228 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -63.35 -36.81 84.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.36 -42.94 61.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.409 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.88 -29.64 73.78 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.463 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -78.86 -42.21 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 121.2 0.524 . . . . 0.0 109.903 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 26' ' ' PRO . 6.5 mp -76.82 -9.82 58.94 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.445 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 t70 61.77 21.29 12.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.421 ' CD1' ' HD2' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -101.6 152.47 38.06 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.132 -179.535 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.72 139.02 35.98 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.503 2.135 . . . . 0.0 112.027 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.62 -19.22 0.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.25 -31.2 49.06 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.237 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.62 -40.36 84.69 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.518 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -61.73 -48.07 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.735 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.16 -52.61 58.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.461 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.47 -43.51 68.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.923 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 52' ' ' ARG . 27.6 t -75.12 -29.3 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.856 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.643 HD21 ' OH ' ' A' ' 65' ' ' TYR . 6.5 tp -68.78 -38.86 80.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.816 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.75 -45.11 86.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.616 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -74.22 -8.23 55.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.111 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.04 70.98 0.73 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.766 0.793 . . . . 0.0 110.531 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.9 p -76.51 -6.36 51.51 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.424 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.51 37.9 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 0.0 110.852 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.8 141.2 28.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.181 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -78.88 126.63 30.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 111.28 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.643 ' OH ' HD21 ' A' ' 57' ' ' LEU . 27.0 m-85 -124.4 154.01 41.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.343 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.625 ' HB2' HG21 ' A' ' 72' ' ' ILE . 26.8 t70 -153.14 146.11 24.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.233 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 tttm 66.04 -101.68 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.672 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -89.96 -14.4 34.15 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.11 29.23 1.68 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.989 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -87.41 172.65 9.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.1 mt -79.59 105.84 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.845 0.355 . . . . 0.0 110.999 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.625 HG21 ' HB2' ' A' ' 66' ' ' ASP . 2.7 tt . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.555 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.112 0 CA-C-O 121.061 0.457 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.583 HG23 ' HB2' ' A' ' 93' ' ' TYR . 1.4 t -144.08 159.39 42.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.566 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 78' ' ' LEU . 5.1 mp -83.12 52.76 2.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 111.053 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HG2' ' CZ ' ' A' ' 93' ' ' TYR . 7.3 tmm_? 57.84 113.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -177.71 -28.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.497 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.433 HG21 ' HA ' ' A' ' 95' ' ' TRP . 4.8 p -89.41 -178.23 5.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.945 0.402 . . . . 0.0 111.332 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.75 -26.98 14.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.345 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 81.7 m-85 -76.56 110.79 11.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.628 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.4 HG22 ' CE1' ' A' ' 93' ' ' TYR . 25.0 t -108.26 139.12 31.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.169 0.509 . . . . 0.0 111.573 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.781 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 14.5 t80 -136.38 108.19 7.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.847 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -103.7 137.12 42.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.806 0.336 . . . . 0.0 111.552 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.542 HG23 ' CE1' ' A' ' 85' ' ' PHE . 2.2 pt -140.03 123.35 17.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.572 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 t0 63.65 -66.68 0.1 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.189 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.5 t70 -168.0 35.2 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.401 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -134.07 113.48 12.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.927 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.21 86.2 5.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 111.0 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -76.0 164.92 25.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.016 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.583 ' HB2' HG23 ' A' ' 77' ' ' THR . 61.0 m-85 -136.2 165.45 25.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.263 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.615 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -150.73 169.98 20.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.922 0.391 . . . . 0.0 111.879 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.433 ' HA ' HG21 ' A' ' 81' ' ' THR . 15.0 m0 -92.93 -23.5 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.931 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.427 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 50.9 m -147.44 167.08 25.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.283 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.998 ' HB1' ' CZ ' ' A' ' 164' ' ' PHE . . . -51.97 -22.44 3.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.011 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.457 ' HA ' HD21 ' A' ' 101' ' ' LEU . 2.4 tp -86.26 -51.55 6.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.615 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 2.7 m-20 -48.14 -25.94 1.68 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.26 -39.1 85.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.515 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -99.18 166.56 11.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 101' ' ' LEU . 12.7 pt -158.03 -43.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.838 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.5 m-85 -162.58 64.46 1.55 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 103' ' ' PHE . 37.8 Cg_exo -60.22 -43.04 37.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.747 2.298 . . . . 0.0 112.416 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.19 -23.76 43.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.376 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -84.09 -38.74 20.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.509 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.838 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.4 tp -57.16 -45.7 84.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.146 0.498 . . . . 0.0 111.309 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.56 25.31 10.09 Favored Glycine 0 C--N 1.319 -0.372 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.508 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.65 174.15 14.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 110.939 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.0 m -81.08 158.14 25.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.756 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -136.77 109.67 7.63 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -81.61 119.78 24.23 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.765 0.793 . . . . 0.0 111.015 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.409 HG22 ' HD2' ' A' ' 85' ' ' PHE . 57.6 t -112.17 129.86 66.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.084 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.4 m -124.21 137.35 54.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.045 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.594 ' HB2' HG23 ' A' ' 124' ' ' VAL . 1.4 m -141.6 173.09 11.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.377 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -134.09 133.24 40.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.6 t -62.44 133.37 54.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.216 0.532 . . . . 0.0 112.213 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.98 -3.81 24.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.891 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.918 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.68 -50.94 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.786 0.327 . . . . 0.0 111.662 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.45 -24.13 21.94 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.306 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.76 5.15 73.44 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.144 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.705 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.07 149.41 56.46 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-O 120.544 0.212 . . . . 0.0 110.631 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 1.0 OUTLIER -82.31 103.85 1.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.667 2.244 . . . . 0.0 110.807 179.324 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 115' ' ' SER . 35.8 m -99.14 144.72 11.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.311 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.419 ' O ' ' HE1' ' A' ' 141' ' ' MET . 81.5 p -151.87 141.72 21.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.431 0.634 . . . . 0.0 110.836 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -138.82 151.39 46.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.875 178.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.802 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.2 m -105.94 115.21 29.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.639 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.915 HG13 ' CE2' ' A' ' 193' ' ' PHE . 38.8 t -96.11 111.73 26.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.853 0.359 . . . . 0.0 111.505 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.422 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -107.22 169.5 6.67 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.938 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.4 Cg_endo -66.23 -19.25 56.52 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.198 1.932 . . . . 0.0 112.816 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 19.6 p -112.66 -26.97 8.37 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 131' ' ' SER . 0.4 OUTLIER 178.39 -162.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.133 0.492 . . . . 0.0 110.043 -179.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -93.68 158.46 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.922 178.578 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -144.66 19.49 1.67 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.448 0.642 . . . . 0.0 112.154 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.802 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.83 86.81 0.08 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.238 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.544 HG13 ' SD ' ' A' ' 141' ' ' MET . 36.3 t -103.25 113.64 40.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.334 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -146.5 122.72 5.67 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.48 155.83 95.05 Favored 'Cis proline' 0 C--N 1.348 0.517 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.26 0.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.39 79.46 0.38 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.178 0.514 . . . . 0.0 110.497 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.01 17.61 0.18 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.597 -0.728 . . . . 0.0 113.243 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.912 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.2 OUTLIER -58.61 158.47 7.76 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.964 0.412 . . . . 0.0 111.441 -179.393 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -128.49 152.32 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.052 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.715 HG22 ' CD1' ' A' ' 164' ' ' PHE . 46.1 t -111.74 147.72 15.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.543 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 32.0 m -120.77 144.91 48.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.804 0.335 . . . . 0.0 110.946 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.886 HD11 ' HB3' ' A' ' 185' ' ' ALA . 1.2 pp -138.04 175.03 9.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.828 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 146' ' ' VAL . 24.3 m . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.749 HG12 ' HB3' ' A' ' 97' ' ' ALA . 22.0 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.885 0.374 . . . . 0.0 111.495 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 163' ' ' HIS . 2.2 m-70 -118.93 159.14 24.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.535 0.683 . . . . 0.0 109.919 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.998 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 15.9 m-30 -111.12 130.6 55.57 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.526 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . 0.614 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 39.4 m-85 -108.48 140.69 41.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.397 0.618 . . . . 0.0 110.545 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.33 -27.64 0.7 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.76 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.581 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 68.2 m -164.95 171.48 13.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.225 0.536 . . . . 0.0 111.746 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 73.0 t -69.23 -32.84 3.52 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.298 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.22 -37.76 3.16 Favored 'Trans proline' 0 CA--C 1.504 -0.983 0 C-N-CA 122.739 2.292 . . . . 0.0 110.389 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.71 -40.17 49.6 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.146 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.9 -45.49 93.49 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.2 mt-10 -78.96 -27.37 43.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.288 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 169' ' ' PRO . 13.8 t70 -70.75 -55.78 7.86 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.457 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' TRP . . . . . 0.918 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 39.2 t-105 -64.64 -28.58 69.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.616 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.85 -41.58 97.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.311 178.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.56 -42.23 55.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.228 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.6 22.75 7.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.294 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' HIS . . . . . 0.799 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -142.66 31.73 1.46 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.889 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.289 179.882 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.799 HD13 ' O ' ' A' ' 178' ' ' HIS . 1.4 tt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.811 0.339 . . . . 0.0 110.762 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.886 ' HB3' HD11 ' A' ' 145' ' ' LEU . . . -142.4 150.08 40.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.221 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.671 HD11 ' HB2' ' A' ' 175' ' ' ALA . 17.2 mm -103.14 161.71 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.961 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.484 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -158.56 162.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.099 0.476 . . . . 0.0 111.833 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.412 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -90.15 128.09 36.26 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.896 178.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.912 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.2 m -46.78 -20.14 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.915 0.388 . . . . 0.0 110.758 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' HIS . . . . . 0.412 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.0 m170 -71.5 -41.68 68.97 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.126 0.488 . . . . 0.0 109.709 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.474 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.7 OUTLIER -82.12 -25.66 34.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.412 179.097 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.83 -24.86 62.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.043 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' PHE . . . . . 0.915 ' CE2' HG13 ' A' ' 128' ' ' VAL . 5.0 t80 -81.15 -24.98 37.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.8 -29.82 33.98 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 191' ' ' GLU . 9.6 mp -82.4 -28.27 31.52 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -28.36 31.4 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.402 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 9.1 tt0 -80.55 -22.99 40.29 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.897 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -73.46 -22.89 60.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.102 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.03 -36.95 51.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.959 0.409 . . . . 0.0 111.246 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -73.07 -24.81 60.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.108 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 . . . . . 0 C--N 1.331 -0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.794 0.33 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -139.59 173.69 11.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.2 mt -151.74 111.44 4.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.949 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -98.43 35.69 1.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t 59.81 64.25 2.91 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.71 -21.99 50.4 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.519 2.146 . . . . 0.0 112.292 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.688 ' CD2' HD21 ' A' ' 42' ' ' LEU . 2.6 mt -52.0 -57.3 9.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.244 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.55 -27.09 62.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.004 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -61.0 -53.27 59.28 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.653 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.9 -25.07 62.61 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.298 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.819 HD11 ' CA ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -67.0 -47.65 70.82 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.824 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.39 -25.85 17.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.115 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -67.74 -22.26 65.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.212 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.6 47.99 88.44 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.12 -0.562 . . . . 0.0 113.039 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.14 153.1 81.07 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.768 0.318 . . . . 0.0 110.928 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.01 109.08 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.596 2.197 . . . . 0.0 111.987 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.686 HG23 HG22 ' A' ' 41' ' ' THR . 11.0 p -115.56 110.17 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.334 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 57.5 p -85.14 177.6 7.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.677 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.09 -37.17 72.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.192 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -26.46 67.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.814 0.34 . . . . 0.0 110.136 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.686 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.4 -42.65 14.34 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.688 HD21 ' CD2' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -63.11 -36.38 83.42 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.2 -43.0 62.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.492 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.01 -30.61 74.18 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.734 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.586 HD12 HG23 ' A' ' 41' ' ' THR . 6.7 mt -79.16 -41.58 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-O 121.055 0.455 . . . . 0.0 110.297 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.443 HD12 HG22 ' A' ' 45' ' ' ILE . 6.5 mp -77.17 -9.66 58.91 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.336 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.5 t70 59.88 21.95 10.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.408 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 6.5 m95 -109.95 158.31 35.36 Favored Pre-proline 0 N--CA 1.451 -0.378 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.162 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.68 142.75 71.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.533 2.155 . . . . 0.0 112.02 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.64 -16.82 1.04 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -78.95 -34.34 44.51 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.062 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -67.47 -41.58 84.39 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.647 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.0 t -63.36 -46.99 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.482 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.91 -51.35 61.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.383 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.96 -37.65 20.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.719 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 52' ' ' ARG . 23.2 t -63.6 -53.01 50.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.793 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.598 HD12 ' N ' ' A' ' 58' ' ' GLU . 3.9 pp -73.52 -16.92 61.26 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.968 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.598 ' N ' HD12 ' A' ' 57' ' ' LEU . 59.2 tt0 -58.12 -19.58 33.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.049 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -119.85 12.57 12.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.825 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -123.06 76.5 1.38 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.771 0.796 . . . . 0.0 110.48 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.9 p -87.43 -26.95 23.02 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.762 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.25 -21.29 63.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.76 141.2 53.6 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.431 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.61 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -84.68 126.96 33.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.117 0.484 . . . . 0.0 111.642 -179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.408 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 14.8 m-85 -100.36 173.14 6.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.163 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -153.11 143.3 22.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.032 0.444 . . . . 0.0 111.504 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 tptp 66.06 -104.06 0.09 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.82 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -92.73 -13.05 29.86 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.715 0.293 . . . . 0.0 111.782 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 128.64 31.98 0.63 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.14 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -87.14 170.56 11.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.82 0.343 . . . . 0.0 110.166 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.67 HD13 HD12 ' A' ' 42' ' ' LEU . 3.7 mp -79.7 109.43 14.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.159 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.866 ' O ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -68.3 -33.66 61.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.107 0.479 . . . . 0.0 111.002 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.819 ' CA ' HD11 ' A' ' 31' ' ' LEU . . . 100.83 -130.47 10.24 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.718 -0.673 . . . . 0.0 112.63 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 102' ' ' ILE . 1.1 m-85 -103.44 -170.61 1.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.847 0.356 . . . . 0.0 110.954 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.01 -29.72 0.15 Allowed Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.51 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 76' ' ' LEU . 3.1 mm? 65.16 -85.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 111.032 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -129.43 159.62 35.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.6 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.8 mt -77.91 51.13 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.89 0.376 . . . . 0.0 111.266 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 4.7 ttt-85 44.47 85.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.635 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.07 23.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.469 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.1 p -119.17 -171.07 2.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.114 0.483 . . . . 0.0 111.599 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 p -104.08 -29.14 11.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.301 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.405 ' CE1' ' O ' ' A' ' 95' ' ' TRP . 10.8 m-85 -79.27 111.83 15.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.628 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.57 140.57 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.059 0.457 . . . . 0.0 111.098 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.826 ' CD1' HG22 ' A' ' 113' ' ' VAL . 43.8 t80 -129.95 106.38 8.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.588 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -100.17 130.54 46.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.607 -0.269 . . . . 0.0 110.921 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.503 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -140.03 124.62 19.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 60.16 -70.37 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.283 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -166.94 34.39 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.251 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -137.71 111.94 8.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.906 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.413 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.4 OUTLIER -78.42 121.56 24.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.837 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 92' ' ' LEU . 3.8 mm? -114.43 164.8 13.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.969 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 79' ' ' ARG . 24.8 m-85 -130.78 165.09 23.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.112 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.632 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -151.79 170.17 20.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.106 0.479 . . . . 0.0 111.848 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.405 ' O ' ' CE1' ' A' ' 83' ' ' TYR . 5.3 m95 -98.81 -18.67 17.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.684 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 28.1 m -147.61 162.55 38.89 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.924 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.609 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -52.03 -22.62 4.2 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 tp -85.79 -51.53 6.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.656 0.265 . . . . 0.0 111.305 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.617 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -45.16 -28.09 0.7 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.963 0.356 . . . . 0.0 111.963 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.632 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -60.41 -39.1 86.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 110.549 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.44 ' HB3' ' CE1' ' A' ' 85' ' ' PHE . 1.3 pt? -121.87 174.9 6.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.059 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 74' ' ' TYR . 19.2 mt -151.31 -46.41 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.044 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -156.92 79.02 3.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.742 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.517 ' HA ' HG12 ' A' ' 107' ' ' ILE . 20.3 Cg_endo -60.78 -40.13 56.89 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.703 2.269 . . . . 0.0 112.41 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.24 -25.94 67.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.547 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 14.3 tp -79.9 -26.47 40.21 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.766 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 104' ' ' PRO . 4.5 mm -64.5 -58.88 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.673 0 CA-C-O 122.117 0.961 . . . . 0.0 111.013 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.54 22.14 13.22 Favored Glycine 0 C--N 1.316 -0.557 0 CA-C-N 113.564 -1.653 . . . . 0.0 111.637 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -151.07 -177.03 5.79 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.925 0.393 . . . . 0.0 110.344 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.54 154.11 20.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.227 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.779 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -136.85 110.06 7.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.639 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -80.38 119.91 23.71 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.767 0.794 . . . . 0.0 111.277 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.826 HG22 ' CD1' ' A' ' 85' ' ' PHE . 47.2 t -112.05 129.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.947 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 27.7 m -122.87 137.56 54.9 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.114 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.546 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.6 OUTLIER -141.4 172.82 12.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.317 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -134.54 133.88 40.79 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.407 ' HB3' ' H ' ' A' ' 121' ' ' GLY . 30.5 t -62.29 130.38 45.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.047 0.451 . . . . 0.0 112.037 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.95 -3.59 23.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.974 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.885 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.54 -49.85 2.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.886 0.374 . . . . 0.0 111.545 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.686 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -91.77 -24.62 19.36 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.281 -179.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 117' ' ' CYS . . . 76.28 5.55 81.78 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.195 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.686 ' H ' HG22 ' A' ' 120' ' ' THR . . . -57.93 148.92 57.51 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-O 120.528 0.204 . . . . 0.0 110.636 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 1.0 OUTLIER -82.31 104.1 1.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.686 2.258 . . . . 0.0 110.806 179.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 115' ' ' SER . 30.5 m -100.16 144.91 11.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.4 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.0 p -151.64 141.49 21.97 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.415 0.626 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -138.55 151.92 47.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.83 178.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.857 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 53.8 m -106.52 113.49 27.03 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.235 -0.438 . . . . 0.0 109.871 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.69 HG13 ' CE2' ' A' ' 193' ' ' PHE . 47.9 t -96.31 111.79 27.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.902 0.382 . . . . 0.0 111.474 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.25 168.53 8.05 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.08 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -65.75 -14.55 45.2 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.49 2.126 . . . . 0.0 113.015 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.9 m -118.84 -26.91 5.93 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 179.6 -163.29 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.16 0.505 . . . . 0.0 110.017 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.723 HG22 ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -96.61 160.47 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.879 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -148.21 20.75 1.09 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.468 0.651 . . . . 0.0 112.194 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.857 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.94 86.69 0.08 Allowed 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.408 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.577 HG13 ' SD ' ' A' ' 141' ' ' MET . 39.2 t -103.54 115.4 45.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.193 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -146.27 122.28 5.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.74 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.87 157.0 99.14 Favored 'Cis proline' 0 C--N 1.347 0.449 0 C-N-CA 123.523 -1.449 . . . . 0.0 112.283 0.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.42 79.15 0.26 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.167 0.508 . . . . 0.0 110.553 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.58 16.61 0.15 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.407 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.868 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -60.13 156.49 15.01 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 121.065 0.459 . . . . 0.0 111.313 -179.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -125.43 151.87 45.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.734 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.739 HG13 ' CE1' ' A' ' 164' ' ' PHE . 18.4 t -113.0 152.22 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.793 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' A' ' 165' ' ' PHE . 1.6 p -120.72 140.98 50.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.938 0.399 . . . . 0.0 110.945 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.664 HD12 HG22 ' A' ' 162' ' ' VAL . 5.7 tp -135.84 175.13 9.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.871 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 147' ' ' LEU . 22.1 t -125.06 158.88 32.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.083 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.67 HD12 ' HA3' ' A' ' 183' ' ' GLY . 37.1 mt -89.23 149.45 42.95 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.964 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.86 129.32 17.28 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.637 2.225 . . . . 0.0 112.256 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -114.01 147.28 38.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.826 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -135.96 35.47 2.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.834 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.31 39.12 0.73 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.126 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -123.08 162.48 22.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.093 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 36.7 p30 -59.37 -176.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 1.1 m -107.18 125.13 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.235 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.29 -50.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.681 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -163.4 -46.86 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.816 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.3 m 57.24 45.21 20.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.001 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 61.42 66.59 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.825 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.75 -26.38 45.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.071 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 51.2 m -143.5 -75.32 0.26 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.869 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.442 ' HB3' HG21 ' A' ' 146' ' ' VAL . 4.8 t-160 55.67 38.18 29.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.736 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.664 HG22 HD12 ' A' ' 145' ' ' LEU . 22.4 t -100.5 110.88 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.499 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -117.1 169.05 9.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.602 0.715 . . . . 0.0 109.801 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.739 ' CE1' HG13 ' A' ' 143' ' ' VAL . 2.5 m-85 -119.38 152.9 36.03 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.127 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.619 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 49.1 m-85 -129.35 133.67 47.52 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.845 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -41.48 -27.51 0.09 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 10.8 p -168.84 174.36 6.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.015 0.436 . . . . 0.0 111.511 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.6 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 85.6 t -68.6 -33.53 4.6 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.673 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.683 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.6 Cg_exo -72.51 -38.17 3.61 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.718 2.279 . . . . 0.0 110.371 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.57 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.54 -39.47 52.75 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.44 -46.02 90.42 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.7 mt-10 -78.78 -28.12 44.61 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.323 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.683 ' N ' ' O ' ' A' ' 169' ' ' PRO . 12.3 t70 -71.33 -55.81 7.26 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.384 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.885 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 58.3 t-105 -64.04 -28.48 69.82 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.24 -0.891 . . . . 0.0 108.739 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -62.99 -42.22 99.79 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.166 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 71.1 m -51.37 -41.74 60.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.399 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 21.04 9.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.421 0.629 . . . . 0.0 111.298 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.544 ' CE1' HD11 ' A' ' 181' ' ' LEU . 2.8 t60 -128.4 28.74 5.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.864 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -91.45 171.07 9.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.709 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 97.12 -27.52 18.04 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.424 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.544 HD11 ' CE1' ' A' ' 178' ' ' HIS . 14.3 mt -63.76 -176.18 0.17 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.765 0.317 . . . . 0.0 110.86 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.74 66.01 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.777 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.67 ' HA3' HD12 ' A' ' 147' ' ' LEU . . . 91.16 -86.28 1.31 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.431 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.529 HD22 HD12 ' A' ' 181' ' ' LEU . 6.0 tp 62.65 122.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.817 0.341 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.29 150.08 42.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.037 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.571 ' CG2' ' HB1' ' A' ' 171' ' ' ALA . 10.6 mm -100.14 159.04 3.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.035 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.444 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -162.02 162.56 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.289 0.566 . . . . 0.0 112.076 179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.415 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -88.53 129.52 35.45 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.669 178.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.868 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.2 m -46.44 -20.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.832 0.349 . . . . 0.0 110.717 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.415 ' N ' ' C ' ' A' ' 188' ' ' SER . 1.8 t-160 -73.82 -42.07 61.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.784 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -82.25 -21.2 36.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.25 179.007 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.4 -24.93 63.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.813 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.69 ' CE2' HG13 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -81.11 -24.91 37.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.72 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.81 -31.26 29.91 Favored Glycine 0 CA--C 1.509 -0.317 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.7 tp -82.13 -29.25 31.74 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -83.12 -27.43 40.59 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -82.28 -21.93 35.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.938 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -81.03 -26.21 36.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -52.68 -30.52 32.39 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.115 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -51.67 -54.46 27.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.117 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -58.46 -31.81 68.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 10.0 m170 -72.47 -40.43 66.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.888 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 mt -79.54 -30.24 41.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.012 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 204' ' ' LEU . 1.4 tt -56.82 -30.83 64.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.072 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 -66.02 121.34 14.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.446 HG23 ' N ' ' A' ' 207' ' ' MET . 9.9 t -59.73 -46.6 88.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . 0.446 ' N ' HG23 ' A' ' 206' ' ' THR . 0.2 OUTLIER -160.54 156.83 26.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.915 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.57 165.23 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.79 87.24 1.41 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 2.3 mmt85 -93.04 116.83 29.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.436 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -176.47 -62.91 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.029 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.0 Cg_endo . . . . . 0 C--O 1.25 1.121 0 C-N-CA 122.34 2.027 . . . . 0.0 112.353 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.87 0.367 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -174.74 149.89 1.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.517 HD22 HD11 ' A' ' 106' ' ' LEU . 13.7 mt -59.92 -29.88 68.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' C ' HG22 ' A' ' 25' ' ' VAL . 0.5 OUTLIER 62.19 -166.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 ' C ' ' A' ' 24' ' ' LEU . 25.7 m 42.51 53.88 8.92 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.695 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.2 -16.97 45.08 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.695 2.263 . . . . 0.0 112.456 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.589 HD23 HG21 ' A' ' 71' ' ' ILE . 2.0 tm? -54.25 -57.44 11.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.949 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.497 ' N ' HD13 ' A' ' 27' ' ' LEU . 9.2 tp -63.7 -27.05 68.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.982 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -68.43 -53.33 24.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.719 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.889 ' HB3' HG21 ' A' ' 37' ' ' VAL . 2.7 mm-40 -72.61 -29.72 63.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.318 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.549 HD12 ' HA3' ' A' ' 73' ' ' GLY . 9.2 tt -67.25 -45.71 75.9 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.56 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.08 -23.06 18.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.82 -22.75 62.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.005 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.3 39.72 98.09 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.898 -0.592 . . . . 0.0 113.26 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -133.38 166.09 31.89 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.595 0.236 . . . . 0.0 110.673 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.64 112.65 2.92 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.517 2.145 . . . . 0.0 112.201 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.889 HG21 ' HB3' ' A' ' 30' ' ' GLU . 33.4 t -112.22 109.92 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.331 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.5 p -90.46 -168.4 2.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.835 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -78.07 -38.44 44.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.513 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -25.31 68.06 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.45 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.722 ' CG2' HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.1 -43.56 12.97 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.422 HD13 HD13 ' A' ' 71' ' ' ILE . 1.5 tp -63.01 -35.46 80.31 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.664 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -74.24 -42.94 58.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.496 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.13 -30.96 74.11 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.579 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.603 HD12 HG23 ' A' ' 41' ' ' THR . 7.3 mt -78.7 -44.44 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 120.995 0.426 . . . . 0.0 110.584 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.577 HD12 HG22 ' A' ' 45' ' ' ILE . 7.3 mp -76.81 -9.8 58.93 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.421 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.6 t70 58.21 22.88 9.65 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -97.81 139.62 21.43 Favored Pre-proline 0 N--CA 1.45 -0.436 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.461 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.508 ' O ' HG23 ' A' ' 53' ' ' VAL . 44.4 Cg_exo -56.07 137.37 79.1 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.445 2.097 . . . . 0.0 111.797 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.85 -22.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -78.33 -36.12 46.73 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.103 0.477 . . . . 0.0 110.951 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.2 mtt-85 -67.07 -40.41 87.02 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -63.01 -47.98 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.487 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.04 -53.69 46.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.117 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.39 -48.28 77.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.836 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 52' ' ' ARG . 41.1 t -64.31 -31.95 55.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.664 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 tp -61.14 -31.4 71.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.581 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 61' ' ' THR . 5.5 tt0 -58.17 -21.83 48.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.814 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -96.13 -19.57 19.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.002 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.558 ' HB1' ' HG1' ' A' ' 63' ' ' THR . . . -99.75 32.07 3.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.466 0.651 . . . . 0.0 110.88 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 58' ' ' GLU . 25.2 p -69.43 -13.04 62.14 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.173 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 89.7 p -90.91 -23.11 20.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.789 0.328 . . . . 0.0 111.266 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.558 ' HG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -56.49 141.23 43.45 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.107 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -78.77 126.96 31.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.397 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.417 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 66.8 m-85 -102.14 173.25 6.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.505 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD2' HD13 ' A' ' 72' ' ' ILE . 14.0 t0 -152.77 147.09 25.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.948 0.404 . . . . 0.0 111.441 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.41 -104.01 0.09 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.745 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.65 -11.1 46.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.726 0.298 . . . . 0.0 111.726 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.04 27.69 1.82 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.076 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -86.64 168.47 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.589 HG21 HD23 ' A' ' 27' ' ' LEU . 2.5 mp -79.64 120.41 30.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.379 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.524 HD13 ' OD2' ' A' ' 66' ' ' ASP . 2.3 tt -108.2 -28.0 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.549 ' HA3' HD12 ' A' ' 31' ' ' LEU . . . 85.17 -156.05 30.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.617 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.22 90.83 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.347 . . . . 0.0 110.959 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.95 -44.63 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.412 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.556 HD21 HD11 ' A' ' 92' ' ' LEU . 3.3 mm? -80.75 150.51 29.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.854 0.359 . . . . 0.0 110.748 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.519 HG21 HG23 ' A' ' 81' ' ' THR . 1.4 t -100.32 152.6 20.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.88 -45.95 76.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -103.47 147.72 26.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.946 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.424 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 3.1 tt0 -59.43 132.21 53.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.519 HG23 HG21 ' A' ' 77' ' ' THR . 35.2 p -110.09 -173.6 2.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 90.6 p -93.62 -35.74 12.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.928 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.424 ' HB2' ' HB3' ' A' ' 94' ' ' ALA . 4.9 m-85 -79.15 109.72 13.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.385 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.55 137.51 34.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.139 0.495 . . . . 0.0 111.377 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.758 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 21.7 t80 -132.58 105.77 7.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.103 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -102.52 135.26 44.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.387 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.48 HG23 ' CE1' ' A' ' 85' ' ' PHE . 2.8 pt -140.14 126.54 22.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t0 61.89 -72.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 87' ' ' ILE . 13.4 t0 -158.05 37.7 0.25 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -140.34 148.74 41.8 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.611 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.88 86.19 2.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.094 0.473 . . . . 0.0 110.571 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.556 HD11 HD21 ' A' ' 76' ' ' LEU . 0.8 OUTLIER -71.6 164.69 25.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.091 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.424 ' CZ ' ' HG3' ' A' ' 80' ' ' GLU . 9.7 m-85 -134.31 165.16 25.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.113 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.625 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -151.16 167.24 28.38 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.152 0.501 . . . . 0.0 111.849 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -101.09 -10.54 20.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.751 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 11.9 m -153.31 160.0 42.63 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.854 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.842 ' HB1' ' CE2' ' A' ' 164' ' ' PHE . . . -51.81 -22.46 3.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.455 ' O ' HD13 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -85.93 -51.34 6.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.674 0.273 . . . . 0.0 111.172 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.625 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 1.9 m-20 -44.38 -27.66 0.46 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.531 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -60.28 -39.2 86.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.892 0.377 . . . . 0.0 110.544 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.857 HD21 HG21 ' A' ' 128' ' ' VAL . 5.3 mt -93.45 -176.1 4.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.032 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 103' ' ' PHE . 7.5 tp -174.67 -40.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.84 ' O ' HG22 ' A' ' 107' ' ' ILE . 0.9 OUTLIER -172.02 65.48 0.39 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.797 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.417 ' HG3' HD22 ' A' ' 101' ' ' LEU . 33.6 Cg_exo -59.85 -42.04 48.94 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.73 2.287 . . . . 0.0 112.351 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.07 -23.91 43.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.332 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.517 HD11 HD22 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.11 -38.33 19.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.481 -179.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -57.19 -45.82 84.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.203 0.525 . . . . 0.0 111.394 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.61 23.37 16.19 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.568 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.41 173.61 13.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.036 0.446 . . . . 0.0 110.954 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.8 m -81.61 156.51 25.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.901 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.758 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -136.76 109.96 7.8 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.847 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.2 mtt-85 -81.28 120.07 24.44 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.717 0.77 . . . . 0.0 111.232 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.3 t -111.07 127.29 68.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.626 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.3 m -122.36 137.6 54.8 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.317 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.595 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.0 OUTLIER -141.5 172.85 12.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.265 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -134.32 133.23 40.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 22.6 t -62.77 131.84 50.23 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.248 0.547 . . . . 0.0 112.222 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.17 -3.59 20.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.988 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.866 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -123.27 -51.07 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.631 -179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -87.68 -24.57 23.85 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.208 -179.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.44 5.45 72.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.114 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.715 ' H ' HG22 ' A' ' 120' ' ' THR . . . -59.94 152.27 60.78 Favored Pre-proline 0 N--CA 1.452 -0.372 0 CA-C-O 120.591 0.234 . . . . 0.0 110.515 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -84.71 105.03 0.97 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.683 2.255 . . . . 0.0 110.947 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.595 HG22 ' C ' ' A' ' 115' ' ' SER . 35.3 m -99.36 144.46 11.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.364 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.427 ' O ' ' HE1' ' A' ' 141' ' ' MET . 82.4 p -151.64 141.68 22.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.424 0.631 . . . . 0.0 110.936 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -138.64 152.09 47.79 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.724 178.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.815 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 20.1 m -106.73 115.23 29.83 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.857 HG21 HD21 ' A' ' 101' ' ' LEU . 42.4 t -96.18 111.81 27.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.843 0.354 . . . . 0.0 111.211 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.97 175.79 1.9 Allowed Pre-proline 0 N--CA 1.454 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.32 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.77 -15.5 33.33 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.629 2.219 . . . . 0.0 112.978 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.414 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 18.0 t -118.96 -25.7 6.19 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 131' ' ' SER . 10.7 pt-20 178.56 -162.02 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.158 0.504 . . . . 0.0 110.036 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -93.44 156.49 3.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.11 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.94 178.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.72 18.59 2.0 Allowed 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.469 0.652 . . . . 0.0 112.279 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.815 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.57 86.45 0.09 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.421 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.536 HG13 ' SD ' ' A' ' 141' ' ' MET . 39.7 t -102.29 115.82 44.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.063 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -146.3 122.25 5.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.748 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.11 160.17 94.37 Favored 'Cis proline' 0 C--N 1.348 0.531 0 C-N-CA 123.495 -1.461 . . . . 0.0 112.362 -0.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.64 78.83 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.673 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.0 16.92 0.16 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.33 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.921 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -58.67 155.03 13.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.984 0.421 . . . . 0.0 111.619 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -124.88 151.9 44.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.977 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.799 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -112.93 149.32 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.666 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 162' ' ' VAL . 9.8 m -120.54 141.39 50.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.544 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.415 ' CD2' HG22 ' A' ' 187' ' ' VAL . 0.7 OUTLIER -146.79 176.64 9.72 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.031 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.75 131.19 72.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.811 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.44 ' CD1' ' HB2' ' A' ' 185' ' ' ALA . 1.5 mp -70.46 -63.29 1.74 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.114 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 73.2 Cg_endo -75.75 -168.23 0.52 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.434 2.09 . . . . 0.0 112.379 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -174.27 115.7 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -149.19 30.87 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -174.91 36.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.036 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.37 74.73 1.48 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.087 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -156.74 31.7 0.31 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.9 m -73.76 -30.24 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 16.1 mtp85 -160.32 -74.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.83 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -140.81 39.4 1.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.998 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 m -99.32 111.41 23.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.952 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -90.08 -68.38 0.79 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 18.1 m -81.09 -45.99 15.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.792 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 5.4 t 80.03 -50.79 0.37 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.31 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -109.06 48.05 0.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.944 0.402 . . . . 0.0 111.112 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 144' ' ' SER . 3.2 p -106.34 110.46 31.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.451 . . . . 0.0 110.948 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -128.4 169.33 14.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.454 0.645 . . . . 0.0 110.379 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.842 ' CE2' ' HB1' ' A' ' 97' ' ' ALA . 14.0 m-85 -107.54 129.66 54.95 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.425 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.568 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 43.7 m-85 -108.78 139.73 43.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.347 0.594 . . . . 0.0 110.589 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -47.65 -26.64 1.58 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.081 -0.963 . . . . 0.0 112.797 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.591 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 49.0 m -164.43 168.99 17.87 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.836 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 82.1 t -68.47 -34.13 5.35 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.019 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.1 Cg_exo -72.5 -37.22 4.37 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.629 2.22 . . . . 0.0 110.27 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.44 -40.39 50.75 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.731 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.81 -46.43 89.54 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 3.0 mm-40 -78.98 -27.87 43.47 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.462 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.5 t70 -69.7 -55.85 8.84 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.165 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.866 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 71.5 t-105 -65.73 -28.3 68.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.795 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.96 -39.95 95.31 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.054 178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.96 -43.66 63.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.249 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.51 22.43 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.289 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.697 ' CE1' HD11 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -145.79 29.89 1.1 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.911 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -108.41 -16.92 14.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.167 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -55.32 -21.25 25.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.481 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.697 HD11 ' CE1' ' A' ' 178' ' ' HIS . 4.1 mt -57.07 -176.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.831 0.348 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -101.29 36.73 1.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.976 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.41 ' HA3' ' CG ' ' A' ' 148' ' ' PRO . . . 149.33 117.62 0.89 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.614 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.417 HD13 ' O ' ' A' ' 178' ' ' HIS . 0.8 OUTLIER -178.7 127.22 0.11 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.379 . . . . 0.0 110.992 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 147' ' ' LEU . . . -141.57 149.09 40.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.815 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 175' ' ' ALA . 16.3 mm -102.13 160.48 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.08 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.481 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.05 164.17 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.257 0.551 . . . . 0.0 112.067 179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.413 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -89.61 127.99 35.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.744 178.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.921 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.0 m -46.63 -20.5 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.824 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.413 ' N ' ' C ' ' A' ' 188' ' ' SER . 2.4 m-70 -72.76 -42.88 63.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.211 0.529 . . . . 0.0 109.746 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.28 -21.92 35.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.153 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.11 61.88 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.832 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.825 ' CE2' HG13 ' A' ' 128' ' ' VAL . 3.3 t80 -81.06 -24.95 37.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.688 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.89 -29.91 33.42 Favored Glycine 0 CA--C 1.51 -0.277 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -28.49 32.32 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.81 -27.97 33.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -82.22 -22.02 36.11 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.99 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -76.06 -23.1 55.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.213 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -51.92 -37.17 51.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.878 0.37 . . . . 0.0 111.143 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -81.08 -28.31 35.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.832 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -58.13 -28.35 64.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.033 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -57.88 -48.52 79.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.976 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.36 -39.4 87.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.75 -43.87 85.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.866 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 59.79 -176.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.919 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 p -71.37 80.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.95 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 2.8 ttm -172.14 126.64 0.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.17 -68.37 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 16.4 t -158.15 130.39 7.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.996 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.37 35.64 3.37 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.986 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.796 HG22 ' HD3' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -70.96 -34.63 3.62 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.795 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.796 ' HD3' HG22 ' A' ' 211' ' ' THR . 63.5 Cg_exo . . . . . 0 C--O 1.249 1.073 0 C-N-CA 121.972 1.781 . . . . 0.0 112.498 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.755 0.312 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.523 ' C ' HD12 ' A' ' 23' ' ' LEU . 6.1 t0 61.89 152.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.523 HD12 ' C ' ' A' ' 22' ' ' ASP . 4.8 mp -148.97 160.86 42.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.7 mt -146.49 -75.99 0.2 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.58 77.61 2.43 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.078 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.664 ' CG ' HD11 ' A' ' 46' ' ' LEU . 57.7 Cg_endo -71.48 -24.77 22.03 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.518 2.145 . . . . 0.0 112.502 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.5 mt -54.89 -57.55 11.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.374 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.22 -27.36 38.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.267 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -53.23 15.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.966 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -66.92 -26.12 66.7 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.49 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.596 HD11 ' CG2' ' A' ' 71' ' ' ILE . 9.5 mt -73.68 -30.3 62.81 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.746 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.34 -28.77 30.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.199 0.524 . . . . 0.0 110.909 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -64.23 -19.46 65.38 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.208 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.0 48.49 83.05 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.038 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.42 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -129.78 164.92 36.94 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 120.658 0.266 . . . . 0.0 110.71 179.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.52 111.41 1.86 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.482 2.121 . . . . 0.0 112.2 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 41' ' ' THR . 24.5 t -120.32 109.98 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.358 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.3 p -91.51 -172.72 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.699 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -74.61 -37.85 62.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.192 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -28.25 68.72 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.973 0.416 . . . . 0.0 110.246 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.724 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.5 -42.36 15.62 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.768 HD13 HD13 ' A' ' 71' ' ' ILE . 0.6 OUTLIER -62.53 -36.74 83.54 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.647 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.62 -42.95 63.91 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.589 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -31.98 77.09 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.613 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.616 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -78.66 -43.36 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 120.936 0.398 . . . . 0.0 110.478 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.664 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.5 mp -78.52 -7.41 57.47 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.485 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 54.91 23.64 5.17 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.413 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 18.0 m0 -101.02 152.03 37.77 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.285 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 53' ' ' VAL . 35.5 Cg_endo -65.18 137.05 50.33 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.433 2.089 . . . . 0.0 111.92 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.22 -21.29 0.76 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.15 -36.69 47.4 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.591 -0.443 . . . . 0.0 110.959 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.875 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.71 -40.52 88.46 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.726 ' O ' HD23 ' A' ' 57' ' ' LEU . 2.1 t -62.84 -47.97 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.423 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.7 -53.7 43.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.239 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.82 73.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.849 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 52' ' ' ARG . 36.7 t -64.36 -34.63 70.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.744 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 53' ' ' VAL . 3.8 mm? -61.88 -32.63 73.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.607 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.634 ' O ' HG23 ' A' ' 61' ' ' THR . 5.7 tt0 -57.9 -22.49 48.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.903 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -94.26 -19.85 20.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.997 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.77 32.22 2.4 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 121.435 0.636 . . . . 0.0 111.041 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 58' ' ' GLU . 38.8 p -62.16 -19.13 62.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.888 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 m -90.09 -21.99 22.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.37 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.61 141.23 55.42 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.384 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.512 ' O ' HG22 ' A' ' 72' ' ' ILE . 4.0 tt0 -78.86 131.06 36.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.081 0.467 . . . . 0.0 111.634 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.452 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.7 m-85 -105.26 173.18 6.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.278 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.54 146.68 26.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 111.43 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.5 -103.48 0.08 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.77 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -89.88 -11.02 43.11 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.452 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.63 29.37 1.43 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.975 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -87.55 172.14 9.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.835 0.35 . . . . 0.0 110.143 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.768 HD13 HD13 ' A' ' 42' ' ' LEU . 2.9 mp -79.58 118.42 27.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.272 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.865 ' O ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -97.96 -33.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.004 0.431 . . . . 0.0 110.958 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.88 -179.19 19.12 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.512 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -147.86 -173.87 4.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.867 0.365 . . . . 0.0 110.891 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.557 ' C ' HD12 ' A' ' 76' ' ' LEU . . . 99.74 27.85 7.74 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.567 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.557 HD12 ' C ' ' A' ' 75' ' ' GLY . 5.6 mp -145.43 151.33 38.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.747 0.308 . . . . 0.0 110.921 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.452 HG21 ' CD1' ' A' ' 95' ' ' TRP . 30.6 p -104.25 159.08 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.811 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.7 mt -91.73 49.21 1.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -178.29 137.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.832 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -65.08 121.32 14.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.801 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.7 p -109.24 -174.89 2.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.083 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 m -93.0 -34.35 13.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.974 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.416 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 7.7 m-85 -83.76 112.41 20.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.316 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.469 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.5 t -107.84 144.15 17.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.0 110.985 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.919 ' CD1' HG22 ' A' ' 113' ' ' VAL . 38.4 t80 -133.93 105.36 6.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.144 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -97.47 131.9 43.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.052 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.464 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.05 124.29 18.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.66 -71.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.934 -0.575 . . . . 0.0 112.537 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -161.22 35.44 0.14 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.601 -179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -137.62 142.28 41.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.295 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.94 86.28 2.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.99 0.424 . . . . 0.0 110.74 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 85' ' ' PHE . 0.3 OUTLIER -71.62 164.7 25.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.781 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -134.91 164.18 28.18 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.161 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.615 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -151.02 167.03 28.91 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.014 0.435 . . . . 0.0 111.881 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.452 ' CD1' HG21 ' A' ' 77' ' ' THR . 8.4 m0 -95.09 -18.92 20.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.62 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.449 ' HB3' HG13 ' A' ' 162' ' ' VAL . 1.7 m -150.11 166.61 29.26 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.154 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.594 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -53.76 -21.81 8.08 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.845 HD13 HG11 ' A' ' 162' ' ' VAL . 10.8 mp -84.67 -51.59 6.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.561 0.22 . . . . 0.0 111.536 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.599 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -47.96 -28.16 2.58 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -60.69 -39.32 88.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.002 0.429 . . . . 0.0 110.58 179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.042 HD21 HG11 ' A' ' 128' ' ' VAL . 1.5 mt -86.35 168.5 13.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.225 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 101' ' ' LEU . 6.8 pt -160.66 -43.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.031 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.808 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.0 OUTLIER 178.16 78.34 0.14 Allowed Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.802 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.453 ' CB ' HG12 ' A' ' 128' ' ' VAL . 52.2 Cg_endo -69.12 -38.8 8.65 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.623 2.216 . . . . 0.0 112.474 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.77 -23.94 45.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.242 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -83.94 -40.9 17.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.259 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.808 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.2 tp -57.37 -46.48 85.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.239 0.542 . . . . 0.0 111.473 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.9 24.75 12.49 Favored Glycine 0 C--N 1.319 -0.392 0 CA-C-N 115.481 -0.782 . . . . 0.0 112.565 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.43 173.79 14.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.976 0.417 . . . . 0.0 110.965 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -81.39 155.67 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.845 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.1 110.0 7.64 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.3 mtm180 -81.23 119.87 24.17 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.816 0.817 . . . . 0.0 111.242 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.919 HG22 ' CD1' ' A' ' 85' ' ' PHE . 48.9 t -111.88 129.89 66.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.162 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.469 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 75.9 p -123.98 137.74 54.56 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.249 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.578 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.53 172.89 12.06 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.343 179.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -134.41 133.3 40.37 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.23 134.65 55.17 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.251 0.548 . . . . 0.0 112.337 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.68 -3.55 22.42 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.284 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.882 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -123.26 -51.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.958 0.409 . . . . 0.0 111.476 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.44 HG23 HG21 ' A' ' 170' ' ' THR . 1.4 p -84.99 -29.44 25.03 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.002 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.02 4.97 79.27 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.402 -0.904 . . . . 0.0 111.219 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . . . -59.11 150.77 60.48 Favored Pre-proline 0 N--CA 1.451 -0.4 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 1.1 Cg_endo -82.54 104.11 1.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.561 2.174 . . . . 0.0 111.093 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.578 HG22 ' C ' ' A' ' 115' ' ' SER . 35.9 m -97.71 144.28 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.985 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.0 p -150.6 142.35 23.72 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.439 0.637 . . . . 0.0 110.856 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.56 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -139.61 151.64 46.17 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.815 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.843 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 52.4 m -107.88 113.91 27.46 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 1.042 HG11 HD21 ' A' ' 101' ' ' LEU . 46.2 t -96.0 111.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.087 0.47 . . . . 0.0 111.403 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.502 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -106.79 177.83 1.24 Allowed Pre-proline 0 N--CA 1.453 -0.315 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.638 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 56.6 Cg_endo -72.55 -20.1 23.91 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 121.961 1.774 . . . . 0.0 112.87 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 26.8 t -109.96 -28.06 8.92 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 131' ' ' SER . 11.8 pt-20 177.63 -162.73 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.11 0.481 . . . . 0.0 110.08 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.69 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -95.72 143.96 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.8 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -129.41 21.82 5.61 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.399 0.619 . . . . 0.0 112.295 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.843 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.66 87.65 0.1 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.225 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.577 HG13 ' SD ' ' A' ' 141' ' ' MET . 41.6 t -104.55 115.59 46.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.332 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -146.37 124.24 6.16 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.652 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.79 157.08 95.24 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.207 0.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.85 79.04 0.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.123 0.487 . . . . 0.0 110.611 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 143.15 19.22 0.23 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.184 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.745 ' HG3' HG21 ' A' ' 189' ' ' VAL . 0.3 OUTLIER -57.73 156.78 8.13 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 120.939 0.4 . . . . 0.0 111.577 -179.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -129.5 152.21 49.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.123 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.669 HG13 ' CD1' ' A' ' 164' ' ' PHE . 21.1 t -115.35 151.03 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.9 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.825 ' O ' HG23 ' A' ' 162' ' ' VAL . 51.6 p -116.81 141.43 48.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.712 0.292 . . . . 0.0 110.405 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 184' ' ' LEU . 1.6 mp -138.16 176.09 9.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.695 HG22 ' HB3' ' A' ' 159' ' ' CYS . 27.0 m -124.99 120.16 57.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.965 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.421 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . 6.5 mp -57.23 -61.9 6.26 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.012 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 68.9 Cg_endo -74.69 -168.18 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.465 2.11 . . . . 0.0 112.267 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.53 115.24 2.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -141.27 146.35 36.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 60.14 31.23 20.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -104.59 77.96 1.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.033 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -131.69 82.41 2.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.501 HG12 ' OG ' ' A' ' 157' ' ' SER . 10.7 p -127.82 -44.97 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.035 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.481 ' N ' HG13 ' A' ' 154' ' ' VAL . 0.0 OUTLIER -173.91 -53.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -165.65 34.15 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.501 ' OG ' HG12 ' A' ' 154' ' ' VAL . 2.3 p -71.76 123.69 23.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -83.54 -73.55 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.695 ' HB3' HG22 ' A' ' 146' ' ' VAL . 59.1 m -77.42 -46.0 24.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.893 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 4.5 t 76.48 0.11 3.14 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.589 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -158.86 63.05 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.956 0.408 . . . . 0.0 110.944 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.845 HG11 HD13 ' A' ' 98' ' ' LEU . 8.9 p -114.74 120.88 65.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -125.65 169.26 12.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.48 0.657 . . . . 0.0 109.973 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.669 ' CD1' HG13 ' A' ' 143' ' ' VAL . 2.7 m-85 -113.01 129.72 56.4 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.728 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.613 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 42.9 m-85 -108.6 140.76 41.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.46 0.647 . . . . 0.0 110.722 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.28 -26.17 1.87 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.978 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.538 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 10.8 t -163.99 169.55 17.84 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.086 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 84.6 t -68.78 -35.11 6.04 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.403 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.5 Cg_exo -72.19 -37.28 4.75 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.83 2.354 . . . . 0.0 110.192 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.571 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -75.95 -41.22 52.22 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.538 178.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.759 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.76 -45.57 93.35 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.0 mt-10 -78.78 -27.96 44.64 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.21 178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.708 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.3 t70 -70.82 -55.97 7.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.604 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.882 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 64.2 t-105 -64.83 -28.83 69.83 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.759 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -61.22 -40.98 96.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.196 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -46.13 65.44 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.246 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -98.02 25.6 5.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.068 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.772 ' NE2' HD11 ' A' ' 181' ' ' LEU . 1.9 t-160 -153.03 33.62 0.48 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.0 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -99.75 -16.04 18.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.144 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -57.13 -19.93 33.27 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.567 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.772 HD11 ' NE2' ' A' ' 178' ' ' HIS . 16.0 mt -66.69 71.45 0.08 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.831 0.348 . . . . 0.0 111.202 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 54.34 28.31 9.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.143 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 102.92 -67.23 0.34 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.518 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.583 HD12 ' O ' ' A' ' 145' ' ' LEU . 6.7 tp 62.82 147.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.831 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.55 149.0 40.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.999 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.609 HD11 ' HB2' ' A' ' 175' ' ' ALA . 19.2 mm -102.9 161.73 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.503 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -157.57 156.69 4.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 112.051 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.8 OUTLIER -82.64 122.11 27.7 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.142 178.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.745 HG21 ' HG3' ' A' ' 141' ' ' MET . 0.9 OUTLIER -41.29 -29.41 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.549 178.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -64.47 -46.13 84.36 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -82.2 -20.8 37.05 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.841 178.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.669 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -72.91 -25.82 61.19 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.852 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -81.65 -24.91 36.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.557 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.75 -28.3 39.02 Favored Glycine 0 CA--C 1.509 -0.326 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 21.1 tp -82.06 -28.38 32.46 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.06 -28.85 29.93 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.405 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -76.19 -21.96 55.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.964 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -81.01 -22.86 39.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.15 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -51.85 -37.4 51.86 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.15 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.98 -55.19 38.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.948 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -27.08 68.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.01 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -55.07 -35.62 64.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.138 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.55 -50.18 10.36 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.839 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.3 tp -59.86 -50.81 72.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -139.26 -174.62 3.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.37 166.83 19.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.957 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -65.29 79.84 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.31 96.0 6.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.0 m -74.77 172.78 11.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.924 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -131.58 -178.97 5.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.831 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.435 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -176.33 -63.0 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.973 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.6 Cg_endo . . . . . 0 C--O 1.248 1.005 0 C-N-CA 122.391 2.06 . . . . 0.0 112.342 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.842 0.353 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -140.75 78.68 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.1 tt -177.02 -40.07 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 mt -76.37 -179.36 5.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.515 HG21 HD12 ' A' ' 28' ' ' LEU . 6.2 m -100.21 96.46 5.08 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.075 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.577 ' CG ' HD11 ' A' ' 46' ' ' LEU . 39.6 Cg_endo -67.06 -29.18 40.53 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.411 2.074 . . . . 0.0 112.312 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.53 -57.36 12.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.041 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.515 HD12 HG21 ' A' ' 25' ' ' VAL . 12.0 mt -57.3 -27.05 61.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.397 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -65.72 -53.24 43.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.087 0.47 . . . . 0.0 109.887 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -77.12 -28.31 54.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.533 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.6 HD21 ' HD2' ' A' ' 74' ' ' TYR . 1.7 tm? -70.77 -52.13 22.66 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.84 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.98 -25.67 22.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.043 0.449 . . . . 0.0 110.981 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.9 mttp -68.71 -21.8 64.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.224 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.27 46.81 93.59 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.026 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -130.0 158.6 73.47 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 0.0 110.815 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.96 110.76 1.39 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.499 2.132 . . . . 0.0 112.065 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.654 HG23 ' CG2' ' A' ' 41' ' ' THR . 11.6 p -118.98 111.0 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.36 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 p -75.85 -178.7 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.967 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.416 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -77.94 -35.86 49.9 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.253 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -24.88 66.68 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.195 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.654 ' CG2' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.13 -42.84 13.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 46' ' ' LEU . 10.3 tp -63.63 -36.25 83.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 176.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.564 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -74.17 -42.48 59.83 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.492 177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.8 -29.02 72.65 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.546 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 41' ' ' THR . 7.1 mt -79.06 -41.45 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 CA-C-O 121.17 0.51 . . . . 0.0 110.074 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 26' ' ' PRO . 6.9 mp -77.15 -9.92 59.07 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.354 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 t70 61.46 21.35 11.96 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -110.08 158.32 35.42 Favored Pre-proline 0 N--CA 1.451 -0.379 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.23 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.63 143.27 56.03 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.611 2.208 . . . . 0.0 111.917 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.3 -16.82 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -32.0 41.52 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 120.967 0.413 . . . . 0.0 111.146 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -68.98 -41.66 77.61 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.643 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.0 t -63.95 -46.44 94.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.56 178.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.71 -50.07 69.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.575 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.13 -35.78 27.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.137 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 52' ' ' ARG . 28.5 t -68.75 -31.05 49.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.081 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.643 HD12 ' O ' ' A' ' 53' ' ' VAL . 4.9 mp -81.08 -17.21 50.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.319 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -58.52 -19.24 35.8 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.256 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.66 17.91 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.705 0.288 . . . . 0.0 111.173 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.448 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . . . -113.12 71.11 0.73 Allowed 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.803 0.811 . . . . 0.0 110.635 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 14.1 p -63.88 -15.27 58.59 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.415 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.1 t -95.19 34.68 1.37 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.734 0.302 . . . . 0.0 110.94 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.5 HG21 HD23 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -95.91 110.93 23.04 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.419 ' HB3' ' CA ' ' A' ' 73' ' ' GLY . 2.2 tt0 -82.3 126.51 32.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.1 0.476 . . . . 0.0 111.997 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 69' ' ' GLY . 5.8 m-85 -110.83 160.3 16.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.14 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.13 143.9 25.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.968 0.413 . . . . 0.0 111.498 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.1 -100.44 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.854 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -93.82 -10.46 34.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.411 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 125.07 33.18 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.939 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -93.99 154.24 17.76 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.533 HD12 ' O ' ' A' ' 37' ' ' VAL . 4.3 mt -79.79 125.19 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.979 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -168.43 -36.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.706 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.419 ' CA ' ' HB3' ' A' ' 64' ' ' GLU . . . -60.93 137.99 48.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.264 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.6 ' HD2' HD21 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -175.99 -164.76 0.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 0.0 110.888 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.42 24.27 1.79 Allowed Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.764 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.771 HD13 ' O ' ' A' ' 93' ' ' TYR . 0.2 OUTLIER 61.7 -82.93 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.844 0.354 . . . . 0.0 111.202 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.465 HG21 HG23 ' A' ' 81' ' ' THR . 12.9 t -102.38 159.09 15.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.938 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.503 HD23 ' C ' ' A' ' 78' ' ' LEU . 9.9 tt -82.21 -40.9 21.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 77' ' ' THR . 4.1 mtt180 -96.8 153.63 17.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 110.979 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -66.25 126.66 29.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.465 HG23 HG21 ' A' ' 77' ' ' THR . 35.5 p -110.59 -172.47 2.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.109 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.27 -32.87 13.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.38 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.405 ' OH ' ' CD2' ' A' ' 163' ' ' HIS . 62.0 m-85 -79.34 110.75 14.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.751 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.829 HG22 ' CE1' ' A' ' 93' ' ' TYR . 25.1 t -104.73 135.0 44.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.964 0.412 . . . . 0.0 111.045 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.936 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 55.1 t80 -127.55 106.6 9.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.579 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -101.5 132.59 47.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.329 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.5 pt -140.03 123.1 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 0.0 111.825 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.6 t70 60.97 -69.94 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.381 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.48 ' N ' ' O ' ' A' ' 87' ' ' ILE . 1.8 t70 -166.24 35.33 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.348 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -136.45 111.96 9.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.013 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -77.91 120.63 23.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.639 HD12 ' CD2' ' A' ' 85' ' ' PHE . 23.2 mt -117.15 165.08 13.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.086 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.829 ' CE1' HG22 ' A' ' 84' ' ' VAL . 6.0 m-85 -133.44 165.16 25.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.362 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.679 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -150.85 173.01 14.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.118 0.485 . . . . 0.0 111.95 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -108.29 -5.67 16.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.832 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 1.6 p -160.09 163.08 34.14 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.13 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.625 ' HB1' ' CZ ' ' A' ' 164' ' ' PHE . . . -51.7 -23.1 4.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.0 tp -88.76 -51.59 5.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.715 0.293 . . . . 0.0 111.349 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.679 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 1.9 m-20 -39.7 -28.81 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -59.72 -35.42 74.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.64 0.257 . . . . 0.0 110.812 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.936 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 14.8 tp -156.93 160.22 38.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.871 0.367 . . . . 0.0 111.553 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 mt -113.52 -31.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.07 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 200' ' ' ASN . 4.1 m-85 -161.81 99.27 1.2 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.964 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.543 ' CB ' HG12 ' A' ' 128' ' ' VAL . 59.7 Cg_endo -71.77 -26.35 19.32 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.578 2.185 . . . . 0.0 112.335 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.36 -23.5 43.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.338 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.9 tp -81.7 -40.5 22.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.573 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.7 tp -54.39 -48.34 68.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 121.171 0.51 . . . . 0.0 111.595 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.22 20.71 22.32 Favored Glycine 0 C--N 1.319 -0.41 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.799 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 173.04 14.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.949 0.404 . . . . 0.0 111.023 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -78.28 152.79 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.644 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.819 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -137.15 109.88 7.56 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.5 mtt180 -83.71 120.57 26.17 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.79 0.805 . . . . 0.0 111.056 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.451 HG22 ' HD1' ' A' ' 85' ' ' PHE . 93.6 t -111.82 130.59 65.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.272 -1.331 . . . . 0.0 112.014 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.4 m -122.45 136.24 54.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.101 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.548 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.4 OUTLIER -141.99 173.17 11.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.684 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 71.6 m80 -134.56 136.64 43.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 165' ' ' PHE . 28.5 t -64.76 134.44 54.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.179 0.514 . . . . 0.0 112.175 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.32 -5.76 34.82 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.819 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.895 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -126.89 -50.91 1.45 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.471 ' CG2' ' HB2' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -74.41 -33.6 63.05 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.217 0.532 . . . . 0.0 110.026 -179.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 73.17 34.92 57.67 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.373 -0.918 . . . . 0.0 110.818 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.471 ' HB2' ' CG2' ' A' ' 120' ' ' THR . . . -100.34 160.32 27.34 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.178 -0.511 . . . . 0.0 109.994 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -87.78 108.02 0.62 Allowed 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.731 2.287 . . . . 0.0 111.257 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.548 HG22 ' C ' ' A' ' 115' ' ' SER . 35.9 m -104.41 144.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.157 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 85.4 p -147.22 142.79 27.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.51 0.671 . . . . 0.0 110.631 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -136.63 152.38 50.37 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.56 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.873 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.1 m -112.26 113.98 26.51 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 23.8 t -96.3 111.91 27.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.84 0.353 . . . . 0.0 111.586 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.47 167.21 9.88 Favored Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.211 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.79 -16.54 55.84 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.521 2.147 . . . . 0.0 113.051 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 27.2 t -116.72 -25.6 7.28 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 131' ' ' SER . 12.5 pt-20 178.94 -162.41 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.123 0.487 . . . . 0.0 109.854 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -96.05 160.14 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.878 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -147.01 18.64 1.25 Allowed 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.422 0.629 . . . . 0.0 112.409 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.873 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.95 86.56 0.08 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.643 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.464 HG13 ' SD ' ' A' ' 141' ' ' MET . 41.0 t -105.07 120.79 56.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.848 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -145.23 126.16 7.49 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.985 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.22 165.53 84.12 Favored 'Cis proline' 0 C--N 1.348 0.546 0 C-N-CA 123.475 -1.469 . . . . 0.0 112.271 -0.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.77 78.01 0.86 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.148 0.499 . . . . 0.0 110.656 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.7 19.32 0.18 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.171 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.682 ' CG ' HG11 ' A' ' 189' ' ' VAL . 10.4 ptm -61.03 160.91 9.16 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.949 0.404 . . . . 0.0 111.396 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.514 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -126.89 152.19 47.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.381 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.722 HG13 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -113.76 147.75 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.863 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.747 ' O ' HG13 ' A' ' 162' ' ' VAL . 56.3 p -117.29 137.52 52.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.697 0.284 . . . . 0.0 110.659 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 146' ' ' VAL . 0.3 OUTLIER -144.11 176.18 9.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.929 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 146' ' ' VAL . 8.5 p -125.18 106.78 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.801 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -57.99 -52.25 75.81 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.147 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 147' ' ' LEU . 44.9 Cg_exo -56.27 160.98 9.81 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.545 2.163 . . . . 0.0 112.299 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 62.54 146.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.958 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -108.05 -24.53 11.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.016 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -112.48 -22.6 10.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.309 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 57.22 55.84 5.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.091 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.528 ' O ' HG13 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -127.59 115.91 19.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 153' ' ' ASP . 5.8 m -159.01 -48.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.131 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.419 ' N ' HG23 ' A' ' 154' ' ' VAL . 5.6 tpp180 -176.44 -66.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -68.66 -48.96 62.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.6 m -104.48 133.91 48.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -125.6 -51.48 1.6 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 41.9 t -80.99 -46.04 15.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.043 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.509 ' HB3' HG23 ' A' ' 162' ' ' VAL . 0.5 OUTLIER 179.33 -36.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.165 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 70.96 60.66 0.18 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.691 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.747 HG13 ' O ' ' A' ' 144' ' ' SER . 21.9 t -112.15 124.62 69.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.233 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.405 ' CD2' ' OH ' ' A' ' 83' ' ' TYR . 5.4 m80 -120.5 165.96 14.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.58 0.705 . . . . 0.0 110.152 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.722 ' CE1' HG13 ' A' ' 143' ' ' VAL . 40.9 m-85 -115.52 140.67 48.94 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.536 178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.591 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 57.0 m-85 -117.6 137.94 52.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.228 0.537 . . . . 0.0 110.287 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.38 -26.13 0.5 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.656 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 30.8 p -167.52 170.65 11.05 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.211 -0.596 . . . . 0.0 111.73 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.603 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 90.5 t -68.03 -34.37 6.09 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.32 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.707 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.8 Cg_exo -72.33 -37.41 4.46 Favored 'Trans proline' 0 CA--C 1.503 -1.06 0 C-N-CA 122.58 2.187 . . . . 0.0 110.321 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.584 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.34 -40.45 51.24 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.733 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.84 -46.38 89.73 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.561 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 2.3 mm-40 -79.09 -27.43 42.98 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.425 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.707 ' N ' ' O ' ' A' ' 169' ' ' PRO . 17.6 t70 -69.8 -55.77 8.93 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.168 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.895 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 54.7 t-105 -65.87 -28.76 69.2 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.652 178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.733 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.47 -39.05 93.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.213 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.5 t -51.98 -45.32 64.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.386 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.34 22.33 7.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.345 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.83 ' ND1' HD11 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -160.75 37.77 0.16 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.903 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -106.03 -10.96 16.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.326 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -93.44 24.57 24.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.559 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.83 HD11 ' ND1' ' A' ' 178' ' ' HIS . 47.5 mt -85.85 56.07 3.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.797 0.332 . . . . 0.0 110.764 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 60.31 28.59 18.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.656 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.4 ' HA3' ' HG2' ' A' ' 148' ' ' PRO . . . 131.51 -105.64 0.63 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.371 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.502 ' CD1' HD12 ' A' ' 181' ' ' LEU . 5.4 tt 63.4 130.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 110.998 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.33 150.1 40.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 111.015 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.3 mm -102.42 159.99 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.923 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.454 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.09 162.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.175 0.512 . . . . 0.0 111.782 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.9 OUTLIER -88.77 125.68 34.99 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.792 178.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.706 HG21 HD23 ' A' ' 126' ' ' LEU . 0.4 OUTLIER -46.98 -20.9 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.596 179.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -69.27 -43.16 74.44 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -82.53 -24.49 34.04 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.249 178.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -71.91 -25.28 61.84 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.534 ' CE2' HG23 ' A' ' 133' ' ' ILE . 2.8 t80 -81.76 -31.38 31.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.145 0.498 . . . . 0.0 110.511 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.16 -30.45 31.06 Favored Glycine 0 CA--C 1.51 -0.253 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.359 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 11.8 mt -81.01 -28.26 35.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.92 -29.07 29.75 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.62 -22.82 34.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.377 -0.411 . . . . 0.0 110.962 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -78.9 -22.8 45.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.23 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.76 -28.71 16.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.201 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 103' ' ' PHE . 63.6 t-20 -81.1 -41.6 22.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.852 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.44 -49.16 78.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.949 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -72.93 -30.52 63.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.5 mt -66.45 -19.94 65.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.215 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.0 tt -80.81 -51.92 8.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.862 0.363 . . . . 0.0 110.944 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.682 ' O ' HG23 ' A' ' 206' ' ' THR . 2.4 pt20 -60.16 159.69 9.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.93 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 205' ' ' GLN . 0.9 OUTLIER -167.21 88.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.799 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 25.0 ttm -56.8 -57.11 13.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.049 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.02 94.51 5.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 23.9 p -140.1 134.38 31.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.932 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? 60.26 31.78 20.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.439 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -67.58 -62.78 3.13 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.041 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.5 Cg_endo . . . . . 0 C--O 1.248 1.018 0 C-N-CA 122.397 2.064 . . . . 0.0 112.372 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.786 0.327 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -130.53 87.81 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.993 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.6 mt -106.94 -32.27 7.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.4 mp -109.13 177.48 4.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.715 HG11 HD12 ' A' ' 28' ' ' LEU . 6.4 t -104.12 90.59 3.17 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.071 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.532 ' HG3' HD11 ' A' ' 46' ' ' LEU . 43.4 Cg_endo -68.18 -43.62 4.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.565 2.176 . . . . 0.0 112.659 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.596 HD12 ' HG ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -51.95 -57.03 10.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 111.132 -179.642 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.715 HD12 HG11 ' A' ' 25' ' ' VAL . 15.7 mt -63.25 -26.83 68.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.011 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.7 ttm-85 -60.34 -53.1 61.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.933 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.745 ' HB3' HG21 ' A' ' 37' ' ' VAL . 24.8 mm-40 -75.32 -22.05 57.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.582 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.758 HD11 ' HA3' ' A' ' 73' ' ' GLY . 1.7 tp -75.15 -52.15 11.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.254 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.0 -36.3 62.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.966 0.412 . . . . 0.0 112.003 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' CG ' ' O ' ' A' ' 30' ' ' GLU . 6.5 ptmt -68.23 -19.52 64.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.155 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.32 56.88 13.14 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.228 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.9 165.76 25.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.653 0.263 . . . . 0.0 110.827 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.57 114.41 3.93 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.546 2.164 . . . . 0.0 112.24 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.745 HG21 ' HB3' ' A' ' 30' ' ' GLU . 25.0 t -126.91 110.45 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.428 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 82.1 p -89.97 -169.84 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -78.04 -37.88 45.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.361 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -29.13 69.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.907 0.384 . . . . 0.0 110.174 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.708 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -83.41 -42.76 16.62 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.653 ' CD1' HD13 ' A' ' 71' ' ' ILE . 10.2 mt -62.15 -36.76 82.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -71.28 -43.02 67.96 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 113.924 -1.489 . . . . 0.0 109.788 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.83 -31.84 70.16 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.86 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.617 HD12 HG23 ' A' ' 41' ' ' THR . 6.7 mt -77.42 -45.44 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-O 120.885 0.374 . . . . 0.0 110.722 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 42' ' ' LEU . 2.0 mm? -76.81 -8.51 57.46 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.567 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 t0 60.5 24.27 13.9 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.425 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 5.3 m95 -111.37 139.8 22.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.181 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.85 144.48 20.79 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.556 2.17 . . . . 0.0 112.252 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.46 -16.69 2.46 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -77.2 -34.88 56.11 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.427 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.603 ' O ' HG23 ' A' ' 56' ' ' VAL . 9.7 mtt85 -67.71 -41.33 83.7 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.636 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -63.82 -47.99 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.389 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.4 -52.53 59.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.299 178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -47.98 -34.99 10.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.891 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 52' ' ' ARG . 36.1 t -63.97 -32.29 56.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.015 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 60' ' ' ALA . 3.6 mm? -66.63 -34.65 78.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.758 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.434 ' O ' HG23 ' A' ' 61' ' ' THR . 4.4 tt0 -56.03 -34.08 65.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.549 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -96.19 -18.36 20.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.737 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . . . -96.6 35.96 1.44 Allowed 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.438 0.637 . . . . 0.0 111.098 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 58' ' ' GLU . 72.6 p -58.75 -18.16 29.26 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.269 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.4 m -112.77 38.12 2.89 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.785 0.326 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 60' ' ' ALA . 0.9 OUTLIER -101.24 141.58 33.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.102 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.503 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -78.62 126.79 31.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.092 0.472 . . . . 0.0 111.257 -179.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CZ ' HG22 ' A' ' 63' ' ' THR . 61.1 m-85 -117.2 173.15 6.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.369 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.595 ' OD1' HD13 ' A' ' 72' ' ' ILE . 0.9 OUTLIER -151.64 146.75 26.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.027 0.441 . . . . 0.0 111.333 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.9 tttm 66.7 -103.33 0.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.813 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -87.92 -11.46 47.53 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.21 26.96 2.56 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.128 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -81.49 169.43 17.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.953 0.406 . . . . 0.0 109.914 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.653 HD13 ' CD1' ' A' ' 42' ' ' LEU . 3.9 mp -79.69 120.13 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.652 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.595 HD13 ' OD1' ' A' ' 66' ' ' ASP . 2.4 tt -107.26 -27.29 3.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.955 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.758 ' HA3' HD11 ' A' ' 31' ' ' LEU . . . 47.17 -150.01 2.38 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.982 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.644 ' H ' HD21 ' A' ' 31' ' ' LEU . 0.3 OUTLIER 62.39 113.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.779 0.323 . . . . 0.0 111.041 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.66 65.12 0.83 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.479 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.1 mt -85.44 145.28 27.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 110.933 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.1 p -109.88 159.1 17.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.772 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -92.2 42.74 1.11 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.011 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -155.06 123.61 6.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' THR . 14.8 pm0 -57.46 -19.76 26.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.43 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' ' O ' ' A' ' 80' ' ' GLU . 54.4 p 36.88 -165.83 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -110.0 -26.26 9.82 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 28.1 m-85 -87.83 117.37 26.62 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.596 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.424 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.7 t -110.1 145.08 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.024 0.44 . . . . 0.0 111.521 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.797 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 17.4 t80 -134.13 107.46 7.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.016 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -102.51 133.03 48.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 0.0 111.843 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.486 HG23 ' CE1' ' A' ' 85' ' ' PHE . 3.8 pt -140.1 124.37 18.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.255 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.5 t70 63.12 -68.27 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.216 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.3 t0 -166.92 36.15 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.413 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -135.76 114.72 12.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.938 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.443 ' CD ' ' H ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -83.1 85.77 7.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.233 0.539 . . . . 0.0 110.885 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 85' ' ' PHE . 0.5 OUTLIER -74.13 165.05 25.83 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.08 179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -134.88 165.28 25.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.365 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.683 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -151.56 169.75 21.33 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 0.0 111.919 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 17.8 m0 -88.24 -25.22 22.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.828 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.903 ' HB2' HG13 ' A' ' 162' ' ' VAL . 3.9 p -147.57 173.0 13.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.388 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.527 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -56.6 -20.87 23.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.826 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.821 HD12 HG11 ' A' ' 162' ' ' VAL . 14.2 mt -87.31 -51.66 5.83 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.59 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 5.3 m-20 -50.12 -24.65 2.87 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.683 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.7 -39.48 88.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.719 0.295 . . . . 0.0 110.651 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 101' ' ' LEU . 4.2 pp -112.08 178.42 4.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.021 0.439 . . . . 0.0 111.106 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 101' ' ' LEU . 4.3 tt -157.93 -45.31 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.11 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.651 ' O ' HG22 ' A' ' 107' ' ' ILE . 8.0 m-85 -164.4 90.89 1.04 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.07 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.666 ' HB3' HG12 ' A' ' 128' ' ' VAL . 60.1 Cg_endo -72.86 -33.69 7.59 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.522 2.148 . . . . 0.0 112.456 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.411 ' HA ' ' CB ' ' A' ' 130' ' ' PRO . . . -78.05 -23.92 47.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.391 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.401 ' CB ' ' HB3' ' A' ' 103' ' ' PHE . 1.9 tp -84.84 -42.73 14.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.223 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -54.7 -48.6 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 121.175 0.512 . . . . 0.0 111.419 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.74 21.6 15.94 Favored Glycine 0 C--N 1.319 -0.408 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.921 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.77 177.36 10.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.053 0.454 . . . . 0.0 111.109 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -83.52 153.74 24.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.926 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.797 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -137.09 109.87 7.58 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.4 mtt180 -82.75 121.05 26.4 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.778 0.799 . . . . 0.0 111.034 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.455 HG22 ' HD2' ' A' ' 85' ' ' PHE . 99.0 t -113.18 132.61 61.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.811 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.424 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 60.5 p -120.77 139.09 53.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.066 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.553 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.3 m -140.73 172.9 12.06 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.26 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -133.61 130.56 38.5 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.8 m -57.33 123.26 14.79 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.044 0.45 . . . . 0.0 111.803 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.34 -9.3 39.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.695 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.693 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.54 -50.59 1.98 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.558 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -75.74 -21.21 57.69 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.965 0.412 . . . . 0.0 110.848 -179.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.45 33.96 86.61 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.118 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.558 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -102.41 167.8 9.86 Favored Pre-proline 0 N--CA 1.451 -0.42 0 CA-C-N 115.421 -0.39 . . . . 0.0 110.43 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.409 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 37.7 Cg_endo -93.22 110.05 0.2 Allowed 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.954 2.436 . . . . 0.0 111.28 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.553 HG22 ' C ' ' A' ' 115' ' ' SER . 35.0 m -108.5 148.32 12.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.547 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.861 ' C ' HD13 ' A' ' 126' ' ' LEU . 79.4 p -149.21 141.44 24.05 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.406 0.622 . . . . 0.0 110.795 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.861 HD13 ' C ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -132.6 153.78 50.69 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.53 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.811 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.2 m -110.99 114.46 27.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.828 178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.765 HG13 ' CE2' ' A' ' 193' ' ' PHE . 38.4 t -96.47 111.89 27.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.881 0.372 . . . . 0.0 111.135 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.412 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -106.65 168.9 7.44 Favored Pre-proline 0 N--CA 1.452 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.958 179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.2 Cg_endo -66.09 -19.27 57.33 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.229 1.953 . . . . 0.0 112.891 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 34.6 p -112.89 -26.12 8.69 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 131' ' ' SER . 11.1 pt-20 178.09 -162.23 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.131 0.491 . . . . 0.0 110.099 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.695 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.35 158.76 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.752 178.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -146.19 20.43 1.4 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.387 0.613 . . . . 0.0 112.299 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.811 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.67 86.47 0.09 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.646 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.631 HG13 ' SD ' ' A' ' 141' ' ' MET . 58.4 t -102.87 113.51 39.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.375 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.447 ' O ' ' HE1' ' A' ' 141' ' ' MET . 4.2 tm-20 -146.26 121.94 5.61 Favored Pre-proline 0 CA--C 1.532 0.271 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.498 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.608 ' HD2' ' HE3' ' A' ' 141' ' ' MET . 55.6 Cg_endo -69.28 157.6 90.53 Favored 'Cis proline' 0 C--N 1.352 0.723 0 C-N-CA 123.459 -1.475 . . . . 0.0 112.737 -0.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -73.02 80.33 1.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.797 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 146.54 16.64 0.15 Allowed Glycine 0 CA--C 1.522 0.491 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.351 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.811 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -61.16 159.24 12.32 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.033 0.444 . . . . 0.0 111.571 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -129.03 152.1 48.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.515 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.697 HG13 ' CD1' ' A' ' 164' ' ' PHE . 4.6 t -115.31 152.97 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.88 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.594 ' O ' HG23 ' A' ' 162' ' ' VAL . 23.5 m -120.0 141.08 50.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.582 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.534 HD13 HG21 ' A' ' 187' ' ' VAL . 5.2 mp -142.23 176.27 9.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.985 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 1.012 HG22 HD12 ' A' ' 184' ' ' LEU . 36.4 t -125.21 144.11 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.811 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.673 HD23 ' HA2' ' A' ' 183' ' ' GLY . 2.1 pp -59.25 160.88 11.07 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.893 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.45 -62.11 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.703 2.269 . . . . 0.0 112.621 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.665 ' N ' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER 64.92 -172.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.835 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -139.39 55.37 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -179.99 -35.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.974 0.416 . . . . 0.0 111.219 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -106.77 135.71 47.83 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -60.63 171.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.933 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.1 p -110.74 -30.27 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.052 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.07 -40.08 6.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.983 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.39 78.06 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.997 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.445 ' HB2' ' CD2' ' A' ' 161' ' ' HIS . 9.1 t -60.84 -80.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.938 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -134.9 -76.18 0.46 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.932 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 5.0 m -81.04 -45.96 15.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.895 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.413 ' O ' ' CB ' ' A' ' 161' ' ' HIS . 1.8 t -162.82 -62.11 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.869 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.651 ' CE1' HG21 ' A' ' 146' ' ' VAL . 0.3 OUTLIER 80.79 -50.49 0.31 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.32 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.903 HG13 ' HB2' ' A' ' 96' ' ' CYS . 2.6 p -107.13 115.81 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.068 0.461 . . . . 0.0 111.155 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.41 ' CE1' ' OH ' ' A' ' 83' ' ' TYR . 3.6 m-70 -126.96 169.38 13.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.555 0.693 . . . . 0.0 110.05 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.697 ' CD1' HG13 ' A' ' 143' ' ' VAL . 1.9 m-85 -108.61 150.69 27.16 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.796 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 37.9 m-85 -132.96 136.26 45.99 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.361 0.601 . . . . 0.0 110.564 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.641 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -39.19 -28.67 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.142 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.498 ' HB3' ' HD2' ' A' ' 169' ' ' PRO . 30.5 t -171.7 176.78 3.58 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.796 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.599 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 85.3 t -69.05 -34.3 4.92 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.552 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.7 Cg_exo -72.55 -38.38 3.4 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.813 2.342 . . . . 0.0 110.396 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.595 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.52 -39.84 51.77 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.043 -0.98 . . . . 0.0 108.546 177.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.706 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.33 -45.37 94.69 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.6 mt-10 -79.19 -27.56 42.6 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.179 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 169' ' ' PRO . 8.8 t70 -70.24 -55.86 8.21 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.421 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.693 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 57.4 t90 -65.17 -28.05 69.13 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.8 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.706 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -66.73 -37.04 83.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.323 178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.3 t -53.09 -46.51 68.69 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.404 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -95.16 22.79 6.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.211 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.501 ' CD2' ' CZ2' ' A' ' 174' ' ' TRP . 79.5 m80 -152.8 45.43 0.69 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.952 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.7 -179.38 3.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.739 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 58.02 29.41 62.25 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.486 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.434 HD12 HD22 ' A' ' 184' ' ' LEU . 4.0 mt -97.05 61.76 1.79 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.931 0.396 . . . . 0.0 110.901 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 55.75 26.5 9.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.929 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.86 ' O ' HG13 ' A' ' 146' ' ' VAL . . . 114.73 128.39 4.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.438 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 1.012 HD12 HG22 ' A' ' 146' ' ' VAL . 1.1 tp -176.92 129.49 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.11 41.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.021 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 175' ' ' ALA . 10.0 mm -99.78 159.45 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.864 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -161.12 162.03 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.361 0.6 . . . . 0.0 111.967 179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -90.8 129.64 36.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.778 178.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.811 HG11 ' HG3' ' A' ' 141' ' ' MET . 1.5 m -46.98 -19.89 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.75 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 8.7 m80 -71.76 -41.84 67.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.798 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.21 -24.22 34.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.364 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.9 61.65 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.175 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.765 ' CE2' HG13 ' A' ' 128' ' ' VAL . 5.4 t80 -81.3 -25.57 36.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.682 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.76 -30.25 32.92 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.08 -28.22 32.48 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.14 -28.32 31.2 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.414 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -82.28 -23.99 34.95 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.883 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.08 -23.04 57.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.146 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -51.89 -33.08 35.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.144 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.99 -25.08 37.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -57.28 -48.45 78.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.948 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -80.07 -31.27 39.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.754 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.625 ' O ' HD13 ' A' ' 203' ' ' LEU . 0.3 OUTLIER -71.42 -24.68 62.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.078 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.04 -51.79 8.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.956 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -161.18 80.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.7 t -82.92 -37.25 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 10.0 mtp -153.22 137.7 16.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.25 146.58 30.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.96 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.7 t 60.66 178.46 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 2.3 mtt180 -89.17 -170.44 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.972 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.437 ' HB ' ' HD3' ' A' ' 212' ' ' PRO . 0.9 OUTLIER 178.4 -55.2 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.848 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.437 ' HD3' ' HB ' ' A' ' 211' ' ' THR . 74.1 Cg_exo . . . . . 0 C--O 1.25 1.095 0 C-N-CA 122.516 2.144 . . . . 0.0 112.436 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.869 0.366 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -104.99 100.36 9.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.826 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -176.07 -171.31 0.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.936 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 tp 63.13 162.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.623 HG21 HD22 ' A' ' 106' ' ' LEU . 17.0 m 41.95 61.12 8.66 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.823 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.607 ' HG2' HD11 ' A' ' 46' ' ' LEU . 52.9 Cg_exo -52.49 -26.23 27.86 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.482 2.122 . . . . 0.0 112.219 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.639 HD22 ' HA2' ' A' ' 73' ' ' GLY . 1.0 OUTLIER -52.13 -57.37 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.352 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 mt -80.17 -27.28 39.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.55 -53.22 51.34 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.548 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.584 ' HG2' HD13 ' A' ' 45' ' ' ILE . 3.0 mp0 -66.03 -23.28 66.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.291 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.609 HD21 ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -69.52 -38.38 77.53 Favored 'General case' 0 CA--C 1.523 -0.08 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.07 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.08 -25.63 13.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.001 0.429 . . . . 0.0 111.174 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.01 -20.87 65.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.073 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.56 42.46 95.61 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.267 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -133.36 165.85 33.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.715 0.293 . . . . 0.0 110.704 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.55 114.28 3.78 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.502 2.135 . . . . 0.0 112.016 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.696 HG12 ' HG ' ' A' ' 42' ' ' LEU . 20.8 t -115.57 110.19 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.421 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.7 p -88.03 -171.65 3.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.746 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -77.99 -36.64 48.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.313 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -29.42 69.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.865 0.364 . . . . 0.0 110.276 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.651 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -83.52 -42.65 16.61 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 178.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.696 ' HG ' HG12 ' A' ' 37' ' ' VAL . 12.6 mt -62.53 -36.56 82.97 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.975 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.87 -43.01 63.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.646 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.28 -31.65 77.76 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.477 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.634 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -79.54 -38.52 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 CA-C-O 121.061 0.458 . . . . 0.0 110.231 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.607 HD11 ' HG2' ' A' ' 26' ' ' PRO . 6.4 mp -78.13 -10.01 59.43 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.178 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 59.38 22.54 10.97 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.439 ' CD1' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -102.77 137.06 19.21 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.189 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.731 ' O ' HG23 ' A' ' 53' ' ' VAL . 10.1 Cg_endo -53.04 142.81 52.8 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.697 2.265 . . . . 0.0 112.207 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.8 -20.64 2.3 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.55 -39.95 36.34 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.121 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.896 ' O ' HG23 ' A' ' 56' ' ' VAL . 13.0 mmt180 -67.93 -38.28 82.7 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.975 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.5 t -65.73 -48.1 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.89 -54.37 30.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.177 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.5 -42.14 64.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.898 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 52' ' ' ARG . 35.9 t -65.06 -31.73 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.747 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 tp -63.21 -35.12 79.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.539 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.59 ' O ' HG23 ' A' ' 61' ' ' THR . 1.8 mp0 -57.49 -22.82 46.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.851 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -96.42 -20.68 18.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.38 31.89 2.96 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.55 0.69 . . . . 0.0 110.916 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 58' ' ' GLU . 21.1 p -71.61 -27.65 63.26 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 52.8 m -75.86 -25.51 56.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.204 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.35 141.25 56.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.042 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.6 ' CG ' HG21 ' A' ' 72' ' ' ILE . 14.5 pt-20 -78.92 133.77 36.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.046 0.45 . . . . 0.0 111.274 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.426 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 55.2 m-85 -105.19 173.42 6.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.48 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -149.82 145.97 26.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.969 0.414 . . . . 0.0 111.499 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 tttp 65.6 -105.03 0.11 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.634 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -86.91 -11.51 50.46 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.713 0.292 . . . . 0.0 111.561 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 122.67 25.87 1.86 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.228 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -78.02 158.79 29.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 110.006 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.669 HD13 ' CD1' ' A' ' 42' ' ' LEU . 1.9 mp -79.74 126.32 39.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.574 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.819 ' O ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -72.16 -28.97 30.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.027 0.442 . . . . 0.0 111.021 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.639 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . 86.62 -106.62 3.13 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.677 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.453 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -53.91 161.77 1.1 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.877 0.37 . . . . 0.0 111.156 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -87.5 125.58 7.6 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.654 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tp -124.63 149.51 47.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.33 . . . . 0.0 110.76 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.7 p -113.72 140.86 47.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.579 ' H ' HD12 ' A' ' 78' ' ' LEU . 5.1 mp -59.75 -23.87 63.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -92.97 123.61 36.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 0.0 111.096 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.2 pt-20 -60.64 -16.76 42.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.461 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.756 HG21 ' HA ' ' A' ' 95' ' ' TRP . 0.5 OUTLIER 37.46 -167.97 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.08 -24.88 12.26 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.113 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -80.78 114.85 19.95 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.55 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.82 136.14 42.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.015 0.436 . . . . 0.0 111.423 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.819 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 56.5 t80 -128.16 104.6 7.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.177 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -98.6 131.12 45.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.396 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -140.06 122.95 17.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.07 -72.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 87' ' ' ILE . 18.3 t0 -159.26 37.11 0.2 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.637 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -139.8 145.95 38.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.56 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.96 86.49 2.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.871 0.367 . . . . 0.0 110.799 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.418 ' HG ' ' CD2' ' A' ' 74' ' ' TYR . 4.3 mm? -71.27 164.79 25.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.589 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.41 ' CD2' ' HA ' ' A' ' 80' ' ' GLU . 5.1 m-85 -131.12 160.08 35.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.356 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.549 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -146.55 161.44 40.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.737 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.756 ' HA ' HG21 ' A' ' 81' ' ' THR . 7.7 m0 -90.61 -24.7 20.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.409 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.436 ' HB3' ' CG1' ' A' ' 162' ' ' VAL . 5.6 m -146.97 172.37 13.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.974 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.716 ' HB1' ' CE2' ' A' ' 164' ' ' PHE . . . -53.77 -21.53 7.51 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.432 ' HB2' HG11 ' A' ' 162' ' ' VAL . 2.1 tp -86.8 -51.53 6.03 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.549 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -45.57 -25.39 0.45 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -60.31 -36.73 78.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.688 0.28 . . . . 0.0 110.87 -179.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.866 HD12 ' CG ' ' A' ' 104' ' ' PRO . 1.9 pt? -137.5 166.18 24.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.004 0.431 . . . . 0.0 111.386 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.405 HG22 ' CZ ' ' A' ' 103' ' ' PHE . 4.1 mp -143.62 -46.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.834 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.405 ' CZ ' HG22 ' A' ' 102' ' ' ILE . 38.5 m-85 -141.1 65.83 23.45 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.664 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.866 ' CG ' HD12 ' A' ' 101' ' ' LEU . 34.3 Cg_exo -57.83 -30.61 89.99 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.742 2.295 . . . . 0.0 112.531 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.36 -23.61 43.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.455 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.623 HD22 HG21 ' A' ' 25' ' ' VAL . 1.1 tt -85.94 -34.04 20.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.143 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 tp -54.51 -47.61 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.174 0.511 . . . . 0.0 111.687 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.91 20.85 25.0 Favored Glycine 0 C--N 1.32 -0.351 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.733 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 173.42 14.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.039 0.447 . . . . 0.0 111.011 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -78.87 151.8 31.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.924 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.819 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.14 109.75 7.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.378 -0.374 . . . . 0.0 112.001 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 44.6 mtm180 -82.35 119.64 24.4 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.818 0.818 . . . . 0.0 111.198 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.768 HG22 ' CD1' ' A' ' 85' ' ' PHE . 39.6 t -111.61 130.47 65.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 114.268 -1.333 . . . . 0.0 112.137 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.0 m -122.29 137.04 54.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.093 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.548 ' HB2' HG23 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.62 172.8 12.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.209 179.818 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -136.68 135.06 37.88 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 26.4 t -61.77 132.14 52.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.227 0.537 . . . . 0.0 112.147 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.48 -3.84 23.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.935 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.915 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.58 -50.6 1.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.616 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -88.98 -24.23 22.45 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.247 -179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.36 5.03 76.05 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.179 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.689 ' H ' HG22 ' A' ' 120' ' ' THR . . . -57.74 151.17 43.54 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.504 0.193 . . . . 0.0 110.579 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 2.5 Cg_endo -84.54 105.8 1.06 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.736 2.29 . . . . 0.0 110.898 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.65 HG12 ' CD ' ' A' ' 138' ' ' PRO . 35.2 m -103.29 145.49 12.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.419 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.906 ' O ' HD13 ' A' ' 126' ' ' LEU . 72.8 p -151.49 141.62 22.22 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.443 0.64 . . . . 0.0 110.699 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.906 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -134.82 152.92 52.14 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.306 178.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.882 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 82.7 m -111.34 113.31 25.69 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.541 HG22 ' HZ ' ' A' ' 193' ' ' PHE . 19.7 t -95.86 111.73 26.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.631 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.14 175.63 2.07 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.401 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.78 -15.62 37.11 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.695 2.263 . . . . 0.0 112.971 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 50.1 m -120.11 -26.03 5.61 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 131' ' ' SER . 14.6 pt-20 179.74 -162.91 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.169 0.509 . . . . 0.0 110.186 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.777 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 0.2 OUTLIER -96.62 161.36 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.992 178.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -149.31 19.25 0.95 Allowed 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 121.298 0.57 . . . . 0.0 112.253 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.882 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.09 86.23 0.08 Allowed 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.593 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.557 HG13 HD12 ' A' ' 126' ' ' LEU . 24.4 t -105.02 118.35 52.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.138 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -146.21 117.12 4.82 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.65 ' CD ' HG12 ' A' ' 124' ' ' VAL . 13.9 Cg_exo -69.47 146.99 83.12 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.643 -1.399 . . . . 0.0 112.28 0.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.18 -33.83 54.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.642 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -98.93 28.98 12.66 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.957 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.759 ' HE1' HD21 ' A' ' 126' ' ' LEU . 1.9 ppp? -64.9 156.55 30.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.126 0.489 . . . . 0.0 111.529 -179.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -128.72 152.32 48.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.616 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.844 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -112.49 150.67 14.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.965 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.678 ' O ' HG23 ' A' ' 162' ' ' VAL . 23.0 p -119.86 140.37 50.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.757 0.313 . . . . 0.0 111.026 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 10.4 mt -139.02 176.28 8.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.873 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 158' ' ' PHE . 18.5 m -125.04 154.39 33.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.051 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' A' ' 149' ' ' GLN . 0.1 OUTLIER 62.47 96.19 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.839 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.32 -19.36 43.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.489 2.126 . . . . 0.0 112.581 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.687 ' HB2' HD12 ' A' ' 147' ' ' LEU . 7.5 mm-40 -53.95 137.86 38.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.834 0.349 . . . . 0.0 111.061 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -63.34 -25.15 68.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.125 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -110.48 -29.15 8.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.222 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.434 ' HB1' ' HG ' ' A' ' 147' ' ' LEU . . . 51.74 29.61 5.98 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.309 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 59.83 -175.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.849 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.616 HG13 ' O ' ' A' ' 154' ' ' VAL . 9.5 p -109.45 70.85 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.98 0.419 . . . . 0.0 111.228 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 8.7 mtp85 -153.43 24.3 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.122 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 54.37 88.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.095 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.65 68.41 1.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.049 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.427 ' HA ' HG23 ' A' ' 146' ' ' VAL . 4.8 p90 -162.15 -55.05 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.743 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 43.6 t -81.31 -15.85 54.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 42.2 t -49.55 -34.59 17.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.396 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -151.91 65.6 0.85 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.779 0.323 . . . . 0.0 111.357 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 144' ' ' SER . 8.0 p -108.15 114.56 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.13 0.491 . . . . 0.0 110.865 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.447 ' N ' ' CD2' ' A' ' 163' ' ' HIS . 2.5 m-70 -126.81 169.24 13.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.609 0.719 . . . . 0.0 110.076 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.844 ' CE1' HG22 ' A' ' 143' ' ' VAL . 11.9 m-85 -106.11 151.71 24.36 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.62 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.535 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 49.2 m-85 -131.13 136.3 48.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.495 0.664 . . . . 0.0 110.502 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -43.42 -26.42 0.2 Allowed 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.798 -1.092 . . . . 0.0 112.67 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.526 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 22.3 p -169.24 172.76 7.1 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.941 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 81.5 t -69.01 -34.04 4.7 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.389 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.76 -37.35 3.91 Favored 'Trans proline' 0 CA--C 1.505 -0.975 0 C-N-CA 122.669 2.246 . . . . 0.0 110.24 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.587 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.6 -40.42 49.54 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.578 178.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.73 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.0 -45.59 92.96 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.6 mt-10 -78.92 -27.56 43.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.119 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 25.3 t70 -70.77 -55.94 7.47 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.451 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.915 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.6 t-105 -65.03 -28.28 69.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.632 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.73 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.59 -40.7 97.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.221 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.2 p -51.85 -43.56 63.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.354 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.82 21.01 7.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.358 0.599 . . . . 0.0 111.353 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.468 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.4 OUTLIER -125.94 27.39 6.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.811 179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -97.91 -178.75 4.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.757 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.6 -28.38 13.66 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.465 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.7 mt -63.94 -174.94 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.94 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -97.94 33.41 2.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.849 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 145.76 126.51 1.82 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.525 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 178' ' ' HIS . 2.9 tt -176.66 116.76 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 110.927 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.65 149.76 41.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.991 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.659 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.9 mm -99.78 159.59 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.954 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.442 HG23 ' HB ' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -160.09 147.81 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.815 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.5 OUTLIER -77.41 124.49 27.95 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.467 177.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.635 HG11 ' HG3' ' A' ' 141' ' ' MET . 1.0 OUTLIER -46.93 -20.67 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.644 179.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.37 -39.63 77.94 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.7 mt-10 -82.46 -28.38 31.28 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.036 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.436 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -63.69 -24.69 67.88 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.116 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.777 ' CZ ' HG23 ' A' ' 133' ' ' ILE . 0.6 OUTLIER -81.15 -24.72 37.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.032 0.444 . . . . 0.0 110.818 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.56 -30.3 33.45 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.17 -28.47 32.07 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -27.87 32.77 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.601 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 0.0 OUTLIER -82.17 -25.85 33.93 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 110.951 179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.418 ' HB3' ' CE1' ' A' ' 202' ' ' HIS . 4.0 mt-10 -73.88 -23.32 59.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.089 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -55.84 -43.3 76.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.128 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.43 ' OD1' HD23 ' A' ' 204' ' ' LEU . 35.6 t30 -81.01 -50.07 10.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.113 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -56.52 -28.85 61.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.253 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . 0.418 ' CE1' ' HB3' ' A' ' 198' ' ' GLU . 2.9 m80 -66.33 -48.49 70.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 203' ' ' LEU . 3.3 mm? -82.16 -42.74 18.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.005 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.43 HD23 ' OD1' ' A' ' 200' ' ' ASN . 4.2 mm? -74.56 -51.9 13.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.022 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 60.29 -169.38 0.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.0 t -60.4 147.52 40.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.961 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 3.5 ptp -113.16 -175.4 2.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.94 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 2.2 m -125.88 175.69 7.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.4 m -111.56 -33.99 6.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 61.16 112.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.432 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -65.64 -62.71 4.1 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.987 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.2 Cg_endo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 122.379 2.053 . . . . 0.0 112.262 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.774 0.321 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 60.45 165.32 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.978 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mp -96.43 104.24 16.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -113.72 77.99 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.911 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 25' ' ' VAL . 11.2 p -171.18 54.18 0.21 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.078 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.626 ' HG3' HD11 ' A' ' 46' ' ' LEU . 57.0 Cg_endo -71.02 -21.81 27.13 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.595 2.197 . . . . 0.0 112.484 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.711 ' HG ' HG21 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -56.46 -57.44 12.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 111.363 -179.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 tp -80.12 -27.43 39.16 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.227 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.426 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -71.54 -53.22 14.53 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.888 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -65.88 -24.52 66.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.506 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.795 HD22 ' HA3' ' A' ' 73' ' ' GLY . 16.4 tp -69.45 -28.93 66.53 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.797 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.73 -22.56 9.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.351 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.2 mmmt -69.11 -21.7 64.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.192 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.95 39.51 94.94 Favored Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.902 -0.59 . . . . 0.0 113.399 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -133.25 166.04 32.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.572 0.225 . . . . 0.0 110.833 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.64 114.12 3.58 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.468 2.112 . . . . 0.0 111.952 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.782 HG23 HG22 ' A' ' 41' ' ' THR . 11.1 p -111.59 109.87 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.438 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.3 p -85.99 -170.47 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.723 ' NH1' HD11 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -78.04 -37.52 46.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.465 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -27.91 68.66 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.199 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.782 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.53 -42.34 15.61 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -62.74 -36.6 83.54 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 176.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.544 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.04 -42.74 62.83 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.604 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.74 -30.19 72.7 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.643 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.556 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.03 -43.51 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.055 0.455 . . . . 0.0 110.397 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.626 HD11 ' HG3' ' A' ' 26' ' ' PRO . 7.2 mp -76.75 -9.83 58.95 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.506 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.5 t70 60.63 21.77 11.64 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.442 ' CD1' ' HD2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -104.47 137.79 19.33 Favored Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.068 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.442 ' HD2' ' CD1' ' A' ' 48' ' ' TRP . 10.7 Cg_endo -53.66 140.01 66.56 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.597 2.198 . . . . 0.0 112.012 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.19 -17.89 1.28 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -78.6 -32.61 47.66 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.258 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.791 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.17 -39.87 86.53 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.05 -48.14 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.586 177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.05 -52.87 57.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.389 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.2 -42.77 66.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.891 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 52' ' ' ARG . 26.9 t -67.76 -31.17 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.539 HD23 ' C ' ' A' ' 57' ' ' LEU . 9.2 tt -63.95 -35.37 80.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.758 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -58.25 -45.12 88.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.755 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -88.05 -7.88 56.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.62 74.98 1.04 Allowed 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.765 0.793 . . . . 0.0 110.133 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 p -106.66 -16.09 14.6 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.332 -1.303 . . . . 0.0 111.42 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.9 m -73.87 -28.13 61.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 111.205 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.17 141.33 50.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.448 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.822 ' O ' HG22 ' A' ' 72' ' ' ILE . 23.9 mt-10 -78.79 126.94 31.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.313 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -103.37 171.78 7.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.463 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 70' ' ' ASN . 1.6 t70 -92.16 -172.76 3.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.479 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -67.55 -35.42 79.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.902 0.382 . . . . 0.0 111.18 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -91.73 12.24 21.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.648 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.28 17.33 74.23 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.156 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 66' ' ' ASP . 24.3 m120 -91.49 165.62 13.28 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.983 0.392 . . . . 0.0 110.04 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.776 HD13 HD13 ' A' ' 42' ' ' LEU . 3.2 mp -79.84 127.8 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.546 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.822 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.4 tt -85.32 -24.95 6.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.022 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.795 ' HA3' HD22 ' A' ' 31' ' ' LEU . . . 66.36 11.95 57.31 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.038 -0.601 . . . . 0.0 113.035 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.786 ' H ' HG23 ' A' ' 72' ' ' ILE . 86.8 m-85 51.45 -176.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.793 0.33 . . . . 0.0 111.092 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.36 -87.3 0.43 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.578 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.54 138.07 46.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 110.895 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.572 HG21 ' CD1' ' A' ' 95' ' ' TRP . 81.7 p -97.82 159.05 15.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.5 -41.41 85.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.979 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 46.9 mtt-85 -110.31 150.29 28.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 93' ' ' TYR . 4.5 tt0 -57.05 132.34 52.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.925 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.8 p -108.44 -173.67 2.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.046 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 116' ' ' HIS . 70.2 m -94.94 -38.54 10.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.016 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.431 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 32.6 m-85 -79.52 111.09 15.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.887 0.375 . . . . 0.0 110.507 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.62 138.13 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.762 ' HD1' HG22 ' A' ' 113' ' ' VAL . 69.4 t80 -123.51 106.73 10.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.544 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -98.06 125.77 43.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.279 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -139.59 122.91 18.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.853 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 t70 59.4 -72.59 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.159 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' A' ' 87' ' ' ILE . 35.1 t0 -165.74 34.15 0.05 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.313 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.3 mmp_? -136.64 111.82 9.06 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.751 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -77.87 120.63 23.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.909 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.95 164.78 11.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 111.022 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.435 ' CZ ' ' HG3' ' A' ' 80' ' ' GLU . 28.4 m-85 -131.49 155.39 47.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.355 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.768 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -150.39 168.41 24.2 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.973 0.416 . . . . 0.0 111.614 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.572 ' CD1' HG21 ' A' ' 77' ' ' THR . 6.3 m95 -100.21 -6.97 25.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.189 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.431 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.5 OUTLIER 178.03 -179.28 0.27 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.827 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 164' ' ' PHE . . . -55.09 164.36 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.729 0.3 . . . . 0.0 110.758 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 tt 70.21 -52.92 0.64 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.103 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.768 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 8.8 t0 -47.3 -29.27 2.38 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.834 0.349 . . . . 0.0 110.867 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.481 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 2.7 p -60.02 -39.44 85.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.717 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER 169.92 153.45 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.554 179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.755 ' O ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -143.33 48.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.391 0.615 . . . . 0.0 110.867 179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.705 ' O ' HG22 ' A' ' 107' ' ' ILE . 16.9 m-85 -166.27 59.27 0.54 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.992 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.583 ' HB3' HG12 ' A' ' 128' ' ' VAL . 61.2 Cg_endo -73.14 -37.67 3.28 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.596 2.197 . . . . 0.0 112.253 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.08 -23.8 43.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.218 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -82.72 -41.06 19.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.26 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.705 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.3 tp -57.68 -46.6 86.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.177 0.513 . . . . 0.0 111.422 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.88 24.29 15.68 Favored Glycine 0 C--N 1.319 -0.405 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.636 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -152.55 173.53 15.06 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.944 0.402 . . . . 0.0 111.003 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.7 m -80.09 153.42 28.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.772 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.752 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -137.06 109.78 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -83.19 120.26 25.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.781 0.8 . . . . 0.0 111.23 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.762 HG22 ' HD1' ' A' ' 85' ' ' PHE . 94.6 t -112.79 130.68 66.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.013 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 m -122.78 136.91 55.02 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.202 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.598 ' HB3' HG23 ' A' ' 124' ' ' VAL . 2.0 t -141.81 173.0 11.91 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.36 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.455 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -133.53 137.23 45.48 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 34.0 t -66.65 134.0 51.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.086 0.47 . . . . 0.0 112.234 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -72.52 -3.98 27.76 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.102 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.888 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.59 -51.34 2.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.928 0.395 . . . . 0.0 111.529 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.716 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.37 -24.18 22.01 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.356 -179.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.15 6.09 73.27 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.114 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.716 ' H ' HG22 ' A' ' 120' ' ' THR . . . -59.39 150.69 63.37 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.552 0.215 . . . . 0.0 110.501 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.0 104.39 1.26 Allowed 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.652 2.235 . . . . 0.0 110.77 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.598 HG23 ' HB3' ' A' ' 115' ' ' SER . 35.0 m -99.22 144.35 12.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.299 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 88.9 p -150.48 141.95 23.43 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.448 0.642 . . . . 0.0 110.639 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.675 HD21 HG11 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -138.26 151.28 47.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.026 179.072 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.871 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 39.2 m -107.1 113.76 27.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.732 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.583 HG12 ' HB3' ' A' ' 104' ' ' PRO . 36.2 t -96.15 111.72 26.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.382 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.23 167.68 9.09 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.793 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.62 -19.16 60.15 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.084 1.856 . . . . 0.0 112.884 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 4.4 m -112.79 -26.73 8.43 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 131' ' ' SER . 2.9 pt-20 178.37 -162.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.15 0.5 . . . . 0.0 110.159 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -96.23 157.75 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.014 178.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -144.85 19.05 1.64 Allowed 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.367 0.603 . . . . 0.0 112.241 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.871 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.9 86.56 0.08 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.326 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.574 HG13 ' SD ' ' A' ' 141' ' ' MET . 23.8 t -104.99 115.92 47.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.431 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.35 124.32 6.2 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.575 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -70.65 154.79 95.81 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 123.874 -1.302 . . . . 0.0 112.247 0.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.42 79.47 0.16 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.106 0.479 . . . . 0.0 110.434 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 141.82 20.46 0.27 Allowed Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.476 -0.784 . . . . 0.0 113.017 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.574 ' SD ' HG13 ' A' ' 136' ' ' VAL . 0.4 OUTLIER -61.06 160.32 10.22 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 121.035 0.445 . . . . 0.0 111.298 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.481 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -129.24 152.29 48.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.091 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.641 HG13 ' CD1' ' A' ' 164' ' ' PHE . 40.5 t -113.98 150.67 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.624 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.745 ' O ' HG13 ' A' ' 162' ' ' VAL . 2.8 p -117.81 138.77 51.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.865 0.364 . . . . 0.0 110.912 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.868 HD21 HG21 ' A' ' 187' ' ' VAL . 1.3 pp -149.93 176.63 10.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.599 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.597 HG13 ' O ' ' A' ' 146' ' ' VAL . 8.9 p -108.09 104.18 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 0.0 110.88 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.605 HD23 ' HB3' ' A' ' 185' ' ' ALA . 0.4 OUTLIER -72.71 -62.39 1.38 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.246 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.835 ' CG ' HD22 ' A' ' 184' ' ' LEU . 38.2 Cg_endo -66.56 83.65 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.514 2.143 . . . . 0.0 112.468 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -175.0 122.81 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.683 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -140.39 116.89 10.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 59.7 40.51 19.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.105 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.551 ' HB3' ' OG ' ' A' ' 157' ' ' SER . . . -97.84 30.33 3.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.058 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.526 ' O ' HG13 ' A' ' 154' ' ' VAL . 1.5 t70 -177.5 -56.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 153' ' ' ASP . 6.1 m -158.95 -47.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.068 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.421 ' N ' HG23 ' A' ' 154' ' ' VAL . 4.6 mtt-85 -152.78 -74.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -80.28 -34.52 36.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.551 ' OG ' ' HB3' ' A' ' 152' ' ' ALA . 23.0 t 63.15 124.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.052 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.438 ' HB2' HG11 ' A' ' 146' ' ' VAL . 3.0 m-85 59.24 31.16 20.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.905 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 29.4 p -72.65 -28.21 62.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.929 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.8 m -86.69 -19.75 28.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.169 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -87.44 53.84 2.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.919 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.745 HG13 ' O ' ' A' ' 144' ' ' SER . 25.2 t -111.7 127.49 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.047 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -113.99 164.81 13.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.717 0.77 . . . . 0.0 110.469 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.641 ' CD1' HG13 ' A' ' 143' ' ' VAL . 3.3 m-85 -122.3 129.83 52.56 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.559 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.679 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 44.8 m-85 -108.54 140.95 41.16 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.45 0.643 . . . . 0.0 110.771 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -48.38 -25.66 1.71 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.878 -1.055 . . . . 0.0 112.78 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.599 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 32.1 m -162.36 165.84 25.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.663 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.625 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 74.9 t -67.66 -33.91 5.94 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.955 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.689 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.63 -36.92 4.44 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.669 2.246 . . . . 0.0 110.262 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.65 -40.37 49.33 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.468 177.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.754 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.72 -45.79 92.44 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.547 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 3.1 mm-40 -78.88 -27.06 43.97 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.351 178.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 169' ' ' PRO . 25.9 t0 -70.62 -55.91 7.69 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.888 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 31.8 t-105 -65.23 -28.97 69.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.635 178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.754 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.43 -39.93 95.8 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.346 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.8 m -52.22 -44.54 64.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.327 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.408 ' O ' ' CD2' ' A' ' 178' ' ' HIS . 0.0 OUTLIER -96.15 22.33 7.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.259 0.552 . . . . 0.0 111.235 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.436 ' NE2' ' CE2' ' A' ' 174' ' ' TRP . 15.8 m-70 -145.46 40.75 1.22 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.084 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -81.53 136.69 35.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.575 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 97.19 -25.5 26.76 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.174 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.409 HD12 ' CA ' ' A' ' 178' ' ' HIS . 3.2 mt -66.76 -175.49 0.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.728 0.299 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.86 -25.37 11.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.051 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -103.76 52.51 0.76 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.182 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.835 HD22 ' CG ' ' A' ' 148' ' ' PRO . 0.2 OUTLIER -56.06 -26.96 51.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.639 0.257 . . . . 0.0 111.14 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.605 ' HB3' HD23 ' A' ' 147' ' ' LEU . . . -135.04 143.65 46.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.949 0.404 . . . . 0.0 111.225 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 175' ' ' ALA . 15.9 mm -103.52 161.56 4.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.94 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.868 HG21 HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -161.99 164.5 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.363 0.601 . . . . 0.0 112.012 179.753 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.424 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -92.97 133.83 35.73 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.49 178.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.675 HG11 HD21 ' A' ' 126' ' ' LEU . 18.3 m -47.43 -18.68 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 120.879 0.371 . . . . 0.0 110.838 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.424 ' N ' ' C ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -73.83 -43.08 59.85 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.037 179.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -20.98 36.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.327 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.38 -25.2 59.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.087 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -81.42 -24.82 36.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.762 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.85 -30.63 31.52 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.4 mt -82.05 -27.62 32.89 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.05 -25.84 39.28 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -82.19 -22.95 35.74 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.56 -0.32 . . . . 0.0 111.116 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -79.67 -24.8 41.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.141 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -53.88 -30.47 45.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 111.189 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.576 ' O ' HD23 ' A' ' 204' ' ' LEU . 2.2 m-80 -55.63 -54.98 37.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.061 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -54.65 -43.08 72.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.157 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.97 -36.22 82.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.819 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.737 ' O ' HD13 ' A' ' 203' ' ' LEU . 0.6 OUTLIER -82.06 -27.61 32.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.037 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 200' ' ' ASN . 4.2 mm? -80.97 -42.13 21.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -58.96 146.41 38.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.917 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.5 t -131.81 -51.81 0.98 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.08 37.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.8 m -95.92 133.4 40.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.998 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.87 -74.81 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.957 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 60.3 106.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.797 HG22 ' HD3' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -78.79 -34.52 0.99 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.881 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.797 ' HD3' HG22 ' A' ' 211' ' ' THR . 63.7 Cg_exo . . . . . 0 C--O 1.248 1.015 0 C-N-CA 121.971 1.78 . . . . 0.0 112.419 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.823 0.344 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.13 175.36 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.924 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.659 ' C ' HD13 ' A' ' 24' ' ' LEU . 6.6 mt -137.98 -178.72 5.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.676 ' N ' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -156.43 30.92 0.33 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.416 HG13 HD23 ' A' ' 24' ' ' LEU . 3.6 m -152.84 70.16 7.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.033 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.833 ' CG ' HD11 ' A' ' 46' ' ' LEU . 58.6 Cg_endo -71.78 -26.38 19.25 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.517 2.145 . . . . 0.0 112.435 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.7 mp -54.16 -57.49 10.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.042 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 31' ' ' LEU . 9.2 mt -63.19 -26.91 69.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -68.68 -53.25 23.45 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 121.118 0.485 . . . . 0.0 109.907 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.769 ' HB3' HG21 ' A' ' 37' ' ' VAL . 0.5 OUTLIER -72.67 -30.76 64.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.297 178.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.783 HD11 ' CA ' ' A' ' 73' ' ' GLY . 9.8 tt -70.81 -49.76 42.9 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.825 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.8 -27.64 30.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.057 0.456 . . . . 0.0 110.973 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.99 -21.1 65.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.136 178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 45.9 94.97 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 121.056 -0.592 . . . . 0.0 113.068 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.656 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -130.86 152.6 80.87 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.622 0.248 . . . . 0.0 110.834 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.89 89.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.643 2.229 . . . . 0.0 112.346 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.769 HG21 ' HB3' ' A' ' 30' ' ' GLU . 39.2 t -97.61 110.7 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.068 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 p -85.34 -172.98 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.007 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.673 ' HE ' HG23 ' A' ' 40' ' ' THR . 0.2 OUTLIER -78.07 -35.51 49.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.339 -179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.673 HG23 ' HE ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -65.74 -27.19 68.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.954 0.407 . . . . 0.0 110.331 179.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.657 ' CG2' HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.19 -42.68 14.49 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 tp -63.05 -35.91 81.82 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.604 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.31 -43.0 61.71 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.59 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.12 -31.49 74.97 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.876 -1.057 . . . . 0.0 111.7 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.604 HD12 HG23 ' A' ' 41' ' ' THR . 6.7 mt -78.81 -44.38 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 CA-C-O 120.873 0.368 . . . . 0.0 110.535 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.833 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.2 mp -76.57 -9.66 58.82 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.434 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.2 t0 59.3 22.15 10.46 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.438 ' HE3' HD23 ' A' ' 46' ' ' LEU . 0.3 OUTLIER -105.01 144.82 29.51 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.55 -1.205 . . . . 0.0 111.274 -179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.3 140.0 81.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.457 2.104 . . . . 0.0 112.033 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.15 -18.39 1.46 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -78.36 -32.38 48.96 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.203 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.859 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -67.14 -40.95 86.84 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -61.98 -48.54 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 114.906 -1.043 . . . . 0.0 108.646 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.68 -53.18 55.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.232 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.62 -46.93 77.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.837 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.859 HG23 ' O ' ' A' ' 52' ' ' ARG . 37.0 t -66.4 -31.84 55.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.714 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 mt -62.1 -32.2 72.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.613 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -56.78 -24.48 50.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.741 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -96.22 -17.88 20.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.905 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.49 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -101.72 32.77 3.24 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.478 0.656 . . . . 0.0 110.816 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 58' ' ' GLU . 27.2 p -67.52 -13.71 62.29 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.212 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 p -88.44 -22.65 23.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.778 0.323 . . . . 0.0 111.368 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.49 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -57.54 141.32 48.23 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.027 179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' O ' HG22 ' A' ' 72' ' ' ILE . 3.4 mt-10 -79.1 127.0 31.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.05 0.452 . . . . 0.0 111.414 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.447 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.8 m-85 -101.74 173.13 6.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.263 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -151.46 146.95 26.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.941 0.4 . . . . 0.0 111.492 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm 66.68 -102.54 0.07 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.865 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -91.85 -10.05 41.12 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 120.95 30.42 1.35 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.028 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.01 170.65 10.93 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.651 HD12 ' O ' ' A' ' 37' ' ' VAL . 3.1 mp -79.84 114.28 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.239 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.6 tt -109.82 -28.93 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.246 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.783 ' CA ' HD11 ' A' ' 31' ' ' LEU . . . 95.43 -179.16 35.93 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.471 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -149.63 67.17 1.0 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.536 ' C ' HD12 ' A' ' 76' ' ' LEU . . . -113.67 25.82 10.67 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.555 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.536 HD12 ' C ' ' A' ' 75' ' ' GLY . 4.8 mp -149.17 156.16 41.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.833 0.349 . . . . 0.0 110.955 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.721 HG21 HG23 ' A' ' 81' ' ' THR . 1.3 t -101.19 159.04 15.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.905 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mt -66.35 -43.79 85.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.992 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -103.59 147.46 27.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.966 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -60.8 128.59 37.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.721 HG23 HG21 ' A' ' 77' ' ' THR . 32.1 p -106.9 -174.46 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.4 -34.45 12.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.432 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 52.2 m-85 -81.15 110.48 16.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.606 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.57 137.25 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.103 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.844 ' CE2' HD23 ' A' ' 101' ' ' LEU . 36.4 t80 -126.82 105.6 8.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.567 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -98.58 126.55 44.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.685 0.279 . . . . 0.0 110.984 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.546 HG21 ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.07 127.19 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 59.18 -77.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.296 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 87' ' ' ILE . 19.4 t0 -160.11 35.34 0.17 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.483 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -138.42 114.05 9.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.503 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -77.82 86.4 4.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.06 0.457 . . . . 0.0 110.894 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -71.73 164.84 25.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.704 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -136.76 162.89 31.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.327 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.607 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -149.59 167.22 26.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.011 0.434 . . . . 0.0 112.068 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -98.88 -8.96 24.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.126 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.432 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -161.15 172.77 16.16 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.983 179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.673 ' HB1' ' CE2' ' A' ' 164' ' ' PHE . . . -55.35 -24.2 28.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.273 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.904 HD22 ' N ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -94.62 -38.03 11.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.175 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.904 ' N ' HD22 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -53.84 -22.0 8.8 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.708 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -60.12 -35.07 74.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.739 0.304 . . . . 0.0 110.482 -179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.844 HD23 ' CE2' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -169.66 147.12 3.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.988 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.699 ' H ' HD13 ' A' ' 101' ' ' LEU . 2.8 tt -107.29 -43.09 6.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.245 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.45 ' N ' HG23 ' A' ' 102' ' ' ILE . 22.6 m-85 -129.57 72.47 81.95 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.05 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.593 ' N ' HD12 ' A' ' 101' ' ' LEU . 26.8 Cg_exo -62.47 -21.06 72.29 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.642 2.228 . . . . 0.0 112.426 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.63 -23.3 42.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.894 0.378 . . . . 0.0 111.407 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.5 tp -86.02 -24.42 26.43 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.589 HG22 ' O ' ' A' ' 104' ' ' PRO . 1.3 tp -57.99 -47.99 85.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.133 0.492 . . . . 0.0 111.679 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.73 19.29 27.49 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.785 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -153.17 175.49 12.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 0.0 111.001 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -78.79 150.15 32.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.799 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.793 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.15 110.03 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -81.26 120.19 24.59 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.852 0.834 . . . . 0.0 111.114 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.807 HG22 ' CD1' ' A' ' 85' ' ' PHE . 33.4 t -111.53 131.01 64.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.15 -1.386 . . . . 0.0 112.024 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.3 m -119.57 137.57 53.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.947 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.529 ' HB2' HG23 ' A' ' 124' ' ' VAL . 1.0 OUTLIER -140.74 172.6 12.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.442 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -135.45 131.76 36.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.681 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.0 m -57.12 123.6 15.84 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.863 0.363 . . . . 0.0 111.963 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -68.06 -9.01 42.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.615 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.681 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.49 -50.6 1.98 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.545 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -76.8 -20.36 56.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.816 0.341 . . . . 0.0 110.935 -178.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.49 33.28 84.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.344 -0.932 . . . . 0.0 111.168 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.545 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -101.4 168.67 8.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.295 . . . . 0.0 110.426 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.422 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 41.6 Cg_endo -94.55 111.13 0.16 Allowed 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 123.043 2.495 . . . . 0.0 111.529 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.752 HG12 ' CD ' ' A' ' 138' ' ' PRO . 34.5 m -110.57 149.32 13.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.569 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.859 ' O ' HD13 ' A' ' 126' ' ' LEU . 76.0 p -149.36 141.82 24.3 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.337 0.589 . . . . 0.0 110.731 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.859 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -133.37 152.42 51.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.131 178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.867 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 60.6 m -112.02 113.06 25.14 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.552 HG22 ' HZ ' ' A' ' 193' ' ' PHE . 23.3 t -96.31 111.88 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 120.626 -0.429 . . . . 0.0 111.351 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.3 p -106.47 175.88 1.89 Allowed Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.212 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -70.11 -13.4 33.74 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.562 2.174 . . . . 0.0 113.192 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.1 t -120.31 -27.7 5.18 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 179.73 -162.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.023 0.439 . . . . 0.0 110.201 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.725 HG23 ' CZ ' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -96.67 155.08 3.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.863 178.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -142.87 19.39 1.98 Allowed 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.347 0.594 . . . . 0.0 112.589 -179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.867 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.15 86.18 0.08 Allowed 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.686 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.517 HG13 HD12 ' A' ' 126' ' ' LEU . 24.5 t -104.83 122.07 57.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.106 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -146.13 124.19 6.28 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.869 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.752 ' CD ' HG12 ' A' ' 124' ' ' VAL . 60.1 Cg_endo -72.3 158.65 96.9 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.226 0.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.31 78.43 0.54 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.224 0.535 . . . . 0.0 110.645 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.41 18.14 0.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.195 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.661 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.5 OUTLIER -60.78 161.14 8.37 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.047 0.423 . . . . 0.0 111.225 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -132.21 152.09 51.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.776 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.929 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -110.15 150.49 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.372 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 68.3 m -123.51 147.45 47.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.92 0.391 . . . . 0.0 111.203 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.62 HD23 ' N ' ' A' ' 146' ' ' VAL . 2.6 tt -129.28 157.81 40.84 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.515 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.914 HG12 ' HD3' ' A' ' 148' ' ' PRO . 20.0 t -125.56 142.12 43.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.904 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.32 68.69 26.77 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.993 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.914 ' HD3' HG12 ' A' ' 146' ' ' VAL . 90.8 Cg_endo -87.82 146.25 6.79 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.922 2.415 . . . . 0.0 112.466 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 59.28 20.84 9.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 121.462 0.649 . . . . 0.0 111.457 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 63.19 86.46 0.12 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.779 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 63.48 106.84 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.095 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -115.84 93.45 4.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.075 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.87 -68.36 0.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.841 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 154' ' ' VAL . 10.8 p -143.31 123.22 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.051 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.28 -68.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 9.2 tp60 -157.52 33.02 0.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 53.7 m -145.16 81.89 1.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -139.6 28.93 2.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.107 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 17.0 p -77.29 -42.74 35.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.914 0.387 . . . . 0.0 110.674 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 161' ' ' HIS . 1.8 m -163.19 -78.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.455 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.666 ' O ' HG23 ' A' ' 146' ' ' VAL . 0.8 OUTLIER 83.69 -51.58 0.14 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.725 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.59 110.95 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -124.67 169.25 12.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.574 0.702 . . . . 0.0 109.756 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.929 ' CE1' HG22 ' A' ' 143' ' ' VAL . 6.2 m-85 -110.63 152.53 26.37 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.982 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 118' ' ' ALA . 18.1 m-85 -134.62 137.06 43.36 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.42 0.629 . . . . 0.0 110.31 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.635 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -37.93 -30.67 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.739 -1.118 . . . . 0.0 113.109 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.52 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 18.7 m -172.6 -179.97 2.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.157 0.503 . . . . 0.0 111.65 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 84.2 t -69.69 -33.49 3.75 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.563 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.693 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.1 Cg_exo -72.94 -39.05 2.5 Favored 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 122.604 2.203 . . . . 0.0 110.5 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.601 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.48 -39.69 52.45 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.122 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.689 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.61 -45.81 92.51 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.3 mt-10 -78.99 -27.39 43.36 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.316 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.693 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.6 t70 -70.51 -55.86 7.93 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.355 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.681 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.7 t-105 -64.91 -28.31 69.44 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.786 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -66.83 -38.68 86.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.264 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 6.8 t -51.45 -42.53 61.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.454 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 6.1 mtpp -94.25 20.48 8.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.363 0.602 . . . . 0.0 111.458 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.55 ' O ' HD22 ' A' ' 184' ' ' LEU . 1.3 m170 -129.62 29.46 5.04 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.759 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -91.51 -166.62 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.48 -32.98 5.98 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.385 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.7 mt -59.17 -175.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.738 0.304 . . . . 0.0 110.793 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.417 ' HB2' ' HA ' ' A' ' 148' ' ' PRO . 4.1 mt-10 -97.99 33.52 2.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.833 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 163.15 -105.43 0.25 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.419 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.55 HD22 ' O ' ' A' ' 178' ' ' HIS . 5.1 tp 62.15 118.74 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.363 . . . . 0.0 110.761 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.83 150.14 39.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 111.518 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.571 HD11 ' HB2' ' A' ' 175' ' ' ALA . 11.9 mm -99.84 160.32 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.611 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.694 HG23 ' HB ' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -157.49 157.72 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.367 0.603 . . . . 0.0 112.198 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.9 OUTLIER -88.41 125.47 34.74 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.542 178.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.661 HG11 ' HG3' ' A' ' 141' ' ' MET . 0.3 OUTLIER -45.9 -21.21 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.556 179.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.407 ' N ' ' C ' ' A' ' 188' ' ' SER . 47.7 m170 -67.58 -40.1 84.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.2 mt-10 -82.32 -27.7 32.1 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.094 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -61.8 -24.71 67.03 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.953 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.725 ' CZ ' HG23 ' A' ' 133' ' ' ILE . 0.6 OUTLIER -79.31 -24.76 42.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.625 179.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.94 -29.71 33.8 Favored Glycine 0 CA--C 1.508 -0.382 0 N-CA-C 111.404 -0.679 . . . . 0.0 111.404 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.27 -28.55 31.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.97 -27.92 32.82 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -82.19 -25.48 34.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.816 0.341 . . . . 0.0 110.839 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -81.05 -22.97 38.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.193 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -51.82 -39.64 59.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.217 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -76.15 -49.35 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -56.27 -39.45 72.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . 0.652 ' O ' HG23 ' A' ' 206' ' ' THR . 0.0 OUTLIER -80.0 -44.79 19.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.951 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 16.7 tp -59.04 -23.13 61.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.165 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.0 tp -81.0 -52.14 7.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -100.66 88.98 3.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 202' ' ' HIS . 0.8 OUTLIER -146.02 -47.38 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.865 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.88 177.05 8.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 54.8 m 60.67 108.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.5 m -75.68 84.75 2.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.54 110.57 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.938 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.789 HG22 ' HD3' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -70.99 -34.56 3.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.753 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.789 ' HD3' HG22 ' A' ' 211' ' ' THR . 60.5 Cg_exo . . . . . 0 C--O 1.249 1.062 0 C-N-CA 121.973 1.782 . . . . 0.0 112.475 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.718 0.294 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -148.37 81.97 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.491 HD23 ' N ' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -130.76 -179.18 5.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.906 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.749 HD13 ' HG ' ' A' ' 106' ' ' LEU . 9.2 mt -137.85 174.24 10.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.805 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 25' ' ' VAL . 23.4 m -57.86 109.33 1.71 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.219 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.715 ' HB2' HD11 ' A' ' 46' ' ' LEU . 48.9 Cg_exo -55.84 -21.07 31.41 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.45 2.1 . . . . 0.0 112.484 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.608 HD11 HG21 ' A' ' 71' ' ' ILE . 8.6 tp -53.39 -57.48 10.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.995 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.776 HD11 HG21 ' A' ' 102' ' ' ILE . 1.3 tt -59.26 -26.78 65.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.183 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.29 -53.35 37.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.032 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -28.8 56.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.398 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 28' ' ' LEU . 8.1 tt -70.57 -52.05 24.22 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.733 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.499 ' HB2' HD23 ' A' ' 28' ' ' LEU . . . -53.54 -26.4 21.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.142 0.496 . . . . 0.0 111.058 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -68.21 -21.63 64.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.172 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.04 45.72 95.44 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.067 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -133.07 150.16 74.76 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.678 0.275 . . . . 0.0 110.767 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -52.85 106.08 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.63 2.22 . . . . 0.0 112.342 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.715 HG23 HG22 ' A' ' 41' ' ' THR . 10.7 p -113.51 109.96 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.176 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.9 p -85.85 -172.2 3.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.872 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 43' ' ' ALA . 6.2 ptt180 -78.03 -35.32 49.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.227 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -26.52 67.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.845 0.355 . . . . 0.0 110.206 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.715 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.59 -42.45 14.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.341 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 42' ' ' LEU . 10.0 tp -63.2 -36.0 82.18 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.639 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.45 -42.94 61.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.543 177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.29 -30.94 73.73 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.694 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.592 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -78.68 -44.59 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 121.0 0.429 . . . . 0.0 110.498 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 26' ' ' PRO . 7.2 mp -76.26 -10.08 59.13 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.405 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.03 21.76 10.91 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.441 ' CH2' ' CZ ' ' A' ' 52' ' ' ARG . 10.6 m95 -107.57 136.77 19.59 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.265 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.2 142.41 16.44 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.5 2.133 . . . . 0.0 112.286 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.77 -16.86 1.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -77.88 -34.46 51.55 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.325 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.753 ' O ' HG23 ' A' ' 56' ' ' VAL . 7.5 tpt180 -67.01 -40.64 87.34 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.639 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.62 -48.11 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.613 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HA ' HD12 ' A' ' 57' ' ' LEU . . . -53.43 -53.38 52.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.354 178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.94 -45.1 71.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.877 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 52' ' ' ARG . 32.5 t -71.48 -30.23 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.723 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 54' ' ' ALA . 13.0 mt -68.06 -39.81 82.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.738 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -57.68 -45.04 86.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.66 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -66.9 -14.97 63.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.027 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.584 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -112.14 70.43 0.71 Allowed 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 121.67 0.748 . . . . 0.0 110.759 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.7 p -83.95 -3.87 58.29 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.247 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 2.0 p -96.41 -20.0 18.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.713 0.292 . . . . 0.0 111.333 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.584 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -52.77 141.23 21.82 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.033 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.73 126.69 31.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.154 0.502 . . . . 0.0 111.65 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.428 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 5.0 m-85 -102.92 163.06 12.43 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.287 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -148.3 133.79 18.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 111.711 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 tptt 70.28 -94.08 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.177 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.23 -15.06 20.0 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 127.95 34.48 0.55 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.124 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -92.67 159.6 15.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.874 0.368 . . . . 0.0 110.193 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.608 HG21 HD11 ' A' ' 27' ' ' LEU . 2.6 mp -79.85 114.45 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.235 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 73' ' ' GLY . 2.5 tt -178.08 -44.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.038 0.447 . . . . 0.0 111.446 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.477 ' N ' HG23 ' A' ' 72' ' ' ILE . . . 66.53 -91.64 0.17 Allowed Glycine 0 C--N 1.32 -0.306 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.456 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.415 ' CZ ' HD21 ' A' ' 78' ' ' LEU . 8.0 p90 -166.89 -178.49 4.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 0.0 110.894 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.34 76.96 0.13 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.616 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 92' ' ' LEU . 8.5 mt 58.71 -86.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.783 0.325 . . . . 0.0 111.082 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.468 HG21 ' HD1' ' A' ' 95' ' ' TRP . 20.1 p -98.96 159.07 15.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.836 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.415 HD21 ' CZ ' ' A' ' 74' ' ' TYR . 1.9 mt -78.4 -50.12 12.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.07 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -97.02 156.71 16.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.993 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -67.46 129.59 40.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.918 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 39.6 p -111.76 -174.48 2.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.93 0.395 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.532 ' HG ' ' CE1' ' A' ' 116' ' ' HIS . 0.2 OUTLIER -91.82 -29.67 16.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.147 -179.866 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -82.09 111.53 18.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.603 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.5 t -105.91 139.51 26.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.019 0.437 . . . . 0.0 111.156 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.941 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 68.9 t80 -129.42 106.63 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.649 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -102.0 128.89 48.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.3 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.6 pt -138.52 124.64 24.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.583 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 61.82 -68.73 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.24 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 87' ' ' ILE . 1.3 p30 -169.33 35.21 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.253 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -137.06 113.18 9.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.1 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.409 ' O ' ' CD ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -81.0 124.69 29.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 76' ' ' LEU . 1.7 mm? -118.63 165.07 14.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.102 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.72 ' O ' HD13 ' A' ' 76' ' ' LEU . 1.5 m-85 -129.22 165.21 21.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.206 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.65 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -151.63 169.58 21.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.12 0.486 . . . . 0.0 111.984 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.468 ' HD1' HG21 ' A' ' 77' ' ' THR . 7.2 m0 -99.3 -11.83 20.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.061 178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 162' ' ' VAL . 0.9 OUTLIER -154.44 162.09 41.34 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.978 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -51.79 -22.28 3.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.769 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.86 -51.5 5.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.693 0.282 . . . . 0.0 111.288 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.65 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -41.55 -26.39 0.07 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.529 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -59.7 -32.34 70.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.309 . . . . 0.0 110.764 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.941 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 12.3 tp -148.76 167.35 25.82 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.36 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.776 HG21 HD11 ' A' ' 28' ' ' LEU . 1.1 tp -118.61 -41.19 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.958 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.431 ' N ' HG23 ' A' ' 102' ' ' ILE . 1.2 t80 -162.89 102.77 1.03 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.778 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.759 ' HG3' HD23 ' A' ' 101' ' ' LEU . 15.6 Cg_exo -68.16 -25.78 36.92 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.75 2.3 . . . . 0.0 112.556 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.05 -23.64 48.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.524 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.749 ' HG ' HD13 ' A' ' 24' ' ' LEU . 8.6 tt -83.05 -42.17 17.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.615 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 tp -53.85 -48.73 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.192 0.52 . . . . 0.0 111.631 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.52 21.53 24.04 Favored Glycine 0 C--N 1.319 -0.396 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.764 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.32 173.52 14.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.955 0.407 . . . . 0.0 111.025 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -78.33 151.54 32.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.868 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.822 ' HB1' ' CE1' ' A' ' 85' ' ' PHE . . . -136.67 109.72 7.71 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.3 mtt-85 -82.28 119.76 24.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.761 0.791 . . . . 0.0 111.08 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 56.2 t -110.07 127.46 66.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.513 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.6 m -116.41 137.23 52.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.248 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.664 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.5 m -140.97 172.91 12.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.379 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.532 ' CE1' ' HG ' ' A' ' 82' ' ' SER . 2.6 p80 -133.58 130.23 38.11 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.689 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.3 m -56.76 122.53 12.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.943 0.402 . . . . 0.0 111.841 -178.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.17 -9.72 42.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.615 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.72 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.81 -51.14 2.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.963 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.552 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -75.5 -21.8 57.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.836 0.351 . . . . 0.0 110.728 -179.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.12 34.06 87.83 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.948 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.552 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -103.09 166.26 12.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.409 -0.395 . . . . 0.0 110.516 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -91.6 111.23 0.31 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.996 2.464 . . . . 0.0 111.196 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.796 HG12 ' HD2' ' A' ' 138' ' ' PRO . 22.0 m -107.7 146.42 13.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.485 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.722 ' C ' HD23 ' A' ' 126' ' ' LEU . 93.2 p -144.91 142.59 29.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.394 0.616 . . . . 0.0 110.216 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.722 HD23 ' C ' ' A' ' 125' ' ' SER . 0.1 OUTLIER -132.91 154.13 50.71 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.539 179.689 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.839 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 22.4 m -110.79 112.38 24.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.376 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.723 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 2.8 t -96.87 111.99 28.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 120.913 0.387 . . . . 0.0 111.423 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 m -108.31 160.73 25.96 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.167 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.23 -16.44 40.5 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.516 2.144 . . . . 0.0 112.968 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 78.1 p -114.35 -27.31 7.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 131' ' ' SER . 0.4 OUTLIER 178.95 -162.83 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.165 0.507 . . . . 0.0 110.061 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.632 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -94.8 166.24 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.657 178.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -155.17 19.39 0.43 Allowed 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.839 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.14 85.79 0.07 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.973 178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.56 HG13 ' SD ' ' A' ' 141' ' ' MET . 51.5 t -100.37 114.87 40.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.522 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -146.37 125.24 6.47 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.235 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.796 ' HD2' HG12 ' A' ' 124' ' ' VAL . 71.6 Cg_endo -76.99 155.68 97.46 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 123.515 -1.452 . . . . 0.0 111.847 -0.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.7 161.32 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 67.41 11.68 59.87 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.68 -0.772 . . . . 0.0 113.132 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.658 ' SD ' HD22 ' A' ' 126' ' ' LEU . 12.6 ptp -61.55 156.59 19.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.151 0.501 . . . . 0.0 111.844 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.534 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.03 152.38 49.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.183 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.685 HG13 ' CD1' ' A' ' 164' ' ' PHE . 11.4 t -113.25 151.64 15.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.688 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.477 ' C ' HD12 ' A' ' 145' ' ' LEU . 14.8 p -120.62 139.51 52.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.795 0.331 . . . . 0.0 110.769 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 144' ' ' SER . 5.3 mp -139.06 176.34 8.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.832 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.671 HG21 ' HB3' ' A' ' 158' ' ' PHE . 21.8 t -112.89 151.23 14.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.938 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.511 HD23 HE21 ' A' ' 149' ' ' GLN . 4.4 tp -56.98 109.01 1.42 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.013 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.4 135.84 29.9 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.526 2.151 . . . . 0.0 112.315 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.511 HE21 HD23 ' A' ' 147' ' ' LEU . 58.0 mt-30 -147.59 145.8 29.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.836 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -97.27 23.13 7.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.074 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -113.7 -19.72 11.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.373 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.26 -69.18 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.033 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -157.96 -176.54 5.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.8 m -109.93 31.05 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.139 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.3 mtp180 -119.03 -59.21 1.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.819 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -176.65 -52.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.9 m 61.83 116.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.053 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.671 ' HB3' HG21 ' A' ' 146' ' ' VAL . 75.6 m-85 61.99 35.27 16.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.007 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -33.52 33.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.774 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 45.4 t -84.43 -0.46 52.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.437 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.579 ' CE1' HD13 ' A' ' 181' ' ' LEU . 8.2 t-80 -94.93 26.87 3.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.687 0.28 . . . . 0.0 111.304 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 96' ' ' CYS . 15.1 t -105.08 113.96 43.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.958 0.409 . . . . 0.0 110.801 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -128.34 169.39 14.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.676 0.75 . . . . 0.0 110.387 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.685 ' CD1' HG13 ' A' ' 143' ' ' VAL . 3.2 m-85 -110.48 151.54 27.42 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.678 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 118' ' ' ALA . 17.8 m-85 -129.15 137.36 51.14 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.559 0.695 . . . . 0.0 110.358 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.689 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -42.7 -28.26 0.22 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.687 -1.142 . . . . 0.0 113.125 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.738 ' HB3' ' HD2' ' A' ' 169' ' ' PRO . 1.0 OUTLIER -166.72 171.62 11.33 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.754 -179.321 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.587 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 92.6 t -68.96 -36.44 7.65 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.341 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.738 ' HD2' ' HB3' ' A' ' 167' ' ' SER . 11.4 Cg_exo -71.37 -37.14 6.02 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.749 2.299 . . . . 0.0 110.063 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.15 -40.22 53.11 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.757 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.04 -45.96 91.27 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.544 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 1.4 mm-40 -78.99 -27.66 43.38 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.557 -1.201 . . . . 0.0 110.452 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 169' ' ' PRO . 13.5 t0 -70.43 -55.61 8.61 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.72 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 30.4 t-105 -65.28 -28.98 69.71 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.712 178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.44 -39.97 94.85 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.394 178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.41 -43.7 62.05 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.396 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -96.02 22.77 7.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.113 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.456 ' O ' HD22 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -132.82 29.16 4.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.928 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -90.66 145.63 24.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.768 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 121.36 -26.11 6.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.454 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.579 HD13 ' CE1' ' A' ' 161' ' ' HIS . 5.0 mt -69.21 68.51 0.2 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.937 0.399 . . . . 0.0 111.052 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' HG3' ' CE2' ' A' ' 158' ' ' PHE . 0.1 OUTLIER 56.99 30.78 18.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.945 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 106.32 -70.47 0.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.551 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.456 HD22 ' O ' ' A' ' 178' ' ' HIS . 7.9 tp 63.68 131.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.872 0.367 . . . . 0.0 110.917 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.43 149.91 41.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.118 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.616 HD11 ' HB2' ' A' ' 175' ' ' ALA . 15.4 mm -102.11 160.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.955 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.48 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.95 163.16 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.221 0.534 . . . . 0.0 111.89 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -86.31 127.97 34.86 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.774 178.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.478 HG12 ' CG2' ' A' ' 143' ' ' VAL . 0.9 OUTLIER -45.16 -22.27 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.685 179.344 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.408 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.8 t-160 -71.9 -43.3 65.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.185 0.517 . . . . 0.0 109.785 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.3 OUTLIER -82.15 -21.0 36.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.353 179.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.45 -25.31 64.04 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.776 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.574 ' CE2' HG23 ' A' ' 133' ' ' ILE . 2.4 m-85 -81.35 -24.89 36.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.111 0.481 . . . . 0.0 110.664 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.99 -31.01 29.98 Favored Glycine 0 CA--C 1.51 -0.273 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.314 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.9 tp -81.06 -29.66 34.96 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -81.23 -26.15 52.98 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -82.18 -21.76 36.35 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.438 -0.381 . . . . 0.0 110.963 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.99 -23.01 41.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.247 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -51.76 -37.46 51.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.063 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -80.98 -40.82 23.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.79 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -30.88 65.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.035 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -65.19 -36.67 84.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.923 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -49.32 78.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.909 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.83 -30.73 65.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.984 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -75.01 -31.55 61.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.2 m -94.67 121.26 36.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.972 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.34 116.32 0.34 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.894 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 12.2 p 59.27 108.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.9 p -97.06 77.9 2.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 7.2 mmp_? 61.92 116.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.999 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.778 HG22 ' HD3' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -71.22 -34.39 3.32 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.744 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.778 ' HD3' HG22 ' A' ' 211' ' ' THR . 66.0 Cg_exo . . . . . 0 C--O 1.25 1.08 0 C-N-CA 121.96 1.774 . . . . 0.0 112.475 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.891 0.376 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.679 ' C ' HD13 ' A' ' 23' ' ' LEU . 4.1 p30 -60.35 -179.72 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.982 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.754 HD23 HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -157.5 -179.93 8.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.957 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.754 HD13 HD23 ' A' ' 23' ' ' LEU . 5.4 mp 61.01 160.57 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.896 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 25' ' ' VAL . 5.3 m -130.41 90.58 40.83 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.02 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 29' ' ' ARG . 76.3 Cg_exo -50.55 -40.43 54.75 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.676 2.25 . . . . 0.0 112.422 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.731 HD11 HD21 ' A' ' 46' ' ' LEU . 6.0 mp -52.79 -57.18 11.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.308 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 28' ' ' LEU . 5.0 tt -79.3 -27.16 42.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.051 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.41 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 3.3 ttt180 -67.52 -53.36 29.22 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.08 -26.5 66.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.6 tp -71.8 -36.77 70.39 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.802 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.26 -29.33 32.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.229 0.538 . . . . 0.0 110.836 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -19.31 65.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.142 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.18 51.75 50.15 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.061 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.6 mtp85 -127.47 165.91 26.57 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.743 0.306 . . . . 0.0 110.741 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.19 111.55 2.05 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.399 2.066 . . . . 0.0 112.097 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.872 HG23 HG22 ' A' ' 41' ' ' THR . 8.1 p -125.85 109.76 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.272 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 t -94.99 -170.06 2.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.965 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 43' ' ' ALA . 20.0 ptt-85 -72.55 -38.69 67.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.608 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -31.0 71.73 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.244 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.872 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -83.1 -41.91 18.01 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.426 HD22 HD12 ' A' ' 71' ' ' ILE . 9.3 tp -62.18 -36.69 82.64 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 176.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.56 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.41 -43.19 64.23 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.646 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.57 -31.68 76.96 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.587 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.617 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -78.95 -44.07 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 121.106 0.479 . . . . 0.0 110.423 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.731 HD21 HD11 ' A' ' 27' ' ' LEU . 6.9 mp -76.75 -9.38 58.63 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.518 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.2 t70 60.08 21.84 11.04 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.416 ' CG ' ' HD2' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -100.27 155.86 35.92 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.223 -179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 48' ' ' TRP . 57.8 Cg_endo -71.58 139.96 35.18 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.551 2.167 . . . . 0.0 112.132 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.14 -19.2 1.81 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -77.84 -35.49 51.1 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 120.986 0.422 . . . . 0.0 111.279 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.846 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.7 -40.34 88.43 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.56 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.39 -48.47 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.54 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.1 -53.93 43.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.259 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.67 75.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.938 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 52' ' ' ARG . 27.3 t -68.6 -31.01 49.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.711 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.412 HD23 HG12 ' A' ' 53' ' ' VAL . 0.9 OUTLIER -66.35 -35.62 80.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.679 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.43 -44.95 85.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.701 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -76.75 -9.78 58.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.038 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -117.4 73.62 0.89 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.723 0.773 . . . . 0.0 110.397 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 3.5 p -96.99 -24.33 15.86 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.138 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.5 m -70.26 -25.46 63.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.216 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.48 141.16 31.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.242 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.602 ' O ' HG22 ' A' ' 72' ' ' ILE . 3.4 mt-10 -78.92 126.9 31.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.063 0.459 . . . . 0.0 111.376 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.421 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 64.1 m-85 -104.29 170.85 7.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.323 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -156.12 145.43 20.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.031 0.443 . . . . 0.0 111.344 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.3 ttpp 66.74 -103.78 0.08 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.8 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -92.3 -13.57 30.13 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 125.92 30.76 0.85 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.154 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -87.34 163.44 16.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.816 HG12 HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -79.79 118.28 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.187 -179.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.796 ' O ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -93.72 -26.01 4.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.208 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.68 -170.79 13.86 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.5 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -162.9 171.17 17.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 110.919 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.3 -59.04 1.38 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.03 HD13 HD11 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -85.43 166.48 16.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.777 0.322 . . . . 0.0 110.736 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.75 HG21 ' HE1' ' A' ' 95' ' ' TRP . 18.0 p -126.43 159.61 32.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.2 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -48.18 -86.57 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.583 0.23 . . . . 0.0 110.804 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.458 ' HG3' ' CD1' ' A' ' 93' ' ' TYR . 4.6 mtp180 -173.71 98.96 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.745 0.307 . . . . 0.0 111.03 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.78 23.54 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.614 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 67.7 p -120.08 -173.66 2.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.13 0.491 . . . . 0.0 111.648 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.4 p -101.07 -25.82 13.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.209 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 97' ' ' ALA . 30.0 m-85 -87.49 116.33 25.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 110.613 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.16 144.89 17.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.066 0.46 . . . . 0.0 111.439 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.834 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 67.9 t80 -131.66 105.85 7.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.516 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -97.25 129.89 44.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.655 0.264 . . . . 0.0 111.269 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.0 OUTLIER -140.07 125.61 20.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 58.69 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 87' ' ' ILE . 17.0 t0 -154.35 37.46 0.43 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.664 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -141.48 145.85 35.73 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.297 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.04 86.59 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.904 0.383 . . . . 0.0 110.867 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.03 HD11 HD13 ' A' ' 76' ' ' LEU . 0.9 OUTLIER -71.1 164.55 25.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.388 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.458 ' CD1' ' HG3' ' A' ' 79' ' ' ARG . 2.1 m-85 -135.36 161.68 34.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.548 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.772 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -148.1 163.72 36.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.057 0.456 . . . . 0.0 111.592 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.75 ' HE1' HG21 ' A' ' 77' ' ' THR . 21.7 m0 -84.24 -20.25 32.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.509 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.441 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.8 OUTLIER -158.59 -177.38 6.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.091 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.604 ' O ' HD21 ' A' ' 101' ' ' LEU . . . -61.38 -16.45 46.58 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.57 HD12 HG21 ' A' ' 162' ' ' VAL . 1.5 tt -86.62 -51.64 6.02 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.856 ' HA ' HD11 ' A' ' 102' ' ' ILE . 0.6 OUTLIER -57.08 -21.24 30.32 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -178.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.772 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -66.1 -39.58 90.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.592 0.234 . . . . 0.0 111.491 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.604 HD21 ' O ' ' A' ' 97' ' ' ALA . 0.1 OUTLIER -92.1 -83.92 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.856 HD11 ' HA ' ' A' ' 99' ' ' ASP . 25.5 mm 78.25 -59.65 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.654 0.264 . . . . 0.0 111.113 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -151.25 65.95 6.89 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.804 0.335 . . . . 0.0 111.056 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.513 ' CB ' HG11 ' A' ' 128' ' ' VAL . 12.3 Cg_exo -71.3 -28.72 18.0 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.969 2.446 . . . . 0.0 112.551 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.6 -23.48 42.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.94 0.4 . . . . 0.0 111.584 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -81.93 -31.29 31.4 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.476 ' O ' HD12 ' A' ' 107' ' ' ILE . 1.0 OUTLIER -56.64 -46.36 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.998 0.428 . . . . 0.0 111.662 -179.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.16 19.36 21.56 Favored Glycine 0 C--N 1.319 -0.379 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.828 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.56 177.23 10.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 110.865 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -75.1 150.87 38.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.665 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.834 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.09 109.82 7.55 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 18.3 mtt180 -84.25 120.99 26.87 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.779 0.8 . . . . 0.0 110.915 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.789 HG22 ' CD1' ' A' ' 85' ' ' PHE . 46.8 t -112.51 130.94 65.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 114.304 -1.316 . . . . 0.0 112.005 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.7 m -122.22 137.61 54.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.133 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.522 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -141.21 172.86 12.09 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.031 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 121' ' ' GLY . 0.1 OUTLIER -132.1 131.37 42.3 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 34.0 m -58.15 125.85 24.98 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.03 0.443 . . . . 0.0 112.165 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -68.75 -8.03 39.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.049 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.622 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -119.0 -51.62 2.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.8 0.334 . . . . 0.0 111.189 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.612 HG21 ' HB3' ' A' ' 166' ' ' ALA . 0.9 OUTLIER -82.66 -23.9 34.01 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.465 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.409 ' N ' ' HB2' ' A' ' 117' ' ' CYS . . . 69.82 6.81 57.31 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.923 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.8 160.08 71.08 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 120.609 0.243 . . . . 0.0 110.671 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -86.55 106.79 0.76 Allowed 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.92 2.413 . . . . 0.0 111.033 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.527 ' HB ' ' CE ' ' A' ' 141' ' ' MET . 26.9 m -103.78 146.59 11.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.822 ' C ' HD13 ' A' ' 126' ' ' LEU . 62.1 p -152.42 142.17 21.95 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.333 0.587 . . . . 0.0 110.928 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.822 HD13 ' C ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -131.96 153.22 50.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.447 178.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.842 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 24.0 m -110.02 113.01 25.38 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.513 HG11 ' CB ' ' A' ' 104' ' ' PRO . 51.5 t -96.53 114.12 32.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.088 0.471 . . . . 0.0 111.955 -178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.41 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.8 OUTLIER -107.32 169.03 7.16 Favored Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.734 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 35.5 Cg_endo -65.86 -19.32 58.67 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.197 1.931 . . . . 0.0 112.885 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -110.68 -27.54 8.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.437 ' HA ' ' CE1' ' A' ' 193' ' ' PHE . 3.7 pt-20 178.85 -164.68 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.069 0.462 . . . . 0.0 110.007 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.742 HG23 ' CE2' ' A' ' 193' ' ' PHE . 0.1 OUTLIER -94.73 152.12 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.708 178.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.31 21.89 2.77 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.308 0.575 . . . . 0.0 112.445 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.842 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.77 87.4 0.09 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.814 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.498 HG13 ' SD ' ' A' ' 141' ' ' MET . 60.9 t -103.72 115.05 44.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.347 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.405 ' O ' ' CE ' ' A' ' 141' ' ' MET . 19.3 tt0 -143.13 123.76 8.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.486 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.499 ' HD2' ' HE3' ' A' ' 141' ' ' MET . 57.8 Cg_endo -70.95 162.25 87.84 Favored 'Cis proline' 0 C--N 1.351 0.68 0 C-N-CA 123.502 -1.457 . . . . 0.0 112.544 -0.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.19 79.91 1.79 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.772 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.16 18.5 0.2 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.268 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.733 ' CG ' HG11 ' A' ' 189' ' ' VAL . 0.4 OUTLIER -63.57 164.22 9.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.06 0.457 . . . . 0.0 111.708 -179.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -129.13 152.09 49.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.453 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.69 HG13 ' CD1' ' A' ' 164' ' ' PHE . 3.3 t -115.8 152.05 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.701 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 8.2 m -120.84 143.1 49.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.958 0.408 . . . . 0.0 111.242 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.54 HD13 HG22 ' A' ' 162' ' ' VAL . 1.6 mm? -123.39 159.53 28.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.604 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 161' ' ' HIS . 41.3 t -125.45 131.52 72.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.103 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.465 HD22 ' HG3' ' A' ' 149' ' ' GLN . 1.3 tt 57.68 87.57 0.14 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.016 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.58 75.02 1.6 Allowed 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.539 2.16 . . . . 0.0 112.318 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.465 ' HG3' HD22 ' A' ' 147' ' ' LEU . 4.6 mm-40 -104.21 167.09 9.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -109.0 -21.67 12.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.136 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.74 -82.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.123 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.58 -169.27 0.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.115 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 61.28 31.6 19.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.976 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 31.2 m -84.75 -32.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.18 -41.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.09 67.9 0.49 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.84 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -175.43 1.04 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.408 ' CD2' HD12 ' A' ' 147' ' ' LEU . 43.1 m-85 -113.45 29.8 7.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.006 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -75.88 -15.97 60.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.149 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 97.4 m -92.4 0.63 57.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.302 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.428 ' O ' HG23 ' A' ' 146' ' ' VAL . 10.0 m-70 -102.22 48.18 0.88 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.952 0.406 . . . . 0.0 110.818 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.57 HG21 HD12 ' A' ' 98' ' ' LEU . 22.0 t -101.14 113.6 37.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.265 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -116.69 169.15 9.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.554 0.692 . . . . 0.0 110.336 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.69 ' CD1' HG13 ' A' ' 143' ' ' VAL . 4.7 m-85 -118.64 153.52 34.17 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.076 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.612 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 59.2 m-85 -132.59 136.14 46.35 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.038 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.612 ' HB3' HG21 ' A' ' 120' ' ' THR . . . -41.87 -27.68 0.13 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.212 -0.904 . . . . 0.0 113.091 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.564 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 74.0 m -165.5 173.67 10.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.194 0.521 . . . . 0.0 111.936 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.8 t -70.0 -33.75 3.75 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.346 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.69 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.19 -37.32 3.47 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.688 2.259 . . . . 0.0 110.289 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.602 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.91 -40.27 47.91 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.483 177.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.726 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.2 -44.88 96.57 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 177.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.0 mt-10 -78.97 -27.22 43.46 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.232 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.69 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.2 t70 -71.04 -55.94 7.2 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.429 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.622 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.3 t-105 -64.59 -28.0 69.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.726 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.726 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -65.01 -40.37 94.8 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.359 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -51.25 -43.26 61.48 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.382 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -95.77 21.86 7.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.374 0.607 . . . . 0.0 111.194 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.461 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -127.71 27.42 5.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.78 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -98.91 178.06 5.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.77 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.93 -27.35 18.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.448 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.573 HD12 ' CD1' ' A' ' 184' ' ' LEU . 8.2 mt -64.84 -176.79 0.29 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.804 0.335 . . . . 0.0 110.948 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.72 58.32 4.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 100.57 143.44 14.18 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.517 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.573 ' CD1' HD12 ' A' ' 181' ' ' LEU . 0.2 OUTLIER -179.05 125.27 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.871 0.367 . . . . 0.0 110.764 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -141.89 150.09 41.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.077 0.465 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.645 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.9 mm -100.91 160.41 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.832 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.463 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -160.54 159.16 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.809 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.5 OUTLIER -86.03 124.96 33.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.908 178.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.733 HG11 ' CG ' ' A' ' 141' ' ' MET . 0.7 OUTLIER -47.83 -20.59 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.608 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -69.35 -41.41 76.63 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.6 mt-10 -82.6 -26.46 32.28 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.058 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -68.75 -25.02 64.52 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.961 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.742 ' CE2' HG23 ' A' ' 133' ' ' ILE . 7.9 t80 -81.61 -26.17 35.1 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.689 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.93 -30.06 32.84 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.1 mt -82.11 -27.35 32.88 Favored 'General case' 0 CA--C 1.513 -0.455 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.11 -26.75 35.88 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.444 ' CG ' ' CE1' ' A' ' 193' ' ' PHE . 46.6 mm-40 -81.91 -24.86 35.4 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.041 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.3 -22.96 61.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.125 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -51.97 -42.4 62.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.272 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -81.18 -29.57 34.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.005 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.66 -27.71 29.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.233 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -57.98 -29.73 65.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.958 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.5 tp -81.95 -30.01 31.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.653 ' O ' HD13 ' A' ' 204' ' ' LEU . 0.3 OUTLIER -60.28 -37.45 80.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 61.22 170.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.6 t -157.43 173.82 16.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.912 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 17.9 mtt 60.24 80.71 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.014 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 74.5 p -115.12 147.76 39.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 9.3 t -98.66 33.72 2.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.88 31.54 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.436 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -67.74 -62.8 3.05 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.983 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.2 Cg_endo . . . . . 0 C--O 1.25 1.107 0 C-N-CA 122.418 2.079 . . . . 0.0 112.367 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.509 ' HB3' HG12 ' A' ' 25' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.825 0.345 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 65.34 -77.41 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.3 tp -143.92 -47.64 0.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.868 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tp -115.62 157.34 24.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.837 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 25' ' ' VAL . 19.1 m -133.19 81.54 56.13 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.096 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.71 -46.19 35.22 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.589 2.193 . . . . 0.0 112.355 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 28' ' ' LEU . 0.6 OUTLIER -51.95 -57.24 10.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 -179.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.538 ' N ' HD12 ' A' ' 27' ' ' LEU . 2.1 mt -72.7 -27.11 61.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.814 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -63.52 -53.22 55.29 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.598 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -69.91 -26.51 64.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.163 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.58 HD11 ' CA ' ' A' ' 73' ' ' GLY . 6.0 tp -70.68 -44.2 67.49 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.686 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.22 -28.54 27.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.138 0.494 . . . . 0.0 110.89 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -64.77 -20.44 66.36 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.181 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.37 54.05 25.57 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.296 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 -133.04 165.36 37.33 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.727 0.298 . . . . 0.0 110.719 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.38 113.5 3.33 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.464 2.109 . . . . 0.0 112.088 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.717 HG13 HG22 ' A' ' 41' ' ' THR . 31.7 t -117.98 109.88 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.458 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.2 p -87.97 179.63 6.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.836 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -70.13 -37.46 75.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.306 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -30.11 70.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.849 0.357 . . . . 0.0 110.074 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.717 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -82.92 -41.96 18.25 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.738 ' CD1' HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -62.49 -37.02 84.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.63 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -71.64 -43.29 66.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.626 177.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.68 -31.03 72.87 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.807 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.585 HD12 HG23 ' A' ' 41' ' ' THR . 6.8 mt -78.59 -43.98 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 CA-C-O 120.997 0.427 . . . . 0.0 110.519 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.539 HD12 HG22 ' A' ' 45' ' ' ILE . 7.2 mp -76.06 -10.18 59.21 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.387 178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 61.0 21.41 11.75 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.412 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 29.6 m95 -107.26 138.78 19.98 Favored Pre-proline 0 N--CA 1.453 -0.3 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.018 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.34 140.54 34.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.74 2.294 . . . . 0.0 112.053 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.33 -16.88 0.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -78.86 -31.86 45.78 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.292 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.76 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -68.61 -40.86 80.21 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.63 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.64 -47.62 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.635 177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.83 -52.35 57.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.442 -1.254 . . . . 0.0 110.352 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.22 -43.09 67.0 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.786 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 52' ' ' ARG . 21.8 t -69.7 -33.58 57.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.756 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.2 mt -61.75 -35.88 79.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.657 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.685 ' O ' HG23 ' A' ' 61' ' ' THR . 5.6 tt0 -57.55 -26.33 61.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.717 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -90.49 -16.46 28.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.028 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' A' ' 63' ' ' THR . . . -98.61 33.58 2.24 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.398 0.618 . . . . 0.0 111.006 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 58' ' ' GLU . 65.6 p -58.93 -20.88 56.02 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.009 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.3 p -88.76 -22.94 23.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.352 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.404 ' HB ' ' HB1' ' A' ' 60' ' ' ALA . 0.8 OUTLIER -59.41 141.21 55.15 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.327 179.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.842 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -85.37 132.16 34.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.112 0.482 . . . . 0.0 111.685 -179.276 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.43 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 76.9 m-85 -105.73 173.23 6.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.959 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -150.37 146.8 26.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.047 0.451 . . . . 0.0 111.535 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 tptt 66.28 -102.64 0.08 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.853 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -90.36 -10.46 43.91 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 119.94 29.56 1.65 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.951 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -86.01 171.31 11.51 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.738 HD13 ' CD1' ' A' ' 42' ' ' LEU . 4.1 mp -79.76 116.8 24.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.316 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.842 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.7 tt -86.49 -25.54 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.252 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.58 ' CA ' HD11 ' A' ' 31' ' ' LEU . . . 98.64 152.22 27.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.441 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -108.65 159.39 16.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.961 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.85 -50.56 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.493 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.774 HD22 ' CD1' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -93.56 156.1 16.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.836 0.35 . . . . 0.0 110.926 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 79' ' ' ARG . 4.8 t -111.01 159.0 18.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.864 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.27 -25.82 64.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.745 ' O ' HG23 ' A' ' 77' ' ' THR . 1.0 OUTLIER -102.86 146.99 27.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.005 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -63.56 129.63 40.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.533 HG23 HG21 ' A' ' 77' ' ' THR . 27.9 p -106.36 -176.47 3.09 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.011 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.1 m -89.57 -31.83 17.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.82 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.439 ' CE2' ' N ' ' A' ' 97' ' ' ALA . 5.3 m-85 -89.53 117.67 28.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.446 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 20.8 t -108.75 139.12 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.078 0.466 . . . . 0.0 111.114 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.876 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 30.3 t80 -123.1 106.92 11.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.887 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -98.2 124.08 42.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.741 0.305 . . . . 0.0 111.144 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.623 HG21 ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.15 126.29 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.62 -77.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.317 178.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.0 t70 -156.11 37.0 0.34 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.633 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -141.45 147.44 37.91 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.578 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.2 86.41 2.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 0.0 110.752 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.774 ' CD1' HD22 ' A' ' 76' ' ' LEU . 3.9 mm? -71.46 164.49 25.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.628 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -131.88 158.9 40.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.749 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.509 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -143.52 163.03 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.281 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.8 m95 -88.33 -5.64 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.137 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.43 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 0.0 OUTLIER 176.06 -175.2 0.11 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.006 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.453 ' CB ' ' CD1' ' A' ' 164' ' ' PHE . . . -61.3 149.42 38.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.76 0.315 . . . . 0.0 110.761 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 97' ' ' ALA . 20.0 mt 82.62 -52.32 0.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.509 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -48.05 -25.09 1.28 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.937 0.399 . . . . 0.0 111.166 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.493 ' HB ' ' CD1' ' A' ' 85' ' ' PHE . 3.1 p -60.15 -39.32 85.95 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.759 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.876 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 22.9 tp -131.4 165.17 24.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.228 0.537 . . . . 0.0 111.842 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.753 HD12 ' CE2' ' A' ' 103' ' ' PHE . 3.3 pt -121.92 -37.34 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.885 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.753 ' CE2' HD12 ' A' ' 102' ' ' ILE . 2.4 p90 -165.61 103.29 0.74 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.84 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.631 ' HB3' HG12 ' A' ' 128' ' ' VAL . 74.0 Cg_endo -75.15 -27.58 9.65 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.745 2.297 . . . . 0.0 112.897 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.17 -23.65 54.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.703 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.71 -40.99 16.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.58 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 tp -56.0 -49.22 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.183 0.516 . . . . 0.0 111.531 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.04 24.02 18.34 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.768 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -152.41 173.24 15.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.064 0.459 . . . . 0.0 111.037 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.411 HG23 ' OG ' ' A' ' 129' ' ' SER . 0.9 OUTLIER -80.79 151.8 28.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.862 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.832 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.4 110.16 7.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -81.44 120.23 24.73 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.719 0.771 . . . . 0.0 111.448 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.745 HG22 ' HD1' ' A' ' 85' ' ' PHE . 58.6 t -112.55 129.63 67.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.381 -1.282 . . . . 0.0 111.79 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 m -122.49 137.15 54.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.393 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.554 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -141.76 173.1 11.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.179 179.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -134.85 135.44 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 36.2 t -64.35 133.83 53.41 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.532 . . . . 0.0 112.132 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -71.43 -4.05 24.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.214 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.897 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -123.37 -51.04 1.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.878 0.37 . . . . 0.0 111.673 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.732 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -87.38 -25.1 24.0 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.016 -179.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.21 5.58 72.01 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.094 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.732 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.7 147.19 72.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.618 0.247 . . . . 0.0 110.513 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.35 104.7 1.66 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.56 2.174 . . . . 0.0 110.422 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.554 HG22 ' C ' ' A' ' 115' ' ' SER . 35.3 m -101.4 145.65 11.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.397 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.89 ' O ' HD13 ' A' ' 126' ' ' LEU . 71.1 p -152.53 142.07 21.75 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.484 0.659 . . . . 0.0 110.929 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.986 HD11 ' CE ' ' A' ' 141' ' ' MET . 0.1 OUTLIER -134.88 153.12 52.18 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.464 178.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.873 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.2 m -109.36 113.09 25.61 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.631 HG12 ' HB3' ' A' ' 104' ' ' PRO . 29.2 t -96.1 111.86 27.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.118 0.485 . . . . 0.0 111.819 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.411 ' OG ' HG23 ' A' ' 110' ' ' THR . 0.4 OUTLIER -106.59 175.51 2.03 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.975 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.43 -6.25 18.76 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.548 2.166 . . . . 0.0 113.286 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.9 m -122.77 -31.31 3.71 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 193' ' ' PHE . 14.5 pt-20 -179.7 -162.3 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.146 0.498 . . . . 0.0 110.005 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -91.78 144.3 9.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.563 178.234 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -133.6 18.2 3.93 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.392 0.615 . . . . 0.0 112.412 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.873 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.03 86.34 0.08 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.523 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.668 HG13 HD12 ' A' ' 126' ' ' LEU . 37.2 t -105.65 120.62 56.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.898 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -146.21 122.14 5.69 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.08 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.458 ' HD2' HG12 ' A' ' 124' ' ' VAL . 53.2 Cg_endo -68.23 167.73 63.35 Favored 'Cis proline' 0 C--N 1.349 0.59 0 C-N-CA 123.626 -1.406 . . . . 0.0 112.951 -0.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.7 83.7 7.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.97 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 140.87 21.08 0.3 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.659 -0.701 . . . . 0.0 113.046 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.986 ' CE ' HD11 ' A' ' 126' ' ' LEU . 9.1 mtp -60.98 164.72 4.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.144 0.497 . . . . 0.0 111.968 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -131.92 151.87 51.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.82 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.702 HG13 ' CD1' ' A' ' 164' ' ' PHE . 7.6 t -112.77 148.98 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.417 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 162' ' ' VAL . 64.4 m -118.29 143.53 46.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.77 0.319 . . . . 0.0 110.854 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.42 ' HA ' ' CG1' ' A' ' 162' ' ' VAL . 0.6 OUTLIER -99.9 147.23 25.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.954 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 146' ' ' VAL . 9.0 p -125.12 107.92 18.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.971 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.607 HD11 ' CB ' ' A' ' 182' ' ' GLU . 1.4 mm? 62.49 84.96 0.18 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -69.31 158.38 57.75 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.57 2.18 . . . . 0.0 112.246 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -146.28 138.74 25.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -100.68 -21.08 15.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -156.61 77.66 0.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.102 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -171.89 146.27 2.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.058 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -176.11 37.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.2 p -109.17 -36.27 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.085 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -169.16 -42.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.954 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -59.27 -31.81 69.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.978 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.0 t -68.02 118.78 11.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.007 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -123.89 28.9 6.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.976 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 29.7 p -81.01 -23.85 38.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.075 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 37.3 t -65.44 -22.48 66.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.251 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 161' ' ' HIS . 3.1 m-70 -112.78 54.54 0.72 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.813 0.34 . . . . 0.0 111.037 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 144' ' ' SER . 0.7 OUTLIER -83.01 174.99 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.38 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -113.68 159.45 19.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.679 0.752 . . . . 0.0 110.177 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.702 ' CD1' HG13 ' A' ' 143' ' ' VAL . 2.3 m-85 -116.9 129.74 56.26 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.837 178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.617 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 29.8 m-85 -108.53 142.39 39.02 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.449 0.642 . . . . 0.0 110.796 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -49.19 -26.15 2.68 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.888 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.608 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 50.7 m -163.3 167.68 21.54 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.862 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 75.1 t -67.92 -33.64 5.35 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.07 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.704 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.4 Cg_exo -73.01 -37.49 3.49 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.667 2.244 . . . . 0.0 110.336 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.586 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.16 -40.59 52.19 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.716 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.8 -45.94 91.67 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.9 mt-10 -78.81 -27.39 44.4 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.313 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.704 ' N ' ' O ' ' A' ' 169' ' ' PRO . 9.5 t70 -70.65 -55.86 7.79 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.383 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.897 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 41.9 t-105 -64.91 -28.62 69.66 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.765 178.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.9 -40.72 95.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.317 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 40.7 t -50.85 -42.55 58.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.369 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.1 20.87 8.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.308 0.575 . . . . 0.0 111.271 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -124.5 25.01 7.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.788 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -95.12 -176.04 3.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.83 -29.85 9.29 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.424 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.535 HD13 ' CD1' ' A' ' 184' ' ' LEU . 1.2 mt -64.5 -175.14 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.86 0.362 . . . . 0.0 110.852 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.607 ' CB ' HD11 ' A' ' 147' ' ' LEU . 1.7 mt-10 -60.02 -20.51 58.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.259 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 147.92 135.0 2.55 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.585 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.535 ' CD1' HD13 ' A' ' 181' ' ' LEU . 1.3 mp -147.59 146.8 29.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.17 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.094 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.684 HD11 ' HB2' ' A' ' 175' ' ' ALA . 14.5 mm -102.32 162.01 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.937 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.487 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -161.69 166.11 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.265 0.555 . . . . 0.0 111.794 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.41 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -89.59 128.13 35.99 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.014 178.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.445 HG12 ' CG2' ' A' ' 143' ' ' VAL . 1.4 m -45.88 -21.71 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.621 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.402 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.8 t60 -71.47 -42.72 67.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.215 0.531 . . . . 0.0 109.98 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -82.28 -21.58 36.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.49 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -73.86 -25.23 59.95 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.092 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 132' ' ' GLU . 72.7 t80 -81.6 -24.77 36.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.585 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.84 -29.11 35.86 Favored Glycine 0 CA--C 1.509 -0.29 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 3.3 mp -82.06 -28.4 32.44 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.32 -28.84 29.26 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.543 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 1.3 tm0? -82.24 -25.26 34.28 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.575 -0.312 . . . . 0.0 111.28 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -76.86 -22.79 52.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.124 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -51.82 -33.63 36.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.963 0.411 . . . . 0.0 111.082 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -81.06 -53.78 6.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 3.7 ttt-85 -55.03 -29.39 57.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.066 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -59.05 -30.57 68.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.911 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 206' ' ' THR . 8.4 mp -66.55 -40.93 89.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.869 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.3 mp -60.02 -35.86 75.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.836 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 68.6 mm-40 -98.27 36.53 1.58 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 203' ' ' LEU . 1.1 p -61.4 150.35 35.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.913 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 6.6 ptp -141.28 120.69 13.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.31 135.82 40.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.6 m -137.72 -70.3 0.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.887 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.91 34.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 212' ' ' PRO . 1.1 m -176.43 -63.02 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.031 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.429 ' N ' HG22 ' A' ' 211' ' ' THR . 19.6 Cg_endo . . . . . 0 C--O 1.249 1.072 0 C-N-CA 122.397 2.065 . . . . 0.0 112.37 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.783 0.325 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -109.4 -61.91 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.911 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 mt -103.36 113.78 27.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.36 -41.33 85.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.4 m 41.17 83.37 0.21 Allowed Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.717 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.759 ' CG ' HD11 ' A' ' 46' ' ' LEU . 43.9 Cg_endo -67.91 -17.02 46.57 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.583 2.189 . . . . 0.0 112.552 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 71' ' ' ILE . 6.0 tp -52.76 -57.41 10.23 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.874 0.368 . . . . 0.0 111.01 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 31' ' ' LEU . 4.4 mm? -70.09 -27.05 64.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -59.76 -53.22 60.53 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.042 -0.527 . . . . 0.0 109.611 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.34 -23.7 61.18 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.272 178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.93 HD13 HD13 ' A' ' 28' ' ' LEU . 9.0 tt -63.13 -49.03 75.99 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.479 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.0 18.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.34 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -24.33 61.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.126 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.64 39.58 96.76 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.34 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -133.32 150.06 74.2 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.696 0.284 . . . . 0.0 110.755 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.67 107.07 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.559 2.172 . . . . 0.0 111.978 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.726 HG23 HG22 ' A' ' 41' ' ' THR . 14.0 p -99.23 112.1 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.519 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 p -93.32 175.62 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.422 ' O ' ' N ' ' A' ' 43' ' ' ALA . 2.1 mpp_? -65.26 -40.33 93.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.302 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.5 -25.09 67.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.869 0.366 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.726 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.11 -43.3 13.17 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -62.79 -36.28 82.61 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 176.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.691 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.2 -43.0 62.05 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 113.992 -1.458 . . . . 0.0 109.595 177.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.79 -30.7 72.58 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.697 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.588 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -78.42 -44.75 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-O 120.999 0.428 . . . . 0.0 110.563 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.759 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.2 mp -75.65 -9.85 58.93 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.491 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.7 t70 59.72 21.92 10.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.446 ' CZ2' ' NH1' ' A' ' 52' ' ' ARG . 1.8 m0 -109.27 146.02 33.03 Favored Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.217 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.13 143.18 52.4 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.557 2.171 . . . . 0.0 112.063 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.19 -16.9 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.65 -33.61 47.04 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.236 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.632 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.95 -41.2 82.83 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.851 HG13 HD23 ' A' ' 42' ' ' LEU . 2.1 t -63.29 -47.65 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.544 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.579 ' HA ' HD13 ' A' ' 57' ' ' LEU . . . -53.49 -52.32 59.93 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.436 -1.256 . . . . 0.0 110.269 178.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.67 -36.65 25.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.019 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 52' ' ' ARG . 28.9 t -59.4 -35.81 60.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.035 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.579 HD13 ' HA ' ' A' ' 54' ' ' ALA . 3.7 mp -60.93 -32.43 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.873 0.368 . . . . 0.0 110.723 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.423 ' O ' HG23 ' A' ' 61' ' ' THR . 1.9 tp10 -58.65 -34.8 71.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.467 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -100.19 -20.42 15.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.87 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.494 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -102.59 33.44 3.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.476 0.655 . . . . 0.0 110.742 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 58' ' ' GLU . 32.1 p -66.99 -13.87 62.32 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.343 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.1 p -88.02 -23.57 23.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.325 . . . . 0.0 111.359 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.494 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -58.22 141.47 50.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.016 179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.68 126.99 31.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 111.326 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -102.1 173.13 6.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.465 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.409 ' HB2' ' ND2' ' A' ' 70' ' ' ASN . 6.6 t0 -97.18 -172.88 2.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.588 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -34.5 76.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.955 0.407 . . . . 0.0 111.128 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.28 1.7 55.36 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.343 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.05 14.45 60.62 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.267 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 66' ' ' ASP . 1.1 p-10 -86.79 146.82 26.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.491 0.645 . . . . 0.0 109.881 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.579 ' O ' HG22 ' A' ' 72' ' ' ILE . 1.7 mp -79.76 143.28 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.905 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 71' ' ' ILE . 0.4 OUTLIER 90.5 -23.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.692 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 53.91 -91.73 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.613 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -131.9 -45.78 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.337 . . . . 0.0 110.818 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -151.63 -160.49 9.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.461 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 mt -110.68 -33.37 6.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.983 0.42 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.615 HG22 ' CD1' ' A' ' 95' ' ' TRP . 0.6 OUTLIER -111.01 159.53 17.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.72 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.72 24.96 1.14 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.619 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 51.56 96.07 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.808 0.337 . . . . 0.0 111.505 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -156.21 -84.76 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.483 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -43.37 163.7 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.844 0.354 . . . . 0.0 111.592 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 84' ' ' VAL . 65.3 m -82.18 -5.88 58.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.97 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -66.21 96.77 0.35 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 110.293 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 82' ' ' SER . 17.8 t -109.69 144.71 17.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.369 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.966 ' CZ ' HD13 ' A' ' 101' ' ' LEU . 33.5 t80 -131.16 107.57 9.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.086 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -102.72 132.46 48.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.517 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' ASP . 2.3 pt -138.74 123.0 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.396 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 62.12 -67.5 0.07 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.134 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.6 m-20 -168.54 34.82 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.304 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -135.57 112.49 10.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.968 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.628 ' C ' HD22 ' A' ' 92' ' ' LEU . 9.3 mpt_? -82.11 124.63 30.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.971 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.628 HD22 ' C ' ' A' ' 91' ' ' ARG . 2.8 mm? -115.57 165.1 13.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -129.75 165.21 22.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.994 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.787 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -153.48 170.97 19.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.939 0.4 . . . . 0.0 111.705 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.615 ' CD1' HG22 ' A' ' 77' ' ' THR . 49.6 m0 -95.25 -17.95 21.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.679 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 160' ' ' CYS . 98.9 m -152.54 166.48 31.87 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.255 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.548 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -54.21 -21.08 8.04 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.515 HD22 ' SG ' ' A' ' 160' ' ' CYS . 8.4 tt -86.93 -51.73 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.787 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 41.4 t0 -50.1 -23.23 2.0 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -60.11 -32.67 71.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.676 0.274 . . . . 0.0 110.688 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.966 HD13 ' CZ ' ' A' ' 85' ' ' PHE . 50.9 tp -140.84 162.22 35.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 111.296 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.795 HD12 ' HB2' ' A' ' 103' ' ' PHE . 2.7 pp -125.24 -39.59 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.28 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.795 ' HB2' HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -163.19 103.22 1.0 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.099 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.563 ' CB ' HG12 ' A' ' 128' ' ' VAL . 74.4 Cg_endo -74.91 -31.76 6.1 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.575 2.184 . . . . 0.0 112.609 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.08 -23.83 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.456 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -82.43 -40.89 20.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.36 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 tp -56.1 -47.15 80.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.154 0.502 . . . . 0.0 111.556 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.04 21.41 20.72 Favored Glycine 0 C--N 1.32 -0.338 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.836 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 174.68 13.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 111.01 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -79.46 151.77 30.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.671 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.824 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -137.02 109.95 7.66 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 65.0 mtm-85 -82.22 121.63 26.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.745 0.783 . . . . 0.0 110.975 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.4 t -113.6 130.76 67.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.961 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.8 m -121.18 137.48 54.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.735 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.58 ' HB3' HG23 ' A' ' 124' ' ' VAL . 3.1 t -141.06 173.01 11.9 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.347 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -131.14 130.74 43.47 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 23.3 m -56.68 123.97 16.75 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.95 0.405 . . . . 0.0 111.811 -178.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.855 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . . . -67.8 -9.44 44.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.617 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.736 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.14 -50.64 2.02 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.559 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -77.12 -21.05 54.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 120.815 0.34 . . . . 0.0 110.895 -178.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.87 33.58 85.89 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.181 -1.009 . . . . 0.0 111.157 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.559 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -102.0 169.12 8.02 Favored Pre-proline 0 N--CA 1.453 -0.324 0 CA-C-N 115.459 -0.37 . . . . 0.0 110.372 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.426 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 51.1 Cg_endo -92.98 108.23 0.19 Allowed 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.92 2.413 . . . . 0.0 111.454 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.58 HG23 ' HB3' ' A' ' 115' ' ' SER . 35.7 m -105.43 146.26 12.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.45 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 81.8 p -148.99 142.49 25.32 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.397 0.618 . . . . 0.0 110.695 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -139.08 151.85 47.06 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.852 178.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.795 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 40.3 m -107.64 114.09 27.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.053 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.563 HG12 ' CB ' ' A' ' 104' ' ' PRO . 10.7 t -96.56 111.83 27.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.853 0.358 . . . . 0.0 111.412 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -106.69 172.18 4.09 Favored Pre-proline 0 N--CA 1.452 -0.362 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.009 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -68.83 -14.64 39.34 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.42 2.08 . . . . 0.0 112.995 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 1.1 t -117.86 -26.46 6.48 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.424 ' HB3' ' O ' ' A' ' 131' ' ' SER . 21.1 pt-20 178.65 -162.56 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.124 0.488 . . . . 0.0 110.01 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.69 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.88 159.2 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.849 178.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -145.67 19.34 1.49 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.402 0.62 . . . . 0.0 112.274 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.795 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.91 86.45 0.08 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.493 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.569 HG13 ' SD ' ' A' ' 141' ' ' MET . 45.2 t -102.42 116.06 45.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.087 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -146.36 121.49 5.47 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.721 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.5 155.35 98.95 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.542 -1.441 . . . . 0.0 112.243 -0.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.29 78.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.57 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 147.76 15.84 0.13 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.713 -0.756 . . . . 0.0 113.503 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.885 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.0 OUTLIER -60.69 157.88 13.79 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.187 0.494 . . . . 0.0 111.227 -179.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -128.63 151.98 48.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.917 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.7 HG13 ' CD1' ' A' ' 164' ' ' PHE . 4.6 t -113.83 150.41 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.307 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.783 ' O ' HG13 ' A' ' 162' ' ' VAL . 0.1 OUTLIER -120.04 146.29 46.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.906 0.384 . . . . 0.0 111.078 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.687 HD22 ' C ' ' A' ' 144' ' ' SER . 3.8 mm? -122.08 158.12 29.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.651 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.741 ' HA ' HD22 ' A' ' 184' ' ' LEU . 34.6 m -125.24 143.71 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.269 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.571 HD23 ' HG2' ' A' ' 182' ' ' GLU . 2.7 tp -91.64 -52.59 0.28 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.89 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.442 ' HD3' ' CB ' ' A' ' 147' ' ' LEU . 17.2 Cg_exo -66.73 -158.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.601 2.201 . . . . 0.0 112.127 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -118.3 -179.39 3.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.749 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -171.18 110.93 0.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.937 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 58.01 83.76 0.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.405 ' CB ' ' CB ' ' A' ' 157' ' ' SER . . . -159.63 176.16 12.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.199 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -113.15 -34.7 5.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.486 HG22 ' N ' ' A' ' 155' ' ' ARG . 12.0 p -67.06 159.05 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.038 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.486 ' N ' HG22 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -60.18 -50.79 72.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.232 -179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -121.95 69.0 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.05 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.469 ' N ' HG13 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -69.04 151.54 46.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.882 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -177.28 53.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.84 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.2 m -61.3 -46.27 91.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.861 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.658 ' O ' HG23 ' A' ' 162' ' ' VAL . 75.8 m -152.42 -75.13 0.13 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.775 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.523 ' HB3' HG21 ' A' ' 146' ' ' VAL . 50.1 m80 48.86 38.05 11.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.783 HG13 ' O ' ' A' ' 144' ' ' SER . 24.2 t -115.88 127.61 73.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.595 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -115.37 169.14 9.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.611 0.719 . . . . 0.0 109.677 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.7 ' CD1' HG13 ' A' ' 143' ' ' VAL . 3.2 m-85 -117.23 153.51 32.75 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.293 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.855 ' CE1' ' HB3' ' A' ' 118' ' ' ALA . 42.3 m-85 -133.16 137.32 46.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.166 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.635 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -38.9 -29.05 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.019 -0.991 . . . . 0.0 112.869 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.492 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 5.0 p -172.02 178.55 2.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.04 0.448 . . . . 0.0 111.54 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.606 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 77.8 t -69.13 -33.14 3.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.583 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.669 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.3 Cg_exo -72.98 -39.31 2.34 Favored 'Trans proline' 0 CA--C 1.505 -0.936 0 C-N-CA 122.731 2.288 . . . . 0.0 110.586 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.569 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.34 -39.44 53.92 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 177.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.728 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.86 -46.04 91.16 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.466 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.3 mt-10 -78.81 -27.66 44.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.225 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 169' ' ' PRO . 22.7 t0 -71.04 -55.74 7.63 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.43 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.736 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 8.1 t-105 -64.79 -28.49 69.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.702 178.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.96 -40.33 94.84 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.249 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.55 -42.79 55.76 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.402 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.407 ' O ' ' CD2' ' A' ' 178' ' ' HIS . 0.2 OUTLIER -97.1 23.7 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.338 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.46 ' O ' HD12 ' A' ' 184' ' ' LEU . 11.1 m170 -152.87 45.12 0.68 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.926 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -112.04 -12.57 13.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.162 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.68 -23.65 22.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.441 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.465 HD12 HD11 ' A' ' 184' ' ' LEU . 7.9 mt -71.51 65.82 0.47 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.864 0.364 . . . . 0.0 110.862 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.571 ' HG2' HD23 ' A' ' 147' ' ' LEU . 5.9 tt0 58.71 26.45 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.972 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 64.16 81.5 0.11 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.588 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 146' ' ' VAL . 29.6 mt -66.87 173.38 3.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.734 0.302 . . . . 0.0 110.698 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -135.14 142.64 46.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.141 0.496 . . . . 0.0 111.3 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.685 HD11 ' HB2' ' A' ' 175' ' ' ALA . 16.0 mm -101.69 160.85 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.758 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.461 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -158.71 157.47 3.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.233 0.54 . . . . 0.0 112.013 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.5 OUTLIER -86.02 127.98 34.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.767 178.461 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.885 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.1 m -46.43 -20.93 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.874 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.4 ' N ' ' C ' ' A' ' 188' ' ' SER . 1.8 t-80 -73.67 -43.3 59.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.208 0.527 . . . . 0.0 109.761 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -82.38 -20.86 36.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.378 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.2 -25.36 61.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.972 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.45 ' CZ ' HG22 ' A' ' 128' ' ' VAL . 3.5 m-85 -81.81 -30.96 31.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.252 0.548 . . . . 0.0 110.37 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.07 -33.48 23.52 Favored Glycine 0 CA--C 1.509 -0.31 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.336 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 195' ' ' LEU . 4.2 tt -76.65 -29.65 56.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.58 -26.88 37.26 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -82.71 -22.69 34.4 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.445 -0.377 . . . . 0.0 110.87 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.38 -22.95 43.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.424 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.7 ' O ' HD23 ' A' ' 203' ' ' LEU . 2.2 m-85 -51.95 -26.87 11.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.77 0.319 . . . . 0.0 111.168 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -81.18 -54.31 5.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -66.09 -44.91 83.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.155 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -54.14 -30.1 47.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.7 HD23 ' O ' ' A' ' 199' ' ' PHE . 0.6 OUTLIER -59.99 -29.49 68.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.952 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 6.6 tp -69.62 -32.01 70.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.986 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 61.71 165.91 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.88 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.1 p -141.43 -177.96 5.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -169.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.909 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 6.3 t -123.7 -43.49 2.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.868 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 62.1 p -59.62 -175.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.994 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 60.88 87.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.873 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.779 HG22 ' HD3' ' A' ' 212' ' ' PRO . 1.0 OUTLIER -78.58 -34.47 1.02 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.76 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.779 ' HD3' HG22 ' A' ' 211' ' ' THR . 65.2 Cg_exo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.015 1.81 . . . . 0.0 112.421 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -146.05 -178.84 6.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.72 -169.0 2.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -156.13 150.28 25.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.833 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 28' ' ' LEU . 19.0 m -63.13 143.09 97.71 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.022 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.544 ' CG ' HD11 ' A' ' 46' ' ' LEU . 66.2 Cg_endo -74.04 -35.68 4.0 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.452 2.101 . . . . 0.0 112.384 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 mt -53.9 -57.47 10.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.194 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.463 HD23 ' HB2' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -55.44 -26.87 44.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.259 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -63.72 -53.21 54.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.152 0.501 . . . . 0.0 109.982 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -78.88 -27.47 44.01 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.627 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.553 HD11 ' H ' ' A' ' 74' ' ' TYR . 3.4 tt -69.78 -52.42 25.37 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.794 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HB2' HD23 ' A' ' 28' ' ' LEU . . . -58.63 -25.93 63.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.043 0.449 . . . . 0.0 110.822 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -70.0 -23.3 63.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.047 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.63 48.8 82.3 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.147 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -133.09 150.17 74.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.715 0.293 . . . . 0.0 110.855 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.64 106.36 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.536 2.157 . . . . 0.0 112.397 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.647 HG23 ' CG2' ' A' ' 41' ' ' THR . 11.2 p -112.32 109.9 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.221 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.5 p -84.15 -175.01 5.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.962 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 43' ' ' ALA . 9.3 mtp180 -76.93 -35.97 56.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.471 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -25.83 67.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.894 0.378 . . . . 0.0 110.348 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.647 ' CG2' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -86.05 -42.74 13.69 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.402 ' O ' HD13 ' A' ' 46' ' ' LEU . 5.2 tp -63.43 -35.92 82.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.559 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -74.06 -42.57 60.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.075 -1.421 . . . . 0.0 109.425 177.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.95 -30.98 74.54 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.567 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.59 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.09 -43.0 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 CA-C-O 121.04 0.448 . . . . 0.0 110.432 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.544 HD11 ' CG ' ' A' ' 26' ' ' PRO . 6.9 mp -78.16 -7.75 57.45 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.509 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.66 23.41 6.15 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -107.63 145.4 31.22 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.264 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.07 139.61 70.95 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.415 2.077 . . . . 0.0 111.961 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.79 -17.46 0.94 Allowed 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -78.56 -32.49 47.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.285 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.603 ' O ' HG23 ' A' ' 56' ' ' VAL . 4.1 mmt85 -67.66 -41.27 84.02 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.559 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.0 t -63.0 -48.07 89.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.516 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -54.01 -51.79 62.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.469 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.64 -37.47 18.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 52' ' ' ARG . 41.6 t -60.21 -33.06 52.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.754 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 57' ' ' LEU . 3.6 mm? -81.06 -26.51 36.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.057 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -56.63 -22.7 36.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.197 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -1.67 11.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.231 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -114.77 72.19 0.78 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.819 0.819 . . . . 0.0 110.618 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.3 p -77.79 -3.96 44.02 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.376 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.2 m -113.14 39.92 2.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.061 0.458 . . . . 0.0 110.706 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.44 141.43 29.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.081 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -78.79 126.58 30.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.067 0.46 . . . . 0.0 111.237 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.413 ' OH ' HD12 ' A' ' 57' ' ' LEU . 31.8 m-85 -119.51 160.83 21.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.402 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.458 ' OD1' HD13 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -154.52 145.6 22.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.87 0.367 . . . . 0.0 111.289 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.1 tptt 66.06 -102.71 0.08 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.68 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.86 -14.04 32.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.728 0.299 . . . . 0.0 111.767 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.4 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 122.79 30.08 1.18 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.145 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 26.5 m-20 -87.39 170.01 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.069 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.44 HD12 ' O ' ' A' ' 37' ' ' VAL . 2.0 mt -79.7 117.37 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.355 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.458 HD13 ' OD1' ' A' ' 66' ' ' ASP . 2.1 tt -89.88 -27.33 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.109 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 105.54 139.06 9.57 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.571 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.553 ' H ' HD11 ' A' ' 31' ' ' LEU . 1.5 t80 -100.99 177.0 5.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.353 . . . . 0.0 110.857 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.97 -43.75 2.12 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.414 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.887 HD23 HD21 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -79.93 155.4 27.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.777 0.322 . . . . 0.0 110.829 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.8 p -132.42 159.06 40.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.877 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.1 mt -85.24 5.72 29.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.476 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.44 113.26 24.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -55.77 -23.15 27.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.332 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 80' ' ' GLU . 0.2 OUTLIER 35.66 -166.22 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 8.2 m -104.82 -25.92 12.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.4 ' OH ' ' CD2' ' A' ' 163' ' ' HIS . 4.8 m-85 -85.5 117.19 24.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.454 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.441 ' HB ' ' OG ' ' A' ' 114' ' ' SER . 2.6 t -109.09 142.54 21.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 111.001 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.838 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 54.5 t80 -130.05 106.95 8.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.62 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -99.53 126.51 45.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.167 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -135.47 122.73 35.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.847 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t0 61.02 -69.1 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.319 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 87' ' ' ILE . 7.5 t70 -167.48 35.29 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.196 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 33.0 mmt-85 -137.6 113.24 9.54 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.986 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.55 121.9 25.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.501 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.887 HD21 HD23 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -114.93 164.69 13.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.323 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -129.03 165.0 22.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.038 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.679 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -152.65 169.03 23.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.987 0.422 . . . . 0.0 112.105 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.446 ' HA ' HG21 ' A' ' 81' ' ' THR . 18.3 m95 -95.03 -19.59 20.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.783 178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.48 166.64 30.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.091 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -51.93 -23.28 4.76 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tp -86.38 -51.65 6.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.745 0.307 . . . . 0.0 111.434 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.622 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -45.03 -28.28 0.67 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.972 -179.303 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.679 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -60.46 -39.56 88.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.321 . . . . 0.0 110.725 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 102' ' ' ILE . 4.2 pp -111.08 -173.45 2.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.989 0.423 . . . . 0.0 111.232 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 101' ' ' LEU . 7.5 tp -165.22 -42.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.052 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.562 ' O ' HG22 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -162.98 76.15 1.91 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.023 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.422 ' CB ' HG12 ' A' ' 128' ' ' VAL . 25.7 Cg_exo -62.96 -34.78 69.87 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.632 2.221 . . . . 0.0 112.374 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.18 -23.66 43.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.472 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -84.15 -39.23 19.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.409 -179.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.0 OUTLIER -58.05 -45.97 88.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.098 0.475 . . . . 0.0 111.371 -179.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.94 24.03 16.23 Favored Glycine 0 C--N 1.318 -0.427 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.474 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.26 173.73 14.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 0.0 111.038 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -80.65 155.3 26.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.838 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.838 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.11 109.83 7.55 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 23.0 mtt85 -81.9 119.8 24.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.771 0.796 . . . . 0.0 111.178 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.793 HG22 ' HD1' ' A' ' 85' ' ' PHE . 96.6 t -112.69 130.22 66.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.061 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.441 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 59.6 p -121.97 137.78 54.67 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.208 178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.624 ' C ' HG22 ' A' ' 124' ' ' VAL . 1.1 m -141.37 173.01 11.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.319 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -135.21 134.72 40.37 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.403 ' O ' ' HA2' ' A' ' 121' ' ' GLY . 35.5 t -62.09 128.84 38.03 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.142 0.496 . . . . 0.0 111.89 -178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.569 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . . . -69.65 -5.52 25.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.84 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.909 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.47 -50.11 2.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.845 0.355 . . . . 0.0 111.682 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.674 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.51 -24.4 21.8 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.058 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 117' ' ' CYS . . . 74.94 6.78 79.94 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.135 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.674 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.19 147.82 64.8 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.643 0.259 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.32 105.73 1.48 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.676 2.251 . . . . 0.0 110.448 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.729 HG12 ' HD2' ' A' ' 138' ' ' PRO . 27.7 m -103.32 145.7 12.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.945 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.955 ' O ' HD13 ' A' ' 126' ' ' LEU . 77.3 p -153.29 141.3 20.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.237 0.541 . . . . 0.0 110.421 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 1.008 HD21 ' HE1' ' A' ' 141' ' ' MET . 0.2 OUTLIER -136.72 153.6 50.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.258 178.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.772 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 89.5 m -105.75 112.57 25.69 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.654 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 62.1 t -96.21 111.95 27.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.935 0.398 . . . . 0.0 111.46 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.453 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -106.14 171.0 5.18 Favored Pre-proline 0 N--CA 1.453 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.853 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 37.7 Cg_endo -67.16 -19.22 51.1 Favored 'Trans proline' 0 N--CA 1.464 -0.228 0 C-N-CA 122.028 1.819 . . . . 0.0 112.965 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 8.5 m -109.25 -29.41 8.5 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 131' ' ' SER . 10.5 pt-20 178.63 -161.83 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.198 0.523 . . . . 0.0 110.101 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -94.26 163.6 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.602 178.424 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -153.07 21.07 0.58 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.295 0.569 . . . . 0.0 112.448 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.772 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.95 86.32 0.08 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.445 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 139' ' ' ALA . 39.5 t -101.59 107.69 22.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.451 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -146.82 119.77 4.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.812 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.729 ' HD2' HG12 ' A' ' 124' ' ' VAL . 73.1 Cg_endo -76.63 145.95 83.04 Favored 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 123.582 -1.424 . . . . 0.0 112.222 0.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.503 ' HA ' HG12 ' A' ' 136' ' ' VAL . . . -61.94 165.47 5.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.746 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 66.89 13.18 61.15 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.312 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 1.008 ' HE1' HD21 ' A' ' 126' ' ' LEU . 0.5 OUTLIER -61.43 158.3 15.03 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.983 0.42 . . . . 0.0 111.613 -179.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.582 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.05 152.35 49.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.241 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.878 ' CG2' HG12 ' A' ' 189' ' ' VAL . 21.3 t -111.92 151.24 13.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.575 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.772 ' O ' HG13 ' A' ' 162' ' ' VAL . 3.3 p -120.18 140.76 50.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.79 0.328 . . . . 0.0 110.804 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 tp -123.96 154.71 39.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.914 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 161' ' ' HIS . 38.3 t -125.61 159.38 33.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.925 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 182' ' ' GLU . 15.4 mt -92.39 148.71 37.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.701 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.58 149.37 79.57 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.512 2.142 . . . . 0.0 112.323 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -108.91 -171.93 1.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.832 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.16 -20.63 12.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -108.03 51.75 0.73 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -168.84 -173.14 1.76 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 60.81 36.47 19.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.4 m -109.98 -38.75 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.067 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.3 mtp180 -130.96 -60.41 0.97 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -176.07 83.48 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.89 126.76 0.22 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.903 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.402 ' HA ' ' CE1' ' A' ' 161' ' ' HIS . 1.3 t80 60.52 40.44 16.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 2.8 t -59.83 -31.09 69.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 1.3 t -165.39 -43.31 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.913 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.534 ' O ' HG23 ' A' ' 146' ' ' VAL . 0.5 OUTLIER 62.34 67.62 0.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.844 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 144' ' ' SER . 30.5 t -110.94 123.39 66.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.4 ' CD2' ' OH ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -117.03 169.23 9.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.602 0.715 . . . . 0.0 110.182 179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.666 ' CE1' HG13 ' A' ' 143' ' ' VAL . 1.8 m-85 -120.48 132.26 55.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.915 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.625 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 54.5 m-85 -108.65 136.15 48.72 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.144 0.497 . . . . 0.0 110.001 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -46.89 -25.79 0.85 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.594 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 40.1 m -163.09 167.49 22.22 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.825 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 77.4 t -68.1 -34.43 6.09 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.97 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.0 Cg_exo -72.69 -36.8 4.48 Favored 'Trans proline' 0 CA--C 1.505 -0.967 0 C-N-CA 122.753 2.302 . . . . 0.0 110.001 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.593 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.75 -40.27 48.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.465 178.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.7 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.45 -45.24 95.1 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.458 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.1 mt-10 -78.93 -27.94 43.77 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.249 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.697 ' N ' ' O ' ' A' ' 169' ' ' PRO . 28.3 t70 -70.19 -55.89 8.19 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.457 0.646 . . . . 0.0 109.475 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.909 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 29.8 t-105 -64.88 -27.74 69.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.83 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.7 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -65.54 -40.27 92.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.265 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -42.29 63.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.471 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -95.11 20.46 9.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.271 0.558 . . . . 0.0 111.435 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.494 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -127.84 29.25 5.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.721 179.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -96.81 -173.06 2.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.802 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.99 -31.24 7.49 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.443 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.549 ' CD1' HD12 ' A' ' 184' ' ' LEU . 4.8 mt -62.67 -174.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.712 0.292 . . . . 0.0 110.854 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.787 ' O ' HD12 ' A' ' 147' ' ' LEU . 3.6 mm-40 -97.62 34.15 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 165.01 -117.58 0.76 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.614 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.549 HD12 ' CD1' ' A' ' 181' ' ' LEU . 1.2 tt 62.5 114.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 110.95 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.423 ' N ' HD23 ' A' ' 184' ' ' LEU . . . -142.24 149.9 40.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 175' ' ' ALA . 10.6 mm -100.29 158.68 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.937 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -162.46 161.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.219 0.533 . . . . 0.0 112.016 179.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.405 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.6 OUTLIER -88.08 127.97 35.41 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.652 178.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.955 HG11 ' SD ' ' A' ' 141' ' ' MET . 2.1 m -48.01 -19.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.405 ' N ' ' C ' ' A' ' 188' ' ' SER . 23.6 m-70 -73.02 -44.39 60.96 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.38 -22.3 35.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.524 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -74.89 -25.18 58.76 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.282 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -81.51 -24.86 36.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.942 0.401 . . . . 0.0 110.666 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.86 -29.81 33.81 Favored Glycine 0 N--CA 1.453 -0.233 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.2 OUTLIER -82.3 -28.3 31.8 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.04 -28.17 31.89 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -82.15 -21.88 36.37 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.44 -0.38 . . . . 0.0 110.995 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -81.12 -22.84 38.77 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.126 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.451 ' CD2' ' CD1' ' A' ' 203' ' ' LEU . 0.5 OUTLIER -52.65 -28.32 20.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.129 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -52.39 -55.08 24.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -58.03 -30.76 66.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.031 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -55.92 5.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.978 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.451 ' CD1' ' CD2' ' A' ' 199' ' ' PHE . 9.9 mt -64.88 -35.21 80.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.973 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.7 tt -70.69 -49.67 44.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -71.24 79.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 2.5 m -84.65 101.65 12.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.905 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 7.5 tpp -63.3 147.52 50.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 59.2 p -142.13 144.79 33.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.927 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.6 t -130.93 35.15 3.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.7 157.63 31.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.441 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -59.53 -62.93 4.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.978 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.6 Cg_endo . . . . . 0 C--O 1.249 1.043 0 C-N-CA 122.363 2.042 . . . . 0.0 112.362 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.857 0.36 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 61.01 112.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp 60.26 158.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.003 HD13 HD23 ' A' ' 106' ' ' LEU . 15.2 mt -100.68 155.02 18.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.39 107.41 0.87 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.172 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.747 ' HB2' HD11 ' A' ' 46' ' ' LEU . 37.1 Cg_exo -60.99 -19.83 64.74 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.49 2.127 . . . . 0.0 112.403 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.5 tt -55.27 -57.62 11.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.447 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -80.27 -27.36 38.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.334 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 8.7 ttt-85 -70.86 -53.31 15.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.941 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -66.5 -25.52 66.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.499 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.755 HD11 ' C ' ' A' ' 72' ' ' ILE . 4.4 tp -72.02 -30.56 65.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.714 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.38 -27.87 26.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.146 0.498 . . . . 0.0 110.944 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -64.76 -19.96 66.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.245 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.64 47.52 89.98 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.098 -0.572 . . . . 0.0 113.134 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.766 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -131.06 143.93 51.46 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.601 0.239 . . . . 0.0 110.676 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -51.46 91.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.458 2.106 . . . . 0.0 112.306 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 35' ' ' ARG . 23.1 t -93.17 112.08 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.281 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 63.9 p -86.73 -176.57 5.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.688 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.6 ptt-85 -75.71 -36.73 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.248 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.48 -27.3 67.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.206 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.64 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.94 -42.52 14.88 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.752 ' CD1' HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -62.73 -36.7 83.85 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.62 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.43 -43.02 64.41 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.625 177.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.23 -31.72 75.01 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.591 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.606 HG22 HD12 ' A' ' 46' ' ' LEU . 7.1 mt -78.02 -46.15 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-O 120.968 0.413 . . . . 0.0 110.409 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.747 HD11 ' HB2' ' A' ' 26' ' ' PRO . 7.9 mp -75.58 -9.51 58.64 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.543 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 60.31 21.65 11.14 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -102.0 160.43 26.45 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.25 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.16 138.99 34.54 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.608 2.205 . . . . 0.0 111.925 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.54 -20.27 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -32.25 47.35 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.045 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -67.39 -40.66 85.69 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.62 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.0 t -62.98 -47.85 90.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.518 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.26 -52.46 58.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.164 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.98 79.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.154 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -66.62 -26.81 38.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.922 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.443 HD23 HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -72.06 -31.77 66.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.632 179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.735 ' O ' HG23 ' A' ' 61' ' ' THR . 7.6 mt-10 -56.17 -23.18 33.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.958 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -88.54 -16.36 32.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.978 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 63' ' ' THR . . . -96.96 33.35 1.92 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.381 0.61 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.735 HG23 ' O ' ' A' ' 58' ' ' GLU . 80.6 p -59.01 -20.76 56.13 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.01 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.6 m -90.21 -21.43 22.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.366 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HB1' ' A' ' 60' ' ' ALA . 0.8 OUTLIER -60.75 141.24 57.13 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.354 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.627 ' O ' HG22 ' A' ' 72' ' ' ILE . 2.1 mt-10 -79.0 131.09 36.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 0.0 111.62 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 74.6 m-85 -104.06 173.06 6.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.169 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -152.73 146.52 25.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 111.541 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 7.3 tptt 65.95 -103.54 0.09 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.799 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -91.95 -12.29 33.81 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 124.6 31.15 0.91 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.006 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -85.75 168.05 14.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.179 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.752 HD13 ' CD1' ' A' ' 42' ' ' LEU . 3.6 mp -79.91 115.76 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.469 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.755 ' C ' HD11 ' A' ' 31' ' ' LEU . 2.3 tt -110.1 -26.02 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.164 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.656 ' HA3' HD21 ' A' ' 31' ' ' LEU . . . 88.99 -133.64 11.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.572 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -176.34 93.88 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.869 0.366 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.07 22.06 1.76 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.585 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.3 mt -147.09 144.04 28.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.716 0.293 . . . . 0.0 110.952 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.8 p -102.8 159.01 15.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.867 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 tt -58.63 -48.03 82.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.935 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -110.65 155.43 22.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.02 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -57.21 129.44 41.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -109.23 -172.68 2.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.985 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 m -94.34 -41.33 9.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.162 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -78.58 108.52 12.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.644 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.86 140.97 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.993 0.425 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.898 ' CZ ' HD22 ' A' ' 101' ' ' LEU . 28.3 t80 -131.03 108.01 9.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.632 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -101.75 136.71 41.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 89' ' ' ASP . 1.1 pt -138.78 122.98 20.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 t70 59.76 -68.94 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.466 178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 87' ' ' ILE . 11.0 t0 -164.94 35.05 0.06 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.447 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -137.83 111.67 8.3 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.793 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -77.91 120.11 22.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.785 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.631 HD12 ' HD2' ' A' ' 85' ' ' PHE . 10.4 mt -109.86 164.86 12.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -133.27 165.05 25.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.131 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 99' ' ' ASP . . . -153.23 169.95 21.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.057 0.456 . . . . 0.0 111.815 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -106.44 -7.42 17.6 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.876 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.888 ' HB3' HG23 ' A' ' 162' ' ' VAL . 76.6 m -152.74 159.94 43.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.331 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.719 ' HB2' ' O ' ' A' ' 162' ' ' VAL . . . -51.5 -25.37 6.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.527 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.417 HD21 HG12 ' A' ' 102' ' ' ILE . 3.6 tt -87.86 -50.27 6.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.12 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.617 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -43.25 -22.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.529 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.4 OUTLIER -59.0 -32.38 69.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.898 HD22 ' CZ ' ' A' ' 85' ' ' PHE . 2.2 tp 178.65 149.19 0.22 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.946 0.403 . . . . 0.0 111.218 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.417 HG12 HD21 ' A' ' 98' ' ' LEU . 5.1 mt -128.45 128.42 68.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.701 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.64 ' HB3' HD12 ' A' ' 106' ' ' LEU . 13.1 m-85 66.84 66.91 0.66 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.923 0.392 . . . . 0.0 110.864 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.474 ' O ' HG12 ' A' ' 107' ' ' ILE . 24.2 Cg_exo -63.65 -20.92 69.98 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.842 2.361 . . . . 0.0 112.404 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.75 -23.67 59.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.916 0.388 . . . . 0.0 111.278 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.003 HD23 HD13 ' A' ' 24' ' ' LEU . 7.7 mt -78.6 -29.75 46.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.24 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 104' ' ' PRO . 3.7 mm -53.17 -61.08 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-O 122.006 0.908 . . . . 0.0 111.051 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.89 18.61 26.77 Favored Glycine 0 C--N 1.315 -0.596 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.294 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.37 -179.95 7.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.714 0.292 . . . . 0.0 110.597 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.54 149.0 26.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.729 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.09 110.34 7.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 56.7 mtt-85 -79.56 119.08 22.03 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.849 0.833 . . . . 0.0 111.223 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.773 HG22 ' CD1' ' A' ' 85' ' ' PHE . 12.2 t -110.49 131.53 61.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 114.314 -1.312 . . . . 0.0 111.983 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.1 m -122.61 137.33 54.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.246 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.547 ' OG ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -140.94 172.77 12.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.062 179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -131.84 130.83 42.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.829 178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 29.5 m -56.02 123.84 15.72 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.029 0.443 . . . . 0.0 111.979 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.39 -6.95 33.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.788 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.625 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -119.47 -50.6 2.32 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.696 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.554 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.16 -13.75 37.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.996 -179.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.406 ' N ' ' HB2' ' A' ' 117' ' ' CYS . . . 64.23 10.34 40.81 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.746 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.554 ' H ' HG22 ' A' ' 120' ' ' THR . . . -71.2 168.99 16.78 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.808 0.337 . . . . 0.0 110.647 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.461 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 53.8 Cg_endo -93.69 108.71 0.17 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.073 2.515 . . . . 0.0 111.629 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.547 HG23 ' OG ' ' A' ' 115' ' ' SER . 34.3 m -106.53 146.84 12.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.341 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.2 p -151.66 142.8 23.21 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.375 0.607 . . . . 0.0 110.771 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.633 ' N ' HD12 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -134.43 151.74 51.36 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.484 178.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.888 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 30.2 m -107.62 113.59 26.99 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.485 HG23 ' CG2' ' A' ' 113' ' ' VAL . 36.2 t -96.51 111.69 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.968 0.413 . . . . 0.0 111.489 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -105.76 169.8 6.58 Favored Pre-proline 0 N--CA 1.452 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.15 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.58 -14.52 44.33 Favored 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.456 2.104 . . . . 0.0 112.982 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 p -118.19 -27.01 6.17 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 179.52 -163.07 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.112 0.482 . . . . 0.0 109.999 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -95.3 162.29 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.717 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -151.41 19.98 0.74 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.888 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.04 86.14 0.08 Allowed 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.791 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.0 t -101.15 122.74 53.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.707 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -146.12 119.3 5.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.98 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.425 ' HD2' HG12 ' A' ' 124' ' ' VAL . 70.8 Cg_endo -74.71 162.3 92.97 Favored 'Cis proline' 0 C--N 1.349 0.595 0 C-N-CA 123.435 -1.485 . . . . 0.0 112.274 0.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -72.82 78.24 1.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.151 0.5 . . . . 0.0 110.737 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 147.4 15.91 0.13 Allowed Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.576 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 126' ' ' LEU . 10.2 ptp -62.51 160.82 12.96 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.079 0.439 . . . . 0.0 111.534 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.567 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.65 152.06 50.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.942 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.773 HG11 ' HB2' ' A' ' 161' ' ' HIS . 2.5 t -117.44 154.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.443 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 55.6 p -121.16 146.8 46.39 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.842 0.353 . . . . 0.0 110.921 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.856 HD21 ' HB3' ' A' ' 185' ' ' ALA . 4.0 pp -113.47 158.4 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.993 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 146' ' ' VAL . 11.1 p -125.18 112.79 32.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.416 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . 1.8 mt -77.01 -61.96 0.64 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.246 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 47.4 Cg_endo -69.98 -50.47 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.475 2.117 . . . . 0.0 112.479 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.491 ' HA ' HG21 ' A' ' 146' ' ' VAL . 5.3 tt0 62.94 145.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.866 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -109.05 -21.5 12.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.193 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -98.73 31.68 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.093 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.473 ' HB2' ' NE2' ' A' ' 149' ' ' GLN . . . -118.62 98.14 6.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.045 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -99.41 35.5 1.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.413 HG23 ' N ' ' A' ' 155' ' ' ARG . 15.5 m -118.67 -44.37 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.413 ' N ' HG23 ' A' ' 154' ' ' VAL . 9.6 ttt180 -173.08 -68.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.979 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -154.79 -45.81 0.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.992 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 m 61.8 158.64 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.963 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -170.18 79.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.873 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 8.9 m -56.59 -26.91 56.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.145 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 145' ' ' LEU . 4.6 t 76.43 0.09 3.15 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.585 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.773 ' HB2' HG11 ' A' ' 143' ' ' VAL . 8.3 p80 178.04 84.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.549 0.214 . . . . 0.0 110.732 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.888 HG23 ' HB3' ' A' ' 96' ' ' CYS . 7.2 p -101.27 -44.89 11.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.467 ' N ' HG13 ' A' ' 162' ' ' VAL . 4.7 m80 -107.19 148.5 28.8 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.65 0.738 . . . . 0.0 109.979 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.757 ' CE2' HG22 ' A' ' 143' ' ' VAL . 40.4 m-85 -109.9 150.67 28.11 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.238 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.57 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 49.7 m-85 -131.83 136.09 47.21 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.557 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.568 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -39.75 -28.32 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.243 -0.889 . . . . 0.0 113.141 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.499 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 11.4 p -170.59 176.45 4.31 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.655 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.61 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 79.6 t -69.4 -34.27 4.61 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.369 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.9 Cg_exo -72.88 -37.55 3.62 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.763 2.309 . . . . 0.0 110.313 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.592 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -77.21 -39.78 47.42 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.471 178.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.701 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.37 -44.56 96.96 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.04 -1.466 . . . . 0.0 107.04 177.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.478 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.6 mt-10 -79.07 -27.95 43.08 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.099 177.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.692 ' N ' ' O ' ' A' ' 169' ' ' PRO . 7.3 t70 -69.92 -56.03 8.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.466 0.651 . . . . 0.0 109.395 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.625 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 35.6 t-105 -64.87 -27.88 69.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.817 178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -66.54 -38.51 87.3 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.218 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.7 -44.32 63.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.302 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -94.95 22.47 6.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.031 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -150.33 30.57 0.68 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.69 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -108.6 -176.09 2.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.936 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 59.32 25.67 60.65 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.492 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 36.7 mt -96.57 44.18 1.07 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 110.827 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 63.07 30.87 16.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.003 0.43 . . . . 0.0 110.724 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 143.05 -127.38 3.1 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.378 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 9.5 tt 62.87 123.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.841 0.353 . . . . 0.0 110.968 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.856 ' HB3' HD21 ' A' ' 145' ' ' LEU . . . -143.24 150.32 39.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.002 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.541 HD11 ' HB2' ' A' ' 175' ' ' ALA . 11.7 mm -99.66 160.82 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.938 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.476 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -165.61 162.9 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.474 0.654 . . . . 0.0 112.197 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.9 OUTLIER -89.16 130.26 35.62 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.905 178.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.538 HG12 ' CG2' ' A' ' 143' ' ' VAL . 1.2 m -46.49 -20.6 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 2.1 m-70 -72.65 -43.36 63.29 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.761 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.24 -21.02 36.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.347 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.75 -25.21 58.93 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 128' ' ' VAL . 9.7 t80 -81.42 -24.86 36.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.703 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.66 -29.98 34.02 Favored Glycine 0 CA--C 1.509 -0.3 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.8 mt -81.59 -27.85 34.06 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.01 -26.52 37.01 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -81.99 -22.02 36.8 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.517 -0.342 . . . . 0.0 111.026 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -74.11 -24.37 59.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -54.06 -39.53 66.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.107 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -81.17 -24.95 37.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.026 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -54.93 -42.91 72.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.039 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -80.01 -30.83 39.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.98 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 7.0 tp -78.29 -19.99 52.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.278 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 204' ' ' LEU . 0.5 OUTLIER -81.05 -52.01 7.87 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.818 0.342 . . . . 0.0 110.92 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -74.16 -177.03 2.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.4 t -71.07 160.7 32.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -110.57 -177.05 3.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.1 158.5 11.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.5 m -105.73 105.38 15.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.909 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.44 -81.18 0.23 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.441 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -59.98 -62.75 5.27 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.98 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.5 Cg_endo . . . . . 0 C--O 1.248 1.019 0 C-N-CA 122.425 2.084 . . . . 0.0 112.307 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.843 0.354 . . . . 0.0 111.037 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -112.28 -43.09 3.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mt -109.95 -31.43 7.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -152.12 167.79 27.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.648 HG22 ' HB2' ' A' ' 27' ' ' LEU . 9.7 p -108.71 99.71 35.37 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.932 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.564 ' HB2' HD11 ' A' ' 46' ' ' LEU . 52.3 Cg_exo -55.15 -20.0 22.69 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.693 2.262 . . . . 0.0 112.851 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.648 ' HB2' HG22 ' A' ' 25' ' ' VAL . 4.8 mp -52.01 -57.4 9.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.747 0.308 . . . . 0.0 111.227 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.623 HD23 ' CG1' ' A' ' 25' ' ' VAL . 3.9 pp -66.42 -26.98 67.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.138 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.451 ' N ' HD12 ' A' ' 28' ' ' LEU . 41.2 mtp85 -68.84 -53.32 22.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.846 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -72.86 -30.32 63.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.318 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 72' ' ' ILE . 5.7 tp -72.57 -43.16 63.79 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.837 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.11 -26.74 17.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 0.0 111.074 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -66.62 -20.62 66.04 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.188 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.91 47.41 89.07 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.136 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -133.07 148.58 69.86 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.622 0.249 . . . . 0.0 110.814 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.01 105.46 0.11 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.556 2.171 . . . . 0.0 112.31 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.739 HG23 HG22 ' A' ' 41' ' ' THR . 11.1 p -107.23 110.0 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.36 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 94.1 p -86.83 -179.54 6.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.744 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.4 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -71.96 -36.36 69.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.246 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.58 -27.39 66.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.908 0.385 . . . . 0.0 110.117 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.739 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.33 -41.61 15.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.488 HD22 ' CD1' ' A' ' 71' ' ' ILE . 7.8 tp -63.53 -36.51 84.02 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 176.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.573 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.21 -42.6 62.46 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.062 -1.426 . . . . 0.0 109.463 177.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.26 -31.09 73.98 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.617 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.574 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -78.78 -44.38 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.978 0 CA-C-O 120.998 0.428 . . . . 0.0 110.518 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.567 HD12 HG22 ' A' ' 45' ' ' ILE . 7.4 mp -76.72 -9.75 58.89 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.412 178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 59.36 22.24 10.62 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.442 ' CE3' ' HG2' ' A' ' 52' ' ' ARG . 7.8 m0 -104.99 144.75 29.37 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.337 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -55.7 138.23 80.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.455 2.103 . . . . 0.0 112.012 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.95 -18.94 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.7 -32.03 46.77 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.106 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.779 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -67.21 -40.53 86.44 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.581 ' O ' HD23 ' A' ' 57' ' ' LEU . 2.1 t -62.26 -48.23 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.667 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.64 -52.74 58.95 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.45 -1.25 . . . . 0.0 110.516 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.64 -45.73 73.81 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.904 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 52' ' ' ARG . 30.1 t -68.83 -29.3 43.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.728 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.837 HD12 ' OH ' ' A' ' 65' ' ' TYR . 2.2 mm? -72.17 -38.52 69.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -57.95 -45.16 87.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.628 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -64.5 -17.18 63.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.36 67.59 0.7 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.748 0.785 . . . . 0.0 110.847 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 p -72.41 -8.64 56.09 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.498 -1.228 . . . . 0.0 111.335 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.0 m -114.51 40.81 2.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.179 0.514 . . . . 0.0 110.781 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.66 141.4 33.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.164 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.456 ' CG ' ' CZ ' ' A' ' 74' ' ' TYR . 1.9 mm-40 -78.77 126.74 31.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.033 0.444 . . . . 0.0 111.16 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.837 ' OH ' HD12 ' A' ' 57' ' ' LEU . 43.9 m-85 -115.16 165.6 12.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.349 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -154.22 144.3 21.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 111.286 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 tptt 66.42 -103.2 0.08 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.861 -0.608 . . . . 0.0 111.733 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -91.55 -13.47 32.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.751 0.31 . . . . 0.0 111.818 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 65' ' ' TYR . . . 124.36 30.65 0.98 Allowed Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.134 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -86.55 168.79 13.36 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.488 ' CD1' HD22 ' A' ' 42' ' ' LEU . 2.1 mp -79.8 121.53 33.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.413 -179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.817 ' O ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -104.21 -29.57 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.005 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.76 171.64 18.33 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.64 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.456 ' CZ ' ' CG ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -151.65 -174.02 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.749 0.309 . . . . 0.0 110.802 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.79 -48.28 3.26 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.575 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.604 HD11 HD22 ' A' ' 92' ' ' LEU . 3.2 mm? -57.6 174.26 0.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.682 0.277 . . . . 0.0 110.953 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.464 HG21 ' C ' ' A' ' 94' ' ' ALA . 15.8 p -113.39 159.55 19.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.709 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.31 48.99 0.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.622 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 43.47 96.42 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.985 0.421 . . . . 0.0 112.067 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -156.99 -88.5 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.475 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -38.63 157.45 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.958 0.408 . . . . 0.0 111.996 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.437 ' O ' HG23 ' A' ' 84' ' ' VAL . 15.0 t -75.07 -10.64 59.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.89 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 97' ' ' ALA . 23.2 m-85 -70.87 101.2 2.09 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG13 ' CE1' ' A' ' 93' ' ' TYR . 9.2 t -110.23 143.61 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.937 0.398 . . . . 0.0 111.186 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.862 ' CD1' HG22 ' A' ' 113' ' ' VAL . 32.5 t80 -134.33 109.25 8.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.352 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.84 125.22 39.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.995 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.477 ' CG2' ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -136.31 122.99 31.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.87 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 59.5 -76.51 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.063 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.9 p-10 -159.15 36.7 0.21 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.461 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -140.94 115.66 9.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.636 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -77.76 85.89 4.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.86 0.362 . . . . 0.0 110.989 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.604 HD22 HD11 ' A' ' 76' ' ' LEU . 51.5 mt -71.97 165.0 25.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.84 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.558 ' CE1' HG13 ' A' ' 84' ' ' VAL . 50.6 m-85 -138.45 165.15 27.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.312 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 100' ' ' THR . . . -144.14 162.04 37.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.866 0.365 . . . . 0.0 111.861 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 4.8 m0 -85.31 -27.43 25.94 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.402 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.438 ' HB2' ' HB ' ' A' ' 162' ' ' VAL . 0.5 OUTLIER -129.89 159.04 37.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.754 179.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.674 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -61.98 -11.87 15.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.83 HD12 HG11 ' A' ' 162' ' ' VAL . 9.0 mt -103.64 -20.76 13.87 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.49 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 14.7 t70 -82.5 -3.6 56.13 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.706 ' HA ' ' HB2' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.54 -39.1 86.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 0.0 110.341 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.648 HD13 ' H ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -98.33 173.77 6.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.719 HD12 ' N ' ' A' ' 103' ' ' PHE . 2.5 pp -154.92 -45.29 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.133 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.719 ' N ' HD12 ' A' ' 102' ' ' ILE . 11.3 m-85 -163.06 79.12 1.72 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.016 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.466 ' CB ' HG12 ' A' ' 128' ' ' VAL . 59.3 Cg_endo -71.92 -32.84 10.71 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.591 2.194 . . . . 0.0 112.294 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.15 -23.78 43.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.263 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.403 HD21 HD11 ' A' ' 24' ' ' LEU . 1.0 OUTLIER -84.89 -40.08 17.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.38 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.1 tp -57.94 -45.34 87.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.263 0.554 . . . . 0.0 111.372 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.19 24.26 15.09 Favored Glycine 0 C--N 1.319 -0.385 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.484 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 tpp180 -151.42 173.62 14.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.065 0.459 . . . . 0.0 110.942 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 m -83.84 157.18 22.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.971 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.575 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.07 110.06 7.7 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 15.2 mtt-85 -80.91 119.03 22.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.732 0.777 . . . . 0.0 111.178 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.862 HG22 ' CD1' ' A' ' 85' ' ' PHE . 13.4 t -108.27 129.54 62.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.847 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.415 ' OG ' ' HB ' ' A' ' 84' ' ' VAL . 1.5 p -124.49 137.62 54.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.318 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.591 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.8 OUTLIER -141.1 172.96 11.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.986 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.401 ' CE1' ' O ' ' A' ' 121' ' ' GLY . 0.8 OUTLIER -130.13 130.94 45.42 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.571 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.1 m -57.76 123.06 14.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 120.873 0.368 . . . . 0.0 111.927 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 165' ' ' PHE . . . -67.78 -8.28 34.48 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.783 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.703 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.43 -50.54 1.99 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.563 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -77.9 -21.15 51.67 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 120.732 0.301 . . . . 0.0 111.198 -178.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.401 ' O ' ' CE1' ' A' ' 116' ' ' HIS . . . 63.31 33.28 86.83 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.01 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.563 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -102.93 169.69 7.18 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.432 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.444 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 58.6 Cg_endo -93.86 107.49 0.16 Allowed 'Trans proline' 0 N--CA 1.443 -1.491 0 C-N-CA 122.922 2.415 . . . . 0.0 111.681 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.591 HG22 ' C ' ' A' ' 115' ' ' SER . 33.8 m -102.54 146.26 10.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.235 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.897 ' O ' HD13 ' A' ' 126' ' ' LEU . 67.0 p -151.87 141.49 21.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.457 0.646 . . . . 0.0 111.196 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.897 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -134.18 153.14 52.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.001 178.48 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.906 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 23.6 m -110.05 114.95 28.89 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 47.8 t -96.2 111.52 26.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.999 0.428 . . . . 0.0 110.869 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 130' ' ' PRO . 0.7 OUTLIER -108.29 176.51 1.57 Allowed Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.461 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 129' ' ' SER . 13.3 Cg_exo -70.33 -12.69 32.25 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.727 2.285 . . . . 0.0 113.112 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 0.8 OUTLIER -121.91 -27.91 4.54 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.076 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 131' ' ' SER . 13.4 pt-20 179.63 -161.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.13 0.49 . . . . 0.0 110.374 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -91.38 156.39 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.758 178.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -146.31 17.16 1.35 Allowed 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.906 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.99 85.04 0.07 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.882 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.472 HG13 HD12 ' A' ' 126' ' ' LEU . 23.1 t -98.88 123.16 51.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.834 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.17 117.09 4.83 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.018 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.12 161.85 93.56 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.423 -1.491 . . . . 0.0 112.087 -0.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.01 78.0 1.69 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 121.117 0.484 . . . . 0.0 110.674 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 144.86 18.76 0.18 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.388 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.836 ' SD ' HD11 ' A' ' 126' ' ' LEU . 6.7 ptm -64.38 161.45 16.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.969 0.385 . . . . 0.0 111.2 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -125.55 152.36 45.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.07 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.516 HG22 ' CE1' ' A' ' 164' ' ' PHE . 61.2 t -114.09 148.9 16.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.822 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.775 ' O ' HG13 ' A' ' 162' ' ' VAL . 50.3 m -120.19 140.87 50.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.769 0.319 . . . . 0.0 110.372 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.516 HD11 ' CD1' ' A' ' 147' ' ' LEU . 2.0 pt? -144.01 176.11 9.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.071 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.44 93.79 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.967 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.516 ' CD1' HD11 ' A' ' 145' ' ' LEU . 0.9 OUTLIER -72.11 -60.86 2.1 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.911 -179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 147' ' ' LEU . 74.4 Cg_endo -75.16 148.56 34.86 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.608 2.205 . . . . 0.0 112.367 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -152.96 121.06 6.17 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.96 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -112.92 -23.35 10.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.166 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.68 106.17 5.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.021 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.501 ' O ' HG22 ' A' ' 154' ' ' VAL . . . -178.35 -36.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.349 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -56.05 100.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.176 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 152' ' ' ALA . 35.0 m -156.39 -44.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.003 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.474 ' N ' HG23 ' A' ' 154' ' ' VAL . 3.2 tpt85 -144.32 -47.38 0.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.682 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -124.64 -62.66 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.715 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 p 56.9 33.31 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.178 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -176.53 37.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.977 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 7.5 p -63.72 -46.15 86.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.812 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.561 ' O ' HG23 ' A' ' 162' ' ' VAL . 0.6 OUTLIER -176.29 -88.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.029 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 32.0 m80 60.52 17.52 7.42 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.444 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.83 HG11 HD12 ' A' ' 98' ' ' LEU . 26.0 t -113.21 121.84 66.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.882 0.372 . . . . 0.0 111.235 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 163' ' ' HIS . 3.2 m-70 -128.14 169.25 14.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.314 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.674 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 10.5 m-30 -110.73 152.95 25.97 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.812 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.595 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 27.1 m-85 -132.54 138.13 47.38 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.582 0.706 . . . . 0.0 110.238 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.571 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -42.66 -28.84 0.26 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.141 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.552 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 71.4 m -166.96 174.7 8.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.121 0.486 . . . . 0.0 111.685 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.601 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.4 t -69.53 -33.84 4.15 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.199 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.4 Cg_exo -73.33 -37.92 2.97 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.81 2.34 . . . . 0.0 110.361 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.577 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.6 -39.63 51.93 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.53 177.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.734 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -62.06 -45.63 92.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 96.2 mt-10 -78.9 -27.68 43.92 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.575 -1.193 . . . . 0.0 110.34 178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.688 ' N ' ' O ' ' A' ' 169' ' ' PRO . 5.5 t70 -71.11 -56.0 7.04 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.301 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.703 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 36.0 t-105 -64.45 -28.91 69.99 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.675 178.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.02 -39.76 94.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.145 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -43.88 63.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.372 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.75 21.92 7.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.177 179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -129.79 23.89 5.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.881 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -81.9 -176.13 5.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.716 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 96.94 -32.67 6.38 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.363 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.2 mt -71.74 61.66 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.902 0.382 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.4 16.73 6.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.456 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 113.07 -63.29 0.29 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.962 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.554 HD23 ' N ' ' A' ' 185' ' ' ALA . 8.1 tt 65.27 151.62 0.05 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.584 0.192 . . . . 0.0 110.513 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.554 ' N ' HD23 ' A' ' 184' ' ' LEU . . . -144.98 150.13 36.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.153 0.502 . . . . 0.0 111.815 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.0 mm -103.95 162.04 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.506 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.462 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -157.35 162.31 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.578 0.704 . . . . 0.0 112.313 179.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -94.97 133.34 38.83 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.375 178.079 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.464 ' CG1' ' HG3' ' A' ' 141' ' ' MET . 2.8 m -47.35 -18.28 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.879 0.371 . . . . 0.0 110.817 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 11.6 m170 -73.67 -44.87 55.54 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 121.18 0.514 . . . . 0.0 109.69 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.576 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.7 OUTLIER -82.41 -20.91 36.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.478 179.152 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.51 -24.79 62.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -80.97 -24.73 37.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.74 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.71 -31.28 30.19 Favored Glycine 0 CA--C 1.509 -0.338 0 N-CA-C 111.339 -0.705 . . . . 0.0 111.339 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 191' ' ' GLU . 8.3 mp -80.8 -28.42 36.3 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -84.92 -24.31 45.67 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.614 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -82.13 -22.01 36.37 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.805 0.336 . . . . 0.0 111.092 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -79.21 -23.15 43.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.186 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -54.24 -38.72 66.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.85 0.357 . . . . 0.0 111.105 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.465 ' HA ' HD12 ' A' ' 203' ' ' LEU . 1.0 OUTLIER -80.73 -54.73 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.926 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -57.87 -31.28 66.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.996 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -76.09 -31.48 58.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.969 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 200' ' ' ASN . 10.1 mt -60.27 -48.5 81.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.4 mt -60.77 -37.44 81.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.948 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -74.55 169.36 17.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.0 t -155.16 35.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.924 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 6.5 mtm -131.64 103.4 6.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.7 -46.83 51.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.86 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.27 137.37 48.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -170.61 1.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.43 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -176.37 -62.95 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.008 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.4 Cg_endo . . . . . 0 C--O 1.249 1.06 0 C-N-CA 122.372 2.048 . . . . 0.0 112.342 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.82 0.343 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.6 t0 60.42 104.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.864 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 60.9 112.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.897 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tp -166.45 82.89 0.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.915 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 m -59.81 148.85 74.83 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.062 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.416 ' CG ' HD11 ' A' ' 46' ' ' LEU . 58.4 Cg_endo -71.57 -37.28 5.61 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.551 2.168 . . . . 0.0 112.317 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.73 -57.14 11.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.568 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -60.23 -26.82 66.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.427 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.42 -53.42 23.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.027 0.441 . . . . 0.0 110.274 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -76.37 -30.1 57.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.419 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.487 HD23 HD22 ' A' ' 28' ' ' LEU . 49.1 tp -70.36 -49.94 44.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.71 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB2' HD13 ' A' ' 28' ' ' LEU . . . -53.48 -25.31 15.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.997 0.427 . . . . 0.0 111.133 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -22.39 64.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.137 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 64.21 48.14 77.83 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.066 -0.588 . . . . 0.0 113.297 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -133.18 155.11 81.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.659 0.266 . . . . 0.0 110.854 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -56.9 108.99 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.518 2.145 . . . . 0.0 111.973 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.768 HG13 HG12 ' A' ' 71' ' ' ILE . 9.6 p -113.58 109.84 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 120.954 0.407 . . . . 0.0 111.394 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 p -87.62 -169.79 2.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.8 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 43' ' ' ALA . 15.8 ttm180 -78.07 -36.84 47.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.406 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.65 -26.96 68.04 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.363 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.76 HG22 HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.56 -42.15 14.65 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.413 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.29 -36.29 83.17 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.83 -42.7 60.49 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.044 -1.435 . . . . 0.0 109.494 177.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.81 -30.84 74.75 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.612 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.582 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.14 -42.48 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 120.949 0.404 . . . . 0.0 110.468 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.546 HD12 HG22 ' A' ' 45' ' ' ILE . 7.1 mp -78.94 -7.43 58.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.505 178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p30 55.37 23.5 5.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.421 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 0.1 OUTLIER -98.89 153.12 37.98 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.272 -179.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.433 ' O ' HG23 ' A' ' 53' ' ' VAL . 49.4 Cg_endo -69.02 137.1 36.75 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.592 2.195 . . . . 0.0 111.923 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.91 -22.18 0.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -78.57 -35.47 45.86 Favored 'General case' 0 CA--C 1.517 -0.313 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.876 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.85 ' O ' HG23 ' A' ' 56' ' ' VAL . 32.2 mmt-85 -66.84 -40.84 88.08 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.11 -48.2 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.544 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.15 -53.47 50.01 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.471 -1.24 . . . . 0.0 110.383 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.7 -49.82 75.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.898 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 52' ' ' ARG . 39.7 t -63.57 -30.66 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.642 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.493 HD11 ' OH ' ' A' ' 65' ' ' TYR . 1.8 tp -62.16 -32.13 72.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.675 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.607 ' O ' HG23 ' A' ' 61' ' ' THR . 3.3 tt0 -57.82 -22.26 46.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -95.93 -18.3 20.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.149 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.448 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -100.95 32.57 3.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.448 0.642 . . . . 0.0 110.85 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.607 HG23 ' O ' ' A' ' 58' ' ' GLU . 26.9 p -67.48 -27.99 67.47 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.956 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.4 t -75.93 -25.56 56.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.254 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.448 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -56.56 141.4 43.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.073 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.711 ' O ' HG22 ' A' ' 72' ' ' ILE . 31.5 mt-10 -78.43 126.87 31.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.493 ' OH ' HD11 ' A' ' 57' ' ' LEU . 39.8 m-85 -102.49 173.08 6.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.583 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.17 -172.77 2.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.564 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.25 -36.99 85.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.516 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -88.46 10.8 18.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.739 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.76 13.11 82.78 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.262 179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -89.03 161.77 16.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.233 0.517 . . . . 0.0 109.827 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.768 HG12 HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -79.76 124.83 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.401 -179.15 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.84 HD11 HD11 ' A' ' 76' ' ' LEU . 2.2 tt -92.73 -21.12 6.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.204 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.14 116.07 0.56 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.602 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.413 ' CD2' ' O ' ' A' ' 74' ' ' TYR . 44.9 p90 -60.31 111.87 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.893 0.377 . . . . 0.0 110.889 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.29 -66.16 0.17 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.84 HD11 HD11 ' A' ' 72' ' ' ILE . 0.8 OUTLIER -63.31 141.43 58.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.849 0.356 . . . . 0.0 110.857 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 16.5 p -123.57 159.55 28.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -46.39 -25.02 0.58 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.664 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.433 ' HD2' ' CD1' ' A' ' 93' ' ' TYR . 18.9 mtm180 79.9 92.03 0.05 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.889 0.376 . . . . 0.0 110.922 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.87 25.14 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.021 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.6 p -122.24 -138.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.959 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.8 p -129.65 -31.12 2.02 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.588 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 96' ' ' CYS . 12.4 m-85 -72.1 104.19 3.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.801 0.334 . . . . 0.0 110.534 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -108.54 141.09 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.347 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.818 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 20.4 t80 -133.78 107.44 7.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.145 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -102.33 134.67 45.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.446 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.479 HG23 ' CE1' ' A' ' 85' ' ' PHE . 2.6 pt -140.06 123.91 18.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.724 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 t0 63.32 -66.7 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.43 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.45 ' N ' ' O ' ' A' ' 87' ' ' ILE . 16.0 m-20 -168.0 35.28 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.499 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -135.61 113.23 10.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.895 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -80.21 86.17 5.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.083 0.468 . . . . 0.0 110.859 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.404 ' CB ' ' O ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -73.65 164.63 26.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.114 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.433 ' CD1' ' HD2' ' A' ' 79' ' ' ARG . 7.9 m-85 -135.49 165.2 26.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.228 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 100' ' ' THR . . . -153.37 173.44 15.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.073 0.463 . . . . 0.0 111.946 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.411 ' O ' ' CE2' ' A' ' 83' ' ' TYR . 12.0 m0 -97.02 -17.58 19.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.008 178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.43 ' HA ' ' CE2' ' A' ' 83' ' ' TYR . 1.2 m -153.96 165.91 34.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.155 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.557 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -52.46 -22.8 5.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.666 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.2 mt -85.22 -51.67 6.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.593 0.235 . . . . 0.0 111.292 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.593 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -49.4 -27.4 4.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.704 0.287 . . . . 0.0 111.542 -179.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.627 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.48 -29.81 69.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.454 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.529 HD23 ' N ' ' A' ' 101' ' ' LEU . 1.8 pt? -154.65 126.3 7.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.773 ' O ' HD13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -96.22 -36.68 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.857 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 106' ' ' LEU . 1.6 m-85 -124.76 78.0 64.61 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.724 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.812 ' O ' HG22 ' A' ' 107' ' ' ILE . 36.1 Cg_exo -61.2 -51.42 4.5 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.631 2.221 . . . . 0.0 112.327 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.85 -23.41 41.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.567 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -90.35 -15.84 30.32 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.812 HG22 ' O ' ' A' ' 104' ' ' PRO . 2.9 tp -47.84 -53.31 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.012 0.434 . . . . 0.0 111.993 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.443 ' H ' HG23 ' A' ' 107' ' ' ILE . . . 102.3 0.73 50.7 Favored Glycine 0 CA--C 1.519 0.344 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.966 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.95 177.88 10.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.785 0.326 . . . . 0.0 110.399 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.35 143.94 44.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.818 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -137.18 109.88 7.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.82 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.7 mtm-85 -81.33 120.05 24.45 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.75 0.786 . . . . 0.0 111.467 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.17 130.9 65.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.827 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.4 m -126.02 137.97 53.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.326 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.594 ' C ' HG22 ' A' ' 124' ' ' VAL . 0.6 OUTLIER -141.34 172.91 12.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.075 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -133.97 135.67 43.64 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.2 t -64.59 131.97 48.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.29 -3.4 23.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.936 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.897 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.91 -50.5 2.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.87 0.367 . . . . 0.0 111.543 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.688 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -90.32 -23.62 21.09 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.457 -179.346 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.56 6.18 75.79 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.251 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.688 ' H ' HG22 ' A' ' 120' ' ' THR . . . -60.03 155.55 43.2 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-O 120.604 0.24 . . . . 0.0 110.457 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -87.97 104.27 0.51 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 122.719 2.279 . . . . 0.0 111.383 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.594 HG22 ' C ' ' A' ' 115' ' ' SER . 33.9 m -98.1 145.14 10.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.1 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.3 p -155.59 142.69 19.19 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.581 0.705 . . . . 0.0 111.26 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.585 HD21 ' SD ' ' A' ' 141' ' ' MET . 0.5 OUTLIER -135.16 153.32 52.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.685 178.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.874 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 32.2 m -108.26 113.84 27.25 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.723 HG13 ' CZ ' ' A' ' 193' ' ' PHE . 41.1 t -95.9 111.51 26.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.026 0.441 . . . . 0.0 111.696 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.409 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.8 OUTLIER -105.86 169.01 7.45 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.744 179.357 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 33.3 Cg_endo -65.42 -18.82 60.87 Favored 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.14 1.893 . . . . 0.0 112.844 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 70.8 m -112.59 -28.2 7.92 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 131' ' ' SER . 22.1 pt-20 179.54 -163.3 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.237 0.541 . . . . 0.0 110.139 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -95.2 158.66 2.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.753 178.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -147.23 19.33 1.22 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.874 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.23 86.19 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.632 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.3 t -105.03 117.65 51.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.024 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.44 117.38 4.77 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.087 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.436 ' CD ' HG12 ' A' ' 124' ' ' VAL . 16.7 Cg_exo -67.57 145.91 75.38 Favored 'Cis proline' 0 C--N 1.349 0.555 0 C-N-CA 123.73 -1.363 . . . . 0.0 112.443 0.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.35 -33.19 52.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.867 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -101.43 30.14 11.02 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.245 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.873 ' SD ' HG11 ' A' ' 189' ' ' VAL . 5.4 ptp -65.22 157.22 29.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 0.0 111.889 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -130.8 152.44 50.14 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.318 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.747 ' CG2' HG12 ' A' ' 189' ' ' VAL . 11.4 t -113.41 153.08 15.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.776 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.404 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 4.4 m -121.7 143.04 49.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.741 0.305 . . . . 0.0 110.608 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.508 HD13 HG21 ' A' ' 187' ' ' VAL . 5.3 mp -145.3 176.08 9.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.109 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 161' ' ' HIS . 35.4 t -125.35 132.49 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.837 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.413 ' CB ' ' HD3' ' A' ' 148' ' ' PRO . 2.5 mp -78.28 -61.66 0.55 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.932 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 147' ' ' LEU . 78.1 Cg_endo -77.04 -168.07 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.595 2.197 . . . . 0.0 112.416 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -174.6 114.64 0.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.935 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.52 -21.25 10.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.286 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -128.82 79.44 1.91 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.861 0.363 . . . . 0.0 111.133 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -179.02 59.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.998 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -177.25 -40.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.97 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.489 HG23 ' N ' ' A' ' 155' ' ' ARG . 28.6 m -61.6 -45.23 99.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.156 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.489 ' N ' HG23 ' A' ' 154' ' ' VAL . 75.6 mtm-85 -135.64 31.06 3.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.949 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 60.46 44.71 11.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 3.0 m -70.42 138.44 51.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.826 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -177.76 62.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -57.73 -41.2 81.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.721 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -177.95 -87.4 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.743 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.41 ' HB3' HG21 ' A' ' 146' ' ' VAL . 9.6 m170 75.93 -47.83 0.58 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.9 t -95.09 103.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.908 0.385 . . . . 0.0 111.52 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.411 ' CD2' ' OH ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -126.03 169.31 12.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.738 0.78 . . . . 0.0 109.765 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.708 ' CD1' HG13 ' A' ' 143' ' ' VAL . 2.0 m-85 -113.0 152.35 29.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 114.522 -1.217 . . . . 0.0 109.912 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 60.6 m-85 -131.44 136.83 48.3 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 121.766 0.793 . . . . 0.0 110.578 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 122' ' ' ALA . . . -47.88 -25.17 1.22 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.624 -1.171 . . . . 0.0 112.797 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.596 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 44.7 m -164.73 167.62 18.79 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.389 -0.524 . . . . 0.0 111.643 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.62 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 78.3 t -68.12 -34.45 6.08 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.896 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.3 Cg_exo -72.45 -37.03 4.6 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.768 2.312 . . . . 0.0 110.103 179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.583 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.19 -40.57 52.0 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.731 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.52 -46.15 91.21 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 1.7 mm-40 -78.97 -27.22 43.48 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.331 178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.709 ' N ' ' O ' ' A' ' 169' ' ' PRO . 26.5 t70 -70.06 -55.76 8.66 Favored 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.192 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.897 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 51.4 t-105 -65.99 -28.29 68.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.723 178.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.731 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -64.24 -39.45 93.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.13 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.0 t -53.71 -42.25 67.86 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.428 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.41 18.46 9.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.382 0.61 . . . . 0.0 111.38 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.438 ' CD2' ' CD1' ' A' ' 174' ' ' TRP . 0.1 OUTLIER -120.31 24.15 10.55 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.727 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -93.38 -176.71 4.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.768 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.52 -32.22 6.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.355 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.5 mt -63.56 -174.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.777 0.323 . . . . 0.0 110.723 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.36 -27.14 67.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.849 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 170.09 159.94 17.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.497 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.589 HD23 ' N ' ' A' ' 185' ' ' ALA . 1.9 tt -179.03 137.68 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.757 0.313 . . . . 0.0 110.751 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.589 ' N ' HD23 ' A' ' 184' ' ' LEU . . . -142.55 150.17 40.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.11 0.481 . . . . 0.0 111.369 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 175' ' ' ALA . 15.5 mm -101.56 161.31 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.747 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.716 HG12 ' CD ' ' A' ' 191' ' ' GLU . 0.0 OUTLIER -159.89 159.79 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.277 0.56 . . . . 0.0 112.15 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 190' ' ' HIS . 42.2 p -89.83 128.59 36.19 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.669 178.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.873 HG11 ' SD ' ' A' ' 141' ' ' MET . 2.4 m -47.72 -19.15 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.993 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.407 ' N ' ' C ' ' A' ' 188' ' ' SER . 59.5 t-80 -72.82 -42.03 64.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.155 0.502 . . . . 0.0 109.821 179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.716 ' CD ' HG12 ' A' ' 187' ' ' VAL . 1.1 pt-20 -82.16 -26.18 33.67 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.177 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -66.22 -24.91 66.69 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.927 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.723 ' CZ ' HG13 ' A' ' 128' ' ' VAL . 1.3 t80 -81.34 -25.58 36.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.68 179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.04 -31.76 27.96 Favored Glycine 0 CA--C 1.509 -0.3 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.1 tp -80.83 -28.55 36.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -82.84 -24.77 52.04 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -82.2 -22.28 36.04 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.524 -0.338 . . . . 0.0 110.969 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -77.74 -22.77 49.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.255 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.13 -39.5 60.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.868 0.366 . . . . 0.0 111.092 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -81.09 -44.34 18.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.872 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.59 -35.16 71.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.072 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.78 -30.28 68.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.8 tp -60.61 -46.77 89.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.56 ' HB3' HG22 ' A' ' 206' ' ' THR . 4.6 mm? -65.59 -52.09 54.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 59.09 31.51 21.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.56 HG22 ' HB3' ' A' ' 204' ' ' LEU . 7.2 t -100.72 116.51 32.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.897 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -157.09 36.35 0.29 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.947 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.4 m -160.35 174.05 14.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 20.0 p -161.48 -68.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.962 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -70.96 -177.83 1.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.417 ' HB ' ' HD3' ' A' ' 212' ' ' PRO . 0.9 OUTLIER 178.8 -55.11 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.903 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.417 ' HD3' ' HB ' ' A' ' 211' ' ' THR . 78.0 Cg_exo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.43 2.087 . . . . 0.0 112.447 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.891 0.377 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -168.44 157.36 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.902 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.7 mt -95.13 125.79 40.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.799 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.526 ' O ' HG13 ' A' ' 25' ' ' VAL . 1.8 tt -85.0 -56.7 3.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.909 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 24' ' ' LEU . 6.1 m -158.82 80.68 2.8 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.155 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.467 ' HA ' ' HB2' ' A' ' 29' ' ' ARG . 53.6 Cg_exo -52.02 -24.55 19.83 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.593 2.195 . . . . 0.0 112.407 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.083 HD12 HD12 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.93 -57.23 12.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.328 -179.432 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.083 HD12 HD12 ' A' ' 27' ' ' LEU . 1.1 mp -72.49 -27.36 62.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.251 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.467 ' HB2' ' HA ' ' A' ' 26' ' ' PRO . 5.3 mmt85 -64.42 -53.28 50.85 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.138 0.494 . . . . 0.0 109.824 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -70.91 -25.01 62.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.409 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.697 HD11 ' HA3' ' A' ' 73' ' ' GLY . 4.5 tp -67.6 -40.27 84.77 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.947 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.23 -25.2 13.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.573 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' NZ ' HG22 ' A' ' 37' ' ' VAL . 1.3 ptpt -70.36 -20.19 62.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.173 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.13 47.69 86.18 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 121.158 -0.544 . . . . 0.0 113.354 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -133.21 158.3 76.09 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.725 0.297 . . . . 0.0 110.74 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.7 91.63 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.566 2.177 . . . . 0.0 112.262 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.614 ' O ' HD12 ' A' ' 71' ' ' ILE . 21.9 t -92.96 114.92 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.353 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.4 p -77.44 -179.62 5.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.847 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -78.2 -32.55 50.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.631 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -68.34 -30.77 69.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.681 0.277 . . . . 0.0 110.642 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 45' ' ' ILE . 0.9 OUTLIER -84.31 -38.51 20.32 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.31 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.805 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 9.3 tp -63.16 -41.71 99.29 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 176.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.977 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -69.74 -42.96 73.26 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.774 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 40' ' ' THR . . . -67.47 -25.84 73.71 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.254 179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.795 HG22 HD23 ' A' ' 46' ' ' LEU . 7.1 mt -76.54 -40.18 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 115.245 -0.478 . . . . 0.0 110.457 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.805 ' HG ' ' O ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -80.22 -6.5 57.93 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.568 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 62.95 30.15 16.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -116.99 149.64 44.52 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.624 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.16 143.72 99.66 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.626 2.218 . . . . 0.0 112.006 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.48 -16.45 2.33 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.95 -31.58 45.11 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.586 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.82 ' O ' HG23 ' A' ' 56' ' ' VAL . 13.5 mtp180 -70.18 -40.0 74.92 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.977 HG21 ' HB2' ' A' ' 43' ' ' ALA . 1.8 t -65.63 -46.36 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.36 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -52.38 -51.7 57.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.112 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.72 -43.24 80.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.7 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 52' ' ' ARG . 27.7 t -70.59 -32.45 49.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.577 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.562 HD22 ' OH ' ' A' ' 65' ' ' TYR . 15.9 mt -61.39 -32.52 72.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.499 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.606 ' O ' HG23 ' A' ' 61' ' ' THR . 3.0 tt0 -57.63 -24.35 56.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.701 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -96.18 -14.43 22.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.161 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.482 ' HB1' ' OG1' ' A' ' 63' ' ' THR . . . -104.11 32.86 3.73 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.466 0.65 . . . . 0.0 110.598 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 58' ' ' GLU . 27.0 p -66.89 -14.39 62.7 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.233 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.6 t -86.78 -23.9 25.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.329 . . . . 0.0 111.346 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.482 ' OG1' ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -55.81 141.23 39.48 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.047 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.543 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -78.99 126.79 31.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.038 0.447 . . . . 0.0 111.474 -179.397 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.562 ' OH ' HD22 ' A' ' 57' ' ' LEU . 13.1 m-85 -100.64 168.81 9.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.267 179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -153.87 143.61 21.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.0 111.549 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.7 tttp 66.9 -102.64 0.07 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.824 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.32 -13.04 28.64 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.74 31.86 0.79 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.051 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -89.67 169.03 11.65 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 37' ' ' VAL . 4.0 mp -79.8 114.25 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.27 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.782 ' O ' HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -103.28 -27.46 3.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.112 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.697 ' HA3' HD11 ' A' ' 31' ' ' LEU . . . 90.17 162.32 38.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.516 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.404 ' O ' ' CG ' ' A' ' 74' ' ' TYR . 11.9 t80 -111.23 31.44 6.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.808 0.337 . . . . 0.0 110.909 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.11 -62.44 1.43 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.556 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 pp -78.73 147.94 33.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.857 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.3 p -107.66 159.05 16.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -75.35 -30.8 60.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.96 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -102.8 147.57 26.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -64.52 122.27 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 28.9 p -106.91 -174.72 2.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 60.2 p -92.65 -37.29 12.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.94 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.407 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 45.6 m-85 -87.24 113.97 23.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.559 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.08 142.73 20.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.984 ' CE2' HD13 ' A' ' 101' ' ' LEU . 59.8 t80 -124.72 105.19 9.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.346 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -98.62 126.23 44.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.779 0.323 . . . . 0.0 111.42 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.621 HD11 ' HB2' ' A' ' 90' ' ' ARG . 6.9 pt -118.76 177.89 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.396 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 87' ' ' ILE . 8.6 t0 -14.52 -53.38 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 87' ' ' ILE . 21.7 p30 -165.74 35.48 0.05 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.033 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.621 ' HB2' HD11 ' A' ' 87' ' ' ILE . 12.1 mmt180 -142.03 113.07 7.47 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.72 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -77.64 119.39 21.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.791 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.9 mp -112.3 164.88 12.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.268 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -133.95 165.14 25.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.099 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.63 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -153.45 171.39 18.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.115 0.483 . . . . 0.0 111.855 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -94.37 -20.27 19.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.007 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.407 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 2.3 m -157.51 179.81 8.89 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.668 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' HB2' ' HD2' ' A' ' 164' ' ' PHE . . . -56.52 -21.89 29.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tp -89.18 -51.92 5.33 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.63 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 4.8 m-20 -46.95 -26.54 1.03 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -60.36 -36.26 77.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.851 0.358 . . . . 0.0 110.666 -179.727 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.984 HD13 ' CE2' ' A' ' 85' ' ' PHE . 3.3 tp -176.78 152.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 15.5 pt -122.82 -39.24 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.519 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.451 ' CZ ' ' ND2' ' A' ' 200' ' ' ASN . 9.2 m-85 -119.7 81.7 25.56 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.168 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.633 ' HA ' HD21 ' A' ' 101' ' ' LEU . 7.3 Cg_exo -72.58 -29.0 13.69 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.797 2.331 . . . . 0.0 112.215 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.09 -23.76 59.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.249 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -78.74 -29.91 45.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.906 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 104' ' ' PRO . 3.9 mm -54.16 -60.55 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 122.082 0.944 . . . . 0.0 110.988 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 100.19 17.29 25.21 Favored Glycine 0 C--N 1.316 -0.545 0 CA-C-N 113.722 -1.581 . . . . 0.0 112.301 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.16 -177.27 5.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.851 0.357 . . . . 0.0 110.462 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.09 148.5 27.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.949 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.795 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.24 110.01 7.59 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -80.8 121.05 25.46 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.714 0.768 . . . . 0.0 110.86 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.822 HG22 ' CD1' ' A' ' 85' ' ' PHE . 90.5 t -113.8 131.78 64.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.934 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.6 p -119.42 138.25 53.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.712 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.535 ' OG ' HG23 ' A' ' 124' ' ' VAL . 0.0 OUTLIER -140.67 172.8 12.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.42 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER -135.15 131.32 36.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.54 178.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.662 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 21.3 m -57.41 124.45 18.98 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.918 0.389 . . . . 0.0 111.902 -178.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.12 -9.49 46.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.628 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.701 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.67 -51.2 2.05 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.557 HG22 ' CB ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -76.24 -20.83 57.05 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.917 0.389 . . . . 0.0 110.767 -179.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.3 33.69 85.38 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.26 -0.971 . . . . 0.0 111.108 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.557 ' CB ' HG22 ' A' ' 120' ' ' THR . . . -100.91 168.01 9.9 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.495 -0.353 . . . . 0.0 110.437 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.418 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 46.3 Cg_endo -93.89 110.27 0.18 Allowed 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 123.024 2.483 . . . . 0.0 111.313 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.535 HG23 ' OG ' ' A' ' 115' ' ' SER . 35.3 m -109.51 148.53 13.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.492 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 86.0 p -147.62 142.43 26.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.509 0.671 . . . . 0.0 110.567 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -135.19 152.13 51.28 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.743 179.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.801 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 42.8 m -111.25 112.31 24.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 104' ' ' PRO . 32.6 t -96.93 114.1 32.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 121.008 0.432 . . . . 0.0 112.137 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.42 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.5 OUTLIER -105.72 170.19 6.15 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.702 179.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.9 Cg_endo -66.64 -19.51 53.9 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.158 1.905 . . . . 0.0 113.001 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 6.9 t -108.87 -27.41 9.73 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 131' ' ' SER . 14.9 pt-20 178.05 -162.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -94.64 162.84 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.472 178.248 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -150.09 21.28 0.87 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.434 0.635 . . . . 0.0 112.326 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.801 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.95 87.4 0.09 Allowed 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.44 178.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.2 t -104.1 119.88 53.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.156 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -146.18 122.9 5.87 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.796 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.506 ' CD ' HG12 ' A' ' 124' ' ' VAL . 61.9 Cg_endo -73.24 159.63 97.03 Favored 'Cis proline' 0 C--N 1.349 0.602 0 C-N-CA 123.382 -1.507 . . . . 0.0 112.322 0.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.92 79.37 0.64 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.134 0.492 . . . . 0.0 110.658 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.26 18.02 0.17 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.573 -0.739 . . . . 0.0 113.282 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.593 ' CG ' HG11 ' A' ' 189' ' ' VAL . 9.8 ptm -60.98 157.82 14.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.019 0.438 . . . . 0.0 111.395 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.492 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -127.13 152.01 47.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.326 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.939 HG22 ' CE1' ' A' ' 164' ' ' PHE . 2.6 t -117.93 152.34 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.991 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.423 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 53.1 p -117.47 143.74 45.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.766 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 146' ' ' VAL . 0.2 OUTLIER -136.54 176.05 9.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.819 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.722 HG12 ' CD1' ' A' ' 184' ' ' LEU . 29.9 m -120.42 159.72 21.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.018 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.9 mt -89.36 149.32 42.48 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.08 -45.92 35.85 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.588 2.192 . . . . 0.0 112.338 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . 0.749 ' OE1' ' HB3' ' A' ' 151' ' ' ALA . 0.7 OUTLIER 61.15 158.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -92.82 -21.4 19.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.179 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.749 ' HB3' ' OE1' ' A' ' 149' ' ' GLN . . . -87.14 -20.13 27.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.366 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -133.87 167.67 20.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.536 ' O ' HG13 ' A' ' 154' ' ' VAL . 1.6 t70 -130.82 -67.93 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 153' ' ' ASP . 5.5 m -159.21 -45.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.162 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -81.57 -30.59 32.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -100.97 58.64 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.942 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.432 ' O ' ' CG ' ' A' ' 158' ' ' PHE . 13.3 t -154.5 -81.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.432 ' CG ' ' O ' ' A' ' 157' ' ' SER . 42.4 p90 43.53 36.46 1.18 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.364 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 17.2 m -73.8 -46.05 47.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.78 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.658 ' SG ' HD13 ' A' ' 181' ' ' LEU . 1.5 m -115.3 -37.12 4.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.826 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.405 ' CG ' ' O ' ' A' ' 161' ' ' HIS . 1.3 t60 63.58 28.29 15.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.053 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 145' ' ' LEU . 75.8 t 57.82 110.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.047 0.451 . . . . 0.0 111.611 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -118.91 169.35 9.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.558 0.694 . . . . 0.0 109.773 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.939 ' CE1' HG22 ' A' ' 143' ' ' VAL . 0.4 OUTLIER -111.05 151.14 28.38 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.036 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 45.6 m-85 -135.83 134.6 39.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.251 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.662 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -38.93 -29.68 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.146 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 35.2 m -170.49 178.0 3.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.062 0.458 . . . . 0.0 111.575 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.61 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 90.5 t -69.57 -33.77 4.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.491 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.684 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.5 Cg_exo -72.64 -38.78 3.0 Favored 'Trans proline' 0 CA--C 1.504 -0.999 0 C-N-CA 122.563 2.175 . . . . 0.0 110.41 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.556 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.23 -39.65 54.05 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.751 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.88 -46.81 87.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.549 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 2.3 mm-40 -78.99 -26.98 43.32 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.5 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 169' ' ' PRO . 4.8 t70 -70.89 -55.72 7.82 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.701 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 32.3 t-105 -65.03 -29.75 70.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.787 178.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.751 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.33 -39.6 95.0 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.242 178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -44.43 62.57 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.338 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.16 23.87 6.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.172 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.598 ' NE2' HD11 ' A' ' 181' ' ' LEU . 2.3 t-160 -136.41 33.38 2.78 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.037 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -95.32 143.79 26.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.675 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 125.54 -24.45 5.83 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.573 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.658 HD13 ' SG ' ' A' ' 160' ' ' CYS . 3.6 mt -68.24 69.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.123 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 55.88 28.64 12.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.119 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 75.6 72.54 1.05 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.515 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.722 ' CD1' HG12 ' A' ' 146' ' ' VAL . 7.9 tp -75.0 152.66 38.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.771 0.32 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -140.28 148.89 42.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.022 0.439 . . . . 0.0 111.121 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.662 HD11 ' HB2' ' A' ' 175' ' ' ALA . 17.1 mm -100.71 160.53 3.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.987 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.473 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -162.79 150.66 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.144 0.497 . . . . 0.0 111.969 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 191' ' ' GLU . 0.6 OUTLIER -78.98 126.07 30.2 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.635 178.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.612 ' HA ' ' HB3' ' A' ' 192' ' ' ALA . 0.2 OUTLIER -46.54 -20.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.885 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -72.24 -45.1 61.63 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 188' ' ' SER . 1.0 OUTLIER -82.73 -22.41 34.44 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.141 178.175 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' A' ' 189' ' ' VAL . . . -67.83 -25.61 65.65 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.729 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.409 ' O ' ' CB ' ' A' ' 197' ' ' GLN . 0.2 OUTLIER -81.75 -24.94 35.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.627 179.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -83.08 -31.52 28.43 Favored Glycine 0 N--CA 1.451 -0.322 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -29.73 31.53 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -82.27 -28.46 40.38 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.409 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 37.5 tt0 -82.47 -22.57 35.13 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.557 -0.321 . . . . 0.0 110.866 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -81.09 -25.23 37.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -51.85 -29.76 20.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 0.0 111.291 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . 0.451 ' ND2' ' CZ ' ' A' ' 103' ' ' PHE . 6.6 m120 -80.43 -55.13 5.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -63.24 -30.57 71.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -80.02 -45.07 19.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.005 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 8.3 tt -58.82 -41.18 86.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.956 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.05 -44.87 83.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -87.38 144.05 26.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.13 -39.97 6.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.919 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 1.6 tmm? -113.58 159.96 19.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 1.5 m -93.2 111.38 23.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.936 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 13.0 t -151.82 -66.0 0.18 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.47 167.51 22.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.436 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -176.4 -63.09 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.993 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.5 Cg_endo . . . . . 0 C--O 1.247 0.943 0 C-N-CA 122.348 2.032 . . . . 0.0 112.34 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.81 0.338 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -65.89 165.62 12.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.0 tp -99.03 98.95 9.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.568 HD21 HH11 ' A' ' 29' ' ' ARG . 0.7 OUTLIER -142.64 150.21 39.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.76 HG11 HD23 ' A' ' 28' ' ' LEU . 21.5 t -110.3 86.8 5.56 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.136 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.796 ' CG ' HD11 ' A' ' 46' ' ' LEU . 43.0 Cg_endo -67.83 -27.12 37.74 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.525 2.15 . . . . 0.0 112.371 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.709 ' HG ' HD21 ' A' ' 42' ' ' LEU . 5.2 mp -52.66 -57.44 10.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.232 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.76 HD23 HG11 ' A' ' 25' ' ' VAL . 3.9 pp -80.07 -27.3 39.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.066 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.568 HH11 HD21 ' A' ' 24' ' ' LEU . 10.6 ttt85 -64.83 -53.29 49.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -65.78 -23.78 66.79 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.287 178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.677 HD11 ' O ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -68.04 -37.59 81.53 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.773 179.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.19 -26.41 17.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.1 0.476 . . . . 0.0 111.03 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -20.97 66.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.226 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.63 48.3 82.63 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.153 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -133.06 157.26 78.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.724 179.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.3 91.02 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.516 2.144 . . . . 0.0 112.121 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.644 HG13 HG22 ' A' ' 41' ' ' THR . 21.5 t -93.01 113.5 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.38 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.8 p -87.0 -174.16 4.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.718 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -77.93 -36.23 49.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.321 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -28.72 69.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.907 0.384 . . . . 0.0 110.09 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.644 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.46 -41.82 16.21 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 178.345 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.709 HD21 ' HG ' ' A' ' 27' ' ' LEU . 2.2 tp -62.63 -36.5 83.01 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.92 -43.27 62.59 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.589 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.74 -30.89 74.95 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.689 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.588 HD12 HG23 ' A' ' 41' ' ' THR . 7.0 mt -79.09 -42.87 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-O 121.067 0.461 . . . . 0.0 110.376 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.796 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.1 mp -76.44 -9.66 58.82 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.41 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.1 t0 60.34 21.64 11.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.43 ' HA ' ' CE3' ' A' ' 48' ' ' TRP . 5.3 m95 -107.48 158.1 34.07 Favored Pre-proline 0 N--CA 1.452 -0.374 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.171 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.02 144.09 62.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.607 2.205 . . . . 0.0 112.114 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.0 -16.92 2.15 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -78.64 -35.04 46.01 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.675 -0.41 . . . . 0.0 111.208 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.828 ' O ' HG23 ' A' ' 56' ' ' VAL . 3.6 ttt-85 -67.6 -41.1 84.59 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.645 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -63.03 -47.73 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.483 177.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.26 -53.11 55.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.206 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.77 -46.92 77.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.794 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 52' ' ' ARG . 30.9 t -67.65 -32.03 55.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.724 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -64.22 -33.26 75.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.657 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.694 ' O ' HG23 ' A' ' 61' ' ' THR . 6.0 tp10 -58.16 -22.06 49.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.88 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -90.85 -17.47 26.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.06 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.428 ' HB1' ' HB ' ' A' ' 63' ' ' THR . . . -97.18 33.09 2.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.367 0.603 . . . . 0.0 111.121 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.694 HG23 ' O ' ' A' ' 58' ' ' GLU . 73.1 p -60.1 -20.63 59.15 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.912 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.56 -22.6 21.2 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.411 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB1' ' A' ' 60' ' ' ALA . 0.8 OUTLIER -58.46 141.06 52.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.523 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -78.85 126.9 31.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.112 0.482 . . . . 0.0 111.604 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.433 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 62.5 m-85 -103.43 173.17 6.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.192 179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.824 ' HB2' HG21 ' A' ' 72' ' ' ILE . 22.5 t70 -153.53 147.87 25.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 0.0 111.416 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.7 tttp 66.28 -102.01 0.07 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.782 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.23 -13.05 33.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 65' ' ' TYR . . . 121.97 30.76 1.18 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.92 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -85.92 164.83 17.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.957 0.408 . . . . 0.0 110.189 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -79.96 109.61 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.336 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.824 HG21 ' HB2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -123.51 -26.88 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.642 -179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.84 174.36 24.39 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.578 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.433 ' CE1' ' HB3' ' A' ' 28' ' ' LEU . 46.7 t80 -173.88 -51.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.814 ' O ' HD12 ' A' ' 92' ' ' LEU . . . -147.05 46.83 0.71 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.553 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.617 HD12 HD13 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -128.15 150.96 49.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.764 0.316 . . . . 0.0 110.96 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.571 ' N ' HD23 ' A' ' 76' ' ' LEU . 67.5 p -99.75 159.08 15.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.812 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.73 -32.66 25.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.025 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -96.53 144.23 26.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.1 122.09 17.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.3 p -107.36 -177.05 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.138 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.451 ' CB ' ' CE1' ' A' ' 116' ' ' HIS . 53.1 m -93.08 -30.47 15.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.904 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.544 ' HE2' ' HB2' ' A' ' 97' ' ' ALA . 20.6 m-85 -86.68 117.35 25.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.362 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.458 HG22 ' HE1' ' A' ' 93' ' ' TYR . 21.2 t -110.01 142.31 22.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.993 0.425 . . . . 0.0 111.488 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.83 ' CZ ' ' HB1' ' A' ' 111' ' ' ALA . 46.2 t80 -125.58 105.21 8.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.717 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -93.14 121.01 34.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.173 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.608 HD11 HD23 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -139.03 122.93 19.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.617 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 58.3 -77.23 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.327 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 87' ' ' ILE . 2.0 t70 -159.38 35.83 0.2 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.432 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -139.79 113.88 8.92 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.641 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -77.78 86.32 4.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.979 0.418 . . . . 0.0 111.02 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.814 HD12 ' O ' ' A' ' 75' ' ' GLY . 3.4 mm? -71.77 164.64 25.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.439 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.458 ' HE1' HG22 ' A' ' 84' ' ' VAL . 40.5 m-85 -137.46 162.2 34.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.821 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 100' ' ' THR . . . -145.03 164.09 32.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.119 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -81.31 -33.37 32.6 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.45 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 59.7 m -152.92 -177.8 6.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.056 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.874 ' HB1' ' CE1' ' A' ' 164' ' ' PHE . . . -61.84 148.86 41.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.706 0.289 . . . . 0.0 110.917 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.48 ' CB ' ' O ' ' A' ' 97' ' ' ALA . 1.7 tt 88.11 -51.48 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.666 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -54.58 -21.61 10.88 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.208 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 85' ' ' PHE . 1.3 p -60.45 -39.51 87.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.381 . . . . 0.0 110.544 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.627 ' O ' HG23 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -110.34 -172.08 1.96 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.174 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.8 HD12 ' CE2' ' A' ' 103' ' ' PHE . 3.3 pt -161.76 -43.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.975 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 102' ' ' ILE . 2.2 p90 -163.0 93.64 1.16 Allowed Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.762 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.672 ' HB3' HG12 ' A' ' 128' ' ' VAL . 74.1 Cg_endo -74.45 -35.07 4.0 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.7 2.266 . . . . 0.0 112.368 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -76.69 -23.99 53.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.386 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.8 tp -84.89 -42.41 15.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.338 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.3 tp -57.18 -46.95 84.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 121.295 0.569 . . . . 0.0 111.417 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 95.52 23.64 18.31 Favored Glycine 0 C--N 1.318 -0.423 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.699 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 173.46 15.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.893 0.378 . . . . 0.0 111.077 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -80.81 152.91 28.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.897 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.83 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -137.16 109.77 7.49 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -83.03 120.64 26.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.78 0.8 . . . . 0.0 111.158 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.75 HG22 ' HD1' ' A' ' 85' ' ' PHE . 60.3 t -112.44 129.44 67.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.385 -1.279 . . . . 0.0 111.963 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.7 m -119.72 137.93 53.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.029 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.695 ' HB2' HG23 ' A' ' 124' ' ' VAL . 3.1 m -141.25 172.8 12.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.478 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.451 ' CE1' ' CB ' ' A' ' 82' ' ' SER . 17.6 p-80 -137.82 132.67 32.98 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 23.0 t -61.15 130.8 48.09 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.152 0.501 . . . . 0.0 112.16 -178.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.91 -3.14 20.8 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.756 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.823 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -121.14 -50.46 2.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.865 0.364 . . . . 0.0 111.601 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.689 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -90.14 -24.67 21.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.29 -179.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.09 81.01 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.108 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.689 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.29 158.68 13.48 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 120.581 0.229 . . . . 0.0 110.483 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -91.49 106.16 0.26 Allowed 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.757 2.305 . . . . 0.0 111.246 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.7 HG12 ' CD ' ' A' ' 138' ' ' PRO . 32.2 m -103.92 145.66 12.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.277 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.926 ' O ' HD13 ' A' ' 126' ' ' LEU . 64.3 p -151.47 141.47 22.09 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.386 0.612 . . . . 0.0 110.79 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.926 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -135.22 153.07 52.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.434 178.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.864 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 54.7 m -110.57 113.52 26.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.814 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.672 HG12 ' HB3' ' A' ' 104' ' ' PRO . 24.2 t -96.04 111.63 26.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.482 -179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.79 171.17 4.94 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.282 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.34 -14.93 46.32 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.503 2.135 . . . . 0.0 113.087 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.9 p -119.88 -27.23 5.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -179.97 -163.57 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.166 0.508 . . . . 0.0 110.17 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 127' ' ' THR . 0.2 OUTLIER -95.88 158.94 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.97 178.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -147.34 18.75 1.21 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 121.404 0.621 . . . . 0.0 112.555 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.864 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.32 85.83 0.07 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.466 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.815 HG13 HD12 ' A' ' 126' ' ' LEU . 21.3 t -106.46 118.13 53.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.334 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -146.45 116.28 4.64 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.691 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.7 ' CD ' HG12 ' A' ' 124' ' ' VAL . 15.4 Cg_exo -68.55 145.25 76.15 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 123.726 -1.364 . . . . 0.0 112.32 0.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.25 -29.31 22.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.698 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -107.55 33.7 6.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.776 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.781 ' SD ' HD11 ' A' ' 126' ' ' LEU . 1.1 ptm -66.26 159.74 25.9 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.068 0.434 . . . . 0.0 111.13 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 165' ' ' PHE . . . -131.58 152.74 50.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.063 0.459 . . . . 0.0 111.604 -177.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.677 ' CG2' HG12 ' A' ' 189' ' ' VAL . 44.4 t -111.12 146.16 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.314 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.468 ' O ' ' HB ' ' A' ' 162' ' ' VAL . 47.4 m -114.8 141.26 48.11 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.689 0.281 . . . . 0.0 110.653 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.612 ' HA ' HG12 ' A' ' 162' ' ' VAL . 6.8 mt -103.18 149.07 25.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.081 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.866 HG22 ' HD3' ' A' ' 148' ' ' PRO . 11.6 p -125.11 137.55 57.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.011 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.762 ' HB2' HD13 ' A' ' 184' ' ' LEU . 2.1 mm? -134.9 73.53 66.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.921 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.866 ' HD3' HG22 ' A' ' 146' ' ' VAL . 70.7 Cg_endo -74.91 -39.84 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.513 2.142 . . . . 0.0 112.37 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -176.63 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.95 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -101.71 -20.58 14.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.092 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -179.91 -35.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.222 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.75 -174.11 0.11 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.14 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.528 ' O ' HG13 ' A' ' 154' ' ' VAL . 3.9 t70 -141.97 -62.96 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.945 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 153' ' ' ASP . 6.6 m -158.77 -44.81 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -57.76 -30.86 65.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.986 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -125.63 61.29 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.03 0.443 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.2 p -171.73 94.81 0.16 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.936 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -161.84 -80.67 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 60.7 m -81.07 -46.01 15.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.905 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 28.9 m 74.18 -1.0 3.19 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.857 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 51.44 43.22 29.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 111.015 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 145' ' ' LEU . 3.5 m -62.04 169.01 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.872 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -116.03 166.81 11.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.525 0.679 . . . . 0.0 109.762 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.874 ' CE1' ' HB1' ' A' ' 97' ' ' ALA . 18.3 m-30 -117.84 129.67 55.8 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.768 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.509 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 19.4 m-85 -108.68 142.58 38.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.401 0.619 . . . . 0.0 110.608 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 141' ' ' MET . . . -46.08 -26.72 0.79 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.825 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.556 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 25.7 p -169.94 170.8 7.47 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.82 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.627 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 72.0 t -67.76 -33.41 5.23 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.32 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.706 ' O ' ' N ' ' A' ' 173' ' ' ASP . 9.2 Cg_exo -72.7 -37.89 3.6 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.724 2.283 . . . . 0.0 110.292 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.08 -40.39 53.23 Favored 'General case' 0 CA--C 1.506 -0.748 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.97 -45.97 91.31 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.6 mt-10 -78.96 -27.63 43.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.244 178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.706 ' N ' ' O ' ' A' ' 169' ' ' PRO . 9.4 t70 -70.79 -55.94 7.44 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.59 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.823 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 77.2 t-105 -65.15 -27.84 69.0 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.685 178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -62.4 -38.99 91.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.215 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 4.3 t -54.68 -47.78 73.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.442 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -95.48 21.6 7.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.258 0.551 . . . . 0.0 111.034 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.697 ' HA ' HD12 ' A' ' 181' ' ' LEU . 78.8 t60 -132.77 29.75 4.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.951 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -87.49 132.72 33.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.604 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 95.02 -25.72 22.47 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.864 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.697 HD12 ' HA ' ' A' ' 178' ' ' HIS . 5.3 mt -83.67 -162.82 0.68 Allowed 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.595 0.236 . . . . 0.0 110.666 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.518 ' HG3' HG21 ' A' ' 146' ' ' VAL . 5.3 tt0 -59.77 82.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.93 0.395 . . . . 0.0 110.845 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.449 ' N ' HG23 ' A' ' 146' ' ' VAL . . . 175.86 -167.88 39.88 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.093 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.762 HD13 ' HB2' ' A' ' 147' ' ' LEU . 4.3 tp -176.48 -58.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.641 0.258 . . . . 0.0 111.406 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -143.64 150.51 38.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.109 0.481 . . . . 0.0 111.539 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 175' ' ' ALA . 12.5 mm -100.7 161.57 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.638 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.471 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -164.48 165.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.398 0.618 . . . . 0.0 112.11 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.5 OUTLIER -93.79 132.79 37.84 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.539 178.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.763 HG11 ' SD ' ' A' ' 141' ' ' MET . 3.6 m -48.27 -17.69 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 120.878 0.37 . . . . 0.0 110.927 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.414 ' N ' ' C ' ' A' ' 188' ' ' SER . 0.6 OUTLIER -73.33 -44.51 58.77 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.134 0.492 . . . . 0.0 109.753 179.075 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -82.38 -21.61 35.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.53 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -76.49 -25.37 54.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.278 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.42 ' CE2' ' HG3' ' A' ' 197' ' ' GLN . 85.8 t80 -81.7 -25.89 35.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.967 0.413 . . . . 0.0 110.722 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.79 -30.25 32.81 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 195' ' ' LEU . 0.2 OUTLIER -81.59 -27.74 34.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -27.33 34.29 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.42 ' HG3' ' CE2' ' A' ' 193' ' ' PHE . 1.5 mm100 -82.33 -23.21 35.22 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.495 -0.352 . . . . 0.0 111.023 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -79.28 -23.08 43.83 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.229 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -52.2 -32.01 34.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.806 0.336 . . . . 0.0 111.126 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -81.14 -55.03 5.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -58.98 -45.9 89.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.975 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -58.94 -31.09 68.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.14 -48.52 17.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 7.2 mt -61.24 -51.99 66.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -60.55 146.78 43.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.6 m -143.7 117.42 9.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 15.4 mtp -81.43 -38.75 25.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 28.6 p -72.8 142.24 48.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.929 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 14.5 p -93.83 121.46 35.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.926 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.6 110.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.849 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.432 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -176.3 -63.0 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.5 Cg_endo . . . . . 0 C--O 1.25 1.083 0 C-N-CA 122.444 2.096 . . . . 0.0 112.294 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.826 0.346 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.34 34.45 3.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mp 63.71 -79.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.998 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 24' ' ' LEU . 3.9 pp -130.88 133.2 45.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.89 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 25' ' ' VAL . 10.8 p -68.36 120.99 78.81 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.022 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.604 ' CG ' HD11 ' A' ' 46' ' ' LEU . 58.7 Cg_endo -71.51 -28.65 17.42 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.403 2.069 . . . . 0.0 112.359 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.487 ' H ' HD12 ' A' ' 27' ' ' LEU . 5.8 mp -52.27 -57.18 10.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.187 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.632 HD13 HD13 ' A' ' 31' ' ' LEU . 4.0 mm? -75.56 -27.14 58.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.921 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -53.45 57.38 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.629 ' OE2' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -71.12 -24.3 62.26 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.126 178.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.632 HD13 HD13 ' A' ' 28' ' ' LEU . 8.8 tt -66.2 -48.24 71.26 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.759 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.49 -26.09 19.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.61 -22.11 65.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.27 178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.77 47.03 92.97 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.147 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -127.42 163.95 39.14 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.694 0.283 . . . . 0.0 110.86 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.34 111.61 2.1 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.553 2.169 . . . . 0.0 112.107 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.692 HG13 HG22 ' A' ' 41' ' ' THR . 22.6 t -116.35 111.04 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.398 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 p -91.39 179.62 5.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.688 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 69.0 mtm180 -69.22 -40.99 77.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.213 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -24.64 66.83 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.279 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.692 HG22 HG13 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -85.96 -44.16 12.59 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.73 HD12 HD13 ' A' ' 71' ' ' ILE . 0.1 OUTLIER -62.8 -36.29 82.67 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 176.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -72.95 -42.83 63.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.073 -1.421 . . . . 0.0 109.57 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -68.51 -31.56 73.98 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.652 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.604 HD12 HG23 ' A' ' 41' ' ' THR . 7.3 mt -78.32 -46.08 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 120.965 0.412 . . . . 0.0 110.528 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.604 HD11 ' CG ' ' A' ' 26' ' ' PRO . 7.7 mp -75.73 -9.61 58.73 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.614 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 t70 59.91 21.78 10.79 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.456 ' CE3' HD23 ' A' ' 46' ' ' LEU . 16.4 m0 -103.68 160.06 27.32 Favored Pre-proline 0 N--CA 1.45 -0.471 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.175 -179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.93 138.79 41.42 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.595 2.197 . . . . 0.0 111.91 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.03 -20.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.55 -32.28 47.78 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.059 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.615 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.48 -40.98 85.27 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.578 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -62.69 -48.02 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.616 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.75 -52.05 61.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.488 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.22 -38.79 27.59 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 52' ' ' ARG . 39.1 t -58.38 -30.06 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.782 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 57' ' ' LEU . 7.2 mp -81.0 -23.62 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.873 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.9 -23.49 31.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.091 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -126.64 5.83 6.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.229 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -123.17 76.94 1.42 Allowed 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.722 0.772 . . . . 0.0 110.441 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.9 p -99.3 -22.44 15.59 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.118 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.5 p -70.5 -26.08 63.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.192 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.46 141.38 42.7 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.087 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' O ' HG22 ' A' ' 72' ' ' ILE . 1.7 tt0 -78.85 126.77 31.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 111.354 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -104.03 171.7 7.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.491 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 70' ' ' ASN . 1.9 t0 -92.45 -172.85 3.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.376 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -37.71 86.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -90.58 9.52 29.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.718 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.76 18.76 62.93 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.663 -0.78 . . . . 0.0 113.065 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 66' ' ' ASP . 56.8 m-20 -92.03 167.34 12.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.076 0.438 . . . . 0.0 110.091 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.73 HD13 HD12 ' A' ' 42' ' ' LEU . 4.1 mp -79.82 119.18 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.329 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 64' ' ' GLU . 2.7 tt -102.49 -27.26 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.028 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.403 ' CA ' HD11 ' A' ' 31' ' ' LEU . . . 64.54 -174.03 15.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.605 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.437 ' CZ ' ' HG3' ' A' ' 90' ' ' ARG . 87.3 m-85 61.0 155.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.881 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.06 -98.5 0.13 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.632 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.591 HD13 ' CD2' ' A' ' 92' ' ' LEU . 4.6 mp 60.71 -87.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.701 0.286 . . . . 0.0 110.68 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.476 HG21 ' HD1' ' A' ' 95' ' ' TRP . 12.3 p -126.06 159.33 33.09 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.501 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.504 ' H ' HD12 ' A' ' 78' ' ' LEU . 0.9 OUTLIER -83.97 52.44 2.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.903 0.383 . . . . 0.0 111.096 -179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.428 ' HA ' ' CD1' ' A' ' 93' ' ' TYR . 27.4 mtm-85 49.38 95.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.088 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 81' ' ' THR . 1.1 tp10 -169.15 -144.09 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.635 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.884 HG21 ' HA ' ' A' ' 95' ' ' TRP . 0.7 OUTLIER 41.19 -173.36 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 178.413 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 17.8 p -107.34 -19.65 13.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.364 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -76.87 111.25 12.21 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.688 0.28 . . . . 0.0 110.485 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.0 137.65 41.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.005 0.431 . . . . 0.0 111.388 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.851 ' CD1' HG22 ' A' ' 113' ' ' VAL . 34.6 t80 -126.79 105.07 8.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.162 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -96.82 124.83 40.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.14 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.548 HG21 ' CE2' ' A' ' 85' ' ' PHE . 1.1 pt -140.15 128.72 26.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.998 0.428 . . . . 0.0 112.109 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 61.13 -77.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.318 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 87' ' ' ILE . 7.6 t70 -156.3 37.39 0.33 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.65 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.437 ' HG3' ' CZ ' ' A' ' 74' ' ' TYR . 4.2 mmm180 -141.78 149.65 40.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.781 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.8 86.22 2.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.013 0.435 . . . . 0.0 110.673 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.591 ' CD2' HD13 ' A' ' 76' ' ' LEU . 8.5 mp -71.39 164.64 25.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.975 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.428 ' CD1' ' HA ' ' A' ' 79' ' ' ARG . 88.9 m-85 -133.48 165.18 25.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.973 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -150.91 166.24 31.19 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.001 0.429 . . . . 0.0 111.962 -179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.884 ' HA ' HG21 ' A' ' 81' ' ' THR . 12.0 m0 -90.75 -23.17 20.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.403 178.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 65.2 m -153.81 174.83 14.05 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.941 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.534 ' HB1' ' CZ ' ' A' ' 164' ' ' PHE . . . -53.83 -21.49 7.65 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -51.78 6.61 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.622 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -49.36 -25.65 2.62 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.696 HG22 ' HB2' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -60.07 -28.97 68.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.952 0.406 . . . . 0.0 110.5 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 102' ' ' ILE . 5.1 tp 70.48 155.67 0.14 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.069 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.719 ' HB ' HG11 ' A' ' 128' ' ' VAL . 2.1 pt -158.84 77.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.789 ' O ' HG22 ' A' ' 107' ' ' ILE . 14.8 p90 -121.2 54.13 4.03 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.947 ' HG3' HG12 ' A' ' 128' ' ' VAL . 28.8 Cg_endo -62.7 -37.61 55.53 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.696 2.264 . . . . 0.0 112.235 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 130' ' ' PRO . . . -64.03 -30.33 71.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.581 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.89 -47.69 13.4 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.952 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 103' ' ' PHE . 0.5 OUTLIER -67.73 -41.09 84.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.23 0.538 . . . . 0.0 111.285 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.82 28.47 8.29 Favored Glycine 0 C--N 1.319 -0.38 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.171 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.14 177.39 10.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.051 0.453 . . . . 0.0 110.895 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.7 m -87.28 160.28 18.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.993 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.663 ' HB1' ' CZ ' ' A' ' 85' ' ' PHE . . . -136.55 109.84 7.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.869 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 55.3 mtt180 -82.96 119.43 24.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.818 0.818 . . . . 0.0 111.185 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.851 HG22 ' CD1' ' A' ' 85' ' ' PHE . 42.0 t -109.98 128.92 65.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.878 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.1 m -121.75 136.72 54.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.961 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.625 ' HB2' HG23 ' A' ' 124' ' ' VAL . 3.4 m -141.5 172.98 11.94 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.493 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -131.06 130.93 43.86 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 166' ' ' ALA . 30.9 m -56.29 125.6 22.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.95 0.405 . . . . 0.0 112.041 -178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.21 -7.0 38.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.79 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.62 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -119.39 -50.56 2.33 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.35 -13.96 36.7 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.898 -179.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 63.8 11.24 42.46 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.674 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.547 ' H ' HG22 ' A' ' 120' ' ' THR . . . -71.83 164.38 58.93 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.697 0.284 . . . . 0.0 110.691 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -89.49 107.98 0.42 Allowed 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 123.037 2.491 . . . . 0.0 111.328 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.625 HG23 ' HB2' ' A' ' 115' ' ' SER . 33.5 m -104.95 146.27 12.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.421 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.891 ' O ' HD13 ' A' ' 126' ' ' LEU . 60.6 p -151.45 141.69 22.32 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.384 0.611 . . . . 0.0 110.883 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.891 HD13 ' O ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -134.3 152.58 51.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.137 178.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.843 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 20.8 m -111.55 114.3 27.28 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.947 HG12 ' HG3' ' A' ' 104' ' ' PRO . 39.7 t -96.09 111.79 27.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.016 0.436 . . . . 0.0 111.243 -179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.491 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.3 OUTLIER -105.68 172.9 3.59 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.215 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 41.2 Cg_endo -67.57 -19.82 47.95 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.271 1.981 . . . . 0.0 113.097 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 0.4 OUTLIER -112.57 -26.7 8.53 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.117 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 131' ' ' SER . 19.9 pt-20 178.62 -161.02 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.19 0.519 . . . . 0.0 110.108 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 127' ' ' THR . 0.3 OUTLIER -91.79 160.5 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.565 178.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -150.18 17.87 0.85 Allowed 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.843 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -172.07 85.12 0.07 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.102 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.407 HG13 HD12 ' A' ' 126' ' ' LEU . 32.9 t -99.6 122.86 51.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.637 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -146.06 118.8 5.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.95 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.413 ' HD2' HG12 ' A' ' 124' ' ' VAL . 60.0 Cg_endo -72.42 159.65 95.8 Favored 'Cis proline' 0 C--N 1.348 0.54 0 C-N-CA 123.396 -1.502 . . . . 0.0 112.094 -0.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.26 78.0 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.103 0.478 . . . . 0.0 110.673 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.13 18.47 0.17 Allowed Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.692 -0.765 . . . . 0.0 113.288 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.873 ' SD ' HD11 ' A' ' 126' ' ' LEU . 6.5 ptm -67.4 164.43 18.67 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.968 0.384 . . . . 0.0 111.303 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -125.0 152.16 44.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.172 0.511 . . . . 0.0 111.049 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.738 HG13 ' CD1' ' A' ' 164' ' ' PHE . 2.5 t -113.08 150.42 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.741 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 165' ' ' PHE . 20.3 p -118.29 140.19 50.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.851 0.358 . . . . 0.0 110.835 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.404 HD21 HG21 ' A' ' 187' ' ' VAL . 0.8 OUTLIER -149.23 176.52 10.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.723 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 146' ' ' VAL . 11.8 p -117.08 112.77 40.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.901 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' A' ' 185' ' ' ALA . 2.7 mt -58.14 -61.76 6.85 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.097 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.867 ' CG ' HD21 ' A' ' 184' ' ' LEU . 56.1 Cg_endo -70.4 145.86 54.64 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.515 2.144 . . . . 0.0 112.339 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -145.34 115.09 7.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -100.44 -21.26 15.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.205 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -133.06 74.52 1.57 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.032 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -153.55 -68.59 0.15 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.035 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.4 t70 68.58 -68.37 0.18 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 155' ' ' ARG . 6.3 m -142.54 -47.12 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.158 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.421 ' N ' HG23 ' A' ' 154' ' ' VAL . 3.7 ttp85 -160.67 52.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.868 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -94.3 -34.74 12.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.1 t -73.63 -174.42 1.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.931 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -140.94 -50.32 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.95 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.93 -46.21 15.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . 0.531 ' HB3' HG23 ' A' ' 162' ' ' VAL . 6.0 t 78.36 -3.25 2.32 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.589 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 182' ' ' GLU . 4.1 m-70 48.44 42.61 18.73 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 120.884 0.373 . . . . 0.0 111.287 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.531 HG23 ' HB3' ' A' ' 160' ' ' CYS . 12.4 t -104.97 110.62 31.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.583 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -120.84 169.44 10.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.565 0.698 . . . . 0.0 109.777 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.738 ' CD1' HG13 ' A' ' 143' ' ' VAL . 49.8 m-85 -115.08 152.67 32.11 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.382 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 37.9 m-85 -134.09 137.84 44.87 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.181 179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.626 ' HB2' ' SG ' ' A' ' 117' ' ' CYS . . . -43.85 -27.92 0.39 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.255 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.569 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 67.8 m -165.98 172.3 11.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.118 0.485 . . . . 0.0 111.577 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 76.2 t -69.38 -34.16 4.53 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.02 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.3 -37.41 3.33 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.645 2.23 . . . . 0.0 110.136 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.59 -40.02 50.84 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.085 -0.962 . . . . 0.0 108.415 177.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.724 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.29 -45.75 93.16 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 95.8 mt-10 -78.79 -27.47 44.48 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.291 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 169' ' ' PRO . 28.8 t70 -71.05 -55.92 7.23 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.517 0.675 . . . . 0.0 109.308 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.62 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 32.9 t-105 -64.59 -28.66 69.78 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.806 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -65.39 -38.55 90.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.349 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.2 t -52.07 -46.42 65.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.469 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.1 mmtt -97.55 24.36 6.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.017 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.723 ' HA ' HD12 ' A' ' 181' ' ' LEU . 3.9 t60 -156.68 45.81 0.42 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.091 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -88.56 125.39 34.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.691 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 91.32 -19.99 43.54 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.261 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.723 HD12 ' HA ' ' A' ' 178' ' ' HIS . 2.8 mt -86.86 87.11 7.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.733 0.301 . . . . 0.0 111.104 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.419 ' HA ' ' CD2' ' A' ' 161' ' ' HIS . 18.8 mt-10 57.62 69.36 0.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.945 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 110.51 91.83 2.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.367 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.867 HD21 ' CG ' ' A' ' 148' ' ' PRO . 3.7 pp -94.67 -3.93 48.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.442 ' HB2' HD12 ' A' ' 147' ' ' LEU . . . -131.34 141.19 49.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.101 0.477 . . . . 0.0 111.353 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 175' ' ' ALA . 18.3 mm -104.44 160.95 4.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.019 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.472 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -160.62 162.63 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.373 0.606 . . . . 0.0 111.775 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 190' ' ' HIS . 1.7 m -92.13 133.99 35.26 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.475 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.536 HG11 ' HG3' ' A' ' 141' ' ' MET . 1.7 m -45.87 -20.27 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.882 0.373 . . . . 0.0 110.654 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.425 ' N ' ' C ' ' A' ' 188' ' ' SER . 93.9 m-70 -70.77 -45.2 65.19 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.818 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.631 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.4 OUTLIER -82.42 -20.89 36.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.656 179.254 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -76.69 -25.36 53.55 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.228 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -81.41 -24.85 36.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.687 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.84 -29.26 35.44 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.631 HD13 ' O ' ' A' ' 191' ' ' GLU . 6.7 mp -82.33 -28.45 31.62 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.05 -28.33 31.43 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -80.84 -21.95 40.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.996 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -75.75 -22.94 56.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.103 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -52.09 -37.87 55.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.932 0.396 . . . . 0.0 111.168 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -69.64 -24.85 63.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.132 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -46.67 85.24 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -80.02 -35.21 37.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.828 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 10.6 tp -61.29 -31.19 71.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.833 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.4 tp -59.39 -39.22 82.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.965 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 60.08 108.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.923 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 73.3 p -141.54 79.07 1.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 3.5 tpt -99.22 -58.65 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.852 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 48.0 p -159.17 -174.04 4.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 2.8 m 60.56 105.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.76 31.49 4.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.95 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.441 ' HB ' ' HD3' ' A' ' 212' ' ' PRO . 0.9 OUTLIER 178.55 -54.94 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.441 ' HD3' ' HB ' ' A' ' 211' ' ' THR . 78.1 Cg_exo . . . . . 0 C--O 1.249 1.075 0 C-N-CA 122.471 2.114 . . . . 0.0 112.368 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.81 0.338 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -87.56 110.27 20.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.691 ' C ' HD22 ' A' ' 24' ' ' LEU . 7.3 mt -132.1 127.85 36.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.691 HD22 ' C ' ' A' ' 23' ' ' LEU . 3.4 mm? -120.47 77.43 1.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.953 HG21 HD12 ' A' ' 28' ' ' LEU . 7.3 p 42.92 59.98 10.69 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.583 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HB2' HD11 ' A' ' 46' ' ' LEU . 48.9 Cg_exo -55.78 -30.05 74.53 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.558 2.172 . . . . 0.0 112.54 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.706 HD12 ' HG ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -52.94 -57.5 10.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.068 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.953 HD12 HG21 ' A' ' 25' ' ' VAL . 82.3 mt -60.87 -27.05 67.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.048 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -60.04 -53.18 60.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.137 0.494 . . . . 0.0 109.673 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -76.75 -25.09 53.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.39 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.703 HD11 ' O ' ' A' ' 73' ' ' GLY . 5.7 tp -67.28 -52.15 44.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.21 -23.68 15.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 111.254 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -70.84 -23.58 62.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.186 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.1 49.15 77.81 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.174 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -132.98 166.02 32.42 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.76 0.314 . . . . 0.0 111.02 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.48 115.16 3.92 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.515 2.144 . . . . 0.0 111.927 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.685 HG23 ' CG2' ' A' ' 41' ' ' THR . 9.3 p -124.21 109.87 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.487 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.9 p -79.15 -176.19 5.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -78.04 -33.44 51.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.315 -179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.59 -28.11 68.25 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.132 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.685 ' CG2' HG23 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -84.59 -41.42 16.44 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.228 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.487 HD13 HD13 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -63.35 -36.81 84.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.613 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.518 ' HB2' HG21 ' A' ' 53' ' ' VAL . . . -73.36 -42.94 61.61 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.409 177.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.88 -29.64 73.78 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.463 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 41' ' ' THR . 6.9 mt -78.86 -42.21 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 121.2 0.524 . . . . 0.0 109.903 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' A' ' 26' ' ' PRO . 6.5 mp -76.82 -9.82 58.94 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.445 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 t70 61.77 21.29 12.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -177.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.421 ' CD1' ' HD2' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -101.6 152.47 38.06 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.132 -179.535 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.72 139.02 35.98 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.503 2.135 . . . . 0.0 112.027 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.62 -19.22 0.56 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.25 -31.2 49.06 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.237 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.64 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -67.62 -40.36 84.69 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.518 HG21 ' HB2' ' A' ' 43' ' ' ALA . 2.1 t -61.73 -48.07 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 115.045 -0.979 . . . . 0.0 108.735 178.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.16 -52.61 58.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.461 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.47 -43.51 68.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.923 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 52' ' ' ARG . 27.6 t -75.12 -29.3 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.856 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.643 HD21 ' OH ' ' A' ' 65' ' ' TYR . 6.5 tp -68.78 -38.86 80.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.816 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -57.75 -45.11 86.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.616 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -74.22 -8.23 55.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.111 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.04 70.98 0.73 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.766 0.793 . . . . 0.0 110.531 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 16.9 p -76.51 -6.36 51.51 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.424 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.51 37.9 2.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 0.0 110.852 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.8 141.2 28.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.181 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -78.88 126.63 30.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.954 0.407 . . . . 0.0 111.28 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.643 ' OH ' HD21 ' A' ' 57' ' ' LEU . 27.0 m-85 -124.4 154.01 41.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.343 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.625 ' HB2' HG21 ' A' ' 72' ' ' ILE . 26.8 t70 -153.14 146.11 24.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.233 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 tttm 66.04 -101.68 0.07 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.672 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -89.96 -14.4 34.15 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.11 29.23 1.68 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.989 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -87.41 172.65 9.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.1 mt -79.59 105.84 9.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.845 0.355 . . . . 0.0 110.999 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.625 HG21 ' HB2' ' A' ' 66' ' ' ASP . 2.7 tt -103.78 -19.99 5.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.555 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.703 ' O ' HD11 ' A' ' 31' ' ' LEU . . . -44.39 95.62 0.01 OUTLIER Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.919 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -83.16 -79.38 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 0.0 110.94 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.682 ' HA2' HD11 ' A' ' 92' ' ' LEU . . . -97.52 -148.42 23.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.492 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.9 -41.29 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.061 0.457 . . . . 0.0 110.911 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.583 HG23 ' HB2' ' A' ' 93' ' ' TYR . 1.4 t -144.08 159.39 42.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.566 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 78' ' ' LEU . 5.1 mp -83.12 52.76 2.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 111.053 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HG2' ' CZ ' ' A' ' 93' ' ' TYR . 7.3 tmm_? 57.84 113.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.97 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -177.71 -28.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.497 -179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.433 HG21 ' HA ' ' A' ' 95' ' ' TRP . 4.8 p -89.41 -178.23 5.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.945 0.402 . . . . 0.0 111.332 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.75 -26.98 14.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.345 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.427 ' CE1' ' HA ' ' A' ' 96' ' ' CYS . 81.7 m-85 -76.56 110.79 11.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.628 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.4 HG22 ' CE1' ' A' ' 93' ' ' TYR . 25.0 t -108.26 139.12 31.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.169 0.509 . . . . 0.0 111.573 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.781 ' CE2' ' HB1' ' A' ' 111' ' ' ALA . 14.5 t80 -136.38 108.19 7.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.847 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -103.7 137.12 42.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.806 0.336 . . . . 0.0 111.552 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.542 HG23 ' CE1' ' A' ' 85' ' ' PHE . 2.2 pt -140.03 123.35 17.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.572 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 t0 63.65 -66.68 0.1 Allowed 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.189 178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 87' ' ' ILE . 4.5 t70 -168.0 35.2 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.401 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -134.07 113.48 12.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.927 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -80.21 86.2 5.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.029 0.442 . . . . 0.0 111.0 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.682 HD11 ' HA2' ' A' ' 75' ' ' GLY . 0.2 OUTLIER -76.0 164.92 25.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.016 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.583 ' HB2' HG23 ' A' ' 77' ' ' THR . 61.0 m-85 -136.2 165.45 25.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.263 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.615 ' HB1' ' CB ' ' A' ' 99' ' ' ASP . . . -150.73 169.98 20.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.922 0.391 . . . . 0.0 111.879 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.433 ' HA ' HG21 ' A' ' 81' ' ' THR . 15.0 m0 -92.93 -23.5 18.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.931 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.427 ' HA ' ' CE1' ' A' ' 83' ' ' TYR . 50.9 m -147.44 167.08 25.33 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.283 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.998 ' HB1' ' CZ ' ' A' ' 164' ' ' PHE . . . -51.97 -22.44 3.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.336 -0.393 . . . . 0.0 112.011 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.457 ' HA ' HD21 ' A' ' 101' ' ' LEU . 2.4 tp -86.26 -51.55 6.2 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.615 ' CB ' ' HB1' ' A' ' 94' ' ' ALA . 2.7 m-20 -48.14 -25.94 1.68 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -60.26 -39.1 85.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.515 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.501 ' O ' HG23 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -99.18 166.56 11.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.501 HG23 ' O ' ' A' ' 101' ' ' LEU . 12.7 pt -158.03 -43.18 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.838 ' O ' HG22 ' A' ' 107' ' ' ILE . 1.5 m-85 -162.58 64.46 1.55 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 103' ' ' PHE . 37.8 Cg_exo -60.22 -43.04 37.78 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.747 2.298 . . . . 0.0 112.416 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -79.19 -23.76 43.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.376 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -84.09 -38.74 20.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.509 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.838 HG22 ' O ' ' A' ' 103' ' ' PHE . 1.4 tp -57.16 -45.7 84.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.146 0.498 . . . . 0.0 111.309 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 98.56 25.31 10.09 Favored Glycine 0 C--N 1.319 -0.372 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.508 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.65 174.15 14.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 110.939 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.0 m -81.08 158.14 25.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.756 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB1' ' CE2' ' A' ' 85' ' ' PHE . . . -136.77 109.67 7.63 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -81.61 119.78 24.23 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.765 0.793 . . . . 0.0 111.015 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.409 HG22 ' HD2' ' A' ' 85' ' ' PHE . 57.6 t -112.17 129.86 66.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.369 -1.287 . . . . 0.0 112.084 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.4 m -124.21 137.35 54.53 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.045 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.594 ' HB2' HG23 ' A' ' 124' ' ' VAL . 1.4 m -141.6 173.09 11.83 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.377 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -134.09 133.24 40.89 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 27.6 t -62.44 133.37 54.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.216 0.532 . . . . 0.0 112.213 -178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.98 -3.81 24.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.891 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.918 ' HB2' ' CG ' ' A' ' 174' ' ' TRP . . . -122.68 -50.94 1.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.786 0.327 . . . . 0.0 111.662 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.705 HG22 ' H ' ' A' ' 122' ' ' ALA . 0.9 OUTLIER -89.45 -24.13 21.94 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.306 -179.4 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.76 5.15 73.44 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.144 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.705 ' H ' HG22 ' A' ' 120' ' ' THR . . . -58.07 149.41 56.46 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-O 120.544 0.212 . . . . 0.0 110.631 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 122' ' ' ALA . 1.0 OUTLIER -82.31 103.85 1.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 122.667 2.244 . . . . 0.0 110.807 179.324 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 115' ' ' SER . 35.8 m -99.14 144.72 11.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.311 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.419 ' O ' ' HE1' ' A' ' 141' ' ' MET . 81.5 p -151.87 141.72 21.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.431 0.634 . . . . 0.0 110.836 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -138.82 151.39 46.99 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.875 178.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.802 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 21.2 m -105.94 115.21 29.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.639 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.915 HG13 ' CE2' ' A' ' 193' ' ' PHE . 38.8 t -96.11 111.73 26.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 120.853 0.359 . . . . 0.0 111.505 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.422 ' CB ' ' HD2' ' A' ' 130' ' ' PRO . 0.6 OUTLIER -107.22 169.5 6.67 Favored Pre-proline 0 N--CA 1.452 -0.335 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.938 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 129' ' ' SER . 36.4 Cg_endo -66.23 -19.25 56.52 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.198 1.932 . . . . 0.0 112.816 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 132' ' ' GLU . 19.6 p -112.66 -26.97 8.37 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 131' ' ' SER . 0.4 OUTLIER 178.39 -162.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.133 0.492 . . . . 0.0 110.043 -179.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.698 HG22 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -93.68 158.46 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.922 178.578 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -144.66 19.49 1.67 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.448 0.642 . . . . 0.0 112.154 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.802 ' HB3' ' OG1' ' A' ' 127' ' ' THR . . . -171.83 86.81 0.08 Allowed 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.238 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.544 HG13 ' SD ' ' A' ' 141' ' ' MET . 36.3 t -103.25 113.64 40.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.334 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -146.5 122.72 5.67 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.575 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.48 155.83 95.05 Favored 'Cis proline' 0 C--N 1.348 0.517 0 C-N-CA 123.847 -1.314 . . . . 0.0 112.26 0.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.39 79.46 0.38 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.178 0.514 . . . . 0.0 110.497 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 145.01 17.61 0.18 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.597 -0.728 . . . . 0.0 113.243 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.912 ' HG3' HG11 ' A' ' 189' ' ' VAL . 0.2 OUTLIER -58.61 158.47 7.76 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.964 0.412 . . . . 0.0 111.441 -179.393 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 171' ' ' ALA . . . -128.49 152.32 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.052 -178.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.715 HG22 ' CD1' ' A' ' 164' ' ' PHE . 46.1 t -111.74 147.72 15.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.543 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.406 ' OG ' ' CE1' ' A' ' 165' ' ' PHE . 32.0 m -120.77 144.91 48.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.804 0.335 . . . . 0.0 110.946 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.886 HD11 ' HB3' ' A' ' 185' ' ' ALA . 1.2 pp -138.04 175.03 9.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.828 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 146' ' ' VAL . 24.3 m -125.04 120.14 57.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 33.0 mt 60.05 87.84 0.13 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.79 63.75 1.27 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.54 2.16 . . . . 0.0 112.307 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -63.54 131.71 48.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.875 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -112.33 33.99 4.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -150.84 30.87 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.086 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.513 ' O ' HG22 ' A' ' 154' ' ' VAL . . . -169.78 -73.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.209 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.535 ' O ' HG13 ' A' ' 154' ' ' VAL . 5.5 t0 58.28 29.96 18.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 153' ' ' ASP . 5.9 m -159.08 174.69 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.111 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 59.9 64.9 1.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 58.86 31.46 21.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.1 t -60.16 -81.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -133.7 8.81 3.89 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.394 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.423 ' HA ' ' CG2' ' A' ' 162' ' ' VAL . 52.9 t -81.13 -15.83 54.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.649 0.262 . . . . 0.0 111.485 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' CYS . . . . . . . . . . . . . 94.2 m -79.76 -0.74 35.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -154.76 54.76 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.743 0.306 . . . . 0.0 111.505 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.749 HG12 ' HB3' ' A' ' 97' ' ' ALA . 22.0 t -104.26 109.76 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.495 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 163' ' ' HIS . 2.2 m-70 -118.93 159.14 24.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.535 0.683 . . . . 0.0 109.919 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.998 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 15.9 m-30 -111.12 130.6 55.57 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.526 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . 0.614 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 39.4 m-85 -108.48 140.69 41.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.397 0.618 . . . . 0.0 110.545 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -45.33 -27.64 0.7 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.088 -0.96 . . . . 0.0 112.76 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.581 ' CB ' ' HD2' ' A' ' 169' ' ' PRO . 68.2 m -164.95 171.48 13.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.225 0.536 . . . . 0.0 111.746 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 169' ' ' PRO . 73.0 t -69.23 -32.84 3.52 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.298 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 0.687 ' O ' ' N ' ' A' ' 173' ' ' ASP . 8.3 Cg_exo -73.22 -37.76 3.16 Favored 'Trans proline' 0 CA--C 1.504 -0.983 0 C-N-CA 122.739 2.292 . . . . 0.0 110.389 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.578 ' HA ' ' HB3' ' A' ' 173' ' ' ASP . 0.9 OUTLIER -76.71 -40.17 49.6 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.146 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 175' ' ' ALA . . . -61.9 -45.49 93.49 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 177.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 175' ' ' ALA . 97.2 mt-10 -78.96 -27.37 43.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.288 177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 169' ' ' PRO . 13.8 t70 -70.75 -55.78 7.86 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.457 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' TRP . . . . . 0.918 ' CG ' ' HB2' ' A' ' 119' ' ' ALA . 39.2 t-105 -64.64 -28.58 69.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.616 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 171' ' ' ALA . . . -63.85 -41.58 97.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.311 178.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.56 -42.23 55.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.228 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.6 22.75 7.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.294 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' HIS . . . . . 0.799 ' O ' HD13 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -142.66 31.73 1.46 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.889 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -107.89 -15.41 14.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.289 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -54.55 -22.49 24.65 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.472 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.544 HD12 HD12 ' A' ' 184' ' ' LEU . 18.2 mt -59.56 -176.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.791 0.329 . . . . 0.0 110.924 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -87.39 54.73 3.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.928 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 110.15 139.89 8.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.536 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.799 HD13 ' O ' ' A' ' 178' ' ' HIS . 1.4 tt -177.19 133.57 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.339 . . . . 0.0 110.762 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.886 ' HB3' HD11 ' A' ' 145' ' ' LEU . . . -142.4 150.08 40.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.221 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.671 HD11 ' HB2' ' A' ' 175' ' ' ALA . 17.2 mm -103.14 161.71 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.961 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.484 ' N ' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -158.56 162.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.099 0.476 . . . . 0.0 111.833 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.412 ' C ' ' N ' ' A' ' 190' ' ' HIS . 0.4 OUTLIER -90.15 128.09 36.26 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.896 178.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.912 HG11 ' HG3' ' A' ' 141' ' ' MET . 2.2 m -46.78 -20.14 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.915 0.388 . . . . 0.0 110.758 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.412 ' N ' ' C ' ' A' ' 188' ' ' SER . 3.0 m170 -71.5 -41.68 68.97 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.126 0.488 . . . . 0.0 109.709 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.474 ' O ' HD13 ' A' ' 195' ' ' LEU . 0.7 OUTLIER -82.12 -25.66 34.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.412 179.097 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.83 -24.86 62.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.043 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PHE . . . . . 0.915 ' CE2' HG13 ' A' ' 128' ' ' VAL . 5.0 t80 -81.15 -24.98 37.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.664 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -82.8 -29.82 33.98 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 111.271 -0.731 . . . . 0.0 111.271 179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.474 HD13 ' O ' ' A' ' 191' ' ' GLU . 9.6 mp -82.4 -28.27 31.52 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -85.03 -28.36 31.4 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.402 ' CB ' ' O ' ' A' ' 193' ' ' PHE . 9.1 tt0 -80.55 -22.99 40.29 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.897 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -73.46 -22.89 60.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.102 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.03 -36.95 51.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.959 0.409 . . . . 0.0 111.246 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -73.07 -24.81 60.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.108 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -49.71 -29.71 7.99 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.223 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -80.01 -31.64 39.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.941 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.5 mt -82.09 -22.17 36.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.085 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.4 tp -59.07 -28.17 66.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.002 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 60.84 99.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.948 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 28.9 m -155.89 79.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 5.3 mtm -59.86 -59.09 5.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.829 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 18.4 m -128.57 162.56 26.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 60.7 p -100.96 141.78 33.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -78.02 -171.0 2.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.984 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.433 ' N ' ' HD2' ' A' ' 212' ' ' PRO . 1.1 m -176.36 -63.01 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.007 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 211' ' ' THR . 19.8 Cg_endo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.442 2.095 . . . . 0.0 112.268 -179.339 . . . . . . . . 1 1 . 1 stop_ save_